data_2lpx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lpx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 121' ' ' TYR . 27.6 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.317 0.58 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.17 142.03 39.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 109.341 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.534 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 9.2 m -93.65 143.14 26.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 118' ' ' THR . 69.9 t80 -124.81 137.5 54.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.57 136.3 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.397 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -124.96 134.19 52.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 86.4 mt-10 -109.93 143.42 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 109.366 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 11' ' ' THR . 72.1 t80 -152.16 139.75 19.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.465 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.3 p -97.73 131.74 43.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB2' HD13 ' A' ' 115' ' ' ILE . 7.6 m -132.79 170.85 14.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -80.6 -175.7 5.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.462 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 7.7 mm 67.4 139.34 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.337 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -70.2 148.89 63.18 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 111.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.47 -52.37 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 111.38 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.86 -50.37 2.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.397 2.064 . . . . 0.0 113.069 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 28.4 mttp -60.76 -35.02 75.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.823 -1.173 . . . . 0.0 109.498 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 23.5 tp -80.59 -36.08 33.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.17 -48.31 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.836 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -61.32 -54.28 45.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -70.25 -4.46 21.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 66.3 t80 -94.11 -32.84 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 25' ' ' LEU . 4.7 m -117.31 -39.19 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.449 ' N ' HG21 ' A' ' 24' ' ' VAL . 22.9 tp -72.87 -38.5 66.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.515 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 30' ' ' LEU . 57.7 m-20 -104.09 11.33 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.77 -41.1 75.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.46 -30.6 65.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 25.6 m120 -101.35 -35.78 9.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.442 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 26' ' ' ASP . 17.5 tp -75.2 -39.65 59.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.542 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 33.1 mt -47.98 -55.01 19.66 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.93 . . . . 0.0 109.56 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.4 Cg_endo -69.26 -19.93 37.85 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.383 2.055 . . . . 0.0 111.721 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 15.7 mttt -74.19 -36.27 64.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.502 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 147' ' ' LEU . 74.6 mt -70.15 -29.99 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.975 . . . . 0.0 109.555 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.79 72.18 12.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.7 Cg_endo -69.67 -43.56 2.66 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.658 2.238 . . . . 0.0 111.694 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.9 -20.62 63.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.9 69.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 59' ' ' PHE . 17.3 m -128.51 154.83 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -73.94 -45.89 47.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.486 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.62 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.37 128.93 35.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.91 144.2 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.525 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 55.4 mt -106.54 119.38 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.458 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.5 mp -63.31 -44.45 94.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.2 mt-10 -159.73 154.6 24.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.11 -41.87 2.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 91.1 m-20 60.52 38.06 19.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.58 35.29 9.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.12 -167.56 13.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.15 129.29 16.93 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.733 2.288 . . . . 0.0 111.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.9 24.88 75.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 91.9 m -80.05 144.59 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.485 ' N ' HG21 ' A' ' 53' ' ' THR . 24.5 mm -110.65 128.62 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 81.9 mttt -114.94 150.16 36.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -132.55 123.49 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.54 HD13 ' CD2' ' A' ' 70' ' ' HIS . 39.8 mt -114.16 136.69 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.3 m -113.73 130.9 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 39' ' ' VAL . 91.0 m-85 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 40.9 p90 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.298 0.57 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 67.7 t -117.27 142.27 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.232 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.451 ' O ' HD22 ' A' ' 86' ' ' LEU . 18.0 mttp -112.03 143.35 43.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.738 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.54 ' CD2' HD13 ' A' ' 57' ' ' ILE . 97.0 m-70 -124.45 143.1 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 19.0 tttm -125.61 139.55 53.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.672 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.9 mt -96.95 137.98 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.388 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 87.1 m-70 -90.52 -49.03 6.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -170.02 149.08 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.43 HG22 ' CE1' ' A' ' 82' ' ' TYR . 37.1 pt -125.81 144.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -127.94 92.4 3.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -63.43 -35.29 79.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.95 -39.38 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.414 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -88.42 5.09 43.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m80 47.68 46.52 18.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.1 m -129.06 132.22 47.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 64.8 t80 -124.78 125.7 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -118.54 140.61 49.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 32.5 p90 -154.4 170.27 21.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 82.9 p -148.88 157.94 43.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.522 ' CD2' ' CD2' ' A' ' 92' ' ' LEU . 5.0 tt -94.99 132.13 40.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.318 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.515 ' N ' HD22 ' A' ' 86' ' ' LEU . 87.8 mt -89.84 -71.68 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 109.592 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.515 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 96.2 mt-10 -127.32 159.27 34.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.484 ' HA2' ' CG2' ' A' ' 68' ' ' VAL . . . -175.37 154.35 17.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.22 -35.39 78.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -1.159 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 96' ' ' ILE . . . -73.16 -23.84 60.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.522 ' CD2' ' CD2' ' A' ' 86' ' ' LEU . 9.1 mp -78.85 -49.49 12.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.04 176.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.0 -10.06 59.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.15 -34.25 26.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD12 HG22 ' A' ' 96' ' ' ILE . 36.5 mt -96.23 132.72 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 93.4 mt-10 -87.1 -179.16 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HE2' HG23 ' A' ' 87' ' ' ILE . 89.9 mttt -56.71 165.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.447 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.547 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 63.7 mt -125.78 131.79 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.878 . . . . 0.0 109.523 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 50.3 t0 -85.98 119.9 26.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 65.8 m-85 -113.04 142.15 46.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 92.7 mt-10 -131.47 136.74 48.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 27.3 m -125.38 131.58 52.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -133.08 125.03 28.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -99.58 128.65 45.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 114' ' ' ILE . 41.3 t -131.15 140.7 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -109.26 147.92 31.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . . . -111.69 161.82 23.84 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 108' ' ' ALA . 49.7 Cg_endo -70.1 -11.69 30.85 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.727 2.284 . . . . 0.0 111.82 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -77.22 -17.13 58.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.939 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.86 -15.22 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.25 173.43 44.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 16' ' ' ALA . 99.1 m -127.75 127.61 43.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.565 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.5 mt -97.95 143.42 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.282 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 12' ' ' SER . 4.2 mt -124.17 123.61 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 18.6 mttt -105.11 131.32 52.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -131.47 132.04 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.861 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.534 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.2 m -112.28 144.62 41.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.048 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.9 m -130.4 145.55 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 0.0 110.072 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 5.1 ttpt -143.75 123.34 13.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 14.8 m-85 -106.87 137.94 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.062 -1.023 . . . . 0.0 109.724 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 67.7 m80 -107.49 148.54 29.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.641 -179.773 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -74.31 -32.2 62.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 34' ' ' ILE . 65.4 mt -68.92 -41.62 77.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.863 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.465 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 60.1 m-85 -53.4 -47.94 69.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -54.69 -40.55 69.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 151' ' ' TYR . 45.8 mt -60.89 -36.95 80.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.379 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 145' ' ' PHE . 92.1 mt -56.04 -55.84 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 35.9 mp0 -68.31 -33.99 75.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.15 60.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 147' ' ' LEU . 64.8 m-85 -60.94 -49.21 78.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.173 . . . . 0.0 109.434 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.522 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 121' ' ' TYR . 73.1 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.4 ' N ' HG11 ' A' ' 3' ' ' VAL . 90.6 m-85 -111.9 148.24 34.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 22.8 m -93.66 140.62 29.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' THR . 73.2 t80 -115.22 131.54 56.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.942 . . . . 0.0 109.643 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.22 138.66 47.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -132.72 129.85 39.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 81.0 mt-10 -105.53 123.96 48.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.282 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -132.99 129.73 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 27.6 p -97.39 140.25 32.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -138.88 172.13 13.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.687 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' ILE . 49.7 m-20 -76.18 -175.65 3.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.502 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp 62.48 140.63 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.46 147.95 65.94 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.541 2.161 . . . . 0.0 111.949 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.92 -52.13 2.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 111.289 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.33 -50.05 3.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.076 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 36.8 mttt -57.96 -39.62 78.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.881 -1.137 . . . . 0.0 109.585 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 23.7 tp -80.56 -27.71 37.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.76 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' O ' HG23 ' A' ' 24' ' ' VAL . 60.4 t80 -61.31 -39.42 90.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 78.3 tttt -66.85 -55.24 15.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.88 0.27 16.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 109.817 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 86.3 t80 -97.01 -29.17 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.096 -1.003 . . . . 0.0 109.539 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.9 m -122.5 -38.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 23.6 tp -72.24 -38.52 68.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 30' ' ' LEU . 72.7 m-20 -102.73 4.46 38.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -0.865 . . . . 0.0 109.545 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.85 -32.88 71.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 109.613 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD2' HD12 ' A' ' 44' ' ' ILE . 91.3 m-20 -57.68 -29.19 64.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.7 m-20 -116.5 -35.86 4.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 26' ' ' ASP . 63.9 tp -62.79 -34.07 76.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 13.5 mt -57.63 -58.93 14.83 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.04 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.51 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -68.32 -9.86 27.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.627 2.218 . . . . 0.0 111.605 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 65.9 mttt -80.39 -38.06 31.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 HG21 ' CB ' ' A' ' 147' ' ' LEU . 88.1 mt -77.95 -28.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.18 69.1 41.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.66 -29.56 24.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.752 2.302 . . . . 0.0 111.771 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -73.41 -26.81 61.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.35 -49.59 73.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.54 156.11 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.4 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -71.87 -46.14 58.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.12 134.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.76 129.14 35.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -122.53 144.12 49.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.521 HG23 ' CG2' ' A' ' 53' ' ' THR . 58.8 mt -106.06 120.28 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.6 mp -68.59 -44.28 74.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 91.6 mt-10 -158.16 157.26 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.31 -40.85 2.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' N ' HG21 ' A' ' 53' ' ' THR . 56.0 t0 56.95 33.4 23.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.427 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 87.9 26.02 30.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.0 -164.44 15.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.3 126.0 12.48 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.674 2.249 . . . . 0.0 111.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.9 36.43 41.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 44' ' ' ILE . 39.8 m -89.12 142.23 27.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -1.162 . . . . 0.0 109.365 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -112.75 124.81 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 44' ' ' ILE . 71.2 mttt -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -133.86 121.85 22.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 21.5 mt -116.75 135.47 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.66 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -119.77 139.24 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 -179.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.1 p90 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 44.0 t -121.18 140.32 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.892 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -115.49 144.72 43.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.415 ' ND1' HD13 ' A' ' 57' ' ' ILE . 75.9 m80 -124.77 135.66 53.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' THR . 53.8 tttp -118.12 141.11 48.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.9 mt -102.88 138.07 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -93.19 -47.52 6.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 p -172.06 153.72 3.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -127.96 145.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -126.57 92.43 3.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -62.45 -35.0 77.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.397 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -71.84 -41.47 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -86.49 5.29 36.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.2 m80 46.69 40.76 9.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 m -124.16 136.5 54.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 82.5 t80 -123.93 125.48 44.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.306 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -117.08 132.38 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.6 p90 -153.59 168.83 24.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -146.83 152.44 38.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 5.8 tt -91.89 134.71 34.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 93.8 mt -89.8 -70.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.907 . . . . 0.0 109.599 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 94.3 mt-10 -125.43 161.23 27.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -179.83 156.29 17.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -58.7 -32.4 69.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -1.164 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.83 -16.43 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.462 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 7.6 mp -86.01 -30.61 22.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 p 59.72 -177.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.95 16.76 13.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -0.892 . . . . 0.0 109.184 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.44 -20.87 7.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 96' ' ' ILE . 9.8 mt -96.05 142.44 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -87.91 179.97 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 41.6 mtmt -57.55 167.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.542 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 74.9 mt -119.83 138.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -90.75 122.58 33.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 69.2 m-85 -116.13 138.7 51.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -134.17 137.18 44.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.24 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -131.2 131.47 44.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.622 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 115' ' ' ILE . 20.1 tttm -129.24 133.49 47.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.469 ' CD2' HG22 ' A' ' 115' ' ' ILE . 17.7 mt -107.31 120.15 41.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.699 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 114' ' ' ILE . 22.6 t -131.94 138.54 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 22.9 m -114.48 151.66 32.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -111.98 172.01 3.88 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.03 -16.89 40.98 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.802 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.96 -16.49 63.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.345 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.04 -17.42 44.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.31 172.54 45.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 85.7 m -119.27 124.11 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -1.127 . . . . 0.0 109.365 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 106' ' ' VAL . 70.8 mt -94.79 143.18 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.137 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.469 HG22 ' CD2' ' A' ' 105' ' ' LEU . 53.8 mt -132.64 132.35 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.951 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 47.8 mttp -107.09 135.32 48.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.7 m -125.47 130.5 51.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.964 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 29.1 m -123.6 143.42 50.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.948 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.2 t -138.77 140.72 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.997 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.513 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 72.7 tttt -136.8 133.92 36.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.464 ' CD2' HD12 ' A' ' 99' ' ' ILE . 31.8 m-85 -110.02 133.63 52.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.677 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.7 m80 -101.68 136.51 41.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.271 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 146' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.315 0.579 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.482 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.8 t60 -61.37 -47.13 87.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.1 mt -63.0 -42.13 99.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.384 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -55.69 -42.04 74.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.361 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 142' ' ' ALA . 98.1 mttt -53.82 -38.09 64.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 147' ' ' LEU . 3.4 mm? -67.21 -40.03 86.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 87.9 mt -53.9 -51.15 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.43 -48.82 79.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.34 -33.03 86.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.62 -46.38 84.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' CD1' HD13 ' A' ' 19' ' ' LEU . 71.5 mt . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' A' ' 122' ' ' HIS . 70.6 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.256 0.55 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -111.48 135.62 51.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 33.2 m -101.87 132.91 47.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.14 132.65 56.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.92 141.51 39.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 65.3 t30 -126.58 131.05 51.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.574 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.01 141.91 46.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 83.2 t80 -162.97 143.71 9.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.448 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 8.7 p -102.42 144.63 30.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 50.1 m -142.84 167.83 21.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' N ' ' OE2' ' A' ' 149' ' ' GLU . 14.1 t0 -78.68 -175.97 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 66.49 140.7 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 109.276 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -71.12 148.07 55.55 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.605 2.203 . . . . 0.0 112.203 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.79 -51.6 3.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.72 . . . . 0.0 111.388 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.25 -43.72 13.89 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.43 2.087 . . . . 0.0 113.046 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 74.9 mttt -64.01 -34.5 78.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.81 -1.181 . . . . 0.0 109.653 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' O ' HD22 ' A' ' 19' ' ' LEU . 9.7 tt -80.64 -31.66 36.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 24' ' ' VAL . 67.7 t80 -65.7 -35.85 81.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.845 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 47.0 mttp -64.52 -42.36 95.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -84.43 -32.18 24.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 53.5 t80 -78.15 -8.02 57.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG22 ' CD1' ' A' ' 20' ' ' PHE . 63.0 t -123.98 -68.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 12.1 tp -57.23 -43.68 83.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 75.9 m-20 -95.05 12.87 27.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.67 -32.67 71.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 97.3 m-20 -66.32 -34.75 78.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.1 t30 -100.06 -43.09 6.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 30.0 tp -53.79 -43.77 69.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 10.8 mt -48.13 -63.35 1.56 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.37 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -68.74 -19.22 41.57 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.502 2.134 . . . . 0.0 111.779 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -66.67 -45.84 77.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 ' CG2' HD13 ' A' ' 147' ' ' LEU . 55.8 mt -72.27 -36.72 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.23 69.98 80.23 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 109.498 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.7 Cg_endo -70.84 -33.88 11.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.588 2.192 . . . . 0.0 111.639 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -75.4 -27.14 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.95 94.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 59' ' ' PHE . 16.5 m -127.01 160.49 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 29.5 ttpt -72.25 -50.37 27.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.476 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.41 132.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.45 123.39 32.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -121.67 144.87 48.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 61.2 mt -105.09 119.49 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 29.0 tp -64.99 -44.29 89.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' CG2' ' A' ' 53' ' ' THR . 74.1 mm-40 -156.97 151.61 25.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 109.09 -42.88 1.84 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.2 m-20 61.9 38.85 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.11 17.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -118.6 -167.02 13.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.98 130.27 18.79 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.697 2.265 . . . . 0.0 111.813 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.29 24.61 76.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.577 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.3 m -79.79 145.16 32.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -1.155 . . . . 0.0 109.525 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 ' N ' HG21 ' A' ' 53' ' ' THR . 62.6 mt -107.88 133.27 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.326 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 41.6 mttt -121.25 151.53 39.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -134.24 120.59 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.356 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 8.7 mt -117.87 134.25 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 40' ' ' LYS . 29.8 p -112.95 139.23 48.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.61 ' CE1' ' CG1' ' A' ' 39' ' ' VAL . 97.7 m-85 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.433 ' C ' HG11 ' A' ' 68' ' ' VAL . 39.4 p90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.279 0.561 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.489 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 3.2 m -130.41 147.12 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 109.299 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -109.82 146.36 35.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.647 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 49.8 m80 -117.42 148.29 41.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 39.0 tttm -129.71 141.39 50.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.0 mt -100.09 135.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -88.95 -48.5 7.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 p -166.0 154.45 11.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 pt -128.54 145.2 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -130.63 92.17 3.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.01 -38.58 91.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.43 -42.35 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 71.9 m-20 -86.68 6.6 30.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.473 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 37.3 m80 45.63 46.39 11.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.553 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.5 m -125.27 139.05 54.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 71.7 t80 -130.53 125.59 34.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.8 t -119.23 132.95 55.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 35.2 p90 -148.76 164.98 32.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.597 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 84.9 p -148.13 152.37 37.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.595 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 23.2 tp -87.41 137.51 32.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.596 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 28.5 mm -94.31 -75.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 94.0 mt-10 -118.77 151.23 38.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -169.21 125.52 1.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -48.97 -34.2 12.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 109.378 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.61 -16.5 63.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 7.0 mp -86.47 -39.45 16.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 69.0 m 62.86 173.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.414 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -74.46 -11.31 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.617 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -80.97 -29.42 35.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 28.8 mt -104.54 120.13 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.7 mm-40 -75.84 -178.92 4.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.358 -0.839 . . . . 0.0 109.242 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.2 mttp -56.69 166.33 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.47 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.55 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 62.0 mt -126.51 133.54 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 109.659 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -91.81 126.61 36.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.5 m-85 -116.63 138.16 51.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' HG22 ' A' ' 117' ' ' THR . 94.3 mt-10 -128.05 135.2 49.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.5 m -129.7 131.74 46.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -139.45 124.7 18.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.5 mm? -95.52 132.19 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.3 t -128.96 139.44 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -112.65 145.0 41.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.93 167.14 9.73 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.53 -9.23 25.41 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.696 2.264 . . . . 0.0 111.77 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -78.21 -15.21 59.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.18 -21.27 29.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.34 169.12 50.99 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.4 m -124.45 126.21 45.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -1.193 . . . . 0.0 109.611 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 11' ' ' THR . 65.7 mt -97.6 142.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.492 HG21 ' CD1' ' A' ' 105' ' ' LEU . 2.6 mp -125.73 125.55 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.682 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 28.0 mttt -115.03 139.08 50.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.121 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 102' ' ' GLU . 91.4 m -132.06 135.65 46.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.878 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 40.8 m -124.52 138.32 54.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.367 -0.833 . . . . 0.0 108.958 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -131.53 155.75 46.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 110.041 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 77.0 mttt -138.06 138.49 38.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.514 ' CD2' HG21 ' A' ' 99' ' ' ILE . 32.7 m-85 -116.57 128.77 55.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 109.623 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 76.2 m80 -99.68 150.54 22.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -0.894 . . . . 0.0 109.432 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -58.26 -47.21 84.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.55 -43.02 99.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -54.84 -47.09 74.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.426 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -52.15 -40.4 61.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.514 HD13 ' CG2' ' A' ' 34' ' ' ILE . 59.6 mt -63.78 -38.14 90.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.3 -49.46 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.548 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 12' ' ' SER . 86.2 tt0 -59.53 -48.44 81.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.91 92.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -57.53 -43.18 84.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 9.8 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.281 0.563 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 5' ' ' THR . 74.4 t80 -110.16 145.97 36.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.548 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 68.5 m -93.73 143.73 26.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -127.52 141.45 51.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.68 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 84.3 tt0 -112.49 133.01 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -117.92 134.49 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 83.1 mt-10 -103.16 109.91 21.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.8 t80 -117.59 131.35 56.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.678 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.564 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 18.7 p -91.81 155.83 17.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.238 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 59.7 p -153.61 171.94 17.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.779 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -80.16 -175.43 5.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.807 . . . . 0.0 109.424 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.52 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 4.2 mm 61.74 141.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.952 . . . . 0.0 109.239 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 49.0 Cg_endo -70.65 146.27 54.21 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.492 2.128 . . . . 0.0 112.001 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.82 -51.7 2.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.655 -0.653 . . . . 0.0 111.348 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.18 -50.02 3.2 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.232 1.954 . . . . 0.0 113.123 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 79.3 mttt -61.48 -38.28 86.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.161 . . . . 0.0 109.686 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.81 -25.61 37.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.71 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 63.8 t80 -66.98 -31.69 72.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 77.1 mttt -72.09 -47.53 50.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.0 60.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 56.0 t80 -79.36 -16.82 55.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.402 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 67.6 t -114.12 -60.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 35.8 mt -59.41 -44.48 92.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.213 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 69.7 m-20 -100.99 24.4 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.331 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.22 -37.43 78.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -70.4 -33.13 71.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -94.17 -30.44 14.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.493 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 30.1 tp -64.14 -43.68 94.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 3.8 mt -50.2 -59.79 6.44 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 50.2 Cg_endo -68.9 -16.31 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.549 2.166 . . . . 0.0 111.84 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.6 tptp -69.05 -40.29 78.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' CG2' ' CD1' ' A' ' 147' ' ' LEU . 59.1 mt -67.44 -33.44 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.52 71.27 14.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -69.86 -30.92 21.05 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.613 2.208 . . . . 0.0 111.502 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.58 -23.57 64.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.205 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 -24.81 23.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.331 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 3.1 t -113.74 133.93 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.345 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -71.92 -50.83 25.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.71 130.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.03 124.81 38.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.27 146.62 46.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.837 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 57.5 mt -104.77 117.81 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.9 mp -63.39 -44.64 94.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 89.9 mt-10 -159.14 155.28 26.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.5 -41.63 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.8 m-20 61.53 35.27 17.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -1.125 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.54 34.11 10.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -120.93 -162.69 11.79 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.17 130.64 19.17 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.699 2.266 . . . . 0.0 111.833 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . 69.31 30.26 71.6 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.55 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 74.4 m -85.86 143.28 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.4 mm -110.97 132.16 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 79.0 mttt -122.83 146.46 47.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -127.71 120.45 28.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.268 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 11.6 mt -117.38 127.49 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -108.6 127.86 54.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.554 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 44.1 p90 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' CE1' ' A' ' 70' ' ' HIS . 3.4 m -121.92 147.98 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.339 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 45.9 mttt -108.01 141.21 40.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 68' ' ' VAL . 73.8 m80 -119.85 133.24 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.85 . . . . 0.0 109.148 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' CB ' HD12 ' A' ' 87' ' ' ILE . 21.1 tttt -116.0 139.69 50.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 63.9 mt -98.17 136.26 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.444 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 89.0 m-70 -90.09 -47.73 7.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 t -170.3 158.6 6.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.09 145.06 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.5 m-20 -124.94 92.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.473 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -65.34 -38.47 90.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.59 -42.5 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 74.1 m-20 -86.87 8.36 23.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.464 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.7 m80 45.76 41.66 7.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 m -121.74 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 67.4 t80 -130.78 122.99 28.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -117.27 134.02 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.584 ' CE1' ' CB ' ' A' ' 101' ' ' TYR . 33.9 p90 -151.12 161.79 42.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 93.4 p -139.16 158.32 44.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 87' ' ' ILE . 6.5 tt -98.62 125.1 43.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.51 ' N ' HD21 ' A' ' 86' ' ' LEU . 31.0 mm -73.7 -68.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 87' ' ' ILE . 94.4 mt-10 -140.92 146.44 37.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.657 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.517 ' CA ' HD11 ' A' ' 92' ' ' LEU . . . -153.24 160.49 29.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.65 -31.07 70.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.482 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 -27.84 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.36 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' CA ' ' A' ' 89' ' ' GLY . 5.7 mp -77.28 -39.74 47.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.387 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 30.6 m 59.52 169.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.31 -8.16 54.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -83.93 -27.97 28.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 109.424 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.497 HD12 HG22 ' A' ' 96' ' ' ILE . 18.7 mt -99.73 146.3 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -90.35 179.9 5.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 109.609 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 37.8 mttt -57.55 162.35 3.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.557 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 40.5 mt -118.56 141.04 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.704 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 59.0 t0 -97.74 119.86 37.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CB ' ' CE1' ' A' ' 84' ' ' TYR . 95.4 m-85 -113.59 144.87 42.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 91.5 mt-10 -138.67 134.13 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -126.84 132.86 50.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.563 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 116' ' ' LYS . 34.2 tttt -130.21 132.9 46.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.29 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -106.67 115.22 29.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 23.5 t -131.58 145.33 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 3.2 m -114.43 153.47 29.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.42 167.6 8.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.353 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.27 -7.8 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.626 2.217 . . . . 0.0 111.811 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -76.74 -13.98 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.57 -16.34 44.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.32 172.16 41.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 94.8 m -116.05 124.97 51.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.444 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 59.8 mt -96.42 127.54 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.252 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.426 HG12 HD12 ' A' ' 105' ' ' LEU . 51.3 mt -113.35 126.77 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 109.768 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 18.1 mttp -103.49 129.35 50.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 108.97 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -129.23 124.78 35.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.155 -0.966 . . . . 0.0 110.096 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.499 ' CG2' HG23 ' A' ' 5' ' ' THR . 23.4 m -106.6 142.96 35.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 108.964 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -129.12 143.06 50.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 109.913 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 24.4 tttt -149.31 119.73 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 109.082 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.481 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 22.0 m-85 -107.99 133.11 52.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 75.3 m80 -96.47 143.57 27.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 109.273 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.763 -179.829 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -74.21 -31.69 62.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.39 -43.73 80.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -54.66 -39.47 68.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.56 -41.71 86.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 109.422 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.556 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 43.5 mt -67.3 -39.24 85.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 30' ' ' LEU . 65.5 mt -54.18 -46.32 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 12' ' ' SER . 42.3 mm-40 -68.89 -40.38 79.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.93 -55.18 27.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -54.85 -56.18 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 109.507 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 44.0 mt . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 121' ' ' TYR . 70.2 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.24 136.75 52.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 30.3 m -101.43 135.95 42.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.421 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 118' ' ' THR . 91.5 m-85 -118.82 139.16 52.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.75 135.48 53.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.78 134.18 55.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 94.8 mt-10 -113.96 126.91 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 65.6 t80 -143.08 136.62 28.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 109.471 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.7 p -103.44 152.23 21.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 109.421 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -154.23 171.1 19.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 14' ' ' ILE . 31.9 t0 -71.79 177.52 4.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 HG12 HD23 ' A' ' 152' ' ' LEU . 1.2 mt 69.6 135.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.404 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 48.2 Cg_endo -69.7 150.11 68.15 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.535 2.156 . . . . 0.0 111.96 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.64 -52.27 3.55 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -64.5 -50.5 2.53 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.425 2.083 . . . . 0.0 113.041 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 94.8 mttt -59.62 -35.56 74.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.801 -1.187 . . . . 0.0 109.485 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 18.7 tp -80.37 -33.39 37.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.937 . . . . 0.0 109.372 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' HB2' HD22 ' A' ' 105' ' ' LEU . 72.8 t80 -56.52 -43.43 79.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 98.5 mttt -58.68 -61.09 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 109.646 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -68.59 -7.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.905 . . . . 0.0 109.611 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CD2' HG12 ' A' ' 24' ' ' VAL . 83.1 t80 -84.02 -32.97 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.667 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.539 HG13 ' CD1' ' A' ' 82' ' ' TYR . 24.9 m -127.73 -33.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.757 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.8 tp -60.95 -65.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.66 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 26' ' ' ASP . 33.5 p30 -93.98 18.95 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -69.09 -35.27 76.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.126 -0.984 . . . . 0.0 109.503 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.5 -42.39 67.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.5 t-20 -97.61 -34.2 11.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 2.6 tm? -69.38 -39.3 78.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 30.7 mt -51.1 -56.32 20.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -69.02 -21.66 36.61 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.524 2.15 . . . . 0.0 111.764 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -66.1 -37.28 85.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.526 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG12 ' CE2' ' A' ' 151' ' ' TYR . 73.3 mt -68.53 -27.16 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.22 69.99 10.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -70.48 -31.61 17.03 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.04 -28.36 60.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.15 -44.11 76.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 ' CG2' ' A' ' 57' ' ' ILE . 4.7 p -125.02 154.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 39' ' ' VAL . 70.4 tttt -77.33 -47.77 19.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.962 . . . . 0.0 109.447 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.15 141.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.529 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.58 119.52 30.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.22 140.67 37.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 55' ' ' LYS . 60.2 mt -106.49 117.55 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 6.5 mp -64.28 -45.76 86.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 53' ' ' THR . 67.3 mm-40 -157.72 155.22 29.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.4 -42.4 1.93 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 85.4 m-20 60.3 36.06 20.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.08 32.88 11.53 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -118.27 -166.34 13.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.85 132.65 23.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.693 2.262 . . . . 0.0 111.656 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.13 29.39 73.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 84.8 m -84.72 144.52 28.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.136 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.478 ' N ' HG21 ' A' ' 53' ' ' THR . 60.1 mt -110.51 128.52 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 44' ' ' ILE . 31.5 mttt -116.57 149.33 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 20.2 tttt -129.88 121.21 26.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.556 HD11 ' CD2' ' A' ' 70' ' ' HIS . 44.9 mt -110.81 134.49 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -119.24 123.13 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.9 . . . . 0.0 109.558 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 37.1 p90 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 48.8 t -123.51 149.88 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' O ' HD21 ' A' ' 86' ' ' LEU . 51.4 mtpt -123.6 143.57 50.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.556 ' CD2' HD11 ' A' ' 57' ' ' ILE . 66.6 m-70 -122.58 141.67 51.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.613 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 82.8 tttt -123.25 139.13 54.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 54.1 mt -97.76 134.18 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.507 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 88.9 m-70 -89.48 -47.6 7.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -170.65 153.79 4.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.15 143.79 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.399 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.48 93.03 3.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -63.15 -35.6 80.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.91 -40.61 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -87.44 1.83 52.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 43.4 m80 50.66 40.51 24.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.5 m -123.02 138.49 54.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.539 ' CD1' HG13 ' A' ' 24' ' ' VAL . 80.3 t80 -127.22 125.94 41.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -117.57 134.37 54.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 109.694 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 29.9 p90 -148.46 167.74 24.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.326 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.507 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 97.1 p -144.23 159.01 43.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.495 ' CD2' HD12 ' A' ' 92' ' ' LEU . 4.5 tt -98.99 133.37 43.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 71' ' ' LYS . 75.8 mt -94.69 -74.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' O ' HG11 ' A' ' 68' ' ' VAL . 95.7 mt-10 -116.08 157.96 23.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 174.82 155.65 12.77 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.37 -29.6 70.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -1.151 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' O ' ' CD1' ' A' ' 96' ' ' ILE . . . -69.5 -32.1 70.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.7 mt -74.27 -32.94 63.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.037 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.65 -177.56 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.537 -0.727 . . . . 0.0 109.287 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -88.47 18.56 4.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.568 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -125.64 -9.59 6.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.869 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 14.2 mt -108.55 145.43 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.055 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' HIS . 88.3 mt-10 -90.04 -179.83 5.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -57.53 166.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.606 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 81.7 mt -125.49 134.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 25.1 t70 -92.25 126.26 37.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 76.0 m-85 -118.72 140.45 49.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.496 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.36 137.52 47.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.433 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 45.3 m -127.45 133.54 49.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -131.11 132.14 44.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD13 HG12 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -107.72 124.07 49.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.5 143.48 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.0 p -108.44 148.04 30.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . . . -111.79 166.74 10.28 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 108' ' ' ALA . 48.5 Cg_endo -69.38 -19.35 38.07 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.741 2.294 . . . . 0.0 111.822 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.57 -17.65 64.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.386 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.75 -23.89 18.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.7 179.75 52.14 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 63.8 m -126.62 126.37 43.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -1.185 . . . . 0.0 109.648 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -92.91 140.67 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.448 HG12 HD13 ' A' ' 105' ' ' LEU . 62.7 mt -127.83 124.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 49.7 mttt -105.62 136.31 45.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.3 m -128.58 126.43 40.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 18.4 m -120.04 138.27 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 108.812 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -137.22 147.02 45.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.231 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 91.2 mttt -129.81 144.08 51.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 99' ' ' ILE . 55.2 m-85 -119.42 129.02 54.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.671 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -96.66 141.96 29.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.384 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.318 0.58 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.443 ' O ' HD23 ' A' ' 147' ' ' LEU . 85.1 t60 -60.63 -43.65 97.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.08 -46.13 79.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -54.81 -33.15 61.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -66.53 -39.77 88.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HG ' ' CG2' ' A' ' 34' ' ' ILE . 3.6 mm? -64.31 -45.06 89.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.381 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.464 ' O ' HD12 ' A' ' 152' ' ' LEU . 81.9 mt -57.04 -55.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.318 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -54.67 -35.95 64.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.95 -29.8 66.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.523 ' CE2' HG12 ' A' ' 34' ' ' ILE . 8.7 m-30 -69.45 -45.4 69.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 32.6 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.423 0.63 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -117.93 155.9 29.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.521 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 10.6 m -93.84 138.83 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 118' ' ' THR . 94.2 m-85 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -114.98 135.84 53.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -120.83 132.51 55.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -107.63 129.14 55.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.538 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.9 t80 -143.19 141.71 31.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.4 p -107.93 148.58 29.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.6 p -149.29 170.8 17.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.979 . . . . 0.0 109.527 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' C ' HD12 ' A' ' 14' ' ' ILE . 14.0 t0 -80.28 -175.86 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.459 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 152' ' ' LEU . 1.1 mp 67.79 140.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -70.21 149.6 64.27 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.213 . . . . 0.0 111.911 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.73 -52.19 3.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.2 -50.34 2.91 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.461 2.107 . . . . 0.0 112.915 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 67.5 mttm -58.91 -34.87 72.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.875 -1.14 . . . . 0.0 109.546 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 152' ' ' LEU . 8.5 tp -81.06 -28.9 35.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.728 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 56.9 t80 -68.76 -33.3 73.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 17.8 tttp -67.14 -45.35 77.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.58 36.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 52.0 t80 -83.79 -15.6 47.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.44 HG21 ' CD2' ' A' ' 20' ' ' PHE . 84.6 t -117.81 -67.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 28.5 tp -55.82 -41.71 74.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.432 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.4 m-20 -97.78 14.72 25.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -68.64 -37.11 79.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.84 -40.75 89.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.7 m120 -94.4 -31.56 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.521 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 38.9 tp -66.44 -42.25 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 6.6 mt -49.99 -57.97 10.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.442 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.68 -22.39 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.485 2.123 . . . . 0.0 111.742 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 151' ' ' TYR . 11.3 tptt -68.5 -42.01 79.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.489 HD13 ' CB ' ' A' ' 147' ' ' LEU . 23.8 mm -61.36 -24.99 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.86 75.06 3.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.7 -32.99 17.74 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.635 2.223 . . . . 0.0 111.645 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -21.77 61.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.62 -41.92 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.419 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' CG1' ' CE2' ' A' ' 59' ' ' PHE . 21.7 m -126.84 148.24 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.402 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HE2' ' CG2' ' A' ' 58' ' ' THR . 11.1 mtmt -72.4 -51.62 19.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.94 129.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.61 124.49 29.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -117.59 146.41 43.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -104.19 126.83 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 4.0 mm? -71.1 -41.47 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.38 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 90.7 mt-10 -159.26 151.16 20.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 107.68 -42.92 1.81 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 44' ' ' ILE . 51.7 t0 64.17 39.63 7.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 0.0 109.569 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 83.25 37.02 13.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.86 -165.99 13.13 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.09 132.69 23.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.702 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 65.43 28.46 73.6 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 84.6 m -82.84 144.13 30.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -1.102 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.507 ' N ' HG23 ' A' ' 53' ' ' THR . 59.5 mt -105.12 126.09 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 mtpt -115.09 152.98 31.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -135.71 124.77 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 70' ' ' HIS . 13.6 mt -113.03 131.75 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.515 ' CG2' ' HE2' ' A' ' 40' ' ' LYS . 75.0 m -109.47 120.62 43.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CE2' ' CG1' ' A' ' 39' ' ' VAL . 90.1 m-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 46.0 p90 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.546 ' CG1' ' CA ' ' A' ' 89' ' ' GLY . 3.3 m -126.6 147.09 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' O ' HD22 ' A' ' 86' ' ' LEU . 70.2 mttt -109.54 147.23 33.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.569 ' CD2' HD11 ' A' ' 57' ' ' ILE . 48.1 m-70 -125.21 140.1 53.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 23.9 tttt -114.96 140.87 48.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 53' ' ' THR . 65.3 mt -98.18 135.27 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.6 m-70 -89.35 -47.21 8.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -175.09 155.49 1.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.567 HG21 ' CE1' ' A' ' 82' ' ' TYR . 35.0 pt -131.05 144.69 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -127.26 93.11 3.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -62.99 -35.94 81.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -72.32 -39.91 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 80' ' ' HIS . 74.7 m-20 -89.3 7.4 35.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.478 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASN . 37.4 m80 44.28 48.83 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 103' ' ' THR . 89.3 m -129.91 129.7 44.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.543 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 75' ' ' ILE . 52.6 t80 -122.19 129.93 52.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.255 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p -124.61 134.62 52.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 35.2 p90 -151.39 164.86 35.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.275 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 77.4 p -142.44 162.44 35.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 99' ' ' ILE . 4.6 tt -101.98 131.49 48.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.507 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 71' ' ' LYS . 80.3 mt -91.98 -76.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.434 -0.791 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 69' ' ' LYS . 89.0 mt-10 -118.96 147.08 44.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.425 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.546 ' CA ' ' CG1' ' A' ' 68' ' ' VAL . . . -166.33 146.44 10.96 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.2 -46.54 45.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -1.153 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.94 -22.83 65.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 6.0 mp -86.77 -37.87 17.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 4.3 m 58.03 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.44 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 95.2 mt-10 -64.96 -9.17 19.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.76 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 96' ' ' ILE . 23.1 m120 -77.41 -35.05 54.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 110.098 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 95' ' ' ASN . 9.0 pt -152.1 106.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 110.189 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 93' ' ' SER . 15.7 mt-10 -135.13 107.49 7.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 109.184 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HD3' ' CB ' ' A' ' 122' ' ' HIS . 15.8 tttt -179.11 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.615 ' CG2' ' CE2' ' A' ' 101' ' ' TYR . 14.1 mt -125.99 123.64 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 54.2 t0 -104.48 113.15 26.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.434 -0.791 . . . . 0.0 108.905 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 73.5 m-85 -103.47 143.07 33.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.98 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -134.7 132.26 38.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.087 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 81' ' ' THR . 41.3 m -123.26 135.26 54.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -141.23 125.61 17.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 16' ' ' ALA . 22.1 mt -98.51 130.46 45.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.3 t -131.9 145.2 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 109.422 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -113.95 142.56 45.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.36 167.55 9.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.81 -14.64 36.2 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.698 2.265 . . . . 0.0 111.843 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -71.2 -16.75 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.02 -16.81 38.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.31 173.21 47.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.4 m -119.32 122.28 41.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -1.131 . . . . 0.0 109.53 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.1 mt -92.57 134.04 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.426 HG12 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -117.9 130.92 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -111.42 129.44 56.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.321 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.3 m -125.26 128.83 48.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.67 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.521 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 38.9 m -115.25 135.85 53.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.35 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -123.26 140.13 53.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.696 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 10.9 ttpt -125.95 139.33 53.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 69.8 m-85 -122.44 135.6 54.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' CB ' ' HD3' ' A' ' 98' ' ' LYS . 1.4 m80 -125.45 -167.11 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.292 0.567 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.571 ' CE1' HD22 ' A' ' 147' ' ' LEU . 58.4 t-80 -60.03 -44.16 94.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.13 -43.08 91.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.2 -38.26 65.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -61.3 -38.55 87.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 143' ' ' HIS . 3.2 mm? -69.83 -29.75 67.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 34.0 mm -60.93 -44.19 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.36 -47.28 67.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.16 -30.96 71.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 33' ' ' LYS . 61.4 t80 -63.46 -49.04 75.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 14' ' ' ILE . 59.6 mt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 11.7 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -112.13 144.68 41.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 40.5 m -93.76 141.25 28.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -117.51 132.09 56.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.59 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.79 137.28 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -118.56 154.16 33.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 70.4 tt0 -133.96 109.87 9.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 43.0 t80 -122.66 128.78 51.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 21.1 p -92.32 149.47 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.296 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.3 p -146.18 166.73 25.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -0.949 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -73.17 -175.7 1.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 65.41 142.48 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.107 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.7 Cg_endo -69.0 146.37 64.62 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.414 2.076 . . . . 0.0 112.041 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.612 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -45.13 -48.12 32.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 111.401 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.72 -40.11 30.99 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.231 1.954 . . . . 0.0 113.094 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 29.7 mttm -67.97 -37.44 81.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -80.57 -28.0 37.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.721 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.91 -33.83 76.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.132 -0.98 . . . . 0.0 109.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 73.5 tttt -66.75 -46.25 75.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.614 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.06 40.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.698 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -80.52 -19.98 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.2 t -117.15 -63.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 109.559 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 32.4 mt -56.88 -40.74 76.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.302 -0.874 . . . . 0.0 109.581 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.9 m-20 -100.34 15.29 28.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.78 -41.57 74.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.685 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 90.4 m-20 -66.07 -30.36 70.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.714 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 94.1 m-20 -97.33 -32.18 12.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 109.589 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 28.4 tp -69.9 -46.5 65.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 5.7 mt -47.0 -57.36 9.37 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.2 Cg_endo -68.73 -25.77 33.43 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.52 2.146 . . . . 0.0 111.867 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 60.7 tttt -75.51 -44.25 44.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.561 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 HG22 ' CB ' ' A' ' 147' ' ' LEU . 62.6 mt -67.78 -34.18 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.677 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.21 72.66 32.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.504 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.1 Cg_endo -70.53 -34.4 12.09 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.713 2.275 . . . . 0.0 111.782 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.22 78.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.554 HG11 ' CE1' ' A' ' 59' ' ' PHE . 23.7 m -125.37 155.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -73.22 -44.64 59.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.79 129.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.13 126.19 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -122.47 150.19 42.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.583 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.7 mt -106.35 121.47 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.7 mp -65.74 -43.99 87.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.412 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.3 mt-10 -159.24 155.06 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.64 -41.0 2.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 89.2 m-20 60.54 40.47 16.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -1.102 . . . . 0.0 109.481 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.74 35.98 12.48 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.69 13.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.7 128.26 15.83 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.698 2.266 . . . . 0.0 111.715 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.65 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 90.0 m -81.07 143.32 32.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 109.587 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.468 ' N ' HG21 ' A' ' 53' ' ' THR . 62.5 mt -110.14 131.67 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.313 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 50.3 mttt -116.42 150.42 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HG3' ' HE2' ' A' ' 69' ' ' LYS . 25.1 tttm -129.63 125.87 37.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.188 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 HD11 ' ND1' ' A' ' 70' ' ' HIS . 32.6 mt -117.39 137.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 50.4 m -114.51 133.2 55.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.554 ' CE1' HG11 ' A' ' 39' ' ' VAL . 91.2 m-85 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 44.1 p90 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 10.8 m -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 81.5 mttt -119.46 147.58 44.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.502 ' ND1' HD11 ' A' ' 57' ' ' ILE . 62.6 m80 -115.95 166.57 11.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.231 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' SER . 42.5 tttp -143.78 140.72 30.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.473 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.4 mt -104.95 127.51 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 74' ' ' SER . 98.6 m-70 -88.8 -29.98 19.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 91.9 p 178.1 154.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.784 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.504 HG21 ' CD1' ' A' ' 82' ' ' TYR . 38.3 pt -135.04 139.56 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -122.7 93.29 3.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -63.27 -37.89 89.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.267 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.06 -41.18 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -88.59 6.18 39.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.561 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m80 46.54 50.57 12.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 103' ' ' THR . 58.2 m -129.76 132.64 46.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.522 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 69.2 t80 -125.19 128.89 49.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.29 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -127.49 139.35 52.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.4 p90 -158.41 177.49 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.437 -0.789 . . . . 0.0 109.091 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 71' ' ' LYS . 89.1 p -151.7 154.77 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' CD2' HD12 ' A' ' 92' ' ' LEU . 25.5 tp -87.91 124.01 33.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.098 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 88.5 mt -80.69 -75.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.852 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 mt-10 -126.46 158.24 36.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 0.0 109.836 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -178.0 134.72 2.49 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -50.67 -37.69 42.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -1.16 . . . . 0.0 109.367 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.36 -17.37 63.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.152 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.53 HD12 ' CD2' ' A' ' 86' ' ' LEU . 6.8 mp -82.6 -42.11 18.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 3.3 t 60.13 177.18 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 97.9 mt-10 -78.89 -3.09 42.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 93' ' ' SER . 34.0 p-10 -90.76 -21.37 21.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 41.6 mt -112.39 132.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.069 -1.02 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 94.4 mt-10 -90.62 -178.56 5.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.148 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 75.6 mttt -56.14 156.63 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.361 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 120' ' ' LYS . 55.4 mt -118.4 136.2 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.668 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 120' ' ' LYS . 91.7 m-20 -92.15 123.84 35.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.395 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 76.2 m-85 -113.79 139.17 49.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.9 mt-10 -134.33 138.85 45.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.403 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' TYR . 28.3 m -127.96 137.45 52.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -139.14 125.32 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.8 mm? -101.5 129.56 47.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' ILE . 50.8 t -131.78 144.33 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -109.64 151.99 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.1 160.68 28.09 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.95 -17.0 36.97 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.639 2.226 . . . . 0.0 111.855 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -77.58 -12.3 59.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.53 30.46 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.46 172.3 55.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 14' ' ' ILE . 99.7 m -124.61 128.23 48.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -1.123 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.5 mt -99.06 136.24 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.455 HG12 HD11 ' A' ' 105' ' ' LEU . 62.7 mt -119.75 131.19 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 51.8 mttp -116.84 125.85 52.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -126.07 137.86 53.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 56.3 m -119.86 135.52 54.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -123.33 137.59 54.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.705 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 67.5 tttt -143.76 134.45 25.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.235 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 39.4 p90 -132.53 146.56 52.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 94.9 m-70 -108.78 159.17 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.495 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.443 ' O ' HD21 ' A' ' 147' ' ' LEU . 64.4 m170 -59.26 -47.4 85.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.297 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -53.45 -48.82 68.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -54.01 -37.86 64.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -58.75 -41.44 86.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -68.33 -37.7 80.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.299 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 19' ' ' LEU . 81.7 mt -59.34 -48.6 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.283 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.5 -47.61 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.02 -33.55 84.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.42 -46.9 80.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.45 HD13 HD12 ' A' ' 19' ' ' LEU . 64.3 mt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.495 ' CG1' ' HE2' ' A' ' 120' ' ' LYS . 13.6 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -92.17 141.45 28.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.563 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 38.7 m -93.66 142.66 27.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -119.67 144.35 47.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.533 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE2' ' HD3' ' A' ' 116' ' ' LYS . 85.5 tt0 -112.81 141.55 46.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -116.04 142.82 46.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -121.23 138.79 54.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.5 t80 -156.3 145.27 20.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.6 p -112.46 147.64 36.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -150.46 171.62 16.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 14' ' ' ILE . 6.8 t70 -78.66 179.54 7.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.34 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.528 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 70.2 142.11 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 109.155 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.6 Cg_endo -68.75 145.9 64.68 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.566 2.177 . . . . 0.0 112.148 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.09 -47.62 43.36 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 111.543 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.1 Cg_endo -64.32 -37.17 41.54 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.081 1.854 . . . . 0.0 113.003 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 78.6 mttt -71.42 -32.43 68.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.884 -1.135 . . . . 0.0 109.556 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.8 tp -80.8 -30.38 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 82' ' ' TYR . 75.0 t80 -61.09 -41.47 96.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.594 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 34.1 tttm -65.16 -52.81 52.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.632 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -8.11 52.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 79.6 t80 -85.45 -34.67 21.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.575 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' CG1' ' CD1' ' A' ' 82' ' ' TYR . 33.1 m -114.48 -37.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' CD2' ' HE2' ' A' ' 21' ' ' LYS . 17.5 tp -71.18 -38.55 72.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.662 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 30' ' ' LEU . 89.2 m-20 -108.09 14.38 25.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.9 -39.69 76.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.533 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' OD2' HD12 ' A' ' 44' ' ' ILE . 89.3 m-20 -58.62 -33.03 69.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.624 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.0 t30 -101.38 -35.91 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 26' ' ' ASP . 2.1 tm? -72.49 -37.47 68.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.7 mt -50.79 -55.8 24.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.2 Cg_endo -68.47 -18.91 43.51 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.43 2.087 . . . . 0.0 111.821 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 40.2 mttt -71.03 -36.71 72.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.51 HG23 ' CB ' ' A' ' 147' ' ' LEU . 79.7 mt -66.63 -29.27 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 38' ' ' ALA . . . -155.87 72.2 5.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.6 Cg_endo -69.89 -32.27 18.35 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.665 2.244 . . . . 0.0 111.771 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -75.23 -25.83 58.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 35' ' ' ALA . . . -73.63 -39.49 64.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.5 p -118.06 151.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' N ' HG21 ' A' ' 39' ' ' VAL . 54.0 tttt -77.56 -47.94 18.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 129.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.22 128.02 34.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -122.52 148.59 44.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 65.6 mt -106.45 118.14 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.428 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 6.8 mp -61.67 -45.41 94.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 67.5 mm-40 -157.83 156.04 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.23 -41.01 2.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.1 m-20 59.1 36.73 24.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 109.488 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.17 33.31 10.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -119.83 -164.99 12.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.72 130.77 19.96 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 30.93 70.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 89.3 m -86.36 141.9 28.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.506 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.419 ' N ' HG22 ' A' ' 53' ' ' THR . 63.3 mt -109.57 129.95 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.335 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 44' ' ' ILE . 48.0 mttt -116.2 146.56 42.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.613 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HB2' HD13 ' A' ' 45' ' ' LEU . 21.7 tttm -131.06 122.33 26.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.509 HG21 ' CG2' ' A' ' 39' ' ' VAL . 28.5 mt -114.98 137.95 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -118.57 131.04 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.562 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.5 p90 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.262 0.553 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 48.4 t -122.28 146.46 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' N ' HG11 ' A' ' 68' ' ' VAL . 26.8 mttt -119.83 139.52 52.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 77.2 m80 -119.64 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 19.2 tttt -112.61 141.17 46.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 109.553 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 HD13 ' OH ' ' A' ' 82' ' ' TYR . 66.6 mt -99.51 134.54 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -91.73 -49.16 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.9 p -167.61 154.7 8.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.569 HG21 ' CD1' ' A' ' 82' ' ' TYR . 39.1 pt -129.53 144.39 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -128.73 91.19 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -63.75 -34.63 78.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.43 -39.24 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -87.82 4.8 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.5 m80 48.12 46.04 19.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.2 m -130.96 132.14 44.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.577 ' CD1' ' CG1' ' A' ' 24' ' ' VAL . 78.5 t80 -124.88 121.27 34.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.353 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.1 p -111.81 139.91 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 33.0 p90 -155.59 167.95 28.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 90.4 p -146.31 158.28 43.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.503 ' CD2' ' CD1' ' A' ' 92' ' ' LEU . 5.4 tt -96.5 121.96 38.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 69' ' ' LYS . 94.8 mt -76.75 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.468 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 95.8 mt-10 -133.44 159.92 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.93 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -174.36 162.2 32.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -65.05 -29.62 70.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 109.631 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 96' ' ' ILE . . . -78.59 -21.75 48.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 92' ' ' LEU . 5.6 mt -78.68 -30.17 45.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 108.999 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 92' ' ' LEU . 66.6 m 46.37 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.88 9.88 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -110.14 -15.55 13.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 18.7 mt -109.36 137.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB2' ' C ' ' A' ' 122' ' ' HIS . 99.6 mt-10 -84.55 -179.4 7.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.299 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 35.4 mtmm -57.21 164.43 1.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 120' ' ' LYS . 53.4 mt -121.79 131.85 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.525 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 120' ' ' LYS . 90.2 m-20 -90.74 126.33 35.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 66.6 m-85 -116.93 142.06 47.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.2 mt-10 -129.19 136.08 49.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.8 m -125.95 129.25 48.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.36 128.1 40.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.169 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 3.0 mm? -99.47 123.3 43.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.2 t -130.83 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 72.2 m -113.78 153.43 29.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . . . -110.56 162.44 20.59 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 108' ' ' ALA . 49.1 Cg_endo -69.79 -18.83 36.66 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.613 2.209 . . . . 0.0 111.713 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -67.3 -15.43 63.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.877 . . . . 0.0 109.375 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.92 35.6 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.54 176.37 44.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 14' ' ' ILE . 98.1 m -117.76 129.26 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.2 mt -98.92 131.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.432 HD12 HD23 ' A' ' 19' ' ' LEU . 39.8 mt -117.38 132.72 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.621 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HD3' ' OE2' ' A' ' 7' ' ' GLU . 84.5 mttt -117.68 132.27 56.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.31 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.4 m -130.77 126.92 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.501 ' CG2' HG23 ' A' ' 5' ' ' THR . 32.8 m -108.71 145.76 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -130.85 137.23 49.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.831 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 100' ' ' ASP . 22.1 tttt -141.67 131.78 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.155 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' HB3' HG21 ' A' ' 99' ' ' ILE . 42.5 p90 -129.02 148.09 50.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.426 ' C ' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -116.58 166.72 11.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.418 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 35.1 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.44 ' O ' HD23 ' A' ' 147' ' ' LEU . 52.5 m170 -58.98 -46.81 87.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.8 mt -55.57 -50.97 68.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.385 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HE1' ' CE1' ' A' ' 23' ' ' PHE . 73.5 m-85 -53.46 -38.04 63.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -61.97 -42.35 99.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.51 ' CB ' HG23 ' A' ' 34' ' ' ILE . 4.1 mm? -63.93 -45.02 91.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 72.1 mt -55.63 -54.54 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.64 -29.95 53.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.93 -32.07 59.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -73.03 -43.25 62.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 152' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.89 136.63 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 29.1 m -93.61 137.19 33.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 109.367 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' THR . 68.4 t80 -119.64 132.79 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -113.94 135.53 53.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.85 . . . . 0.0 109.357 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 42.4 t-20 -119.64 141.12 49.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -115.1 138.14 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 78.1 t80 -154.9 146.53 23.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.8 p -113.22 147.17 38.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.411 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 59.8 p -149.61 171.67 16.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.651 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 14' ' ' ILE . 13.4 t0 -77.85 -175.45 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 68.71 141.06 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.9 Cg_endo -69.66 147.16 62.87 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.618 2.212 . . . . 0.0 112.115 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.86 -50.32 7.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.08 -45.75 9.53 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.297 1.998 . . . . 0.0 113.003 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 20.9 mttm -61.42 -33.04 73.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.782 -1.199 . . . . 0.0 109.542 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD1' HD21 ' A' ' 152' ' ' LEU . 12.4 tp -80.55 -31.75 36.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.725 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.0 -32.05 71.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 109.848 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 23.2 tttt -65.98 -44.57 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.609 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.55 -19.73 32.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 55.9 t80 -83.29 -15.92 48.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.53 -63.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.363 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 42.1 mt -57.97 -43.63 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.8 m-20 -96.24 15.42 21.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.391 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -69.49 -22.23 63.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.475 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 90.2 m-20 -77.36 -35.54 54.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 m120 -98.01 -31.5 12.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.491 ' CD2' HG23 ' A' ' 148' ' ' ILE . 18.4 tp -63.3 -39.06 93.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 1.1 mp -55.53 -59.42 11.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 50.5 Cg_endo -70.67 -11.27 29.39 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.674 2.249 . . . . 0.0 111.605 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -73.33 -43.94 59.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.857 . . . . 0.0 109.395 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' CG2' ' CD2' ' A' ' 147' ' ' LEU . 86.5 mt -66.6 -38.81 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.71 76.44 23.91 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.47 -31.64 17.01 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.714 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -74.49 -22.6 58.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -71.81 -37.53 70.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.87 . . . . 0.0 109.362 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.6 p -120.45 146.35 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -73.64 -45.99 49.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.1 142.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.563 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.97 130.32 53.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -127.63 154.12 45.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.568 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 25.9 mt -105.85 122.04 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.7 mp -68.15 -43.76 77.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.361 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.3 mt-10 -159.3 157.7 31.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.47 -40.46 2.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' HA ' HD12 ' A' ' 44' ' ' ILE . 89.8 m-20 58.95 37.44 24.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 26.32 29.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -111.63 -166.3 18.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.93 130.07 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.682 2.255 . . . . 0.0 111.757 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.27 69.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.568 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 97.9 m -80.77 142.53 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -1.181 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 53' ' ' THR . 64.3 mt -112.86 130.1 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 71.7 mttt -124.75 146.38 49.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.647 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -122.83 121.72 36.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 17.4 mt -114.75 132.51 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.2 m -113.12 116.82 30.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 53.9 p90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 36.7 p90 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.333 0.587 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' CG1' ' CA ' ' A' ' 89' ' ' GLY . 4.1 m -125.55 147.83 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 51.1 mttt -103.29 144.69 31.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.612 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 64.3 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 20.9 tttm -125.02 139.09 54.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.56 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 53' ' ' THR . 70.6 mt -100.95 129.63 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.07 -45.76 9.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -170.3 141.42 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.621 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 pt -123.42 143.83 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -127.77 91.27 3.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -63.59 -37.34 86.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.76 -42.72 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -86.15 3.09 44.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.433 ' O ' HD21 ' A' ' 105' ' ' LEU . 56.0 m80 52.97 45.12 29.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.109 -0.995 . . . . 0.0 109.491 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -126.76 139.83 52.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.6 t80 -132.98 125.77 30.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -120.76 127.36 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.494 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 36.1 p90 -146.64 171.14 15.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.482 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 69.1 p -151.5 151.36 31.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.0 109.704 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 32.1 tp -88.71 108.02 19.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.853 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.519 ' CG1' ' HB2' ' A' ' 71' ' ' LYS . 95.9 mt -59.11 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HG2' HG23 ' A' ' 87' ' ' ILE . 78.2 mm-40 -138.96 169.74 17.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.724 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.481 ' CA ' ' CG1' ' A' ' 68' ' ' VAL . . . -179.55 135.79 2.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -50.37 -41.27 51.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.485 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.74 68.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.624 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.515 HD13 ' CD2' ' A' ' 86' ' ' LEU . 7.5 mp -78.64 -33.4 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 4.0 m 61.47 178.19 0.12 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.299 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -78.86 -13.95 59.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.555 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -78.11 -28.69 48.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 34.4 mt -105.84 125.83 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.101 -0.999 . . . . 0.0 109.746 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 91.3 mt-10 -80.89 -179.41 7.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.16 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 17.5 ptpt -57.02 159.4 4.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 69.5 mt -117.79 138.65 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.596 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.482 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 61.1 t0 -95.13 125.72 39.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.574 ' CZ ' HG22 ' A' ' 99' ' ' ILE . 90.9 m-85 -117.3 134.08 55.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -123.71 137.64 54.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -127.99 136.72 51.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -139.77 125.62 19.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.7 mm? -100.16 130.01 46.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.4 t -131.79 140.66 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.6 p -113.27 148.38 35.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.86 164.59 14.38 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.544 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.34 -10.73 28.73 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 111.74 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -76.02 -15.52 60.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.06 -19.02 28.05 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.88 170.68 45.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.526 HG23 ' CA ' ' A' ' 16' ' ' ALA . 88.4 m -123.8 127.04 47.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.149 . . . . 0.0 109.605 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.3 mt -96.95 139.2 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 109.235 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.512 HG22 ' CD1' ' A' ' 105' ' ' LEU . 4.7 mt -124.62 121.96 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 45.0 mttt -107.67 139.11 42.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.075 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 m -127.98 130.06 47.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 110.076 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -125.97 140.28 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.875 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -145.21 155.54 43.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 110.196 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.469 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 25.5 mttp -129.97 148.53 51.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' CD1' HG23 ' A' ' 99' ' ' ILE . 80.4 m-85 -118.13 121.81 41.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 0.0 109.834 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.495 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 61.2 m170 -89.86 143.5 26.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.577 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.266 0.555 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -59.86 -50.64 73.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.411 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 6.6 mp -68.23 -48.0 66.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.96 -45.44 67.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.594 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -58.0 -40.65 81.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 34' ' ' ILE . 17.1 tp -60.08 -39.47 86.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.491 HG23 ' CD2' ' A' ' 30' ' ' LEU . 76.0 mt -53.76 -52.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.278 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.411 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 81.5 tt0 -54.73 -38.84 67.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.194 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.69 91.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 147' ' ' LEU . 15.4 m-85 -71.38 -42.45 68.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.09 . . . . 0.0 109.337 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 148' ' ' ILE . 6.4 mp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -110.81 154.07 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.417 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.52 HG22 ' CG2' ' A' ' 118' ' ' THR . 23.5 m -94.1 140.36 29.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -111.81 139.77 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -113.25 140.35 48.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -130.1 160.07 34.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 74.6 tt0 -142.72 130.8 21.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 75.7 t80 -141.78 140.32 33.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.565 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.0 p -90.68 143.56 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.513 ' OG ' ' CD1' ' A' ' 115' ' ' ILE . 83.3 p -141.06 161.29 38.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.588 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -78.35 179.7 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.29 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 68.6 141.88 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.232 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.3 Cg_endo -69.32 146.98 64.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.507 2.138 . . . . 0.0 112.158 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.62 -50.57 7.02 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 111.39 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.77 -49.98 3.63 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.23 1.953 . . . . 0.0 112.923 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 28.8 mttm -60.75 -35.98 77.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.866 -1.146 . . . . 0.0 109.672 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 tp -81.01 -28.4 35.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 69.4 t80 -69.54 -35.01 75.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.82 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 29.8 tttp -67.34 -37.87 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -88.54 -30.77 19.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.64 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 72.6 t80 -77.3 -12.15 59.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.6 t -117.76 -63.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 47.8 mt -65.3 -41.43 94.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.8 m-20 -94.82 9.65 38.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.529 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -70.19 -45.54 66.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.954 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.1 -25.31 67.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 58.8 t30 -101.27 -33.88 9.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD12 ' CG ' ' A' ' 151' ' ' TYR . 22.0 tp -75.27 -34.56 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.9 mt -51.34 -54.94 33.2 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.707 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -69.07 -20.32 38.23 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.425 2.084 . . . . 0.0 111.988 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 30.2 mmtt -71.32 -34.99 71.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.44 -27.99 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.97 64.62 42.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.5 -46.14 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.671 2.247 . . . . 0.0 111.705 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -65.63 -22.87 66.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -73.29 -50.52 21.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG23 ' CG2' ' A' ' 57' ' ' ILE . 7.4 p -111.61 149.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.476 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -73.25 -46.2 51.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.51 131.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.35 128.03 34.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.439 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -123.93 142.88 50.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.459 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.1 mt -106.46 118.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 27.2 tp -60.2 -44.94 94.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.9 mt-10 -159.68 157.02 28.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.6 -42.06 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 53' ' ' THR . 88.1 m-20 58.26 37.41 26.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.11 31.35 20.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.471 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -115.56 -166.28 14.81 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.7 130.9 20.23 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.737 2.291 . . . . 0.0 111.598 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.74 29.62 73.94 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 94.3 m -82.76 140.64 32.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.432 ' N ' HG21 ' A' ' 53' ' ' THR . 22.3 mm -105.81 129.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.276 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 91.3 mttt -114.74 147.3 39.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.655 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 57.3 tttm -131.02 121.52 25.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 0.0 109.297 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' A' ' 70' ' ' HIS . 60.8 mt -114.04 135.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.6 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 m -123.96 119.46 29.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 33.6 p90 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.567 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 38.9 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.308 0.575 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 86' ' ' LEU . 43.0 t -124.08 144.48 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' O ' HD11 ' A' ' 86' ' ' LEU . 35.2 mttt -116.9 139.66 50.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.594 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 81.0 m-70 -116.98 144.87 44.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 25.0 tttt -124.01 142.39 51.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.444 HD13 ' OH ' ' A' ' 82' ' ' TYR . 58.3 mt -102.96 131.07 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.448 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 97.2 m-70 -90.5 -48.64 6.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.2 m -163.81 149.49 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -129.89 145.47 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 82.0 m-20 -128.3 91.16 3.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -62.31 -37.66 86.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.96 -40.67 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.4 m-20 -87.8 7.88 28.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 46.5 m80 45.72 40.34 6.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -119.46 136.43 54.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.4 t80 -127.52 126.28 41.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 t -121.06 128.16 52.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 34.1 p90 -145.72 170.26 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -148.1 157.96 43.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.594 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 22.6 tp -93.27 136.75 33.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 71' ' ' LYS . 26.9 mm -99.13 -71.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 68' ' ' VAL . 95.0 mt-10 -118.98 160.78 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 172.44 128.59 1.06 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -46.21 -31.82 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 109.604 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.56 68.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' N ' HD21 ' A' ' 92' ' ' LEU . 3.6 mt -74.69 -33.03 62.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 3.5 m 53.14 -177.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.66 -0.65 . . . . 0.0 109.567 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.0 12.53 7.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 26.7 p-10 -111.72 -10.75 14.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mt -114.5 140.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 93.7 mt-10 -91.96 -179.52 5.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.312 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.445 ' HD3' HD11 ' A' ' 87' ' ' ILE . 52.2 mttp -57.08 161.91 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 120' ' ' LYS . 49.0 mt -120.47 135.62 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.608 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' LYS . 60.6 t0 -93.04 120.13 33.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 73.1 m-85 -113.8 139.13 49.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.48 135.34 44.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.318 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 m -131.11 135.64 47.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -139.18 129.13 25.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.888 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 16' ' ' ALA . 31.6 mt -98.69 129.61 45.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.7 t -132.05 136.17 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.9 OUTLIER -111.2 146.6 36.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -106.54 171.38 4.8 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 48.4 Cg_endo -69.52 -15.06 37.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.666 2.244 . . . . 0.0 111.791 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.79 -20.81 61.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.9 -25.61 11.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.44 171.55 51.37 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.456 HG21 ' CA ' ' A' ' 16' ' ' ALA . 93.8 m -125.87 124.62 41.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.0 mt -97.5 139.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.263 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.518 HD13 ' CE2' ' A' ' 145' ' ' PHE . 3.2 mt -121.57 127.96 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.741 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 50.5 mttp -105.87 127.98 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 m -123.43 133.65 54.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.52 ' CG2' HG22 ' A' ' 5' ' ' THR . 60.8 m -119.79 133.54 55.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 0.0 109.016 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -120.32 131.33 54.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 110.006 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 99' ' ' ILE . 78.5 tttt -140.66 130.35 24.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.526 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 32.9 p90 -132.11 149.17 52.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.805 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -114.15 158.67 21.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.183 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.43 ' CA ' ' HG3' ' A' ' 97' ' ' GLU . 82.2 p . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.633 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.448 ' O ' HD21 ' A' ' 147' ' ' LEU . 41.0 t-80 -60.19 -53.21 60.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.0 -36.07 80.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 109.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.533 ' CE2' ' OE2' ' A' ' 149' ' ' GLU . 46.6 t80 -53.44 -43.06 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.197 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 59.4 tttm -59.29 -38.63 80.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 143' ' ' HIS . 3.6 mm? -62.58 -36.13 81.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.231 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 152' ' ' LEU . 98.8 mt -53.68 -55.74 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.163 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.533 ' OE2' ' CE2' ' A' ' 145' ' ' PHE . 40.5 mp0 -54.33 -43.74 71.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.943 . . . . 0.0 109.043 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.48 -29.45 71.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.539 ' CG ' HD12 ' A' ' 30' ' ' LEU . 54.5 t80 -61.16 -43.58 98.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.3 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.53 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.226 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.333 0.587 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.531 ' N ' HG22 ' A' ' 3' ' ' VAL . 94.8 m-85 -116.31 149.57 39.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.587 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 27.6 m -93.56 140.99 28.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.46 137.98 53.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.616 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -108.02 132.76 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.27 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.06 133.41 53.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.52 131.86 54.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.435 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 86.0 t80 -146.56 149.48 33.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 22.0 p -117.96 149.9 40.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 23.2 t -148.51 164.57 33.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.636 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' CD1' ' A' ' 14' ' ' ILE . 21.1 t0 -72.71 -178.44 2.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 69.05 142.06 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.273 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -69.65 147.21 63.09 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 111.964 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.71 -51.44 3.76 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.507 -0.745 . . . . 0.0 111.267 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.19 -50.66 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.318 2.012 . . . . 0.0 113.068 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 95.6 mttt -59.1 -34.98 72.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.808 -1.182 . . . . 0.0 109.55 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' CD1' HD12 ' A' ' 152' ' ' LEU . 22.4 tp -80.77 -36.86 31.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.445 ' O ' HG21 ' A' ' 24' ' ' VAL . 60.0 t80 -57.87 -32.6 67.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 19.8 tttt -71.57 -52.39 18.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 109.623 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.44 3.06 14.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.446 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 86.0 t80 -99.86 -33.37 10.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 25' ' ' LEU . 9.8 m -114.19 -46.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.888 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' N ' ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -68.7 -33.93 74.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.97 . . . . 0.0 109.478 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 59.0 m-20 -106.33 8.93 32.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.81 -37.05 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' OD2' HD12 ' A' ' 44' ' ' ILE . 92.7 m-20 -57.35 -37.28 72.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.647 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 86.7 m-20 -100.86 -37.65 8.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 26.0 tp -63.96 -43.05 96.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 9.3 mt -47.8 -60.0 4.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.68 -22.74 37.12 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.55 2.166 . . . . 0.0 111.63 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.9 tptm -66.26 -47.06 74.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.534 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG22 ' CB ' ' A' ' 147' ' ' LEU . 67.8 mt -67.91 -36.13 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.534 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.97 71.58 62.52 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.6 Cg_endo -70.4 -37.37 7.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.681 2.254 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.53 -23.06 60.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.34 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 59' ' ' PHE . 21.4 m -125.54 149.16 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -72.13 -47.53 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.386 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.98 131.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.59 119.31 27.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -115.53 144.37 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.9 mt -106.6 119.67 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 26.4 tp -64.86 -44.12 90.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.3 mt-10 -159.32 154.48 25.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.95 -42.71 1.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 61.84 39.06 14.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.537 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 84.46 34.92 15.23 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -119.33 -166.84 13.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.02 131.85 21.7 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.726 2.284 . . . . 0.0 111.709 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.49 28.82 72.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.534 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 96.3 m -83.88 144.78 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.504 ' N ' HG22 ' A' ' 53' ' ' THR . 22.1 mm -112.15 131.94 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.95 . . . . 0.0 109.28 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.4 mtmt -130.09 148.39 51.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' HE3' ' CD2' ' A' ' 67' ' ' TYR . 67.8 tttt -125.76 126.71 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 14.7 mt -115.92 130.93 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.4 m -107.74 132.02 53.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.341 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE1' ' CG1' ' A' ' 39' ' ' VAL . 97.9 m-85 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 37.3 p90 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.306 0.574 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -126.65 145.58 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' GLU . 34.7 mttt -102.33 140.52 36.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.624 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 42.3 m170 -115.91 140.92 48.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.297 -0.877 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -124.02 139.22 54.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' HA2' ' A' ' 49' ' ' GLY . 63.3 mt -101.7 135.74 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.455 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 93.9 m-70 -89.17 -48.97 7.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.2 t -174.24 151.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.442 HG22 ' CD1' ' A' ' 82' ' ' TYR . 41.2 pt -127.05 144.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -123.45 90.5 3.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -61.57 -36.8 81.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.466 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.84 -37.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.63 2.85 56.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' O ' HD21 ' A' ' 105' ' ' LEU . 40.5 m80 51.34 46.98 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.8 m -128.8 135.18 48.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.87 . . . . 0.0 109.541 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.46 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 61.5 t80 -128.8 121.55 28.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -116.46 137.8 51.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -152.2 166.37 31.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.301 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.455 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 89.4 p -145.43 160.11 42.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.49 HD21 ' N ' ' A' ' 87' ' ' ILE . 5.3 tt -100.77 131.81 46.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.49 ' N ' HD21 ' A' ' 86' ' ' LEU . 23.1 mm -89.13 -73.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.583 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 88.3 mt-10 -121.15 151.79 39.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.513 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.53 ' CA ' ' CG1' ' A' ' 68' ' ' VAL . . . -171.4 154.73 22.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.35 -49.19 75.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 0.0 109.403 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.85 -27.01 59.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.522 HD13 ' CA ' ' A' ' 89' ' ' GLY . 5.7 mp -80.7 -30.24 36.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' LEU . 3.7 m 56.43 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.48 -7.67 34.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 109.236 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 96' ' ' ILE . 26.1 m120 -72.73 -42.29 64.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.285 -0.884 . . . . 0.0 109.668 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 96' ' ' ILE . 2.5 pp -156.25 121.82 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 110.477 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.1 mt-10 -136.59 107.03 6.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.818 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 78.6 tttt -179.01 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.392 -0.817 . . . . 0.0 108.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG21 ' CE2' ' A' ' 101' ' ' TYR . 18.8 mt -123.92 117.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -93.78 118.78 31.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.87 . . . . 0.0 109.011 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 68.1 m-85 -109.23 137.73 46.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.8 mt-10 -130.34 129.79 43.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -120.8 134.92 55.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -133.73 121.65 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.099 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 3.1 mm? -95.12 118.85 32.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.759 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 60.5 t -131.88 140.2 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 109.313 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.1 t -107.61 148.05 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -105.71 173.11 3.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.97 -16.22 36.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.671 2.248 . . . . 0.0 111.8 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.48 27.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.62 176.63 53.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.455 HG23 ' CA ' ' A' ' 16' ' ' ALA . 65.3 m -122.88 125.05 44.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.3 mt -96.2 139.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.36 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.442 HG12 HD11 ' A' ' 105' ' ' LEU . 28.7 mt -123.65 123.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.737 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -105.27 133.83 49.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.102 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 86.2 m -131.44 128.93 40.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.0 109.902 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.587 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -111.7 142.97 43.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.067 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.1 m -135.09 140.62 45.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.987 . . . . 0.0 109.845 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 72.0 tttt -132.29 147.14 52.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.535 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 96.2 m-85 -126.6 140.31 52.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.81 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 75.8 m-70 -130.55 -177.83 4.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.196 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.49 ' CB ' HG22 ' A' ' 96' ' ' ILE . 36.2 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.68 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.512 ' CE1' HD22 ' A' ' 147' ' ' LEU . 58.2 t-80 -61.35 -35.58 77.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.519 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.07 -44.37 92.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.446 ' HA ' HD12 ' A' ' 148' ' ' ILE . 66.3 m-85 -53.33 -39.18 63.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -57.33 -41.39 79.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 147' ' ' LEU . 3.2 mm? -67.97 -37.92 82.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 145' ' ' PHE . 81.2 mt -54.16 -44.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 86.8 tt0 -65.64 -45.74 81.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.11 -39.79 96.49 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.472 ' CD2' HD13 ' A' ' 30' ' ' LEU . 63.5 t80 -57.35 -50.21 73.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -1.12 . . . . 0.0 109.407 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 19' ' ' LEU . 49.2 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 121' ' ' TYR . 59.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.9 t80 -87.43 147.51 25.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.554 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 22.0 m -93.51 141.89 27.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.6 140.72 51.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.582 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -110.19 136.19 49.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -118.64 131.07 56.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.644 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 92.4 mt-10 -111.48 111.68 22.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.245 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 47.7 t80 -126.95 130.59 50.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 16.2 p -94.0 151.74 19.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 85.8 p -147.15 163.53 36.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' CB ' HD13 ' A' ' 14' ' ' ILE . 90.6 m-20 -71.45 -175.77 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 5.0 mp 63.12 142.43 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.6 Cg_endo -69.24 146.56 63.81 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.534 2.156 . . . . 0.0 112.173 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.604 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.46 -47.43 47.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.614 -0.679 . . . . 0.0 111.474 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.2 Cg_endo -63.93 -45.67 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.999 1.799 . . . . 0.0 112.899 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 61.0 mttm -64.45 -35.0 79.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 148' ' ' ILE . 25.9 tp -80.9 -29.66 35.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 24' ' ' VAL . 60.6 t80 -63.02 -37.01 85.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 34.7 tttp -65.51 -42.52 91.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.971 . . . . 0.0 109.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -83.33 -29.96 27.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CE1' HG23 ' A' ' 103' ' ' THR . 63.2 t80 -76.63 -18.73 58.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 58.2 t -113.87 -67.0 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -57.99 -42.08 84.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 75.2 m-20 -96.35 12.92 29.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.574 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -64.4 -35.67 81.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 109.598 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -65.04 -33.89 77.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.9 t30 -94.34 -33.78 13.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.512 HD12 ' CD1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -65.06 -46.14 82.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 4.6 mt -48.2 -58.71 7.35 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.72 -21.34 38.89 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.487 2.124 . . . . 0.0 111.558 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 39.1 tptt -65.15 -40.35 94.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG21 HD22 ' A' ' 144' ' ' LEU . 37.7 mm -61.78 -29.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.12 73.15 5.1 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.463 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.8 Cg_endo -69.97 -31.8 18.93 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.675 2.25 . . . . 0.0 111.833 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -70.71 -24.85 62.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.62 -40.23 61.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 57' ' ' ILE . 4.9 p -112.74 147.24 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' N ' HG22 ' A' ' 39' ' ' VAL . 67.8 tttt -75.37 -45.14 41.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.42 131.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.49 126.5 35.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.307 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.13 150.44 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.655 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.516 HG23 ' CG2' ' A' ' 53' ' ' THR . 60.9 mt -106.17 121.34 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 0.0 109.37 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.6 mp -66.47 -44.0 83.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.8 mt-10 -159.34 157.53 30.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.67 -40.42 2.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 44' ' ' ILE . 56.6 t0 58.32 40.34 24.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.459 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.432 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 83.88 33.72 20.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.09 -167.19 13.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.72 129.12 17.08 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.595 2.197 . . . . 0.0 111.695 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 72.47 26.35 72.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.516 ' CG2' HG23 ' A' ' 44' ' ' ILE . 96.4 m -78.99 144.51 34.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 ' N ' HG23 ' A' ' 53' ' ' THR . 63.3 mt -114.33 129.66 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 44' ' ' ILE . 3.3 mtmt -124.54 149.63 46.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HB2' HD13 ' A' ' 45' ' ' LEU . 11.0 ttpp -130.72 126.1 35.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.523 HG22 ' CG2' ' A' ' 39' ' ' VAL . 36.1 mt -114.94 133.76 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.3 m -115.1 130.92 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.339 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.405 ' CE1' ' HB ' ' A' ' 39' ' ' VAL . 91.6 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.3 p90 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.459 HG11 ' HA3' ' A' ' 89' ' ' GLY . 46.8 t -125.49 144.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' O ' HD23 ' A' ' 86' ' ' LEU . 22.0 mttt -116.21 143.24 45.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -123.28 142.76 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.439 ' HB2' HD12 ' A' ' 87' ' ' ILE . 17.8 tttp -123.91 140.66 52.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 64.4 mt -100.75 133.16 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.497 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 89.7 m-70 -90.68 -48.49 7.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.5 m -165.03 154.13 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.75 144.89 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -127.83 93.39 3.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.608 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -65.92 -38.12 87.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.319 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.22 -42.06 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -87.3 4.98 40.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.574 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 105' ' ' LEU . 66.7 m80 48.46 41.9 17.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.962 . . . . 0.0 109.472 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.8 m -122.05 136.66 54.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 62.6 t80 -129.12 127.07 40.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.369 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 t -121.77 133.43 54.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.652 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 38.5 p90 -149.51 162.96 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.497 ' OG ' ' NE2' ' A' ' 73' ' ' HIS . 55.4 m -138.87 149.26 44.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' A' ' 92' ' ' LEU . 5.4 tt -88.26 133.81 33.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 71.4 mt -91.45 -77.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.608 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 68' ' ' VAL . 74.4 mm-40 -115.37 161.81 18.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.651 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HG11 ' A' ' 68' ' ' VAL . . . 171.56 160.31 19.81 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.87 -34.06 74.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.665 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.82 -31.47 71.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.724 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.541 ' N ' HD21 ' A' ' 92' ' ' LEU . 5.8 mt -70.71 -27.77 64.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 109.152 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 92' ' ' LEU . 0.6 OUTLIER 43.73 -166.01 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.645 -0.66 . . . . 0.0 109.457 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.24 14.71 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.579 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -124.39 -11.73 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 92' ' ' LEU . 50.7 mt -111.97 126.26 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.701 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 96.6 mt-10 -77.05 -179.57 5.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 16.3 mttp -57.29 167.06 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 83.2 mt -123.29 137.99 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.04 122.75 34.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.427 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 89.9 m-85 -114.62 138.6 50.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.509 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.474 ' O ' ' CG2' ' A' ' 117' ' ' THR . 93.7 mt-10 -131.68 131.48 43.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.382 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 23' ' ' PHE . 28.6 m -125.85 137.26 53.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -139.03 128.14 23.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -98.5 117.6 33.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.8 t -131.72 143.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.275 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 44.2 m -114.36 151.77 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.11 167.83 8.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.05 -17.22 40.9 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.773 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -64.54 -14.7 58.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.42 -14.8 50.67 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.86 178.37 40.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 99.1 m -117.99 131.36 56.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -1.171 . . . . 0.0 109.727 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.9 mt -101.75 131.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.14 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.13 128.24 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.428 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 61.9 mttp -113.21 124.97 53.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 102' ' ' GLU . 62.0 m -129.84 132.72 46.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.007 . . . . 0.0 109.981 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.51 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 44.0 m -112.48 135.17 53.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 0.0 109.057 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.3 m -125.97 143.12 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.463 ' O ' HG21 ' A' ' 99' ' ' ILE . 16.7 tttm -139.26 133.61 31.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 108.969 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 3' ' ' VAL . 61.5 m-85 -111.36 131.83 54.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.816 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.5 m80 -100.74 138.84 37.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.273 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.448 ' O ' HD23 ' A' ' 147' ' ' LEU . 85.6 t60 -58.37 -44.5 88.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.393 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 34' ' ' ILE . 55.8 mt -56.88 -47.66 79.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -54.11 -37.98 64.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.302 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.26 -43.25 87.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 147' ' ' LEU . 3.7 mm? -62.93 -36.92 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.512 ' CD1' HD12 ' A' ' 30' ' ' LEU . 29.3 mm -55.74 -44.45 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.506 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 94.1 mt-10 -66.86 -36.64 82.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.92 95.65 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.02 -44.75 83.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -1.149 . . . . 0.0 109.565 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 14' ' ' ILE . 37.8 mt . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.574 HG11 ' CD2' ' A' ' 122' ' ' HIS . 7.3 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.239 0.542 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.518 ' N ' HG21 ' A' ' 3' ' ' VAL . 82.9 m-85 -113.35 152.77 29.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.526 HG21 ' CG2' ' A' ' 118' ' ' THR . 35.1 m -93.46 142.42 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.18 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -119.21 128.3 54.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.826 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -109.41 138.42 45.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.143 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.45 129.75 45.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.872 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.7 mt-10 -109.37 123.52 49.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.026 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 11' ' ' THR . 54.6 t80 -135.97 135.54 39.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.846 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.489 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 14.5 p -94.68 131.31 40.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.124 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 115' ' ' ILE . 94.4 p -130.55 177.16 7.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.863 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 149' ' ' GLU . 41.3 p-10 -80.78 -175.32 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.441 HG12 ' OD1' ' A' ' 13' ' ' ASP . 6.7 mm 68.24 136.12 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 49.2 Cg_endo -70.84 149.58 60.23 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.452 2.101 . . . . 0.0 111.888 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.83 -52.36 3.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 0.0 111.176 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.72 -50.36 2.45 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.432 2.088 . . . . 0.0 113.228 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 31.2 mttt -61.62 -34.67 76.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.838 -1.164 . . . . 0.0 109.888 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.402 ' C ' HD21 ' A' ' 19' ' ' LEU . 8.8 tt -80.59 -28.47 37.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -72.35 -34.61 68.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.608 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -68.08 -41.12 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.7 -23.3 27.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -82.96 -14.45 54.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.96 -55.94 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.592 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.6 tp -67.77 -38.82 83.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 30' ' ' LEU . 55.0 m-20 -104.83 18.29 22.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.87 -37.2 76.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.338 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 42' ' ' ALA . 52.6 t0 -76.78 -20.64 56.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.679 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 93.4 m-20 -104.42 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 19.0 tp -70.98 -38.83 72.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 8.0 mt -55.71 -56.7 27.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -69.63 -11.41 30.94 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.393 2.062 . . . . 0.0 111.67 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 12.0 mttm -83.43 -36.52 24.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.54 ' CG2' ' CD1' ' A' ' 147' ' ' LEU . 80.3 mt -76.88 -30.72 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.48 75.44 7.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.6 Cg_endo -69.63 -28.58 25.71 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.706 2.271 . . . . 0.0 111.694 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.11 -23.88 54.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.278 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.95 65.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.487 HG21 ' CG2' ' A' ' 57' ' ' ILE . 5.7 p -116.62 150.75 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 58' ' ' THR . 27.7 tttm -75.46 -51.69 12.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 130.71 0.05 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . . . -94.54 123.0 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -125.82 152.18 45.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 64.7 mt -105.96 119.2 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 25.5 tp -61.99 -43.73 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.4 mt-10 -160.05 154.92 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . 105.54 -42.28 1.94 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.8 m-20 61.39 36.61 17.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 87.33 34.37 10.64 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.0 -165.17 12.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.96 131.12 20.3 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.733 2.288 . . . . 0.0 111.783 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.53 27.94 72.89 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.58 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 88.7 m -83.23 142.57 31.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -1.162 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.455 ' N ' HG22 ' A' ' 53' ' ' THR . 24.0 mm -108.79 131.5 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' CE ' HD12 ' A' ' 72' ' ' ILE . 64.2 mttt -117.17 148.79 41.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 48.4 tttp -132.92 127.24 33.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.346 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.567 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 42.5 mt -120.15 131.37 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 40' ' ' LYS . 62.4 m -114.63 127.26 55.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.423 ' OH ' ' OE1' ' A' ' 88' ' ' GLU . 40.1 p90 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.498 ' CG2' ' HA2' ' A' ' 89' ' ' GLY . 41.2 t -124.28 148.21 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.58 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' HG12 ' A' ' 68' ' ' VAL . 85.7 mttt -121.51 144.1 48.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 109.359 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.567 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 90.9 m-70 -122.9 138.48 54.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 54' ' ' ILE . 40.0 tttt -117.61 141.85 47.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 44.0 mt -103.03 131.5 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.583 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.412 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 97.1 m-70 -92.62 -41.98 9.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.579 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -171.31 146.21 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.566 HG21 ' CE1' ' A' ' 82' ' ' TYR . 34.2 pt -129.4 143.49 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.05 90.92 3.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.86 -35.33 76.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.79 -41.92 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 80' ' ' HIS . 76.1 m-20 -87.86 10.16 19.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 79' ' ' ASN . 65.8 m80 44.42 42.79 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.471 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 m -123.31 132.84 54.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.566 ' CE1' HG21 ' A' ' 75' ' ' ILE . 70.2 t80 -120.18 124.18 45.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.8 t -118.16 128.84 55.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 30.8 p90 -155.87 171.19 20.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.855 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.7 p -142.45 162.64 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 69' ' ' LYS . 5.0 tt -98.86 129.37 45.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 23.9 mm -88.17 -74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 95.5 mt-10 -115.24 159.17 21.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.498 ' HA2' ' CG2' ' A' ' 68' ' ' VAL . . . -178.29 159.54 25.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -60.66 -46.6 89.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -1.106 . . . . 0.0 109.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.57 -23.64 67.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 5.9 mp -82.71 -44.11 16.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 13.9 t 60.18 163.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.317 -0.864 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.68 -11.2 53.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASN . 3.4 m-20 -72.38 -40.26 67.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.613 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 123' ' ' THR . 41.8 pt -151.71 131.34 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 30.5 mt-10 -146.34 106.45 4.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.921 . . . . 0.0 108.967 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 39.5 tptt -179.63 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.872 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.632 ' CG2' ' CE2' ' A' ' 101' ' ' TYR . 4.3 mt -124.59 118.16 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.917 -1.114 . . . . 0.0 110.005 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -94.86 121.58 36.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 108.901 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 99' ' ' ILE . 64.9 m-85 -114.14 136.73 52.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.956 . . . . 0.0 109.932 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.1 mt-10 -130.24 126.27 36.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 108.983 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.8 m -123.29 131.62 53.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.854 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -138.39 122.64 18.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.195 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.6 mm? -94.26 130.81 40.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 78.3 t -131.52 135.53 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.0 p -106.81 142.62 36.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.87 169.36 6.39 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.1 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.717 2.278 . . . . 0.0 111.77 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.23 -15.37 61.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.36 53.06 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.11 168.24 32.34 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.5 m -119.61 126.55 51.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 109.525 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.9 mt -95.73 136.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 12' ' ' SER . 3.1 mt -119.27 119.93 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 10.7 mtpt -105.13 121.17 43.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.11 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 80.1 m -126.73 134.07 50.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 0.0 109.934 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.526 ' CG2' HG21 ' A' ' 5' ' ' THR . 61.9 m -116.68 138.48 51.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.107 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -131.57 141.58 49.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.479 ' HE2' ' NE2' ' A' ' 122' ' ' HIS . 22.5 tttt -136.32 149.82 48.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.18 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.535 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 94.5 m-85 -127.99 142.7 51.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.06 -1.025 . . . . 0.0 109.766 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.574 ' CD2' HG11 ' A' ' 3' ' ' VAL . 64.3 m80 -134.95 165.15 25.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.473 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 25.7 p . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.729 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -57.09 -48.77 77.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.424 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.76 -39.51 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -53.96 -41.77 68.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.336 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.4 -41.95 86.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.54 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 48.7 mt -57.43 -41.08 79.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 152' ' ' LEU . 88.3 mt -54.87 -47.41 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.451 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 83.2 mt-10 -54.71 -47.17 74.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.179 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.54 -27.27 71.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.433 ' CG ' HD13 ' A' ' 30' ' ' LEU . 66.6 t80 -59.14 -47.26 85.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -1.113 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 152' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.464 ' CG1' ' HE2' ' A' ' 120' ' ' LYS . 7.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -110.57 156.68 20.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.362 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 17.8 m -93.56 142.78 26.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.403 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -119.41 135.23 54.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -110.45 133.8 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.272 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.02 131.84 54.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.61 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.64 122.88 47.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.319 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 11' ' ' THR . 82.0 t80 -142.82 146.57 34.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.61 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.568 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.0 p -108.29 142.45 38.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.208 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.418 ' CB ' HD11 ' A' ' 115' ' ' ILE . 20.8 t -141.12 159.17 42.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.965 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.45 -175.96 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 66.08 141.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.009 . . . . 0.0 109.146 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.2 Cg_endo -70.01 146.52 58.9 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.444 2.096 . . . . 0.0 112.001 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.21 -50.61 6.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.543 -0.723 . . . . 0.0 111.403 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.09 -50.31 3.03 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.29 1.993 . . . . 0.0 113.076 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 33.3 mttp -59.66 -33.59 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.19 . . . . 0.0 109.515 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 19' ' ' LEU . 9.9 tt -80.92 -34.39 33.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD1' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -64.81 -32.13 73.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 20.3 tttm -68.89 -46.29 68.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.74 38.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.737 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' HD21 ' A' ' 19' ' ' LEU . 68.1 t80 -86.42 -17.71 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 82' ' ' TYR . 66.5 t -115.9 -51.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 27.9 tp -68.46 -40.33 81.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 79.2 m-20 -103.38 18.6 21.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.97 -35.98 74.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 95.2 m-20 -67.76 -32.07 72.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 20.8 t-20 -99.34 -43.63 6.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -55.7 -42.61 75.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.775 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 13.8 mt -49.78 -62.32 2.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.516 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.51 -16.98 43.59 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.498 2.132 . . . . 0.0 111.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -67.54 -45.23 76.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.533 ' CG2' ' CD1' ' A' ' 147' ' ' LEU . 75.7 mt -70.23 -35.17 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.705 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.73 71.76 57.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.61 -30.98 17.53 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 111.715 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -75.06 -30.09 60.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.14 97.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.587 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG22 ' CG2' ' A' ' 57' ' ' ILE . 4.0 p -121.13 150.26 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -74.92 -47.47 29.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 178.48 129.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.28 125.65 36.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.49 155.7 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.9 mt -106.03 120.65 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -65.81 -44.0 86.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 92.9 mt-10 -158.81 154.92 26.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.76 -42.48 1.91 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 59.99 40.17 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.354 -1.086 . . . . 0.0 109.558 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 33.76 22.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -121.36 -168.46 13.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.59 130.0 18.77 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.705 2.27 . . . . 0.0 111.714 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.01 25.88 72.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.581 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.3 m -79.18 143.12 35.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.471 ' N ' HG21 ' A' ' 53' ' ' THR . 68.4 mt -112.51 132.05 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -123.49 150.79 43.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -132.34 122.84 25.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.599 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 36.1 mt -113.34 140.58 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.622 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.5 m -120.69 128.3 52.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.577 -179.922 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.5 p90 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 40.9 t -124.85 143.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.451 ' HE3' HG22 ' A' ' 87' ' ' ILE . 49.5 mtmt -113.19 147.59 37.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 91.9 m-70 -122.85 136.84 55.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 53' ' ' THR . 66.0 tttt -117.31 138.21 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.382 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 62.8 mt -99.72 132.98 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -90.5 -45.71 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.3 p -169.91 148.84 3.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.08 144.47 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 86.0 m-20 -131.05 92.16 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -62.8 -34.8 78.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.402 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.54 -39.86 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.407 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 77.1 m-20 -87.28 4.7 41.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.424 ' O ' HD21 ' A' ' 105' ' ' LEU . 31.8 m80 48.44 43.88 20.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.4 m -126.58 136.99 53.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD1' HG12 ' A' ' 24' ' ' VAL . 61.3 t80 -131.19 127.47 38.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.8 p -121.45 137.18 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -151.37 169.3 22.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 83.0 p -145.55 160.96 40.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.516 ' CD2' ' CD1' ' A' ' 92' ' ' LEU . 4.1 tt -97.59 119.57 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.374 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 93.5 mt -75.58 -56.7 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 87' ' ' ILE . 75.4 mm-40 -148.46 162.04 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -0.99 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HG23 ' A' ' 68' ' ' VAL . . . -174.33 150.8 11.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.12 -26.61 66.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -1.131 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.429 ' O ' HD13 ' A' ' 96' ' ' ILE . . . -78.34 -28.73 47.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 92' ' ' LEU . 2.9 mt -75.19 -33.05 61.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 108.755 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m 52.85 -173.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.606 -0.684 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.25 -3.42 49.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.68 -36.24 14.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.517 ' HB ' ' CA ' ' A' ' 92' ' ' LEU . 42.6 mt -92.3 130.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 110.041 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 70.4 mm-40 -88.55 -178.35 5.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.6 mttp -56.12 153.62 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 121' ' ' TYR . 53.8 mt -118.03 137.68 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 119' ' ' SER . 87.4 m-20 -93.17 124.95 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.36 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 83.7 m-85 -117.24 140.67 49.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' THR . 93.6 mt-10 -133.76 136.65 44.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -128.4 137.44 51.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -139.76 128.95 23.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.532 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.8 mm? -98.31 130.57 44.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.19 145.93 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.7 p -112.68 143.07 44.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.0 109.478 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.46 164.93 13.83 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.39 -18.05 38.96 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.634 2.222 . . . . 0.0 111.771 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.01 -15.51 63.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.862 . . . . 0.0 109.43 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.45 26.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.49 -179.84 50.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 66.4 m -124.75 126.87 46.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.159 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 106' ' ' VAL . 66.1 mt -90.38 137.9 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.337 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.558 HD13 ' CZ ' ' A' ' 145' ' ' PHE . 45.6 mt -119.84 129.11 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -118.8 127.0 53.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 0.0 109.205 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.5 m -126.44 134.46 50.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.729 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.0 m -116.87 142.73 46.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 109.094 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.549 ' OG ' ' CE1' ' A' ' 101' ' ' TYR . 27.1 t -139.33 148.85 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.041 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 82.3 tttt -136.5 130.71 32.93 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.564 ' CE2' HD13 ' A' ' 99' ' ' ILE . 27.8 m-85 -108.76 126.65 53.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.073 -1.017 . . . . 0.0 109.924 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 34.3 m170 -98.02 146.88 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.16 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.097 -1.002 . . . . 0.0 109.57 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -56.91 -50.94 71.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.92 -47.27 85.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.558 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 49.4 t80 -53.35 -43.26 67.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -55.11 -43.26 73.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.302 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 65.2 mt -56.69 -45.02 82.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.463 ' O ' HD11 ' A' ' 152' ' ' LEU . 93.4 mt -53.8 -52.02 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.298 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.418 ' CG ' ' OG ' ' A' ' 12' ' ' SER . 83.7 tt0 -54.27 -41.82 69.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.233 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -77.57 -23.42 67.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 147' ' ' LEU . 70.1 t80 -63.18 -45.68 90.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.341 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.347 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 121' ' ' TYR . 48.8 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -123.14 150.52 43.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' CG2' ' A' ' 118' ' ' THR . 19.9 m -93.95 138.13 32.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 118' ' ' THR . 77.5 t80 -122.86 134.51 54.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.43 133.77 55.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -121.78 131.66 54.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.8 mt-10 -104.04 118.95 37.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 11' ' ' THR . 62.4 t80 -133.29 132.39 41.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.5 p -93.9 142.96 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 24.4 m -135.3 160.48 38.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.673 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' ILE . 96.5 m-20 -69.26 -175.72 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 61.78 141.72 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.959 . . . . 0.0 109.077 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 46.0 Cg_endo -69.21 146.23 62.92 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.452 2.102 . . . . 0.0 111.978 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.12 -49.82 8.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.592 -0.692 . . . . 0.0 111.365 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -63.93 -49.32 4.09 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.252 1.968 . . . . 0.0 113.027 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 96.6 mttt -62.09 -35.48 78.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.523 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' PHE . 20.4 tp -80.57 -27.98 37.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.563 ' CG ' HG21 ' A' ' 24' ' ' VAL . 64.1 t80 -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -60.4 -43.89 96.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.4 -20.56 40.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.558 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 71.0 t80 -99.09 6.64 46.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 82' ' ' TYR . 94.6 t -135.0 -78.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.144 -0.973 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.02 -49.22 74.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 80.0 m-20 -99.07 12.14 36.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' CA ' ' A' ' 24' ' ' VAL . . . -69.53 -36.4 76.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -73.18 -29.87 63.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.8 m120 -91.06 -29.01 17.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.481 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 30' ' ' LEU . 1.8 tm? -73.52 -34.15 65.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.877 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 19.7 mt -51.32 -55.8 25.75 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.605 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.56 -17.89 43.16 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.499 2.132 . . . . 0.0 111.856 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 42.5 mttt -71.09 -40.45 71.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 109.521 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' CG2' HD13 ' A' ' 147' ' ' LEU . 87.9 mt -68.13 -34.63 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.74 70.39 19.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -70.18 -34.58 12.91 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.656 2.237 . . . . 0.0 111.727 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.75 -19.9 65.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.25 -26.56 21.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 1.9 t -118.01 139.79 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.1 -51.08 23.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.48 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.39 117.67 29.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.22 147.76 45.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.317 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 74.3 mt -106.36 118.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -60.58 -45.19 94.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.7 mt-10 -159.32 157.87 31.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 108.35 -43.03 1.79 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.9 m-20 59.76 38.33 21.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.09 33.01 21.92 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -118.78 -168.2 14.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.03 130.75 19.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.692 2.261 . . . . 0.0 111.668 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 71.51 26.73 72.59 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 88.2 m -80.37 140.3 36.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 64.2 mt -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 2.9 mtpt -119.22 149.17 42.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -131.87 124.43 29.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 20.5 mt -119.96 131.38 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -111.99 121.66 45.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.341 -0.849 . . . . 0.0 109.109 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.484 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 35.4 p90 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.326 0.584 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 70' ' ' HIS . 4.6 m -134.47 150.31 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 109.089 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 86' ' ' LEU . 37.6 mttt -106.45 139.91 40.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 68' ' ' VAL . 70.3 m80 -114.42 143.82 44.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 109.17 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -127.35 138.95 53.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.709 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 59.1 mt -98.69 131.15 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.17 -49.16 6.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m -163.34 152.12 14.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.413 HD11 ' HE3' ' A' ' 77' ' ' LYS . 25.8 pt -129.21 145.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 69.0 m-20 -122.15 107.09 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.924 . . . . 0.0 109.289 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HE3' HD11 ' A' ' 75' ' ' ILE . 36.4 mttt -82.7 -25.77 32.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 108.553 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -46.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 65.5 m-80 -80.56 -5.37 56.67 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.492 -0.755 . . . . 0.0 109.651 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 m80 60.16 42.74 15.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.497 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 63.5 m -124.36 135.04 53.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.574 ' CD1' HG11 ' A' ' 24' ' ' VAL . 65.9 t80 -124.63 129.5 50.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -122.14 135.28 54.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.649 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.625 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.9 p90 -151.48 168.09 25.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.307 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 95.3 p -149.59 152.16 35.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.571 HD11 ' CE1' ' A' ' 70' ' ' HIS . 37.7 tp -91.96 117.42 29.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.292 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG22 ' HG3' ' A' ' 88' ' ' GLU . 24.1 mm -70.4 -71.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.735 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -128.06 169.35 14.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.0 109.803 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 176.72 137.36 2.63 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -47.55 -40.5 19.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -1.167 . . . . 0.0 109.694 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.23 -15.52 62.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 86' ' ' LEU . 7.0 mp -87.89 -43.79 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 m 61.93 178.43 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.408 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.17 -2.05 39.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.632 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -91.75 -21.58 20.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 96' ' ' ILE . 51.5 mt -111.3 141.36 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -0.931 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -95.6 179.84 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 3.8 pttm -57.52 164.61 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.545 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 68.2 mt -120.72 134.23 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 61.9 t0 -89.7 122.7 33.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 77.9 m-85 -115.51 139.8 49.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.275 -0.891 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 94.1 mt-10 -131.04 136.85 48.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 81' ' ' THR . 53.6 m -132.07 133.17 44.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 115' ' ' ILE . 22.7 tttt -131.61 133.36 44.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 109.477 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' A' ' 16' ' ' ALA . 1.2 mp -103.84 125.1 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 40.1 t -131.76 140.43 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 92.7 p -110.57 141.32 43.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -0.933 . . . . 0.0 109.452 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.436 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . . . -109.75 164.74 14.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.556 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 108' ' ' ALA . 49.6 Cg_endo -69.96 -7.12 20.33 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.752 2.301 . . . . 0.0 111.791 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -78.82 -18.5 53.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.91 -29.45 7.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.87 174.53 55.09 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -122.14 125.57 46.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.1 mt -90.22 138.34 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 104' ' ' LYS . 44.0 mt -125.87 127.8 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.794 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 53.5 mttp -105.05 128.71 53.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -125.88 129.85 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 110.007 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 5' ' ' THR . 33.1 m -118.49 133.87 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 108.923 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.8 m -123.8 142.46 51.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.09 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 75.9 tttt -139.38 129.44 25.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 25.2 m-85 -111.65 131.57 55.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 109.884 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 71.4 m80 -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.424 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 22.0 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.52 -41.58 98.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 35.3 mt -61.71 -45.98 91.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -53.28 -42.96 67.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -62.47 -39.67 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.473 HD13 ' CG2' ' A' ' 34' ' ' ILE . 60.5 mt -66.72 -40.73 88.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.401 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' LEU . 82.2 mt -56.01 -45.73 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 96.6 mt-10 -60.66 -46.64 89.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.76 -39.87 96.96 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.453 ' CE1' HD21 ' A' ' 30' ' ' LEU . 42.0 t80 -53.4 -55.38 25.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -1.088 . . . . 0.0 109.462 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 9.6 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.37 156.66 22.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 109.381 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 57.3 m -93.42 143.51 26.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.29 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -109.63 141.97 41.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.278 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -127.83 129.66 47.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 91.2 mt-10 -101.76 124.78 47.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 11' ' ' THR . 46.9 t80 -136.25 127.03 27.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 15.1 p -90.42 154.73 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.446 ' HB2' ' CG ' ' A' ' 149' ' ' GLU . 88.9 p -149.32 167.9 24.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 87.3 m-20 -77.2 -175.25 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.4 mt 63.4 142.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.3 Cg_endo -70.34 147.25 58.75 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.533 2.155 . . . . 0.0 112.106 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.14 -50.4 8.14 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 111.429 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.08 -50.27 3.08 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.303 2.002 . . . . 0.0 113.031 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 60.4 mttt -61.93 -37.02 83.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.429 HD12 HG21 ' A' ' 148' ' ' ILE . 27.6 tp -81.3 -24.95 36.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.116 -0.99 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 77' ' ' LYS . 66.1 t80 -72.96 -34.56 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 109.859 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 17.5 mttp -67.25 -45.78 75.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.765 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.12 42.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.624 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 59.4 t80 -76.53 -15.69 59.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 44.2 t -119.68 -53.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 46.0 mt -67.85 -40.45 83.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 80.3 m-20 -100.52 11.11 40.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -70.18 -31.66 69.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.628 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -68.64 -21.83 64.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 27.8 m120 -114.23 -37.81 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.075 -1.016 . . . . 0.0 109.485 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.566 HD11 ' CG ' ' A' ' 151' ' ' TYR . 30.1 tp -58.2 -36.94 73.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 11.5 mt -55.78 -60.5 8.47 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.188 -0.945 . . . . 0.0 109.195 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.519 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.45 -11.35 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.558 2.172 . . . . 0.0 111.583 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 18.7 mttt -80.84 -35.63 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 109.607 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.448 ' CG2' HD11 ' A' ' 147' ' ' LEU . 87.6 mt -73.54 -31.18 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . . . -137.36 68.49 54.4 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.4 Cg_endo -70.15 -31.42 18.83 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.7 2.266 . . . . 0.0 111.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.33 -29.29 63.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 35' ' ' ALA . . . -74.32 -42.02 60.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 57' ' ' ILE . 5.6 p -128.72 149.23 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.389 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 39' ' ' VAL . 21.9 mtpp -71.89 -51.69 20.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.1 144.24 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.67 120.32 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -113.19 156.18 23.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.584 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 22.1 mm -106.83 133.89 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 20.5 tp -78.98 -37.91 38.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 57.8 mm-40 -159.06 133.6 7.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.462 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 104.22 -34.74 5.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' N ' HG23 ' A' ' 44' ' ' ILE . 5.3 m-20 51.49 56.98 7.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -1.109 . . . . 0.0 109.794 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.08 25.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.73 -168.78 14.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.14 133.43 26.69 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.595 2.197 . . . . 0.0 111.47 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.16 20.96 58.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 49.5 m -73.38 146.83 44.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 0.0 109.741 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.518 ' N ' HG22 ' A' ' 53' ' ' THR . 23.8 mm -106.39 135.8 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 45.5 mttt -115.95 143.26 45.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 63.0 tttm -129.68 129.86 44.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' CG2' HG23 ' A' ' 39' ' ' VAL . 44.0 mt -125.59 130.53 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.887 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -112.17 128.1 56.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.132 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 57' ' ' ILE . 75.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.504 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 45.8 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.343 0.592 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 61.4 t -118.44 141.77 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.267 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 50.3 mttt -116.56 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.552 ' CE1' ' HG ' ' A' ' 86' ' ' LEU . 94.0 m-70 -120.97 144.84 48.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 45.3 tttt -121.36 140.88 51.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 66.0 mt -99.22 134.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.436 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.465 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.8 m-70 -88.93 -48.47 7.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.0 p -169.84 150.95 4.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 21.1 pt -129.08 144.78 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -129.42 92.68 3.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.5 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 95.2 mttt -64.28 -36.29 83.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.73 -42.75 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -87.66 6.68 33.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.414 ' O ' HD23 ' A' ' 105' ' ' LEU . 69.0 m80 47.88 44.6 18.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.497 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.6 m -124.38 138.5 54.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.38 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 52.6 t80 -134.26 132.46 39.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 m -126.28 140.47 52.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.5 p90 -153.01 171.6 18.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.3 p -149.53 152.67 35.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.552 ' HG ' ' CE1' ' A' ' 70' ' ' HIS . 4.6 tt -87.97 127.59 35.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 71' ' ' LYS . 82.9 mt -86.35 -72.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.441 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 95.3 mt-10 -122.74 160.58 25.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.468 ' CA ' HG23 ' A' ' 68' ' ' VAL . . . -177.91 153.73 13.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -61.83 -25.48 67.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -1.13 . . . . 0.0 109.556 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.41 46.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.9 mt -71.71 -31.85 67.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 108.853 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m 50.21 -172.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.626 -0.671 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.26 15.04 9.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.427 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -116.39 -17.87 10.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 23.5 mt -109.34 141.47 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 94.0 mt-10 -90.7 -179.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 31.6 mttp -57.62 176.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.687 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 59.0 mt -133.18 133.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.414 -0.804 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 119' ' ' SER . 80.5 m-20 -87.28 121.4 29.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 67.0 m-85 -114.39 144.1 43.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 89.1 mt-10 -132.81 139.24 47.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.7 m -135.41 128.45 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.558 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -134.88 124.66 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.7 mm? -93.7 129.12 40.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 57.5 t -131.99 141.53 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.49 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.5 p -108.43 146.53 32.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.04 164.79 14.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.01 -17.61 36.35 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.673 2.249 . . . . 0.0 111.848 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.76 -15.34 61.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -15.45 35.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.22 170.03 46.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 14' ' ' ILE . 94.1 m -119.96 126.13 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 67.0 mt -93.16 139.56 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 105' ' ' LEU . 56.2 mt -127.1 121.89 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.728 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 58.0 mttp -106.82 132.37 52.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.046 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 74.0 m -131.74 129.79 41.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 30.2 m -113.15 148.63 34.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 0.0 108.922 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 55.3 m -140.23 148.44 41.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.51 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 77.3 tttt -138.35 127.25 23.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.162 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.464 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 40.3 m-85 -105.49 121.98 45.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 78.8 m80 -101.74 141.33 34.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.423 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 28.8 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -58.94 -43.94 91.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.6 mt -56.94 -49.07 76.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.13 -43.92 67.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -58.97 -41.05 86.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 151' ' ' TYR . 52.4 mt -64.22 -40.05 95.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.897 . . . . 0.0 109.364 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 152' ' ' LEU . 63.8 mt -55.51 -53.18 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.157 -0.965 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' HD12 ' A' ' 14' ' ' ILE . 73.1 mm-40 -54.38 -40.21 67.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.176 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.79 -26.03 59.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.566 ' CG ' HD11 ' A' ' 30' ' ' LEU . 60.0 t80 -60.82 -45.99 92.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -1.126 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.3 -0.875 . . . . 0.0 109.398 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 122' ' ' HIS . 80.9 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.21 140.9 48.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.269 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.5 m -105.25 131.73 52.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -0.946 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.47 138.82 54.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.378 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.61 136.15 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -117.39 135.58 53.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.41 124.25 51.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 80.6 t80 -146.17 141.7 27.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.528 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.2 p -107.93 151.29 25.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 21.7 t -151.38 154.38 36.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.629 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 10.8 t0 -66.31 -175.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 mm 72.44 141.67 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 109.356 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.1 Cg_endo -69.55 146.24 60.89 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.481 2.12 . . . . 0.0 112.027 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -42.96 -49.33 14.22 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 111.595 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.5 -50.33 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.145 1.897 . . . . 0.0 113.169 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 67.6 mttt -61.46 -30.35 70.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 109.583 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 152' ' ' LEU . 22.6 tp -80.61 -33.71 35.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.685 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 24' ' ' VAL . 83.0 t80 -61.7 -41.39 97.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.884 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.5 mttt -65.22 -55.14 20.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.47 -11.0 60.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.761 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 72.8 t80 -87.61 -33.43 18.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.1 m -115.75 -40.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.826 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 20.7 tp -71.39 -34.33 70.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.016 . . . . 0.0 109.435 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 76.7 m-20 -108.04 11.46 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.521 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.83 -40.19 76.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -57.5 -32.82 67.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.2 m120 -102.27 -36.36 8.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 26' ' ' ASP . 42.6 tp -72.75 -34.52 67.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.584 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 27.3 mt -53.69 -55.61 33.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -68.9 -17.54 41.49 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -72.52 -39.3 67.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 144' ' ' LEU . 87.1 mt -72.25 -32.63 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.88 72.53 16.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -69.96 -31.97 18.61 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.69 2.26 . . . . 0.0 111.799 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.17 -26.26 62.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.33 -48.27 76.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.56 HG13 ' CE2' ' A' ' 59' ' ' PHE . 17.4 m -128.39 157.53 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -73.53 -42.69 61.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.61 135.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -0.87 . . . . 0.0 109.463 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.54 119.0 27.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.27 147.98 40.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.2 mt -106.08 121.12 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.4 tp -65.55 -43.71 89.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.5 mt-10 -159.22 155.81 27.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.33 -40.93 2.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.0 m-20 60.7 40.05 16.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.222 -1.164 . . . . 0.0 109.58 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 35.21 15.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.56 13.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.73 129.64 17.98 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.758 2.305 . . . . 0.0 111.69 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.96 77.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.0 m -80.02 143.82 33.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -1.129 . . . . 0.0 109.58 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.466 ' N ' HG21 ' A' ' 53' ' ' THR . 64.3 mt -113.94 127.98 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 56.9 mttt -112.44 152.76 28.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 19.1 tttt -134.62 126.61 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.572 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 53.1 mt -116.26 139.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -115.86 129.0 56.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.437 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.56 ' CE2' HG13 ' A' ' 39' ' ' VAL . 82.9 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.544 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 41.1 p90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.351 0.596 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.546 HG22 ' CZ ' ' A' ' 59' ' ' PHE . 59.2 t -119.43 144.71 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.274 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.9 mttm -121.44 138.29 54.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.562 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.572 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 93.5 m-70 -112.12 135.76 52.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.2 139.1 49.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 47.3 mt -104.62 132.03 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -89.13 -47.69 7.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -169.79 153.79 5.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.41 HG23 ' CE1' ' A' ' 82' ' ' TYR . 31.6 pt -128.87 144.1 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.394 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -124.91 92.83 3.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -63.13 -35.25 79.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.92 -40.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -87.93 4.63 44.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 105' ' ' LEU . 39.7 m80 47.74 38.36 8.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.482 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -120.74 138.14 54.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 78.0 t80 -125.7 127.77 46.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -118.97 134.01 55.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.676 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 28.2 p90 -157.47 170.07 23.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.205 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 92.9 p -149.0 156.8 42.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 0.0 109.9 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD23 ' CD1' ' A' ' 92' ' ' LEU . 36.4 tp -91.25 110.86 22.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.201 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 88' ' ' GLU . 4.3 tt -74.93 -47.16 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.54 ' N ' ' CG2' ' A' ' 87' ' ' ILE . 97.5 mt-10 -142.3 167.16 22.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.891 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 68' ' ' VAL . . . 172.96 146.55 5.47 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.94 -27.55 65.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.61 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.86 51.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 92' ' ' LEU . 3.3 mt -76.31 -33.18 59.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 108.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.4 m 55.12 -179.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.628 -0.67 . . . . 0.0 109.292 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.62 5.29 21.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -97.88 -28.04 14.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 96' ' ' ILE . 58.8 mt -104.87 137.87 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.4 mm-40 -83.87 -179.47 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 22.7 pttm -57.26 164.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 47.7 mt -124.62 133.94 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 82.9 m-20 -90.42 126.18 35.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.875 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 93.4 m-85 -121.09 134.87 55.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.204 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -128.21 138.06 52.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.639 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.3 m -128.9 134.43 48.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -132.61 133.08 43.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.574 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -102.83 123.46 46.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 48.2 t -129.02 141.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.3 OUTLIER -113.71 146.49 39.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.565 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -110.63 174.07 2.56 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.507 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 48.9 Cg_endo -69.3 -16.58 39.58 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.734 2.289 . . . . 0.0 111.807 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.35 -20.61 63.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.265 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.43 -22.07 25.18 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.26 176.53 54.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 80.1 m -125.21 126.01 44.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -1.158 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.5 mt -91.05 140.64 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 109.172 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.459 HG12 HD12 ' A' ' 105' ' ' LEU . 55.3 mt -123.94 120.71 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -109.88 132.13 54.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.9 m -127.21 128.74 46.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 143.02 49.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 89.8 p -144.69 147.24 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 110.399 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.52 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 51.6 mttp -122.03 144.11 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.498 ' CD1' HD13 ' A' ' 99' ' ' ILE . 98.1 m-85 -112.11 124.32 52.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 110.065 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 78.9 m80 -99.91 129.25 45.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.131 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 109.685 -179.703 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.28 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' CD1' HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.42 -46.71 83.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.45 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 78.7 m-85 -53.89 -38.42 64.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.54 -43.43 79.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -66.11 -42.44 89.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.465 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 85.9 mt -60.95 -38.55 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.405 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 65.8 tt0 -64.52 -37.3 87.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.26 -41.46 31.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 21.3 m-85 -65.18 -42.54 93.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.521 ' CD1' HD11 ' A' ' 19' ' ' LEU . 60.8 mt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 121' ' ' TYR . 72.6 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.26 0.552 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.44 141.02 47.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.519 HG23 ' CG2' ' A' ' 118' ' ' THR . 23.6 m -93.44 143.78 25.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -124.7 138.99 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.727 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -115.27 131.81 56.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -119.8 133.3 55.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -105.54 125.41 50.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -136.41 133.3 36.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.4 p -100.9 143.32 31.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.254 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.461 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 43.7 p -141.11 171.63 13.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.653 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ILE . 67.0 m-20 -76.03 -175.99 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.461 HG22 ' CD ' ' A' ' 18' ' ' LYS . 6.6 mm 62.85 138.36 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 49.5 Cg_endo -70.15 150.16 65.46 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.592 2.194 . . . . 0.0 112.059 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.64 -52.25 6.4 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 111.129 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 43.0 Cg_endo -64.89 -49.13 3.15 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.276 1.984 . . . . 0.0 112.907 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' HG2' ' A' ' 15' ' ' PRO . 13.4 ttmt -57.98 -38.03 75.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.93 -1.106 . . . . 0.0 109.572 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.41 ' CD1' HG22 ' A' ' 148' ' ' ILE . 20.8 tp -75.28 -39.09 60.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.496 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 71.2 t80 -55.45 -47.14 76.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.0 tttt -46.63 -44.15 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.937 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -107.47 14.98 25.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.175 -0.953 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 92.4 t80 -96.22 -33.0 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 82' ' ' TYR . 31.3 m -126.09 -39.88 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.811 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 24' ' ' VAL . 15.5 tp -57.32 -66.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.738 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 34.6 p30 -92.27 13.41 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.484 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -68.78 -35.0 76.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.7 m-20 -59.23 -41.52 88.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -96.62 -29.22 13.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.634 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.533 HD23 ' CE1' ' A' ' 151' ' ' TYR . 3.4 tm? -72.98 -38.9 66.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 32.2 mt -52.25 -55.46 31.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.65 -17.5 42.82 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.41 2.073 . . . . 0.0 111.753 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 28.5 mttm -73.36 -37.06 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' CG2' HD12 ' A' ' 147' ' ' LEU . 88.6 mt -71.28 -27.76 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.15 69.23 16.04 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.84 -29.71 23.07 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.58 2.187 . . . . 0.0 111.683 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -71.96 -28.1 63.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -49.28 44.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 40' ' ' LYS . 3.0 p -119.55 150.98 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.499 ' N ' HG23 ' A' ' 39' ' ' VAL . 19.2 tttm -75.68 -51.78 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.72 136.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.81 129.27 38.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.88 148.95 42.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.4 mt -106.25 119.16 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 24.2 tp -64.32 -44.69 90.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.9 mt-10 -159.47 155.35 26.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.72 -39.75 2.69 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.9 m-20 61.74 41.05 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 82.59 36.75 15.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.83 -165.4 12.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.56 130.55 19.78 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.726 2.284 . . . . 0.0 111.797 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 25.28 75.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.573 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 99.0 m -80.7 145.91 31.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.508 ' N ' HG21 ' A' ' 53' ' ' THR . 26.2 mm -115.47 132.29 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 mtmp? -128.98 148.39 50.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.03 125.31 44.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.283 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.581 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 11.3 mt -115.41 134.91 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.671 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 p -115.55 142.15 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.36 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.95 . . . . 0.0 109.591 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 38.2 t -124.98 145.39 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -113.73 142.86 45.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.581 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 67.8 m170 -116.73 133.42 56.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -115.16 137.67 51.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.5 mt -101.89 134.65 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.483 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.6 m-70 -91.17 -46.85 7.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 t -173.53 147.66 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.51 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 82' ' ' TYR . 29.0 pt -123.57 144.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 91.6 m-20 -121.58 91.9 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.416 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -63.31 -36.89 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.55 -41.82 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 1.18 56.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.2 m80 54.32 42.34 31.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.994 . . . . 0.0 109.406 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 40.2 m -118.17 142.51 47.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CD1' HG11 ' A' ' 24' ' ' VAL . 65.2 t80 -134.73 123.76 24.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.5 m -117.55 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 31.4 p90 -150.87 172.94 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -149.41 155.46 40.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 3.0 tt -97.17 118.74 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 87.6 mt -75.46 -56.88 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.627 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 94.6 mt-10 -149.09 160.43 43.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -165.46 152.8 22.44 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -58.17 -24.22 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -1.101 . . . . 0.0 109.324 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -85.48 -27.43 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 92' ' ' LEU . 2.0 mt -76.63 -32.81 58.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.839 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 92' ' ' LEU . 30.2 t 47.77 -174.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' N ' ' OG ' ' A' ' 93' ' ' SER . 97.5 mt-10 -76.37 -6.49 51.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -0.994 . . . . 0.0 109.461 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -83.1 -38.91 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.85 . . . . 0.0 109.83 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.524 ' HB ' ' CA ' ' A' ' 92' ' ' LEU . 34.6 mt -91.7 135.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.817 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . 38.3 mt-10 -90.14 -179.26 5.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 70.1 mttt -57.04 158.5 4.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.563 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.567 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 60.4 mt -125.21 131.39 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 120' ' ' LYS . 88.2 m-20 -88.65 124.0 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 75.6 m-85 -115.51 142.24 46.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.671 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -131.93 134.81 46.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.349 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 50.3 m -128.64 138.53 52.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -140.71 127.56 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.274 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 20' ' ' PHE . 37.9 mt -96.49 128.56 43.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.691 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 114' ' ' ILE . 46.8 t -132.0 140.86 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.56 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -113.72 144.41 42.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.67 166.21 11.2 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.32 -11.48 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.706 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -76.41 -16.81 59.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.33 -24.4 18.2 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.16 54.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 92.1 m -123.65 122.15 37.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -1.185 . . . . 0.0 109.707 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.0 mt -87.72 144.31 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.061 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.14 117.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.871 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -97.81 131.98 43.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 108.943 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.8 m -128.91 121.59 28.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 110.007 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.519 ' CG2' HG23 ' A' ' 5' ' ' THR . 32.3 m -114.67 141.09 48.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 108.85 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -138.58 156.71 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 110.329 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 71.1 tttt -147.57 142.64 27.07 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CB ' HG12 ' A' ' 99' ' ' ILE . 26.6 p90 -135.99 148.55 48.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 109.916 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 97' ' ' GLU . 93.9 m-70 -104.48 172.71 6.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 109.517 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.175 -0.953 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -71.46 -37.62 71.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.448 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.59 -44.31 78.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.845 . . . . 0.0 109.363 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 27.3 m-85 -54.38 -44.91 72.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 23.3 mttm -57.48 -36.3 71.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.455 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 34' ' ' ILE . 57.7 mt -66.02 -38.85 89.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.49 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 34.4 mm -56.42 -56.5 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 19.5 mp0 -56.53 -36.52 69.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 109.36 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.77 -27.66 62.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.533 ' CE1' HD23 ' A' ' 30' ' ' LEU . 72.8 t80 -63.7 -41.72 98.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -1.068 . . . . 0.0 109.411 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 122' ' ' HIS . 78.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.5 136.36 52.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 48.3 m -95.51 136.74 35.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 118' ' ' THR . 98.4 m-85 -119.49 134.78 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.57 137.29 47.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.443 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 37.1 t-20 -113.54 149.88 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -133.4 134.12 43.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.562 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 11' ' ' THR . 64.6 t80 -161.79 131.71 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.502 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.567 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 15.1 p -98.25 157.39 16.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -157.52 177.01 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.569 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.448 ' O ' ' OG1' ' A' ' 113' ' ' THR . 1.1 mp 64.06 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 109.379 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -70.41 147.46 58.7 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.628 2.219 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.21 -51.55 3.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 111.129 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 40.9 Cg_endo -63.63 -50.62 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.339 2.026 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 41.5 mttm -58.6 -37.53 76.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 109.59 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD13 ' CD1' ' A' ' 152' ' ' LEU . 30.5 tp -80.79 -30.03 36.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.771 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.2 -32.86 74.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 109.77 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.7 mtpm? -64.16 -50.12 69.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.609 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -79.46 -16.47 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 49.8 t80 -86.1 -13.44 47.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.4 t -123.8 -58.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 7.1 mp -65.5 -39.92 92.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 42.3 m-20 -98.09 12.56 34.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -69.74 -40.75 76.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.33 -35.23 79.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 29.2 t-20 -93.72 -33.91 13.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 31.9 tp -72.86 -44.97 60.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 26.0 mt -45.59 -55.91 11.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -69.18 -26.36 30.38 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 111.801 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 31.2 tttm -71.57 -38.94 70.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.655 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 30' ' ' LEU . 63.8 mt -64.26 -24.27 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.578 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . . . -159.08 73.2 3.51 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 50.2 Cg_endo -70.16 -30.61 20.17 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.664 2.243 . . . . 0.0 111.875 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -74.1 -21.13 60.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -73.04 -42.02 63.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 59' ' ' PHE . 17.9 m -126.36 152.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.53 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.84 -43.43 62.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.57 129.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.54 125.13 31.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.37 150.91 40.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.4 mt -106.59 118.27 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.9 tp -62.61 -44.9 95.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.517 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.2 mt-10 -159.87 155.48 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.78 -41.14 2.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.2 m-20 60.11 37.74 20.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.156 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.03 34.92 9.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.433 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.98 -167.17 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.89 129.22 17.09 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.679 2.253 . . . . 0.0 111.77 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 73.5 22.44 78.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.54 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.3 m -77.03 144.47 38.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' N ' HG21 ' A' ' 53' ' ' THR . 65.9 mt -115.39 127.44 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 87.0 mttt -115.92 150.86 36.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 ttpp -132.91 122.44 24.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' CE1' ' A' ' 70' ' ' HIS . 31.7 mt -113.3 135.06 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.2 m -118.14 131.83 56.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CE2' HG13 ' A' ' 39' ' ' VAL . 13.5 m-85 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.474 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 39.0 p90 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.281 0.563 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG23 ' CA ' ' A' ' 89' ' ' GLY . 25.5 t -131.26 155.15 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.56 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' O ' HD21 ' A' ' 86' ' ' LEU . 45.1 mtmt -124.27 154.3 40.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.547 ' CE1' HD11 ' A' ' 57' ' ' ILE . 61.2 m170 -123.31 150.14 43.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' SER . 57.9 tttt -132.86 138.15 46.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 31.1 mt -104.32 124.04 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.523 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 98.4 m-70 -89.0 -27.39 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 59.7 p 178.9 153.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -136.0 142.53 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.4 m-20 -123.51 94.58 4.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.51 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.26 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 -42.91 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.315 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -87.96 8.14 27.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 48.2 m80 46.28 48.97 13.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.348 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 31.0 m -126.27 136.1 52.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 68.8 t80 -129.98 123.79 31.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -124.52 135.77 53.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.761 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.9 p90 -147.96 -177.14 5.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.523 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 88.8 p -151.41 150.83 30.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.524 ' CD1' HD12 ' A' ' 92' ' ' LEU . 3.1 tt -87.5 119.52 27.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.517 ' N ' HD21 ' A' ' 86' ' ' LEU . 97.4 mt -76.09 -63.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 73.6 mm-40 -138.65 154.38 48.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.725 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.496 ' CA ' HG23 ' A' ' 68' ' ' VAL . . . -173.15 142.88 6.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.09 -32.56 47.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 109.645 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -20.17 61.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.524 HD12 ' CD1' ' A' ' 86' ' ' LEU . 9.7 mp -85.18 -36.02 21.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 40.5 t 61.79 173.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.73 -7.11 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -84.82 -39.71 18.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.631 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 96' ' ' ILE . 29.8 mt -87.52 143.8 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 92.8 mt-10 -91.37 -179.33 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 46.9 mtmt -56.86 160.86 3.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.96 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.534 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 66.4 mt -120.91 136.65 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 119' ' ' SER . 88.9 m-20 -92.78 126.23 37.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 80.4 m-85 -117.81 137.76 52.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 118' ' ' THR . 94.5 mt-10 -125.01 142.08 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.481 HG23 ' CE1' ' A' ' 23' ' ' PHE . 25.9 m -129.86 136.09 49.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 109.334 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.482 ' NZ ' HG23 ' A' ' 106' ' ' VAL . 25.0 tttt -139.26 128.94 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.6 mm? -106.33 112.5 25.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.491 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' ILE . 9.4 t -130.57 128.47 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.9 p -114.78 154.22 28.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.957 . . . . 0.0 110.105 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.32 161.54 26.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.634 -0.666 . . . . 0.0 109.248 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.7 Cg_endo -68.5 92.21 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.375 2.05 . . . . 0.0 110.368 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 34.6 t60 78.93 17.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.19 12.83 26.35 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 82.95 -151.39 28.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 52.9 m -126.42 134.69 50.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.998 -1.295 . . . . 0.0 109.797 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' VAL . 49.8 mt -107.05 134.47 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.031 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 105' ' ' LEU . 28.4 mt -116.57 116.83 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 29.2 mttp -105.89 130.55 53.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.968 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -124.63 130.66 52.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 109.966 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.3 m -126.02 139.23 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.433 -0.792 . . . . 0.0 108.997 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 94.8 p -143.47 152.16 41.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 90.1 mttt -125.86 143.35 51.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.108 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' O ' HG21 ' A' ' 3' ' ' VAL . 82.7 m-85 -111.17 123.48 50.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.752 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -95.16 136.79 35.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.241 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.587 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.49 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 86.7 t60 -61.86 -44.66 96.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.4 mt -53.64 -46.87 70.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.487 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -53.42 -32.75 51.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -68.25 -34.55 76.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.955 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 3.2 mm? -71.82 -38.86 70.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 76.4 mt -60.02 -46.01 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -69.61 -34.09 73.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.64 -42.24 88.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 27.1 m-85 -63.13 -46.17 88.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 19' ' ' LEU . 67.8 mt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 94.0 t . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.566 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -100.8 146.1 27.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.566 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 24.8 m -93.55 139.47 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.283 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.45 136.23 53.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.577 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -113.69 135.22 54.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.29 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -114.88 131.02 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 90.3 mt-10 -113.99 132.91 55.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.164 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.4 t80 -146.5 144.84 29.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.746 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.539 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 20.4 p -109.64 144.71 37.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.469 ' CB ' ' HG2' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -152.23 179.38 8.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.7 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 71.9 m-20 -80.62 -175.71 5.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.468 HD13 ' HG3' ' A' ' 149' ' ' GLU . 2.6 mt 69.1 135.13 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 51.0 Cg_endo -71.09 148.14 55.84 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 112.012 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -39.41 -51.46 4.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.557 -0.714 . . . . 0.0 111.311 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.28 -50.32 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.338 2.025 . . . . 0.0 113.072 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 30.9 mttt -59.33 -36.16 75.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.94 -1.1 . . . . 0.0 109.505 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 tp -80.78 -27.08 36.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.93 -38.28 79.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.959 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 60.7 tttt -66.01 -45.07 82.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -29.63 44.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 56.7 t80 -80.88 -10.95 59.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.9 -55.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.5 tp -69.57 -36.7 76.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.7 m-20 -102.99 15.77 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -70.2 -40.34 74.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.768 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 87.8 m-20 -66.35 -24.74 66.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.067 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.4 m120 -105.69 -43.22 4.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.967 . . . . 0.0 109.629 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 18.3 tp -59.91 -36.06 76.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 22.4 mt -54.16 -60.1 8.35 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -67.99 -14.0 39.85 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.614 2.209 . . . . 0.0 111.801 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 75.8 mttt -75.07 -40.7 59.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 34' ' ' ILE . 83.2 mt -73.84 -31.28 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.21 67.12 14.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -70.11 -31.81 18.29 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -70.96 -26.02 62.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -70.78 -43.65 68.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.935 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.526 ' CG2' HG21 ' A' ' 57' ' ' ILE . 5.6 p -116.36 146.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.497 ' N ' HG22 ' A' ' 39' ' ' VAL . 87.1 tttt -73.74 -46.06 48.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 177.47 136.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.68 130.84 44.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.381 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -125.43 151.63 45.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.502 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -105.96 123.41 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.478 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.5 mp -69.22 -43.11 74.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 109.495 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.1 mt-10 -158.99 158.79 33.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.68 -41.15 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 53' ' ' THR . 90.4 m-20 59.35 39.71 21.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -1.113 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.51 34.2 26.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.47 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -121.9 -165.39 12.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.01 127.65 14.69 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.664 2.242 . . . . 0.0 111.691 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.5 24.85 69.36 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 60.3 m -81.19 140.96 34.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -1.145 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.14 133.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -121.52 148.06 44.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.688 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -130.52 124.49 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.241 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 HG21 ' CG2' ' A' ' 39' ' ' VAL . 22.3 mt -118.41 133.17 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -118.76 123.2 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.866 . . . . 0.0 109.35 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 41.6 p90 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 42.3 p90 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.375 0.607 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG21 ' CA ' ' A' ' 89' ' ' GLY . 43.3 t -121.81 150.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.435 -0.79 . . . . 0.0 109.047 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 34.6 mttt -118.12 140.67 49.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.703 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -120.2 131.15 54.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 20.6 tttp -111.4 141.72 44.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.0 mt -100.48 132.18 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.466 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.8 m-70 -91.05 -49.25 6.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.535 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.1 t -166.32 147.81 6.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.91 144.78 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -124.34 91.58 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -62.53 -35.31 79.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.49 -40.56 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.37 8.74 26.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.449 ' O ' HD22 ' A' ' 105' ' ' LEU . 48.8 m80 45.86 44.79 11.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.8 m -125.78 136.59 53.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 72.0 t80 -127.8 127.17 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.459 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -119.45 135.68 54.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 40.5 p90 -151.97 168.77 24.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -145.52 156.04 43.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 5.2 tt -92.57 124.93 36.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.443 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.516 ' O ' ' CD ' ' A' ' 98' ' ' LYS . 27.1 mm -79.45 -66.34 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 94.7 mt-10 -139.24 160.64 39.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.519 ' CA ' HG21 ' A' ' 68' ' ' VAL . . . -176.41 157.54 23.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -61.16 -27.08 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.181 . . . . 0.0 109.559 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 96' ' ' ILE . . . -76.03 -32.06 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 6.7 mp -75.23 -48.78 21.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.9 m 61.34 170.6 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -72.56 -5.66 38.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.607 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 46.6 mt -98.24 151.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 90.2 mt-10 -94.81 -179.98 5.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 87' ' ' ILE . 32.4 mmtm -57.37 159.57 4.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.489 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.485 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 54.8 mt -120.72 136.5 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' LYS . 59.7 t0 -98.66 125.1 43.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 88.6 m-85 -116.9 142.74 46.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -133.0 138.42 46.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.7 m -130.52 137.71 49.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -138.98 131.64 28.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.348 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.512 ' N ' HD23 ' A' ' 105' ' ' LEU . 2.9 mm? -103.73 115.72 31.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.562 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 114' ' ' ILE . 4.3 t -131.88 131.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 63.1 p -114.69 154.57 28.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.057 -1.027 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.62 162.15 22.13 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.565 -0.71 . . . . 0.0 109.316 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.6 Cg_endo -68.92 95.0 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.369 2.046 . . . . 0.0 110.472 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 26.3 m-70 78.28 11.48 1.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.58 9.09 44.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 83.45 -146.89 23.9 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 90.6 m -126.73 133.95 50.76 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.118 -1.225 . . . . 0.0 109.659 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -108.65 130.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.2 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.28 117.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.725 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 42.7 mttp -105.15 129.23 53.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.083 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.4 m -128.15 129.6 46.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 109.868 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.52 ' CG2' HG22 ' A' ' 5' ' ' THR . 51.4 m -111.3 139.64 46.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.159 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -128.56 135.95 50.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.881 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 99' ' ' ILE . 35.7 tttm -139.13 139.15 37.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.819 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 36.5 p90 -134.08 151.26 51.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.08 -1.012 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.9 m80 -109.06 154.79 21.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.546 -179.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . 0.449 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 65.5 m170 -69.5 -35.27 75.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.91 -42.57 73.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 54.7 m-85 -54.26 -46.19 72.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.484 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -60.67 -34.56 74.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 143' ' ' HIS . 41.8 mt -65.26 -38.32 89.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 83.4 mt -54.19 -56.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 12' ' ' SER . 30.8 mp0 -55.67 -44.05 76.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.1 -26.23 72.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.475 ' CD1' HD12 ' A' ' 30' ' ' LEU . 64.0 t80 -70.37 -41.38 73.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -1.103 . . . . 0.0 109.387 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.374 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 121' ' ' TYR . 27.6 t -118.64 133.14 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.17 142.03 39.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 109.341 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.534 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 9.2 m -93.65 143.14 26.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 118' ' ' THR . 69.9 t80 -124.81 137.5 54.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.57 136.3 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.397 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -124.96 134.19 52.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 86.4 mt-10 -109.93 143.42 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 109.366 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 11' ' ' THR . 72.1 t80 -152.16 139.75 19.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.465 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.3 p -97.73 131.74 43.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB2' HD13 ' A' ' 115' ' ' ILE . 7.6 m -132.79 170.85 14.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -80.6 -175.7 5.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.462 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 7.7 mm 67.4 139.34 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.337 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -70.2 148.89 63.18 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 111.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.47 -52.37 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 111.38 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.86 -50.37 2.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.397 2.064 . . . . 0.0 113.069 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 28.4 mttp -60.76 -35.02 75.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.823 -1.173 . . . . 0.0 109.498 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 23.5 tp -80.59 -36.08 33.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.17 -48.31 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.836 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -61.32 -54.28 45.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -70.25 -4.46 21.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 66.3 t80 -94.11 -32.84 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 25' ' ' LEU . 4.7 m -117.31 -39.19 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' N ' HG21 ' A' ' 24' ' ' VAL . 22.9 tp -72.87 -38.5 66.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.515 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 30' ' ' LEU . 57.7 m-20 -104.09 11.33 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.77 -41.1 75.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.46 -30.6 65.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 25.6 m120 -101.35 -35.78 9.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.442 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 26' ' ' ASP . 17.5 tp -75.2 -39.65 59.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.542 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 33.1 mt -47.98 -55.01 19.66 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.93 . . . . 0.0 109.56 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.4 Cg_endo -69.26 -19.93 37.85 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.383 2.055 . . . . 0.0 111.721 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 15.7 mttt -74.19 -36.27 64.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.502 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 147' ' ' LEU . 74.6 mt -70.15 -29.99 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.975 . . . . 0.0 109.555 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.79 72.18 12.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.7 Cg_endo -69.67 -43.56 2.66 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.658 2.238 . . . . 0.0 111.694 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.9 -20.62 63.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.9 69.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 59' ' ' PHE . 17.3 m -128.51 154.83 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -73.94 -45.89 47.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.486 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.62 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.37 128.93 35.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.91 144.2 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.525 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 55.4 mt -106.54 119.38 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.458 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.5 mp -63.31 -44.45 94.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.2 mt-10 -159.73 154.6 24.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.11 -41.87 2.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 91.1 m-20 60.52 38.06 19.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.58 35.29 9.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.12 -167.56 13.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.15 129.29 16.93 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.733 2.288 . . . . 0.0 111.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.9 24.88 75.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 91.9 m -80.05 144.59 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.485 ' N ' HG21 ' A' ' 53' ' ' THR . 24.5 mm -110.65 128.62 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 81.9 mttt -114.94 150.16 36.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -132.55 123.49 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.54 HD13 ' CD2' ' A' ' 70' ' ' HIS . 39.8 mt -114.16 136.69 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.3 m -113.73 130.9 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 39' ' ' VAL . 91.0 m-85 -102.48 131.28 49.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.523 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.91 6.17 47.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -116.04 167.88 10.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -1.2 . . . . 0.0 109.404 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.24 -126.4 8.22 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 65' ' ' TYR . 99.8 p -60.98 174.8 0.58 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -1.148 . . . . 0.0 109.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -71.46 -35.2 70.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' O ' ' OG ' ' A' ' 63' ' ' SER . 41.6 p90 -133.5 170.69 15.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 154.35 143.4 3.67 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 40.9 p90 -160.97 144.04 12.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -1.16 . . . . 0.0 109.749 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 67.7 t -117.27 142.27 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.232 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.451 ' O ' HD22 ' A' ' 86' ' ' LEU . 18.0 mttp -112.03 143.35 43.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.738 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.54 ' CD2' HD13 ' A' ' 57' ' ' ILE . 97.0 m-70 -124.45 143.1 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 19.0 tttm -125.61 139.55 53.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.672 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.9 mt -96.95 137.98 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.388 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 87.1 m-70 -90.52 -49.03 6.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -170.02 149.08 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.43 HG22 ' CE1' ' A' ' 82' ' ' TYR . 37.1 pt -125.81 144.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -127.94 92.4 3.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -63.43 -35.29 79.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.95 -39.38 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.414 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -88.42 5.09 43.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m80 47.68 46.52 18.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.1 m -129.06 132.22 47.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 64.8 t80 -124.78 125.7 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -118.54 140.61 49.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 32.5 p90 -154.4 170.27 21.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 82.9 p -148.88 157.94 43.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.522 ' CD2' ' CD2' ' A' ' 92' ' ' LEU . 5.0 tt -94.99 132.13 40.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.318 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.515 ' N ' HD22 ' A' ' 86' ' ' LEU . 87.8 mt -89.84 -71.68 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 109.592 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.515 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 96.2 mt-10 -127.32 159.27 34.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.484 ' HA2' ' CG2' ' A' ' 68' ' ' VAL . . . -175.37 154.35 17.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.409 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 82.6 m-20 -62.22 -35.39 78.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -1.159 . . . . 0.0 109.434 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 96' ' ' ILE . . . -73.16 -23.84 60.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.522 ' CD2' ' CD2' ' A' ' 86' ' ' LEU . 9.1 mp -78.85 -49.49 12.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.04 176.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.435 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 97.4 mt-10 -76.0 -10.06 59.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.518 ' HA ' ' CE ' ' A' ' 124' ' ' LYS . 27.6 m120 -83.15 -34.25 26.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD12 HG22 ' A' ' 96' ' ' ILE . 36.5 mt -96.23 132.72 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 93.4 mt-10 -87.1 -179.16 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HE2' HG23 ' A' ' 87' ' ' ILE . 89.9 mttt -56.71 165.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.447 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.547 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 63.7 mt -125.78 131.79 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.878 . . . . 0.0 109.523 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 50.3 t0 -85.98 119.9 26.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 65.8 m-85 -113.04 142.15 46.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 92.7 mt-10 -131.47 136.74 48.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 27.3 m -125.38 131.58 52.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -133.08 125.03 28.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -99.58 128.65 45.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 114' ' ' ILE . 41.3 t -131.15 140.7 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -109.26 147.92 31.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . . . -111.69 161.82 23.84 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 108' ' ' ALA . 49.7 Cg_endo -70.1 -11.69 30.85 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.727 2.284 . . . . 0.0 111.82 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -77.22 -17.13 58.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.939 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.86 -15.22 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.25 173.43 44.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 16' ' ' ALA . 99.1 m -127.75 127.61 43.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.565 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.5 mt -97.95 143.42 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.282 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 12' ' ' SER . 4.2 mt -124.17 123.61 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 18.6 mttt -105.11 131.32 52.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -131.47 132.04 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.861 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.534 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.2 m -112.28 144.62 41.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.048 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.9 m -130.4 145.55 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 0.0 110.072 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 5.1 ttpt -143.75 123.34 13.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.512 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 14.8 m-85 -106.87 137.94 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.062 -1.023 . . . . 0.0 109.724 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 67.7 m80 -107.49 148.54 29.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 15.4 p -126.55 159.62 32.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 95' ' ' ASN . 4.2 mtmp? -58.27 -44.06 88.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.51 -60.57 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 93.9 m-20 -98.19 -32.45 11.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.491 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 123' ' ' THR . 3.5 m -52.24 117.78 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 94.9 mt-10 -131.65 165.41 23.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.516 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.7 tt -117.87 171.54 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.289 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -99.13 131.9 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -54.25 -37.84 65.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.467 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 71.4 mm-40 -59.29 -39.74 83.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.91 -42.72 89.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 138' ' ' LYS . 47.6 t -65.38 -41.37 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -55.66 -41.82 74.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.406 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.25 94.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.862 . . . . 0.0 109.391 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.49 96.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.512 ' NZ ' ' OH ' ' A' ' 121' ' ' TYR . 22.1 mmtm -56.31 -43.09 78.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -50.68 73.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.397 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 90.0 mttt -57.69 -42.03 82.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.354 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.25 -46.68 82.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.364 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.71 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -74.31 -32.2 62.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 65.4 mt -68.92 -41.62 77.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.863 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.465 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 60.1 m-85 -53.4 -47.94 69.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -54.69 -40.55 69.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 151' ' ' TYR . 45.8 mt -60.89 -36.95 80.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.379 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 145' ' ' PHE . 92.1 mt -56.04 -55.84 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 35.9 mp0 -68.31 -33.99 75.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.15 60.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 147' ' ' LEU . 64.8 m-85 -60.94 -49.21 78.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.173 . . . . 0.0 109.434 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.31 -39.74 73.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -62.96 -40.21 97.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.02 -41.19 87.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.46 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.82 79.23 0.35 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.8 142.85 44.32 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.678 2.252 . . . . 0.0 111.672 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -113.64 147.42 38.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.73 -31.41 70.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.08 -40.54 77.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.443 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 121' ' ' TYR . 73.1 t -117.9 136.36 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.158 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.4 ' N ' HG11 ' A' ' 3' ' ' VAL . 90.6 m-85 -111.9 148.24 34.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 22.8 m -93.66 140.62 29.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' THR . 73.2 t80 -115.22 131.54 56.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.942 . . . . 0.0 109.643 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.22 138.66 47.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -132.72 129.85 39.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 81.0 mt-10 -105.53 123.96 48.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.282 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -132.99 129.73 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 27.6 p -97.39 140.25 32.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -138.88 172.13 13.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.687 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' ILE . 49.7 m-20 -76.18 -175.65 3.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.502 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp 62.48 140.63 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.46 147.95 65.94 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.541 2.161 . . . . 0.0 111.949 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.92 -52.13 2.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 111.289 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.33 -50.05 3.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.076 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 36.8 mttt -57.96 -39.62 78.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.881 -1.137 . . . . 0.0 109.585 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 23.7 tp -80.56 -27.71 37.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.76 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' O ' HG23 ' A' ' 24' ' ' VAL . 60.4 t80 -61.31 -39.42 90.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 78.3 tttt -66.85 -55.24 15.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.88 0.27 16.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 109.817 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 86.3 t80 -97.01 -29.17 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.096 -1.003 . . . . 0.0 109.539 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.9 m -122.5 -38.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 23.6 tp -72.24 -38.52 68.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 30' ' ' LEU . 72.7 m-20 -102.73 4.46 38.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -0.865 . . . . 0.0 109.545 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.85 -32.88 71.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 109.613 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD2' HD12 ' A' ' 44' ' ' ILE . 91.3 m-20 -57.68 -29.19 64.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.7 m-20 -116.5 -35.86 4.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 26' ' ' ASP . 63.9 tp -62.79 -34.07 76.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 13.5 mt -57.63 -58.93 14.83 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.04 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.51 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -68.32 -9.86 27.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.627 2.218 . . . . 0.0 111.605 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 65.9 mttt -80.39 -38.06 31.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 HG21 ' CB ' ' A' ' 147' ' ' LEU . 88.1 mt -77.95 -28.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.18 69.1 41.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.66 -29.56 24.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.752 2.302 . . . . 0.0 111.771 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -73.41 -26.81 61.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.35 -49.59 73.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -126.54 156.11 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.4 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -71.87 -46.14 58.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.12 134.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.76 129.14 35.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -122.53 144.12 49.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.521 HG23 ' CG2' ' A' ' 53' ' ' THR . 58.8 mt -106.06 120.28 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.6 mp -68.59 -44.28 74.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 91.6 mt-10 -158.16 157.26 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.31 -40.85 2.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' N ' HG21 ' A' ' 53' ' ' THR . 56.0 t0 56.95 33.4 23.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.427 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 87.9 26.02 30.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.0 -164.44 15.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.3 126.0 12.48 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.674 2.249 . . . . 0.0 111.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.9 36.43 41.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 44' ' ' ILE . 39.8 m -89.12 142.23 27.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -1.162 . . . . 0.0 109.365 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -112.75 124.81 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 44' ' ' ILE . 71.2 mttt -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -133.86 121.85 22.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 21.5 mt -116.75 135.47 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.66 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -119.77 139.24 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -95.84 133.23 40.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.53 27.19 7.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.83 -31.47 68.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -1.181 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.22 -52.44 2.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.2 p -61.13 -32.12 71.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -133.92 146.23 50.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -118.0 136.34 53.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 175.13 -179.25 46.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.1 p90 -160.31 146.08 15.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.154 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 44.0 t -121.18 140.32 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.892 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -115.49 144.72 43.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.415 ' ND1' HD13 ' A' ' 57' ' ' ILE . 75.9 m80 -124.77 135.66 53.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' THR . 53.8 tttp -118.12 141.11 48.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.9 mt -102.88 138.07 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -93.19 -47.52 6.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 p -172.06 153.72 3.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 pt -127.96 145.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -126.57 92.43 3.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -62.45 -35.0 77.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.397 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -71.84 -41.47 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -86.49 5.29 36.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.2 m80 46.69 40.76 9.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 m -124.16 136.5 54.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 82.5 t80 -123.93 125.48 44.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.306 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -117.08 132.38 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.6 p90 -153.59 168.83 24.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -146.83 152.44 38.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 5.8 tt -91.89 134.71 34.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 93.8 mt -89.8 -70.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.907 . . . . 0.0 109.599 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 94.3 mt-10 -125.43 161.23 27.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -179.83 156.29 17.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 85.0 m-20 -58.7 -32.4 69.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -1.164 . . . . 0.0 109.432 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.83 -16.43 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 7.6 mp -86.01 -30.61 22.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 p 59.72 -177.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.95 16.76 13.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -0.892 . . . . 0.0 109.184 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.458 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 0.7 OUTLIER -119.44 -20.87 7.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 109.368 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 96' ' ' ILE . 9.8 mt -96.05 142.44 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -87.91 179.97 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 41.6 mtmt -57.55 167.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.542 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 74.9 mt -119.83 138.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -90.75 122.58 33.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 69.2 m-85 -116.13 138.7 51.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -134.17 137.18 44.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.24 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -131.2 131.47 44.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.622 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 115' ' ' ILE . 20.1 tttm -129.24 133.49 47.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.469 ' CD2' HG22 ' A' ' 115' ' ' ILE . 17.7 mt -107.31 120.15 41.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.699 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 114' ' ' ILE . 22.6 t -131.94 138.54 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 22.9 m -114.48 151.66 32.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -111.98 172.01 3.88 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.03 -16.89 40.98 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.802 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.96 -16.49 63.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.345 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.04 -17.42 44.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.31 172.54 45.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 85.7 m -119.27 124.11 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -1.127 . . . . 0.0 109.365 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 106' ' ' VAL . 70.8 mt -94.79 143.18 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.137 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.469 HG22 ' CD2' ' A' ' 105' ' ' LEU . 53.8 mt -132.64 132.35 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.951 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 47.8 mttp -107.09 135.32 48.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.7 m -125.47 130.5 51.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.964 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 29.1 m -123.6 143.42 50.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.948 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.2 t -138.77 140.72 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.997 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.513 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 72.7 tttt -136.8 133.92 36.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.464 ' CD2' HD12 ' A' ' 99' ' ' ILE . 31.8 m-85 -110.02 133.63 52.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.677 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.7 m80 -101.68 136.51 41.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.271 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.464 ' HB ' HG21 ' A' ' 127' ' ' VAL . 11.1 p -109.82 149.84 29.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -54.09 -52.73 60.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.488 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.33 -73.03 0.04 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.6 p30 -107.93 -1.38 20.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -1.176 . . . . 0.0 109.801 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 HG21 ' HB ' ' A' ' 123' ' ' THR . 19.8 m -60.44 134.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.408 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.57 162.09 18.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.492 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.49 HD13 ' CD1' ' A' ' 96' ' ' ILE . 16.7 tt -128.42 171.64 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.574 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 21.7 mttm -94.26 127.39 40.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -55.06 -39.54 69.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.58 -36.8 76.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.574 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 36.0 m80 -70.69 -41.37 72.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.57 -41.47 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.49 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -61.05 -39.27 89.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -62.75 -42.96 99.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.424 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.4 -44.09 98.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -63.34 -42.36 98.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.04 -42.13 97.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.375 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 31.3 mttt -61.05 -41.32 96.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -44.35 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 146' ' ' LYS . . . -71.02 -35.33 71.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.482 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.8 t60 -61.37 -47.13 87.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.1 mt -63.0 -42.13 99.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.384 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -55.69 -42.04 74.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.361 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 142' ' ' ALA . 98.1 mttt -53.82 -38.09 64.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 147' ' ' LEU . 3.4 mm? -67.21 -40.03 86.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 87.9 mt -53.9 -51.15 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.43 -48.82 79.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.34 -33.03 86.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.62 -46.38 84.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' CD1' HD13 ' A' ' 19' ' ' LEU . 71.5 mt -64.87 -42.21 95.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 109.365 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.67 -38.02 77.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -127.11 84.01 64.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 138.77 35.18 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.649 2.233 . . . . 0.0 111.859 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.4 p -75.13 158.0 33.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.273 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.64 155.12 26.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -56.22 -40.52 74.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.516 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' A' ' 122' ' ' HIS . 70.6 t -121.37 136.09 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.588 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -111.48 135.62 51.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 33.2 m -101.87 132.91 47.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.14 132.65 56.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.92 141.51 39.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 65.3 t30 -126.58 131.05 51.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.574 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.01 141.91 46.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 83.2 t80 -162.97 143.71 9.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.448 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 8.7 p -102.42 144.63 30.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 50.1 m -142.84 167.83 21.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' N ' ' OE2' ' A' ' 149' ' ' GLU . 14.1 t0 -78.68 -175.97 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 66.49 140.7 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 109.276 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -71.12 148.07 55.55 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.605 2.203 . . . . 0.0 112.203 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.79 -51.6 3.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.72 . . . . 0.0 111.388 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.25 -43.72 13.89 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.43 2.087 . . . . 0.0 113.046 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 74.9 mttt -64.01 -34.5 78.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.81 -1.181 . . . . 0.0 109.653 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' O ' HD22 ' A' ' 19' ' ' LEU . 9.7 tt -80.64 -31.66 36.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 24' ' ' VAL . 67.7 t80 -65.7 -35.85 81.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.845 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 47.0 mttp -64.52 -42.36 95.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -84.43 -32.18 24.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 53.5 t80 -78.15 -8.02 57.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG22 ' CD1' ' A' ' 20' ' ' PHE . 63.0 t -123.98 -68.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 12.1 tp -57.23 -43.68 83.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 75.9 m-20 -95.05 12.87 27.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.67 -32.67 71.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 97.3 m-20 -66.32 -34.75 78.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.1 t30 -100.06 -43.09 6.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 30.0 tp -53.79 -43.77 69.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 10.8 mt -48.13 -63.35 1.56 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.37 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -68.74 -19.22 41.57 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.502 2.134 . . . . 0.0 111.779 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -66.67 -45.84 77.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' CG2' HD13 ' A' ' 147' ' ' LEU . 55.8 mt -72.27 -36.72 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.23 69.98 80.23 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 109.498 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.7 Cg_endo -70.84 -33.88 11.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.588 2.192 . . . . 0.0 111.639 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -75.4 -27.14 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.95 94.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' CG1' ' CE1' ' A' ' 59' ' ' PHE . 16.5 m -127.01 160.49 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 29.5 ttpt -72.25 -50.37 27.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.476 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.41 132.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.45 123.39 32.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -121.67 144.87 48.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 61.2 mt -105.09 119.49 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 29.0 tp -64.99 -44.29 89.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' CG2' ' A' ' 53' ' ' THR . 74.1 mm-40 -156.97 151.61 25.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 109.09 -42.88 1.84 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.2 m-20 61.9 38.85 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.11 17.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -118.6 -167.02 13.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.98 130.27 18.79 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.697 2.265 . . . . 0.0 111.813 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.29 24.61 76.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.577 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.3 m -79.79 145.16 32.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -1.155 . . . . 0.0 109.525 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 ' N ' HG21 ' A' ' 53' ' ' THR . 62.6 mt -107.88 133.27 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.326 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 41.6 mttt -121.25 151.53 39.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -134.24 120.59 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.356 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 8.7 mt -117.87 134.25 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 40' ' ' LYS . 29.8 p -112.95 139.23 48.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.61 ' CE1' ' CG1' ' A' ' 39' ' ' VAL . 97.7 m-85 -107.73 143.18 36.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.35 36.98 0.93 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.55 -30.13 53.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 0.0 109.568 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.83 -80.09 0.35 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -59.61 -27.25 66.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -1.155 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -125.21 129.49 50.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -126.78 135.75 51.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 176.92 179.27 47.24 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' C ' HG11 ' A' ' 68' ' ' VAL . 39.4 p90 -154.09 144.05 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -1.176 . . . . 0.0 109.585 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.489 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 3.2 m -130.41 147.12 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 109.299 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -109.82 146.36 35.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.647 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 49.8 m80 -117.42 148.29 41.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 39.0 tttm -129.71 141.39 50.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.0 mt -100.09 135.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -88.95 -48.5 7.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 p -166.0 154.45 11.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 pt -128.54 145.2 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -130.63 92.17 3.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.01 -38.58 91.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.43 -42.35 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 71.9 m-20 -86.68 6.6 30.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.473 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 37.3 m80 45.63 46.39 11.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.553 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.5 m -125.27 139.05 54.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 71.7 t80 -130.53 125.59 34.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.8 t -119.23 132.95 55.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 35.2 p90 -148.76 164.98 32.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.597 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 84.9 p -148.13 152.37 37.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.595 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 23.2 tp -87.41 137.51 32.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.596 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 28.5 mm -94.31 -75.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 94.0 mt-10 -118.77 151.23 38.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -169.21 125.52 1.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 67.3 m-20 -48.97 -34.2 12.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 109.378 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.61 -16.5 63.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 7.0 mp -86.47 -39.45 16.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 69.0 m 62.86 173.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.414 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 72.8 mm-40 -74.46 -11.31 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.617 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 127' ' ' VAL . 31.1 m-20 -80.97 -29.42 35.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 28.8 mt -104.54 120.13 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.7 mm-40 -75.84 -178.92 4.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.358 -0.839 . . . . 0.0 109.242 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.2 mttp -56.69 166.33 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.47 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.55 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 62.0 mt -126.51 133.54 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 109.659 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -91.81 126.61 36.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.5 m-85 -116.63 138.16 51.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' HG22 ' A' ' 117' ' ' THR . 94.3 mt-10 -128.05 135.2 49.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.5 m -129.7 131.74 46.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -139.45 124.7 18.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.5 mm? -95.52 132.19 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.3 t -128.96 139.44 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -112.65 145.0 41.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.93 167.14 9.73 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.53 -9.23 25.41 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.696 2.264 . . . . 0.0 111.77 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -78.21 -15.21 59.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.18 -21.27 29.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.34 169.12 50.99 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.4 m -124.45 126.21 45.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -1.193 . . . . 0.0 109.611 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 11' ' ' THR . 65.7 mt -97.6 142.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.492 HG21 ' CD1' ' A' ' 105' ' ' LEU . 2.6 mp -125.73 125.55 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.682 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 28.0 mttt -115.03 139.08 50.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.121 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 102' ' ' GLU . 91.4 m -132.06 135.65 46.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.878 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 40.8 m -124.52 138.32 54.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.367 -0.833 . . . . 0.0 108.958 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -131.53 155.75 46.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 110.041 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 77.0 mttt -138.06 138.49 38.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.514 ' CD2' HG21 ' A' ' 99' ' ' ILE . 32.7 m-85 -116.57 128.77 55.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 109.623 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 76.2 m80 -99.68 150.54 22.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -0.894 . . . . 0.0 109.432 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.49 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 5.8 p -126.01 161.06 28.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HB2' HG21 ' A' ' 127' ' ' VAL . 13.3 mtmt -56.83 -35.91 69.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 165.42 -64.69 0.22 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 57.9 t0 -97.92 -22.31 16.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -1.151 . . . . 0.0 109.715 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.49 ' CG2' ' HB ' ' A' ' 123' ' ' THR . 6.1 m -59.43 112.48 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 109.505 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 98.6 mt-10 -114.65 174.85 5.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.394 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.88 171.4 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -98.51 133.16 43.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.78 -39.97 65.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.33 -38.33 76.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -68.68 -42.24 78.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.78 -43.0 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 109.41 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 23.8 tptm -56.12 -41.6 75.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.64 -46.94 77.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.35 96.46 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 tttp -59.84 -43.16 94.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -1.135 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 76.3 mm-40 -60.46 -43.22 97.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -55.66 -46.1 77.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.28 81.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.346 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.92 85.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.389 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -58.26 -47.21 84.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.55 -43.02 99.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -54.84 -47.09 74.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.426 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -52.15 -40.4 61.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.514 HD13 ' CG2' ' A' ' 34' ' ' ILE . 59.6 mt -63.78 -38.14 90.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.3 -49.46 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.548 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 12' ' ' SER . 86.2 tt0 -59.53 -48.44 81.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.91 92.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 59.1 t80 -57.53 -43.18 84.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' O ' ' ND1' ' A' ' 155' ' ' HIS . 72.8 mt -68.8 -32.17 71.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -70.05 -37.68 75.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 39.8 p30 -100.21 7.6 44.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 155' ' ' HIS . 3.3 p-80 -51.13 121.76 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.537 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.09 -25.53 26.96 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.661 2.241 . . . . 0.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.6 t -129.36 141.81 50.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.8 -33.27 70.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.415 ' O ' ' OD1' ' A' ' 160' ' ' ASN . 93.4 m-85 -114.79 136.65 52.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 159' ' ' TYR . 88.2 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 9.8 p -113.26 139.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -1.228 . . . . 0.0 109.527 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 5' ' ' THR . 74.4 t80 -110.16 145.97 36.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.548 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 68.5 m -93.73 143.73 26.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -127.52 141.45 51.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.68 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 84.3 tt0 -112.49 133.01 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -117.92 134.49 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 83.1 mt-10 -103.16 109.91 21.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.8 t80 -117.59 131.35 56.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.678 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.564 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 18.7 p -91.81 155.83 17.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.238 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 59.7 p -153.61 171.94 17.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.779 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -80.16 -175.43 5.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.807 . . . . 0.0 109.424 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.52 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 4.2 mm 61.74 141.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.952 . . . . 0.0 109.239 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 49.0 Cg_endo -70.65 146.27 54.21 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.492 2.128 . . . . 0.0 112.001 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.82 -51.7 2.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.655 -0.653 . . . . 0.0 111.348 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.18 -50.02 3.2 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.232 1.954 . . . . 0.0 113.123 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 79.3 mttt -61.48 -38.28 86.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.161 . . . . 0.0 109.686 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.81 -25.61 37.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.71 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 63.8 t80 -66.98 -31.69 72.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 77.1 mttt -72.09 -47.53 50.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.0 60.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 56.0 t80 -79.36 -16.82 55.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.402 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 67.6 t -114.12 -60.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 35.8 mt -59.41 -44.48 92.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.213 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 69.7 m-20 -100.99 24.4 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.331 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.22 -37.43 78.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -70.4 -33.13 71.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -94.17 -30.44 14.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.493 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 30.1 tp -64.14 -43.68 94.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 3.8 mt -50.2 -59.79 6.44 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 50.2 Cg_endo -68.9 -16.31 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.549 2.166 . . . . 0.0 111.84 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.6 tptp -69.05 -40.29 78.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' CG2' ' CD1' ' A' ' 147' ' ' LEU . 59.1 mt -67.44 -33.44 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.52 71.27 14.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -69.86 -30.92 21.05 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.613 2.208 . . . . 0.0 111.502 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.58 -23.57 64.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.205 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 -24.81 23.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.331 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.588 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 3.1 t -113.74 133.93 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.345 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -71.92 -50.83 25.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.71 130.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.03 124.81 38.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.27 146.62 46.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.837 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 57.5 mt -104.77 117.81 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.9 mp -63.39 -44.64 94.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 89.9 mt-10 -159.14 155.28 26.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.5 -41.63 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.8 m-20 61.53 35.27 17.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -1.125 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.54 34.11 10.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -120.93 -162.69 11.79 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.17 130.64 19.17 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.699 2.266 . . . . 0.0 111.833 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . 69.31 30.26 71.6 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.55 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 74.4 m -85.86 143.28 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.4 mm -110.97 132.16 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 79.0 mttt -122.83 146.46 47.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -127.71 120.45 28.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.268 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 11.6 mt -117.38 127.49 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -108.6 127.86 54.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -107.06 141.25 38.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.81 131.5 5.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.09 -38.36 62.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -1.118 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.99 -163.04 20.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 89.0 p -125.41 154.8 41.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -1.135 . . . . 0.0 109.495 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' A' ' 63' ' ' SER . 0.2 OUTLIER 69.36 9.43 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 65' ' ' TYR . 44.7 t80 -80.84 -17.71 49.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.541 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . 155.5 131.19 1.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 44.1 p90 -154.63 144.17 21.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' CE1' ' A' ' 70' ' ' HIS . 3.4 m -121.92 147.98 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.339 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 45.9 mttt -108.01 141.21 40.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 68' ' ' VAL . 73.8 m80 -119.85 133.24 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.85 . . . . 0.0 109.148 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' CB ' HD12 ' A' ' 87' ' ' ILE . 21.1 tttt -116.0 139.69 50.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 63.9 mt -98.17 136.26 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.444 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 89.0 m-70 -90.09 -47.73 7.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 t -170.3 158.6 6.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.09 145.06 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.5 m-20 -124.94 92.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.473 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -65.34 -38.47 90.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.59 -42.5 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 74.1 m-20 -86.87 8.36 23.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.464 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.7 m80 45.76 41.66 7.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 m -121.74 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 67.4 t80 -130.78 122.99 28.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -117.27 134.02 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.584 ' CE1' ' CB ' ' A' ' 101' ' ' TYR . 33.9 p90 -151.12 161.79 42.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 93.4 p -139.16 158.32 44.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 87' ' ' ILE . 6.5 tt -98.62 125.1 43.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.51 ' N ' HD21 ' A' ' 86' ' ' LEU . 31.0 mm -73.7 -68.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 87' ' ' ILE . 94.4 mt-10 -140.92 146.44 37.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.657 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' CA ' HD11 ' A' ' 92' ' ' LEU . . . -153.24 160.49 29.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 67.0 m-20 -60.65 -31.07 70.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.482 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 -27.84 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.36 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' CA ' ' A' ' 89' ' ' GLY . 5.7 mp -77.28 -39.74 47.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.387 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 30.6 m 59.52 169.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.31 -8.16 54.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 124' ' ' LYS . 61.2 m-20 -83.93 -27.97 28.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.497 HD12 HG22 ' A' ' 96' ' ' ILE . 18.7 mt -99.73 146.3 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -90.35 179.9 5.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 109.609 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 37.8 mttt -57.55 162.35 3.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.557 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 40.5 mt -118.56 141.04 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.704 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 59.0 t0 -97.74 119.86 37.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.584 ' CB ' ' CE1' ' A' ' 84' ' ' TYR . 95.4 m-85 -113.59 144.87 42.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 91.5 mt-10 -138.67 134.13 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -126.84 132.86 50.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.563 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 116' ' ' LYS . 34.2 tttt -130.21 132.9 46.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.29 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -106.67 115.22 29.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 23.5 t -131.58 145.33 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 3.2 m -114.43 153.47 29.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.42 167.6 8.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.353 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.27 -7.8 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.626 2.217 . . . . 0.0 111.811 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -76.74 -13.98 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.57 -16.34 44.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.32 172.16 41.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 94.8 m -116.05 124.97 51.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.444 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 59.8 mt -96.42 127.54 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.252 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.426 HG12 HD12 ' A' ' 105' ' ' LEU . 51.3 mt -113.35 126.77 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 109.768 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 18.1 mttp -103.49 129.35 50.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 108.97 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -129.23 124.78 35.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.155 -0.966 . . . . 0.0 110.096 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.499 ' CG2' HG23 ' A' ' 5' ' ' THR . 23.4 m -106.6 142.96 35.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 108.964 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -129.12 143.06 50.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 109.913 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 24.4 tttt -149.31 119.73 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 109.082 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.481 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 22.0 m-85 -107.99 133.11 52.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 75.3 m80 -96.47 143.57 27.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 109.273 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.407 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 27.7 p -109.91 152.48 25.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.763 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 2.8 tttt -62.49 -66.14 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 109.339 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -168.08 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 55.0 p30 -133.41 2.13 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 0.0 109.363 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 5.5 p -43.36 -45.82 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.358 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 95.9 mt-10 61.29 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.52 172.4 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.326 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.519 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 52.1 tttp -104.06 125.99 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.55 -38.08 63.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.8 -35.23 79.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.519 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 61.9 m170 -69.51 -40.27 77.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.8 t -68.06 -43.24 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -62.15 -38.51 89.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.24 98.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.57 -39.82 98.35 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.21 -46.21 88.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -1.109 . . . . 0.0 109.439 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -62.72 -44.69 95.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -52.93 -45.92 67.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.23 90.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.3 -30.54 64.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.336 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -74.21 -31.69 62.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.39 -43.73 80.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -54.66 -39.47 68.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.56 -41.71 86.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 109.422 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.556 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 43.5 mt -67.3 -39.24 85.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 30' ' ' LEU . 65.5 mt -54.18 -46.32 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 12' ' ' SER . 42.3 mm-40 -68.89 -40.38 79.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.93 -55.18 27.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -54.85 -56.18 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 109.507 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 44.0 mt -58.7 -40.54 83.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.87 -48.14 70.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.418 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -57.36 -58.86 6.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.403 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 50.1 68.71 3.18 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.36 128.62 15.73 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.803 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.4 t -49.94 -37.33 31.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.52 161.49 24.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -60.38 -32.26 71.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.478 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 121' ' ' TYR . 70.2 t -116.1 136.13 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.479 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.24 136.75 52.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 30.3 m -101.43 135.95 42.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.421 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 118' ' ' THR . 91.5 m-85 -118.82 139.16 52.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.75 135.48 53.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.78 134.18 55.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 94.8 mt-10 -113.96 126.91 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 65.6 t80 -143.08 136.62 28.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 109.471 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.7 p -103.44 152.23 21.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 109.421 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -154.23 171.1 19.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 14' ' ' ILE . 31.9 t0 -71.79 177.52 4.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 HG12 HD23 ' A' ' 152' ' ' LEU . 1.2 mt 69.6 135.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.404 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 48.2 Cg_endo -69.7 150.11 68.15 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.535 2.156 . . . . 0.0 111.96 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.64 -52.27 3.55 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -64.5 -50.5 2.53 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.425 2.083 . . . . 0.0 113.041 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 94.8 mttt -59.62 -35.56 74.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.801 -1.187 . . . . 0.0 109.485 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 18.7 tp -80.37 -33.39 37.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.937 . . . . 0.0 109.372 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' HB2' HD22 ' A' ' 105' ' ' LEU . 72.8 t80 -56.52 -43.43 79.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 98.5 mttt -58.68 -61.09 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 109.646 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -68.59 -7.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.905 . . . . 0.0 109.611 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CD2' HG12 ' A' ' 24' ' ' VAL . 83.1 t80 -84.02 -32.97 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.667 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.539 HG13 ' CD1' ' A' ' 82' ' ' TYR . 24.9 m -127.73 -33.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.757 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.8 tp -60.95 -65.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.66 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 26' ' ' ASP . 33.5 p30 -93.98 18.95 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -69.09 -35.27 76.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.126 -0.984 . . . . 0.0 109.503 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.5 -42.39 67.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.5 t-20 -97.61 -34.2 11.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 2.6 tm? -69.38 -39.3 78.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 30.7 mt -51.1 -56.32 20.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -69.02 -21.66 36.61 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.524 2.15 . . . . 0.0 111.764 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -66.1 -37.28 85.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.526 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG12 ' CE2' ' A' ' 151' ' ' TYR . 73.3 mt -68.53 -27.16 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.22 69.99 10.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -70.48 -31.61 17.03 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.04 -28.36 60.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.15 -44.11 76.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 ' CG2' ' A' ' 57' ' ' ILE . 4.7 p -125.02 154.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 39' ' ' VAL . 70.4 tttt -77.33 -47.77 19.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.962 . . . . 0.0 109.447 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.15 141.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.529 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.58 119.52 30.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.22 140.67 37.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 55' ' ' LYS . 60.2 mt -106.49 117.55 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 6.5 mp -64.28 -45.76 86.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 53' ' ' THR . 67.3 mm-40 -157.72 155.22 29.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.4 -42.4 1.93 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 85.4 m-20 60.3 36.06 20.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.08 32.88 11.53 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -118.27 -166.34 13.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.85 132.65 23.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.693 2.262 . . . . 0.0 111.656 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.13 29.39 73.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 84.8 m -84.72 144.52 28.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.136 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.478 ' N ' HG21 ' A' ' 53' ' ' THR . 60.1 mt -110.51 128.52 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 44' ' ' ILE . 31.5 mttt -116.57 149.33 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 20.2 tttt -129.88 121.21 26.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.556 HD11 ' CD2' ' A' ' 70' ' ' HIS . 44.9 mt -110.81 134.49 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -119.24 123.13 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -92.55 138.02 31.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.9 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.98 -165.91 41.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.93 135.95 57.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 65' ' ' TYR . . . -179.31 -164.05 31.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.7 m -66.02 -24.58 66.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -128.22 139.13 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 62' ' ' GLY . 58.3 m-85 -119.29 135.79 54.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 151.39 -166.93 30.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 37.1 p90 -147.32 147.92 30.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 109.445 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 48.8 t -123.51 149.88 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' O ' HD21 ' A' ' 86' ' ' LEU . 51.4 mtpt -123.6 143.57 50.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.556 ' CD2' HD11 ' A' ' 57' ' ' ILE . 66.6 m-70 -122.58 141.67 51.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.613 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 82.8 tttt -123.25 139.13 54.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 54.1 mt -97.76 134.18 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.507 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 88.9 m-70 -89.48 -47.6 7.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -170.65 153.79 4.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.15 143.79 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.399 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.48 93.03 3.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -63.15 -35.6 80.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.91 -40.61 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -87.44 1.83 52.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 43.4 m80 50.66 40.51 24.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.5 m -123.02 138.49 54.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.539 ' CD1' HG13 ' A' ' 24' ' ' VAL . 80.3 t80 -127.22 125.94 41.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -117.57 134.37 54.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 109.694 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 29.9 p90 -148.46 167.74 24.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.326 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.507 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 97.1 p -144.23 159.01 43.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.495 ' CD2' HD12 ' A' ' 92' ' ' LEU . 4.5 tt -98.99 133.37 43.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 71' ' ' LYS . 75.8 mt -94.69 -74.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' O ' HG11 ' A' ' 68' ' ' VAL . 95.7 mt-10 -116.08 157.96 23.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 174.82 155.65 12.77 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 64.3 m-20 -62.37 -29.6 70.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -1.151 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' O ' ' CD1' ' A' ' 96' ' ' ILE . . . -69.5 -32.1 70.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.7 mt -74.27 -32.94 63.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.037 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.65 -177.56 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.537 -0.727 . . . . 0.0 109.287 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' C ' ' HE3' ' A' ' 124' ' ' LYS . 90.1 mt-10 -88.47 18.56 4.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.568 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 127' ' ' VAL . 14.1 m120 -125.64 -9.59 6.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.869 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 14.2 mt -108.55 145.43 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.055 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 88.3 mt-10 -90.04 -179.83 5.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -57.53 166.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.606 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 81.7 mt -125.49 134.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 25.1 t70 -92.25 126.26 37.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 76.0 m-85 -118.72 140.45 49.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.496 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.36 137.52 47.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.433 HG22 ' CZ ' ' A' ' 23' ' ' PHE . 45.3 m -127.45 133.54 49.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -131.11 132.14 44.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD13 HG12 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -107.72 124.07 49.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.5 143.48 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.0 p -108.44 148.04 30.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 109' ' ' PRO . . . -111.79 166.74 10.28 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 108' ' ' ALA . 48.5 Cg_endo -69.38 -19.35 38.07 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.741 2.294 . . . . 0.0 111.822 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.57 -17.65 64.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.386 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.75 -23.89 18.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.7 179.75 52.14 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 63.8 m -126.62 126.37 43.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -1.185 . . . . 0.0 109.648 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -92.91 140.67 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.448 HG12 HD13 ' A' ' 105' ' ' LEU . 62.7 mt -127.83 124.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 49.7 mttt -105.62 136.31 45.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.3 m -128.58 126.43 40.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 18.4 m -120.04 138.27 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 108.812 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -137.22 147.02 45.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.231 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 100' ' ' ASP . 91.2 mttt -129.81 144.08 51.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 99' ' ' ILE . 55.2 m-85 -119.42 129.02 54.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.671 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -96.66 141.96 29.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.384 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.489 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 80.7 p -106.08 145.05 31.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 40.5 mttt -67.8 -42.89 80.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.03 -75.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -104.23 7.16 35.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.133 . . . . 0.0 109.532 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 123' ' ' THR . 14.0 p -64.7 132.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -129.02 151.08 50.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 0.0 109.499 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.41 171.56 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -102.26 133.9 46.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -53.28 -39.8 64.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.406 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 73.6 mm-40 -60.43 -38.01 82.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -67.53 -42.18 83.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.0 -45.11 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.418 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -56.58 -40.38 75.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.1 -41.67 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.76 -41.41 95.91 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -62.54 -42.24 99.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -1.145 . . . . 0.0 109.392 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.78 -42.83 94.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 32.7 tttm -56.4 -46.11 80.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.42 68.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.71 75.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.443 ' O ' HD23 ' A' ' 147' ' ' LEU . 85.1 t60 -60.63 -43.65 97.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 73.6 mt -56.08 -46.13 79.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -54.81 -33.15 61.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -66.53 -39.77 88.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HG ' ' CG2' ' A' ' 34' ' ' ILE . 3.6 mm? -64.31 -45.06 89.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.381 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.464 ' O ' HD12 ' A' ' 152' ' ' LEU . 81.9 mt -57.04 -55.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.318 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -54.67 -35.95 64.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.95 -29.8 66.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.523 ' CE2' HG12 ' A' ' 34' ' ' ILE . 8.7 m-30 -69.45 -45.4 69.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.5 mp -75.05 -50.42 16.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -53.39 -35.84 60.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.096 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.86 -33.37 40.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.318 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.79 66.4 4.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.98 -12.37 32.35 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.726 2.284 . . . . 0.0 111.671 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 99.8 p -118.28 151.66 37.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.69 144.28 38.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 160' ' ' ASN . 36.4 p90 -65.03 -32.73 74.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.464 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' TYR . 77.3 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 32.6 t -118.17 139.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -117.93 155.9 29.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.521 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 10.6 m -93.84 138.83 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 118' ' ' THR . 94.2 m-85 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -114.98 135.84 53.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -120.83 132.51 55.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -107.63 129.14 55.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.538 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.9 t80 -143.19 141.71 31.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.4 p -107.93 148.58 29.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.6 p -149.29 170.8 17.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.979 . . . . 0.0 109.527 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' C ' HD12 ' A' ' 14' ' ' ILE . 14.0 t0 -80.28 -175.86 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.459 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 152' ' ' LEU . 1.1 mp 67.79 140.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -70.21 149.6 64.27 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.213 . . . . 0.0 111.911 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.73 -52.19 3.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.2 -50.34 2.91 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.461 2.107 . . . . 0.0 112.915 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 67.5 mttm -58.91 -34.87 72.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.875 -1.14 . . . . 0.0 109.546 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 152' ' ' LEU . 8.5 tp -81.06 -28.9 35.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.728 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 56.9 t80 -68.76 -33.3 73.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 17.8 tttp -67.14 -45.35 77.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -25.58 36.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 52.0 t80 -83.79 -15.6 47.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.44 HG21 ' CD2' ' A' ' 20' ' ' PHE . 84.6 t -117.81 -67.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 28.5 tp -55.82 -41.71 74.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.432 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.4 m-20 -97.78 14.72 25.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -68.64 -37.11 79.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.84 -40.75 89.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.7 m120 -94.4 -31.56 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.521 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 38.9 tp -66.44 -42.25 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 6.6 mt -49.99 -57.97 10.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.442 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.68 -22.39 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.485 2.123 . . . . 0.0 111.742 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 151' ' ' TYR . 11.3 tptt -68.5 -42.01 79.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.489 HD13 ' CB ' ' A' ' 147' ' ' LEU . 23.8 mm -61.36 -24.99 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.86 75.06 3.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.7 -32.99 17.74 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.635 2.223 . . . . 0.0 111.645 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -21.77 61.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.62 -41.92 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.419 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' CG1' ' CE2' ' A' ' 59' ' ' PHE . 21.7 m -126.84 148.24 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.402 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HE2' ' CG2' ' A' ' 58' ' ' THR . 11.1 mtmt -72.4 -51.62 19.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.94 129.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.61 124.49 29.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -117.59 146.41 43.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -104.19 126.83 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 4.0 mm? -71.1 -41.47 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.38 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 90.7 mt-10 -159.26 151.16 20.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 107.68 -42.92 1.81 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 44' ' ' ILE . 51.7 t0 64.17 39.63 7.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 0.0 109.569 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 83.25 37.02 13.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.86 -165.99 13.13 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.09 132.69 23.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.702 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 65.43 28.46 73.6 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 84.6 m -82.84 144.13 30.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -1.102 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.507 ' N ' HG23 ' A' ' 53' ' ' THR . 59.5 mt -105.12 126.09 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 mtpt -115.09 152.98 31.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -135.71 124.77 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 70' ' ' HIS . 13.6 mt -113.03 131.75 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.515 ' CG2' ' HE2' ' A' ' 40' ' ' LYS . 75.0 m -109.47 120.62 43.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CE2' ' CG1' ' A' ' 39' ' ' VAL . 90.1 m-85 -92.53 135.74 33.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.67 -176.42 36.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 22.0 pt-20 -52.02 125.02 14.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -1.188 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.565 ' O ' ' CZ ' ' A' ' 65' ' ' TYR . . . 167.58 -156.98 29.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -70.71 -12.54 61.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -1.187 . . . . 0.0 109.442 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -114.3 138.64 50.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.44 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 62' ' ' GLY . 91.6 m-85 -130.69 150.27 51.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.92 -166.5 41.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 46.0 p90 -139.07 150.15 45.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 109.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.546 ' CG1' ' CA ' ' A' ' 89' ' ' GLY . 3.3 m -126.6 147.09 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' O ' HD22 ' A' ' 86' ' ' LEU . 70.2 mttt -109.54 147.23 33.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.569 ' CD2' HD11 ' A' ' 57' ' ' ILE . 48.1 m-70 -125.21 140.1 53.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 23.9 tttt -114.96 140.87 48.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 53' ' ' THR . 65.3 mt -98.18 135.27 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.6 m-70 -89.35 -47.21 8.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -175.09 155.49 1.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.567 HG21 ' CE1' ' A' ' 82' ' ' TYR . 35.0 pt -131.05 144.69 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -127.26 93.11 3.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -62.99 -35.94 81.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -72.32 -39.91 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 80' ' ' HIS . 74.7 m-20 -89.3 7.4 35.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.478 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASN . 37.4 m80 44.28 48.83 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 103' ' ' THR . 89.3 m -129.91 129.7 44.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.543 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 75' ' ' ILE . 52.6 t80 -122.19 129.93 52.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.255 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p -124.61 134.62 52.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 35.2 p90 -151.39 164.86 35.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.275 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 77.4 p -142.44 162.44 35.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 99' ' ' ILE . 4.6 tt -101.98 131.49 48.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.507 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 71' ' ' LYS . 80.3 mt -91.98 -76.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.434 -0.791 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 69' ' ' LYS . 89.0 mt-10 -118.96 147.08 44.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.425 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.546 ' CA ' ' CG1' ' A' ' 68' ' ' VAL . . . -166.33 146.44 10.96 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 65' ' ' TYR . 4.1 t0 -49.2 -46.54 45.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -1.153 . . . . 0.0 109.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.94 -22.83 65.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 6.0 mp -86.77 -37.87 17.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 4.3 m 58.03 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 95.2 mt-10 -64.96 -9.17 19.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.76 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 124' ' ' LYS . 23.1 m120 -77.41 -35.05 54.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 110.098 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 95' ' ' ASN . 9.0 pt -152.1 106.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 110.189 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 93' ' ' SER . 15.7 mt-10 -135.13 107.49 7.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 109.184 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HD3' ' CB ' ' A' ' 122' ' ' HIS . 15.8 tttt -179.11 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.615 ' CG2' ' CE2' ' A' ' 101' ' ' TYR . 14.1 mt -125.99 123.64 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 54.2 t0 -104.48 113.15 26.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.434 -0.791 . . . . 0.0 108.905 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 73.5 m-85 -103.47 143.07 33.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.98 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -134.7 132.26 38.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.087 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 81' ' ' THR . 41.3 m -123.26 135.26 54.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -141.23 125.61 17.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 16' ' ' ALA . 22.1 mt -98.51 130.46 45.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.3 t -131.9 145.2 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 109.422 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -113.95 142.56 45.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.36 167.55 9.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.81 -14.64 36.2 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.698 2.265 . . . . 0.0 111.843 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -71.2 -16.75 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.02 -16.81 38.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.31 173.21 47.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.4 m -119.32 122.28 41.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -1.131 . . . . 0.0 109.53 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.1 mt -92.57 134.04 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.426 HG12 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -117.9 130.92 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -111.42 129.44 56.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.321 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.3 m -125.26 128.83 48.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.67 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.521 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 38.9 m -115.25 135.85 53.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.35 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -123.26 140.13 53.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.696 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 10.9 ttpt -125.95 139.33 53.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CG ' ' CG1' ' A' ' 134' ' ' VAL . 69.8 m-85 -122.44 135.6 54.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' CB ' ' HD3' ' A' ' 98' ' ' LYS . 1.4 m80 -125.45 -167.11 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.3 p -135.33 152.53 51.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' ASN . 19.6 tptm -59.38 -53.61 56.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -168.74 -70.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.58 4.47 18.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -1.181 . . . . 0.0 109.967 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 95' ' ' ASN . 43.1 t -95.34 115.76 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -96.11 170.58 9.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.593 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 171.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 133' ' ' HIS . 23.1 mtpt -97.01 136.79 37.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.56 -33.76 70.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.65 -36.47 82.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 130' ' ' LYS . 36.3 m-70 -74.29 -39.25 63.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.377 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.569 ' CG1' ' CG ' ' A' ' 121' ' ' TYR . 58.5 t -67.44 -42.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -58.41 -40.67 83.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.68 -44.01 72.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.42 -42.76 95.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -57.9 -44.05 86.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.403 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -53.54 -44.59 69.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.06 79.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.05 84.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.513 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.571 ' CE1' HD22 ' A' ' 147' ' ' LEU . 58.4 t-80 -60.03 -44.16 94.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.13 -43.08 91.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.2 -38.26 65.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -61.3 -38.55 87.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 143' ' ' HIS . 3.2 mm? -69.83 -29.75 67.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 34.0 mm -60.93 -44.19 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.36 -47.28 67.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.16 -30.96 71.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 33' ' ' LYS . 61.4 t80 -63.46 -49.04 75.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 14' ' ' ILE . 59.6 mt -61.46 -43.6 98.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -60.9 -42.63 98.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.11 -39.54 92.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.421 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.97 160.03 41.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.04 161.35 46.28 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.634 2.222 . . . . 0.0 111.844 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.1 m -53.31 -32.94 51.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.408 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -87.09 139.41 30.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -107.03 135.0 49.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.538 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 11.7 p -118.32 143.66 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -112.13 144.68 41.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 40.5 m -93.76 141.25 28.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -117.51 132.09 56.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.59 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.79 137.28 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -118.56 154.16 33.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 70.4 tt0 -133.96 109.87 9.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 43.0 t80 -122.66 128.78 51.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 21.1 p -92.32 149.47 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.296 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.3 p -146.18 166.73 25.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -0.949 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -73.17 -175.7 1.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 65.41 142.48 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.107 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.7 Cg_endo -69.0 146.37 64.62 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.414 2.076 . . . . 0.0 112.041 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.612 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -45.13 -48.12 32.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 111.401 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.72 -40.11 30.99 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.231 1.954 . . . . 0.0 113.094 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 29.7 mttm -67.97 -37.44 81.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -80.57 -28.0 37.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.721 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.91 -33.83 76.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.132 -0.98 . . . . 0.0 109.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 73.5 tttt -66.75 -46.25 75.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.614 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.06 40.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.698 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -80.52 -19.98 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.2 t -117.15 -63.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 109.559 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 32.4 mt -56.88 -40.74 76.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.302 -0.874 . . . . 0.0 109.581 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.9 m-20 -100.34 15.29 28.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.78 -41.57 74.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.685 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 90.4 m-20 -66.07 -30.36 70.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.714 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 94.1 m-20 -97.33 -32.18 12.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 109.589 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 28.4 tp -69.9 -46.5 65.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 5.7 mt -47.0 -57.36 9.37 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.2 Cg_endo -68.73 -25.77 33.43 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.52 2.146 . . . . 0.0 111.867 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 60.7 tttt -75.51 -44.25 44.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.561 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 HG22 ' CB ' ' A' ' 147' ' ' LEU . 62.6 mt -67.78 -34.18 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.677 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.21 72.66 32.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.504 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.1 Cg_endo -70.53 -34.4 12.09 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.713 2.275 . . . . 0.0 111.782 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.22 78.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG11 ' CE1' ' A' ' 59' ' ' PHE . 23.7 m -125.37 155.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -73.22 -44.64 59.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.79 129.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.13 126.19 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -122.47 150.19 42.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.583 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.7 mt -106.35 121.47 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.7 mp -65.74 -43.99 87.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.412 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.3 mt-10 -159.24 155.06 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.64 -41.0 2.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 89.2 m-20 60.54 40.47 16.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -1.102 . . . . 0.0 109.481 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.74 35.98 12.48 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.69 13.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.7 128.26 15.83 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.698 2.266 . . . . 0.0 111.715 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.65 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.583 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 90.0 m -81.07 143.32 32.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 109.587 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.468 ' N ' HG21 ' A' ' 53' ' ' THR . 62.5 mt -110.14 131.67 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.313 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 50.3 mttt -116.42 150.42 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HG3' ' HE2' ' A' ' 69' ' ' LYS . 25.1 tttm -129.63 125.87 37.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.188 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 HD11 ' ND1' ' A' ' 70' ' ' HIS . 32.6 mt -117.39 137.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 50.4 m -114.51 133.2 55.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.554 ' CE1' HG11 ' A' ' 39' ' ' VAL . 91.2 m-85 -103.53 130.33 50.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . -93.99 -69.29 1.08 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.24 133.47 39.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 0.0 109.377 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 -172.18 49.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.5 m 46.32 25.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -1.121 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' TYR . 56.3 m170 46.2 45.78 12.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 15.3 m-85 44.06 36.09 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -90.49 -179.33 43.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 44.1 p90 -144.05 146.72 33.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -1.106 . . . . 0.0 109.398 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 10.8 m -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 81.5 mttt -119.46 147.58 44.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.502 ' ND1' HD11 ' A' ' 57' ' ' ILE . 62.6 m80 -115.95 166.57 11.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.231 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' SER . 42.5 tttp -143.78 140.72 30.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.473 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.4 mt -104.95 127.51 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 74' ' ' SER . 98.6 m-70 -88.8 -29.98 19.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 91.9 p 178.1 154.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.784 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.504 HG21 ' CD1' ' A' ' 82' ' ' TYR . 38.3 pt -135.04 139.56 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -122.7 93.29 3.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -63.27 -37.89 89.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.267 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.06 -41.18 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -88.59 6.18 39.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.561 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m80 46.54 50.57 12.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 103' ' ' THR . 58.2 m -129.76 132.64 46.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.522 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 69.2 t80 -125.19 128.89 49.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.29 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -127.49 139.35 52.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.4 p90 -158.41 177.49 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.437 -0.789 . . . . 0.0 109.091 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 71' ' ' LYS . 89.1 p -151.7 154.77 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' CD2' HD12 ' A' ' 92' ' ' LEU . 25.5 tp -87.91 124.01 33.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.098 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 88.5 mt -80.69 -75.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.852 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 mt-10 -126.46 158.24 36.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 0.0 109.836 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -178.0 134.72 2.49 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 51.2 m-20 -50.67 -37.69 42.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -1.16 . . . . 0.0 109.367 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.36 -17.37 63.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.152 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.53 HD12 ' CD2' ' A' ' 86' ' ' LEU . 6.8 mp -82.6 -42.11 18.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 3.3 t 60.13 177.18 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.523 ' O ' ' CD ' ' A' ' 124' ' ' LYS . 97.9 mt-10 -78.89 -3.09 42.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' O ' HG23 ' A' ' 127' ' ' VAL . 34.0 p-10 -90.76 -21.37 21.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 41.6 mt -112.39 132.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.069 -1.02 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 94.4 mt-10 -90.62 -178.56 5.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.148 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 75.6 mttt -56.14 156.63 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.361 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 120' ' ' LYS . 55.4 mt -118.4 136.2 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.668 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 120' ' ' LYS . 91.7 m-20 -92.15 123.84 35.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.395 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 76.2 m-85 -113.79 139.17 49.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.9 mt-10 -134.33 138.85 45.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.403 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' TYR . 28.3 m -127.96 137.45 52.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -139.14 125.32 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.8 mm? -101.5 129.56 47.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' ILE . 50.8 t -131.78 144.33 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -109.64 151.99 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.1 160.68 28.09 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.95 -17.0 36.97 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.639 2.226 . . . . 0.0 111.855 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -77.58 -12.3 59.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.53 30.46 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.46 172.3 55.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 14' ' ' ILE . 99.7 m -124.61 128.23 48.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -1.123 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.5 mt -99.06 136.24 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.455 HG12 HD11 ' A' ' 105' ' ' LEU . 62.7 mt -119.75 131.19 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 51.8 mttp -116.84 125.85 52.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -126.07 137.86 53.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 56.3 m -119.86 135.52 54.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -123.33 137.59 54.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.705 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 67.5 tttt -143.76 134.45 25.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.235 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 39.4 p90 -132.53 146.56 52.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 94.9 m-70 -108.78 159.17 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.495 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 28.6 p -131.17 161.76 31.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' GLU . 4.2 mtmp? -56.94 -35.0 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.389 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -172.58 64.75 0.13 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 90.6 m-20 60.72 38.61 18.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -1.134 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 123' ' ' THR . 18.6 m -48.95 135.2 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.74 139.17 39.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 tt -129.5 170.8 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.537 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 43.2 mttt -92.39 129.23 38.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -55.7 -38.07 69.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.29 -37.56 80.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.373 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.537 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 64.4 m170 -67.61 -43.98 79.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.261 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.44 -45.67 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 109.472 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 24.8 tttt -60.67 -43.83 97.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -59.23 -46.78 87.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.58 97.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.63 -45.85 92.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.117 . . . . 0.0 109.334 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 94.9 mt-10 -61.94 -42.46 99.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 55.9 mtmt -59.0 -43.97 91.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.7 72.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.383 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.44 79.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.443 ' O ' HD21 ' A' ' 147' ' ' LEU . 64.4 m170 -59.26 -47.4 85.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.297 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 53.6 mt -53.45 -48.82 68.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.417 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -54.01 -37.86 64.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -58.75 -41.44 86.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -68.33 -37.7 80.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.299 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 19' ' ' LEU . 81.7 mt -59.34 -48.6 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.283 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.5 -47.61 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.02 -33.55 84.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.42 -46.9 80.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.45 HD13 HD12 ' A' ' 19' ' ' LEU . 64.3 mt -66.15 -40.03 90.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -64.09 -41.17 97.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.71 -33.94 77.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 109.514 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 132.62 75.23 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.09 152.74 67.73 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.662 2.241 . . . . 0.0 111.856 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' ASN . 21.1 t -70.6 148.91 47.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.444 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.57 -32.97 74.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 160' ' ' ASN . 18.9 m-30 -62.58 -34.82 77.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 157' ' ' SER . 43.4 p-10 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.495 ' CG1' ' HE2' ' A' ' 120' ' ' LYS . 13.6 p -113.53 140.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -92.17 141.45 28.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.563 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 38.7 m -93.66 142.66 27.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -119.67 144.35 47.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.533 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE2' ' HD3' ' A' ' 116' ' ' LYS . 85.5 tt0 -112.81 141.55 46.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -116.04 142.82 46.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -121.23 138.79 54.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.5 t80 -156.3 145.27 20.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.6 p -112.46 147.64 36.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -150.46 171.62 16.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 14' ' ' ILE . 6.8 t70 -78.66 179.54 7.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.34 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.528 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 70.2 142.11 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 109.155 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.6 Cg_endo -68.75 145.9 64.68 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.566 2.177 . . . . 0.0 112.148 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.09 -47.62 43.36 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 111.543 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.1 Cg_endo -64.32 -37.17 41.54 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.081 1.854 . . . . 0.0 113.003 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 78.6 mttt -71.42 -32.43 68.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.884 -1.135 . . . . 0.0 109.556 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.8 tp -80.8 -30.38 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 82' ' ' TYR . 75.0 t80 -61.09 -41.47 96.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.594 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 34.1 tttm -65.16 -52.81 52.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.632 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -8.11 52.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 79.6 t80 -85.45 -34.67 21.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.575 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' CG1' ' CD1' ' A' ' 82' ' ' TYR . 33.1 m -114.48 -37.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' CD2' ' HE2' ' A' ' 21' ' ' LYS . 17.5 tp -71.18 -38.55 72.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.662 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 30' ' ' LEU . 89.2 m-20 -108.09 14.38 25.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.9 -39.69 76.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.533 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' OD2' HD12 ' A' ' 44' ' ' ILE . 89.3 m-20 -58.62 -33.03 69.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.624 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.0 t30 -101.38 -35.91 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 26' ' ' ASP . 2.1 tm? -72.49 -37.47 68.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.7 mt -50.79 -55.8 24.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.2 Cg_endo -68.47 -18.91 43.51 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.43 2.087 . . . . 0.0 111.821 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 40.2 mttt -71.03 -36.71 72.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.51 HG23 ' CB ' ' A' ' 147' ' ' LEU . 79.7 mt -66.63 -29.27 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 38' ' ' ALA . . . -155.87 72.2 5.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.6 Cg_endo -69.89 -32.27 18.35 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.665 2.244 . . . . 0.0 111.771 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -75.23 -25.83 58.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 35' ' ' ALA . . . -73.63 -39.49 64.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.5 p -118.06 151.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' N ' HG21 ' A' ' 39' ' ' VAL . 54.0 tttt -77.56 -47.94 18.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 129.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.22 128.02 34.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -122.52 148.59 44.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 65.6 mt -106.45 118.14 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.428 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 6.8 mp -61.67 -45.41 94.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 53' ' ' THR . 67.5 mm-40 -157.83 156.04 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.23 -41.01 2.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.1 m-20 59.1 36.73 24.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 109.488 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.17 33.31 10.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -119.83 -164.99 12.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.72 130.77 19.96 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 30.93 70.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 89.3 m -86.36 141.9 28.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.506 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.419 ' N ' HG22 ' A' ' 53' ' ' THR . 63.3 mt -109.57 129.95 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.335 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 44' ' ' ILE . 48.0 mttt -116.2 146.56 42.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.613 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HB2' HD13 ' A' ' 45' ' ' LEU . 21.7 tttm -131.06 122.33 26.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.509 HG21 ' CG2' ' A' ' 39' ' ' VAL . 28.5 mt -114.98 137.95 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -118.57 131.04 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -104.07 135.81 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.562 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.7 -170.06 54.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.95 -30.2 67.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -1.141 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.06 5.79 62.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.1 p -65.78 -24.42 66.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -125.75 176.08 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.898 . . . . 0.0 109.454 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -54.27 168.64 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 126.21 65.39 0.16 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.5 p90 -151.45 144.25 24.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -1.14 . . . . 0.0 109.61 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 48.4 t -122.28 146.46 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' N ' HG11 ' A' ' 68' ' ' VAL . 26.8 mttt -119.83 139.52 52.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 77.2 m80 -119.64 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 19.2 tttt -112.61 141.17 46.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 109.553 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 HD13 ' OH ' ' A' ' 82' ' ' TYR . 66.6 mt -99.51 134.54 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -91.73 -49.16 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.9 p -167.61 154.7 8.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.569 HG21 ' CD1' ' A' ' 82' ' ' TYR . 39.1 pt -129.53 144.39 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -128.73 91.19 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -63.75 -34.63 78.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.43 -39.24 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -87.82 4.8 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.5 m80 48.12 46.04 19.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.2 m -130.96 132.14 44.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.577 ' CD1' ' CG1' ' A' ' 24' ' ' VAL . 78.5 t80 -124.88 121.27 34.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.353 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.1 p -111.81 139.91 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 33.0 p90 -155.59 167.95 28.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 90.4 p -146.31 158.28 43.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.503 ' CD2' ' CD1' ' A' ' 92' ' ' LEU . 5.4 tt -96.5 121.96 38.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 69' ' ' LYS . 94.8 mt -76.75 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.468 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 95.8 mt-10 -133.44 159.92 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.93 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -174.36 162.2 32.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.451 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 39.2 m-20 -65.05 -29.62 70.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 109.631 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 96' ' ' ILE . . . -78.59 -21.75 48.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 92' ' ' LEU . 5.6 mt -78.68 -30.17 45.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 108.999 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 92' ' ' LEU . 66.6 m 46.37 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.88 9.88 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HB3' ' CG2' ' A' ' 127' ' ' VAL . 76.3 m-20 -110.14 -15.55 13.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 18.7 mt -109.36 137.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB2' ' C ' ' A' ' 122' ' ' HIS . 99.6 mt-10 -84.55 -179.4 7.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.299 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 35.4 mtmm -57.21 164.43 1.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 120' ' ' LYS . 53.4 mt -121.79 131.85 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.525 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 120' ' ' LYS . 90.2 m-20 -90.74 126.33 35.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 66.6 m-85 -116.93 142.06 47.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.2 mt-10 -129.19 136.08 49.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.8 m -125.95 129.25 48.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.36 128.1 40.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.169 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 3.0 mm? -99.47 123.3 43.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.2 t -130.83 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 72.2 m -113.78 153.43 29.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . . . -110.56 162.44 20.59 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 108' ' ' ALA . 49.1 Cg_endo -69.79 -18.83 36.66 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.613 2.209 . . . . 0.0 111.713 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -67.3 -15.43 63.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.877 . . . . 0.0 109.375 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.92 35.6 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.54 176.37 44.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 14' ' ' ILE . 98.1 m -117.76 129.26 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.2 mt -98.92 131.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.432 HD12 HD23 ' A' ' 19' ' ' LEU . 39.8 mt -117.38 132.72 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.621 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HD3' ' OE2' ' A' ' 7' ' ' GLU . 84.5 mttt -117.68 132.27 56.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.31 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.4 m -130.77 126.92 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.501 ' CG2' HG23 ' A' ' 5' ' ' THR . 32.8 m -108.71 145.76 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -130.85 137.23 49.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.831 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 100' ' ' ASP . 22.1 tttt -141.67 131.78 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.155 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' HB3' HG21 ' A' ' 99' ' ' ILE . 42.5 p90 -129.02 148.09 50.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.426 ' C ' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -116.58 166.72 11.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 126' ' ' ASP . 35.1 p -129.94 156.97 43.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.77 -41.75 78.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -141.42 42.66 1.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.459 ' HA ' ' OG1' ' A' ' 123' ' ' THR . 91.1 m-20 60.19 46.46 10.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 95' ' ' ASN . 9.6 p -55.0 -21.5 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 83.6 tt0 63.79 143.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 tt -124.25 170.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 30.0 mttp -85.56 122.27 29.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.943 . . . . 0.0 109.293 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -47.52 -37.83 12.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.152 -0.967 . . . . 0.0 109.431 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 70.2 mm-40 -57.29 -38.83 74.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.312 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.42 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 67.2 m170 -66.16 -44.33 84.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.325 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.51 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 109.274 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -56.48 -42.55 78.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.62 97.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.81 93.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -58.89 -44.01 91.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.306 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.37 -39.67 89.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 18.7 tttt -58.25 -45.53 87.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 109.36 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.69 -47.9 73.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.79 88.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.381 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.44 ' O ' HD23 ' A' ' 147' ' ' LEU . 52.5 m170 -58.98 -46.81 87.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 59.8 mt -55.57 -50.97 68.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.385 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 141' ' ' ALA . 73.5 m-85 -53.46 -38.04 63.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -61.97 -42.35 99.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.51 ' CB ' HG23 ' A' ' 34' ' ' ILE . 4.1 mm? -63.93 -45.02 91.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 72.1 mt -55.63 -54.54 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.64 -29.95 53.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.93 -32.07 59.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 57.7 m-85 -73.03 -43.25 62.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 152' ' ' LEU . 6.3 mp -75.12 -45.75 38.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -55.74 -34.47 65.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.985 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.17 -32.82 21.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.342 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 60.1 60.09 4.13 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 151' ' ' TYR . 49.7 Cg_endo -70.38 147.93 59.96 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.707 2.272 . . . . 0.0 111.664 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.4 m -116.62 147.3 42.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -106.74 148.41 28.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -64.21 -32.49 74.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.538 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 7.7 p -105.86 142.6 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -1.202 . . . . 0.0 109.452 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.89 136.63 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 29.1 m -93.61 137.19 33.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 109.367 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' CE2' ' HE3' ' A' ' 138' ' ' LYS . 68.4 t80 -119.64 132.79 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -113.94 135.53 53.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.85 . . . . 0.0 109.357 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 42.4 t-20 -119.64 141.12 49.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -115.1 138.14 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 78.1 t80 -154.9 146.53 23.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.8 p -113.22 147.17 38.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.411 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 59.8 p -149.61 171.67 16.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.651 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 14' ' ' ILE . 13.4 t0 -77.85 -175.45 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 68.71 141.06 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.9 Cg_endo -69.66 147.16 62.87 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.618 2.212 . . . . 0.0 112.115 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.86 -50.32 7.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.08 -45.75 9.53 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.297 1.998 . . . . 0.0 113.003 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 20.9 mttm -61.42 -33.04 73.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.782 -1.199 . . . . 0.0 109.542 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD1' HD21 ' A' ' 152' ' ' LEU . 12.4 tp -80.55 -31.75 36.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.725 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.0 -32.05 71.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 109.848 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 23.2 tttt -65.98 -44.57 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.609 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.55 -19.73 32.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 55.9 t80 -83.29 -15.92 48.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.3 t -118.53 -63.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.363 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 42.1 mt -57.97 -43.63 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.8 m-20 -96.24 15.42 21.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.391 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -69.49 -22.23 63.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.475 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 90.2 m-20 -77.36 -35.54 54.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 m120 -98.01 -31.5 12.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.491 ' CD2' HG23 ' A' ' 148' ' ' ILE . 18.4 tp -63.3 -39.06 93.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 1.1 mp -55.53 -59.42 11.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 50.5 Cg_endo -70.67 -11.27 29.39 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.674 2.249 . . . . 0.0 111.605 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -73.33 -43.94 59.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.857 . . . . 0.0 109.395 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' CG2' ' CD2' ' A' ' 147' ' ' LEU . 86.5 mt -66.6 -38.81 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.71 76.44 23.91 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.47 -31.64 17.01 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.714 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -74.49 -22.6 58.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' OE2' ' A' ' 61' ' ' GLU . . . -71.81 -37.53 70.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.87 . . . . 0.0 109.362 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.6 p -120.45 146.35 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -73.64 -45.99 49.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.1 142.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.563 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.97 130.32 53.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -127.63 154.12 45.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.568 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 25.9 mt -105.85 122.04 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.7 mp -68.15 -43.76 77.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.361 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.3 mt-10 -159.3 157.7 31.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.47 -40.46 2.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' HA ' HD12 ' A' ' 44' ' ' ILE . 89.8 m-20 58.95 37.44 24.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 26.32 29.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -111.63 -166.3 18.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.93 130.07 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.682 2.255 . . . . 0.0 111.757 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.27 69.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.568 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 97.9 m -80.77 142.53 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -1.181 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 53' ' ' THR . 64.3 mt -112.86 130.1 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 71.7 mttt -124.75 146.38 49.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.647 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -122.83 121.72 36.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 17.4 mt -114.75 132.51 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.2 m -113.12 116.82 30.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 53.9 p90 -119.99 143.54 47.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 65' ' ' TYR . . . -126.53 46.98 1.04 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.423 ' OE2' ' CB ' ' A' ' 38' ' ' ALA . 97.6 mt-10 -67.44 -42.76 82.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.52 175.1 54.45 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.6 p -56.33 -24.81 46.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.57 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -105.25 -174.75 2.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.545 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.425 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 98.9 m-85 -119.07 131.72 55.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -126.05 174.88 17.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 36.7 p90 -157.76 144.25 17.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -1.204 . . . . 0.0 109.545 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' CG1' ' CA ' ' A' ' 89' ' ' GLY . 4.1 m -125.55 147.83 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 51.1 mttt -103.29 144.69 31.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.612 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 64.3 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 20.9 tttm -125.02 139.09 54.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.56 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 53' ' ' THR . 70.6 mt -100.95 129.63 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.07 -45.76 9.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -170.3 141.42 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.621 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 pt -123.42 143.83 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -127.77 91.27 3.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -63.59 -37.34 86.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.76 -42.72 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -86.15 3.09 44.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' O ' HD21 ' A' ' 105' ' ' LEU . 56.0 m80 52.97 45.12 29.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.109 -0.995 . . . . 0.0 109.491 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -126.76 139.83 52.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.6 t80 -132.98 125.77 30.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -120.76 127.36 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.494 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 36.1 p90 -146.64 171.14 15.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.482 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 69.1 p -151.5 151.36 31.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.0 109.704 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 32.1 tp -88.71 108.02 19.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.853 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.519 ' CG1' ' HB2' ' A' ' 71' ' ' LYS . 95.9 mt -59.11 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HG2' HG23 ' A' ' 87' ' ' ILE . 78.2 mm-40 -138.96 169.74 17.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.724 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' CA ' ' CG1' ' A' ' 68' ' ' VAL . . . -179.55 135.79 2.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 69.3 m-20 -50.37 -41.27 51.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.485 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.74 68.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.624 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.515 HD13 ' CD2' ' A' ' 86' ' ' LEU . 7.5 mp -78.64 -33.4 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 4.0 m 61.47 178.19 0.12 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.299 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 98.2 mt-10 -78.86 -13.95 59.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.555 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.46 ' O ' HG12 ' A' ' 127' ' ' VAL . 15.2 m120 -78.11 -28.69 48.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 34.4 mt -105.84 125.83 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.101 -0.999 . . . . 0.0 109.746 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.495 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 91.3 mt-10 -80.89 -179.41 7.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.16 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 17.5 ptpt -57.02 159.4 4.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 69.5 mt -117.79 138.65 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.596 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.482 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 61.1 t0 -95.13 125.72 39.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.574 ' CZ ' HG22 ' A' ' 99' ' ' ILE . 90.9 m-85 -117.3 134.08 55.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -123.71 137.64 54.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -127.99 136.72 51.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -139.77 125.62 19.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.7 mm? -100.16 130.01 46.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.4 t -131.79 140.66 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.6 p -113.27 148.38 35.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.86 164.59 14.38 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.544 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.34 -10.73 28.73 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 111.74 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -76.02 -15.52 60.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.06 -19.02 28.05 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.88 170.68 45.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.526 HG23 ' CA ' ' A' ' 16' ' ' ALA . 88.4 m -123.8 127.04 47.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.149 . . . . 0.0 109.605 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.3 mt -96.95 139.2 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 109.235 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.512 HG22 ' CD1' ' A' ' 105' ' ' LEU . 4.7 mt -124.62 121.96 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 45.0 mttt -107.67 139.11 42.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.075 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 m -127.98 130.06 47.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 110.076 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -125.97 140.28 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.875 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -145.21 155.54 43.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 110.196 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.469 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 25.5 mttp -129.97 148.53 51.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' CD1' HG23 ' A' ' 99' ' ' ILE . 80.4 m-85 -118.13 121.81 41.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 0.0 109.834 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.495 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 61.2 m170 -89.86 143.5 26.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.498 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 28.5 p -129.51 157.62 41.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.48 ' HE3' ' CG1' ' A' ' 127' ' ' VAL . 4.8 mtmt -52.05 -45.81 64.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.36 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 164.02 -43.96 0.31 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 52.9 p30 -135.52 18.89 3.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.498 ' CG2' ' HB ' ' A' ' 123' ' ' THR . 8.3 m -54.21 -40.6 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 95.4 mt-10 61.6 128.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.571 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.27 171.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -99.62 133.31 44.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -56.38 -35.49 67.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.443 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.27 -38.69 84.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.13 -41.71 81.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.27 -41.43 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -61.25 -37.2 82.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -60.87 -44.28 97.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.53 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.55 -41.24 99.81 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.53 ' HE3' ' CE2' ' A' ' 6' ' ' TYR . 63.6 tttm -59.72 -42.17 92.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -1.147 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' A' ' 143' ' ' HIS . 75.1 mm-40 -64.38 -36.36 83.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.544 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 144' ' ' LEU . 84.6 mttt -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.73 69.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 109.478 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.9 -42.23 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 139' ' ' GLU . 86.2 m-70 -59.86 -50.64 73.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.411 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 6.6 mp -68.23 -48.0 66.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.96 -45.44 67.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.594 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -58.0 -40.65 81.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 34' ' ' ILE . 17.1 tp -60.08 -39.47 86.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.491 HG23 ' CD2' ' A' ' 30' ' ' LEU . 76.0 mt -53.76 -52.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.278 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.411 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 81.5 tt0 -54.73 -38.84 67.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.194 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 154' ' ' ASP . . . -61.33 -35.69 91.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 147' ' ' LEU . 15.4 m-85 -71.38 -42.45 68.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.09 . . . . 0.0 109.337 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 148' ' ' ILE . 6.4 mp -75.51 -37.85 59.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.6 tttp -60.13 -36.58 77.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 26.2 p30 -101.47 -9.8 20.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -44.51 139.79 3.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 160' ' ' ASN . 49.0 Cg_endo -69.53 -24.89 30.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.732 2.288 . . . . 0.0 111.808 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 90.8 p -60.93 -29.07 69.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.377 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 160' ' ' ASN . 76.5 mm-40 -112.32 160.57 17.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' O ' ' HB2' ' A' ' 160' ' ' ASN . 58.1 t80 66.94 -63.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 158' ' ' GLU . 11.6 m120 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 p -117.42 139.76 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -1.158 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -110.81 154.07 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.417 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.52 HG22 ' CG2' ' A' ' 118' ' ' THR . 23.5 m -94.1 140.36 29.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -111.81 139.77 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -113.25 140.35 48.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -130.1 160.07 34.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 74.6 tt0 -142.72 130.8 21.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 75.7 t80 -141.78 140.32 33.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.565 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.0 p -90.68 143.56 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.513 ' OG ' ' CD1' ' A' ' 115' ' ' ILE . 83.3 p -141.06 161.29 38.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.588 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -78.35 179.7 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.29 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 68.6 141.88 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.232 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.3 Cg_endo -69.32 146.98 64.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.507 2.138 . . . . 0.0 112.158 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.62 -50.57 7.02 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 111.39 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.77 -49.98 3.63 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.23 1.953 . . . . 0.0 112.923 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 28.8 mttm -60.75 -35.98 77.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.866 -1.146 . . . . 0.0 109.672 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 tp -81.01 -28.4 35.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 69.4 t80 -69.54 -35.01 75.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.82 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 29.8 tttp -67.34 -37.87 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -88.54 -30.77 19.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.64 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 72.6 t80 -77.3 -12.15 59.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.6 t -117.76 -63.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.599 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 47.8 mt -65.3 -41.43 94.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.8 m-20 -94.82 9.65 38.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.529 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -70.19 -45.54 66.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.954 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.1 -25.31 67.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 58.8 t30 -101.27 -33.88 9.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD12 ' CG ' ' A' ' 151' ' ' TYR . 22.0 tp -75.27 -34.56 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.9 mt -51.34 -54.94 33.2 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.707 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -69.07 -20.32 38.23 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.425 2.084 . . . . 0.0 111.988 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 30.2 mmtt -71.32 -34.99 71.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.44 -27.99 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.97 64.62 42.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.5 -46.14 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.671 2.247 . . . . 0.0 111.705 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -65.63 -22.87 66.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -73.29 -50.52 21.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG23 ' CG2' ' A' ' 57' ' ' ILE . 7.4 p -111.61 149.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.476 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -73.25 -46.2 51.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.51 131.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.35 128.03 34.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.439 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -123.93 142.88 50.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.459 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.1 mt -106.46 118.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 27.2 tp -60.2 -44.94 94.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.9 mt-10 -159.68 157.02 28.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.6 -42.06 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 53' ' ' THR . 88.1 m-20 58.26 37.41 26.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.11 31.35 20.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -115.56 -166.28 14.81 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.7 130.9 20.23 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.737 2.291 . . . . 0.0 111.598 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.74 29.62 73.94 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 94.3 m -82.76 140.64 32.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.432 ' N ' HG21 ' A' ' 53' ' ' THR . 22.3 mm -105.81 129.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.276 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 91.3 mttt -114.74 147.3 39.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.655 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 57.3 tttm -131.02 121.52 25.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 0.0 109.297 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' A' ' 70' ' ' HIS . 60.8 mt -114.04 135.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.6 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 m -123.96 119.46 29.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 33.6 p90 -124.48 143.5 50.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.47 86.99 0.62 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -51.13 -38.11 50.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.67 -100.25 0.22 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.1 m -62.0 -28.22 69.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -129.1 155.15 45.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.504 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -116.05 143.57 45.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -138.84 170.96 23.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 38.9 p90 -155.76 144.09 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.139 . . . . 0.0 109.657 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 86' ' ' LEU . 43.0 t -124.08 144.48 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' O ' HD11 ' A' ' 86' ' ' LEU . 35.2 mttt -116.9 139.66 50.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.594 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 81.0 m-70 -116.98 144.87 44.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 25.0 tttt -124.01 142.39 51.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.444 HD13 ' OH ' ' A' ' 82' ' ' TYR . 58.3 mt -102.96 131.07 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.448 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 97.2 m-70 -90.5 -48.64 6.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.2 m -163.81 149.49 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -129.89 145.47 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 82.0 m-20 -128.3 91.16 3.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -62.31 -37.66 86.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.96 -40.67 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.4 m-20 -87.8 7.88 28.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 46.5 m80 45.72 40.34 6.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -119.46 136.43 54.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.4 t80 -127.52 126.28 41.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 t -121.06 128.16 52.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 34.1 p90 -145.72 170.26 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -148.1 157.96 43.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.594 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 22.6 tp -93.27 136.75 33.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 71' ' ' LYS . 26.9 mm -99.13 -71.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 68' ' ' VAL . 95.0 mt-10 -118.98 160.78 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 172.44 128.59 1.06 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 38.0 m-20 -46.21 -31.82 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 109.604 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.56 68.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' N ' HD21 ' A' ' 92' ' ' LEU . 3.6 mt -74.69 -33.03 62.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 3.5 m 53.14 -177.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.66 -0.65 . . . . 0.0 109.567 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.0 12.53 7.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 26.7 p-10 -111.72 -10.75 14.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mt -114.5 140.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 93.7 mt-10 -91.96 -179.52 5.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.312 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.445 ' HD3' HD11 ' A' ' 87' ' ' ILE . 52.2 mttp -57.08 161.91 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 120' ' ' LYS . 49.0 mt -120.47 135.62 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.608 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' LYS . 60.6 t0 -93.04 120.13 33.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 73.1 m-85 -113.8 139.13 49.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.48 135.34 44.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.318 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 m -131.11 135.64 47.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -139.18 129.13 25.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.888 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 16' ' ' ALA . 31.6 mt -98.69 129.61 45.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.7 t -132.05 136.17 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.9 OUTLIER -111.2 146.6 36.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -106.54 171.38 4.8 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 48.4 Cg_endo -69.52 -15.06 37.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.666 2.244 . . . . 0.0 111.791 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.79 -20.81 61.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.9 -25.61 11.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.44 171.55 51.37 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.456 HG21 ' CA ' ' A' ' 16' ' ' ALA . 93.8 m -125.87 124.62 41.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.0 mt -97.5 139.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.263 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.518 HD13 ' CE2' ' A' ' 145' ' ' PHE . 3.2 mt -121.57 127.96 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.741 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 50.5 mttp -105.87 127.98 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 m -123.43 133.65 54.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.52 ' CG2' HG22 ' A' ' 5' ' ' THR . 60.8 m -119.79 133.54 55.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 0.0 109.016 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -120.32 131.33 54.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 110.006 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 99' ' ' ILE . 78.5 tttt -140.66 130.35 24.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.526 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 32.9 p90 -132.11 149.17 52.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.805 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -114.15 158.67 21.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.183 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.43 ' CA ' ' HG3' ' A' ' 97' ' ' GLU . 82.2 p -130.52 157.09 43.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -55.01 -25.88 33.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.268 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . 160.01 43.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 91.0 m-20 61.92 41.97 10.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.1 -55.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -176.44 103.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.22 171.79 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -135.81 133.36 37.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.65 -38.72 67.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.41 -36.69 83.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.373 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -65.13 -46.45 80.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.94 -46.93 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 54.4 tttt -57.92 -41.21 82.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.38 77.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.9 . . . . 0.0 109.363 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.93 93.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.8 mtmm -64.28 -39.03 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 109.327 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.77 -38.52 91.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.415 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.24 -40.52 70.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.338 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.47 88.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.336 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.448 ' O ' HD21 ' A' ' 147' ' ' LEU . 41.0 t-80 -60.19 -53.21 60.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.0 -36.07 80.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 109.39 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.533 ' CE2' ' OE2' ' A' ' 149' ' ' GLU . 46.6 t80 -53.44 -43.06 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.197 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 59.4 tttm -59.29 -38.63 80.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 143' ' ' HIS . 3.6 mm? -62.58 -36.13 81.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.231 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 152' ' ' LEU . 98.8 mt -53.68 -55.74 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.163 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' OE2' ' CE2' ' A' ' 145' ' ' PHE . 40.5 mp0 -54.33 -43.74 71.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.943 . . . . 0.0 109.043 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.48 -29.45 71.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.539 ' CG ' HD12 ' A' ' 30' ' ' LEU . 54.5 t80 -61.16 -43.58 98.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.3 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.53 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.4 mp -75.49 -44.7 42.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.226 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -53.31 -33.89 55.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 108.701 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.89 -34.14 57.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 74.79 1.14 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.449 ' HB2' ' HG3' ' A' ' 158' ' ' GLU . 49.6 Cg_endo -69.29 -40.33 6.21 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.794 2.329 . . . . 0.0 112.01 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 65.4 m 47.61 24.32 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.251 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 156' ' ' PRO . 94.0 mt-10 -55.36 139.61 42.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.76 141.43 46.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.454 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 8.0 p -111.55 145.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -1.137 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.531 ' N ' HG22 ' A' ' 3' ' ' VAL . 94.8 m-85 -116.31 149.57 39.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.587 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 27.6 m -93.56 140.99 28.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.46 137.98 53.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.616 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -108.02 132.76 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.27 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.06 133.41 53.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.52 131.86 54.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.435 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 86.0 t80 -146.56 149.48 33.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 22.0 p -117.96 149.9 40.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 23.2 t -148.51 164.57 33.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.636 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' CD1' ' A' ' 14' ' ' ILE . 21.1 t0 -72.71 -178.44 2.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 69.05 142.06 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.273 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -69.65 147.21 63.09 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 111.964 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.71 -51.44 3.76 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.507 -0.745 . . . . 0.0 111.267 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.19 -50.66 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.318 2.012 . . . . 0.0 113.068 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 95.6 mttt -59.1 -34.98 72.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.808 -1.182 . . . . 0.0 109.55 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' CD1' HD12 ' A' ' 152' ' ' LEU . 22.4 tp -80.77 -36.86 31.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.445 ' O ' HG21 ' A' ' 24' ' ' VAL . 60.0 t80 -57.87 -32.6 67.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 19.8 tttt -71.57 -52.39 18.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 109.623 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.44 3.06 14.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 86.0 t80 -99.86 -33.37 10.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 25' ' ' LEU . 9.8 m -114.19 -46.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.888 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' N ' ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -68.7 -33.93 74.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.97 . . . . 0.0 109.478 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 59.0 m-20 -106.33 8.93 32.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.81 -37.05 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' OD2' HD12 ' A' ' 44' ' ' ILE . 92.7 m-20 -57.35 -37.28 72.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.647 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 86.7 m-20 -100.86 -37.65 8.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 26.0 tp -63.96 -43.05 96.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 9.3 mt -47.8 -60.0 4.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.68 -22.74 37.12 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.55 2.166 . . . . 0.0 111.63 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.9 tptm -66.26 -47.06 74.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.534 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG22 ' CB ' ' A' ' 147' ' ' LEU . 67.8 mt -67.91 -36.13 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.534 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.97 71.58 62.52 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.6 Cg_endo -70.4 -37.37 7.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.681 2.254 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.53 -23.06 60.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.34 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 59' ' ' PHE . 21.4 m -125.54 149.16 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -72.13 -47.53 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.386 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.98 131.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.59 119.31 27.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -115.53 144.37 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.9 mt -106.6 119.67 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 26.4 tp -64.86 -44.12 90.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.3 mt-10 -159.32 154.48 25.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.95 -42.71 1.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 61.84 39.06 14.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.537 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 84.46 34.92 15.23 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -119.33 -166.84 13.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.02 131.85 21.7 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.726 2.284 . . . . 0.0 111.709 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.49 28.82 72.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.534 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 96.3 m -83.88 144.78 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.504 ' N ' HG22 ' A' ' 53' ' ' THR . 22.1 mm -112.15 131.94 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.95 . . . . 0.0 109.28 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.4 mtmt -130.09 148.39 51.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' HE3' ' CD2' ' A' ' 67' ' ' TYR . 67.8 tttt -125.76 126.71 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 14.7 mt -115.92 130.93 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.4 m -107.74 132.02 53.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.341 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE1' ' CG1' ' A' ' 39' ' ' VAL . 97.9 m-85 -104.47 132.46 50.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.5 -178.86 30.76 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -57.93 -24.56 58.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -1.207 . . . . 0.0 109.337 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.25 -8.97 55.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.6 p -62.19 -27.67 69.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 109.532 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 76.3 m80 -92.16 3.19 55.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.401 ' CE1' ' HE1' ' A' ' 67' ' ' TYR . 75.2 t80 61.13 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.02 90.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 37.3 p90 -145.47 146.3 31.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.497 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -126.65 145.58 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' GLU . 34.7 mttt -102.33 140.52 36.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.624 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 42.3 m170 -115.91 140.92 48.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.297 -0.877 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -124.02 139.22 54.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' HA2' ' A' ' 49' ' ' GLY . 63.3 mt -101.7 135.74 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.455 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 93.9 m-70 -89.17 -48.97 7.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.2 t -174.24 151.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.442 HG22 ' CD1' ' A' ' 82' ' ' TYR . 41.2 pt -127.05 144.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -123.45 90.5 3.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -61.57 -36.8 81.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.466 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.84 -37.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.63 2.85 56.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.44 ' O ' HD21 ' A' ' 105' ' ' LEU . 40.5 m80 51.34 46.98 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.8 m -128.8 135.18 48.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.87 . . . . 0.0 109.541 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.46 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 61.5 t80 -128.8 121.55 28.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -116.46 137.8 51.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -152.2 166.37 31.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.301 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.455 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 89.4 p -145.43 160.11 42.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.49 HD21 ' N ' ' A' ' 87' ' ' ILE . 5.3 tt -100.77 131.81 46.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.49 ' N ' HD21 ' A' ' 86' ' ' LEU . 23.1 mm -89.13 -73.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.583 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 88.3 mt-10 -121.15 151.79 39.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.513 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.53 ' CA ' ' CG1' ' A' ' 68' ' ' VAL . . . -171.4 154.73 22.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.35 -49.19 75.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 0.0 109.403 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.85 -27.01 59.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.522 HD13 ' CA ' ' A' ' 89' ' ' GLY . 5.7 mp -80.7 -30.24 36.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' LEU . 3.7 m 56.43 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 97.6 mt-10 -68.48 -7.67 34.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 109.236 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 96' ' ' ILE . 26.1 m120 -72.73 -42.29 64.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.285 -0.884 . . . . 0.0 109.668 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 96' ' ' ILE . 2.5 pp -156.25 121.82 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 110.477 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.1 mt-10 -136.59 107.03 6.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.818 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 78.6 tttt -179.01 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.392 -0.817 . . . . 0.0 108.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG21 ' CE2' ' A' ' 101' ' ' TYR . 18.8 mt -123.92 117.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -93.78 118.78 31.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.87 . . . . 0.0 109.011 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 68.1 m-85 -109.23 137.73 46.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.8 mt-10 -130.34 129.79 43.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -120.8 134.92 55.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -133.73 121.65 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.099 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 3.1 mm? -95.12 118.85 32.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.759 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 60.5 t -131.88 140.2 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 109.313 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.1 t -107.61 148.05 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -105.71 173.11 3.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.97 -16.22 36.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.671 2.248 . . . . 0.0 111.8 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.48 27.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.62 176.63 53.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.455 HG23 ' CA ' ' A' ' 16' ' ' ALA . 65.3 m -122.88 125.05 44.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.3 mt -96.2 139.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.36 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.442 HG12 HD11 ' A' ' 105' ' ' LEU . 28.7 mt -123.65 123.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.737 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -105.27 133.83 49.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.102 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 86.2 m -131.44 128.93 40.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.0 109.902 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.587 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -111.7 142.97 43.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.067 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.1 m -135.09 140.62 45.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.987 . . . . 0.0 109.845 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 72.0 tttt -132.29 147.14 52.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.535 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 96.2 m-85 -126.6 140.31 52.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.81 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 75.8 m-70 -130.55 -177.83 4.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.196 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.49 ' CB ' HG22 ' A' ' 96' ' ' ILE . 36.2 p -128.07 147.35 50.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.68 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 94' ' ' GLU . 31.7 mtpt -52.98 -49.12 66.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.491 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -135.31 -65.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -163.52 39.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -1.186 . . . . 0.0 109.7 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -82.56 130.02 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 109.28 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -80.62 149.64 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.0 tt -134.46 171.78 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -92.8 121.24 33.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -54.43 -42.38 70.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.04 -35.01 74.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.424 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -65.68 -45.05 84.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.449 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.67 -42.33 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -57.9 -39.44 77.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.33 -44.02 83.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.16 96.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -59.58 -44.95 93.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -1.131 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -60.18 -43.06 96.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mttm -53.64 -43.18 68.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.22 75.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.74 85.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.512 ' CE1' HD22 ' A' ' 147' ' ' LEU . 58.2 t-80 -61.35 -35.58 77.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.519 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 38.6 mt -64.07 -44.37 92.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.446 ' HA ' HD12 ' A' ' 148' ' ' ILE . 66.3 m-85 -53.33 -39.18 63.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -57.33 -41.39 79.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 147' ' ' LEU . 3.2 mm? -67.97 -37.92 82.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 145' ' ' PHE . 81.2 mt -54.16 -44.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 86.8 tt0 -65.64 -45.74 81.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.11 -39.79 96.49 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.472 ' CD2' HD13 ' A' ' 30' ' ' LEU . 63.5 t80 -57.35 -50.21 73.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -1.12 . . . . 0.0 109.407 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 19' ' ' LEU . 49.2 mt -62.58 -41.93 99.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.467 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 69.9 tttt -56.48 -44.96 81.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.58 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.36 -39.59 87.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -127.54 79.25 73.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.421 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 153' ' ' LYS . 49.6 Cg_endo -70.03 -24.6 28.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.768 2.312 . . . . 0.0 111.756 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.1 p -149.39 159.08 44.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.04 133.15 47.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -62.75 -39.51 94.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.442 179.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 121' ' ' TYR . 59.8 t -115.36 138.45 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.169 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.9 t80 -87.43 147.51 25.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.554 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 22.0 m -93.51 141.89 27.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.6 140.72 51.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.582 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -110.19 136.19 49.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -118.64 131.07 56.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.644 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 92.4 mt-10 -111.48 111.68 22.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.245 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 47.7 t80 -126.95 130.59 50.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 16.2 p -94.0 151.74 19.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 85.8 p -147.15 163.53 36.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' CB ' HD13 ' A' ' 14' ' ' ILE . 90.6 m-20 -71.45 -175.77 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 5.0 mp 63.12 142.43 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.6 Cg_endo -69.24 146.56 63.81 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.534 2.156 . . . . 0.0 112.173 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.46 -47.43 47.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.614 -0.679 . . . . 0.0 111.474 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.2 Cg_endo -63.93 -45.67 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.999 1.799 . . . . 0.0 112.899 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 61.0 mttm -64.45 -35.0 79.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 148' ' ' ILE . 25.9 tp -80.9 -29.66 35.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 24' ' ' VAL . 60.6 t80 -63.02 -37.01 85.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 34.7 tttp -65.51 -42.52 91.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.971 . . . . 0.0 109.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -83.33 -29.96 27.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CE1' HG23 ' A' ' 103' ' ' THR . 63.2 t80 -76.63 -18.73 58.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 58.2 t -113.87 -67.0 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -57.99 -42.08 84.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 75.2 m-20 -96.35 12.92 29.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.574 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -64.4 -35.67 81.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 109.598 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -65.04 -33.89 77.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.9 t30 -94.34 -33.78 13.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.512 HD12 ' CD1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -65.06 -46.14 82.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 4.6 mt -48.2 -58.71 7.35 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.72 -21.34 38.89 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.487 2.124 . . . . 0.0 111.558 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 39.1 tptt -65.15 -40.35 94.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG21 HD22 ' A' ' 144' ' ' LEU . 37.7 mm -61.78 -29.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.12 73.15 5.1 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.463 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.8 Cg_endo -69.97 -31.8 18.93 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.675 2.25 . . . . 0.0 111.833 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -70.71 -24.85 62.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.62 -40.23 61.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 57' ' ' ILE . 4.9 p -112.74 147.24 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' N ' HG22 ' A' ' 39' ' ' VAL . 67.8 tttt -75.37 -45.14 41.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.42 131.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.49 126.5 35.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.307 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.13 150.44 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.655 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.516 HG23 ' CG2' ' A' ' 53' ' ' THR . 60.9 mt -106.17 121.34 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 0.0 109.37 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.6 mp -66.47 -44.0 83.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.8 mt-10 -159.34 157.53 30.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.67 -40.42 2.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 44' ' ' ILE . 56.6 t0 58.32 40.34 24.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.459 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 83.88 33.72 20.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.09 -167.19 13.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.72 129.12 17.08 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.595 2.197 . . . . 0.0 111.695 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 72.47 26.35 72.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.516 ' CG2' HG23 ' A' ' 44' ' ' ILE . 96.4 m -78.99 144.51 34.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 ' N ' HG23 ' A' ' 53' ' ' THR . 63.3 mt -114.33 129.66 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 44' ' ' ILE . 3.3 mtmt -124.54 149.63 46.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HB2' HD13 ' A' ' 45' ' ' LEU . 11.0 ttpp -130.72 126.1 35.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.523 HG22 ' CG2' ' A' ' 39' ' ' VAL . 36.1 mt -114.94 133.76 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.471 ' CG2' ' HA2' ' A' ' 62' ' ' GLY . 88.3 m -115.1 130.92 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.405 ' CE1' ' HB ' ' A' ' 39' ' ' VAL . 91.6 m-85 -108.39 143.38 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.1 -169.33 41.91 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.2 -28.56 64.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA2' ' CG2' ' A' ' 58' ' ' THR . . . 131.9 36.51 0.31 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.4 m -61.02 157.77 14.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -1.162 . . . . 0.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -58.4 -34.1 70.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.93 151.82 24.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.474 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.457 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 103.71 51.22 0.97 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.3 p90 -146.9 146.78 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.459 HG11 ' HA3' ' A' ' 89' ' ' GLY . 46.8 t -125.49 144.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' O ' HD23 ' A' ' 86' ' ' LEU . 22.0 mttt -116.21 143.24 45.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -123.28 142.76 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.439 ' HB2' HD12 ' A' ' 87' ' ' ILE . 17.8 tttp -123.91 140.66 52.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 64.4 mt -100.75 133.16 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.497 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 89.7 m-70 -90.68 -48.49 7.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.5 m -165.03 154.13 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.75 144.89 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -127.83 93.39 3.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.608 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -65.92 -38.12 87.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.319 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.22 -42.06 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -87.3 4.98 40.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.574 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 105' ' ' LEU . 66.7 m80 48.46 41.9 17.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.962 . . . . 0.0 109.472 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.8 m -122.05 136.66 54.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 62.6 t80 -129.12 127.07 40.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.369 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 t -121.77 133.43 54.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.652 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 38.5 p90 -149.51 162.96 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.497 ' OG ' ' NE2' ' A' ' 73' ' ' HIS . 55.4 m -138.87 149.26 44.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' A' ' 92' ' ' LEU . 5.4 tt -88.26 133.81 33.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.524 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 71.4 mt -91.45 -77.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.608 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 68' ' ' VAL . 74.4 mm-40 -115.37 161.81 18.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.651 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HG11 ' A' ' 68' ' ' VAL . . . 171.56 160.31 19.81 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.457 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 72.0 m-20 -60.87 -34.06 74.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.665 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.82 -31.47 71.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.724 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.541 ' N ' HD21 ' A' ' 92' ' ' LEU . 5.8 mt -70.71 -27.77 64.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 109.152 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 92' ' ' LEU . 0.6 OUTLIER 43.73 -166.01 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.645 -0.66 . . . . 0.0 109.457 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.24 14.71 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.579 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 25.9 p-10 -124.39 -11.73 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 92' ' ' LEU . 50.7 mt -111.97 126.26 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.701 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 96.6 mt-10 -77.05 -179.57 5.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 16.3 mttp -57.29 167.06 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 83.2 mt -123.29 137.99 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.04 122.75 34.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.427 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 89.9 m-85 -114.62 138.6 50.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.509 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' O ' ' CG2' ' A' ' 117' ' ' THR . 93.7 mt-10 -131.68 131.48 43.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.382 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 23' ' ' PHE . 28.6 m -125.85 137.26 53.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -139.03 128.14 23.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -98.5 117.6 33.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.8 t -131.72 143.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.275 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 44.2 m -114.36 151.77 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.11 167.83 8.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.05 -17.22 40.9 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.773 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -64.54 -14.7 58.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.42 -14.8 50.67 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.86 178.37 40.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 99.1 m -117.99 131.36 56.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -1.171 . . . . 0.0 109.727 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.9 mt -101.75 131.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.14 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.13 128.24 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.428 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 61.9 mttp -113.21 124.97 53.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 102' ' ' GLU . 62.0 m -129.84 132.72 46.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.007 . . . . 0.0 109.981 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.51 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 44.0 m -112.48 135.17 53.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 0.0 109.057 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.3 m -125.97 143.12 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.463 ' O ' HG21 ' A' ' 99' ' ' ILE . 16.7 tttm -139.26 133.61 31.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 108.969 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 3' ' ' VAL . 61.5 m-85 -111.36 131.83 54.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.816 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.5 m80 -100.74 138.84 37.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.273 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 12.7 p -107.82 156.72 18.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 95' ' ' ASN . 14.2 mmtt -56.74 -41.7 78.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.71 -78.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -101.74 -1.25 32.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -1.184 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.513 ' CG2' ' HB ' ' A' ' 123' ' ' THR . 30.0 m -61.72 130.04 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -113.9 158.2 21.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.515 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.4 tt -128.54 170.61 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 81.9 tttt -86.41 120.77 28.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.51 -42.51 33.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' OE1' ' HE2' ' A' ' 130' ' ' LYS . 93.7 mt-10 -57.17 -38.8 74.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.421 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.528 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 64.3 m170 -65.43 -44.41 87.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.02 -48.3 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.356 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.63 -43.54 80.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.291 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.53 -43.83 80.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.99 -43.17 93.16 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.06 -45.56 90.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -1.14 . . . . 0.0 109.372 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.47 -42.48 96.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.33 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 60.0 mttp -53.99 -44.63 71.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.306 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.76 -46.82 83.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.343 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.87 85.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.448 ' O ' HD23 ' A' ' 147' ' ' LEU . 85.6 t60 -58.37 -44.5 88.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.393 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 34' ' ' ILE . 55.8 mt -56.88 -47.66 79.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -54.11 -37.98 64.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.302 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.26 -43.25 87.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 147' ' ' LEU . 3.7 mm? -62.93 -36.92 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.512 ' CD1' HD12 ' A' ' 30' ' ' LEU . 29.3 mm -55.74 -44.45 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 94.1 mt-10 -66.86 -36.64 82.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.92 95.65 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.02 -44.75 83.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -1.149 . . . . 0.0 109.565 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 14' ' ' ILE . 37.8 mt -60.97 -40.83 94.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -63.31 -39.31 94.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -60.86 -36.86 80.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.471 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.02 126.44 81.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.457 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 159' ' ' TYR . 50.1 Cg_endo -70.25 -9.8 26.75 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.71 2.273 . . . . 0.0 111.841 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 86.7 p -59.27 -27.29 65.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 109.485 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.28 -35.85 81.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 156' ' ' PRO . 98.3 m-85 -121.87 140.51 52.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.428 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.525 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.574 HG11 ' CD2' ' A' ' 122' ' ' HIS . 7.3 p -109.55 144.49 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.518 ' N ' HG21 ' A' ' 3' ' ' VAL . 82.9 m-85 -113.35 152.77 29.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 109.228 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.526 HG21 ' CG2' ' A' ' 118' ' ' THR . 35.1 m -93.46 142.42 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.18 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -119.21 128.3 54.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.826 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -109.41 138.42 45.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.143 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.45 129.75 45.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.872 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.7 mt-10 -109.37 123.52 49.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.026 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 11' ' ' THR . 54.6 t80 -135.97 135.54 39.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.846 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.489 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 14.5 p -94.68 131.31 40.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.124 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 115' ' ' ILE . 94.4 p -130.55 177.16 7.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.863 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 149' ' ' GLU . 41.3 p-10 -80.78 -175.32 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.441 HG12 ' OD1' ' A' ' 13' ' ' ASP . 6.7 mm 68.24 136.12 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 49.2 Cg_endo -70.84 149.58 60.23 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.452 2.101 . . . . 0.0 111.888 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.83 -52.36 3.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 0.0 111.176 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.72 -50.36 2.45 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.432 2.088 . . . . 0.0 113.228 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 31.2 mttt -61.62 -34.67 76.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.838 -1.164 . . . . 0.0 109.888 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.402 ' C ' HD21 ' A' ' 19' ' ' LEU . 8.8 tt -80.59 -28.47 37.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -72.35 -34.61 68.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.608 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -68.08 -41.12 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.7 -23.3 27.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -82.96 -14.45 54.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.96 -55.94 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.592 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.6 tp -67.77 -38.82 83.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 30' ' ' LEU . 55.0 m-20 -104.83 18.29 22.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.87 -37.2 76.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.338 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 42' ' ' ALA . 52.6 t0 -76.78 -20.64 56.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.679 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 93.4 m-20 -104.42 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 19.0 tp -70.98 -38.83 72.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 8.0 mt -55.71 -56.7 27.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -69.63 -11.41 30.94 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.393 2.062 . . . . 0.0 111.67 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 12.0 mttm -83.43 -36.52 24.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.54 ' CG2' ' CD1' ' A' ' 147' ' ' LEU . 80.3 mt -76.88 -30.72 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.48 75.44 7.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.6 Cg_endo -69.63 -28.58 25.71 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.706 2.271 . . . . 0.0 111.694 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.11 -23.88 54.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.278 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.95 65.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.487 HG21 ' CG2' ' A' ' 57' ' ' ILE . 5.7 p -116.62 150.75 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 58' ' ' THR . 27.7 tttm -75.46 -51.69 12.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 130.71 0.05 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . . . -94.54 123.0 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -125.82 152.18 45.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 64.7 mt -105.96 119.2 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 25.5 tp -61.99 -43.73 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.4 mt-10 -160.05 154.92 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . 105.54 -42.28 1.94 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.8 m-20 61.39 36.61 17.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 87.33 34.37 10.64 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.0 -165.17 12.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.96 131.12 20.3 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.733 2.288 . . . . 0.0 111.783 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.53 27.94 72.89 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.58 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 88.7 m -83.23 142.57 31.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -1.162 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.455 ' N ' HG22 ' A' ' 53' ' ' THR . 24.0 mm -108.79 131.5 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' CE ' HD12 ' A' ' 72' ' ' ILE . 64.2 mttt -117.17 148.79 41.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 48.4 tttp -132.92 127.24 33.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.346 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.567 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 42.5 mt -120.15 131.37 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 40' ' ' LYS . 62.4 m -114.63 127.26 55.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 64' ' ' HIS . 97.8 m-85 -92.0 136.57 33.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.6 129.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 82.9 tt0 -64.92 -42.68 94.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.85 -51.11 0.38 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -81.18 174.56 11.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 59' ' ' PHE . 39.7 m170 55.58 58.98 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' GLY . 94.1 m-85 -57.7 -16.75 11.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.504 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' TYR . . . -43.82 144.34 1.83 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.423 ' OH ' ' OE1' ' A' ' 88' ' ' GLU . 40.1 p90 -151.89 146.52 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.299 -1.118 . . . . 0.0 109.295 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.498 ' CG2' ' HA2' ' A' ' 89' ' ' GLY . 41.2 t -124.28 148.21 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.58 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' HG12 ' A' ' 68' ' ' VAL . 85.7 mttt -121.51 144.1 48.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 109.359 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.567 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 90.9 m-70 -122.9 138.48 54.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 54' ' ' ILE . 40.0 tttt -117.61 141.85 47.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 44.0 mt -103.03 131.5 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.583 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.412 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 97.1 m-70 -92.62 -41.98 9.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.579 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -171.31 146.21 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.566 HG21 ' CE1' ' A' ' 82' ' ' TYR . 34.2 pt -129.4 143.49 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.05 90.92 3.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.86 -35.33 76.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.79 -41.92 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 80' ' ' HIS . 76.1 m-20 -87.86 10.16 19.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 79' ' ' ASN . 65.8 m80 44.42 42.79 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.471 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 m -123.31 132.84 54.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.566 ' CE1' HG21 ' A' ' 75' ' ' ILE . 70.2 t80 -120.18 124.18 45.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.8 t -118.16 128.84 55.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 30.8 p90 -155.87 171.19 20.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.855 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.7 p -142.45 162.64 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 69' ' ' LYS . 5.0 tt -98.86 129.37 45.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 23.9 mm -88.17 -74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 95.5 mt-10 -115.24 159.17 21.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.498 ' HA2' ' CG2' ' A' ' 68' ' ' VAL . . . -178.29 159.54 25.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -60.66 -46.6 89.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -1.106 . . . . 0.0 109.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.57 -23.64 67.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 5.9 mp -82.71 -44.11 16.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 13.9 t 60.18 163.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.317 -0.864 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.68 -11.2 53.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 3.4 m-20 -72.38 -40.26 67.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.613 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 123' ' ' THR . 41.8 pt -151.71 131.34 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 30.5 mt-10 -146.34 106.45 4.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.921 . . . . 0.0 108.967 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 39.5 tptt -179.63 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.872 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.632 ' CG2' ' CE2' ' A' ' 101' ' ' TYR . 4.3 mt -124.59 118.16 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.917 -1.114 . . . . 0.0 110.005 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -94.86 121.58 36.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 108.901 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 99' ' ' ILE . 64.9 m-85 -114.14 136.73 52.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.956 . . . . 0.0 109.932 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.1 mt-10 -130.24 126.27 36.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 108.983 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.8 m -123.29 131.62 53.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.854 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -138.39 122.64 18.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.195 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.6 mm? -94.26 130.81 40.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 78.3 t -131.52 135.53 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.0 p -106.81 142.62 36.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.87 169.36 6.39 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.1 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.717 2.278 . . . . 0.0 111.77 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.23 -15.37 61.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.36 53.06 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.11 168.24 32.34 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.5 m -119.61 126.55 51.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 109.525 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.9 mt -95.73 136.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 12' ' ' SER . 3.1 mt -119.27 119.93 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 10.7 mtpt -105.13 121.17 43.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.11 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 80.1 m -126.73 134.07 50.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 0.0 109.934 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.526 ' CG2' HG21 ' A' ' 5' ' ' THR . 61.9 m -116.68 138.48 51.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.107 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -131.57 141.58 49.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.479 ' HE2' ' NE2' ' A' ' 122' ' ' HIS . 22.5 tttt -136.32 149.82 48.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.18 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.535 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 94.5 m-85 -127.99 142.7 51.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.06 -1.025 . . . . 0.0 109.766 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.574 ' CD2' HG11 ' A' ' 3' ' ' VAL . 64.3 m80 -134.95 165.15 25.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.473 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 25.7 p -116.3 149.38 39.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.729 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 23.6 mttm -60.7 -53.3 59.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -121.07 -66.48 0.26 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -174.32 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 95' ' ' ASN . 47.1 t -58.74 -36.05 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 82.8 tt0 65.44 144.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.705 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.407 HD12 HD13 ' A' ' 96' ' ' ILE . 16.1 tt -127.5 171.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 78.7 tttt -85.39 125.65 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.39 -41.28 69.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 130' ' ' LYS . 95.5 mt-10 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 66.4 m170 -66.49 -42.46 87.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.384 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.6 t -69.39 -44.07 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.464 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -55.8 -42.45 75.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.7 -44.5 81.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -37.53 94.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -60.12 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.39 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -63.7 -43.16 97.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.381 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.93 -45.28 82.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.44 95.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.907 . . . . 0.0 109.43 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.4 99.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.438 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -57.09 -48.77 77.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.424 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.76 -39.51 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -53.96 -41.77 68.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.336 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.4 -41.95 86.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.54 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 48.7 mt -57.43 -41.08 79.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 152' ' ' LEU . 88.3 mt -54.87 -47.41 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.451 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 83.2 mt-10 -54.71 -47.17 74.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.179 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.54 -27.27 71.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.433 ' CG ' HD13 ' A' ' 30' ' ' LEU . 66.6 t80 -59.14 -47.26 85.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -1.113 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 152' ' ' LEU . 6.5 mp -73.66 -49.53 25.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -55.6 -30.85 61.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.257 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 52.8 t0 -85.98 -29.65 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.863 . . . . 0.0 109.309 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 154' ' ' ASP . 42.3 p-80 40.24 66.28 3.39 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.539 -0.726 . . . . 0.0 109.977 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.81 139.3 36.32 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.632 2.222 . . . . 0.0 111.562 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.7 p -117.56 157.83 25.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -113.46 146.29 39.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 71.0 t80 -129.9 137.36 50.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.573 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 159' ' ' TYR . 42.1 p-10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.464 ' CG1' ' HE2' ' A' ' 120' ' ' LYS . 7.8 p -114.15 139.73 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.513 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -110.57 156.68 20.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.362 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 17.8 m -93.56 142.78 26.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.403 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -119.41 135.23 54.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -110.45 133.8 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.272 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.02 131.84 54.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.61 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.64 122.88 47.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.319 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 11' ' ' THR . 82.0 t80 -142.82 146.57 34.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.61 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.568 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.0 p -108.29 142.45 38.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.208 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.418 ' CB ' HD11 ' A' ' 115' ' ' ILE . 20.8 t -141.12 159.17 42.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.965 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.45 -175.96 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 66.08 141.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.009 . . . . 0.0 109.146 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.2 Cg_endo -70.01 146.52 58.9 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.444 2.096 . . . . 0.0 112.001 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.21 -50.61 6.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.543 -0.723 . . . . 0.0 111.403 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.09 -50.31 3.03 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.29 1.993 . . . . 0.0 113.076 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 33.3 mttp -59.66 -33.59 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.19 . . . . 0.0 109.515 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 19' ' ' LEU . 9.9 tt -80.92 -34.39 33.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD1' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -64.81 -32.13 73.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 20.3 tttm -68.89 -46.29 68.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.74 38.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.737 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' HD21 ' A' ' 19' ' ' LEU . 68.1 t80 -86.42 -17.71 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 82' ' ' TYR . 66.5 t -115.9 -51.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 27.9 tp -68.46 -40.33 81.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 79.2 m-20 -103.38 18.6 21.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -69.97 -35.98 74.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 95.2 m-20 -67.76 -32.07 72.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 20.8 t-20 -99.34 -43.63 6.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -55.7 -42.61 75.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.775 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 13.8 mt -49.78 -62.32 2.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.516 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.51 -16.98 43.59 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.498 2.132 . . . . 0.0 111.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' NZ ' ' CG ' ' A' ' 159' ' ' TYR . 21.3 tptm -67.54 -45.23 76.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.623 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.533 ' CG2' ' CD1' ' A' ' 147' ' ' LEU . 75.7 mt -70.23 -35.17 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.705 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.73 71.76 57.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.61 -30.98 17.53 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 111.715 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -75.06 -30.09 60.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.14 97.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.587 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG22 ' CG2' ' A' ' 57' ' ' ILE . 4.0 p -121.13 150.26 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -74.92 -47.47 29.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 178.48 129.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.28 125.65 36.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.49 155.7 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.9 mt -106.03 120.65 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -65.81 -44.0 86.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 92.9 mt-10 -158.81 154.92 26.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.76 -42.48 1.91 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 59.99 40.17 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.354 -1.086 . . . . 0.0 109.558 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 33.76 22.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -121.36 -168.46 13.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.59 130.0 18.77 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.705 2.27 . . . . 0.0 111.714 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.01 25.88 72.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.581 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.3 m -79.18 143.12 35.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.471 ' N ' HG21 ' A' ' 53' ' ' THR . 68.4 mt -112.51 132.05 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -123.49 150.79 43.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -132.34 122.84 25.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.599 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 36.1 mt -113.34 140.58 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.622 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.5 m -120.69 128.3 52.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -103.85 136.43 43.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.0 164.92 37.98 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.79 142.07 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -1.14 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.12 11.86 83.92 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -120.38 143.15 48.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -102.22 -3.97 26.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.545 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.2 154.89 27.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . 95.03 60.22 1.08 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.5 p90 -138.55 144.38 39.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 40.9 t -124.85 143.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.451 ' HE3' HG22 ' A' ' 87' ' ' ILE . 49.5 mtmt -113.19 147.59 37.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 91.9 m-70 -122.85 136.84 55.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 53' ' ' THR . 66.0 tttt -117.31 138.21 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.382 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 62.8 mt -99.72 132.98 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -90.5 -45.71 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.3 p -169.91 148.84 3.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.08 144.47 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 86.0 m-20 -131.05 92.16 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -62.8 -34.8 78.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.402 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.54 -39.86 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.407 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 77.1 m-20 -87.28 4.7 41.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.424 ' O ' HD21 ' A' ' 105' ' ' LEU . 31.8 m80 48.44 43.88 20.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.4 m -126.58 136.99 53.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD1' HG12 ' A' ' 24' ' ' VAL . 61.3 t80 -131.19 127.47 38.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.8 p -121.45 137.18 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -151.37 169.3 22.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 83.0 p -145.55 160.96 40.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.516 ' CD2' ' CD1' ' A' ' 92' ' ' LEU . 4.1 tt -97.59 119.57 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.374 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 93.5 mt -75.58 -56.7 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 87' ' ' ILE . 75.4 mm-40 -148.46 162.04 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -0.99 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA3' HG23 ' A' ' 68' ' ' VAL . . . -174.33 150.8 11.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 7.9 t0 -60.12 -26.61 66.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -1.131 . . . . 0.0 109.563 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.429 ' O ' HD13 ' A' ' 96' ' ' ILE . . . -78.34 -28.73 47.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 92' ' ' LEU . 2.9 mt -75.19 -33.05 61.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 108.755 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m 52.85 -173.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.606 -0.684 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' ' HD2' ' A' ' 124' ' ' LYS . 96.9 mt-10 -80.25 -3.42 49.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.68 -36.24 14.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.517 ' HB ' ' CA ' ' A' ' 92' ' ' LEU . 42.6 mt -92.3 130.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 110.041 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 70.4 mm-40 -88.55 -178.35 5.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.6 mttp -56.12 153.62 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 121' ' ' TYR . 53.8 mt -118.03 137.68 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 119' ' ' SER . 87.4 m-20 -93.17 124.95 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.36 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 83.7 m-85 -117.24 140.67 49.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' THR . 93.6 mt-10 -133.76 136.65 44.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -128.4 137.44 51.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -139.76 128.95 23.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.532 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.8 mm? -98.31 130.57 44.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.19 145.93 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.7 p -112.68 143.07 44.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.0 109.478 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.46 164.93 13.83 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.39 -18.05 38.96 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.634 2.222 . . . . 0.0 111.771 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.01 -15.51 63.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.862 . . . . 0.0 109.43 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.45 26.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.49 -179.84 50.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 66.4 m -124.75 126.87 46.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.159 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 106' ' ' VAL . 66.1 mt -90.38 137.9 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.337 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.558 HD13 ' CZ ' ' A' ' 145' ' ' PHE . 45.6 mt -119.84 129.11 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -118.8 127.0 53.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 0.0 109.205 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.5 m -126.44 134.46 50.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.729 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.0 m -116.87 142.73 46.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 109.094 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.549 ' OG ' ' CE1' ' A' ' 101' ' ' TYR . 27.1 t -139.33 148.85 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.041 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 82.3 tttt -136.5 130.71 32.93 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.564 ' CE2' HD13 ' A' ' 99' ' ' ILE . 27.8 m-85 -108.76 126.65 53.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.073 -1.017 . . . . 0.0 109.924 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.461 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 34.3 m170 -98.02 146.88 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.16 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 p -129.23 162.02 28.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.097 -1.002 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 94' ' ' GLU . 28.7 mtpp -53.68 -48.97 68.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -169.24 -62.33 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -154.3 51.46 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -1.113 . . . . 0.0 109.634 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 85.5 t -65.02 -22.87 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 109.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 68.3 tt0 70.56 127.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.7 tt -128.95 170.91 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -94.13 125.8 38.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.37 -40.55 68.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.4 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.75 -35.29 77.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -66.36 -44.38 83.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.882 . . . . 0.0 109.428 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.72 -43.82 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.909 . . . . 0.0 109.422 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 32.7 ttpt -60.3 -39.55 87.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.354 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -59.84 -43.02 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.6 -43.12 99.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HE2' ' OH ' ' A' ' 121' ' ' TYR . 35.5 mmtp -62.02 -41.41 98.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' O ' ' CD2' ' A' ' 143' ' ' HIS . 96.7 mt-10 -62.32 -43.04 99.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 98.8 mttt -57.56 -42.04 82.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.893 . . . . 0.0 109.374 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.09 -42.66 93.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.16 85.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 139' ' ' GLU . 86.3 m-70 -56.91 -50.94 71.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.92 -47.27 85.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.558 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 49.4 t80 -53.35 -43.26 67.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -55.11 -43.26 73.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.302 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 65.2 mt -56.69 -45.02 82.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.463 ' O ' HD11 ' A' ' 152' ' ' LEU . 93.4 mt -53.8 -52.02 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.298 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.418 ' CG ' ' OG ' ' A' ' 12' ' ' SER . 83.7 tt0 -54.27 -41.82 69.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.233 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -77.57 -23.42 67.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 147' ' ' LEU . 70.1 t80 -63.18 -45.68 90.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.341 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.6 mp -75.01 -42.01 58.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.347 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -53.43 -34.12 56.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 0.0 108.863 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 155' ' ' HIS . 89.9 m-20 -76.66 -40.92 47.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.011 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' ASP . 6.8 t-160 43.15 68.22 3.08 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 159' ' ' TYR . 48.7 Cg_endo -69.82 132.49 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.733 2.288 . . . . 0.0 111.824 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.8 m -59.29 -26.26 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 158' ' ' GLU . 73.1 mm-40 -70.76 -34.34 71.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.477 ' CG ' ' NZ ' ' A' ' 33' ' ' LYS . 25.2 m-85 -123.2 134.02 54.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.439 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 121' ' ' TYR . 48.8 t -118.2 134.4 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -1.156 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -123.14 150.52 43.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' CG2' ' A' ' 118' ' ' THR . 19.9 m -93.95 138.13 32.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 118' ' ' THR . 77.5 t80 -122.86 134.51 54.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.43 133.77 55.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -121.78 131.66 54.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.8 mt-10 -104.04 118.95 37.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 11' ' ' THR . 62.4 t80 -133.29 132.39 41.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.5 p -93.9 142.96 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 24.4 m -135.3 160.48 38.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.673 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' ILE . 96.5 m-20 -69.26 -175.72 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 61.78 141.72 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.959 . . . . 0.0 109.077 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 46.0 Cg_endo -69.21 146.23 62.92 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.452 2.102 . . . . 0.0 111.978 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.12 -49.82 8.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.592 -0.692 . . . . 0.0 111.365 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -63.93 -49.32 4.09 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.252 1.968 . . . . 0.0 113.027 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 96.6 mttt -62.09 -35.48 78.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.523 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' PHE . 20.4 tp -80.57 -27.98 37.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.563 ' CG ' HG21 ' A' ' 24' ' ' VAL . 64.1 t80 -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -60.4 -43.89 96.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.4 -20.56 40.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.558 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 71.0 t80 -99.09 6.64 46.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 82' ' ' TYR . 94.6 t -135.0 -78.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.144 -0.973 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.02 -49.22 74.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 80.0 m-20 -99.07 12.14 36.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' CA ' ' A' ' 24' ' ' VAL . . . -69.53 -36.4 76.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -73.18 -29.87 63.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.8 m120 -91.06 -29.01 17.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.481 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 30' ' ' LEU . 1.8 tm? -73.52 -34.15 65.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.877 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 19.7 mt -51.32 -55.8 25.75 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.605 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.56 -17.89 43.16 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.499 2.132 . . . . 0.0 111.856 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 42.5 mttt -71.09 -40.45 71.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 109.521 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' CG2' HD13 ' A' ' 147' ' ' LEU . 87.9 mt -68.13 -34.63 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.74 70.39 19.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -70.18 -34.58 12.91 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.656 2.237 . . . . 0.0 111.727 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.75 -19.9 65.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.25 -26.56 21.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 1.9 t -118.01 139.79 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.1 -51.08 23.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.48 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.39 117.67 29.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.22 147.76 45.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.317 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 74.3 mt -106.36 118.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -60.58 -45.19 94.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.7 mt-10 -159.32 157.87 31.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 108.35 -43.03 1.79 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.9 m-20 59.76 38.33 21.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.09 33.01 21.92 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 53' ' ' THR . . . -118.78 -168.2 14.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.03 130.75 19.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.692 2.261 . . . . 0.0 111.668 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 71.51 26.73 72.59 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 88.2 m -80.37 140.3 36.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 64.2 mt -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 2.9 mtpt -119.22 149.17 42.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -131.87 124.43 29.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 20.5 mt -119.96 131.38 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -111.99 121.66 45.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.341 -0.849 . . . . 0.0 109.109 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 60' ' ' GLY . 82.1 m-85 -91.05 133.26 35.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.484 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 59' ' ' PHE . . . -43.36 155.36 0.19 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.3 157.16 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -1.169 . . . . 0.0 109.543 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.91 71.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -106.93 155.35 19.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -56.35 -27.87 57.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CE1' ' CB ' ' A' ' 91' ' ' ALA . 16.0 m-85 -122.58 142.63 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . -86.58 -64.83 1.42 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 35.4 p90 -158.25 144.8 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -1.199 . . . . 0.0 109.905 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 70' ' ' HIS . 4.6 m -134.47 150.31 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 109.089 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 86' ' ' LEU . 37.6 mttt -106.45 139.91 40.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.576 ' CE1' HG22 ' A' ' 68' ' ' VAL . 70.3 m80 -114.42 143.82 44.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 109.17 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -127.35 138.95 53.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.709 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 59.1 mt -98.69 131.15 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.17 -49.16 6.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m -163.34 152.12 14.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.413 HD11 ' HE3' ' A' ' 77' ' ' LYS . 25.8 pt -129.21 145.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 69.0 m-20 -122.15 107.09 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.924 . . . . 0.0 109.289 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HE3' HD11 ' A' ' 75' ' ' ILE . 36.4 mttt -82.7 -25.77 32.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 108.553 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -46.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 65.5 m-80 -80.56 -5.37 56.67 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.492 -0.755 . . . . 0.0 109.651 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 m80 60.16 42.74 15.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.497 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 63.5 m -124.36 135.04 53.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.574 ' CD1' HG11 ' A' ' 24' ' ' VAL . 65.9 t80 -124.63 129.5 50.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -122.14 135.28 54.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.649 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.625 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.9 p90 -151.48 168.09 25.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.307 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 95.3 p -149.59 152.16 35.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.571 HD11 ' CE1' ' A' ' 70' ' ' HIS . 37.7 tp -91.96 117.42 29.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.292 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG22 ' HG3' ' A' ' 88' ' ' GLU . 24.1 mm -70.4 -71.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.735 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -128.06 169.35 14.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.0 109.803 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 176.72 137.36 2.63 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.447 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 31.3 m-20 -47.55 -40.5 19.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -1.167 . . . . 0.0 109.694 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.494 ' CB ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.23 -15.52 62.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 86' ' ' LEU . 7.0 mp -87.89 -43.79 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 m 61.93 178.43 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.408 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.17 -2.05 39.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.632 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 127' ' ' VAL . 16.5 p-10 -91.75 -21.58 20.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 96' ' ' ILE . 51.5 mt -111.3 141.36 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -0.931 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -95.6 179.84 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 3.8 pttm -57.52 164.61 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.545 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 68.2 mt -120.72 134.23 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 61.9 t0 -89.7 122.7 33.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 77.9 m-85 -115.51 139.8 49.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.275 -0.891 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 94.1 mt-10 -131.04 136.85 48.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 81' ' ' THR . 53.6 m -132.07 133.17 44.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 115' ' ' ILE . 22.7 tttt -131.61 133.36 44.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 109.477 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' A' ' 16' ' ' ALA . 1.2 mp -103.84 125.1 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 40.1 t -131.76 140.43 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 92.7 p -110.57 141.32 43.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -0.933 . . . . 0.0 109.452 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.436 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . . . -109.75 164.74 14.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.556 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 108' ' ' ALA . 49.6 Cg_endo -69.96 -7.12 20.33 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.752 2.301 . . . . 0.0 111.791 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -78.82 -18.5 53.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.91 -29.45 7.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.87 174.53 55.09 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.9 m -122.14 125.57 46.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 109.539 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.1 mt -90.22 138.34 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 104' ' ' LYS . 44.0 mt -125.87 127.8 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.794 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 53.5 mttp -105.05 128.71 53.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -125.88 129.85 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 110.007 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 5' ' ' THR . 33.1 m -118.49 133.87 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 108.923 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.8 m -123.8 142.46 51.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.09 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 75.9 tttt -139.38 129.44 25.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 121' ' ' TYR . 25.2 m-85 -111.65 131.57 55.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 109.884 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 71.4 m80 -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 22.0 p -112.63 163.22 14.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -58.01 -35.93 71.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 169.9 -79.68 0.1 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -98.17 9.57 42.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -1.115 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 95' ' ' ASN . 55.4 t -63.14 130.12 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.7 151.05 29.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.504 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.6 tt -125.08 171.44 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.2 131.77 44.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.513 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.37 -38.31 68.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.97 -38.0 81.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -68.57 -40.44 80.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 -42.42 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -58.89 -41.5 87.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.48 79.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.24 98.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -60.84 -45.15 95.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.36 -40.21 95.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -57.37 -44.12 84.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.335 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.23 -48.65 64.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.72 77.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.331 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.52 -41.58 98.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 35.3 mt -61.71 -45.98 91.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -53.28 -42.96 67.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -62.47 -39.67 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.473 HD13 ' CG2' ' A' ' 34' ' ' ILE . 60.5 mt -66.72 -40.73 88.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.401 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' LEU . 82.2 mt -56.01 -45.73 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 96.6 mt-10 -60.66 -46.64 89.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.76 -39.87 96.96 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.453 ' CE1' HD21 ' A' ' 30' ' ' LEU . 42.0 t80 -53.4 -55.38 25.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -1.088 . . . . 0.0 109.462 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.84 -42.22 97.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -56.36 -44.79 80.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.446 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 155' ' ' HIS . 90.7 m-20 -56.96 -53.63 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 154' ' ' ASP . 2.8 t-160 44.49 76.22 0.56 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.526 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 128.97 15.95 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -59.51 -33.32 71.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.72 146.5 25.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -110.6 140.57 44.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.855 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.435 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 9.6 p -114.81 138.76 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -1.166 . . . . 0.0 109.511 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.37 156.66 22.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 109.381 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 57.3 m -93.42 143.51 26.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.29 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -109.63 141.97 41.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.278 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -127.83 129.66 47.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 91.2 mt-10 -101.76 124.78 47.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 11' ' ' THR . 46.9 t80 -136.25 127.03 27.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 15.1 p -90.42 154.73 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.446 ' HB2' ' CG ' ' A' ' 149' ' ' GLU . 88.9 p -149.32 167.9 24.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 87.3 m-20 -77.2 -175.25 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.4 mt 63.4 142.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.3 Cg_endo -70.34 147.25 58.75 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.533 2.155 . . . . 0.0 112.106 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.14 -50.4 8.14 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 111.429 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.08 -50.27 3.08 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.303 2.002 . . . . 0.0 113.031 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 60.4 mttt -61.93 -37.02 83.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.429 HD12 HG21 ' A' ' 148' ' ' ILE . 27.6 tp -81.3 -24.95 36.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.116 -0.99 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 77' ' ' LYS . 66.1 t80 -72.96 -34.56 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 109.859 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 17.5 mttp -67.25 -45.78 75.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.765 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.12 42.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.624 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 59.4 t80 -76.53 -15.69 59.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 44.2 t -119.68 -53.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 46.0 mt -67.85 -40.45 83.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 80.3 m-20 -100.52 11.11 40.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -70.18 -31.66 69.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.628 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -68.64 -21.83 64.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 27.8 m120 -114.23 -37.81 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.075 -1.016 . . . . 0.0 109.485 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 HD11 ' CG ' ' A' ' 151' ' ' TYR . 30.1 tp -58.2 -36.94 73.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 11.5 mt -55.78 -60.5 8.47 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.188 -0.945 . . . . 0.0 109.195 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.519 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.45 -11.35 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.558 2.172 . . . . 0.0 111.583 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 18.7 mttt -80.84 -35.63 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 109.607 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.448 ' CG2' HD11 ' A' ' 147' ' ' LEU . 87.6 mt -73.54 -31.18 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . . . -137.36 68.49 54.4 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.4 Cg_endo -70.15 -31.42 18.83 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.7 2.266 . . . . 0.0 111.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.33 -29.29 63.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 35' ' ' ALA . . . -74.32 -42.02 60.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 57' ' ' ILE . 5.6 p -128.72 149.23 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.389 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' CD ' ' OE2' ' A' ' 61' ' ' GLU . 21.9 mtpp -71.89 -51.69 20.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.1 144.24 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.67 120.32 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -113.19 156.18 23.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.584 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 22.1 mm -106.83 133.89 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 20.5 tp -78.98 -37.91 38.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 57.8 mm-40 -159.06 133.6 7.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.462 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 104.22 -34.74 5.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' N ' HG23 ' A' ' 44' ' ' ILE . 5.3 m-20 51.49 56.98 7.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -1.109 . . . . 0.0 109.794 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.08 25.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.73 -168.78 14.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.14 133.43 26.69 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.595 2.197 . . . . 0.0 111.47 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.16 20.96 58.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 49.5 m -73.38 146.83 44.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 0.0 109.741 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.518 ' N ' HG22 ' A' ' 53' ' ' THR . 23.8 mm -106.39 135.8 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 45.5 mttt -115.95 143.26 45.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 63.0 tttm -129.68 129.86 44.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' CG2' HG23 ' A' ' 39' ' ' VAL . 44.0 mt -125.59 130.53 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.887 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -112.17 128.1 56.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.132 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 57' ' ' ILE . 75.2 m-85 -103.15 132.31 49.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' PHE . . . 50.09 178.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' OE2' ' CD ' ' A' ' 40' ' ' LYS . 65.2 mm-40 -142.08 168.64 19.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 0.0 109.431 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.76 87.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.9 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.174 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -56.13 -46.93 79.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -140.33 175.45 9.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.359 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.12 67.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.504 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 45.8 p90 -151.85 143.97 23.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -1.162 . . . . 0.0 109.514 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 61.4 t -118.44 141.77 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.267 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 50.3 mttt -116.56 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.552 ' CE1' ' HG ' ' A' ' 86' ' ' LEU . 94.0 m-70 -120.97 144.84 48.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 45.3 tttt -121.36 140.88 51.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 66.0 mt -99.22 134.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.436 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.465 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.8 m-70 -88.93 -48.47 7.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.0 p -169.84 150.95 4.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 21.1 pt -129.08 144.78 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -129.42 92.68 3.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.5 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 95.2 mttt -64.28 -36.29 83.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.73 -42.75 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -87.66 6.68 33.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.414 ' O ' HD23 ' A' ' 105' ' ' LEU . 69.0 m80 47.88 44.6 18.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.497 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.6 m -124.38 138.5 54.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.38 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 52.6 t80 -134.26 132.46 39.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 m -126.28 140.47 52.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.5 p90 -153.01 171.6 18.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.3 p -149.53 152.67 35.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.552 ' HG ' ' CE1' ' A' ' 70' ' ' HIS . 4.6 tt -87.97 127.59 35.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 71' ' ' LYS . 82.9 mt -86.35 -72.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.441 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 95.3 mt-10 -122.74 160.58 25.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.468 ' CA ' HG23 ' A' ' 68' ' ' VAL . . . -177.91 153.73 13.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -61.83 -25.48 67.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -1.13 . . . . 0.0 109.556 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.41 46.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.9 mt -71.71 -31.85 67.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 108.853 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m 50.21 -172.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.626 -0.671 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.26 15.04 9.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.427 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -116.39 -17.87 10.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 23.5 mt -109.34 141.47 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 94.0 mt-10 -90.7 -179.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 31.6 mttp -57.62 176.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.687 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 59.0 mt -133.18 133.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.414 -0.804 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 119' ' ' SER . 80.5 m-20 -87.28 121.4 29.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 67.0 m-85 -114.39 144.1 43.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 89.1 mt-10 -132.81 139.24 47.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.7 m -135.41 128.45 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.558 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -134.88 124.66 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.7 mm? -93.7 129.12 40.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 57.5 t -131.99 141.53 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.49 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.5 p -108.43 146.53 32.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.04 164.79 14.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.01 -17.61 36.35 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.673 2.249 . . . . 0.0 111.848 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.76 -15.34 61.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -15.45 35.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.22 170.03 46.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 14' ' ' ILE . 94.1 m -119.96 126.13 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 67.0 mt -93.16 139.56 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 105' ' ' LEU . 56.2 mt -127.1 121.89 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.728 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 58.0 mttp -106.82 132.37 52.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.046 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 74.0 m -131.74 129.79 41.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 30.2 m -113.15 148.63 34.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 0.0 108.922 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 55.3 m -140.23 148.44 41.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.51 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 77.3 tttt -138.35 127.25 23.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.162 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.464 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 40.3 m-85 -105.49 121.98 45.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 78.8 m80 -101.74 141.33 34.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.423 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 28.8 p -119.2 146.82 44.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 20.9 tptm -67.26 -44.2 79.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 109.355 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -141.76 38.4 1.5 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 93.0 m-20 61.76 46.83 6.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -1.12 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 9.3 p -49.51 -22.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 81.2 tt0 64.85 134.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.53 171.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.597 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.497 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 46.1 tttp -81.19 125.04 29.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -52.6 -42.59 64.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.497 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 65.9 m170 -66.9 -42.35 85.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.53 -46.65 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.421 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -55.86 -43.18 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.69 78.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.41 -40.99 98.36 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -58.71 -48.62 80.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -1.169 . . . . 0.0 109.348 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' O ' ' CD2' ' A' ' 143' ' ' HIS . 94.4 mt-10 -61.28 -41.4 96.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 20.0 tttt -57.69 -45.36 85.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.0 88.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 109.361 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.84 95.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 139' ' ' GLU . 76.3 m-70 -58.94 -43.94 91.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 47.6 mt -56.94 -49.07 76.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.13 -43.92 67.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -58.97 -41.05 86.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 151' ' ' TYR . 52.4 mt -64.22 -40.05 95.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.897 . . . . 0.0 109.364 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 152' ' ' LEU . 63.8 mt -55.51 -53.18 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.157 -0.965 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' HD12 ' A' ' 14' ' ' ILE . 73.1 mm-40 -54.38 -40.21 67.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.176 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.79 -26.03 59.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.566 ' CG ' HD11 ' A' ' 30' ' ' LEU . 60.0 t80 -60.82 -45.99 92.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -1.126 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.7 mp -74.26 -46.86 38.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.3 -0.875 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -53.33 -42.22 66.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -76.38 -33.31 58.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -118.93 88.94 37.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.06 150.23 66.08 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.651 2.234 . . . . 0.0 111.881 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.5 t -88.94 140.41 29.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.379 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -112.73 160.58 17.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.592 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -111.7 138.16 48.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.453 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 122' ' ' HIS . 80.9 t -119.58 134.53 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 109.554 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.21 140.9 48.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.269 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.5 m -105.25 131.73 52.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -0.946 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 97.5 m-85 -124.47 138.82 54.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.378 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.61 136.15 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -117.39 135.58 53.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.41 124.25 51.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 80.6 t80 -146.17 141.7 27.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.528 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.2 p -107.93 151.29 25.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 21.7 t -151.38 154.38 36.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.629 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 10.8 t0 -66.31 -175.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 mm 72.44 141.67 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 109.356 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.1 Cg_endo -69.55 146.24 60.89 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.481 2.12 . . . . 0.0 112.027 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -42.96 -49.33 14.22 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 111.595 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.5 -50.33 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.145 1.897 . . . . 0.0 113.169 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 67.6 mttt -61.46 -30.35 70.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 109.583 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 152' ' ' LEU . 22.6 tp -80.61 -33.71 35.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.685 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 24' ' ' VAL . 83.0 t80 -61.7 -41.39 97.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.884 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.5 mttt -65.22 -55.14 20.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.47 -11.0 60.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.761 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 72.8 t80 -87.61 -33.43 18.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.1 m -115.75 -40.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.826 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 20.7 tp -71.39 -34.33 70.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.016 . . . . 0.0 109.435 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 76.7 m-20 -108.04 11.46 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.521 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.83 -40.19 76.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -57.5 -32.82 67.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.2 m120 -102.27 -36.36 8.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 26' ' ' ASP . 42.6 tp -72.75 -34.52 67.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.584 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 27.3 mt -53.69 -55.61 33.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -68.9 -17.54 41.49 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -72.52 -39.3 67.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' CD1' ' A' ' 144' ' ' LEU . 87.1 mt -72.25 -32.63 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.88 72.53 16.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -69.96 -31.97 18.61 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.69 2.26 . . . . 0.0 111.799 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.17 -26.26 62.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.33 -48.27 76.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.56 HG13 ' CE2' ' A' ' 59' ' ' PHE . 17.4 m -128.39 157.53 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -73.53 -42.69 61.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.61 135.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -0.87 . . . . 0.0 109.463 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.54 119.0 27.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.27 147.98 40.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.2 mt -106.08 121.12 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.4 tp -65.55 -43.71 89.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.5 mt-10 -159.22 155.81 27.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.33 -40.93 2.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.0 m-20 60.7 40.05 16.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.222 -1.164 . . . . 0.0 109.58 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 35.21 15.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.56 13.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.73 129.64 17.98 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.758 2.305 . . . . 0.0 111.69 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.96 77.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.582 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.0 m -80.02 143.82 33.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -1.129 . . . . 0.0 109.58 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.466 ' N ' HG21 ' A' ' 53' ' ' THR . 64.3 mt -113.94 127.98 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 56.9 mttt -112.44 152.76 28.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 19.1 tttt -134.62 126.61 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.572 ' CD1' ' CD2' ' A' ' 70' ' ' HIS . 53.1 mt -116.26 139.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -115.86 129.0 56.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.437 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.56 ' CE2' HG13 ' A' ' 39' ' ' VAL . 82.9 m-85 -99.08 136.63 38.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.4 57.43 0.49 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -34.07 68.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -1.172 . . . . 0.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 64' ' ' HIS . . . 118.51 119.99 2.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.6 m 45.68 25.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -1.197 . . . . 0.0 109.601 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 62' ' ' GLY . 73.7 m-70 -132.32 160.98 34.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -117.61 143.36 46.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 174.15 137.87 2.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 41.1 p90 -157.0 144.53 18.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -1.209 . . . . 0.0 109.752 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.546 HG22 ' CZ ' ' A' ' 59' ' ' PHE . 59.2 t -119.43 144.71 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.274 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.9 mttm -121.44 138.29 54.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.562 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.572 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 93.5 m-70 -112.12 135.76 52.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.2 139.1 49.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 47.3 mt -104.62 132.03 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -89.13 -47.69 7.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -169.79 153.79 5.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.41 HG23 ' CE1' ' A' ' 82' ' ' TYR . 31.6 pt -128.87 144.1 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.394 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -124.91 92.83 3.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -63.13 -35.25 79.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.92 -40.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -87.93 4.63 44.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 105' ' ' LEU . 39.7 m80 47.74 38.36 8.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.482 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -120.74 138.14 54.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 78.0 t80 -125.7 127.77 46.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -118.97 134.01 55.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.676 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 28.2 p90 -157.47 170.07 23.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.205 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 92.9 p -149.0 156.8 42.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 0.0 109.9 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD23 ' CD1' ' A' ' 92' ' ' LEU . 36.4 tp -91.25 110.86 22.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.201 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 88' ' ' GLU . 4.3 tt -74.93 -47.16 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' N ' ' CG2' ' A' ' 87' ' ' ILE . 97.5 mt-10 -142.3 167.16 22.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.891 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 68' ' ' VAL . . . 172.96 146.55 5.47 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.451 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 55.6 m-20 -58.94 -27.55 65.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.86 51.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 92' ' ' LEU . 3.3 mt -76.31 -33.18 59.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 108.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.4 m 55.12 -179.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.628 -0.67 . . . . 0.0 109.292 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.62 5.29 21.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.526 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 73.3 m-20 -97.88 -28.04 14.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 96' ' ' ILE . 58.8 mt -104.87 137.87 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.4 mm-40 -83.87 -179.47 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 22.7 pttm -57.26 164.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 47.7 mt -124.62 133.94 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.529 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 82.9 m-20 -90.42 126.18 35.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.875 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 93.4 m-85 -121.09 134.87 55.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.204 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -128.21 138.06 52.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.639 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.3 m -128.9 134.43 48.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -132.61 133.08 43.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.574 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.9 mm? -102.83 123.46 46.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 48.2 t -129.02 141.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.3 OUTLIER -113.71 146.49 39.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.565 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -110.63 174.07 2.56 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.507 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 108' ' ' ALA . 48.9 Cg_endo -69.3 -16.58 39.58 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.734 2.289 . . . . 0.0 111.807 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.35 -20.61 63.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.265 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.43 -22.07 25.18 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.26 176.53 54.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 80.1 m -125.21 126.01 44.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -1.158 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.5 mt -91.05 140.64 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 109.172 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.459 HG12 HD12 ' A' ' 105' ' ' LEU . 55.3 mt -123.94 120.71 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -109.88 132.13 54.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.9 m -127.21 128.74 46.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 143.02 49.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 89.8 p -144.69 147.24 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 110.399 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.52 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 51.6 mttp -122.03 144.11 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.498 ' CD1' HD13 ' A' ' 99' ' ' ILE . 98.1 m-85 -112.11 124.32 52.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 110.065 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 78.9 m80 -99.91 129.25 45.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.131 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.1 p -122.89 160.67 25.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 109.685 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -71.32 -34.94 71.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . 176.29 47.76 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 95.1 m-20 61.96 48.67 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -1.137 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 95' ' ' ASN . 91.6 t -54.7 -57.14 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -178.95 104.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 tt -138.73 171.79 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.239 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.42 ' HE2' ' OE1' ' A' ' 132' ' ' GLU . 74.4 tttt -142.1 130.91 22.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.604 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -54.06 -41.48 68.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' OE1' ' HE2' ' A' ' 130' ' ' LYS . 95.2 mt-10 -59.83 -37.21 78.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.898 . . . . 0.0 109.487 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -66.09 -43.84 86.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.01 -47.8 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.423 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -57.68 -42.36 83.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.5 72.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 109.297 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.63 95.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 6' ' ' TYR . 48.2 mmtm -62.77 -41.75 99.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -1.108 . . . . 0.0 109.361 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.89 -40.49 95.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.4 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.56 -42.56 88.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.11 90.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.39 86.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.28 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' CD1' HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.42 -46.71 83.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.45 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 78.7 m-85 -53.89 -38.42 64.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.54 -43.43 79.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -66.11 -42.44 89.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.465 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 85.9 mt -60.95 -38.55 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.405 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 65.8 tt0 -64.52 -37.3 87.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.26 -41.46 31.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 21.3 m-85 -65.18 -42.54 93.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.521 ' CD1' HD11 ' A' ' 19' ' ' LEU . 60.8 mt -67.58 -31.66 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -66.71 -41.45 87.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 42.7 p30 -99.5 7.82 45.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -60.92 131.92 91.83 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.43 ' HD2' ' ND1' ' A' ' 155' ' ' HIS . 49.1 Cg_endo -70.24 147.2 59.23 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.692 2.261 . . . . 0.0 111.774 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.3 m -64.6 156.07 31.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.0 -33.25 75.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -62.06 -33.64 74.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.525 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 121' ' ' TYR . 72.6 t -117.0 136.06 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 109.535 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.44 141.02 47.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.519 HG23 ' CG2' ' A' ' 118' ' ' THR . 23.6 m -93.44 143.78 25.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -124.7 138.99 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.727 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -115.27 131.81 56.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -119.8 133.3 55.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -105.54 125.41 50.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -136.41 133.3 36.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.4 p -100.9 143.32 31.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.254 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 43.7 p -141.11 171.63 13.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.653 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ILE . 67.0 m-20 -76.03 -175.99 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.461 HG22 ' CD ' ' A' ' 18' ' ' LYS . 6.6 mm 62.85 138.36 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 49.5 Cg_endo -70.15 150.16 65.46 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.592 2.194 . . . . 0.0 112.059 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.64 -52.25 6.4 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 111.129 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 43.0 Cg_endo -64.89 -49.13 3.15 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.276 1.984 . . . . 0.0 112.907 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' HG2' ' A' ' 15' ' ' PRO . 13.4 ttmt -57.98 -38.03 75.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.93 -1.106 . . . . 0.0 109.572 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.41 ' CD1' HG22 ' A' ' 148' ' ' ILE . 20.8 tp -75.28 -39.09 60.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.496 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 71.2 t80 -55.45 -47.14 76.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.0 tttt -46.63 -44.15 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.937 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -107.47 14.98 25.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.175 -0.953 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 92.4 t80 -96.22 -33.0 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 82' ' ' TYR . 31.3 m -126.09 -39.88 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.811 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 24' ' ' VAL . 15.5 tp -57.32 -66.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.738 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 34.6 p30 -92.27 13.41 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.484 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -68.78 -35.0 76.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.7 m-20 -59.23 -41.52 88.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -96.62 -29.22 13.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.634 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 HD23 ' CE1' ' A' ' 151' ' ' TYR . 3.4 tm? -72.98 -38.9 66.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 32.2 mt -52.25 -55.46 31.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.65 -17.5 42.82 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.41 2.073 . . . . 0.0 111.753 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 28.5 mttm -73.36 -37.06 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' CG2' HD12 ' A' ' 147' ' ' LEU . 88.6 mt -71.28 -27.76 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.15 69.23 16.04 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.84 -29.71 23.07 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.58 2.187 . . . . 0.0 111.683 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -71.96 -28.1 63.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -49.28 44.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 40' ' ' LYS . 3.0 p -119.55 150.98 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.499 ' N ' HG23 ' A' ' 39' ' ' VAL . 19.2 tttm -75.68 -51.78 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.72 136.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.81 129.27 38.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.88 148.95 42.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.4 mt -106.25 119.16 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 24.2 tp -64.32 -44.69 90.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.9 mt-10 -159.47 155.35 26.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.72 -39.75 2.69 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.9 m-20 61.74 41.05 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 72' ' ' ILE . . . 82.59 36.75 15.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.83 -165.4 12.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.56 130.55 19.78 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.726 2.284 . . . . 0.0 111.797 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 25.28 75.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.573 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 99.0 m -80.7 145.91 31.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.508 ' N ' HG21 ' A' ' 53' ' ' THR . 26.2 mm -115.47 132.29 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 mtmp? -128.98 148.39 50.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.03 125.31 44.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.283 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.581 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 11.3 mt -115.41 134.91 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.671 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 p -115.55 142.15 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.36 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -117.74 140.92 49.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.95 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.21 -165.22 53.11 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.79 171.24 7.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.0 109.4 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.12 -35.24 8.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.3 m -54.74 -37.09 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -99.06 152.94 19.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.35 144.38 41.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.372 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.69 109.69 0.59 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 -144.21 148.05 34.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -1.176 . . . . 0.0 109.384 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 88' ' ' GLU . 38.2 t -124.98 145.39 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -113.73 142.86 45.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.581 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 67.8 m170 -116.73 133.42 56.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -115.16 137.67 51.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.5 mt -101.89 134.65 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.483 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.6 m-70 -91.17 -46.85 7.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 t -173.53 147.66 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.51 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 82' ' ' TYR . 29.0 pt -123.57 144.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 91.6 m-20 -121.58 91.9 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.416 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -63.31 -36.89 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.55 -41.82 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 1.18 56.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.2 m80 54.32 42.34 31.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.994 . . . . 0.0 109.406 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 40.2 m -118.17 142.51 47.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CD1' HG11 ' A' ' 24' ' ' VAL . 65.2 t80 -134.73 123.76 24.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.5 m -117.55 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 31.4 p90 -150.87 172.94 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -149.41 155.46 40.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 3.0 tt -97.17 118.74 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 87.6 mt -75.46 -56.88 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.627 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 94.6 mt-10 -149.09 160.43 43.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . -165.46 152.8 22.44 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -58.17 -24.22 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -1.101 . . . . 0.0 109.324 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -85.48 -27.43 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 92' ' ' LEU . 2.0 mt -76.63 -32.81 58.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.839 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 92' ' ' LEU . 30.2 t 47.77 -174.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' O ' ' HD2' ' A' ' 124' ' ' LYS . 97.5 mt-10 -76.37 -6.49 51.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -0.994 . . . . 0.0 109.461 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.476 ' HA ' ' HD2' ' A' ' 124' ' ' LYS . 89.0 m-20 -83.1 -38.91 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.85 . . . . 0.0 109.83 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.524 ' HB ' ' CA ' ' A' ' 92' ' ' LEU . 34.6 mt -91.7 135.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.817 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . 38.3 mt-10 -90.14 -179.26 5.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 70.1 mttt -57.04 158.5 4.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.563 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.567 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 60.4 mt -125.21 131.39 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 120' ' ' LYS . 88.2 m-20 -88.65 124.0 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 75.6 m-85 -115.51 142.24 46.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.671 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -131.93 134.81 46.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.349 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 50.3 m -128.64 138.53 52.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -140.71 127.56 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.274 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 20' ' ' PHE . 37.9 mt -96.49 128.56 43.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.691 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 114' ' ' ILE . 46.8 t -132.0 140.86 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.56 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.5 p -113.72 144.41 42.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.67 166.21 11.2 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.32 -11.48 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.706 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -76.41 -16.81 59.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.33 -24.4 18.2 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.16 54.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 92.1 m -123.65 122.15 37.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -1.185 . . . . 0.0 109.707 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.0 mt -87.72 144.31 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.061 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.14 117.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.871 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -97.81 131.98 43.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 108.943 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.8 m -128.91 121.59 28.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 110.007 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.519 ' CG2' HG23 ' A' ' 5' ' ' THR . 32.3 m -114.67 141.09 48.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 108.85 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -138.58 156.71 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 110.329 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 71.1 tttt -147.57 142.64 27.07 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CB ' HG12 ' A' ' 99' ' ' ILE . 26.6 p90 -135.99 148.55 48.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 109.916 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 97' ' ' GLU . 93.9 m-70 -104.48 172.71 6.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 109.517 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 124' ' ' LYS . 26.7 p -125.7 151.01 47.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.175 -0.953 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 95' ' ' ASN . 14.5 tttt -44.21 -54.68 5.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.268 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.16 -43.19 0.14 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 59.2 p30 -133.23 6.78 3.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.371 -1.076 . . . . 0.0 109.373 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.02 122.34 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.22 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -104.34 144.93 30.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.4 tt -124.99 171.15 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -98.5 121.35 40.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.14 -39.7 44.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.418 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 72.6 mm-40 -57.03 -37.75 72.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.35 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -67.27 -41.75 85.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.35 -42.97 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -55.53 -36.66 66.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.515 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.2 -45.68 83.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.01 -39.14 93.88 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -59.74 -40.65 88.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -1.176 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -62.47 -39.21 92.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -59.48 -43.74 93.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.392 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.29 83.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.77 -31.06 70.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -71.46 -37.62 71.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.448 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 mt -67.59 -44.31 78.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.845 . . . . 0.0 109.363 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 27.3 m-85 -54.38 -44.91 72.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 23.3 mttm -57.48 -36.3 71.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.455 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 34' ' ' ILE . 57.7 mt -66.02 -38.85 89.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.49 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 34.4 mm -56.42 -56.5 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 19.5 mp0 -56.53 -36.52 69.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 109.36 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.77 -27.66 62.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.533 ' CE1' HD23 ' A' ' 30' ' ' LEU . 72.8 t80 -63.7 -41.72 98.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -1.068 . . . . 0.0 109.411 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 152' ' ' LEU . 6.1 mp -75.72 -46.81 29.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -53.77 -33.99 57.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.002 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -81.74 -32.14 31.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 109.039 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.89 75.53 57.32 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.64 -16.83 38.27 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.742 2.294 . . . . 0.0 111.706 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.514 ' O ' ' ND2' ' A' ' 160' ' ' ASN . 91.5 p -61.14 -20.37 62.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.0 109.377 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -62.13 -35.0 77.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.5 ' CD1' ' CE ' ' A' ' 18' ' ' LYS . 78.0 t80 -55.68 -38.73 70.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.543 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 157' ' ' SER . 19.1 m120 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.432 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 122' ' ' HIS . 78.1 t -121.76 134.17 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -1.129 . . . . 0.0 109.522 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.5 136.36 52.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 48.3 m -95.51 136.74 35.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.569 ' CG ' ' HE2' ' A' ' 138' ' ' LYS . 98.4 m-85 -119.49 134.78 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.57 137.29 47.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.443 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 37.1 t-20 -113.54 149.88 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -133.4 134.12 43.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.562 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 11' ' ' THR . 64.6 t80 -161.79 131.71 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.502 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.567 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 15.1 p -98.25 157.39 16.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -157.52 177.01 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.569 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.448 ' O ' ' OG1' ' A' ' 113' ' ' THR . 1.1 mp 64.06 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 109.379 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -70.41 147.46 58.7 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.628 2.219 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.21 -51.55 3.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 111.129 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 40.9 Cg_endo -63.63 -50.62 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.339 2.026 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 41.5 mttm -58.6 -37.53 76.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 109.59 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD13 ' CD1' ' A' ' 152' ' ' LEU . 30.5 tp -80.79 -30.03 36.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.771 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.2 -32.86 74.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 109.77 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.7 mtpm? -64.16 -50.12 69.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.609 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -79.46 -16.47 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 49.8 t80 -86.1 -13.44 47.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.4 t -123.8 -58.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 7.1 mp -65.5 -39.92 92.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 42.3 m-20 -98.09 12.56 34.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -69.74 -40.75 76.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -63.33 -35.23 79.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 29.2 t-20 -93.72 -33.91 13.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 31.9 tp -72.86 -44.97 60.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 26.0 mt -45.59 -55.91 11.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -69.18 -26.36 30.38 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 111.801 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 31.2 tttm -71.57 -38.94 70.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.655 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 30' ' ' LEU . 63.8 mt -64.26 -24.27 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.578 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . . . -159.08 73.2 3.51 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 50.2 Cg_endo -70.16 -30.61 20.17 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.664 2.243 . . . . 0.0 111.875 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -74.1 -21.13 60.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -73.04 -42.02 63.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 59' ' ' PHE . 17.9 m -126.36 152.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.53 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.84 -43.43 62.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.57 129.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.54 125.13 31.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.37 150.91 40.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.4 mt -106.59 118.27 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.9 tp -62.61 -44.9 95.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.517 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 94.2 mt-10 -159.87 155.48 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.78 -41.14 2.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.2 m-20 60.11 37.74 20.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.156 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.03 34.92 9.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.433 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.98 -167.17 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.89 129.22 17.09 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.679 2.253 . . . . 0.0 111.77 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 73.5 22.44 78.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.54 ' CG2' ' CG2' ' A' ' 44' ' ' ILE . 92.3 m -77.03 144.47 38.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' N ' HG21 ' A' ' 53' ' ' THR . 65.9 mt -115.39 127.44 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 87.0 mttt -115.92 150.86 36.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 ttpp -132.91 122.44 24.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' CE1' ' A' ' 70' ' ' HIS . 31.7 mt -113.3 135.06 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.2 m -118.14 131.83 56.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CE2' HG13 ' A' ' 39' ' ' VAL . 13.5 m-85 -99.77 128.93 45.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.62 -177.99 42.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -126.97 130.65 50.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -1.176 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.46 66.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.3 p -123.52 145.46 48.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -1.17 . . . . 0.0 109.423 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -108.35 3.69 23.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.25 157.04 26.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.433 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.505 ' N ' ' OD2' ' A' ' 90' ' ' ASP . . . 76.65 60.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.474 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 39.0 p90 -140.35 144.07 36.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG23 ' CA ' ' A' ' 89' ' ' GLY . 25.5 t -131.26 155.15 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.56 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' O ' HD21 ' A' ' 86' ' ' LEU . 45.1 mtmt -124.27 154.3 40.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.547 ' CE1' HD11 ' A' ' 57' ' ' ILE . 61.2 m170 -123.31 150.14 43.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' SER . 57.9 tttt -132.86 138.15 46.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 31.1 mt -104.32 124.04 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.523 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 98.4 m-70 -89.0 -27.39 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 59.7 p 178.9 153.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -136.0 142.53 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.4 m-20 -123.51 94.58 4.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.51 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.26 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 -42.91 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.315 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -87.96 8.14 27.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 48.2 m80 46.28 48.97 13.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.348 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 31.0 m -126.27 136.1 52.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 68.8 t80 -129.98 123.79 31.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -124.52 135.77 53.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.761 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.9 p90 -147.96 -177.14 5.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.523 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 88.8 p -151.41 150.83 30.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.524 ' CD1' HD12 ' A' ' 92' ' ' LEU . 3.1 tt -87.5 119.52 27.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.517 ' N ' HD21 ' A' ' 86' ' ' LEU . 97.4 mt -76.09 -63.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 73.6 mm-40 -138.65 154.38 48.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.725 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.496 ' CA ' HG23 ' A' ' 68' ' ' VAL . . . -173.15 142.88 6.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' A' ' 66' ' ' GLY . 6.0 m-20 -53.09 -32.56 47.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -20.17 61.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.524 HD12 ' CD1' ' A' ' 86' ' ' LEU . 9.7 mp -85.18 -36.02 21.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 40.5 t 61.79 173.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 98.1 mt-10 -79.73 -7.11 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.403 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 53.1 m-20 -84.82 -39.71 18.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.631 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 96' ' ' ILE . 29.8 mt -87.52 143.8 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 92.8 mt-10 -91.37 -179.33 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 46.9 mtmt -56.86 160.86 3.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.96 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.534 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 66.4 mt -120.91 136.65 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 119' ' ' SER . 88.9 m-20 -92.78 126.23 37.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 80.4 m-85 -117.81 137.76 52.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 118' ' ' THR . 94.5 mt-10 -125.01 142.08 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.481 HG23 ' CE1' ' A' ' 23' ' ' PHE . 25.9 m -129.86 136.09 49.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 109.334 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.482 ' NZ ' HG23 ' A' ' 106' ' ' VAL . 25.0 tttt -139.26 128.94 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 2.6 mm? -106.33 112.5 25.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.491 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' ILE . 9.4 t -130.57 128.47 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.9 p -114.78 154.22 28.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.957 . . . . 0.0 110.105 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -96.32 161.54 26.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.634 -0.666 . . . . 0.0 109.248 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.7 Cg_endo -68.5 92.21 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.375 2.05 . . . . 0.0 110.368 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 34.6 t60 78.93 17.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.19 12.83 26.35 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 82.95 -151.39 28.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 52.9 m -126.42 134.69 50.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.998 -1.295 . . . . 0.0 109.797 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' VAL . 49.8 mt -107.05 134.47 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.031 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 105' ' ' LEU . 28.4 mt -116.57 116.83 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 29.2 mttp -105.89 130.55 53.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.968 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -124.63 130.66 52.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 109.966 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.3 m -126.02 139.23 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.433 -0.792 . . . . 0.0 108.997 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 94.8 p -143.47 152.16 41.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 90.1 mttt -125.86 143.35 51.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.108 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' O ' HG21 ' A' ' 3' ' ' VAL . 82.7 m-85 -111.17 123.48 50.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.752 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -95.16 136.79 35.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.241 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.488 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 21.6 p -129.28 152.65 48.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.587 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 94' ' ' GLU . 76.2 mttt -61.65 -56.42 20.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.15 -69.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -116.46 39.05 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -1.18 . . . . 0.0 109.555 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 95' ' ' ASN . 13.5 m -44.31 -35.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 127' ' ' VAL . 85.1 tt0 60.17 119.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -137.33 171.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 133' ' ' HIS . 55.6 mttm -102.91 129.54 49.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -56.14 -34.15 65.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.3 -36.6 80.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.393 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 130' ' ' LYS . 35.9 m-70 -73.16 -37.14 66.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.66 -44.79 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.6 tttt -59.94 -40.13 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.846 . . . . 0.0 109.441 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.48 93.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.409 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.49 -49.09 76.99 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.569 ' HE2' ' CG ' ' A' ' 6' ' ' TYR . 30.3 mttt -63.96 -42.79 97.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.39 -41.82 88.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 50.1 tttp -53.89 -45.39 71.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.7 -47.71 71.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.569 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.67 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.49 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 86.7 t60 -61.86 -44.66 96.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 81.4 mt -53.64 -46.87 70.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -53.42 -32.75 51.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -68.25 -34.55 76.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.955 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 3.2 mm? -71.82 -38.86 70.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 76.4 mt -60.02 -46.01 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -69.61 -34.09 73.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.64 -42.24 88.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 27.1 m-85 -63.13 -46.17 88.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 19' ' ' LEU . 67.8 mt -57.69 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -55.56 -43.1 75.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -58.65 -39.83 81.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.53 ' NE2' ' ND2' ' A' ' 160' ' ' ASN . 2.0 m170 -109.75 107.36 59.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.33 -19.31 33.59 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.646 2.231 . . . . 0.0 111.763 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 51.1 m -120.18 143.2 48.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.5 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.65 -36.25 78.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.421 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -119.89 143.58 47.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.53 ' ND2' ' NE2' ' A' ' 155' ' ' HIS . 42.7 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.449 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 94.0 t -117.53 144.11 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.566 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -100.8 146.1 27.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.566 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 24.8 m -93.55 139.47 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.283 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.45 136.23 53.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.577 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -113.69 135.22 54.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.29 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -114.88 131.02 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 90.3 mt-10 -113.99 132.91 55.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.164 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.4 t80 -146.5 144.84 29.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.746 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.539 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 20.4 p -109.64 144.71 37.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.469 ' CB ' ' HG2' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -152.23 179.38 8.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.7 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 71.9 m-20 -80.62 -175.71 5.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.468 HD13 ' HG3' ' A' ' 149' ' ' GLU . 2.6 mt 69.1 135.13 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 51.0 Cg_endo -71.09 148.14 55.84 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 112.012 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -39.41 -51.46 4.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.557 -0.714 . . . . 0.0 111.311 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.28 -50.32 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.338 2.025 . . . . 0.0 113.072 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HD2' ' CG ' ' A' ' 15' ' ' PRO . 30.9 mttt -59.33 -36.16 75.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.94 -1.1 . . . . 0.0 109.505 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 tp -80.78 -27.08 36.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.93 -38.28 79.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.959 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 60.7 tttt -66.01 -45.07 82.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -29.63 44.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 56.7 t80 -80.88 -10.95 59.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.9 -55.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.531 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.5 tp -69.57 -36.7 76.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.7 m-20 -102.99 15.77 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 31' ' ' ILE . . . -70.2 -40.34 74.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.768 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' OD1' ' NZ ' ' A' ' 55' ' ' LYS . 87.8 m-20 -66.35 -24.74 66.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.067 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.4 m120 -105.69 -43.22 4.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.967 . . . . 0.0 109.629 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 18.3 tp -59.91 -36.06 76.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 22.4 mt -54.16 -60.1 8.35 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -67.99 -14.0 39.85 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.614 2.209 . . . . 0.0 111.801 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 75.8 mttt -75.07 -40.7 59.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 34' ' ' ILE . 83.2 mt -73.84 -31.28 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.21 67.12 14.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -70.11 -31.81 18.29 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -70.96 -26.02 62.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -70.78 -43.65 68.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.935 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' CG2' HG21 ' A' ' 57' ' ' ILE . 5.6 p -116.36 146.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' N ' HG22 ' A' ' 39' ' ' VAL . 87.1 tttt -73.74 -46.06 48.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 177.47 136.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.68 130.84 44.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.381 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -125.43 151.63 45.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.502 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -105.96 123.41 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.478 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 6.5 mp -69.22 -43.11 74.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 109.495 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 93.1 mt-10 -158.99 158.79 33.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.68 -41.15 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 53' ' ' THR . 90.4 m-20 59.35 39.71 21.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -1.113 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.51 34.2 26.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.47 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -121.9 -165.39 12.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.01 127.65 14.69 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.664 2.242 . . . . 0.0 111.691 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.5 24.85 69.36 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 60.3 m -81.19 140.96 34.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -1.145 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.14 133.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -121.52 148.06 44.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.688 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -130.52 124.49 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.241 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 HG21 ' CG2' ' A' ' 39' ' ' VAL . 22.3 mt -118.41 133.17 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -118.76 123.2 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.866 . . . . 0.0 109.35 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 41.6 p90 -123.48 138.73 54.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.71 133.34 3.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.39 -34.95 78.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -1.102 . . . . 0.0 109.448 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.29 -39.47 0.71 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -57.38 -40.41 78.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.526 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -111.31 154.99 23.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.81 142.56 48.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.933 . . . . 0.0 109.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -177.84 136.59 3.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 42.3 p90 -155.96 144.19 19.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -1.228 . . . . 0.0 110.031 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG21 ' CA ' ' A' ' 89' ' ' GLY . 43.3 t -121.81 150.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.435 -0.79 . . . . 0.0 109.047 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 34.6 mttt -118.12 140.67 49.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.703 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -120.2 131.15 54.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 20.6 tttp -111.4 141.72 44.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.0 mt -100.48 132.18 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.466 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.8 m-70 -91.05 -49.25 6.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.535 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.1 t -166.32 147.81 6.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.91 144.78 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -124.34 91.58 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -62.53 -35.31 79.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.49 -40.56 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.37 8.74 26.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.449 ' O ' HD22 ' A' ' 105' ' ' LEU . 48.8 m80 45.86 44.79 11.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.8 m -125.78 136.59 53.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 72.0 t80 -127.8 127.17 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.459 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -119.45 135.68 54.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 40.5 p90 -151.97 168.77 24.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -145.52 156.04 43.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 5.2 tt -92.57 124.93 36.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.443 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.516 ' O ' ' CD ' ' A' ' 98' ' ' LYS . 27.1 mm -79.45 -66.34 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 94.7 mt-10 -139.24 160.64 39.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' CA ' HG21 ' A' ' 68' ' ' VAL . . . -176.41 157.54 23.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 62.4 m-20 -61.16 -27.08 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.181 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 96' ' ' ILE . . . -76.03 -32.06 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 6.7 mp -75.23 -48.78 21.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.9 m 61.34 170.6 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -72.56 -5.66 38.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.447 ' O ' HG13 ' A' ' 127' ' ' VAL . 86.1 m-20 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.607 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 46.6 mt -98.24 151.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 90.2 mt-10 -94.81 -179.98 5.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 87' ' ' ILE . 32.4 mmtm -57.37 159.57 4.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.489 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.485 HG23 ' CZ ' ' A' ' 101' ' ' TYR . 54.8 mt -120.72 136.5 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' LYS . 59.7 t0 -98.66 125.1 43.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 88.6 m-85 -116.9 142.74 46.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -133.0 138.42 46.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.7 m -130.52 137.71 49.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -138.98 131.64 28.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.348 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.512 ' N ' HD23 ' A' ' 105' ' ' LEU . 2.9 mm? -103.73 115.72 31.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.562 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 114' ' ' ILE . 4.3 t -131.88 131.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 63.1 p -114.69 154.57 28.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.057 -1.027 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.62 162.15 22.13 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.565 -0.71 . . . . 0.0 109.316 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.6 Cg_endo -68.92 95.0 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.369 2.046 . . . . 0.0 110.472 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 26.3 m-70 78.28 11.48 1.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.58 9.09 44.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 83.45 -146.89 23.9 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 90.6 m -126.73 133.95 50.76 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.118 -1.225 . . . . 0.0 109.659 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -108.65 130.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.2 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.28 117.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.725 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 42.7 mttp -105.15 129.23 53.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.083 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.4 m -128.15 129.6 46.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 109.868 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.52 ' CG2' HG22 ' A' ' 5' ' ' THR . 51.4 m -111.3 139.64 46.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.159 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -128.56 135.95 50.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.881 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 99' ' ' ILE . 35.7 tttm -139.13 139.15 37.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.819 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 36.5 p90 -134.08 151.26 51.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.08 -1.012 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.9 m80 -109.06 154.79 21.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.489 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 80.5 p -102.99 142.67 33.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.546 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 11.5 tptt -56.42 -45.88 80.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.17 -53.49 0.14 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 83.5 m-20 -116.37 -6.77 11.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.563 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 123' ' ' THR . 14.5 p -55.84 125.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 94.9 mt-10 -118.31 151.09 38.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.939 . . . . 0.0 109.389 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.94 171.64 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.547 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 87.3 mttt -108.28 133.08 53.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.63 -36.18 69.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.16 -35.99 78.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.503 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.547 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 63.1 m170 -70.86 -39.83 72.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -66.76 -41.68 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -58.8 -38.13 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.135 -0.978 . . . . 0.0 109.414 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.81 97.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.24 -36.22 92.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 48.4 mtpt -64.01 -42.63 97.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -1.114 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.56 -41.75 96.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.447 ' O ' HD23 ' A' ' 144' ' ' LEU . 54.1 tttp -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.83 84.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.69 -30.76 71.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.449 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 65.5 m170 -69.5 -35.27 75.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 140' ' ' LYS . 4.0 mm? -69.91 -42.57 73.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 54.7 m-85 -54.26 -46.19 72.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.484 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -60.67 -34.56 74.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 143' ' ' HIS . 41.8 mt -65.26 -38.32 89.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 83.4 mt -54.19 -56.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 12' ' ' SER . 30.8 mp0 -55.67 -44.05 76.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.1 -26.23 72.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.475 ' CD1' HD12 ' A' ' 30' ' ' LEU . 64.0 t80 -70.37 -41.38 73.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -1.103 . . . . 0.0 109.387 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp -74.15 -44.82 52.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.374 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -53.61 -35.8 61.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 155' ' ' HIS . 19.9 t70 -81.55 -32.49 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 0.0 109.206 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 154' ' ' ASP . 0.7 OUTLIER 43.95 65.09 6.21 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.566 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.26 -19.54 33.62 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.689 2.26 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 95.6 p -67.35 -30.16 69.9 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -56.96 -33.82 67.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.508 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.99 -38.96 80.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 34.9 t30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.406 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 122' ' ' HIS . 27.6 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.317 0.58 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.17 142.03 39.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 109.341 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.649 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.2 m -93.65 143.14 26.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -124.81 137.5 54.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.57 136.3 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.397 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -124.96 134.19 52.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 86.4 mt-10 -109.93 143.42 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 109.366 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 11' ' ' THR . 72.1 t80 -152.16 139.75 19.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 11.3 p -97.73 131.74 43.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.435 ' HG ' ' HE2' ' A' ' 10' ' ' PHE . 7.6 m -132.79 170.85 14.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -80.6 -175.7 5.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' LYS . 7.7 mm 67.4 139.34 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.337 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -70.2 148.89 63.18 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 111.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.47 -52.37 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 111.38 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.86 -50.37 2.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.397 2.064 . . . . 0.0 113.069 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.4 mttp -60.76 -35.02 75.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.823 -1.173 . . . . 0.0 109.498 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 149' ' ' GLU . 23.5 tp -80.59 -36.08 33.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.577 ' HD1' HD23 ' A' ' 105' ' ' LEU . 80.6 t80 -59.17 -48.31 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.836 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -61.32 -54.28 45.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.25 -4.46 21.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.89 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.3 t80 -94.11 -32.84 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' A' ' 82' ' ' TYR . 4.7 m -117.31 -39.19 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 25' ' ' LEU . 22.9 tp -72.87 -38.5 66.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.515 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -104.09 11.33 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.77 -41.1 75.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 44' ' ' ILE . 84.5 m-20 -57.46 -30.6 65.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 25.6 m120 -101.35 -35.78 9.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.442 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 33' ' ' LYS . 17.5 tp -75.2 -39.65 59.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' A' ' 27' ' ' ALA . 33.1 mt -47.98 -55.01 19.66 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.93 . . . . 0.0 109.56 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.4 Cg_endo -69.26 -19.93 37.85 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.383 2.055 . . . . 0.0 111.721 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.7 mttt -74.19 -36.27 64.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.502 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.6 mt -70.15 -29.99 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.975 . . . . 0.0 109.555 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.79 72.18 12.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.7 Cg_endo -69.67 -43.56 2.66 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.658 2.238 . . . . 0.0 111.694 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.9 -20.62 63.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.9 69.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.926 HG12 ' CE1' ' A' ' 59' ' ' PHE . 17.3 m -128.51 154.83 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -73.94 -45.89 47.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.486 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.62 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.37 128.93 35.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.91 144.2 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.525 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 55.4 mt -106.54 119.38 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.458 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -63.31 -44.45 94.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.73 154.6 24.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.11 -41.87 2.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 91.1 m-20 60.52 38.06 19.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.741 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.58 35.29 9.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.503 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.12 -167.56 13.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.15 129.29 16.93 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.733 2.288 . . . . 0.0 111.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.9 24.88 75.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 46' ' ' GLU . 91.9 m -80.05 144.59 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.473 HG22 HD13 ' A' ' 45' ' ' LEU . 24.5 mm -110.65 128.62 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 81.9 mttt -114.94 150.16 36.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HB2' HD11 ' A' ' 45' ' ' LEU . 43.8 tttm -132.55 123.49 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 70' ' ' HIS . 39.8 mt -114.16 136.69 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.3 m -113.73 130.9 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.926 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.0 m-85 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 40.9 p90 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.298 0.57 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.955 HG22 ' CA ' ' A' ' 89' ' ' GLY . 67.7 t -117.27 142.27 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.232 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 88' ' ' GLU . 18.0 mttp -112.03 143.35 43.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.738 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' ILE . 97.0 m-70 -124.45 143.1 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.778 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.0 tttm -125.61 139.55 53.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.672 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.9 mt -96.95 137.98 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.388 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.446 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 87.1 m-70 -90.52 -49.03 6.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -170.02 149.08 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.1 pt -125.81 144.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 83.9 m-20 -127.94 92.4 3.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -63.43 -35.29 79.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.95 -39.38 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.414 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 30.2 m120 -88.42 5.09 43.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m80 47.68 46.52 18.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.1 m -129.06 132.22 47.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 64.8 t80 -124.78 125.7 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -118.54 140.61 49.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 32.5 p90 -154.4 170.27 21.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 82.9 p -148.88 157.94 43.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.0 tt -94.99 132.13 40.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.318 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.959 ' N ' HD23 ' A' ' 86' ' ' LEU . 87.8 mt -89.84 -71.68 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 109.592 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.88 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -127.32 159.27 34.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.955 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -175.37 154.35 17.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.22 -35.39 78.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -1.159 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -73.16 -23.84 60.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.989 ' CD2' HD22 ' A' ' 86' ' ' LEU . 9.1 mp -78.85 -49.49 12.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.04 176.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.0 -10.06 59.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.15 -34.25 26.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 92' ' ' LEU . 36.5 mt -96.23 132.72 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 93.4 mt-10 -87.1 -179.16 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.744 ' HE2' HG23 ' A' ' 87' ' ' ILE . 89.9 mttt -56.71 165.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.447 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.776 HG23 ' O ' ' A' ' 120' ' ' LYS . 63.7 mt -125.78 131.79 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.878 . . . . 0.0 109.523 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 50.3 t0 -85.98 119.9 26.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 65.8 m-85 -113.04 142.15 46.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' THR . 92.7 mt-10 -131.47 136.74 48.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 23' ' ' PHE . 27.3 m -125.38 131.58 52.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' C ' HD22 ' A' ' 105' ' ' LEU . 56.2 tttt -133.08 125.03 28.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.845 HD13 HG23 ' A' ' 115' ' ' ILE . 2.9 mm? -99.58 128.65 45.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 114' ' ' ILE . 41.3 t -131.15 140.7 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -109.26 147.92 31.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.69 161.82 23.84 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.7 Cg_endo -70.1 -11.69 30.85 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.727 2.284 . . . . 0.0 111.82 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -77.22 -17.13 58.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.939 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.86 -15.22 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.25 173.43 44.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 99.1 m -127.75 127.61 43.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.565 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 64.5 mt -97.95 143.42 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.282 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.845 HG23 HD13 ' A' ' 105' ' ' LEU . 4.2 mt -124.17 123.61 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 18.6 mttt -105.11 131.32 52.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 102' ' ' GLU . 85.7 m -131.47 132.04 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.2 m -112.28 144.62 41.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.048 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.9 m -130.4 145.55 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 0.0 110.072 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' ILE . 5.1 ttpt -143.75 123.34 13.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 99' ' ' ILE . 14.8 m-85 -106.87 137.94 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.062 -1.023 . . . . 0.0 109.724 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' HG21 ' A' ' 3' ' ' VAL . 67.7 m80 -107.49 148.54 29.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.641 -179.773 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -74.31 -32.2 62.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 144' ' ' LEU . 65.4 mt -68.92 -41.62 77.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.863 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.465 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 60.1 m-85 -53.4 -47.94 69.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -54.69 -40.55 69.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 151' ' ' TYR . 45.8 mt -60.89 -36.95 80.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.379 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 145' ' ' PHE . 92.1 mt -56.04 -55.84 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 19' ' ' LEU . 35.9 mp0 -68.31 -33.99 75.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.15 60.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 147' ' ' LEU . 64.8 m-85 -60.94 -49.21 78.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.173 . . . . 0.0 109.434 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.522 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.732 HG11 ' O ' ' A' ' 121' ' ' TYR . 73.1 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.9 148.24 34.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 22.8 m -93.66 140.62 29.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' THR . 73.2 t80 -115.22 131.54 56.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.942 . . . . 0.0 109.643 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.22 138.66 47.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -132.72 129.85 39.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 81.0 mt-10 -105.53 123.96 48.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.282 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -132.99 129.73 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 114' ' ' ILE . 27.6 p -97.39 140.25 32.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -138.88 172.13 13.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.687 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' ILE . 49.7 m-20 -76.18 -175.65 3.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mp 62.48 140.63 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.46 147.95 65.94 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.541 2.161 . . . . 0.0 111.949 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.92 -52.13 2.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 111.289 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.33 -50.05 3.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.076 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 14' ' ' ILE . 36.8 mttt -57.96 -39.62 78.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.881 -1.137 . . . . 0.0 109.585 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 23.7 tp -80.56 -27.71 37.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.76 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.835 ' HB2' HD12 ' A' ' 105' ' ' LEU . 60.4 t80 -61.31 -39.42 90.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 78.3 tttt -66.85 -55.24 15.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.88 0.27 16.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 109.817 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -97.01 -29.17 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.096 -1.003 . . . . 0.0 109.539 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.9 m -122.5 -38.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 23.6 tp -72.24 -38.52 68.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 72.7 m-20 -102.73 4.46 38.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -0.865 . . . . 0.0 109.545 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.85 -32.88 71.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 109.613 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.3 m-20 -57.68 -29.19 64.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.7 m-20 -116.5 -35.86 4.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 63.9 tp -62.79 -34.07 76.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.5 mt -57.63 -58.93 14.83 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.04 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -68.32 -9.86 27.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.627 2.218 . . . . 0.0 111.605 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 65.9 mttt -80.39 -38.06 31.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 147' ' ' LEU . 88.1 mt -77.95 -28.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.18 69.1 41.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.66 -29.56 24.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.752 2.302 . . . . 0.0 111.771 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -73.41 -26.81 61.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.35 -49.59 73.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.7 m -126.54 156.11 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.4 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -71.87 -46.14 58.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.12 134.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.76 129.14 35.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -122.53 144.12 49.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 58.8 mt -106.06 120.28 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -68.59 -44.28 74.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 53' ' ' THR . 91.6 mt-10 -158.16 157.26 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.31 -40.85 2.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 56.95 33.4 23.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.9 26.02 30.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.0 -164.44 15.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.3 126.0 12.48 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.674 2.249 . . . . 0.0 111.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.9 36.43 41.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' GLU . 39.8 m -89.12 142.23 27.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -1.162 . . . . 0.0 109.365 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -112.75 124.81 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' HG12 ' A' ' 44' ' ' ILE . 71.2 mttt -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HB2' HD11 ' A' ' 45' ' ' LEU . 47.7 tttm -133.86 121.85 22.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 70' ' ' HIS . 21.5 mt -116.75 135.47 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.66 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -119.77 139.24 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.773 ' HE1' HG23 ' A' ' 68' ' ' VAL . 93.0 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.1 p90 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG23 ' HE1' ' A' ' 59' ' ' PHE . 44.0 t -121.18 140.32 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.892 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 32.3 mttt -115.49 144.72 43.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.46 ' CE1' HD12 ' A' ' 57' ' ' ILE . 75.9 m80 -124.77 135.66 53.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HB2' HD11 ' A' ' 87' ' ' ILE . 53.8 tttp -118.12 141.11 48.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.9 mt -102.88 138.07 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -93.19 -47.52 6.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 p -172.06 153.72 3.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 82' ' ' TYR . 31.8 pt -127.96 145.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -126.57 92.43 3.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -62.45 -35.0 77.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.397 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -71.84 -41.47 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -86.49 5.29 36.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.2 m80 46.69 40.76 9.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 m -124.16 136.5 54.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 82.5 t80 -123.93 125.48 44.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.306 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -117.08 132.38 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.6 p90 -153.59 168.83 24.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -146.83 152.44 38.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.8 tt -91.89 134.71 34.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.94 ' N ' HD23 ' A' ' 86' ' ' LEU . 93.8 mt -89.8 -70.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.907 . . . . 0.0 109.599 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.775 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.3 mt-10 -125.43 161.23 27.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -179.83 156.29 17.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -58.7 -32.4 69.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -1.164 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.83 -16.43 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.933 HD21 HD22 ' A' ' 86' ' ' LEU . 7.6 mp -86.01 -30.61 22.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 p 59.72 -177.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.95 16.76 13.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -0.892 . . . . 0.0 109.184 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.44 -20.87 7.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 9.8 mt -96.05 142.44 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -87.91 179.97 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 41.6 mtmt -57.55 167.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 120' ' ' LYS . 74.9 mt -119.83 138.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -90.75 122.58 33.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 69.2 m-85 -116.13 138.7 51.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -134.17 137.18 44.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.24 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.559 HG21 ' CE2' ' A' ' 23' ' ' PHE . 44.7 m -131.2 131.47 44.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.622 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -129.24 133.49 47.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 20' ' ' PHE . 17.7 mt -107.31 120.15 41.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.699 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 114' ' ' ILE . 22.6 t -131.94 138.54 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 22.9 m -114.48 151.66 32.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.98 172.01 3.88 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.03 -16.89 40.98 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.802 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.96 -16.49 63.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.345 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.04 -17.42 44.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.31 172.54 45.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 85.7 m -119.27 124.11 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -1.127 . . . . 0.0 109.365 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 11' ' ' THR . 70.8 mt -94.79 143.18 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.137 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.742 HG23 HD23 ' A' ' 105' ' ' LEU . 53.8 mt -132.64 132.35 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.951 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 47.8 mttp -107.09 135.32 48.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.7 m -125.47 130.5 51.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.964 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 29.1 m -123.6 143.42 50.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.948 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.2 t -138.77 140.72 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.997 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 99' ' ' ILE . 72.7 tttt -136.8 133.92 36.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.732 ' O ' HG11 ' A' ' 3' ' ' VAL . 31.8 m-85 -110.02 133.63 52.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.677 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.7 m80 -101.68 136.51 41.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.271 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 146' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.315 0.579 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.482 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.8 t60 -61.37 -47.13 87.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 144' ' ' LEU . 55.1 mt -63.0 -42.13 99.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.384 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 148' ' ' ILE . 57.4 t80 -55.69 -42.04 74.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.361 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 142' ' ' ALA . 98.1 mttt -53.82 -38.09 64.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -67.21 -40.03 86.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 145' ' ' PHE . 87.9 mt -53.9 -51.15 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.43 -48.82 79.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.34 -33.03 86.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.62 -46.38 84.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 14' ' ' ILE . 71.5 mt . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 122' ' ' HIS . 70.6 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.256 0.55 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -111.48 135.62 51.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 33.2 m -101.87 132.91 47.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.14 132.65 56.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.92 141.51 39.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 65.3 t30 -126.58 131.05 51.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.574 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.01 141.91 46.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 83.2 t80 -162.97 143.71 9.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.448 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 8.7 p -102.42 144.63 30.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 115' ' ' ILE . 50.1 m -142.84 167.83 21.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.1 t0 -78.68 -175.97 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 66.49 140.7 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 109.276 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 49.6 Cg_endo -71.12 148.07 55.55 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.605 2.203 . . . . 0.0 112.203 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.79 -51.6 3.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.72 . . . . 0.0 111.388 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.25 -43.72 13.89 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.43 2.087 . . . . 0.0 113.046 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG22 ' A' ' 14' ' ' ILE . 74.9 mttt -64.01 -34.5 78.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.81 -1.181 . . . . 0.0 109.653 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.7 tt -80.64 -31.66 36.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.83 ' CE1' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -65.7 -35.85 81.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.845 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 47.0 mttp -64.52 -42.36 95.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -84.43 -32.18 24.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' A' ' 103' ' ' THR . 53.5 t80 -78.15 -8.02 57.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.83 HG21 ' CE1' ' A' ' 20' ' ' PHE . 63.0 t -123.98 -68.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 12.1 tp -57.23 -43.68 83.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 75.9 m-20 -95.05 12.87 27.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.868 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.67 -32.67 71.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 44' ' ' ILE . 97.3 m-20 -66.32 -34.75 78.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.1 t30 -100.06 -43.09 6.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD21 HG23 ' A' ' 148' ' ' ILE . 30.0 tp -53.79 -43.77 69.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 27' ' ' ALA . 10.8 mt -48.13 -63.35 1.56 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.37 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -68.74 -19.22 41.57 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.502 2.134 . . . . 0.0 111.779 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -66.67 -45.84 77.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.8 mt -72.27 -36.72 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.23 69.98 80.23 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 109.498 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.7 Cg_endo -70.84 -33.88 11.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.588 2.192 . . . . 0.0 111.639 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -75.4 -27.14 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.95 94.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.027 HG12 ' CE1' ' A' ' 59' ' ' PHE . 16.5 m -127.01 160.49 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 29.5 ttpt -72.25 -50.37 27.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.476 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.41 132.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.45 123.39 32.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -121.67 144.87 48.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 28' ' ' ASP . 61.2 mt -105.09 119.49 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 29.0 tp -64.99 -44.29 89.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 53' ' ' THR . 74.1 mm-40 -156.97 151.61 25.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.473 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 109.09 -42.88 1.84 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.2 m-20 61.9 38.85 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.779 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.75 35.11 17.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -118.6 -167.02 13.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.98 130.27 18.79 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.697 2.265 . . . . 0.0 111.813 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.29 24.61 76.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.79 145.16 32.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -1.155 . . . . 0.0 109.525 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.88 133.27 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.326 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 41.6 mttt -121.25 151.53 39.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -134.24 120.59 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.356 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 8.7 mt -117.87 134.25 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 40' ' ' LYS . 29.8 p -112.95 139.23 48.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.027 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.7 m-85 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.279 0.561 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -130.41 147.12 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 109.299 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' O ' HD12 ' A' ' 86' ' ' LEU . 30.8 mttt -109.82 146.36 35.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.647 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 49.8 m80 -117.42 148.29 41.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.616 ' CB ' HD11 ' A' ' 87' ' ' ILE . 39.0 tttm -129.71 141.39 50.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.0 mt -100.09 135.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -88.95 -48.5 7.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 p -166.0 154.45 11.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 pt -128.54 145.2 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -130.63 92.17 3.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.01 -38.58 91.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.43 -42.35 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 29.6 m120 -86.68 6.6 30.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 37.3 m80 45.63 46.39 11.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.553 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.5 m -125.27 139.05 54.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 71.7 t80 -130.53 125.59 34.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.8 t -119.23 132.95 55.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 35.2 p90 -148.76 164.98 32.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.597 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 84.9 p -148.13 152.37 37.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.058 HD23 HD21 ' A' ' 92' ' ' LEU . 23.2 tp -87.41 137.51 32.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.596 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 71' ' ' LYS . 28.5 mm -94.31 -75.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.0 mt-10 -118.77 151.23 38.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.684 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -169.21 125.52 1.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -48.97 -34.2 12.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 109.378 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.61 -16.5 63.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.058 HD21 HD23 ' A' ' 86' ' ' LEU . 7.0 mp -86.47 -39.45 16.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 69.0 m 62.86 173.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.414 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -74.46 -11.31 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.617 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -80.97 -29.42 35.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 28.8 mt -104.54 120.13 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.7 mm-40 -75.84 -178.92 4.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.358 -0.839 . . . . 0.0 109.242 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.494 ' HE2' HG23 ' A' ' 87' ' ' ILE . 36.2 mttp -56.69 166.33 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.47 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 120' ' ' LYS . 62.0 mt -126.51 133.54 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 109.659 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 120' ' ' LYS . 90.7 m-20 -91.81 126.61 36.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.5 m-85 -116.63 138.16 51.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 117' ' ' THR . 94.3 mt-10 -128.05 135.2 49.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.621 HG21 ' CE1' ' A' ' 23' ' ' PHE . 40.5 m -129.7 131.74 46.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -139.45 124.7 18.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -95.52 132.19 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.3 t -128.96 139.44 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -112.65 145.0 41.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -107.93 167.14 9.73 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.53 -9.23 25.41 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.696 2.264 . . . . 0.0 111.77 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -78.21 -15.21 59.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.18 -21.27 29.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.34 169.12 50.99 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.4 m -124.45 126.21 45.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -1.193 . . . . 0.0 109.611 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 65.7 mt -97.6 142.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.844 HG23 HD13 ' A' ' 105' ' ' LEU . 2.6 mp -125.73 125.55 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.682 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 28.0 mttt -115.03 139.08 50.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.121 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 102' ' ' GLU . 91.4 m -132.06 135.65 46.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.878 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 40.8 m -124.52 138.32 54.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.367 -0.833 . . . . 0.0 108.958 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -131.53 155.75 46.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 110.041 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.0 mttt -138.06 138.49 38.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 3' ' ' VAL . 32.7 m-85 -116.57 128.77 55.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 109.623 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.723 ' HA ' HG22 ' A' ' 3' ' ' VAL . 90.9 m-70 -99.68 150.54 22.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -0.894 . . . . 0.0 109.432 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -58.26 -47.21 84.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 144' ' ' LEU . 45.0 mt -62.55 -43.02 99.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 67.0 t80 -54.84 -47.09 74.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.426 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -52.15 -40.4 61.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 147' ' ' LEU . 59.6 mt -63.78 -38.14 90.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.753 HG23 HD21 ' A' ' 30' ' ' LEU . 82.4 mt -55.3 -49.46 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.548 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 13' ' ' ASP . 86.2 tt0 -59.53 -48.44 81.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.91 92.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -57.53 -43.18 84.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 14' ' ' ILE . 72.8 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.986 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.8 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.281 0.563 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 5' ' ' THR . 74.4 t80 -110.16 145.97 36.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.548 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 68.5 m -93.73 143.73 26.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -127.52 141.45 51.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.68 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 84.3 tt0 -112.49 133.01 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -117.92 134.49 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -103.16 109.91 21.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.8 t80 -117.59 131.35 56.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.678 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.564 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 18.7 p -91.81 155.83 17.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.238 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 115' ' ' ILE . 59.7 p -153.61 171.94 17.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.779 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -80.16 -175.43 5.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.807 . . . . 0.0 109.424 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 15' ' ' PRO . 4.2 mm 61.74 141.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.952 . . . . 0.0 109.239 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 14' ' ' ILE . 49.0 Cg_endo -70.65 146.27 54.21 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.492 2.128 . . . . 0.0 112.001 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.82 -51.7 2.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.655 -0.653 . . . . 0.0 111.348 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.18 -50.02 3.2 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.232 1.954 . . . . 0.0 113.123 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 79.3 mttt -61.48 -38.28 86.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.161 . . . . 0.0 109.686 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.81 -25.61 37.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.71 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 63.8 t80 -66.98 -31.69 72.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 77.1 mttt -72.09 -47.53 50.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.0 60.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.795 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.0 t80 -79.36 -16.82 55.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.402 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 67.6 t -114.12 -60.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 35.8 mt -59.41 -44.48 92.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.213 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 69.7 m-20 -100.99 24.4 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.331 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.22 -37.43 78.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -70.4 -33.13 71.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -94.17 -30.44 14.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.493 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.546 HD21 HG23 ' A' ' 148' ' ' ILE . 30.1 tp -64.14 -43.68 94.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 27' ' ' ALA . 3.8 mt -50.2 -59.79 6.44 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 50.2 Cg_endo -68.9 -16.31 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.549 2.166 . . . . 0.0 111.84 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.6 tptp -69.05 -40.29 78.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.612 HG23 HD13 ' A' ' 147' ' ' LEU . 59.1 mt -67.44 -33.44 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.52 71.27 14.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.3 Cg_endo -69.86 -30.92 21.05 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.613 2.208 . . . . 0.0 111.502 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.58 -23.57 64.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.205 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 -24.81 23.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.331 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 59' ' ' PHE . 3.1 t -113.74 133.93 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.345 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -71.92 -50.83 25.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.71 130.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.03 124.81 38.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.27 146.62 46.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.837 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 57.5 mt -104.77 117.81 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.9 mp -63.39 -44.64 94.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.906 ' O ' HG23 ' A' ' 53' ' ' THR . 89.9 mt-10 -159.14 155.28 26.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.5 -41.63 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.8 m-20 61.53 35.27 17.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -1.125 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.822 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.54 34.11 10.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.93 -162.69 11.79 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.17 130.64 19.17 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.699 2.266 . . . . 0.0 111.833 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . 69.31 30.26 71.6 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.906 HG23 ' O ' ' A' ' 46' ' ' GLU . 74.4 m -85.86 143.28 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.4 mm -110.97 132.16 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 72' ' ' ILE . 79.0 mttt -122.83 146.46 47.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -127.71 120.45 28.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.268 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 11.6 mt -117.38 127.49 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -108.6 127.86 54.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.597 ' HE1' HG22 ' A' ' 39' ' ' VAL . 85.1 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 44.1 p90 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.4 m -121.92 147.98 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.339 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 45.9 mttt -108.01 141.21 40.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 68' ' ' VAL . 73.8 m80 -119.85 133.24 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.85 . . . . 0.0 109.148 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' A' ' 87' ' ' ILE . 21.1 tttt -116.0 139.69 50.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 63.9 mt -98.17 136.26 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 89.0 m-70 -90.09 -47.73 7.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 t -170.3 158.6 6.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.09 145.06 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.5 m-20 -124.94 92.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.473 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -65.34 -38.47 90.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.59 -42.5 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 74.1 m-20 -86.87 8.36 23.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.464 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.7 m80 45.76 41.66 7.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 m -121.74 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 67.4 t80 -130.78 122.99 28.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -117.27 134.02 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 33.9 p90 -151.12 161.79 42.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 93.4 p -139.16 158.32 44.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 87' ' ' ILE . 6.5 tt -98.62 125.1 43.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.802 HG22 ' HG3' ' A' ' 88' ' ' GLU . 31.0 mm -73.7 -68.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.4 mt-10 -140.92 146.44 37.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.657 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -153.24 160.49 29.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 68' ' ' VAL . 67.0 m-20 -60.65 -31.07 70.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.482 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 -27.84 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.36 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' ILE . 5.7 mp -77.28 -39.74 47.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.387 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 30.6 m 59.52 169.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.31 -8.16 54.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -83.93 -27.97 28.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 109.424 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 92' ' ' LEU . 18.7 mt -99.73 146.3 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -90.35 179.9 5.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 109.609 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.68 ' HE2' HG23 ' A' ' 87' ' ' ILE . 37.8 mttt -57.55 162.35 3.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 120' ' ' LYS . 40.5 mt -118.56 141.04 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.704 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 59.0 t0 -97.74 119.86 37.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 95.4 m-85 -113.59 144.87 42.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 91.5 mt-10 -138.67 134.13 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.3 m -126.84 132.86 50.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.563 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 105' ' ' LEU . 34.2 tttt -130.21 132.9 46.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.29 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -106.67 115.22 29.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 23.5 t -131.58 145.33 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 3.2 m -114.43 153.47 29.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.42 167.6 8.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.353 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.27 -7.8 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.626 2.217 . . . . 0.0 111.811 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -76.74 -13.98 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.57 -16.34 44.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.32 172.16 41.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 94.8 m -116.05 124.97 51.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.444 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 59.8 mt -96.42 127.54 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.252 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 105' ' ' LEU . 51.3 mt -113.35 126.77 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 109.768 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 18.1 mttp -103.49 129.35 50.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 108.97 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -129.23 124.78 35.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.155 -0.966 . . . . 0.0 110.096 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 23.4 m -106.6 142.96 35.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 108.964 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -129.12 143.06 50.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 109.913 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 99' ' ' ILE . 24.4 tttt -149.31 119.73 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 109.082 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.986 ' O ' HG21 ' A' ' 3' ' ' VAL . 22.0 m-85 -107.99 133.11 52.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 75.3 m80 -96.47 143.57 27.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 109.273 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.763 -179.829 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -74.21 -31.69 62.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.39 -43.73 80.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 148' ' ' ILE . 77.4 m-85 -54.66 -39.47 68.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.56 -41.71 86.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 109.422 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG23 ' A' ' 34' ' ' ILE . 43.5 mt -67.3 -39.24 85.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.546 HG23 HD21 ' A' ' 30' ' ' LEU . 65.5 mt -54.18 -46.32 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 12' ' ' SER . 42.3 mm-40 -68.89 -40.38 79.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.93 -55.18 27.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -54.85 -56.18 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 109.507 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 44.0 mt . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 121' ' ' TYR . 70.2 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.24 136.75 52.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 30.3 m -101.43 135.95 42.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.421 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' THR . 91.5 m-85 -118.82 139.16 52.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.75 135.48 53.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.78 134.18 55.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 94.8 mt-10 -113.96 126.91 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 65.6 t80 -143.08 136.62 28.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 109.471 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.7 p -103.44 152.23 21.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 109.421 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -154.23 171.1 19.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' HD12 ' A' ' 14' ' ' ILE . 31.9 t0 -71.79 177.52 4.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.2 mt 69.6 135.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.404 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.2 Cg_endo -69.7 150.11 68.15 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.535 2.156 . . . . 0.0 111.96 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.926 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -38.64 -52.27 3.55 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -64.5 -50.5 2.53 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.425 2.083 . . . . 0.0 113.041 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 94.8 mttt -59.62 -35.56 74.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.801 -1.187 . . . . 0.0 109.485 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 18.7 tp -80.37 -33.39 37.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.937 . . . . 0.0 109.372 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' VAL . 72.8 t80 -56.52 -43.43 79.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 98.5 mttt -58.68 -61.09 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 109.646 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -68.59 -7.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.905 . . . . 0.0 109.611 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 103' ' ' THR . 83.1 t80 -84.02 -32.97 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.667 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 82' ' ' TYR . 24.9 m -127.73 -33.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.757 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.8 tp -60.95 -65.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.66 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' CG ' ' HA ' ' A' ' 22' ' ' ALA . 33.5 p30 -93.98 18.95 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.09 -35.27 76.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.126 -0.984 . . . . 0.0 109.503 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.5 -42.39 67.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.5 t-20 -97.61 -34.2 11.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.923 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.6 tm? -69.38 -39.3 78.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.539 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 30.7 mt -51.1 -56.32 20.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -69.02 -21.66 36.61 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.524 2.15 . . . . 0.0 111.764 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -66.1 -37.28 85.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.526 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' CE2' ' A' ' 151' ' ' TYR . 73.3 mt -68.53 -27.16 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.22 69.99 10.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -70.48 -31.61 17.03 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.04 -28.36 60.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.15 -44.11 76.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 57' ' ' ILE . 4.7 p -125.02 154.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -77.33 -47.77 19.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.962 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.15 141.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.529 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.58 119.52 30.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.22 140.67 37.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.441 HG12 ' HG2' ' A' ' 55' ' ' LYS . 60.2 mt -106.49 117.55 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -64.28 -45.76 86.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 53' ' ' THR . 67.3 mm-40 -157.72 155.22 29.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.4 -42.4 1.93 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 85.4 m-20 60.3 36.06 20.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.778 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.08 32.88 11.53 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.467 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.27 -166.34 13.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.85 132.65 23.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.693 2.262 . . . . 0.0 111.656 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.13 29.39 73.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.8 m -84.72 144.52 28.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.136 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 45' ' ' LEU . 60.1 mt -110.51 128.52 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' HG12 ' A' ' 44' ' ' ILE . 31.5 mttt -116.57 149.33 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.2 tttt -129.88 121.21 26.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.879 HG23 HG21 ' A' ' 39' ' ' VAL . 44.9 mt -110.81 134.49 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -119.24 123.13 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HE2' HG23 ' A' ' 68' ' ' VAL . 95.7 m-85 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.9 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 37.1 p90 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 89' ' ' GLY . 48.8 t -123.51 149.88 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 51.4 mtpt -123.6 143.57 50.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -122.58 141.67 51.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.613 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HB2' HD11 ' A' ' 87' ' ' ILE . 82.8 tttt -123.25 139.13 54.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 54.1 mt -97.76 134.18 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 88.9 m-70 -89.48 -47.6 7.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -170.65 153.79 4.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.15 143.79 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.399 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.48 93.03 3.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -63.15 -35.6 80.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.91 -40.61 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -87.44 1.83 52.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 43.4 m80 50.66 40.51 24.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.5 m -123.02 138.49 54.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.644 ' CD1' HG11 ' A' ' 24' ' ' VAL . 80.3 t80 -127.22 125.94 41.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -117.57 134.37 54.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 109.694 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 29.9 p90 -148.46 167.74 24.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.326 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 97.1 p -144.23 159.01 43.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.948 ' CD2' HD11 ' A' ' 92' ' ' LEU . 4.5 tt -98.99 133.37 43.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.93 ' N ' HD23 ' A' ' 86' ' ' LEU . 75.8 mt -94.69 -74.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.7 mt-10 -116.08 157.96 23.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 174.82 155.65 12.77 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.37 -29.6 70.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -1.151 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -69.5 -32.1 70.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.948 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.7 mt -74.27 -32.94 63.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.037 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.65 -177.56 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.537 -0.727 . . . . 0.0 109.287 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -88.47 18.56 4.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.568 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -125.64 -9.59 6.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.869 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 91' ' ' ALA . 14.2 mt -108.55 145.43 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.055 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 88.3 mt-10 -90.04 -179.83 5.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.656 ' HE2' HG23 ' A' ' 87' ' ' ILE . 49.1 mttt -57.53 166.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.606 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 120' ' ' LYS . 81.7 mt -125.49 134.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 25.1 t70 -92.25 126.26 37.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.0 m-85 -118.72 140.45 49.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.496 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.36 137.52 47.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 23' ' ' PHE . 45.3 m -127.45 133.54 49.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -131.11 132.14 44.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -107.72 124.07 49.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.5 143.48 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.0 p -108.44 148.04 30.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.79 166.74 10.28 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.5 Cg_endo -69.38 -19.35 38.07 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.741 2.294 . . . . 0.0 111.822 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.57 -17.65 64.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.386 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.75 -23.89 18.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.7 179.75 52.14 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 63.8 m -126.62 126.37 43.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -1.185 . . . . 0.0 109.648 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -92.91 140.67 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 105' ' ' LEU . 62.7 mt -127.83 124.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 49.7 mttt -105.62 136.31 45.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.3 m -128.58 126.43 40.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 18.4 m -120.04 138.27 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 108.812 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -137.22 147.02 45.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.231 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 99' ' ' ILE . 91.2 mttt -129.81 144.08 51.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' VAL . 55.2 m-85 -119.42 129.02 54.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.671 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -96.66 141.96 29.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.384 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.318 0.58 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.41 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.1 t60 -60.63 -43.65 97.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 144' ' ' LEU . 73.6 mt -56.08 -46.13 79.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -54.81 -33.15 61.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -66.53 -39.77 88.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -64.31 -45.06 89.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.381 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.04 -55.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -54.67 -35.95 64.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.95 -29.8 66.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CE2' HG12 ' A' ' 34' ' ' ILE . 8.7 m-30 -69.45 -45.4 69.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 122' ' ' HIS . 32.6 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.423 0.63 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -117.93 155.9 29.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.667 HG22 ' CG2' ' A' ' 118' ' ' THR . 10.6 m -93.84 138.83 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 118' ' ' THR . 94.2 m-85 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -114.98 135.84 53.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -120.83 132.51 55.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -107.63 129.14 55.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.538 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.9 t80 -143.19 141.71 31.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.4 p -107.93 148.58 29.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.6 p -149.29 170.8 17.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.979 . . . . 0.0 109.527 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.0 t0 -80.28 -175.86 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.459 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 67.79 140.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -70.21 149.6 64.27 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.213 . . . . 0.0 111.911 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.73 -52.19 3.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.2 -50.34 2.91 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.461 2.107 . . . . 0.0 112.915 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB2' HG22 ' A' ' 14' ' ' ILE . 67.5 mttm -58.91 -34.87 72.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.875 -1.14 . . . . 0.0 109.546 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD12 HD11 ' A' ' 152' ' ' LEU . 8.5 tp -81.06 -28.9 35.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.728 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 56.9 t80 -68.76 -33.3 73.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 17.8 tttp -67.14 -45.35 77.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.12 -25.58 36.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.745 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 52.0 t80 -83.79 -15.6 47.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.935 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.6 t -117.81 -67.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 28.5 tp -55.82 -41.71 74.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.432 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.4 m-20 -97.78 14.72 25.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.864 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -68.64 -37.11 79.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.84 -40.75 89.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.7 m120 -94.4 -31.56 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.84 HD21 HD12 ' A' ' 148' ' ' ILE . 38.9 tp -66.44 -42.25 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 27' ' ' ALA . 6.6 mt -49.99 -57.97 10.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.442 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.68 -22.39 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.485 2.123 . . . . 0.0 111.742 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 11.3 tptt -68.5 -42.01 79.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 147' ' ' LEU . 23.8 mm -61.36 -24.99 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.86 75.06 3.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.7 -32.99 17.74 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.635 2.223 . . . . 0.0 111.645 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -21.77 61.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.62 -41.92 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.419 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' A' ' 59' ' ' PHE . 21.7 m -126.84 148.24 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.402 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HE2' ' CG2' ' A' ' 58' ' ' THR . 11.1 mtmt -72.4 -51.62 19.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.94 129.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.61 124.49 29.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -117.59 146.41 43.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -104.19 126.83 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.0 mm? -71.1 -41.47 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.38 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.96 ' O ' HG23 ' A' ' 53' ' ' THR . 90.7 mt-10 -159.26 151.16 20.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 107.68 -42.92 1.81 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 t0 64.17 39.63 7.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 0.0 109.569 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.776 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.25 37.02 13.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.86 -165.99 13.13 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.09 132.69 23.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.702 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 65.43 28.46 73.6 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.6 m -82.84 144.13 30.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -1.102 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 59.5 mt -105.12 126.09 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 mtpt -115.09 152.98 31.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -135.71 124.77 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' CD2' ' A' ' 70' ' ' HIS . 13.6 mt -113.03 131.75 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.529 ' CG2' ' HE2' ' A' ' 40' ' ' LYS . 75.0 m -109.47 120.62 43.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' A' ' 39' ' ' VAL . 90.1 m-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 46.0 p90 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.857 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.3 m -126.6 147.09 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 88' ' ' GLU . 70.2 mttt -109.54 147.23 33.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 57' ' ' ILE . 48.1 m-70 -125.21 140.1 53.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 87' ' ' ILE . 23.9 tttt -114.96 140.87 48.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.945 HD12 ' HB ' ' A' ' 53' ' ' THR . 65.3 mt -98.18 135.27 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.6 m-70 -89.35 -47.21 8.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -175.09 155.49 1.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.402 HG22 ' CE1' ' A' ' 82' ' ' TYR . 35.0 pt -131.05 144.69 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -127.26 93.11 3.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -62.99 -35.94 81.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -72.32 -39.91 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 80' ' ' HIS . 30.8 m120 -89.3 7.4 35.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.478 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASN . 37.4 m80 44.28 48.83 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -129.91 129.7 44.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.543 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 75' ' ' ILE . 52.6 t80 -122.19 129.93 52.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.255 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p -124.61 134.62 52.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 35.2 p90 -151.39 164.86 35.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.275 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 77.4 p -142.44 162.44 35.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 87' ' ' ILE . 4.6 tt -101.98 131.49 48.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.507 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.937 ' N ' HD23 ' A' ' 86' ' ' LEU . 80.3 mt -91.98 -76.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.434 -0.791 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.785 ' HG3' HG22 ' A' ' 87' ' ' ILE . 89.0 mt-10 -118.96 147.08 44.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.425 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.857 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -166.33 146.44 10.96 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' H ' HG12 ' A' ' 68' ' ' VAL . 4.1 t0 -49.2 -46.54 45.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -1.153 . . . . 0.0 109.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.94 -22.83 65.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.8 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.0 mp -86.77 -37.87 17.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 4.3 m 58.03 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 95.2 mt-10 -64.96 -9.17 19.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.76 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -77.41 -35.05 54.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 110.098 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 96' ' ' ILE . 9.0 pt -152.1 106.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 110.189 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 93' ' ' SER . 15.7 mt-10 -135.13 107.49 7.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 109.184 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 122' ' ' HIS . 15.8 tttt -179.11 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.663 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 14.1 mt -125.99 123.64 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 54.2 t0 -104.48 113.15 26.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.434 -0.791 . . . . 0.0 108.905 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 73.5 m-85 -103.47 143.07 33.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.98 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -134.7 132.26 38.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.087 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.579 HG21 ' CE1' ' A' ' 23' ' ' PHE . 41.3 m -123.26 135.26 54.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -141.23 125.61 17.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 20' ' ' PHE . 22.1 mt -98.51 130.46 45.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.3 t -131.9 145.2 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 109.422 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -113.95 142.56 45.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.36 167.55 9.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.81 -14.64 36.2 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.698 2.265 . . . . 0.0 111.843 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -71.2 -16.75 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.02 -16.81 38.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.31 173.21 47.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.4 m -119.32 122.28 41.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -1.131 . . . . 0.0 109.53 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.1 mt -92.57 134.04 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 105' ' ' LEU . 25.3 mt -117.9 130.92 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -111.42 129.44 56.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.321 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.3 m -125.26 128.83 48.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.67 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.667 ' CG2' HG22 ' A' ' 5' ' ' THR . 38.9 m -115.25 135.85 53.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.35 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -123.26 140.13 53.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.696 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 10.9 ttpt -125.95 139.33 53.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 69.8 m-85 -122.44 135.6 54.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.2 m-70 -125.45 -167.11 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.292 0.567 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.466 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 66.8 t60 -60.03 -44.16 94.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.13 -43.08 91.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.2 -38.26 65.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -61.3 -38.55 87.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' A' ' 34' ' ' ILE . 3.2 mm? -69.83 -29.75 67.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.84 HD12 HD21 ' A' ' 30' ' ' LEU . 34.0 mm -60.93 -44.19 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.36 -47.28 67.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.16 -30.96 71.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.594 ' CE1' ' HG2' ' A' ' 33' ' ' LYS . 61.4 t80 -63.46 -49.04 75.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.829 HD12 HD13 ' A' ' 14' ' ' ILE . 59.6 mt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 ' O ' ' A' ' 121' ' ' TYR . 11.7 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -112.13 144.68 41.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 40.5 m -93.76 141.25 28.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -117.51 132.09 56.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.59 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.79 137.28 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -118.56 154.16 33.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 114' ' ' ILE . 70.4 tt0 -133.96 109.87 9.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 43.0 t80 -122.66 128.78 51.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 21.1 p -92.32 149.47 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.296 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.3 p -146.18 166.73 25.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -0.949 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 14' ' ' ILE . 99.3 m-20 -73.17 -175.7 1.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 65.41 142.48 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.107 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.7 Cg_endo -69.0 146.37 64.62 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.414 2.076 . . . . 0.0 112.041 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -45.13 -48.12 32.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 111.401 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.72 -40.11 30.99 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.231 1.954 . . . . 0.0 113.094 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.556 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 29.7 mttm -67.97 -37.44 81.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -80.57 -28.0 37.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.721 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.549 ' HD1' HD23 ' A' ' 105' ' ' LEU . 68.7 t80 -65.91 -33.83 76.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.132 -0.98 . . . . 0.0 109.821 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.891 ' HG3' HD12 ' A' ' 25' ' ' LEU . 73.5 tttt -66.75 -46.25 75.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.614 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.06 40.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.698 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.798 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 65.4 t80 -80.52 -19.98 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.549 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 77.2 t -117.15 -63.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.891 HD12 ' HG3' ' A' ' 21' ' ' LYS . 32.4 mt -56.88 -40.74 76.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.302 -0.874 . . . . 0.0 109.581 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.9 m-20 -100.34 15.29 28.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.78 -41.57 74.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.685 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.708 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.4 m-20 -66.07 -30.36 70.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.714 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 94.1 m-20 -97.33 -32.18 12.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 109.589 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 28.4 tp -69.9 -46.5 65.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 27' ' ' ALA . 5.7 mt -47.0 -57.36 9.37 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.2 Cg_endo -68.73 -25.77 33.43 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.52 2.146 . . . . 0.0 111.867 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 60.7 tttt -75.51 -44.25 44.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.561 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' A' ' 147' ' ' LEU . 62.6 mt -67.78 -34.18 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.677 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.21 72.66 32.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.504 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.1 Cg_endo -70.53 -34.4 12.09 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.713 2.275 . . . . 0.0 111.782 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.22 78.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.733 HG12 ' CE1' ' A' ' 59' ' ' PHE . 23.7 m -125.37 155.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -73.22 -44.64 59.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.79 129.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.13 126.19 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -122.47 150.19 42.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.708 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.7 mt -106.35 121.47 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -65.74 -43.99 87.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.412 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.24 155.06 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.64 -41.0 2.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 89.2 m-20 60.54 40.47 16.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -1.102 . . . . 0.0 109.481 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.833 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.74 35.98 12.48 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.69 13.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.7 128.26 15.83 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.698 2.266 . . . . 0.0 111.715 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.65 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 90.0 m -81.07 143.32 32.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 109.587 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 45' ' ' LEU . 62.5 mt -110.14 131.67 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.313 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 50.3 mttt -116.42 150.42 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.589 ' HB2' HD11 ' A' ' 45' ' ' LEU . 25.1 tttm -129.63 125.87 37.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.188 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 68' ' ' VAL . 32.6 mt -117.39 137.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 50.4 m -114.51 133.2 55.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.733 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.2 m-85 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.474 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 44.1 p90 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 10.8 m -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 86' ' ' LEU . 81.5 mttt -119.46 147.58 44.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.582 ' NE2' HD13 ' A' ' 86' ' ' LEU . 62.6 m80 -115.95 166.57 11.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.231 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' SER . 42.5 tttp -143.78 140.72 30.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.473 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.4 mt -104.95 127.51 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 74' ' ' SER . 98.6 m-70 -88.8 -29.98 19.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 91.9 p 178.1 154.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.784 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' ILE . 38.3 pt -135.04 139.56 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -122.7 93.29 3.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -63.27 -37.89 89.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.267 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.06 -41.18 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -88.59 6.18 39.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.561 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m80 46.54 50.57 12.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.2 m -129.76 132.64 46.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.522 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 69.2 t80 -125.19 128.89 49.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.29 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -127.49 139.35 52.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.4 p90 -158.41 177.49 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.437 -0.789 . . . . 0.0 109.091 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' LYS . 89.1 p -151.7 154.77 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.898 ' CD2' HD11 ' A' ' 92' ' ' LEU . 25.5 tp -87.91 124.01 33.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.098 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.856 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.5 mt -80.69 -75.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.852 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.856 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.6 mt-10 -126.46 158.24 36.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 0.0 109.836 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -178.0 134.72 2.49 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -50.67 -37.69 42.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -1.16 . . . . 0.0 109.367 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.36 -17.37 63.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.152 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.898 HD11 ' CD2' ' A' ' 86' ' ' LEU . 6.8 mp -82.6 -42.11 18.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 3.3 t 60.13 177.18 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 97.9 mt-10 -78.89 -3.09 42.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 93' ' ' SER . 34.0 p-10 -90.76 -21.37 21.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 41.6 mt -112.39 132.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.069 -1.02 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 94.4 mt-10 -90.62 -178.56 5.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.148 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.676 ' NZ ' HG23 ' A' ' 87' ' ' ILE . 75.6 mttt -56.14 156.63 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.361 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 120' ' ' LYS . 55.4 mt -118.4 136.2 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.668 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 120' ' ' LYS . 91.7 m-20 -92.15 123.84 35.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.395 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 76.2 m-85 -113.79 139.17 49.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.9 mt-10 -134.33 138.85 45.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.403 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.707 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.3 m -127.96 137.45 52.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 105' ' ' LEU . 54.8 tttt -139.14 125.32 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -101.5 129.56 47.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' ILE . 50.8 t -131.78 144.33 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -109.64 151.99 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.1 160.68 28.09 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.2 Cg_endo -69.95 -17.0 36.97 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.639 2.226 . . . . 0.0 111.855 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -77.58 -12.3 59.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.53 30.46 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.46 172.3 55.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 99.7 m -124.61 128.23 48.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -1.123 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.628 HG21 ' OE2' ' A' ' 9' ' ' GLU . 64.5 mt -99.06 136.24 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 105' ' ' LEU . 62.7 mt -119.75 131.19 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 51.8 mttp -116.84 125.85 52.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -126.07 137.86 53.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 56.3 m -119.86 135.52 54.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -123.33 137.59 54.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.705 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 99' ' ' ILE . 67.5 tttt -143.76 134.45 25.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.235 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.015 ' O ' HG21 ' A' ' 3' ' ' VAL . 39.4 p90 -132.53 146.56 52.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 94.9 m-70 -108.78 159.17 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.495 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -59.26 -47.4 85.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.297 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -53.45 -48.82 68.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HA ' HD12 ' A' ' 148' ' ' ILE . 72.8 m-85 -54.01 -37.86 64.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -58.75 -41.44 86.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.689 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -68.33 -37.7 80.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.299 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 23' ' ' PHE . 81.7 mt -59.34 -48.6 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.283 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.5 -47.61 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.02 -33.55 84.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.42 -46.9 80.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 14' ' ' ILE . 64.3 mt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.845 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -92.17 141.45 28.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.563 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 38.7 m -93.66 142.66 27.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -119.67 144.35 47.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.533 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' HD3' ' A' ' 116' ' ' LYS . 85.5 tt0 -112.81 141.55 46.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -116.04 142.82 46.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -121.23 138.79 54.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.5 t80 -156.3 145.27 20.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.6 p -112.46 147.64 36.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -150.46 171.62 16.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' ILE . 6.8 t70 -78.66 179.54 7.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.34 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 70.2 142.11 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 109.155 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.6 Cg_endo -68.75 145.9 64.68 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.566 2.177 . . . . 0.0 112.148 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 105' ' ' LEU . . . -46.09 -47.62 43.36 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 111.543 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.1 Cg_endo -64.32 -37.17 41.54 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.081 1.854 . . . . 0.0 113.003 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 78.6 mttt -71.42 -32.43 68.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.884 -1.135 . . . . 0.0 109.556 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.8 tp -80.8 -30.38 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CE1' ' HB2' ' A' ' 82' ' ' TYR . 75.0 t80 -61.09 -41.47 96.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.594 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.583 ' NZ ' HD23 ' A' ' 25' ' ' LEU . 34.1 tttm -65.16 -52.81 52.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.632 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -8.11 52.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.988 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.6 t80 -85.45 -34.67 21.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.575 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.841 HG11 ' CD1' ' A' ' 82' ' ' TYR . 33.1 m -114.48 -37.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.583 HD23 ' NZ ' ' A' ' 21' ' ' LYS . 17.5 tp -71.18 -38.55 72.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.662 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.2 m-20 -108.09 14.38 25.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.9 -39.69 76.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.533 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.655 ' OD2' HD11 ' A' ' 44' ' ' ILE . 89.3 m-20 -58.62 -33.03 69.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.624 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.0 t30 -101.38 -35.91 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.968 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.1 tm? -72.49 -37.47 68.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 27' ' ' ALA . 28.7 mt -50.79 -55.8 24.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.2 Cg_endo -68.47 -18.91 43.51 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.43 2.087 . . . . 0.0 111.821 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 40.2 mttt -71.03 -36.71 72.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 HG23 ' HG ' ' A' ' 147' ' ' LEU . 79.7 mt -66.63 -29.27 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.87 72.2 5.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.6 Cg_endo -69.89 -32.27 18.35 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.665 2.244 . . . . 0.0 111.771 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -75.23 -25.83 58.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.63 -39.49 64.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 57' ' ' ILE . 3.5 p -118.06 151.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -77.56 -47.94 18.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 129.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.22 128.02 34.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -122.52 148.59 44.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.655 HD11 ' OD2' ' A' ' 28' ' ' ASP . 65.6 mt -106.45 118.14 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.428 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.8 mp -61.67 -45.41 94.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' HG23 ' A' ' 53' ' ' THR . 67.5 mm-40 -157.83 156.04 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.23 -41.01 2.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 59.1 36.73 24.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.837 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.17 33.31 10.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.83 -164.99 12.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.72 130.77 19.96 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 30.93 70.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 46' ' ' GLU . 89.3 m -86.36 141.9 28.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.506 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.3 mt -109.57 129.95 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.335 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.491 ' HE3' HD11 ' A' ' 72' ' ' ILE . 48.0 mttt -116.2 146.56 42.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.613 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 tttm -131.06 122.33 26.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 39' ' ' VAL . 28.5 mt -114.98 137.95 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -118.57 131.04 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.562 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.5 p90 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.262 0.553 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 86' ' ' LEU . 48.4 t -122.28 146.46 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 87' ' ' ILE . 26.8 mttt -119.83 139.52 52.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 77.2 m80 -119.64 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.2 tttt -112.61 141.17 46.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 109.553 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' A' ' 53' ' ' THR . 66.6 mt -99.51 134.54 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -91.73 -49.16 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.9 p -167.61 154.7 8.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.53 144.39 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 74.8 m-20 -128.73 91.19 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -63.75 -34.63 78.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.43 -39.24 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 30.2 m120 -87.82 4.8 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.5 m80 48.12 46.04 19.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.2 m -130.96 132.14 44.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.841 ' CD1' HG11 ' A' ' 24' ' ' VAL . 78.5 t80 -124.88 121.27 34.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.353 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.1 p -111.81 139.91 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 33.0 p90 -155.59 167.95 28.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 90.4 p -146.31 158.28 43.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.995 HD22 ' CD1' ' A' ' 92' ' ' LEU . 5.4 tt -96.5 121.96 38.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.822 HG22 ' HG3' ' A' ' 88' ' ' GLU . 94.8 mt -76.75 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.871 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.8 mt-10 -133.44 159.92 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.93 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.36 162.2 32.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -65.05 -29.62 70.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 109.631 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.59 -21.75 48.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.995 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 mt -78.68 -30.17 45.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 108.999 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 92' ' ' LEU . 66.6 m 46.37 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.88 9.88 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -110.14 -15.55 13.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 91' ' ' ALA . 18.7 mt -109.36 137.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 122' ' ' HIS . 99.6 mt-10 -84.55 -179.4 7.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.299 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 35.4 mtmm -57.21 164.43 1.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 120' ' ' LYS . 53.4 mt -121.79 131.85 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.525 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 120' ' ' LYS . 90.2 m-20 -90.74 126.33 35.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 66.6 m-85 -116.93 142.06 47.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.2 mt-10 -129.19 136.08 49.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.8 m -125.95 129.25 48.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.492 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.0 tttt -130.36 128.1 40.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.169 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.0 mm? -99.47 123.3 43.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.2 t -130.83 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 72.2 m -113.78 153.43 29.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.56 162.44 20.59 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.1 Cg_endo -69.79 -18.83 36.66 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.613 2.209 . . . . 0.0 111.713 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -67.3 -15.43 63.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.877 . . . . 0.0 109.375 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.92 35.6 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.54 176.37 44.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 16' ' ' ALA . 98.1 m -117.76 129.26 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.2 mt -98.92 131.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.62 HG23 HD13 ' A' ' 105' ' ' LEU . 39.8 mt -117.38 132.72 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.621 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HD3' ' OE2' ' A' ' 7' ' ' GLU . 84.5 mttt -117.68 132.27 56.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.31 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.4 m -130.77 126.92 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.542 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.8 m -108.71 145.76 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -130.85 137.23 49.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.831 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 3' ' ' VAL . 22.1 tttt -141.67 131.78 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.155 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.845 ' O ' HG21 ' A' ' 3' ' ' VAL . 42.5 p90 -129.02 148.09 50.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.426 ' HB3' ' OE1' ' A' ' 97' ' ' GLU . 77.5 m80 -116.58 166.72 11.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 35.1 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 147' ' ' LEU . 52.5 m170 -58.98 -46.81 87.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.8 mt -55.57 -50.97 68.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.385 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.405 ' HE1' ' CE1' ' A' ' 23' ' ' PHE . 73.5 m-85 -53.46 -38.04 63.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -61.97 -42.35 99.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HG ' HG23 ' A' ' 34' ' ' ILE . 4.1 mm? -63.93 -45.02 91.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 19' ' ' LEU . 72.1 mt -55.63 -54.54 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.64 -29.95 53.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.93 -32.07 59.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -73.03 -43.25 62.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.89 136.63 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 29.1 m -93.61 137.19 33.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 109.367 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 118' ' ' THR . 68.4 t80 -119.64 132.79 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -113.94 135.53 53.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.85 . . . . 0.0 109.357 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 42.4 t-20 -119.64 141.12 49.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -115.1 138.14 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 78.1 t80 -154.9 146.53 23.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.8 p -113.22 147.17 38.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.422 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 59.8 p -149.61 171.67 16.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.651 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' O ' HD12 ' A' ' 14' ' ' ILE . 13.4 t0 -77.85 -175.45 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.71 141.06 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.9 Cg_endo -69.66 147.16 62.87 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.618 2.212 . . . . 0.0 112.115 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.695 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -40.86 -50.32 7.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.08 -45.75 9.53 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.297 1.998 . . . . 0.0 113.003 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 20.9 mttm -61.42 -33.04 73.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.782 -1.199 . . . . 0.0 109.542 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD12 HD22 ' A' ' 152' ' ' LEU . 12.4 tp -80.55 -31.75 36.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.725 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.878 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 73.7 t80 -69.0 -32.05 71.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 109.848 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.749 ' HG3' HD12 ' A' ' 25' ' ' LEU . 23.2 tttt -65.98 -44.57 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.609 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.55 -19.73 32.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 103' ' ' THR . 55.9 t80 -83.29 -15.92 48.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.3 t -118.53 -63.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.363 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.749 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.1 mt -57.97 -43.63 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.8 m-20 -96.24 15.42 21.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.391 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.735 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -69.49 -22.23 63.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.664 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.2 m-20 -77.36 -35.54 54.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.401 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 m120 -98.01 -31.5 12.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 148' ' ' ILE . 18.4 tp -63.3 -39.06 93.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -55.53 -59.42 11.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 50.5 Cg_endo -70.67 -11.27 29.39 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.674 2.249 . . . . 0.0 111.605 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -73.33 -43.94 59.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.857 . . . . 0.0 109.395 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.128 HG23 ' CD2' ' A' ' 147' ' ' LEU . 86.5 mt -66.6 -38.81 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.71 76.44 23.91 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.47 -31.64 17.01 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.714 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -74.49 -22.6 58.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -71.81 -37.53 70.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.87 . . . . 0.0 109.362 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG21 ' CG2' ' A' ' 57' ' ' ILE . 2.6 p -120.45 146.35 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -73.64 -45.99 49.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.1 142.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.563 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.97 130.32 53.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -127.63 154.12 45.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.664 HD11 ' OD2' ' A' ' 28' ' ' ASP . 25.9 mt -105.85 122.04 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -68.15 -43.76 77.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.361 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.3 157.7 31.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.47 -40.46 2.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 58.95 37.44 24.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.697 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.91 26.32 29.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -111.63 -166.3 18.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.93 130.07 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.682 2.255 . . . . 0.0 111.757 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.27 69.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.922 HG23 ' O ' ' A' ' 46' ' ' GLU . 97.9 m -80.77 142.53 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -1.181 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HD13 ' A' ' 45' ' ' LEU . 64.3 mt -112.86 130.1 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HG2' HG23 ' A' ' 44' ' ' ILE . 71.7 mttt -124.75 146.38 49.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.647 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 44.4 tttt -122.83 121.72 36.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.668 HD12 ' CD2' ' A' ' 70' ' ' HIS . 17.4 mt -114.75 132.51 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.2 m -113.12 116.82 30.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 53.9 p90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 36.7 p90 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.333 0.587 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.1 m -125.55 147.83 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' HD12 ' A' ' 86' ' ' LEU . 51.1 mttt -103.29 144.69 31.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.987 ' CE1' HD13 ' A' ' 86' ' ' LEU . 64.3 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.9 tttm -125.02 139.09 54.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.56 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.82 HD12 ' HB ' ' A' ' 53' ' ' THR . 70.6 mt -100.95 129.63 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.07 -45.76 9.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -170.3 141.42 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.621 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 pt -123.42 143.83 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -127.77 91.27 3.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -63.59 -37.34 86.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.76 -42.72 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -86.15 3.09 44.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 56.0 m80 52.97 45.12 29.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.109 -0.995 . . . . 0.0 109.491 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -126.76 139.83 52.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.6 t80 -132.98 125.77 30.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -120.76 127.36 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 36.1 p90 -146.64 171.14 15.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 69.1 p -151.5 151.36 31.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.0 109.704 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.987 HD13 ' CE1' ' A' ' 70' ' ' HIS . 32.1 tp -88.71 108.02 19.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.853 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' A' ' 88' ' ' GLU . 95.9 mt -59.11 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.853 ' HG2' HG22 ' A' ' 87' ' ' ILE . 78.2 mm-40 -138.96 169.74 17.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.724 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.86 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -179.55 135.79 2.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -50.37 -41.27 51.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.485 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.74 68.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.624 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.5 mp -78.64 -33.4 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 4.0 m 61.47 178.19 0.12 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.299 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -78.86 -13.95 59.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.555 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -78.11 -28.69 48.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 34.4 mt -105.84 125.83 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.101 -0.999 . . . . 0.0 109.746 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 91.3 mt-10 -80.89 -179.41 7.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.16 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 17.5 ptpt -57.02 159.4 4.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 120' ' ' LYS . 69.5 mt -117.79 138.65 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.596 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 61.1 t0 -95.13 125.72 39.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 90.9 m-85 -117.3 134.08 55.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -123.71 137.64 54.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.807 HG21 ' CE1' ' A' ' 23' ' ' PHE . 30.9 m -127.99 136.72 51.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.573 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.5 tttt -139.77 125.62 19.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.906 HD13 HG23 ' A' ' 115' ' ' ILE . 2.7 mm? -100.16 130.01 46.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.4 t -131.79 140.66 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.6 p -113.27 148.38 35.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.86 164.59 14.38 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.2 Cg_endo -70.34 -10.73 28.73 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 111.74 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -76.02 -15.52 60.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.06 -19.02 28.05 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.88 170.68 45.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.695 HG21 ' HA ' ' A' ' 16' ' ' ALA . 88.4 m -123.8 127.04 47.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.149 . . . . 0.0 109.605 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.3 mt -96.95 139.2 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 109.235 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.906 HG23 HD13 ' A' ' 105' ' ' LEU . 4.7 mt -124.62 121.96 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 45.0 mttt -107.67 139.11 42.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.075 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 m -127.98 130.06 47.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 110.076 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -125.97 140.28 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.875 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -145.21 155.54 43.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 110.196 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 99' ' ' ILE . 25.5 mttp -129.97 148.53 51.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.528 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 80.4 m-85 -118.13 121.81 41.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 0.0 109.834 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 61.2 m170 -89.86 143.5 26.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.577 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.266 0.555 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -59.86 -50.64 73.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.411 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 6.6 mp -68.23 -48.0 66.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.803 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 62.3 t80 -52.96 -45.44 67.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -58.0 -40.65 81.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.128 ' CD2' HG23 ' A' ' 34' ' ' ILE . 17.1 tp -60.08 -39.47 86.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 30' ' ' LEU . 76.0 mt -53.76 -52.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.278 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 81.5 tt0 -54.73 -38.84 67.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.194 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.69 91.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 147' ' ' LEU . 15.4 m-85 -71.38 -42.45 68.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.09 . . . . 0.0 109.337 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 19' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -110.81 154.07 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.417 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 120' ' ' LYS . 23.5 m -94.1 140.36 29.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -111.81 139.77 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -113.25 140.35 48.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -130.1 160.07 34.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.56 ' OE2' HG21 ' A' ' 114' ' ' ILE . 74.6 tt0 -142.72 130.8 21.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 75.7 t80 -141.78 140.32 33.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.565 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.0 p -90.68 143.56 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.956 ' OG ' HD11 ' A' ' 115' ' ' ILE . 83.3 p -141.06 161.29 38.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.588 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 14' ' ' ILE . 29.4 t0 -78.35 179.7 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.29 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.6 141.88 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.232 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.3 Cg_endo -69.32 146.98 64.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.507 2.138 . . . . 0.0 112.158 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.62 -50.57 7.02 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 111.39 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.77 -49.98 3.63 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.23 1.953 . . . . 0.0 112.923 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.8 mttm -60.75 -35.98 77.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.866 -1.146 . . . . 0.0 109.672 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 19' ' ' LEU . 25.4 tp -81.01 -28.4 35.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.973 ' HB2' HD12 ' A' ' 105' ' ' LEU . 69.4 t80 -69.54 -35.01 75.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.82 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HG3' HD12 ' A' ' 25' ' ' LEU . 29.8 tttp -67.34 -37.87 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -88.54 -30.77 19.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.64 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.83 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.6 t80 -77.3 -12.15 59.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -117.76 -63.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' HG3' ' A' ' 21' ' ' LYS . 47.8 mt -65.3 -41.43 94.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.8 m-20 -94.82 9.65 38.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.529 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.19 -45.54 66.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.954 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.563 ' OD2' HD11 ' A' ' 44' ' ' ILE . 94.6 m-20 -65.1 -25.31 67.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 58.8 t30 -101.27 -33.88 9.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.597 HD11 ' CD2' ' A' ' 151' ' ' TYR . 22.0 tp -75.27 -34.56 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 27' ' ' ALA . 34.9 mt -51.34 -54.94 33.2 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.707 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -69.07 -20.32 38.23 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.425 2.084 . . . . 0.0 111.988 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 30' ' ' LEU . 30.2 mmtt -71.32 -34.99 71.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.44 -27.99 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.97 64.62 42.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.5 -46.14 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.671 2.247 . . . . 0.0 111.705 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -65.63 -22.87 66.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -73.29 -50.52 21.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 57' ' ' ILE . 7.4 p -111.61 149.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.476 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -73.25 -46.2 51.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.51 131.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.35 128.03 34.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.439 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -123.93 142.88 50.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.563 HD11 ' OD2' ' A' ' 28' ' ' ASP . 56.1 mt -106.46 118.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 27.2 tp -60.2 -44.94 94.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 53' ' ' THR . 94.9 mt-10 -159.68 157.02 28.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 105.6 -42.06 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 58.26 37.41 26.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.871 ' H ' HG21 ' A' ' 53' ' ' THR . . . 86.11 31.35 20.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -115.56 -166.28 14.81 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.7 130.9 20.23 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.737 2.291 . . . . 0.0 111.598 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.74 29.62 73.94 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' H ' ' A' ' 49' ' ' GLY . 94.3 m -82.76 140.64 32.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 44' ' ' ILE . 22.3 mm -105.81 129.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.276 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 91.3 mttt -114.74 147.3 39.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.655 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 57.3 tttm -131.02 121.52 25.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 0.0 109.297 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 39' ' ' VAL . 60.8 mt -114.04 135.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.6 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 m -123.96 119.46 29.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 33.6 p90 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.567 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 38.9 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.308 0.575 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.046 HG12 HD11 ' A' ' 86' ' ' LEU . 43.0 t -124.08 144.48 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 35.2 mttt -116.9 139.66 50.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.6 ' NE2' HD13 ' A' ' 86' ' ' LEU . 79.7 m80 -116.98 144.87 44.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' CB ' HD11 ' A' ' 87' ' ' ILE . 25.0 tttt -124.01 142.39 51.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.703 HD12 ' HB ' ' A' ' 53' ' ' THR . 58.3 mt -102.96 131.07 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.411 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 97.2 m-70 -90.5 -48.64 6.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.2 m -163.81 149.49 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -129.89 145.47 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 82.0 m-20 -128.3 91.16 3.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -62.31 -37.66 86.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.96 -40.67 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.4 m-20 -87.8 7.88 28.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 46.5 m80 45.72 40.34 6.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -119.46 136.43 54.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.4 t80 -127.52 126.28 41.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 t -121.06 128.16 52.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 34.1 p90 -145.72 170.26 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -148.1 157.96 43.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.046 HD11 HG12 ' A' ' 68' ' ' VAL . 22.6 tp -93.27 136.75 33.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.58 HG23 ' HE3' ' A' ' 98' ' ' LYS . 26.9 mm -99.13 -71.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.0 mt-10 -118.98 160.78 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 172.44 128.59 1.06 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -46.21 -31.82 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 109.604 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.56 68.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD21 HD23 ' A' ' 86' ' ' LEU . 3.6 mt -74.69 -33.03 62.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 3.5 m 53.14 -177.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.66 -0.65 . . . . 0.0 109.567 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.0 12.53 7.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 26.7 p-10 -111.72 -10.75 14.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mt -114.5 140.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 93.7 mt-10 -91.96 -179.52 5.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.312 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HE3' HG23 ' A' ' 87' ' ' ILE . 52.2 mttp -57.08 161.91 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.492 HG12 ' HB2' ' A' ' 121' ' ' TYR . 49.0 mt -120.47 135.62 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.608 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 120' ' ' LYS . 60.6 t0 -93.04 120.13 33.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 73.1 m-85 -113.8 139.13 49.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.48 135.34 44.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.318 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 m -131.11 135.64 47.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -139.18 129.13 25.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.888 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 20' ' ' PHE . 31.6 mt -98.69 129.61 45.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.7 t -132.05 136.17 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.9 OUTLIER -111.2 146.6 36.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.861 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -106.54 171.38 4.8 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.861 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.4 Cg_endo -69.52 -15.06 37.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.666 2.244 . . . . 0.0 111.791 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.79 -20.81 61.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.9 -25.61 11.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.44 171.55 51.37 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 93.8 m -125.87 124.62 41.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.56 HG21 ' OE2' ' A' ' 9' ' ' GLU . 68.0 mt -97.5 139.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.263 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.956 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.2 mt -121.57 127.96 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.741 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 50.5 mttp -105.87 127.98 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 m -123.43 133.65 54.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.462 ' CG2' HG22 ' A' ' 5' ' ' THR . 60.8 m -119.79 133.54 55.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 0.0 109.016 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -120.32 131.33 54.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 110.006 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HB2' HG23 ' A' ' 5' ' ' THR . 78.5 tttt -140.66 130.35 24.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 3' ' ' VAL . 32.9 p90 -132.11 149.17 52.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.805 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.5 ' ND1' HG11 ' A' ' 3' ' ' VAL . 98.8 m-70 -114.15 158.67 21.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.183 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.428 ' CA ' ' HG3' ' A' ' 97' ' ' GLU . 82.2 p . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.633 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.19 -53.21 60.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HA ' HD23 ' A' ' 147' ' ' LEU . 25.4 mt -62.0 -36.07 80.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 109.39 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.915 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 46.6 t80 -53.44 -43.06 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.197 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 59.4 tttm -59.29 -38.63 80.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -62.58 -36.13 81.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.231 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.538 HD13 ' HD1' ' A' ' 23' ' ' PHE . 98.8 mt -53.68 -55.74 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.163 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.533 ' OE2' ' CE2' ' A' ' 145' ' ' PHE . 40.5 mp0 -54.33 -43.74 71.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.943 . . . . 0.0 109.043 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.48 -29.45 71.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.597 ' CD2' HD11 ' A' ' 30' ' ' LEU . 54.5 t80 -61.16 -43.58 98.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.3 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.713 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.226 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.988 HG21 ' O ' ' A' ' 121' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.333 0.587 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.31 149.57 39.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 118' ' ' THR . 27.6 m -93.56 140.99 28.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.46 137.98 53.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.616 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -108.02 132.76 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.27 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.06 133.41 53.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.52 131.86 54.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.435 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 86.0 t80 -146.56 149.48 33.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 22.0 p -117.96 149.9 40.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 23.2 t -148.51 164.57 33.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.636 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.796 ' O ' HD12 ' A' ' 14' ' ' ILE . 21.1 t0 -72.71 -178.44 2.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 HD12 ' A' ' 152' ' ' LEU . 1.0 OUTLIER 69.05 142.06 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.273 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.8 Cg_endo -69.65 147.21 63.09 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 111.964 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -38.71 -51.44 3.76 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.507 -0.745 . . . . 0.0 111.267 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.19 -50.66 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.318 2.012 . . . . 0.0 113.068 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 95.6 mttt -59.1 -34.98 72.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.808 -1.182 . . . . 0.0 109.55 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 152' ' ' LEU . 22.4 tp -80.77 -36.86 31.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 24' ' ' VAL . 60.0 t80 -57.87 -32.6 67.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HA ' HD13 ' A' ' 25' ' ' LEU . 19.8 tttt -71.57 -52.39 18.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 109.623 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.44 3.06 14.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.0 t80 -99.86 -33.37 10.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.793 ' CG2' HD12 ' A' ' 25' ' ' LEU . 9.8 m -114.19 -46.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.888 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.793 HD12 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -68.7 -33.93 74.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.97 . . . . 0.0 109.478 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 59.0 m-20 -106.33 8.93 32.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.81 -37.05 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 44' ' ' ILE . 92.7 m-20 -57.35 -37.28 72.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.647 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 86.7 m-20 -100.86 -37.65 8.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 26.0 tp -63.96 -43.05 96.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 9.3 mt -47.8 -60.0 4.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.68 -22.74 37.12 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.55 2.166 . . . . 0.0 111.63 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.9 tptm -66.26 -47.06 74.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.534 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG21 ' CB ' ' A' ' 147' ' ' LEU . 67.8 mt -67.91 -36.13 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.534 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.97 71.58 62.52 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.6 Cg_endo -70.4 -37.37 7.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.681 2.254 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.53 -23.06 60.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.34 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' CE1' ' A' ' 59' ' ' PHE . 21.4 m -125.54 149.16 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -72.13 -47.53 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.386 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.98 131.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.59 119.31 27.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -115.53 144.37 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.579 HG23 ' HG2' ' A' ' 55' ' ' LYS . 50.9 mt -106.6 119.67 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 26.4 tp -64.86 -44.12 90.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.938 ' O ' HG23 ' A' ' 53' ' ' THR . 94.3 mt-10 -159.32 154.48 25.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.95 -42.71 1.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 61.84 39.06 14.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.537 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.46 34.92 15.23 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.479 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.33 -166.84 13.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.02 131.85 21.7 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.726 2.284 . . . . 0.0 111.709 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.49 28.82 72.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.938 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.3 m -83.88 144.78 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 53' ' ' THR . 22.1 mm -112.15 131.94 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.95 . . . . 0.0 109.28 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 44' ' ' ILE . 4.4 mtmt -130.09 148.39 51.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.542 ' HE3' ' CD2' ' A' ' 67' ' ' TYR . 67.8 tttt -125.76 126.71 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 14.7 mt -115.92 130.93 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.4 m -107.74 132.02 53.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.341 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.866 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.9 m-85 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 37.3 p90 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.306 0.574 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.868 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -126.65 145.58 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 88' ' ' GLU . 34.7 mttt -102.33 140.52 36.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.624 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 42.3 m170 -115.91 140.92 48.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.297 -0.877 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -124.02 139.22 54.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 49' ' ' GLY . 63.3 mt -101.7 135.74 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 93.9 m-70 -89.17 -48.97 7.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.2 t -174.24 151.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.569 HG22 ' CD1' ' A' ' 82' ' ' TYR . 41.2 pt -127.05 144.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -123.45 90.5 3.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -61.57 -36.8 81.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.466 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.84 -37.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -91.63 2.85 56.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.5 m80 51.34 46.98 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.8 m -128.8 135.18 48.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.87 . . . . 0.0 109.541 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' HG22 ' A' ' 75' ' ' ILE . 61.5 t80 -128.8 121.55 28.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -116.46 137.8 51.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -152.2 166.37 31.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.301 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 89.4 p -145.43 160.11 42.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.3 tt -100.77 131.81 46.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.1 mm -89.13 -73.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.583 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 87' ' ' ILE . 88.3 mt-10 -121.15 151.79 39.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.513 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.868 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -171.4 154.73 22.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 68' ' ' VAL . 6.0 t0 -56.35 -49.19 75.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 0.0 109.403 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.85 -27.01 59.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.7 mp -80.7 -30.24 36.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' LEU . 3.7 m 56.43 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.48 -7.67 34.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 109.236 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 96' ' ' ILE . 26.1 m120 -72.73 -42.29 64.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.285 -0.884 . . . . 0.0 109.668 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -156.25 121.82 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 110.477 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 92' ' ' LEU . 22.1 mt-10 -136.59 107.03 6.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.818 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 122' ' ' HIS . 78.6 tttt -179.01 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.392 -0.817 . . . . 0.0 108.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.658 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 18.8 mt -123.92 117.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -93.78 118.78 31.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.87 . . . . 0.0 109.011 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.658 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 68.1 m-85 -109.23 137.73 46.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.8 mt-10 -130.34 129.79 43.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.5 m -120.8 134.92 55.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HD22 ' A' ' 105' ' ' LEU . 32.5 tttt -133.73 121.65 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.099 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.802 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.1 mm? -95.12 118.85 32.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.759 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 60.5 t -131.88 140.2 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 109.313 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.1 t -107.61 148.05 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.905 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -105.71 173.11 3.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.905 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.97 -16.22 36.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.671 2.248 . . . . 0.0 111.8 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.48 27.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.62 176.63 53.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.714 HG21 ' HA ' ' A' ' 16' ' ' ALA . 65.3 m -122.88 125.05 44.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.3 mt -96.2 139.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.36 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 105' ' ' LEU . 28.7 mt -123.65 123.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.737 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -105.27 133.83 49.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.102 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 86.2 m -131.44 128.93 40.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.0 109.902 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.596 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.1 m -111.7 142.97 43.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.067 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.1 m -135.09 140.62 45.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.987 . . . . 0.0 109.845 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 72.0 tttt -132.29 147.14 52.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.988 ' O ' HG21 ' A' ' 3' ' ' VAL . 96.2 m-85 -126.6 140.31 52.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.81 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 75.8 m-70 -130.55 -177.83 4.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.196 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 96' ' ' ILE . 36.2 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.68 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.447 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 64.3 t60 -61.35 -35.58 77.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.519 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 144' ' ' LEU . 38.6 mt -64.07 -44.37 92.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.672 ' HA ' HD12 ' A' ' 148' ' ' ILE . 66.3 m-85 -53.33 -39.18 63.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -57.33 -41.39 79.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -67.97 -37.92 82.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 145' ' ' PHE . 81.2 mt -54.16 -44.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 86.8 tt0 -65.64 -45.74 81.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.11 -39.79 96.49 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.35 -50.21 73.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -1.12 . . . . 0.0 109.407 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 14' ' ' ILE . 49.2 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.798 HG21 ' O ' ' A' ' 121' ' ' TYR . 59.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.9 t80 -87.43 147.51 25.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.578 HG22 ' CG2' ' A' ' 118' ' ' THR . 22.0 m -93.51 141.89 27.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.6 140.72 51.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.582 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -110.19 136.19 49.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -118.64 131.07 56.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.644 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 92.4 mt-10 -111.48 111.68 22.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.245 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 47.7 t80 -126.95 130.59 50.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 16.2 p -94.0 151.74 19.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 85.8 p -147.15 163.53 36.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 14' ' ' ILE . 90.6 m-20 -71.45 -175.77 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.692 HD12 ' C ' ' A' ' 13' ' ' ASP . 5.0 mp 63.12 142.43 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.6 Cg_endo -69.24 146.56 63.81 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.534 2.156 . . . . 0.0 112.173 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.632 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.46 -47.43 47.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.614 -0.679 . . . . 0.0 111.474 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.2 Cg_endo -63.93 -45.67 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.999 1.799 . . . . 0.0 112.899 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.562 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 61.0 mttm -64.45 -35.0 79.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 152' ' ' LEU . 25.9 tp -80.9 -29.66 35.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HD2' HD23 ' A' ' 105' ' ' LEU . 60.6 t80 -63.02 -37.01 85.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 34.7 tttp -65.51 -42.52 91.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.971 . . . . 0.0 109.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -83.33 -29.96 27.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE1' HG21 ' A' ' 103' ' ' THR . 63.2 t80 -76.63 -18.73 58.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 58.2 t -113.87 -67.0 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 25' ' ' LEU . 18.1 tp -57.99 -42.08 84.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 75.2 m-20 -96.35 12.92 29.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.574 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.973 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -64.4 -35.67 81.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 109.598 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.5 m-20 -65.04 -33.89 77.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.9 t30 -94.34 -33.78 13.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -65.06 -46.14 82.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 27' ' ' ALA . 4.6 mt -48.2 -58.71 7.35 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.72 -21.34 38.89 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.487 2.124 . . . . 0.0 111.558 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 39.1 tptt -65.15 -40.35 94.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.62 HD12 ' HB3' ' A' ' 147' ' ' LEU . 37.7 mm -61.78 -29.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.12 73.15 5.1 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.463 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -69.97 -31.8 18.93 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.675 2.25 . . . . 0.0 111.833 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -70.71 -24.85 62.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.62 -40.23 61.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.708 HG21 HG23 ' A' ' 57' ' ' ILE . 4.9 p -112.74 147.24 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -75.37 -45.14 41.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.42 131.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.49 126.5 35.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.307 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.13 150.44 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.655 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.714 HD11 ' OD2' ' A' ' 28' ' ' ASP . 60.9 mt -106.17 121.34 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 0.0 109.37 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -66.47 -44.0 83.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 53' ' ' THR . 93.8 mt-10 -159.34 157.53 30.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.67 -40.42 2.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 58.32 40.34 24.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.459 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.737 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.88 33.72 20.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.09 -167.19 13.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.72 129.12 17.08 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.595 2.197 . . . . 0.0 111.695 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 72.47 26.35 72.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.4 m -78.99 144.51 34.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 45' ' ' LEU . 63.3 mt -114.33 129.66 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 3.3 mtmt -124.54 149.63 46.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.0 ttpp -130.72 126.1 35.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.708 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -114.94 133.76 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.3 m -115.1 130.92 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.339 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CE1' ' HB ' ' A' ' 39' ' ' VAL . 91.6 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.3 p90 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.732 HG22 ' CA ' ' A' ' 89' ' ' GLY . 46.8 t -125.49 144.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -116.21 143.24 45.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 55' ' ' LYS . 79.6 m80 -123.28 142.76 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 87' ' ' ILE . 17.8 tttp -123.91 140.66 52.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 64.4 mt -100.75 133.16 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 89.7 m-70 -90.68 -48.49 7.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.5 m -165.03 154.13 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.75 144.89 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.6 m-20 -127.83 93.39 3.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -65.92 -38.12 87.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.319 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.22 -42.06 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 72.3 m-20 -87.3 4.98 40.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.574 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 105' ' ' LEU . 66.7 m80 48.46 41.9 17.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.962 . . . . 0.0 109.472 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.8 m -122.05 136.66 54.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 62.6 t80 -129.12 127.07 40.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.369 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 t -121.77 133.43 54.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.652 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 38.5 p90 -149.51 162.96 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 73' ' ' HIS . 55.4 m -138.87 149.26 44.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.4 tt -88.26 133.81 33.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.974 HG23 ' HE2' ' A' ' 98' ' ' LYS . 71.4 mt -91.45 -77.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.608 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.79 ' HG2' HG22 ' A' ' 87' ' ' ILE . 74.4 mm-40 -115.37 161.81 18.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.651 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.732 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 171.56 160.31 19.81 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.87 -34.06 74.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.665 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.73 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -67.82 -31.47 71.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.724 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.951 HD11 ' CD2' ' A' ' 86' ' ' LEU . 5.8 mt -70.71 -27.77 64.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 109.152 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 92' ' ' LEU . 0.6 OUTLIER 43.73 -166.01 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.645 -0.66 . . . . 0.0 109.457 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.24 14.71 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.579 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -124.39 -11.73 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.73 HD12 ' O ' ' A' ' 91' ' ' ALA . 50.7 mt -111.97 126.26 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.701 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 96.6 mt-10 -77.05 -179.57 5.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.974 ' HE2' HG23 ' A' ' 87' ' ' ILE . 16.3 mttp -57.29 167.06 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 120' ' ' LYS . 83.2 mt -123.29 137.99 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.04 122.75 34.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.427 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 89.9 m-85 -114.62 138.6 50.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.509 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 117' ' ' THR . 93.7 mt-10 -131.68 131.48 43.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.382 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.835 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.6 m -125.85 137.26 53.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' C ' HD22 ' A' ' 105' ' ' LEU . 18.4 tttp -139.03 128.14 23.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -98.5 117.6 33.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.8 t -131.72 143.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.275 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 44.2 m -114.36 151.77 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.11 167.83 8.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.524 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.9 Cg_endo -69.05 -17.22 40.9 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.773 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -64.54 -14.7 58.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.42 -14.8 50.67 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.86 178.37 40.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 99.1 m -117.99 131.36 56.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -1.171 . . . . 0.0 109.727 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.9 mt -101.75 131.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.14 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.13 128.24 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 61.9 mttp -113.21 124.97 53.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 102' ' ' GLU . 62.0 m -129.84 132.72 46.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.007 . . . . 0.0 109.981 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.578 ' CG2' HG22 ' A' ' 5' ' ' THR . 44.0 m -112.48 135.17 53.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 0.0 109.057 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.3 m -125.97 143.12 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.7 tttm -139.26 133.61 31.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 108.969 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.798 ' O ' HG21 ' A' ' 3' ' ' VAL . 61.5 m-85 -111.36 131.83 54.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.816 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.5 m80 -100.74 138.84 37.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.273 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.37 -44.5 88.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.393 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 34' ' ' ILE . 55.8 mt -56.88 -47.66 79.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -54.11 -37.98 64.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.302 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.26 -43.25 87.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -62.93 -36.92 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' CD1' HD11 ' A' ' 30' ' ' LEU . 29.3 mm -55.74 -44.45 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.506 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 94.1 mt-10 -66.86 -36.64 82.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.92 95.65 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.02 -44.75 83.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -1.149 . . . . 0.0 109.565 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.929 HD11 HD13 ' A' ' 19' ' ' LEU . 37.8 mt . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.3 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.239 0.542 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -113.35 152.77 29.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 109.228 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 35.1 m -93.46 142.42 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.18 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -119.21 128.3 54.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.826 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -109.41 138.42 45.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.143 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.45 129.75 45.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.872 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 116' ' ' LYS . 88.7 mt-10 -109.37 123.52 49.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.026 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 11' ' ' THR . 54.6 t80 -135.97 135.54 39.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.846 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 114' ' ' ILE . 14.5 p -94.68 131.31 40.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.124 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.747 ' OG ' HD11 ' A' ' 115' ' ' ILE . 94.4 p -130.55 177.16 7.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.863 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 14' ' ' ILE . 41.3 p-10 -80.78 -175.32 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 152' ' ' LEU . 6.7 mm 68.24 136.12 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.2 Cg_endo -70.84 149.58 60.23 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.452 2.101 . . . . 0.0 111.888 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.83 -52.36 3.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 0.0 111.176 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.72 -50.36 2.45 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.432 2.088 . . . . 0.0 113.228 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 31.2 mttt -61.62 -34.67 76.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.838 -1.164 . . . . 0.0 109.888 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.8 tt -80.59 -28.47 37.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.63 ' HD1' HD23 ' A' ' 105' ' ' LEU . 74.6 t80 -72.35 -34.61 68.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.608 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -68.08 -41.12 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.7 -23.3 27.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.841 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.2 t80 -82.96 -14.45 54.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -119.96 -55.94 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.6 tp -67.77 -38.82 83.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 55.0 m-20 -104.83 18.29 22.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.946 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.87 -37.2 76.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.338 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 42' ' ' ALA . 52.6 t0 -76.78 -20.64 56.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.679 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 93.4 m-20 -104.42 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 HG23 ' A' ' 148' ' ' ILE . 19.0 tp -70.98 -38.83 72.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 27' ' ' ALA . 8.0 mt -55.71 -56.7 27.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -69.63 -11.41 30.94 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.393 2.062 . . . . 0.0 111.67 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 12.0 mttm -83.43 -36.52 24.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 147' ' ' LEU . 80.3 mt -76.88 -30.72 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.48 75.44 7.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.6 Cg_endo -69.63 -28.58 25.71 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.706 2.271 . . . . 0.0 111.694 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.11 -23.88 54.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.278 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.95 65.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 57' ' ' ILE . 5.7 p -116.62 150.75 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 58' ' ' THR . 27.7 tttm -75.46 -51.69 12.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 130.71 0.05 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . . . -94.54 123.0 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -125.82 152.18 45.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 64.7 mt -105.96 119.2 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 25.5 tp -61.99 -43.73 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 53' ' ' THR . 94.4 mt-10 -160.05 154.92 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.54 -42.28 1.94 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.8 m-20 61.39 36.61 17.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.33 34.37 10.64 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.0 -165.17 12.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.96 131.12 20.3 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.733 2.288 . . . . 0.0 111.783 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.53 27.94 72.89 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.7 m -83.23 142.57 31.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -1.162 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.456 HD13 ' HG3' ' A' ' 71' ' ' LYS . 24.0 mm -108.79 131.5 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' CE ' HD11 ' A' ' 72' ' ' ILE . 64.2 mttt -117.17 148.79 41.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 48.4 tttp -132.92 127.24 33.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.346 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.582 HD11 ' CD2' ' A' ' 70' ' ' HIS . 42.5 mt -120.15 131.37 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 40' ' ' LYS . 62.4 m -114.63 127.26 55.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.711 ' HE2' HG23 ' A' ' 68' ' ' VAL . 97.8 m-85 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.419 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 40.1 p90 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.892 HG22 ' HA2' ' A' ' 89' ' ' GLY . 41.2 t -124.28 148.21 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.58 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 85.7 mttt -121.51 144.1 48.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 109.359 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 57' ' ' ILE . 90.9 m-70 -122.9 138.48 54.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HG3' HD13 ' A' ' 54' ' ' ILE . 40.0 tttt -117.61 141.85 47.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 44.0 mt -103.03 131.5 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.583 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 97.1 m-70 -92.62 -41.98 9.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.579 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -171.31 146.21 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.4 143.49 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.05 90.92 3.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 96.7 mttt -60.86 -35.33 76.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.79 -41.92 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 80' ' ' HIS . 32.4 m120 -87.86 10.16 19.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 79' ' ' ASN . 65.8 m80 44.42 42.79 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.471 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 m -123.31 132.84 54.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.498 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 70.2 t80 -120.18 124.18 45.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.8 t -118.16 128.84 55.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 30.8 p90 -155.87 171.19 20.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.855 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.7 p -142.45 162.64 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 99' ' ' ILE . 5.0 tt -98.86 129.37 45.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.855 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.9 mm -88.17 -74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.762 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.5 mt-10 -115.24 159.17 21.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.892 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -178.29 159.54 25.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -60.66 -46.6 89.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -1.106 . . . . 0.0 109.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.57 -23.64 67.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.9 mp -82.71 -44.11 16.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 13.9 t 60.18 163.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.317 -0.864 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.68 -11.2 53.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASN . 3.4 m-20 -72.38 -40.26 67.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.613 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 123' ' ' THR . 41.8 pt -151.71 131.34 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 30.5 mt-10 -146.34 106.45 4.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.921 . . . . 0.0 108.967 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 39.5 tptt -179.63 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.872 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.893 HD12 HD13 ' A' ' 86' ' ' LEU . 4.3 mt -124.59 118.16 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.917 -1.114 . . . . 0.0 110.005 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -94.86 121.58 36.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 108.901 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 99' ' ' ILE . 64.9 m-85 -114.14 136.73 52.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.956 . . . . 0.0 109.932 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.1 mt-10 -130.24 126.27 36.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 108.983 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.829 HG21 ' CE2' ' A' ' 23' ' ' PHE . 29.8 m -123.29 131.62 53.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -138.39 122.64 18.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.195 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -94.26 130.81 40.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 78.3 t -131.52 135.53 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.0 p -106.81 142.62 36.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.87 169.36 6.39 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.1 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.717 2.278 . . . . 0.0 111.77 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.23 -15.37 61.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.36 53.06 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.11 168.24 32.34 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.5 m -119.61 126.55 51.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 109.525 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 11' ' ' THR . 65.9 mt -95.73 136.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.747 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.1 mt -119.27 119.93 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 9' ' ' GLU . 10.7 mtpt -105.13 121.17 43.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.11 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 80.1 m -126.73 134.07 50.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 0.0 109.934 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 61.9 m -116.68 138.48 51.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.107 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -131.57 141.58 49.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HE2' ' NE2' ' A' ' 122' ' ' HIS . 22.5 tttt -136.32 149.82 48.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.18 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.977 ' O ' HG21 ' A' ' 3' ' ' VAL . 94.5 m-85 -127.99 142.7 51.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.06 -1.025 . . . . 0.0 109.766 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 64.3 m80 -134.95 165.15 25.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 96' ' ' ILE . 25.7 p . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.729 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -57.09 -48.77 77.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.424 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.76 -39.51 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.633 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 58.9 t80 -53.96 -41.77 68.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.336 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.4 -41.95 86.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.545 ' HB2' HD13 ' A' ' 34' ' ' ILE . 48.7 mt -57.43 -41.08 79.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.743 HG23 HD21 ' A' ' 30' ' ' LEU . 88.3 mt -54.87 -47.41 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 83.2 mt-10 -54.71 -47.17 74.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.179 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.54 -27.27 71.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.14 -47.26 85.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -1.113 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -110.57 156.68 20.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.362 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 17.8 m -93.56 142.78 26.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.403 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -119.41 135.23 54.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -110.45 133.8 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.272 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.02 131.84 54.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.61 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.64 122.88 47.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.319 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 11' ' ' THR . 82.0 t80 -142.82 146.57 34.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.61 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.568 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.0 p -108.29 142.45 38.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.208 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.418 ' OG ' ' CG ' ' A' ' 149' ' ' GLU . 20.8 t -141.12 159.17 42.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.965 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.45 -175.96 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 66.08 141.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.009 . . . . 0.0 109.146 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.2 Cg_endo -70.01 146.52 58.9 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.444 2.096 . . . . 0.0 112.001 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.21 -50.61 6.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.543 -0.723 . . . . 0.0 111.403 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.09 -50.31 3.03 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.29 1.993 . . . . 0.0 113.076 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 33.3 mttp -59.66 -33.59 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.19 . . . . 0.0 109.515 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.9 tt -80.92 -34.39 33.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.808 ' CE1' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -64.81 -32.13 73.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 20.3 tttm -68.89 -46.29 68.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.74 38.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.737 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.874 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 68.1 t80 -86.42 -17.71 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.808 HG21 ' CE1' ' A' ' 20' ' ' PHE . 66.5 t -115.9 -51.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 27.9 tp -68.46 -40.33 81.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 79.2 m-20 -103.38 18.6 21.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.874 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.97 -35.98 74.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.682 ' OD2' HD11 ' A' ' 44' ' ' ILE . 95.2 m-20 -67.76 -32.07 72.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 20.8 t-20 -99.34 -43.63 6.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 148' ' ' ILE . 15.9 tp -55.7 -42.61 75.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.775 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.8 mt -49.78 -62.32 2.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.516 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.51 -16.98 43.59 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.498 2.132 . . . . 0.0 111.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -67.54 -45.23 76.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 147' ' ' LEU . 75.7 mt -70.23 -35.17 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.705 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.73 71.76 57.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.61 -30.98 17.53 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 111.715 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -75.06 -30.09 60.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.14 97.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.587 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG23 ' A' ' 57' ' ' ILE . 4.0 p -121.13 150.26 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -74.92 -47.47 29.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 178.48 129.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.28 125.65 36.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.49 155.7 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.682 HD11 ' OD2' ' A' ' 28' ' ' ASP . 54.9 mt -106.03 120.65 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -65.81 -44.0 86.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 53' ' ' THR . 92.9 mt-10 -158.81 154.92 26.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.76 -42.48 1.91 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 59.99 40.17 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.354 -1.086 . . . . 0.0 109.558 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.671 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.17 33.76 22.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.36 -168.46 13.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.59 130.0 18.77 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.705 2.27 . . . . 0.0 111.714 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.01 25.88 72.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.851 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.18 143.12 35.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 68.4 mt -112.51 132.05 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -123.49 150.79 43.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -132.34 122.84 25.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.701 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -113.34 140.58 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.622 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.5 m -120.69 128.3 52.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.577 -179.922 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.5 p90 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' CA ' ' A' ' 89' ' ' GLY . 40.9 t -124.85 143.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 49.5 mtmt -113.19 147.59 37.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 91.9 m-70 -122.85 136.84 55.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' THR . 66.0 tttt -117.31 138.21 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.382 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 62.8 mt -99.72 132.98 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -90.5 -45.71 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.3 p -169.91 148.84 3.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.08 144.47 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.0 m-20 -131.05 92.16 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -62.8 -34.8 78.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.402 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.54 -39.86 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 31.3 m120 -87.28 4.7 41.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 48.44 43.88 20.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.4 m -126.58 136.99 53.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 61.3 t80 -131.19 127.47 38.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.8 p -121.45 137.18 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -151.37 169.3 22.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 83.0 p -145.55 160.96 40.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 92' ' ' LEU . 4.1 tt -97.59 119.57 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.374 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.847 HG22 ' HG2' ' A' ' 88' ' ' GLU . 93.5 mt -75.58 -56.7 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HG2' HG22 ' A' ' 87' ' ' ILE . 75.4 mm-40 -148.46 162.04 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -0.99 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.33 150.8 11.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.12 -26.61 66.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -1.131 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.34 -28.73 47.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 86' ' ' LEU . 2.9 mt -75.19 -33.05 61.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 108.755 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m 52.85 -173.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.606 -0.684 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.25 -3.42 49.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.68 -36.24 14.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 92' ' ' LEU . 42.6 mt -92.3 130.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 110.041 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 70.4 mm-40 -88.55 -178.35 5.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.6 mttp -56.12 153.62 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.753 HD13 ' CE2' ' A' ' 121' ' ' TYR . 53.8 mt -118.03 137.68 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 87.4 m-20 -93.17 124.95 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.36 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 83.7 m-85 -117.24 140.67 49.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 117' ' ' THR . 93.6 mt-10 -133.76 136.65 44.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -128.4 137.44 51.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -139.76 128.95 23.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -98.31 130.57 44.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.19 145.93 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.7 p -112.68 143.07 44.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.0 109.478 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.46 164.93 13.83 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.8 Cg_endo -69.39 -18.05 38.96 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.634 2.222 . . . . 0.0 111.771 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.01 -15.51 63.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.862 . . . . 0.0 109.43 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.45 26.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.49 -179.84 50.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 66.4 m -124.75 126.87 46.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.159 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 106' ' ' VAL . 66.1 mt -90.38 137.9 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.337 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.753 HD13 ' HZ ' ' A' ' 145' ' ' PHE . 45.6 mt -119.84 129.11 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -118.8 127.0 53.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 0.0 109.205 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 102' ' ' GLU . 52.5 m -126.44 134.46 50.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.729 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.0 m -116.87 142.73 46.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 109.094 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.486 ' OG ' ' CE1' ' A' ' 101' ' ' TYR . 27.1 t -139.33 148.85 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.041 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.737 ' O ' HG23 ' A' ' 99' ' ' ILE . 82.3 tttt -136.5 130.71 32.93 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.901 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.8 m-85 -108.76 126.65 53.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.073 -1.017 . . . . 0.0 109.924 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 34.3 m170 -98.02 146.88 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.16 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.097 -1.002 . . . . 0.0 109.57 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -56.91 -50.94 71.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.92 -47.27 85.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.753 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 49.4 t80 -53.35 -43.26 67.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -55.11 -43.26 73.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.302 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 34' ' ' ILE . 65.2 mt -56.69 -45.02 82.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 30' ' ' LEU . 93.4 mt -53.8 -52.02 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.298 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.418 ' CG ' ' OG ' ' A' ' 12' ' ' SER . 83.7 tt0 -54.27 -41.82 69.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.233 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -77.57 -23.42 67.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 147' ' ' LEU . 70.1 t80 -63.18 -45.68 90.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.341 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.347 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 48.8 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -123.14 150.52 43.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.617 HG22 ' CG2' ' A' ' 118' ' ' THR . 19.9 m -93.95 138.13 32.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' THR . 77.5 t80 -122.86 134.51 54.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.43 133.77 55.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -121.78 131.66 54.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.8 mt-10 -104.04 118.95 37.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 11' ' ' THR . 62.4 t80 -133.29 132.39 41.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.5 p -93.9 142.96 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 24.4 m -135.3 160.48 38.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.673 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' ILE . 96.5 m-20 -69.26 -175.72 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.739 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mt 61.78 141.72 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.959 . . . . 0.0 109.077 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.0 Cg_endo -69.21 146.23 62.92 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.452 2.102 . . . . 0.0 111.978 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.941 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -41.12 -49.82 8.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.592 -0.692 . . . . 0.0 111.365 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -63.93 -49.32 4.09 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.252 1.968 . . . . 0.0 113.027 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.557 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 96.6 mttt -62.09 -35.48 78.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.523 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' PHE . 20.4 tp -80.57 -27.98 37.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.892 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 64.1 t80 -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -60.4 -43.89 96.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.4 -20.56 40.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.988 ' C ' ' HB2' ' A' ' 27' ' ' ALA . 71.0 t80 -99.09 6.64 46.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.892 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -135.0 -78.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.144 -0.973 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.02 -49.22 74.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 80.0 m-20 -99.07 12.14 36.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' C ' ' A' ' 23' ' ' PHE . . . -69.53 -36.4 76.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 31' ' ' ILE . 52.6 t0 -73.18 -29.87 63.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 87.1 m-20 -91.06 -29.01 17.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.481 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.98 ' O ' HD13 ' A' ' 30' ' ' LEU . 1.8 tm? -73.52 -34.15 65.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.877 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 19.7 mt -51.32 -55.8 25.75 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.605 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.56 -17.89 43.16 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.499 2.132 . . . . 0.0 111.856 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.64 ' HD2' HD22 ' A' ' 30' ' ' LEU . 42.5 mttt -71.09 -40.45 71.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 109.521 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.504 ' CG2' HD13 ' A' ' 147' ' ' LEU . 87.9 mt -68.13 -34.63 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.74 70.39 19.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -70.18 -34.58 12.91 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.656 2.237 . . . . 0.0 111.727 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.75 -19.9 65.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.25 -26.56 21.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 1.9 t -118.01 139.79 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.1 -51.08 23.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.48 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.39 117.67 29.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.22 147.76 45.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.317 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 74.3 mt -106.36 118.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -60.58 -45.19 94.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 53' ' ' THR . 94.7 mt-10 -159.32 157.87 31.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 108.35 -43.03 1.79 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.9 m-20 59.76 38.33 21.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.09 33.01 21.92 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.436 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.78 -168.2 14.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.03 130.75 19.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.692 2.261 . . . . 0.0 111.668 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 71.51 26.73 72.59 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.2 m -80.37 140.3 36.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 64.2 mt -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 2.9 mtpt -119.22 149.17 42.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -131.87 124.43 29.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.641 HD12 ' CE1' ' A' ' 70' ' ' HIS . 20.5 mt -119.96 131.38 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -111.99 121.66 45.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.341 -0.849 . . . . 0.0 109.109 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.484 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 35.4 p90 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.326 0.584 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.812 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.6 m -134.47 150.31 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 109.089 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.644 ' O ' HD12 ' A' ' 86' ' ' LEU . 37.6 mttt -106.45 139.91 40.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.774 ' NE2' HD13 ' A' ' 86' ' ' LEU . 70.3 m80 -114.42 143.82 44.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 109.17 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 17.8 tttp -127.35 138.95 53.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.709 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 59.1 mt -98.69 131.15 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.17 -49.16 6.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m -163.34 152.12 14.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.8 pt -129.21 145.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 69.0 m-20 -122.15 107.09 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.924 . . . . 0.0 109.289 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -82.7 -25.77 32.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 108.553 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -46.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 65.5 m-80 -80.56 -5.37 56.67 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.492 -0.755 . . . . 0.0 109.651 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 m80 60.16 42.74 15.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.497 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 63.5 m -124.36 135.04 53.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 65.9 t80 -124.63 129.5 50.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -122.14 135.28 54.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.649 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.625 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.9 p90 -151.48 168.09 25.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.307 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 95.3 p -149.59 152.16 35.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 70' ' ' HIS . 37.7 tp -91.96 117.42 29.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.292 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.831 HG22 ' HG3' ' A' ' 88' ' ' GLU . 24.1 mm -70.4 -71.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.735 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.831 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -128.06 169.35 14.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.0 109.803 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.812 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . 176.72 137.36 2.63 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -47.55 -40.5 19.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -1.167 . . . . 0.0 109.694 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.23 -15.52 62.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.0 mp -87.89 -43.79 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 m 61.93 178.43 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.408 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.17 -2.05 39.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.632 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 16.5 p-10 -91.75 -21.58 20.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 51.5 mt -111.3 141.36 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -0.931 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -95.6 179.84 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 3.8 pttm -57.52 164.61 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 120' ' ' LYS . 68.2 mt -120.72 134.23 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 61.9 t0 -89.7 122.7 33.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 77.9 m-85 -115.51 139.8 49.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.275 -0.891 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 94.1 mt-10 -131.04 136.85 48.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.928 HG21 ' CE2' ' A' ' 23' ' ' PHE . 53.6 m -132.07 133.17 44.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 22.7 tttt -131.61 133.36 44.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 109.477 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 16' ' ' ALA . 1.2 mp -103.84 125.1 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 40.1 t -131.76 140.43 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.7 p -110.57 141.32 43.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -0.933 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -109.75 164.74 14.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.556 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.6 Cg_endo -69.96 -7.12 20.33 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.752 2.301 . . . . 0.0 111.791 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -78.82 -18.5 53.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.91 -29.45 7.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.87 174.53 55.09 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 106' ' ' VAL . 86.9 m -122.14 125.57 46.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 109.539 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.1 mt -90.22 138.34 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.604 HG23 HD12 ' A' ' 105' ' ' LEU . 44.0 mt -125.87 127.8 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.794 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 53.5 mttp -105.05 128.71 53.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -125.88 129.85 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 110.007 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.617 ' CG2' HG22 ' A' ' 5' ' ' THR . 33.1 m -118.49 133.87 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 108.923 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.8 m -123.8 142.46 51.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.09 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 99' ' ' ILE . 75.9 tttt -139.38 129.44 25.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' A' ' 99' ' ' ILE . 25.2 m-85 -111.65 131.57 55.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 109.884 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 71.4 m80 -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.42 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 22.0 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.52 -41.58 98.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 144' ' ' LEU . 35.3 mt -61.71 -45.98 91.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -53.28 -42.96 67.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -62.47 -39.67 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.504 HD13 ' CG2' ' A' ' 34' ' ' ILE . 60.5 mt -66.72 -40.73 88.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.401 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.41 HD13 ' HD1' ' A' ' 23' ' ' PHE . 82.2 mt -56.01 -45.73 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 96.6 mt-10 -60.66 -46.64 89.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.76 -39.87 96.96 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -53.4 -55.38 25.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -1.088 . . . . 0.0 109.462 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.739 HD12 HD13 ' A' ' 14' ' ' ILE . 66.1 mt . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.991 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.6 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.37 156.66 22.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 109.381 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 57.3 m -93.42 143.51 26.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.29 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -109.63 141.97 41.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.278 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -127.83 129.66 47.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 91.2 mt-10 -101.76 124.78 47.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 11' ' ' THR . 46.9 t80 -136.25 127.03 27.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 15.1 p -90.42 154.73 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.563 ' OG ' HD11 ' A' ' 115' ' ' ILE . 88.9 p -149.32 167.9 24.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 87.3 m-20 -77.2 -175.25 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.981 HD12 ' OE1' ' A' ' 149' ' ' GLU . 6.4 mt 63.4 142.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.3 Cg_endo -70.34 147.25 58.75 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.533 2.155 . . . . 0.0 112.106 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.14 -50.4 8.14 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 111.429 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.08 -50.27 3.08 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.303 2.002 . . . . 0.0 113.031 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 60.4 mttt -61.93 -37.02 83.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 149' ' ' GLU . 27.6 tp -81.3 -24.95 36.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.116 -0.99 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' HD1' HD23 ' A' ' 105' ' ' LEU . 66.1 t80 -72.96 -34.56 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 109.859 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 17.5 mttp -67.25 -45.78 75.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.765 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.12 42.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.624 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 59.4 t80 -76.53 -15.69 59.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 44.2 t -119.68 -53.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 46.0 mt -67.85 -40.45 83.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 80.3 m-20 -100.52 11.11 40.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.18 -31.66 69.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.628 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -68.64 -21.83 64.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 27.8 m120 -114.23 -37.81 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.075 -1.016 . . . . 0.0 109.485 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.656 HD11 ' CG ' ' A' ' 151' ' ' TYR . 30.1 tp -58.2 -36.94 73.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 27' ' ' ALA . 11.5 mt -55.78 -60.5 8.47 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.188 -0.945 . . . . 0.0 109.195 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.45 -11.35 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.558 2.172 . . . . 0.0 111.583 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 18.7 mttt -80.84 -35.63 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 109.607 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 147' ' ' LEU . 87.6 mt -73.54 -31.18 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 68.49 54.4 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.4 Cg_endo -70.15 -31.42 18.83 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.7 2.266 . . . . 0.0 111.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.33 -29.29 63.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.02 60.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 ' CG2' ' A' ' 57' ' ' ILE . 5.6 p -128.72 149.23 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.389 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -71.89 -51.69 20.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.608 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.1 144.24 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.67 120.32 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -113.19 156.18 23.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.646 HG21 ' N ' ' A' ' 48' ' ' ASP . 22.1 mm -106.83 133.89 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.5 tp -78.98 -37.91 38.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.813 ' O ' HG23 ' A' ' 53' ' ' THR . 57.8 mm-40 -159.06 133.6 7.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 104.22 -34.74 5.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 44' ' ' ILE . 5.3 m-20 51.49 56.98 7.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -1.109 . . . . 0.0 109.794 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.918 ' H ' HG21 ' A' ' 53' ' ' THR . . . 80.09 36.08 25.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.73 -168.78 14.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.14 133.43 26.69 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.595 2.197 . . . . 0.0 111.47 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.16 20.96 58.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.918 HG21 ' H ' ' A' ' 49' ' ' GLY . 49.5 m -73.38 146.83 44.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 0.0 109.741 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 23.8 mm -106.39 135.8 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' CE ' HD11 ' A' ' 72' ' ' ILE . 45.5 mttt -115.95 143.26 45.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 63.0 tttm -129.68 129.86 44.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 39' ' ' VAL . 44.0 mt -125.59 130.53 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.887 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -112.17 128.1 56.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.132 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HE2' HG23 ' A' ' 68' ' ' VAL . 75.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 45.8 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.343 0.592 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.86 HG22 ' HA2' ' A' ' 89' ' ' GLY . 61.4 t -118.44 141.77 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.267 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 50.3 mttt -116.56 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.47 ' CD2' ' HG ' ' A' ' 86' ' ' LEU . 75.7 m80 -120.97 144.84 48.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.753 ' HB2' HD11 ' A' ' 87' ' ' ILE . 45.3 tttt -121.36 140.88 51.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.559 HD11 ' CE ' ' A' ' 55' ' ' LYS . 66.0 mt -99.22 134.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.436 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.8 m-70 -88.93 -48.47 7.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.0 p -169.84 150.95 4.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' CE1' ' A' ' 82' ' ' TYR . 21.1 pt -129.08 144.78 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -129.42 92.68 3.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.511 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 95.2 mttt -64.28 -36.29 83.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.73 -42.75 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -87.66 6.68 33.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.0 m80 47.88 44.6 18.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.6 m -124.38 138.5 54.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.38 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 52.6 t80 -134.26 132.46 39.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 m -126.28 140.47 52.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.5 p90 -153.01 171.6 18.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.3 p -149.53 152.67 35.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 92' ' ' LEU . 4.6 tt -87.97 127.59 35.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.817 ' N ' HD23 ' A' ' 86' ' ' LEU . 82.9 mt -86.35 -72.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.441 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.779 ' O ' HG13 ' A' ' 68' ' ' VAL . 95.3 mt-10 -122.74 160.58 25.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -177.91 153.73 13.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -61.83 -25.48 67.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -1.13 . . . . 0.0 109.556 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.69 -30.41 46.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.975 HD11 HD22 ' A' ' 86' ' ' LEU . 3.9 mt -71.71 -31.85 67.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 108.853 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m 50.21 -172.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.626 -0.671 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.26 15.04 9.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.427 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -116.39 -17.87 10.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 91' ' ' ALA . 23.5 mt -109.34 141.47 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 94.0 mt-10 -90.7 -179.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.664 ' HE2' HG23 ' A' ' 87' ' ' ILE . 31.6 mttp -57.62 176.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.687 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 120' ' ' LYS . 59.0 mt -133.18 133.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.414 -0.804 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' SER . 80.5 m-20 -87.28 121.4 29.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 67.0 m-85 -114.39 144.1 43.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 117' ' ' THR . 89.1 mt-10 -132.81 139.24 47.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 23' ' ' PHE . 32.7 m -135.41 128.45 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -134.88 124.66 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.7 mm? -93.7 129.12 40.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 57.5 t -131.99 141.53 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.49 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.5 p -108.43 146.53 32.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.04 164.79 14.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.8 Cg_endo -70.01 -17.61 36.35 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.673 2.249 . . . . 0.0 111.848 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.76 -15.34 61.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -15.45 35.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.22 170.03 46.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.1 m -119.96 126.13 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 67.0 mt -93.16 139.56 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.563 HD11 ' OG ' ' A' ' 12' ' ' SER . 56.2 mt -127.1 121.89 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.728 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 58.0 mttp -106.82 132.37 52.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.046 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 102' ' ' GLU . 74.0 m -131.74 129.79 41.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 30.2 m -113.15 148.63 34.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 0.0 108.922 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 55.3 m -140.23 148.44 41.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.827 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.3 tttt -138.35 127.25 23.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.162 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.991 ' O ' HG21 ' A' ' 3' ' ' VAL . 40.3 m-85 -105.49 121.98 45.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 78.8 m80 -101.74 141.33 34.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 28.8 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -58.94 -43.94 91.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 47.6 mt -56.94 -49.07 76.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 148' ' ' ILE . 65.7 m-85 -53.13 -43.92 67.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -58.97 -41.05 86.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 151' ' ' TYR . 52.4 mt -64.22 -40.05 95.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.897 . . . . 0.0 109.364 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 145' ' ' PHE . 63.8 mt -55.51 -53.18 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.157 -0.965 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.981 ' OE1' HD12 ' A' ' 14' ' ' ILE . 73.1 mm-40 -54.38 -40.21 67.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.176 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.79 -26.03 59.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.656 ' CG ' HD11 ' A' ' 30' ' ' LEU . 60.0 t80 -60.82 -45.99 92.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -1.126 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.3 -0.875 . . . . 0.0 109.398 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 122' ' ' HIS . 80.9 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.21 140.9 48.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.269 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.5 m -105.25 131.73 52.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -0.946 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.47 138.82 54.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.378 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.61 136.15 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -117.39 135.58 53.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.41 124.25 51.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 80.6 t80 -146.17 141.7 27.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.528 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.2 p -107.93 151.29 25.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 21.7 t -151.38 154.38 36.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.629 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 10.8 t0 -66.31 -175.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 mm 72.44 141.67 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 109.356 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.55 146.24 60.89 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.481 2.12 . . . . 0.0 112.027 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -42.96 -49.33 14.22 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 111.595 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.5 -50.33 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.145 1.897 . . . . 0.0 113.169 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.56 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 67.6 mttt -61.46 -30.35 70.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 109.583 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 148' ' ' ILE . 22.6 tp -80.61 -33.71 35.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.685 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.72 ' HD1' HD23 ' A' ' 105' ' ' LEU . 83.0 t80 -61.7 -41.39 97.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.884 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.5 mttt -65.22 -55.14 20.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.47 -11.0 60.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.761 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.909 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.8 t80 -87.61 -33.43 18.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.1 m -115.75 -40.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.826 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' N ' HG23 ' A' ' 24' ' ' VAL . 20.7 tp -71.39 -34.33 70.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.016 . . . . 0.0 109.435 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 76.7 m-20 -108.04 11.46 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.83 -40.19 76.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -57.5 -32.82 67.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.2 m120 -102.27 -36.36 8.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 148' ' ' ILE . 42.6 tp -72.75 -34.52 67.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.584 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 27' ' ' ALA . 27.3 mt -53.69 -55.61 33.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -68.9 -17.54 41.49 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -72.52 -39.3 67.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.717 HD12 HD11 ' A' ' 144' ' ' LEU . 87.1 mt -72.25 -32.63 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.88 72.53 16.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -69.96 -31.97 18.61 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.69 2.26 . . . . 0.0 111.799 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.17 -26.26 62.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.33 -48.27 76.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.4 m -128.39 157.53 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -73.53 -42.69 61.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.61 135.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -0.87 . . . . 0.0 109.463 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.54 119.0 27.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.27 147.98 40.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.2 mt -106.08 121.12 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.4 tp -65.55 -43.71 89.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' THR . 93.5 mt-10 -159.22 155.81 27.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.33 -40.93 2.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.0 m-20 60.7 40.05 16.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.222 -1.164 . . . . 0.0 109.58 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.24 35.21 15.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.86 -166.56 13.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.73 129.64 17.98 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.758 2.305 . . . . 0.0 111.69 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.96 77.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.0 m -80.02 143.82 33.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -1.129 . . . . 0.0 109.58 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.94 127.98 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' CE ' HD11 ' A' ' 72' ' ' ILE . 56.9 mttt -112.44 152.76 28.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 19.1 tttt -134.62 126.61 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 70' ' ' HIS . 53.1 mt -116.26 139.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -115.86 129.0 56.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.437 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 68' ' ' VAL . 82.9 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.544 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 41.1 p90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.351 0.596 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.009 ' CG1' HD11 ' A' ' 86' ' ' LEU . 59.2 t -119.43 144.71 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.274 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.9 mttm -121.44 138.29 54.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.562 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.78 ' CE1' HD13 ' A' ' 86' ' ' LEU . 93.5 m-70 -112.12 135.76 52.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.2 139.1 49.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 47.3 mt -104.62 132.03 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -89.13 -47.69 7.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -169.79 153.79 5.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.87 144.1 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -124.91 92.83 3.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -63.13 -35.25 79.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.92 -40.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -87.93 4.63 44.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 m80 47.74 38.36 8.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.482 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -120.74 138.14 54.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 78.0 t80 -125.7 127.77 46.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -118.97 134.01 55.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.676 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 28.2 p90 -157.47 170.07 23.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.205 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 92.9 p -149.0 156.8 42.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 0.0 109.9 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.009 HD11 ' CG1' ' A' ' 68' ' ' VAL . 36.4 tp -91.25 110.86 22.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.201 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 88' ' ' GLU . 4.3 tt -74.93 -47.16 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 68' ' ' VAL . 97.5 mt-10 -142.3 167.16 22.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.891 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.919 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . 172.96 146.55 5.47 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.94 -27.55 65.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.61 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.86 51.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.883 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.3 mt -76.31 -33.18 59.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 108.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.4 m 55.12 -179.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.628 -0.67 . . . . 0.0 109.292 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.62 5.29 21.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -97.88 -28.04 14.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 58.8 mt -104.87 137.87 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.4 mm-40 -83.87 -179.47 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 22.7 pttm -57.26 164.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' LYS . 47.7 mt -124.62 133.94 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 82.9 m-20 -90.42 126.18 35.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.875 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 93.4 m-85 -121.09 134.87 55.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.204 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -128.21 138.06 52.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.639 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.654 HG21 ' CE2' ' A' ' 23' ' ' PHE . 61.3 m -128.9 134.43 48.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.535 ' C ' HD22 ' A' ' 105' ' ' LEU . 46.5 tttt -132.61 133.08 43.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -102.83 123.46 46.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 48.2 t -129.02 141.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.3 OUTLIER -113.71 146.49 39.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.565 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.63 174.07 2.56 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.507 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.9 Cg_endo -69.3 -16.58 39.58 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.734 2.289 . . . . 0.0 111.807 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.35 -20.61 63.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.265 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.43 -22.07 25.18 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.26 176.53 54.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.501 HG21 ' HA ' ' A' ' 16' ' ' ALA . 80.1 m -125.21 126.01 44.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -1.158 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.5 mt -91.05 140.64 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 109.172 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 105' ' ' LEU . 55.3 mt -123.94 120.71 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -109.88 132.13 54.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.9 m -127.21 128.74 46.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 143.02 49.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 89.8 p -144.69 147.24 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 110.399 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 99' ' ' ILE . 51.6 mttp -122.03 144.11 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.751 ' O ' HG22 ' A' ' 3' ' ' VAL . 98.1 m-85 -112.11 124.32 52.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 110.065 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.801 ' HA ' HG22 ' A' ' 3' ' ' VAL . 90.8 m-70 -99.91 129.25 45.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.131 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 109.685 -179.703 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.28 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.42 -46.71 83.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.45 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 78.7 m-85 -53.89 -38.42 64.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.54 -43.43 79.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -66.11 -42.44 89.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 30' ' ' LEU . 85.9 mt -60.95 -38.55 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 13' ' ' ASP . 65.8 tt0 -64.52 -37.3 87.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.26 -41.46 31.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 21.3 m-85 -65.18 -42.54 93.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 14' ' ' ILE . 60.8 mt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 122' ' ' HIS . 72.6 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.26 0.552 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.44 141.02 47.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.483 HG22 ' CG2' ' A' ' 118' ' ' THR . 23.6 m -93.44 143.78 25.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -124.7 138.99 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.727 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -115.27 131.81 56.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -119.8 133.3 55.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -105.54 125.41 50.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -136.41 133.3 36.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.4 p -100.9 143.32 31.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.254 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 43.7 p -141.11 171.63 13.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.653 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ILE . 67.0 m-20 -76.03 -175.99 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 18' ' ' LYS . 6.6 mm 62.85 138.36 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 49.5 Cg_endo -70.15 150.16 65.46 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.592 2.194 . . . . 0.0 112.059 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.64 -52.25 6.4 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 111.129 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 43.0 Cg_endo -64.89 -49.13 3.15 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.276 1.984 . . . . 0.0 112.907 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 14' ' ' ILE . 13.4 ttmt -57.98 -38.03 75.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.93 -1.106 . . . . 0.0 109.572 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.971 HD11 HG22 ' A' ' 148' ' ' ILE . 20.8 tp -75.28 -39.09 60.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB2' HD12 ' A' ' 105' ' ' LEU . 71.2 t80 -55.45 -47.14 76.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.0 tttt -46.63 -44.15 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.937 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -107.47 14.98 25.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.175 -0.953 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.809 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 92.4 t80 -96.22 -33.0 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 ' HD2' ' A' ' 23' ' ' PHE . 31.3 m -126.09 -39.88 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.811 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 25' ' ' LEU . 15.5 tp -57.32 -66.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.738 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 34.6 p30 -92.27 13.41 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.484 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.78 -35.0 76.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.7 m-20 -59.23 -41.52 88.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -96.62 -29.22 13.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.634 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -72.98 -38.9 66.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 27' ' ' ALA . 32.2 mt -52.25 -55.46 31.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.65 -17.5 42.82 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.41 2.073 . . . . 0.0 111.753 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 28.5 mttm -73.36 -37.06 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' HD13 ' A' ' 147' ' ' LEU . 88.6 mt -71.28 -27.76 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.15 69.23 16.04 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.84 -29.71 23.07 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.58 2.187 . . . . 0.0 111.683 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -71.96 -28.1 63.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -49.28 44.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 57' ' ' ILE . 3.0 p -119.55 150.98 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.68 -51.78 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.72 136.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.81 129.27 38.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.88 148.95 42.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.4 mt -106.25 119.16 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 24.2 tp -64.32 -44.69 90.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.9 mt-10 -159.47 155.35 26.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.72 -39.75 2.69 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.9 m-20 61.74 41.05 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.821 ' H ' HG21 ' A' ' 53' ' ' THR . . . 82.59 36.75 15.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.83 -165.4 12.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.56 130.55 19.78 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.726 2.284 . . . . 0.0 111.797 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 25.28 75.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 99.0 m -80.7 145.91 31.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 53' ' ' THR . 26.2 mm -115.47 132.29 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 mtmp? -128.98 148.39 50.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.03 125.31 44.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.283 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.726 HD11 ' CD2' ' A' ' 70' ' ' HIS . 11.3 mt -115.41 134.91 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.671 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 39' ' ' VAL . 19.5 p -115.55 142.15 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.95 . . . . 0.0 109.591 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.948 HG22 ' CA ' ' A' ' 89' ' ' GLY . 38.2 t -124.98 145.39 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -113.73 142.86 45.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.726 ' CD2' HD11 ' A' ' 57' ' ' ILE . 4.3 m-70 -116.73 133.42 56.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -115.16 137.67 51.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.5 mt -101.89 134.65 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.6 m-70 -91.17 -46.85 7.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 t -173.53 147.66 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.51 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 82' ' ' TYR . 29.0 pt -123.57 144.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 91.6 m-20 -121.58 91.9 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.416 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -63.31 -36.89 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.55 -41.82 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 1.18 56.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.2 m80 54.32 42.34 31.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.994 . . . . 0.0 109.406 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 40.2 m -118.17 142.51 47.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.535 ' CD1' HG22 ' A' ' 75' ' ' ILE . 65.2 t80 -134.73 123.76 24.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.5 m -117.55 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 31.4 p90 -150.87 172.94 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -149.41 155.46 40.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 92' ' ' LEU . 3.0 tt -97.17 118.74 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.966 HG22 ' HG3' ' A' ' 88' ' ' GLU . 87.6 mt -75.46 -56.88 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.627 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.966 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.6 mt-10 -149.09 160.43 43.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.948 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -165.46 152.8 22.44 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -58.17 -24.22 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -1.101 . . . . 0.0 109.324 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.48 -27.43 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 96' ' ' ILE . 2.0 mt -76.63 -32.81 58.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.839 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 92' ' ' LEU . 30.2 t 47.77 -174.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' N ' ' OG ' ' A' ' 93' ' ' SER . 97.5 mt-10 -76.37 -6.49 51.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -0.994 . . . . 0.0 109.461 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -83.1 -38.91 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.85 . . . . 0.0 109.83 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 92' ' ' LEU . 34.6 mt -91.7 135.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.817 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . 38.3 mt-10 -90.14 -179.26 5.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.872 ' HE2' HG23 ' A' ' 87' ' ' ILE . 70.1 mttt -57.04 158.5 4.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.563 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 120' ' ' LYS . 60.4 mt -125.21 131.39 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' LYS . 88.2 m-20 -88.65 124.0 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 75.6 m-85 -115.51 142.24 46.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.671 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -131.93 134.81 46.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.349 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.489 HG21 ' CE2' ' A' ' 23' ' ' PHE . 50.3 m -128.64 138.53 52.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -140.71 127.56 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.274 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 20' ' ' PHE . 37.9 mt -96.49 128.56 43.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.691 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 113' ' ' THR . 46.8 t -132.0 140.86 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.56 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 98.5 p -113.72 144.41 42.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.67 166.21 11.2 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 109.525 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.693 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.0 Cg_endo -70.32 -11.48 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.706 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -76.41 -16.81 59.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.33 -24.4 18.2 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.16 54.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 92.1 m -123.65 122.15 37.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -1.185 . . . . 0.0 109.707 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.0 mt -87.72 144.31 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.061 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.462 HG23 HD23 ' A' ' 105' ' ' LEU . 56.8 mt -131.14 117.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.871 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -97.81 131.98 43.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 108.943 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.8 m -128.91 121.59 28.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 110.007 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.3 m -114.67 141.09 48.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 108.85 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -138.58 156.71 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 110.329 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 99' ' ' ILE . 71.1 tttt -147.57 142.64 27.07 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CB ' HG12 ' A' ' 99' ' ' ILE . 26.6 p90 -135.99 148.55 48.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 109.916 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 97' ' ' GLU . 93.9 m-70 -104.48 172.71 6.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 109.517 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.175 -0.953 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -71.46 -37.62 71.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.448 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 144' ' ' LEU . 49.5 mt -67.59 -44.31 78.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.845 . . . . 0.0 109.363 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 27.3 m-85 -54.38 -44.91 72.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 23.3 mttm -57.48 -36.3 71.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.455 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD13 ' CG2' ' A' ' 34' ' ' ILE . 57.7 mt -66.02 -38.85 89.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.971 HG22 HD11 ' A' ' 19' ' ' LEU . 34.4 mm -56.42 -56.5 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 19.5 mp0 -56.53 -36.52 69.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 109.36 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.77 -27.66 62.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.498 ' CE1' HD21 ' A' ' 30' ' ' LEU . 72.8 t80 -63.7 -41.72 98.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -1.068 . . . . 0.0 109.411 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 121' ' ' TYR . 78.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.5 136.36 52.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 48.3 m -95.51 136.74 35.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 118' ' ' THR . 98.4 m-85 -119.49 134.78 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.57 137.29 47.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.443 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 37.1 t-20 -113.54 149.88 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -133.4 134.12 43.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.562 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 11' ' ' THR . 64.6 t80 -161.79 131.71 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.502 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.567 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 15.1 p -98.25 157.39 16.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -157.52 177.01 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.569 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.4 t0 -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.851 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 64.06 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 109.379 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -70.41 147.46 58.7 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.628 2.219 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.21 -51.55 3.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 111.129 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 40.9 Cg_endo -63.63 -50.62 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.339 2.026 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 41.5 mttm -58.6 -37.53 76.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 109.59 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 152' ' ' LEU . 30.5 tp -80.79 -30.03 36.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.771 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -65.2 -32.86 74.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 109.77 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.7 mtpm? -64.16 -50.12 69.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.609 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -79.46 -16.47 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 103' ' ' THR . 49.8 t80 -86.1 -13.44 47.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.783 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 86.4 t -123.8 -58.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp -65.5 -39.92 92.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 42.3 m-20 -98.09 12.56 34.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -40.75 76.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 44' ' ' ILE . 88.6 m-20 -63.33 -35.23 79.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 29.2 t-20 -93.72 -33.91 13.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 31.9 tp -72.86 -44.97 60.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 27' ' ' ALA . 26.0 mt -45.59 -55.91 11.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -69.18 -26.36 30.38 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 111.801 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 31.2 tttm -71.57 -38.94 70.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.655 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 30' ' ' LEU . 63.8 mt -64.26 -24.27 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.578 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -159.08 73.2 3.51 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 50.2 Cg_endo -70.16 -30.61 20.17 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.664 2.243 . . . . 0.0 111.875 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -74.1 -21.13 60.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -73.04 -42.02 63.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.9 m -126.36 152.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.53 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.84 -43.43 62.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.57 129.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.54 125.13 31.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.37 150.91 40.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.4 mt -106.59 118.27 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.9 tp -62.61 -44.9 95.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.517 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.87 155.48 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.78 -41.14 2.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.2 m-20 60.11 37.74 20.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.156 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.739 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.03 34.92 9.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.98 -167.17 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.89 129.22 17.09 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.679 2.253 . . . . 0.0 111.77 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.5 22.44 78.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -77.03 144.47 38.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.54 HG23 ' CD1' ' A' ' 87' ' ' ILE . 65.9 mt -115.39 127.44 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 87.0 mttt -115.92 150.86 36.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 ttpp -132.91 122.44 24.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 39' ' ' VAL . 31.7 mt -113.3 135.06 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.2 m -118.14 131.83 56.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CE2' HG12 ' A' ' 39' ' ' VAL . 13.5 m-85 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 39.0 p90 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.281 0.563 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG11 HD11 ' A' ' 86' ' ' LEU . 25.5 t -131.26 155.15 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.56 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 45.1 mtmt -124.27 154.3 40.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 6.2 m-70 -123.31 150.14 43.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HB2' HG13 ' A' ' 87' ' ' ILE . 57.9 tttt -132.86 138.15 46.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 31.1 mt -104.32 124.04 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 98.4 m-70 -89.0 -27.39 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 59.7 p 178.9 153.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -136.0 142.53 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.4 m-20 -123.51 94.58 4.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.51 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.26 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 -42.91 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.315 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -87.96 8.14 27.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 48.2 m80 46.28 48.97 13.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.348 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 31.0 m -126.27 136.1 52.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 68.8 t80 -129.98 123.79 31.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -124.52 135.77 53.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.761 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.9 p90 -147.96 -177.14 5.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 88.8 p -151.41 150.83 30.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 87' ' ' ILE . 3.1 tt -87.5 119.52 27.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' A' ' 88' ' ' GLU . 97.4 mt -76.09 -63.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 87' ' ' ILE . 73.6 mm-40 -138.65 154.38 48.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.725 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.544 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -173.15 142.88 6.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.09 -32.56 47.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 109.645 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -20.17 61.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 86' ' ' LEU . 9.7 mp -85.18 -36.02 21.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 40.5 t 61.79 173.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.73 -7.11 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -84.82 -39.71 18.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.631 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 29.8 mt -87.52 143.8 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 92.8 mt-10 -91.37 -179.33 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 46.9 mtmt -56.86 160.86 3.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.96 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 120' ' ' LYS . 66.4 mt -120.91 136.65 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 119' ' ' SER . 88.9 m-20 -92.78 126.23 37.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 80.4 m-85 -117.81 137.76 52.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 118' ' ' THR . 94.5 mt-10 -125.01 142.08 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 23' ' ' PHE . 25.9 m -129.86 136.09 49.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 109.334 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.528 ' C ' HD22 ' A' ' 105' ' ' LEU . 25.0 tttt -139.26 128.94 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.847 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -106.33 112.5 25.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.491 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 9.4 t -130.57 128.47 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.9 p -114.78 154.22 28.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.957 . . . . 0.0 110.105 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -96.32 161.54 26.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.634 -0.666 . . . . 0.0 109.248 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.7 Cg_endo -68.5 92.21 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.375 2.05 . . . . 0.0 110.368 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 34.6 t60 78.93 17.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -112.19 12.83 26.35 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 82.95 -151.39 28.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 52.9 m -126.42 134.69 50.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.998 -1.295 . . . . 0.0 109.797 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 49.8 mt -107.05 134.47 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.031 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.503 HG23 HD13 ' A' ' 105' ' ' LEU . 28.4 mt -116.57 116.83 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 29.2 mttp -105.89 130.55 53.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.968 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -124.63 130.66 52.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 109.966 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.3 m -126.02 139.23 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.433 -0.792 . . . . 0.0 108.997 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 94.8 p -143.47 152.16 41.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 99' ' ' ILE . 90.1 mttt -125.86 143.35 51.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.108 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CD1' HD13 ' A' ' 99' ' ' ILE . 82.7 m-85 -111.17 123.48 50.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.752 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -95.16 136.79 35.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.241 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.587 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.49 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 86.7 t60 -61.86 -44.66 96.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 147' ' ' LEU . 81.4 mt -53.64 -46.87 70.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -53.42 -32.75 51.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -68.25 -34.55 76.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.955 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -71.82 -38.86 70.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 76.4 mt -60.02 -46.01 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -69.61 -34.09 73.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.64 -42.24 88.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 27.1 m-85 -63.13 -46.17 88.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.851 HD12 HD13 ' A' ' 14' ' ' ILE . 67.8 mt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.941 HG11 ' O ' ' A' ' 121' ' ' TYR . 94.0 t . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.566 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -100.8 146.1 27.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.566 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 24.8 m -93.55 139.47 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.283 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.45 136.23 53.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.577 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -113.69 135.22 54.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.29 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 27.3 t30 -114.88 131.02 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 90.3 mt-10 -113.99 132.91 55.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.164 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.4 t80 -146.5 144.84 29.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.746 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.756 HG22 HG12 ' A' ' 114' ' ' ILE . 20.4 p -109.64 144.71 37.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -152.23 179.38 8.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.7 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 71.9 m-20 -80.62 -175.71 5.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 13' ' ' ASP . 2.6 mt 69.1 135.13 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 51.0 Cg_endo -71.09 148.14 55.84 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 112.012 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -39.41 -51.46 4.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.557 -0.714 . . . . 0.0 111.311 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.28 -50.32 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.338 2.025 . . . . 0.0 113.072 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 30.9 mttt -59.33 -36.16 75.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.94 -1.1 . . . . 0.0 109.505 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 tp -80.78 -27.08 36.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 24' ' ' VAL . 73.8 t80 -68.93 -38.28 79.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.959 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 60.7 tttt -66.01 -45.07 82.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -29.63 44.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.642 ' HD2' HD13 ' A' ' 148' ' ' ILE . 56.7 t80 -80.88 -10.95 59.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 20' ' ' PHE . 97.8 t -121.9 -55.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.5 tp -69.57 -36.7 76.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.7 m-20 -102.99 15.77 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.783 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -70.2 -40.34 74.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.768 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.656 ' OD2' HD11 ' A' ' 44' ' ' ILE . 87.8 m-20 -66.35 -24.74 66.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.067 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.4 m120 -105.69 -43.22 4.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.967 . . . . 0.0 109.629 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 18.3 tp -59.91 -36.06 76.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 27' ' ' ALA . 22.4 mt -54.16 -60.1 8.35 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -67.99 -14.0 39.85 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.614 2.209 . . . . 0.0 111.801 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 75.8 mttt -75.07 -40.7 59.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.2 mt -73.84 -31.28 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.21 67.12 14.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -70.11 -31.81 18.29 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -70.96 -26.02 62.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -70.78 -43.65 68.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.935 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 57' ' ' ILE . 5.6 p -116.36 146.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -73.74 -46.06 48.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 177.47 136.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.68 130.84 44.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.381 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -125.43 151.63 45.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.656 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.6 mt -105.96 123.41 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.478 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -69.22 -43.11 74.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 109.495 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 53' ' ' THR . 93.1 mt-10 -158.99 158.79 33.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.479 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.68 -41.15 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.4 m-20 59.35 39.71 21.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -1.113 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.848 ' H ' HG21 ' A' ' 53' ' ' THR . . . 81.51 34.2 26.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.9 -165.39 12.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.01 127.65 14.69 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.664 2.242 . . . . 0.0 111.691 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.5 24.85 69.36 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 46' ' ' GLU . 60.3 m -81.19 140.96 34.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -1.145 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.14 133.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.594 ' CE ' HD11 ' A' ' 72' ' ' ILE . 46.7 mttt -121.52 148.06 44.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.688 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 85.8 tttt -130.52 124.49 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.241 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 39' ' ' VAL . 22.3 mt -118.41 133.17 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -118.76 123.2 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.866 . . . . 0.0 109.35 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 41.6 p90 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 42.3 p90 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.375 0.607 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 86' ' ' LEU . 43.3 t -121.81 150.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.435 -0.79 . . . . 0.0 109.047 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 34.6 mttt -118.12 140.67 49.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.703 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.478 ' CE1' HD12 ' A' ' 57' ' ' ILE . 80.8 m80 -120.2 131.15 54.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.6 tttp -111.4 141.72 44.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CE ' ' A' ' 55' ' ' LYS . 60.0 mt -100.48 132.18 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.8 m-70 -91.05 -49.25 6.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.535 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.1 t -166.32 147.81 6.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.91 144.78 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -124.34 91.58 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -62.53 -35.31 79.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.49 -40.56 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -88.37 8.74 26.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.8 m80 45.86 44.79 11.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.8 m -125.78 136.59 53.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 72.0 t80 -127.8 127.17 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.459 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -119.45 135.68 54.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 40.5 p90 -151.97 168.77 24.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.467 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -145.52 156.04 43.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.914 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.2 tt -92.57 124.93 36.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.443 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.839 HG22 ' HG3' ' A' ' 88' ' ' GLU . 27.1 mm -79.45 -66.34 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.839 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.7 mt-10 -139.24 160.64 39.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.703 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -176.41 157.54 23.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -61.16 -27.08 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.181 . . . . 0.0 109.559 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -32.06 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.914 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.7 mp -75.23 -48.78 21.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.9 m 61.34 170.6 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -72.56 -5.66 38.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.607 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 92' ' ' LEU . 46.6 mt -98.24 151.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 90.2 mt-10 -94.81 -179.98 5.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 87' ' ' ILE . 32.4 mmtm -57.37 159.57 4.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.489 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 120' ' ' LYS . 54.8 mt -120.72 136.5 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 120' ' ' LYS . 59.7 t0 -98.66 125.1 43.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 88.6 m-85 -116.9 142.74 46.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -133.0 138.42 46.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.7 m -130.52 137.71 49.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 105' ' ' LEU . 22.7 tttt -138.98 131.64 28.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.348 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -103.73 115.72 31.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.562 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 114' ' ' ILE . 4.3 t -131.88 131.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 63.1 p -114.69 154.57 28.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.057 -1.027 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -99.62 162.15 22.13 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.565 -0.71 . . . . 0.0 109.316 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.6 Cg_endo -68.92 95.0 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.369 2.046 . . . . 0.0 110.472 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 11.5 m80 78.28 11.48 1.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -105.58 9.09 44.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 83.45 -146.89 23.9 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 90.6 m -126.73 133.95 50.76 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.118 -1.225 . . . . 0.0 109.659 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.756 HG12 HG22 ' A' ' 11' ' ' THR . 61.2 mt -108.65 130.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.2 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 ' CD1' ' A' ' 105' ' ' LEU . 5.2 mt -109.28 117.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.725 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 42.7 mttp -105.15 129.23 53.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.083 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.4 m -128.15 129.6 46.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 109.868 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 5' ' ' THR . 51.4 m -111.3 139.64 46.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.159 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -128.56 135.95 50.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.881 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 99' ' ' ILE . 35.7 tttm -139.13 139.15 37.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.819 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.941 ' O ' HG11 ' A' ' 3' ' ' VAL . 36.5 p90 -134.08 151.26 51.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.08 -1.012 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.9 m80 -109.06 154.79 21.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.546 -179.934 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 143' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 65.5 m170 -69.5 -35.27 75.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.91 -42.57 73.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 54.7 m-85 -54.26 -46.19 72.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.484 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 84.7 tttt -60.67 -34.56 74.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 143' ' ' HIS . 41.8 mt -65.26 -38.32 89.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 23' ' ' PHE . 83.4 mt -54.19 -56.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 12' ' ' SER . 30.8 mp0 -55.67 -44.05 76.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.1 -26.23 72.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.48 ' OH ' ' HD3' ' A' ' 33' ' ' LYS . 64.0 t80 -70.37 -41.38 73.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -1.103 . . . . 0.0 109.387 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.374 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 122' ' ' HIS . 27.6 t -118.64 133.14 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.17 142.03 39.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 109.341 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.649 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.2 m -93.65 143.14 26.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -124.81 137.5 54.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.57 136.3 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.397 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -124.96 134.19 52.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 86.4 mt-10 -109.93 143.42 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 109.366 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 11' ' ' THR . 72.1 t80 -152.16 139.75 19.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 11.3 p -97.73 131.74 43.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.435 ' HG ' ' HE2' ' A' ' 10' ' ' PHE . 7.6 m -132.79 170.85 14.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -80.6 -175.7 5.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' LYS . 7.7 mm 67.4 139.34 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.337 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -70.2 148.89 63.18 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 111.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.47 -52.37 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 111.38 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.86 -50.37 2.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.397 2.064 . . . . 0.0 113.069 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.4 mttp -60.76 -35.02 75.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.823 -1.173 . . . . 0.0 109.498 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 149' ' ' GLU . 23.5 tp -80.59 -36.08 33.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.577 ' HD1' HD23 ' A' ' 105' ' ' LEU . 80.6 t80 -59.17 -48.31 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.836 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -61.32 -54.28 45.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.25 -4.46 21.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.89 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.3 t80 -94.11 -32.84 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' A' ' 82' ' ' TYR . 4.7 m -117.31 -39.19 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 25' ' ' LEU . 22.9 tp -72.87 -38.5 66.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.515 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -104.09 11.33 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.77 -41.1 75.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 44' ' ' ILE . 84.5 m-20 -57.46 -30.6 65.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 25.6 m120 -101.35 -35.78 9.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.442 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 33' ' ' LYS . 17.5 tp -75.2 -39.65 59.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' A' ' 27' ' ' ALA . 33.1 mt -47.98 -55.01 19.66 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.93 . . . . 0.0 109.56 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.4 Cg_endo -69.26 -19.93 37.85 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.383 2.055 . . . . 0.0 111.721 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.7 mttt -74.19 -36.27 64.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.502 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.6 mt -70.15 -29.99 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.975 . . . . 0.0 109.555 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.79 72.18 12.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.7 Cg_endo -69.67 -43.56 2.66 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.658 2.238 . . . . 0.0 111.694 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.9 -20.62 63.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.9 69.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.926 HG12 ' CE1' ' A' ' 59' ' ' PHE . 17.3 m -128.51 154.83 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -73.94 -45.89 47.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.486 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.62 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.37 128.93 35.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.91 144.2 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.525 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 55.4 mt -106.54 119.38 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.458 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -63.31 -44.45 94.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.73 154.6 24.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.11 -41.87 2.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 91.1 m-20 60.52 38.06 19.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.741 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.58 35.29 9.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.503 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.12 -167.56 13.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.15 129.29 16.93 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.733 2.288 . . . . 0.0 111.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.9 24.88 75.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 46' ' ' GLU . 91.9 m -80.05 144.59 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.473 HG22 HD13 ' A' ' 45' ' ' LEU . 24.5 mm -110.65 128.62 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 81.9 mttt -114.94 150.16 36.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HB2' HD11 ' A' ' 45' ' ' LEU . 43.8 tttm -132.55 123.49 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 70' ' ' HIS . 39.8 mt -114.16 136.69 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.3 m -113.73 130.9 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.926 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.0 m-85 -102.48 131.28 49.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.523 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.91 6.17 47.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -116.04 167.88 10.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -1.2 . . . . 0.0 109.404 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.24 -126.4 8.22 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 65' ' ' TYR . 99.8 p -60.98 174.8 0.58 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -1.148 . . . . 0.0 109.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -71.46 -35.2 70.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' O ' ' OG ' ' A' ' 63' ' ' SER . 41.6 p90 -133.5 170.69 15.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 154.35 143.4 3.67 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 40.9 p90 -160.97 144.04 12.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -1.16 . . . . 0.0 109.749 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.955 HG22 ' CA ' ' A' ' 89' ' ' GLY . 67.7 t -117.27 142.27 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.232 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 88' ' ' GLU . 18.0 mttp -112.03 143.35 43.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.738 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' ILE . 97.0 m-70 -124.45 143.1 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.778 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.0 tttm -125.61 139.55 53.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.672 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.9 mt -96.95 137.98 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.388 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.446 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 87.1 m-70 -90.52 -49.03 6.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -170.02 149.08 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.1 pt -125.81 144.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 83.9 m-20 -127.94 92.4 3.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -63.43 -35.29 79.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.95 -39.38 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.414 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 30.2 m120 -88.42 5.09 43.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m80 47.68 46.52 18.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.1 m -129.06 132.22 47.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 64.8 t80 -124.78 125.7 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -118.54 140.61 49.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 32.5 p90 -154.4 170.27 21.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 82.9 p -148.88 157.94 43.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.0 tt -94.99 132.13 40.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.318 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.959 ' N ' HD23 ' A' ' 86' ' ' LEU . 87.8 mt -89.84 -71.68 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 109.592 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.88 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -127.32 159.27 34.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.955 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -175.37 154.35 17.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 82.6 m-20 -62.22 -35.39 78.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -1.159 . . . . 0.0 109.434 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -73.16 -23.84 60.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.989 ' CD2' HD22 ' A' ' 86' ' ' LEU . 9.1 mp -78.85 -49.49 12.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.04 176.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 97.4 mt-10 -76.0 -10.06 59.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.654 ' O ' HG21 ' A' ' 127' ' ' VAL . 27.6 m120 -83.15 -34.25 26.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 92' ' ' LEU . 36.5 mt -96.23 132.72 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 93.4 mt-10 -87.1 -179.16 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.744 ' HE2' HG23 ' A' ' 87' ' ' ILE . 89.9 mttt -56.71 165.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.447 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.776 HG23 ' O ' ' A' ' 120' ' ' LYS . 63.7 mt -125.78 131.79 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.878 . . . . 0.0 109.523 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 50.3 t0 -85.98 119.9 26.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 65.8 m-85 -113.04 142.15 46.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' THR . 92.7 mt-10 -131.47 136.74 48.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 23' ' ' PHE . 27.3 m -125.38 131.58 52.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' C ' HD22 ' A' ' 105' ' ' LEU . 56.2 tttt -133.08 125.03 28.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.845 HD13 HG23 ' A' ' 115' ' ' ILE . 2.9 mm? -99.58 128.65 45.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 114' ' ' ILE . 41.3 t -131.15 140.7 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -109.26 147.92 31.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.69 161.82 23.84 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.7 Cg_endo -70.1 -11.69 30.85 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.727 2.284 . . . . 0.0 111.82 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -77.22 -17.13 58.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.939 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.86 -15.22 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.25 173.43 44.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 99.1 m -127.75 127.61 43.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.565 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 64.5 mt -97.95 143.42 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.282 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.845 HG23 HD13 ' A' ' 105' ' ' LEU . 4.2 mt -124.17 123.61 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 18.6 mttt -105.11 131.32 52.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 102' ' ' GLU . 85.7 m -131.47 132.04 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.2 m -112.28 144.62 41.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.048 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.9 m -130.4 145.55 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 0.0 110.072 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' ILE . 5.1 ttpt -143.75 123.34 13.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 99' ' ' ILE . 14.8 m-85 -106.87 137.94 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.062 -1.023 . . . . 0.0 109.724 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' HG21 ' A' ' 3' ' ' VAL . 67.7 m80 -107.49 148.54 29.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.011 ' HB ' HG23 ' A' ' 127' ' ' VAL . 15.4 p -126.55 159.62 32.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 95' ' ' ASN . 4.2 mtmp? -58.27 -44.06 88.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.51 -60.57 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 93.9 m-20 -98.19 -32.45 11.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.491 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.011 HG23 ' HB ' ' A' ' 123' ' ' THR . 3.5 m -52.24 117.78 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 94.9 mt-10 -131.65 165.41 23.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.516 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.7 tt -117.87 171.54 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.289 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -99.13 131.9 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -54.25 -37.84 65.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.467 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 71.4 mm-40 -59.29 -39.74 83.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -65.91 -42.72 89.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' A' ' 138' ' ' LYS . 47.6 t -65.38 -41.37 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -55.66 -41.82 74.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.406 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.25 94.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.862 . . . . 0.0 109.391 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.49 96.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.512 ' NZ ' ' OH ' ' A' ' 121' ' ' TYR . 22.1 mmtm -56.31 -43.09 78.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -50.68 73.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.397 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 90.0 mttt -57.69 -42.03 82.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.354 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.25 -46.68 82.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.364 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.71 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -74.31 -32.2 62.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 65.4 mt -68.92 -41.62 77.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.863 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.465 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 60.1 m-85 -53.4 -47.94 69.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -54.69 -40.55 69.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 151' ' ' TYR . 45.8 mt -60.89 -36.95 80.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.379 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 145' ' ' PHE . 92.1 mt -56.04 -55.84 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 19' ' ' LEU . 35.9 mp0 -68.31 -33.99 75.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.15 60.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 147' ' ' LEU . 64.8 m-85 -60.94 -49.21 78.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.173 . . . . 0.0 109.434 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.31 -39.74 73.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -62.96 -40.21 97.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.02 -41.19 87.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.46 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.82 79.23 0.35 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.8 142.85 44.32 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.678 2.252 . . . . 0.0 111.672 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -113.64 147.42 38.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.73 -31.41 70.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.08 -40.54 77.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.443 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.732 HG11 ' O ' ' A' ' 121' ' ' TYR . 73.1 t -117.9 136.36 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.158 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.9 148.24 34.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 22.8 m -93.66 140.62 29.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' THR . 73.2 t80 -115.22 131.54 56.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.942 . . . . 0.0 109.643 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.22 138.66 47.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -132.72 129.85 39.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 81.0 mt-10 -105.53 123.96 48.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.282 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -132.99 129.73 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 114' ' ' ILE . 27.6 p -97.39 140.25 32.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -138.88 172.13 13.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.687 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' ILE . 49.7 m-20 -76.18 -175.65 3.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mp 62.48 140.63 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.46 147.95 65.94 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.541 2.161 . . . . 0.0 111.949 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.92 -52.13 2.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 111.289 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.33 -50.05 3.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.076 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 14' ' ' ILE . 36.8 mttt -57.96 -39.62 78.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.881 -1.137 . . . . 0.0 109.585 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 23.7 tp -80.56 -27.71 37.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.76 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.835 ' HB2' HD12 ' A' ' 105' ' ' LEU . 60.4 t80 -61.31 -39.42 90.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 78.3 tttt -66.85 -55.24 15.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.88 0.27 16.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 109.817 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -97.01 -29.17 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.096 -1.003 . . . . 0.0 109.539 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.9 m -122.5 -38.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 23.6 tp -72.24 -38.52 68.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 72.7 m-20 -102.73 4.46 38.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -0.865 . . . . 0.0 109.545 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.85 -32.88 71.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 109.613 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.3 m-20 -57.68 -29.19 64.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.7 m-20 -116.5 -35.86 4.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 63.9 tp -62.79 -34.07 76.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.5 mt -57.63 -58.93 14.83 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.04 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -68.32 -9.86 27.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.627 2.218 . . . . 0.0 111.605 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 65.9 mttt -80.39 -38.06 31.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 147' ' ' LEU . 88.1 mt -77.95 -28.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.18 69.1 41.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.66 -29.56 24.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.752 2.302 . . . . 0.0 111.771 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -73.41 -26.81 61.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.35 -49.59 73.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.7 m -126.54 156.11 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.4 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -71.87 -46.14 58.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.12 134.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.76 129.14 35.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -122.53 144.12 49.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 58.8 mt -106.06 120.28 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -68.59 -44.28 74.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 53' ' ' THR . 91.6 mt-10 -158.16 157.26 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.31 -40.85 2.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 56.95 33.4 23.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.9 26.02 30.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.0 -164.44 15.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.3 126.0 12.48 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.674 2.249 . . . . 0.0 111.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.9 36.43 41.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' GLU . 39.8 m -89.12 142.23 27.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -1.162 . . . . 0.0 109.365 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -112.75 124.81 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' HG12 ' A' ' 44' ' ' ILE . 71.2 mttt -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HB2' HD11 ' A' ' 45' ' ' LEU . 47.7 tttm -133.86 121.85 22.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 70' ' ' HIS . 21.5 mt -116.75 135.47 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.66 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -119.77 139.24 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.773 ' HE1' HG23 ' A' ' 68' ' ' VAL . 93.0 m-85 -95.84 133.23 40.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.53 27.19 7.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.83 -31.47 68.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -1.181 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.22 -52.44 2.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.2 p -61.13 -32.12 71.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -133.92 146.23 50.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -118.0 136.34 53.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . 175.13 -179.25 46.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.1 p90 -160.31 146.08 15.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.154 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG23 ' HE1' ' A' ' 59' ' ' PHE . 44.0 t -121.18 140.32 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.892 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 32.3 mttt -115.49 144.72 43.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.46 ' CE1' HD12 ' A' ' 57' ' ' ILE . 75.9 m80 -124.77 135.66 53.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HB2' HD11 ' A' ' 87' ' ' ILE . 53.8 tttp -118.12 141.11 48.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.9 mt -102.88 138.07 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -93.19 -47.52 6.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 p -172.06 153.72 3.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 82' ' ' TYR . 31.8 pt -127.96 145.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -126.57 92.43 3.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -62.45 -35.0 77.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.397 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -71.84 -41.47 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -86.49 5.29 36.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.2 m80 46.69 40.76 9.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 m -124.16 136.5 54.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 82.5 t80 -123.93 125.48 44.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.306 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -117.08 132.38 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.6 p90 -153.59 168.83 24.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -146.83 152.44 38.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.8 tt -91.89 134.71 34.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.94 ' N ' HD23 ' A' ' 86' ' ' LEU . 93.8 mt -89.8 -70.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.907 . . . . 0.0 109.599 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.775 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.3 mt-10 -125.43 161.23 27.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -179.83 156.29 17.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' OD1' ' HA3' ' A' ' 66' ' ' GLY . 85.0 m-20 -58.7 -32.4 69.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -1.164 . . . . 0.0 109.432 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.83 -16.43 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.933 HD21 HD22 ' A' ' 86' ' ' LEU . 7.6 mp -86.01 -30.61 22.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 p 59.72 -177.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.95 16.76 13.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -0.892 . . . . 0.0 109.184 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.855 ' O ' HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -119.44 -20.87 7.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 109.368 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.469 ' CD1' HD12 ' A' ' 129' ' ' ILE . 9.8 mt -96.05 142.44 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -87.91 179.97 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 41.6 mtmt -57.55 167.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 120' ' ' LYS . 74.9 mt -119.83 138.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -90.75 122.58 33.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 69.2 m-85 -116.13 138.7 51.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -134.17 137.18 44.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.24 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.559 HG21 ' CE2' ' A' ' 23' ' ' PHE . 44.7 m -131.2 131.47 44.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.622 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -129.24 133.49 47.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 20' ' ' PHE . 17.7 mt -107.31 120.15 41.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.699 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 114' ' ' ILE . 22.6 t -131.94 138.54 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 22.9 m -114.48 151.66 32.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.98 172.01 3.88 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.03 -16.89 40.98 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.802 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.96 -16.49 63.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.345 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.04 -17.42 44.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.31 172.54 45.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 85.7 m -119.27 124.11 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -1.127 . . . . 0.0 109.365 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 11' ' ' THR . 70.8 mt -94.79 143.18 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.137 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.742 HG23 HD23 ' A' ' 105' ' ' LEU . 53.8 mt -132.64 132.35 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.951 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 47.8 mttp -107.09 135.32 48.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.7 m -125.47 130.5 51.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.964 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 29.1 m -123.6 143.42 50.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.948 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.2 t -138.77 140.72 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.997 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 99' ' ' ILE . 72.7 tttt -136.8 133.92 36.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.732 ' O ' HG11 ' A' ' 3' ' ' VAL . 31.8 m-85 -110.02 133.63 52.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.677 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.7 m80 -101.68 136.51 41.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.271 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 11.1 p -109.82 149.84 29.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 95' ' ' ASN . 3.7 mtpm? -54.09 -52.73 60.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.33 -73.03 0.04 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.6 p30 -107.93 -1.38 20.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -1.176 . . . . 0.0 109.801 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.855 HG21 ' O ' ' A' ' 95' ' ' ASN . 19.8 m -60.44 134.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.408 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.57 162.09 18.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.492 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 96' ' ' ILE . 16.7 tt -128.42 171.64 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.592 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 21.7 mttm -94.26 127.39 40.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -55.06 -39.54 69.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.58 -36.8 76.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.592 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 36.0 m80 -70.69 -41.37 72.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.481 HG12 ' HE3' ' A' ' 138' ' ' LYS . 57.8 t -66.57 -41.47 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -61.05 -39.27 89.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -62.75 -42.96 99.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.424 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.4 -44.09 98.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE3' HG12 ' A' ' 134' ' ' VAL . 92.8 mttt -63.34 -42.36 98.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.455 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.04 -42.13 97.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.375 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 31.3 mttt -61.05 -41.32 96.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -44.35 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 146' ' ' LYS . . . -71.02 -35.33 71.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.482 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.8 t60 -61.37 -47.13 87.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.1 mt -63.0 -42.13 99.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.384 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 148' ' ' ILE . 57.4 t80 -55.69 -42.04 74.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.361 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 142' ' ' ALA . 98.1 mttt -53.82 -38.09 64.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -67.21 -40.03 86.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 145' ' ' PHE . 87.9 mt -53.9 -51.15 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.43 -48.82 79.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.34 -33.03 86.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.62 -46.38 84.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 14' ' ' ILE . 71.5 mt -64.87 -42.21 95.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 109.365 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.67 -38.02 77.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -127.11 84.01 64.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 138.77 35.18 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.649 2.233 . . . . 0.0 111.859 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.4 p -75.13 158.0 33.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.273 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.64 155.12 26.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -56.22 -40.52 74.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.516 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 122' ' ' HIS . 70.6 t -121.37 136.09 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.588 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -111.48 135.62 51.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 33.2 m -101.87 132.91 47.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.14 132.65 56.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.92 141.51 39.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 65.3 t30 -126.58 131.05 51.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.574 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.01 141.91 46.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 83.2 t80 -162.97 143.71 9.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.448 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 8.7 p -102.42 144.63 30.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 115' ' ' ILE . 50.1 m -142.84 167.83 21.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.1 t0 -78.68 -175.97 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 66.49 140.7 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 109.276 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 49.6 Cg_endo -71.12 148.07 55.55 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.605 2.203 . . . . 0.0 112.203 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.79 -51.6 3.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.72 . . . . 0.0 111.388 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.25 -43.72 13.89 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.43 2.087 . . . . 0.0 113.046 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG22 ' A' ' 14' ' ' ILE . 74.9 mttt -64.01 -34.5 78.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.81 -1.181 . . . . 0.0 109.653 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.7 tt -80.64 -31.66 36.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.83 ' CE1' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -65.7 -35.85 81.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.845 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 47.0 mttp -64.52 -42.36 95.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -84.43 -32.18 24.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' A' ' 103' ' ' THR . 53.5 t80 -78.15 -8.02 57.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.83 HG21 ' CE1' ' A' ' 20' ' ' PHE . 63.0 t -123.98 -68.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 12.1 tp -57.23 -43.68 83.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 75.9 m-20 -95.05 12.87 27.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.868 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.67 -32.67 71.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 44' ' ' ILE . 97.3 m-20 -66.32 -34.75 78.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.1 t30 -100.06 -43.09 6.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD21 HG23 ' A' ' 148' ' ' ILE . 30.0 tp -53.79 -43.77 69.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 27' ' ' ALA . 10.8 mt -48.13 -63.35 1.56 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.37 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -68.74 -19.22 41.57 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.502 2.134 . . . . 0.0 111.779 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -66.67 -45.84 77.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.8 mt -72.27 -36.72 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.23 69.98 80.23 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 109.498 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.7 Cg_endo -70.84 -33.88 11.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.588 2.192 . . . . 0.0 111.639 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -75.4 -27.14 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.95 94.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.027 HG12 ' CE1' ' A' ' 59' ' ' PHE . 16.5 m -127.01 160.49 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 29.5 ttpt -72.25 -50.37 27.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.476 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.41 132.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.45 123.39 32.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -121.67 144.87 48.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 28' ' ' ASP . 61.2 mt -105.09 119.49 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 29.0 tp -64.99 -44.29 89.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 53' ' ' THR . 74.1 mm-40 -156.97 151.61 25.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.473 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 109.09 -42.88 1.84 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.2 m-20 61.9 38.85 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.779 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.75 35.11 17.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -118.6 -167.02 13.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.98 130.27 18.79 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.697 2.265 . . . . 0.0 111.813 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.29 24.61 76.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.79 145.16 32.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -1.155 . . . . 0.0 109.525 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.88 133.27 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.326 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 41.6 mttt -121.25 151.53 39.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -134.24 120.59 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.356 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 8.7 mt -117.87 134.25 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 40' ' ' LYS . 29.8 p -112.95 139.23 48.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.027 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.7 m-85 -107.73 143.18 36.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.35 36.98 0.93 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.55 -30.13 53.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 0.0 109.568 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.83 -80.09 0.35 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -59.61 -27.25 66.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -1.155 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -125.21 129.49 50.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -126.78 135.75 51.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 176.92 179.27 47.24 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 -154.09 144.05 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -1.176 . . . . 0.0 109.585 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -130.41 147.12 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 109.299 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' O ' HD12 ' A' ' 86' ' ' LEU . 30.8 mttt -109.82 146.36 35.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.647 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 49.8 m80 -117.42 148.29 41.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.616 ' CB ' HD11 ' A' ' 87' ' ' ILE . 39.0 tttm -129.71 141.39 50.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.0 mt -100.09 135.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -88.95 -48.5 7.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 p -166.0 154.45 11.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 pt -128.54 145.2 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -130.63 92.17 3.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.01 -38.58 91.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.43 -42.35 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 29.6 m120 -86.68 6.6 30.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 37.3 m80 45.63 46.39 11.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.553 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.5 m -125.27 139.05 54.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 71.7 t80 -130.53 125.59 34.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.8 t -119.23 132.95 55.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 35.2 p90 -148.76 164.98 32.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.597 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 84.9 p -148.13 152.37 37.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.058 HD23 HD21 ' A' ' 92' ' ' LEU . 23.2 tp -87.41 137.51 32.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.596 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 71' ' ' LYS . 28.5 mm -94.31 -75.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.0 mt-10 -118.77 151.23 38.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.684 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -169.21 125.52 1.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 67.3 m-20 -48.97 -34.2 12.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 109.378 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.61 -16.5 63.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.058 HD21 HD23 ' A' ' 86' ' ' LEU . 7.0 mp -86.47 -39.45 16.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 69.0 m 62.86 173.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.414 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 72.8 mm-40 -74.46 -11.31 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.617 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.47 ' O ' HG21 ' A' ' 127' ' ' VAL . 31.1 m-20 -80.97 -29.42 35.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 28.8 mt -104.54 120.13 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.7 mm-40 -75.84 -178.92 4.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.358 -0.839 . . . . 0.0 109.242 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.494 ' HE2' HG23 ' A' ' 87' ' ' ILE . 36.2 mttp -56.69 166.33 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.47 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 120' ' ' LYS . 62.0 mt -126.51 133.54 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 109.659 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 120' ' ' LYS . 90.7 m-20 -91.81 126.61 36.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.5 m-85 -116.63 138.16 51.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 117' ' ' THR . 94.3 mt-10 -128.05 135.2 49.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.621 HG21 ' CE1' ' A' ' 23' ' ' PHE . 40.5 m -129.7 131.74 46.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -139.45 124.7 18.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -95.52 132.19 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.3 t -128.96 139.44 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -112.65 145.0 41.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -107.93 167.14 9.73 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.53 -9.23 25.41 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.696 2.264 . . . . 0.0 111.77 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -78.21 -15.21 59.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.18 -21.27 29.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.34 169.12 50.99 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.4 m -124.45 126.21 45.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -1.193 . . . . 0.0 109.611 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 65.7 mt -97.6 142.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.844 HG23 HD13 ' A' ' 105' ' ' LEU . 2.6 mp -125.73 125.55 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.682 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 28.0 mttt -115.03 139.08 50.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.121 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 102' ' ' GLU . 91.4 m -132.06 135.65 46.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.878 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 40.8 m -124.52 138.32 54.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.367 -0.833 . . . . 0.0 108.958 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -131.53 155.75 46.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 110.041 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.0 mttt -138.06 138.49 38.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 3' ' ' VAL . 32.7 m-85 -116.57 128.77 55.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 109.623 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.723 ' HA ' HG22 ' A' ' 3' ' ' VAL . 90.9 m-70 -99.68 150.54 22.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -0.894 . . . . 0.0 109.432 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.018 ' HB ' HG23 ' A' ' 127' ' ' VAL . 5.8 p -126.01 161.06 28.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.456 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 13.3 mtmt -56.83 -35.91 69.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 165.42 -64.69 0.22 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 57.9 t0 -97.92 -22.31 16.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -1.151 . . . . 0.0 109.715 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.018 HG23 ' HB ' ' A' ' 123' ' ' THR . 6.1 m -59.43 112.48 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 109.505 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 98.6 mt-10 -114.65 174.85 5.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.394 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.88 171.4 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -98.51 133.16 43.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.78 -39.97 65.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.33 -38.33 76.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -68.68 -42.24 78.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.78 -43.0 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 109.41 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 23.8 tptm -56.12 -41.6 75.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.64 -46.94 77.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.35 96.46 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 tttp -59.84 -43.16 94.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -1.135 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 76.3 mm-40 -60.46 -43.22 97.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -55.66 -46.1 77.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.28 81.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.346 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.92 85.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.389 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -58.26 -47.21 84.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 144' ' ' LEU . 45.0 mt -62.55 -43.02 99.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 67.0 t80 -54.84 -47.09 74.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.426 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -52.15 -40.4 61.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 147' ' ' LEU . 59.6 mt -63.78 -38.14 90.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.753 HG23 HD21 ' A' ' 30' ' ' LEU . 82.4 mt -55.3 -49.46 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.548 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 13' ' ' ASP . 86.2 tt0 -59.53 -48.44 81.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.91 92.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 59.1 t80 -57.53 -43.18 84.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 14' ' ' ILE . 72.8 mt -68.8 -32.17 71.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -70.05 -37.68 75.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 39.8 p30 -100.21 7.6 44.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.507 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 3.3 p-80 -51.13 121.76 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.537 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.09 -25.53 26.96 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.661 2.241 . . . . 0.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.6 t -129.36 141.81 50.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.8 -33.27 70.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.415 ' O ' ' OD1' ' A' ' 160' ' ' ASN . 93.4 m-85 -114.79 136.65 52.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 159' ' ' TYR . 88.2 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.986 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.8 p -113.26 139.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -1.228 . . . . 0.0 109.527 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 5' ' ' THR . 74.4 t80 -110.16 145.97 36.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.548 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 68.5 m -93.73 143.73 26.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -127.52 141.45 51.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.68 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 84.3 tt0 -112.49 133.01 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -117.92 134.49 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -103.16 109.91 21.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.8 t80 -117.59 131.35 56.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.678 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.564 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 18.7 p -91.81 155.83 17.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.238 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 115' ' ' ILE . 59.7 p -153.61 171.94 17.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.779 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -80.16 -175.43 5.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.807 . . . . 0.0 109.424 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 15' ' ' PRO . 4.2 mm 61.74 141.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.952 . . . . 0.0 109.239 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 14' ' ' ILE . 49.0 Cg_endo -70.65 146.27 54.21 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.492 2.128 . . . . 0.0 112.001 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.82 -51.7 2.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.655 -0.653 . . . . 0.0 111.348 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.18 -50.02 3.2 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.232 1.954 . . . . 0.0 113.123 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 79.3 mttt -61.48 -38.28 86.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.161 . . . . 0.0 109.686 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.81 -25.61 37.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.71 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 63.8 t80 -66.98 -31.69 72.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 77.1 mttt -72.09 -47.53 50.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.0 60.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.795 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.0 t80 -79.36 -16.82 55.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.402 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 67.6 t -114.12 -60.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 35.8 mt -59.41 -44.48 92.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.213 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 69.7 m-20 -100.99 24.4 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.331 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.22 -37.43 78.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -70.4 -33.13 71.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -94.17 -30.44 14.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.493 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.546 HD21 HG23 ' A' ' 148' ' ' ILE . 30.1 tp -64.14 -43.68 94.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 27' ' ' ALA . 3.8 mt -50.2 -59.79 6.44 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 50.2 Cg_endo -68.9 -16.31 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.549 2.166 . . . . 0.0 111.84 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.6 tptp -69.05 -40.29 78.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.612 HG23 HD13 ' A' ' 147' ' ' LEU . 59.1 mt -67.44 -33.44 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.52 71.27 14.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.3 Cg_endo -69.86 -30.92 21.05 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.613 2.208 . . . . 0.0 111.502 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.58 -23.57 64.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.205 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 -24.81 23.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.331 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 59' ' ' PHE . 3.1 t -113.74 133.93 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.345 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -71.92 -50.83 25.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.71 130.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.03 124.81 38.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.27 146.62 46.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.837 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 57.5 mt -104.77 117.81 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.9 mp -63.39 -44.64 94.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.906 ' O ' HG23 ' A' ' 53' ' ' THR . 89.9 mt-10 -159.14 155.28 26.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.5 -41.63 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.8 m-20 61.53 35.27 17.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -1.125 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.822 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.54 34.11 10.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.93 -162.69 11.79 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.17 130.64 19.17 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.699 2.266 . . . . 0.0 111.833 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . 69.31 30.26 71.6 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.906 HG23 ' O ' ' A' ' 46' ' ' GLU . 74.4 m -85.86 143.28 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.4 mm -110.97 132.16 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 72' ' ' ILE . 79.0 mttt -122.83 146.46 47.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -127.71 120.45 28.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.268 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 11.6 mt -117.38 127.49 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -108.6 127.86 54.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.597 ' HE1' HG22 ' A' ' 39' ' ' VAL . 85.1 m-85 -107.06 141.25 38.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.554 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.81 131.5 5.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.09 -38.36 62.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -1.118 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.99 -163.04 20.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 89.0 p -125.41 154.8 41.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -1.135 . . . . 0.0 109.495 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' A' ' 63' ' ' SER . 0.2 OUTLIER 69.36 9.43 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 65' ' ' TYR . 44.7 t80 -80.84 -17.71 49.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.541 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . 155.5 131.19 1.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 44.1 p90 -154.63 144.17 21.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.4 m -121.92 147.98 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.339 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 45.9 mttt -108.01 141.21 40.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 68' ' ' VAL . 73.8 m80 -119.85 133.24 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.85 . . . . 0.0 109.148 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' A' ' 87' ' ' ILE . 21.1 tttt -116.0 139.69 50.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 63.9 mt -98.17 136.26 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 89.0 m-70 -90.09 -47.73 7.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 t -170.3 158.6 6.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.09 145.06 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.5 m-20 -124.94 92.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.473 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -65.34 -38.47 90.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.59 -42.5 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 74.1 m-20 -86.87 8.36 23.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.464 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.7 m80 45.76 41.66 7.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 m -121.74 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 67.4 t80 -130.78 122.99 28.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -117.27 134.02 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 33.9 p90 -151.12 161.79 42.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 93.4 p -139.16 158.32 44.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 87' ' ' ILE . 6.5 tt -98.62 125.1 43.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.802 HG22 ' HG3' ' A' ' 88' ' ' GLU . 31.0 mm -73.7 -68.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.4 mt-10 -140.92 146.44 37.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.657 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -153.24 160.49 29.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 68' ' ' VAL . 67.0 m-20 -60.65 -31.07 70.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.482 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 -27.84 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.36 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' ILE . 5.7 mp -77.28 -39.74 47.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.387 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 30.6 m 59.52 169.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.31 -8.16 54.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.537 ' HB3' HG23 ' A' ' 127' ' ' VAL . 61.2 m-20 -83.93 -27.97 28.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 92' ' ' LEU . 18.7 mt -99.73 146.3 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -90.35 179.9 5.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 109.609 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.68 ' HE2' HG23 ' A' ' 87' ' ' ILE . 37.8 mttt -57.55 162.35 3.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 120' ' ' LYS . 40.5 mt -118.56 141.04 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.704 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 59.0 t0 -97.74 119.86 37.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 95.4 m-85 -113.59 144.87 42.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 91.5 mt-10 -138.67 134.13 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.3 m -126.84 132.86 50.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.563 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 105' ' ' LEU . 34.2 tttt -130.21 132.9 46.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.29 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -106.67 115.22 29.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 23.5 t -131.58 145.33 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 3.2 m -114.43 153.47 29.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.42 167.6 8.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.353 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.27 -7.8 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.626 2.217 . . . . 0.0 111.811 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -76.74 -13.98 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.57 -16.34 44.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.32 172.16 41.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 94.8 m -116.05 124.97 51.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.444 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 59.8 mt -96.42 127.54 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.252 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 105' ' ' LEU . 51.3 mt -113.35 126.77 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 109.768 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 18.1 mttp -103.49 129.35 50.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 108.97 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -129.23 124.78 35.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.155 -0.966 . . . . 0.0 110.096 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 23.4 m -106.6 142.96 35.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 108.964 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -129.12 143.06 50.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 109.913 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 99' ' ' ILE . 24.4 tttt -149.31 119.73 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 109.082 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.986 ' O ' HG21 ' A' ' 3' ' ' VAL . 22.0 m-85 -107.99 133.11 52.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 75.3 m80 -96.47 143.57 27.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 109.273 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.415 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 27.7 p -109.91 152.48 25.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.763 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 2.8 tttt -62.49 -66.14 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 109.339 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -168.08 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 55.0 p30 -133.41 2.13 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 0.0 109.363 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 128' ' ' GLU . 5.5 p -43.36 -45.82 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.358 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 127' ' ' VAL . 95.9 mt-10 61.29 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.52 172.4 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.326 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 52.1 tttp -104.06 125.99 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.55 -38.08 63.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.8 -35.23 79.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 61.9 m170 -69.51 -40.27 77.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.8 t -68.06 -43.24 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -62.15 -38.51 89.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.24 98.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.57 -39.82 98.35 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.21 -46.21 88.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -1.109 . . . . 0.0 109.439 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -62.72 -44.69 95.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -52.93 -45.92 67.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.23 90.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.3 -30.54 64.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.336 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -74.21 -31.69 62.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.39 -43.73 80.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 148' ' ' ILE . 77.4 m-85 -54.66 -39.47 68.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.56 -41.71 86.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 109.422 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG23 ' A' ' 34' ' ' ILE . 43.5 mt -67.3 -39.24 85.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.546 HG23 HD21 ' A' ' 30' ' ' LEU . 65.5 mt -54.18 -46.32 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 12' ' ' SER . 42.3 mm-40 -68.89 -40.38 79.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.93 -55.18 27.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -54.85 -56.18 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 109.507 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 44.0 mt -58.7 -40.54 83.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.87 -48.14 70.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.418 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -57.36 -58.86 6.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.403 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 50.1 68.71 3.18 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.36 128.62 15.73 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.803 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.4 t -49.94 -37.33 31.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.52 161.49 24.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -60.38 -32.26 71.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.478 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 121' ' ' TYR . 70.2 t -116.1 136.13 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.479 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.24 136.75 52.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 30.3 m -101.43 135.95 42.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.421 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' THR . 91.5 m-85 -118.82 139.16 52.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.75 135.48 53.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.78 134.18 55.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 94.8 mt-10 -113.96 126.91 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 65.6 t80 -143.08 136.62 28.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 109.471 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.7 p -103.44 152.23 21.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 109.421 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -154.23 171.1 19.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' HD12 ' A' ' 14' ' ' ILE . 31.9 t0 -71.79 177.52 4.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.2 mt 69.6 135.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.404 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.2 Cg_endo -69.7 150.11 68.15 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.535 2.156 . . . . 0.0 111.96 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.926 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -38.64 -52.27 3.55 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -64.5 -50.5 2.53 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.425 2.083 . . . . 0.0 113.041 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 94.8 mttt -59.62 -35.56 74.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.801 -1.187 . . . . 0.0 109.485 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 18.7 tp -80.37 -33.39 37.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.937 . . . . 0.0 109.372 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' VAL . 72.8 t80 -56.52 -43.43 79.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 98.5 mttt -58.68 -61.09 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 109.646 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -68.59 -7.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.905 . . . . 0.0 109.611 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 103' ' ' THR . 83.1 t80 -84.02 -32.97 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.667 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 82' ' ' TYR . 24.9 m -127.73 -33.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.757 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.8 tp -60.95 -65.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.66 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' CG ' ' HA ' ' A' ' 22' ' ' ALA . 33.5 p30 -93.98 18.95 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.09 -35.27 76.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.126 -0.984 . . . . 0.0 109.503 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.5 -42.39 67.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.5 t-20 -97.61 -34.2 11.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.923 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.6 tm? -69.38 -39.3 78.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.539 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 30.7 mt -51.1 -56.32 20.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -69.02 -21.66 36.61 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.524 2.15 . . . . 0.0 111.764 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -66.1 -37.28 85.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.526 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' CE2' ' A' ' 151' ' ' TYR . 73.3 mt -68.53 -27.16 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.22 69.99 10.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -70.48 -31.61 17.03 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.04 -28.36 60.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.15 -44.11 76.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 57' ' ' ILE . 4.7 p -125.02 154.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -77.33 -47.77 19.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.962 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.15 141.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.529 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.58 119.52 30.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.22 140.67 37.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.441 HG12 ' HG2' ' A' ' 55' ' ' LYS . 60.2 mt -106.49 117.55 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -64.28 -45.76 86.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 53' ' ' THR . 67.3 mm-40 -157.72 155.22 29.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.4 -42.4 1.93 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 85.4 m-20 60.3 36.06 20.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.778 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.08 32.88 11.53 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.27 -166.34 13.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.85 132.65 23.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.693 2.262 . . . . 0.0 111.656 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.13 29.39 73.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.8 m -84.72 144.52 28.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.136 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 45' ' ' LEU . 60.1 mt -110.51 128.52 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' HG12 ' A' ' 44' ' ' ILE . 31.5 mttt -116.57 149.33 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.2 tttt -129.88 121.21 26.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.879 HG23 HG21 ' A' ' 39' ' ' VAL . 44.9 mt -110.81 134.49 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -119.24 123.13 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HE2' HG23 ' A' ' 68' ' ' VAL . 95.7 m-85 -92.55 138.02 31.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.9 . . . . 0.0 109.558 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.98 -165.91 41.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.93 135.95 57.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 65' ' ' TYR . . . -179.31 -164.05 31.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.7 m -66.02 -24.58 66.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -128.22 139.13 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 62' ' ' GLY . 58.3 m-85 -119.29 135.79 54.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 151.39 -166.93 30.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 37.1 p90 -147.32 147.92 30.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 109.445 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 89' ' ' GLY . 48.8 t -123.51 149.88 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 51.4 mtpt -123.6 143.57 50.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -122.58 141.67 51.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.613 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HB2' HD11 ' A' ' 87' ' ' ILE . 82.8 tttt -123.25 139.13 54.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 54.1 mt -97.76 134.18 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 88.9 m-70 -89.48 -47.6 7.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -170.65 153.79 4.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.15 143.79 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.399 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.48 93.03 3.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -63.15 -35.6 80.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.91 -40.61 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -87.44 1.83 52.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 43.4 m80 50.66 40.51 24.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.5 m -123.02 138.49 54.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.644 ' CD1' HG11 ' A' ' 24' ' ' VAL . 80.3 t80 -127.22 125.94 41.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -117.57 134.37 54.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 109.694 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 29.9 p90 -148.46 167.74 24.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.326 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 97.1 p -144.23 159.01 43.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.948 ' CD2' HD11 ' A' ' 92' ' ' LEU . 4.5 tt -98.99 133.37 43.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.93 ' N ' HD23 ' A' ' 86' ' ' LEU . 75.8 mt -94.69 -74.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.7 mt-10 -116.08 157.96 23.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 174.82 155.65 12.77 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.432 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 64.3 m-20 -62.37 -29.6 70.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -1.151 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -69.5 -32.1 70.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.948 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.7 mt -74.27 -32.94 63.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.037 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.65 -177.56 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.537 -0.727 . . . . 0.0 109.287 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -88.47 18.56 4.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.568 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.523 ' O ' HG21 ' A' ' 127' ' ' VAL . 14.1 m120 -125.64 -9.59 6.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.869 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 91' ' ' ALA . 14.2 mt -108.55 145.43 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.055 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 88.3 mt-10 -90.04 -179.83 5.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.656 ' HE2' HG23 ' A' ' 87' ' ' ILE . 49.1 mttt -57.53 166.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.606 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 120' ' ' LYS . 81.7 mt -125.49 134.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 25.1 t70 -92.25 126.26 37.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.0 m-85 -118.72 140.45 49.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.496 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.36 137.52 47.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 23' ' ' PHE . 45.3 m -127.45 133.54 49.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -131.11 132.14 44.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -107.72 124.07 49.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.5 143.48 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.0 p -108.44 148.04 30.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.79 166.74 10.28 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.5 Cg_endo -69.38 -19.35 38.07 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.741 2.294 . . . . 0.0 111.822 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.57 -17.65 64.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.386 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.75 -23.89 18.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.7 179.75 52.14 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 63.8 m -126.62 126.37 43.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -1.185 . . . . 0.0 109.648 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -92.91 140.67 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 105' ' ' LEU . 62.7 mt -127.83 124.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 49.7 mttt -105.62 136.31 45.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.3 m -128.58 126.43 40.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 18.4 m -120.04 138.27 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 108.812 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -137.22 147.02 45.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.231 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 99' ' ' ILE . 91.2 mttt -129.81 144.08 51.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' VAL . 55.2 m-85 -119.42 129.02 54.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.671 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -96.66 141.96 29.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.384 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.496 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 80.7 p -106.08 145.05 31.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 40.5 mttt -67.8 -42.89 80.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.03 -75.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -104.23 7.16 35.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.133 . . . . 0.0 109.532 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 95' ' ' ASN . 14.0 p -64.7 132.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -129.02 151.08 50.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 0.0 109.499 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.41 171.56 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -102.26 133.9 46.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -53.28 -39.8 64.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 73.6 mm-40 -60.43 -38.01 82.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -67.53 -42.18 83.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.0 -45.11 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.418 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -56.58 -40.38 75.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.1 -41.67 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.76 -41.41 95.91 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -62.54 -42.24 99.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -1.145 . . . . 0.0 109.392 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.78 -42.83 94.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 32.7 tttm -56.4 -46.11 80.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.42 68.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.71 75.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.41 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.1 t60 -60.63 -43.65 97.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 73.6 mt -56.08 -46.13 79.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -54.81 -33.15 61.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -66.53 -39.77 88.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -64.31 -45.06 89.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.381 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.04 -55.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -54.67 -35.95 64.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.95 -29.8 66.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CE2' HG12 ' A' ' 34' ' ' ILE . 8.7 m-30 -69.45 -45.4 69.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp -75.05 -50.42 16.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -53.39 -35.84 60.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.096 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.86 -33.37 40.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.318 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.79 66.4 4.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.98 -12.37 32.35 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.726 2.284 . . . . 0.0 111.671 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 99.8 p -118.28 151.66 37.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.69 144.28 38.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 160' ' ' ASN . 36.4 p90 -65.03 -32.73 74.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.464 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' TYR . 77.3 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 122' ' ' HIS . 32.6 t -118.17 139.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -117.93 155.9 29.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.667 HG22 ' CG2' ' A' ' 118' ' ' THR . 10.6 m -93.84 138.83 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 118' ' ' THR . 94.2 m-85 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -114.98 135.84 53.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -120.83 132.51 55.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -107.63 129.14 55.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.538 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.9 t80 -143.19 141.71 31.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.4 p -107.93 148.58 29.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.6 p -149.29 170.8 17.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.979 . . . . 0.0 109.527 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.0 t0 -80.28 -175.86 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.459 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 67.79 140.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -70.21 149.6 64.27 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.213 . . . . 0.0 111.911 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.73 -52.19 3.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.2 -50.34 2.91 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.461 2.107 . . . . 0.0 112.915 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB2' HG22 ' A' ' 14' ' ' ILE . 67.5 mttm -58.91 -34.87 72.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.875 -1.14 . . . . 0.0 109.546 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD12 HD11 ' A' ' 152' ' ' LEU . 8.5 tp -81.06 -28.9 35.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.728 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 56.9 t80 -68.76 -33.3 73.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 17.8 tttp -67.14 -45.35 77.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.12 -25.58 36.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.745 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 52.0 t80 -83.79 -15.6 47.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.935 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.6 t -117.81 -67.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 28.5 tp -55.82 -41.71 74.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.432 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.4 m-20 -97.78 14.72 25.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.864 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -68.64 -37.11 79.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.84 -40.75 89.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.7 m120 -94.4 -31.56 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.84 HD21 HD12 ' A' ' 148' ' ' ILE . 38.9 tp -66.44 -42.25 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 27' ' ' ALA . 6.6 mt -49.99 -57.97 10.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.442 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.68 -22.39 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.485 2.123 . . . . 0.0 111.742 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 11.3 tptt -68.5 -42.01 79.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 147' ' ' LEU . 23.8 mm -61.36 -24.99 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.86 75.06 3.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.7 -32.99 17.74 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.635 2.223 . . . . 0.0 111.645 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -21.77 61.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.62 -41.92 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.419 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' A' ' 59' ' ' PHE . 21.7 m -126.84 148.24 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.402 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HE2' ' CG2' ' A' ' 58' ' ' THR . 11.1 mtmt -72.4 -51.62 19.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.94 129.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.61 124.49 29.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -117.59 146.41 43.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -104.19 126.83 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.0 mm? -71.1 -41.47 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.38 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.96 ' O ' HG23 ' A' ' 53' ' ' THR . 90.7 mt-10 -159.26 151.16 20.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 107.68 -42.92 1.81 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 t0 64.17 39.63 7.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 0.0 109.569 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.776 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.25 37.02 13.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.86 -165.99 13.13 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.09 132.69 23.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.702 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 65.43 28.46 73.6 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.6 m -82.84 144.13 30.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -1.102 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 59.5 mt -105.12 126.09 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 mtpt -115.09 152.98 31.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -135.71 124.77 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' CD2' ' A' ' 70' ' ' HIS . 13.6 mt -113.03 131.75 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.529 ' CG2' ' HE2' ' A' ' 40' ' ' LYS . 75.0 m -109.47 120.62 43.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' A' ' 39' ' ' VAL . 90.1 m-85 -92.53 135.74 33.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.67 -176.42 36.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 22.0 pt-20 -52.02 125.02 14.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -1.188 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.565 ' O ' ' CZ ' ' A' ' 65' ' ' TYR . . . 167.58 -156.98 29.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -70.71 -12.54 61.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -1.187 . . . . 0.0 109.442 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -114.3 138.64 50.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.44 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 62' ' ' GLY . 91.6 m-85 -130.69 150.27 51.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.92 -166.5 41.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 46.0 p90 -139.07 150.15 45.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 109.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.857 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.3 m -126.6 147.09 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 88' ' ' GLU . 70.2 mttt -109.54 147.23 33.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 57' ' ' ILE . 48.1 m-70 -125.21 140.1 53.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 87' ' ' ILE . 23.9 tttt -114.96 140.87 48.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.945 HD12 ' HB ' ' A' ' 53' ' ' THR . 65.3 mt -98.18 135.27 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.6 m-70 -89.35 -47.21 8.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -175.09 155.49 1.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.402 HG22 ' CE1' ' A' ' 82' ' ' TYR . 35.0 pt -131.05 144.69 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -127.26 93.11 3.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -62.99 -35.94 81.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -72.32 -39.91 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 80' ' ' HIS . 30.8 m120 -89.3 7.4 35.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.478 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASN . 37.4 m80 44.28 48.83 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -129.91 129.7 44.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.543 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 75' ' ' ILE . 52.6 t80 -122.19 129.93 52.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.255 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p -124.61 134.62 52.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 35.2 p90 -151.39 164.86 35.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.275 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 77.4 p -142.44 162.44 35.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 87' ' ' ILE . 4.6 tt -101.98 131.49 48.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.507 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.937 ' N ' HD23 ' A' ' 86' ' ' LEU . 80.3 mt -91.98 -76.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.434 -0.791 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.785 ' HG3' HG22 ' A' ' 87' ' ' ILE . 89.0 mt-10 -118.96 147.08 44.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.425 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.857 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -166.33 146.44 10.96 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 65' ' ' TYR . 4.1 t0 -49.2 -46.54 45.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -1.153 . . . . 0.0 109.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.94 -22.83 65.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.8 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.0 mp -86.77 -37.87 17.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 4.3 m 58.03 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 95.2 mt-10 -64.96 -9.17 19.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.76 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.978 ' HB3' HG11 ' A' ' 127' ' ' VAL . 23.1 m120 -77.41 -35.05 54.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 110.098 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.666 ' CD1' HD12 ' A' ' 129' ' ' ILE . 9.0 pt -152.1 106.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 110.189 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 93' ' ' SER . 15.7 mt-10 -135.13 107.49 7.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 109.184 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 122' ' ' HIS . 15.8 tttt -179.11 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.663 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 14.1 mt -125.99 123.64 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 54.2 t0 -104.48 113.15 26.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.434 -0.791 . . . . 0.0 108.905 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 73.5 m-85 -103.47 143.07 33.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.98 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -134.7 132.26 38.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.087 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.579 HG21 ' CE1' ' A' ' 23' ' ' PHE . 41.3 m -123.26 135.26 54.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -141.23 125.61 17.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 20' ' ' PHE . 22.1 mt -98.51 130.46 45.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.3 t -131.9 145.2 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 109.422 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -113.95 142.56 45.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.36 167.55 9.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.81 -14.64 36.2 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.698 2.265 . . . . 0.0 111.843 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -71.2 -16.75 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.02 -16.81 38.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.31 173.21 47.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.4 m -119.32 122.28 41.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -1.131 . . . . 0.0 109.53 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.1 mt -92.57 134.04 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 105' ' ' LEU . 25.3 mt -117.9 130.92 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -111.42 129.44 56.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.321 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.3 m -125.26 128.83 48.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.67 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.667 ' CG2' HG22 ' A' ' 5' ' ' THR . 38.9 m -115.25 135.85 53.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.35 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -123.26 140.13 53.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.696 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 10.9 ttpt -125.95 139.33 53.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.759 ' CD2' HG13 ' A' ' 134' ' ' VAL . 69.8 m-85 -122.44 135.6 54.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.2 m-70 -125.45 -167.11 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.3 p -135.33 152.53 51.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' ASN . 19.6 tptm -59.38 -53.61 56.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -168.74 -70.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.58 4.47 18.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -1.181 . . . . 0.0 109.967 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.978 HG11 ' HB3' ' A' ' 95' ' ' ASN . 43.1 t -95.34 115.76 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -96.11 170.58 9.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.593 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' A' ' 96' ' ' ILE . 16.2 tt -134.62 171.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 133' ' ' HIS . 23.1 mtpt -97.01 136.79 37.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.56 -33.76 70.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.65 -36.47 82.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CD2' ' HB2' ' A' ' 130' ' ' LYS . 36.3 m-70 -74.29 -39.25 63.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.377 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.759 HG13 ' CD2' ' A' ' 121' ' ' TYR . 58.5 t -67.44 -42.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -58.41 -40.67 83.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.68 -44.01 72.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.42 -42.76 95.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -57.9 -44.05 86.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.403 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 48.0 mttp -53.54 -44.59 69.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.06 79.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.05 84.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.513 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.466 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 66.8 t60 -60.03 -44.16 94.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.1 mt -59.13 -43.08 91.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.2 -38.26 65.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -61.3 -38.55 87.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' A' ' 34' ' ' ILE . 3.2 mm? -69.83 -29.75 67.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.84 HD12 HD21 ' A' ' 30' ' ' LEU . 34.0 mm -60.93 -44.19 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.36 -47.28 67.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.16 -30.96 71.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.594 ' CE1' ' HG2' ' A' ' 33' ' ' LYS . 61.4 t80 -63.46 -49.04 75.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.829 HD12 HD13 ' A' ' 14' ' ' ILE . 59.6 mt -61.46 -43.6 98.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -60.9 -42.63 98.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.11 -39.54 92.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.421 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.97 160.03 41.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.04 161.35 46.28 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.634 2.222 . . . . 0.0 111.844 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.1 m -53.31 -32.94 51.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.408 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -87.09 139.41 30.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -107.03 135.0 49.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.538 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 ' O ' ' A' ' 121' ' ' TYR . 11.7 p -118.32 143.66 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -112.13 144.68 41.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 40.5 m -93.76 141.25 28.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -117.51 132.09 56.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.59 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.79 137.28 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -118.56 154.16 33.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 114' ' ' ILE . 70.4 tt0 -133.96 109.87 9.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 43.0 t80 -122.66 128.78 51.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 21.1 p -92.32 149.47 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.296 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.3 p -146.18 166.73 25.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -0.949 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 14' ' ' ILE . 99.3 m-20 -73.17 -175.7 1.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 65.41 142.48 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.107 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.7 Cg_endo -69.0 146.37 64.62 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.414 2.076 . . . . 0.0 112.041 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -45.13 -48.12 32.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 111.401 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.72 -40.11 30.99 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.231 1.954 . . . . 0.0 113.094 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.556 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 29.7 mttm -67.97 -37.44 81.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -80.57 -28.0 37.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.721 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.549 ' HD1' HD23 ' A' ' 105' ' ' LEU . 68.7 t80 -65.91 -33.83 76.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.132 -0.98 . . . . 0.0 109.821 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.891 ' HG3' HD12 ' A' ' 25' ' ' LEU . 73.5 tttt -66.75 -46.25 75.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.614 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.06 40.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.698 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.798 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 65.4 t80 -80.52 -19.98 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.549 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 77.2 t -117.15 -63.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.891 HD12 ' HG3' ' A' ' 21' ' ' LYS . 32.4 mt -56.88 -40.74 76.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.302 -0.874 . . . . 0.0 109.581 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.9 m-20 -100.34 15.29 28.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.78 -41.57 74.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.685 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.708 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.4 m-20 -66.07 -30.36 70.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.714 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 94.1 m-20 -97.33 -32.18 12.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 109.589 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 28.4 tp -69.9 -46.5 65.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 27' ' ' ALA . 5.7 mt -47.0 -57.36 9.37 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.2 Cg_endo -68.73 -25.77 33.43 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.52 2.146 . . . . 0.0 111.867 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 60.7 tttt -75.51 -44.25 44.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.561 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' A' ' 147' ' ' LEU . 62.6 mt -67.78 -34.18 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.677 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.21 72.66 32.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.504 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.1 Cg_endo -70.53 -34.4 12.09 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.713 2.275 . . . . 0.0 111.782 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.22 78.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.733 HG12 ' CE1' ' A' ' 59' ' ' PHE . 23.7 m -125.37 155.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -73.22 -44.64 59.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.79 129.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.13 126.19 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -122.47 150.19 42.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.708 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.7 mt -106.35 121.47 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -65.74 -43.99 87.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.412 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.24 155.06 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.64 -41.0 2.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 89.2 m-20 60.54 40.47 16.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -1.102 . . . . 0.0 109.481 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.833 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.74 35.98 12.48 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.69 13.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.7 128.26 15.83 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.698 2.266 . . . . 0.0 111.715 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.65 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 90.0 m -81.07 143.32 32.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 109.587 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 45' ' ' LEU . 62.5 mt -110.14 131.67 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.313 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 50.3 mttt -116.42 150.42 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.589 ' HB2' HD11 ' A' ' 45' ' ' LEU . 25.1 tttm -129.63 125.87 37.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.188 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 68' ' ' VAL . 32.6 mt -117.39 137.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 50.4 m -114.51 133.2 55.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.733 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.2 m-85 -103.53 130.33 50.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . -93.99 -69.29 1.08 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.24 133.47 39.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 0.0 109.377 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 -172.18 49.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.5 m 46.32 25.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -1.121 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' TYR . 56.3 m170 46.2 45.78 12.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 15.3 m-85 44.06 36.09 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -90.49 -179.33 43.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.474 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 44.1 p90 -144.05 146.72 33.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -1.106 . . . . 0.0 109.398 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 10.8 m -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 86' ' ' LEU . 81.5 mttt -119.46 147.58 44.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.582 ' NE2' HD13 ' A' ' 86' ' ' LEU . 62.6 m80 -115.95 166.57 11.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.231 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' SER . 42.5 tttp -143.78 140.72 30.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.473 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.4 mt -104.95 127.51 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 74' ' ' SER . 98.6 m-70 -88.8 -29.98 19.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 91.9 p 178.1 154.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.784 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' ILE . 38.3 pt -135.04 139.56 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -122.7 93.29 3.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -63.27 -37.89 89.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.267 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.06 -41.18 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -88.59 6.18 39.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.561 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m80 46.54 50.57 12.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.2 m -129.76 132.64 46.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.522 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 69.2 t80 -125.19 128.89 49.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.29 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -127.49 139.35 52.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.4 p90 -158.41 177.49 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.437 -0.789 . . . . 0.0 109.091 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' LYS . 89.1 p -151.7 154.77 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.898 ' CD2' HD11 ' A' ' 92' ' ' LEU . 25.5 tp -87.91 124.01 33.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.098 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.856 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.5 mt -80.69 -75.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.852 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.856 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.6 mt-10 -126.46 158.24 36.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 0.0 109.836 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -178.0 134.72 2.49 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 51.2 m-20 -50.67 -37.69 42.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -1.16 . . . . 0.0 109.367 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.36 -17.37 63.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.152 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.898 HD11 ' CD2' ' A' ' 86' ' ' LEU . 6.8 mp -82.6 -42.11 18.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 3.3 t 60.13 177.18 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.523 ' O ' ' CD ' ' A' ' 124' ' ' LYS . 97.9 mt-10 -78.89 -3.09 42.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' HA ' ' HE3' ' A' ' 124' ' ' LYS . 34.0 p-10 -90.76 -21.37 21.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 41.6 mt -112.39 132.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.069 -1.02 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 94.4 mt-10 -90.62 -178.56 5.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.148 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.676 ' NZ ' HG23 ' A' ' 87' ' ' ILE . 75.6 mttt -56.14 156.63 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.361 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 120' ' ' LYS . 55.4 mt -118.4 136.2 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.668 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 120' ' ' LYS . 91.7 m-20 -92.15 123.84 35.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.395 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 76.2 m-85 -113.79 139.17 49.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.9 mt-10 -134.33 138.85 45.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.403 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.707 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.3 m -127.96 137.45 52.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 105' ' ' LEU . 54.8 tttt -139.14 125.32 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -101.5 129.56 47.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' ILE . 50.8 t -131.78 144.33 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -109.64 151.99 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.1 160.68 28.09 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.2 Cg_endo -69.95 -17.0 36.97 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.639 2.226 . . . . 0.0 111.855 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -77.58 -12.3 59.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.53 30.46 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.46 172.3 55.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 99.7 m -124.61 128.23 48.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -1.123 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.628 HG21 ' OE2' ' A' ' 9' ' ' GLU . 64.5 mt -99.06 136.24 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 105' ' ' LEU . 62.7 mt -119.75 131.19 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 51.8 mttp -116.84 125.85 52.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -126.07 137.86 53.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 56.3 m -119.86 135.52 54.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -123.33 137.59 54.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.705 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 99' ' ' ILE . 67.5 tttt -143.76 134.45 25.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.235 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.015 ' O ' HG21 ' A' ' 3' ' ' VAL . 39.4 p90 -132.53 146.56 52.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 94.9 m-70 -108.78 159.17 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.495 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.771 ' HB ' HG22 ' A' ' 127' ' ' VAL . 28.6 p -131.17 161.76 31.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' GLU . 4.2 mtmp? -56.94 -35.0 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.389 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -172.58 64.75 0.13 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 90.6 m-20 60.72 38.61 18.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -1.134 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.771 HG22 ' HB ' ' A' ' 123' ' ' THR . 18.6 m -48.95 135.2 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.74 139.17 39.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 tt -129.5 170.8 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.539 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 43.2 mttt -92.39 129.23 38.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -55.7 -38.07 69.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.29 -37.56 80.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.373 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.539 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 64.4 m170 -67.61 -43.98 79.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.261 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.44 -45.67 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 109.472 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 24.8 tttt -60.67 -43.83 97.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -59.23 -46.78 87.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA2' ' CE ' ' A' ' 140' ' ' LYS . . . -59.23 -42.58 97.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.63 -45.85 92.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.117 . . . . 0.0 109.334 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 94.9 mt-10 -61.94 -42.46 99.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 55.9 mtmt -59.0 -43.97 91.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.7 72.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.383 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.44 79.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -59.26 -47.4 85.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.297 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 53.6 mt -53.45 -48.82 68.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.417 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HA ' HD12 ' A' ' 148' ' ' ILE . 72.8 m-85 -54.01 -37.86 64.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -58.75 -41.44 86.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.689 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -68.33 -37.7 80.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.299 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 23' ' ' PHE . 81.7 mt -59.34 -48.6 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.283 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.5 -47.61 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.02 -33.55 84.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.42 -46.9 80.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 14' ' ' ILE . 64.3 mt -66.15 -40.03 90.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -64.09 -41.17 97.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.71 -33.94 77.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 109.514 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 132.62 75.23 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.09 152.74 67.73 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.662 2.241 . . . . 0.0 111.856 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' ASN . 21.1 t -70.6 148.91 47.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.444 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.57 -32.97 74.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 160' ' ' ASN . 18.9 m-30 -62.58 -34.82 77.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 157' ' ' SER . 43.4 p-10 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.845 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p -113.53 140.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -92.17 141.45 28.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.563 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 38.7 m -93.66 142.66 27.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -119.67 144.35 47.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.533 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' HD3' ' A' ' 116' ' ' LYS . 85.5 tt0 -112.81 141.55 46.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -116.04 142.82 46.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -121.23 138.79 54.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.5 t80 -156.3 145.27 20.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.6 p -112.46 147.64 36.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -150.46 171.62 16.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' ILE . 6.8 t70 -78.66 179.54 7.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.34 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 70.2 142.11 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 109.155 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.6 Cg_endo -68.75 145.9 64.68 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.566 2.177 . . . . 0.0 112.148 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 105' ' ' LEU . . . -46.09 -47.62 43.36 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 111.543 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.1 Cg_endo -64.32 -37.17 41.54 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.081 1.854 . . . . 0.0 113.003 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 78.6 mttt -71.42 -32.43 68.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.884 -1.135 . . . . 0.0 109.556 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.8 tp -80.8 -30.38 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CE1' ' HB2' ' A' ' 82' ' ' TYR . 75.0 t80 -61.09 -41.47 96.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.594 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.583 ' NZ ' HD23 ' A' ' 25' ' ' LEU . 34.1 tttm -65.16 -52.81 52.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.632 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -8.11 52.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.988 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.6 t80 -85.45 -34.67 21.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.575 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.841 HG11 ' CD1' ' A' ' 82' ' ' TYR . 33.1 m -114.48 -37.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.583 HD23 ' NZ ' ' A' ' 21' ' ' LYS . 17.5 tp -71.18 -38.55 72.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.662 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.2 m-20 -108.09 14.38 25.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.9 -39.69 76.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.533 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.655 ' OD2' HD11 ' A' ' 44' ' ' ILE . 89.3 m-20 -58.62 -33.03 69.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.624 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.0 t30 -101.38 -35.91 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.968 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.1 tm? -72.49 -37.47 68.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 27' ' ' ALA . 28.7 mt -50.79 -55.8 24.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.2 Cg_endo -68.47 -18.91 43.51 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.43 2.087 . . . . 0.0 111.821 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 40.2 mttt -71.03 -36.71 72.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 HG23 ' HG ' ' A' ' 147' ' ' LEU . 79.7 mt -66.63 -29.27 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.87 72.2 5.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.6 Cg_endo -69.89 -32.27 18.35 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.665 2.244 . . . . 0.0 111.771 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -75.23 -25.83 58.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.63 -39.49 64.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 57' ' ' ILE . 3.5 p -118.06 151.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -77.56 -47.94 18.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 129.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.22 128.02 34.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -122.52 148.59 44.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.655 HD11 ' OD2' ' A' ' 28' ' ' ASP . 65.6 mt -106.45 118.14 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.428 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.8 mp -61.67 -45.41 94.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' HG23 ' A' ' 53' ' ' THR . 67.5 mm-40 -157.83 156.04 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.23 -41.01 2.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 59.1 36.73 24.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.837 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.17 33.31 10.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.83 -164.99 12.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.72 130.77 19.96 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 30.93 70.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 46' ' ' GLU . 89.3 m -86.36 141.9 28.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.506 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.3 mt -109.57 129.95 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.335 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.491 ' HE3' HD11 ' A' ' 72' ' ' ILE . 48.0 mttt -116.2 146.56 42.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.613 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 tttm -131.06 122.33 26.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 39' ' ' VAL . 28.5 mt -114.98 137.95 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -118.57 131.04 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -104.07 135.81 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.562 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.7 -170.06 54.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.95 -30.2 67.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -1.141 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.06 5.79 62.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.1 p -65.78 -24.42 66.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -125.75 176.08 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.898 . . . . 0.0 109.454 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -54.27 168.64 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 126.21 65.39 0.16 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.5 p90 -151.45 144.25 24.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -1.14 . . . . 0.0 109.61 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 86' ' ' LEU . 48.4 t -122.28 146.46 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 87' ' ' ILE . 26.8 mttt -119.83 139.52 52.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 77.2 m80 -119.64 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.2 tttt -112.61 141.17 46.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 109.553 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' A' ' 53' ' ' THR . 66.6 mt -99.51 134.54 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -91.73 -49.16 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.9 p -167.61 154.7 8.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.53 144.39 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 74.8 m-20 -128.73 91.19 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -63.75 -34.63 78.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.43 -39.24 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 30.2 m120 -87.82 4.8 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.5 m80 48.12 46.04 19.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.2 m -130.96 132.14 44.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.841 ' CD1' HG11 ' A' ' 24' ' ' VAL . 78.5 t80 -124.88 121.27 34.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.353 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.1 p -111.81 139.91 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 33.0 p90 -155.59 167.95 28.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 90.4 p -146.31 158.28 43.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.995 HD22 ' CD1' ' A' ' 92' ' ' LEU . 5.4 tt -96.5 121.96 38.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.822 HG22 ' HG3' ' A' ' 88' ' ' GLU . 94.8 mt -76.75 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.871 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.8 mt-10 -133.44 159.92 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.93 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.36 162.2 32.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 39.2 m-20 -65.05 -29.62 70.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 109.631 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.59 -21.75 48.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.995 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 mt -78.68 -30.17 45.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 108.999 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 92' ' ' LEU . 66.6 m 46.37 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.88 9.88 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.633 ' HB3' HG21 ' A' ' 127' ' ' VAL . 76.3 m-20 -110.14 -15.55 13.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 91' ' ' ALA . 18.7 mt -109.36 137.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 122' ' ' HIS . 99.6 mt-10 -84.55 -179.4 7.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.299 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 35.4 mtmm -57.21 164.43 1.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 120' ' ' LYS . 53.4 mt -121.79 131.85 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.525 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 120' ' ' LYS . 90.2 m-20 -90.74 126.33 35.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 66.6 m-85 -116.93 142.06 47.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.2 mt-10 -129.19 136.08 49.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.8 m -125.95 129.25 48.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.492 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.0 tttt -130.36 128.1 40.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.169 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.0 mm? -99.47 123.3 43.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.2 t -130.83 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 72.2 m -113.78 153.43 29.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.56 162.44 20.59 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.1 Cg_endo -69.79 -18.83 36.66 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.613 2.209 . . . . 0.0 111.713 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -67.3 -15.43 63.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.877 . . . . 0.0 109.375 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.92 35.6 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.54 176.37 44.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 16' ' ' ALA . 98.1 m -117.76 129.26 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.2 mt -98.92 131.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.62 HG23 HD13 ' A' ' 105' ' ' LEU . 39.8 mt -117.38 132.72 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.621 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HD3' ' OE2' ' A' ' 7' ' ' GLU . 84.5 mttt -117.68 132.27 56.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.31 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.4 m -130.77 126.92 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.542 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.8 m -108.71 145.76 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -130.85 137.23 49.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.831 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 3' ' ' VAL . 22.1 tttt -141.67 131.78 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.155 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.845 ' O ' HG21 ' A' ' 3' ' ' VAL . 42.5 p90 -129.02 148.09 50.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.426 ' HB3' ' OE1' ' A' ' 97' ' ' GLU . 77.5 m80 -116.58 166.72 11.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 126' ' ' ASP . 35.1 p -129.94 156.97 43.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.77 -41.75 78.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -141.42 42.66 1.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 123' ' ' THR . 91.1 m-20 60.19 46.46 10.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 95' ' ' ASN . 9.6 p -55.0 -21.5 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 83.6 tt0 63.79 143.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 tt -124.25 170.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.419 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 30.0 mttp -85.56 122.27 29.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.943 . . . . 0.0 109.293 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -47.52 -37.83 12.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.152 -0.967 . . . . 0.0 109.431 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 70.2 mm-40 -57.29 -38.83 74.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.312 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.419 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 67.2 m170 -66.16 -44.33 84.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.325 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.51 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 109.274 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -56.48 -42.55 78.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.62 97.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.81 93.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -58.89 -44.01 91.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.306 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.37 -39.67 89.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 18.7 tttt -58.25 -45.53 87.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 109.36 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.69 -47.9 73.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.79 88.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.381 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 147' ' ' LEU . 7.6 m-70 -58.98 -46.81 87.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 59.8 mt -55.57 -50.97 68.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.385 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 141' ' ' ALA . 73.5 m-85 -53.46 -38.04 63.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -61.97 -42.35 99.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HG ' HG23 ' A' ' 34' ' ' ILE . 4.1 mm? -63.93 -45.02 91.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 19' ' ' LEU . 72.1 mt -55.63 -54.54 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.64 -29.95 53.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.93 -32.07 59.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 57.7 m-85 -73.03 -43.25 62.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.3 mp -75.12 -45.75 38.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -55.74 -34.47 65.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.985 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.17 -32.82 21.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.342 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 60.1 60.09 4.13 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 151' ' ' TYR . 49.7 Cg_endo -70.38 147.93 59.96 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.707 2.272 . . . . 0.0 111.664 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.4 m -116.62 147.3 42.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -106.74 148.41 28.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -64.21 -32.49 74.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.538 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 7.7 p -105.86 142.6 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -1.202 . . . . 0.0 109.452 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.89 136.63 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 29.1 m -93.61 137.19 33.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 109.367 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.554 ' CE2' ' HE3' ' A' ' 138' ' ' LYS . 68.4 t80 -119.64 132.79 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -113.94 135.53 53.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.85 . . . . 0.0 109.357 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 42.4 t-20 -119.64 141.12 49.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -115.1 138.14 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 78.1 t80 -154.9 146.53 23.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.8 p -113.22 147.17 38.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.422 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 59.8 p -149.61 171.67 16.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.651 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' O ' HD12 ' A' ' 14' ' ' ILE . 13.4 t0 -77.85 -175.45 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.71 141.06 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.9 Cg_endo -69.66 147.16 62.87 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.618 2.212 . . . . 0.0 112.115 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.695 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -40.86 -50.32 7.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.08 -45.75 9.53 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.297 1.998 . . . . 0.0 113.003 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 20.9 mttm -61.42 -33.04 73.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.782 -1.199 . . . . 0.0 109.542 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD12 HD22 ' A' ' 152' ' ' LEU . 12.4 tp -80.55 -31.75 36.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.725 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.878 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 73.7 t80 -69.0 -32.05 71.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 109.848 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.749 ' HG3' HD12 ' A' ' 25' ' ' LEU . 23.2 tttt -65.98 -44.57 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.609 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.55 -19.73 32.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 103' ' ' THR . 55.9 t80 -83.29 -15.92 48.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.3 t -118.53 -63.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.363 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.749 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.1 mt -57.97 -43.63 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.8 m-20 -96.24 15.42 21.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.391 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.735 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -69.49 -22.23 63.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.664 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.2 m-20 -77.36 -35.54 54.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.401 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 m120 -98.01 -31.5 12.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 148' ' ' ILE . 18.4 tp -63.3 -39.06 93.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -55.53 -59.42 11.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 50.5 Cg_endo -70.67 -11.27 29.39 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.674 2.249 . . . . 0.0 111.605 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -73.33 -43.94 59.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.857 . . . . 0.0 109.395 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.128 HG23 ' CD2' ' A' ' 147' ' ' LEU . 86.5 mt -66.6 -38.81 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.71 76.44 23.91 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.47 -31.64 17.01 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.714 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -74.49 -22.6 58.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.845 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -71.81 -37.53 70.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.87 . . . . 0.0 109.362 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG21 ' CG2' ' A' ' 57' ' ' ILE . 2.6 p -120.45 146.35 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -73.64 -45.99 49.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.1 142.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.563 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.97 130.32 53.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -127.63 154.12 45.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.664 HD11 ' OD2' ' A' ' 28' ' ' ASP . 25.9 mt -105.85 122.04 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -68.15 -43.76 77.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.361 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.3 157.7 31.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.47 -40.46 2.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 58.95 37.44 24.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.697 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.91 26.32 29.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -111.63 -166.3 18.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.93 130.07 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.682 2.255 . . . . 0.0 111.757 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.27 69.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.922 HG23 ' O ' ' A' ' 46' ' ' GLU . 97.9 m -80.77 142.53 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -1.181 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HD13 ' A' ' 45' ' ' LEU . 64.3 mt -112.86 130.1 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HG2' HG23 ' A' ' 44' ' ' ILE . 71.7 mttt -124.75 146.38 49.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.647 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 44.4 tttt -122.83 121.72 36.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.668 HD12 ' CD2' ' A' ' 70' ' ' HIS . 17.4 mt -114.75 132.51 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.2 m -113.12 116.82 30.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 53.9 p90 -119.99 143.54 47.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' HA3' ' CD1' ' A' ' 65' ' ' TYR . . . -126.53 46.98 1.04 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.845 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 97.6 mt-10 -67.44 -42.76 82.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.52 175.1 54.45 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.6 p -56.33 -24.81 46.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.57 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -105.25 -174.75 2.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.545 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 98.9 m-85 -119.07 131.72 55.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -126.05 174.88 17.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 36.7 p90 -157.76 144.25 17.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -1.204 . . . . 0.0 109.545 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.1 m -125.55 147.83 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' HD12 ' A' ' 86' ' ' LEU . 51.1 mttt -103.29 144.69 31.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.987 ' CE1' HD13 ' A' ' 86' ' ' LEU . 64.3 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.9 tttm -125.02 139.09 54.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.56 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.82 HD12 ' HB ' ' A' ' 53' ' ' THR . 70.6 mt -100.95 129.63 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.07 -45.76 9.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -170.3 141.42 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.621 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 pt -123.42 143.83 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -127.77 91.27 3.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -63.59 -37.34 86.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.76 -42.72 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -86.15 3.09 44.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 56.0 m80 52.97 45.12 29.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.109 -0.995 . . . . 0.0 109.491 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -126.76 139.83 52.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.6 t80 -132.98 125.77 30.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -120.76 127.36 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 36.1 p90 -146.64 171.14 15.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 69.1 p -151.5 151.36 31.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.0 109.704 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.987 HD13 ' CE1' ' A' ' 70' ' ' HIS . 32.1 tp -88.71 108.02 19.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.853 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' A' ' 88' ' ' GLU . 95.9 mt -59.11 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.853 ' HG2' HG22 ' A' ' 87' ' ' ILE . 78.2 mm-40 -138.96 169.74 17.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.724 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.86 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -179.55 135.79 2.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 69.3 m-20 -50.37 -41.27 51.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.485 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.74 68.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.624 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.5 mp -78.64 -33.4 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 4.0 m 61.47 178.19 0.12 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.299 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 98.2 mt-10 -78.86 -13.95 59.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.555 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.831 ' O ' HG11 ' A' ' 127' ' ' VAL . 15.2 m120 -78.11 -28.69 48.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 34.4 mt -105.84 125.83 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.101 -0.999 . . . . 0.0 109.746 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 91.3 mt-10 -80.89 -179.41 7.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.16 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 17.5 ptpt -57.02 159.4 4.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 120' ' ' LYS . 69.5 mt -117.79 138.65 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.596 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 61.1 t0 -95.13 125.72 39.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 90.9 m-85 -117.3 134.08 55.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -123.71 137.64 54.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.807 HG21 ' CE1' ' A' ' 23' ' ' PHE . 30.9 m -127.99 136.72 51.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.573 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.5 tttt -139.77 125.62 19.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.906 HD13 HG23 ' A' ' 115' ' ' ILE . 2.7 mm? -100.16 130.01 46.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.4 t -131.79 140.66 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.6 p -113.27 148.38 35.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.86 164.59 14.38 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.2 Cg_endo -70.34 -10.73 28.73 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 111.74 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -76.02 -15.52 60.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.06 -19.02 28.05 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.88 170.68 45.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.695 HG21 ' HA ' ' A' ' 16' ' ' ALA . 88.4 m -123.8 127.04 47.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.149 . . . . 0.0 109.605 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.3 mt -96.95 139.2 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 109.235 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.906 HG23 HD13 ' A' ' 105' ' ' LEU . 4.7 mt -124.62 121.96 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 45.0 mttt -107.67 139.11 42.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.075 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 m -127.98 130.06 47.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 110.076 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -125.97 140.28 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.875 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -145.21 155.54 43.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 110.196 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 99' ' ' ILE . 25.5 mttp -129.97 148.53 51.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.528 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 80.4 m-85 -118.13 121.81 41.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 0.0 109.834 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 61.2 m170 -89.86 143.5 26.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.51 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 28.5 p -129.51 157.62 41.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.771 ' HE3' HG12 ' A' ' 127' ' ' VAL . 4.8 mtmt -52.05 -45.81 64.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.36 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 164.02 -43.96 0.31 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 52.9 p30 -135.52 18.89 3.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.831 HG11 ' O ' ' A' ' 95' ' ' ASN . 8.3 m -54.21 -40.6 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 127' ' ' VAL . 95.4 mt-10 61.6 128.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.571 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.27 171.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -99.62 133.31 44.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -56.38 -35.49 67.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.443 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.27 -38.69 84.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.13 -41.71 81.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.27 -41.43 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -61.25 -37.2 82.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -60.87 -44.28 97.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.53 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.55 -41.24 99.81 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HE3' ' CE2' ' A' ' 6' ' ' TYR . 63.6 tttm -59.72 -42.17 92.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -1.147 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.5 ' HB3' ' CE1' ' A' ' 143' ' ' HIS . 75.1 mm-40 -64.38 -36.36 83.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.544 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.457 ' O ' HD13 ' A' ' 144' ' ' LEU . 84.6 mttt -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.73 69.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 109.478 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.9 -42.23 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.5 ' CE1' ' HB3' ' A' ' 139' ' ' GLU . 36.6 m80 -59.86 -50.64 73.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.411 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 6.6 mp -68.23 -48.0 66.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.803 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 62.3 t80 -52.96 -45.44 67.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -58.0 -40.65 81.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.128 ' CD2' HG23 ' A' ' 34' ' ' ILE . 17.1 tp -60.08 -39.47 86.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 30' ' ' LEU . 76.0 mt -53.76 -52.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.278 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 81.5 tt0 -54.73 -38.84 67.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.194 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 154' ' ' ASP . . . -61.33 -35.69 91.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 147' ' ' LEU . 15.4 m-85 -71.38 -42.45 68.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.09 . . . . 0.0 109.337 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 19' ' ' LEU . 6.4 mp -75.51 -37.85 59.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.6 tttp -60.13 -36.58 77.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 26.2 p30 -101.47 -9.8 20.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -44.51 139.79 3.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 160' ' ' ASN . 49.0 Cg_endo -69.53 -24.89 30.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.732 2.288 . . . . 0.0 111.808 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 90.8 p -60.93 -29.07 69.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.377 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 160' ' ' ASN . 76.5 mm-40 -112.32 160.57 17.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 158' ' ' GLU . 58.1 t80 66.94 -63.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 158' ' ' GLU . 11.6 m120 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p -117.42 139.76 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -1.158 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -110.81 154.07 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.417 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 120' ' ' LYS . 23.5 m -94.1 140.36 29.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -111.81 139.77 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -113.25 140.35 48.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -130.1 160.07 34.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.56 ' OE2' HG21 ' A' ' 114' ' ' ILE . 74.6 tt0 -142.72 130.8 21.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 75.7 t80 -141.78 140.32 33.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.565 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.0 p -90.68 143.56 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.956 ' OG ' HD11 ' A' ' 115' ' ' ILE . 83.3 p -141.06 161.29 38.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.588 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 14' ' ' ILE . 29.4 t0 -78.35 179.7 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.29 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.6 141.88 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.232 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.3 Cg_endo -69.32 146.98 64.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.507 2.138 . . . . 0.0 112.158 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.62 -50.57 7.02 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 111.39 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.77 -49.98 3.63 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.23 1.953 . . . . 0.0 112.923 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.8 mttm -60.75 -35.98 77.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.866 -1.146 . . . . 0.0 109.672 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 19' ' ' LEU . 25.4 tp -81.01 -28.4 35.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.973 ' HB2' HD12 ' A' ' 105' ' ' LEU . 69.4 t80 -69.54 -35.01 75.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.82 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HG3' HD12 ' A' ' 25' ' ' LEU . 29.8 tttp -67.34 -37.87 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -88.54 -30.77 19.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.64 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.83 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.6 t80 -77.3 -12.15 59.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -117.76 -63.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' HG3' ' A' ' 21' ' ' LYS . 47.8 mt -65.3 -41.43 94.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.8 m-20 -94.82 9.65 38.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.529 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.19 -45.54 66.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.954 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.563 ' OD2' HD11 ' A' ' 44' ' ' ILE . 94.6 m-20 -65.1 -25.31 67.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 58.8 t30 -101.27 -33.88 9.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.597 HD11 ' CD2' ' A' ' 151' ' ' TYR . 22.0 tp -75.27 -34.56 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 27' ' ' ALA . 34.9 mt -51.34 -54.94 33.2 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.707 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -69.07 -20.32 38.23 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.425 2.084 . . . . 0.0 111.988 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 30' ' ' LEU . 30.2 mmtt -71.32 -34.99 71.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.44 -27.99 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.97 64.62 42.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.5 -46.14 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.671 2.247 . . . . 0.0 111.705 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -65.63 -22.87 66.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -73.29 -50.52 21.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 57' ' ' ILE . 7.4 p -111.61 149.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.476 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -73.25 -46.2 51.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.51 131.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.35 128.03 34.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.439 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -123.93 142.88 50.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.563 HD11 ' OD2' ' A' ' 28' ' ' ASP . 56.1 mt -106.46 118.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 27.2 tp -60.2 -44.94 94.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 53' ' ' THR . 94.9 mt-10 -159.68 157.02 28.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 105.6 -42.06 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 58.26 37.41 26.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.871 ' H ' HG21 ' A' ' 53' ' ' THR . . . 86.11 31.35 20.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -115.56 -166.28 14.81 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.7 130.9 20.23 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.737 2.291 . . . . 0.0 111.598 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.74 29.62 73.94 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' H ' ' A' ' 49' ' ' GLY . 94.3 m -82.76 140.64 32.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 44' ' ' ILE . 22.3 mm -105.81 129.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.276 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 91.3 mttt -114.74 147.3 39.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.655 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 57.3 tttm -131.02 121.52 25.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 0.0 109.297 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 39' ' ' VAL . 60.8 mt -114.04 135.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.6 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 m -123.96 119.46 29.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 33.6 p90 -124.48 143.5 50.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.47 86.99 0.62 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -51.13 -38.11 50.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.67 -100.25 0.22 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.1 m -62.0 -28.22 69.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -129.1 155.15 45.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.504 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -116.05 143.57 45.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -138.84 170.96 23.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 38.9 p90 -155.76 144.09 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.139 . . . . 0.0 109.657 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.046 HG12 HD11 ' A' ' 86' ' ' LEU . 43.0 t -124.08 144.48 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 35.2 mttt -116.9 139.66 50.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.6 ' NE2' HD13 ' A' ' 86' ' ' LEU . 79.7 m80 -116.98 144.87 44.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' CB ' HD11 ' A' ' 87' ' ' ILE . 25.0 tttt -124.01 142.39 51.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.703 HD12 ' HB ' ' A' ' 53' ' ' THR . 58.3 mt -102.96 131.07 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.411 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 97.2 m-70 -90.5 -48.64 6.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.2 m -163.81 149.49 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -129.89 145.47 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 82.0 m-20 -128.3 91.16 3.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -62.31 -37.66 86.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.96 -40.67 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.4 m-20 -87.8 7.88 28.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 46.5 m80 45.72 40.34 6.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -119.46 136.43 54.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.4 t80 -127.52 126.28 41.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 t -121.06 128.16 52.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 34.1 p90 -145.72 170.26 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -148.1 157.96 43.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.046 HD11 HG12 ' A' ' 68' ' ' VAL . 22.6 tp -93.27 136.75 33.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.58 HG23 ' HE3' ' A' ' 98' ' ' LYS . 26.9 mm -99.13 -71.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.0 mt-10 -118.98 160.78 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 172.44 128.59 1.06 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 38.0 m-20 -46.21 -31.82 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 109.604 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.56 68.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD21 HD23 ' A' ' 86' ' ' LEU . 3.6 mt -74.69 -33.03 62.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 3.5 m 53.14 -177.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.66 -0.65 . . . . 0.0 109.567 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.0 12.53 7.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 26.7 p-10 -111.72 -10.75 14.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mt -114.5 140.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 93.7 mt-10 -91.96 -179.52 5.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.312 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HE3' HG23 ' A' ' 87' ' ' ILE . 52.2 mttp -57.08 161.91 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.492 HG12 ' HB2' ' A' ' 121' ' ' TYR . 49.0 mt -120.47 135.62 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.608 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 120' ' ' LYS . 60.6 t0 -93.04 120.13 33.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 73.1 m-85 -113.8 139.13 49.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.48 135.34 44.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.318 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 m -131.11 135.64 47.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -139.18 129.13 25.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.888 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 20' ' ' PHE . 31.6 mt -98.69 129.61 45.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.7 t -132.05 136.17 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.9 OUTLIER -111.2 146.6 36.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.861 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -106.54 171.38 4.8 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.861 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.4 Cg_endo -69.52 -15.06 37.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.666 2.244 . . . . 0.0 111.791 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.79 -20.81 61.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.9 -25.61 11.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.44 171.55 51.37 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 93.8 m -125.87 124.62 41.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.56 HG21 ' OE2' ' A' ' 9' ' ' GLU . 68.0 mt -97.5 139.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.263 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.956 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.2 mt -121.57 127.96 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.741 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 50.5 mttp -105.87 127.98 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 m -123.43 133.65 54.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.462 ' CG2' HG22 ' A' ' 5' ' ' THR . 60.8 m -119.79 133.54 55.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 0.0 109.016 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -120.32 131.33 54.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 110.006 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HB2' HG23 ' A' ' 5' ' ' THR . 78.5 tttt -140.66 130.35 24.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 3' ' ' VAL . 32.9 p90 -132.11 149.17 52.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.805 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.5 ' ND1' HG11 ' A' ' 3' ' ' VAL . 98.8 m-70 -114.15 158.67 21.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.183 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.428 ' CA ' ' HG3' ' A' ' 97' ' ' GLU . 82.2 p -130.52 157.09 43.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -55.01 -25.88 33.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.268 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . 160.01 43.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 91.0 m-20 61.92 41.97 10.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 95' ' ' ASN . 60.8 t -53.1 -55.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.432 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -176.44 103.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.22 171.79 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -135.81 133.36 37.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.65 -38.72 67.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.41 -36.69 83.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.373 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -65.13 -46.45 80.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.94 -46.93 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 54.4 tttt -57.92 -41.21 82.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.38 77.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.9 . . . . 0.0 109.363 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.93 93.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.8 mtmm -64.28 -39.03 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 109.327 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.77 -38.52 91.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.415 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.24 -40.52 70.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.338 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.47 88.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.336 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.19 -53.21 60.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HA ' HD23 ' A' ' 147' ' ' LEU . 25.4 mt -62.0 -36.07 80.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 109.39 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.915 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 46.6 t80 -53.44 -43.06 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.197 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 59.4 tttm -59.29 -38.63 80.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -62.58 -36.13 81.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.231 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.538 HD13 ' HD1' ' A' ' 23' ' ' PHE . 98.8 mt -53.68 -55.74 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.163 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' OE2' ' CE2' ' A' ' 145' ' ' PHE . 40.5 mp0 -54.33 -43.74 71.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.943 . . . . 0.0 109.043 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.48 -29.45 71.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.597 ' CD2' HD11 ' A' ' 30' ' ' LEU . 54.5 t80 -61.16 -43.58 98.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.3 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.713 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.4 mp -75.49 -44.7 42.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.226 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -53.31 -33.89 55.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 108.701 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.89 -34.14 57.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 74.79 1.14 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 158' ' ' GLU . 49.6 Cg_endo -69.29 -40.33 6.21 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.794 2.329 . . . . 0.0 112.01 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 65.4 m 47.61 24.32 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.251 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 156' ' ' PRO . 94.0 mt-10 -55.36 139.61 42.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.76 141.43 46.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.454 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.988 HG21 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -111.55 145.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -1.137 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.31 149.57 39.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 118' ' ' THR . 27.6 m -93.56 140.99 28.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.46 137.98 53.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.616 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -108.02 132.76 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.27 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.06 133.41 53.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.52 131.86 54.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.435 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 86.0 t80 -146.56 149.48 33.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 22.0 p -117.96 149.9 40.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 23.2 t -148.51 164.57 33.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.636 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.796 ' O ' HD12 ' A' ' 14' ' ' ILE . 21.1 t0 -72.71 -178.44 2.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 HD12 ' A' ' 152' ' ' LEU . 1.0 OUTLIER 69.05 142.06 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.273 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.8 Cg_endo -69.65 147.21 63.09 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 111.964 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -38.71 -51.44 3.76 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.507 -0.745 . . . . 0.0 111.267 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.19 -50.66 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.318 2.012 . . . . 0.0 113.068 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 95.6 mttt -59.1 -34.98 72.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.808 -1.182 . . . . 0.0 109.55 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 152' ' ' LEU . 22.4 tp -80.77 -36.86 31.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 24' ' ' VAL . 60.0 t80 -57.87 -32.6 67.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HA ' HD13 ' A' ' 25' ' ' LEU . 19.8 tttt -71.57 -52.39 18.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 109.623 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.44 3.06 14.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.0 t80 -99.86 -33.37 10.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.793 ' CG2' HD12 ' A' ' 25' ' ' LEU . 9.8 m -114.19 -46.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.888 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.793 HD12 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -68.7 -33.93 74.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.97 . . . . 0.0 109.478 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 59.0 m-20 -106.33 8.93 32.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.81 -37.05 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 44' ' ' ILE . 92.7 m-20 -57.35 -37.28 72.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.647 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 86.7 m-20 -100.86 -37.65 8.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 26.0 tp -63.96 -43.05 96.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 9.3 mt -47.8 -60.0 4.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.68 -22.74 37.12 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.55 2.166 . . . . 0.0 111.63 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.9 tptm -66.26 -47.06 74.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.534 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG21 ' CB ' ' A' ' 147' ' ' LEU . 67.8 mt -67.91 -36.13 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.534 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.97 71.58 62.52 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.6 Cg_endo -70.4 -37.37 7.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.681 2.254 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.53 -23.06 60.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.34 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' CE1' ' A' ' 59' ' ' PHE . 21.4 m -125.54 149.16 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -72.13 -47.53 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.386 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.98 131.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.59 119.31 27.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -115.53 144.37 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.579 HG23 ' HG2' ' A' ' 55' ' ' LYS . 50.9 mt -106.6 119.67 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 26.4 tp -64.86 -44.12 90.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.938 ' O ' HG23 ' A' ' 53' ' ' THR . 94.3 mt-10 -159.32 154.48 25.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.95 -42.71 1.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 61.84 39.06 14.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.537 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.46 34.92 15.23 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.33 -166.84 13.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.02 131.85 21.7 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.726 2.284 . . . . 0.0 111.709 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.49 28.82 72.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.938 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.3 m -83.88 144.78 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 53' ' ' THR . 22.1 mm -112.15 131.94 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.95 . . . . 0.0 109.28 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 44' ' ' ILE . 4.4 mtmt -130.09 148.39 51.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.542 ' HE3' ' CD2' ' A' ' 67' ' ' TYR . 67.8 tttt -125.76 126.71 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 14.7 mt -115.92 130.93 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.4 m -107.74 132.02 53.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.341 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.866 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.9 m-85 -104.47 132.46 50.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.5 -178.86 30.76 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -57.93 -24.56 58.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -1.207 . . . . 0.0 109.337 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.25 -8.97 55.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.6 p -62.19 -27.67 69.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 109.532 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 76.3 m80 -92.16 3.19 55.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 75.2 t80 61.13 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.02 90.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 37.3 p90 -145.47 146.3 31.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.497 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.868 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -126.65 145.58 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 88' ' ' GLU . 34.7 mttt -102.33 140.52 36.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.624 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 42.3 m170 -115.91 140.92 48.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.297 -0.877 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -124.02 139.22 54.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 49' ' ' GLY . 63.3 mt -101.7 135.74 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 93.9 m-70 -89.17 -48.97 7.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.2 t -174.24 151.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.569 HG22 ' CD1' ' A' ' 82' ' ' TYR . 41.2 pt -127.05 144.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -123.45 90.5 3.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -61.57 -36.8 81.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.466 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.84 -37.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -91.63 2.85 56.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.5 m80 51.34 46.98 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.8 m -128.8 135.18 48.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.87 . . . . 0.0 109.541 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' HG22 ' A' ' 75' ' ' ILE . 61.5 t80 -128.8 121.55 28.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -116.46 137.8 51.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -152.2 166.37 31.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.301 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 89.4 p -145.43 160.11 42.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.3 tt -100.77 131.81 46.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.1 mm -89.13 -73.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.583 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 87' ' ' ILE . 88.3 mt-10 -121.15 151.79 39.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.513 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.868 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -171.4 154.73 22.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 68' ' ' VAL . 6.0 t0 -56.35 -49.19 75.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 0.0 109.403 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.85 -27.01 59.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.7 mp -80.7 -30.24 36.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' LEU . 3.7 m 56.43 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 97.6 mt-10 -68.48 -7.67 34.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 109.236 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.797 ' HB3' HG11 ' A' ' 127' ' ' VAL . 26.1 m120 -72.73 -42.29 64.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.285 -0.884 . . . . 0.0 109.668 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -156.25 121.82 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 110.477 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 92' ' ' LEU . 22.1 mt-10 -136.59 107.03 6.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.818 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 122' ' ' HIS . 78.6 tttt -179.01 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.392 -0.817 . . . . 0.0 108.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.658 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 18.8 mt -123.92 117.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -93.78 118.78 31.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.87 . . . . 0.0 109.011 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.658 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 68.1 m-85 -109.23 137.73 46.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.8 mt-10 -130.34 129.79 43.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.5 m -120.8 134.92 55.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HD22 ' A' ' 105' ' ' LEU . 32.5 tttt -133.73 121.65 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.099 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.802 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.1 mm? -95.12 118.85 32.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.759 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 60.5 t -131.88 140.2 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 109.313 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.1 t -107.61 148.05 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.905 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -105.71 173.11 3.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.905 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.97 -16.22 36.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.671 2.248 . . . . 0.0 111.8 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.48 27.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.62 176.63 53.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.714 HG21 ' HA ' ' A' ' 16' ' ' ALA . 65.3 m -122.88 125.05 44.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.3 mt -96.2 139.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.36 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 105' ' ' LEU . 28.7 mt -123.65 123.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.737 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -105.27 133.83 49.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.102 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 86.2 m -131.44 128.93 40.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.0 109.902 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.596 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.1 m -111.7 142.97 43.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.067 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.1 m -135.09 140.62 45.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.987 . . . . 0.0 109.845 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 72.0 tttt -132.29 147.14 52.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.988 ' O ' HG21 ' A' ' 3' ' ' VAL . 96.2 m-85 -126.6 140.31 52.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.81 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 75.8 m-70 -130.55 -177.83 4.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.196 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 96' ' ' ILE . 36.2 p -128.07 147.35 50.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.68 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 94' ' ' GLU . 31.7 mtpt -52.98 -49.12 66.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.491 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -135.31 -65.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -163.52 39.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -1.186 . . . . 0.0 109.7 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.797 HG11 ' HB3' ' A' ' 95' ' ' ASN . 1.0 OUTLIER -82.56 130.02 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 109.28 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -80.62 149.64 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.0 tt -134.46 171.78 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -92.8 121.24 33.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -54.43 -42.38 70.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.04 -35.01 74.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.424 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -65.68 -45.05 84.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.449 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.67 -42.33 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -57.9 -39.44 77.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.33 -44.02 83.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.16 96.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -59.58 -44.95 93.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -1.131 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -60.18 -43.06 96.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mttm -53.64 -43.18 68.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.22 75.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.74 85.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.447 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 64.3 t60 -61.35 -35.58 77.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.519 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 38.6 mt -64.07 -44.37 92.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.672 ' HA ' HD12 ' A' ' 148' ' ' ILE . 66.3 m-85 -53.33 -39.18 63.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -57.33 -41.39 79.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -67.97 -37.92 82.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 145' ' ' PHE . 81.2 mt -54.16 -44.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 86.8 tt0 -65.64 -45.74 81.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.11 -39.79 96.49 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.35 -50.21 73.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -1.12 . . . . 0.0 109.407 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 14' ' ' ILE . 49.2 mt -62.58 -41.93 99.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.467 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 69.9 tttt -56.48 -44.96 81.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.58 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.36 -39.59 87.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -127.54 79.25 73.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.421 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 153' ' ' LYS . 49.6 Cg_endo -70.03 -24.6 28.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.768 2.312 . . . . 0.0 111.756 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.1 p -149.39 159.08 44.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.04 133.15 47.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -62.75 -39.51 94.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.442 179.884 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.798 HG21 ' O ' ' A' ' 121' ' ' TYR . 59.8 t -115.36 138.45 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.169 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.9 t80 -87.43 147.51 25.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.578 HG22 ' CG2' ' A' ' 118' ' ' THR . 22.0 m -93.51 141.89 27.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.6 140.72 51.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.582 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -110.19 136.19 49.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -118.64 131.07 56.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.644 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 92.4 mt-10 -111.48 111.68 22.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.245 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 47.7 t80 -126.95 130.59 50.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 16.2 p -94.0 151.74 19.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 85.8 p -147.15 163.53 36.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 14' ' ' ILE . 90.6 m-20 -71.45 -175.77 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.692 HD12 ' C ' ' A' ' 13' ' ' ASP . 5.0 mp 63.12 142.43 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.6 Cg_endo -69.24 146.56 63.81 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.534 2.156 . . . . 0.0 112.173 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.632 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.46 -47.43 47.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.614 -0.679 . . . . 0.0 111.474 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.2 Cg_endo -63.93 -45.67 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.999 1.799 . . . . 0.0 112.899 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.562 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 61.0 mttm -64.45 -35.0 79.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 152' ' ' LEU . 25.9 tp -80.9 -29.66 35.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HD2' HD23 ' A' ' 105' ' ' LEU . 60.6 t80 -63.02 -37.01 85.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 34.7 tttp -65.51 -42.52 91.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.971 . . . . 0.0 109.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -83.33 -29.96 27.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE1' HG21 ' A' ' 103' ' ' THR . 63.2 t80 -76.63 -18.73 58.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 58.2 t -113.87 -67.0 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 25' ' ' LEU . 18.1 tp -57.99 -42.08 84.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 75.2 m-20 -96.35 12.92 29.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.574 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.973 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -64.4 -35.67 81.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 109.598 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.5 m-20 -65.04 -33.89 77.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.9 t30 -94.34 -33.78 13.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -65.06 -46.14 82.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 27' ' ' ALA . 4.6 mt -48.2 -58.71 7.35 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.72 -21.34 38.89 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.487 2.124 . . . . 0.0 111.558 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 39.1 tptt -65.15 -40.35 94.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.62 HD12 ' HB3' ' A' ' 147' ' ' LEU . 37.7 mm -61.78 -29.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.12 73.15 5.1 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.463 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -69.97 -31.8 18.93 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.675 2.25 . . . . 0.0 111.833 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -70.71 -24.85 62.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.62 -40.23 61.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.708 HG21 HG23 ' A' ' 57' ' ' ILE . 4.9 p -112.74 147.24 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -75.37 -45.14 41.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.42 131.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.49 126.5 35.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.307 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.13 150.44 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.655 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.714 HD11 ' OD2' ' A' ' 28' ' ' ASP . 60.9 mt -106.17 121.34 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 0.0 109.37 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -66.47 -44.0 83.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 53' ' ' THR . 93.8 mt-10 -159.34 157.53 30.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.67 -40.42 2.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 58.32 40.34 24.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.459 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.737 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.88 33.72 20.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.09 -167.19 13.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.72 129.12 17.08 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.595 2.197 . . . . 0.0 111.695 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 72.47 26.35 72.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.4 m -78.99 144.51 34.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 45' ' ' LEU . 63.3 mt -114.33 129.66 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 3.3 mtmt -124.54 149.63 46.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.0 ttpp -130.72 126.1 35.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.708 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -114.94 133.76 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.484 ' CG2' ' HA2' ' A' ' 62' ' ' GLY . 88.3 m -115.1 130.92 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CE1' ' HB ' ' A' ' 39' ' ' VAL . 91.6 m-85 -108.39 143.38 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.1 -169.33 41.91 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.2 -28.56 64.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' HA2' ' CG2' ' A' ' 58' ' ' THR . . . 131.9 36.51 0.31 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.4 m -61.02 157.77 14.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -1.162 . . . . 0.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -58.4 -34.1 70.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.93 151.82 24.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.474 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 103.71 51.22 0.97 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.3 p90 -146.9 146.78 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.732 HG22 ' CA ' ' A' ' 89' ' ' GLY . 46.8 t -125.49 144.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -116.21 143.24 45.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 55' ' ' LYS . 79.6 m80 -123.28 142.76 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 87' ' ' ILE . 17.8 tttp -123.91 140.66 52.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 64.4 mt -100.75 133.16 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 89.7 m-70 -90.68 -48.49 7.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.5 m -165.03 154.13 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.75 144.89 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.6 m-20 -127.83 93.39 3.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -65.92 -38.12 87.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.319 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.22 -42.06 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 72.3 m-20 -87.3 4.98 40.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.574 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 105' ' ' LEU . 66.7 m80 48.46 41.9 17.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.962 . . . . 0.0 109.472 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.8 m -122.05 136.66 54.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 62.6 t80 -129.12 127.07 40.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.369 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 t -121.77 133.43 54.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.652 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 38.5 p90 -149.51 162.96 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 73' ' ' HIS . 55.4 m -138.87 149.26 44.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.4 tt -88.26 133.81 33.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.974 HG23 ' HE2' ' A' ' 98' ' ' LYS . 71.4 mt -91.45 -77.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.608 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.79 ' HG2' HG22 ' A' ' 87' ' ' ILE . 74.4 mm-40 -115.37 161.81 18.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.651 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.732 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 171.56 160.31 19.81 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 72.0 m-20 -60.87 -34.06 74.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.665 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.73 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -67.82 -31.47 71.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.724 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.951 HD11 ' CD2' ' A' ' 86' ' ' LEU . 5.8 mt -70.71 -27.77 64.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 109.152 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 92' ' ' LEU . 0.6 OUTLIER 43.73 -166.01 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.645 -0.66 . . . . 0.0 109.457 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.24 14.71 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.579 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.73 ' O ' HG21 ' A' ' 127' ' ' VAL . 25.9 p-10 -124.39 -11.73 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.73 HD12 ' O ' ' A' ' 91' ' ' ALA . 50.7 mt -111.97 126.26 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.701 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 96.6 mt-10 -77.05 -179.57 5.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.974 ' HE2' HG23 ' A' ' 87' ' ' ILE . 16.3 mttp -57.29 167.06 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 120' ' ' LYS . 83.2 mt -123.29 137.99 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.04 122.75 34.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.427 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 89.9 m-85 -114.62 138.6 50.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.509 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 117' ' ' THR . 93.7 mt-10 -131.68 131.48 43.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.382 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.835 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.6 m -125.85 137.26 53.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' C ' HD22 ' A' ' 105' ' ' LEU . 18.4 tttp -139.03 128.14 23.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -98.5 117.6 33.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.8 t -131.72 143.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.275 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 44.2 m -114.36 151.77 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.11 167.83 8.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.524 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.9 Cg_endo -69.05 -17.22 40.9 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.773 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -64.54 -14.7 58.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.42 -14.8 50.67 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.86 178.37 40.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 99.1 m -117.99 131.36 56.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -1.171 . . . . 0.0 109.727 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.9 mt -101.75 131.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.14 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.13 128.24 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 61.9 mttp -113.21 124.97 53.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 102' ' ' GLU . 62.0 m -129.84 132.72 46.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.007 . . . . 0.0 109.981 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.578 ' CG2' HG22 ' A' ' 5' ' ' THR . 44.0 m -112.48 135.17 53.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 0.0 109.057 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.3 m -125.97 143.12 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.7 tttm -139.26 133.61 31.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 108.969 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.798 ' O ' HG21 ' A' ' 3' ' ' VAL . 61.5 m-85 -111.36 131.83 54.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.816 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.5 m80 -100.74 138.84 37.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.273 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 127' ' ' VAL . 12.7 p -107.82 156.72 18.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 95' ' ' ASN . 14.2 mmtt -56.74 -41.7 78.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.71 -78.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -101.74 -1.25 32.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -1.184 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.73 HG21 ' O ' ' A' ' 95' ' ' ASN . 30.0 m -61.72 130.04 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -113.9 158.2 21.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.515 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.4 tt -128.54 170.61 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.545 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 81.9 tttt -86.41 120.77 28.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.51 -42.51 33.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' OE1' ' HE2' ' A' ' 130' ' ' LYS . 93.7 mt-10 -57.17 -38.8 74.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.421 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 64.3 m170 -65.43 -44.41 87.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.02 -48.3 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.356 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.63 -43.54 80.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.291 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.53 -43.83 80.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.99 -43.17 93.16 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.06 -45.56 90.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -1.14 . . . . 0.0 109.372 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.47 -42.48 96.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.33 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 60.0 mttp -53.99 -44.63 71.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.306 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.76 -46.82 83.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.343 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.87 85.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.37 -44.5 88.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.393 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.8 mt -56.88 -47.66 79.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -54.11 -37.98 64.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.302 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.26 -43.25 87.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -62.93 -36.92 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' CD1' HD11 ' A' ' 30' ' ' LEU . 29.3 mm -55.74 -44.45 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 94.1 mt-10 -66.86 -36.64 82.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.92 95.65 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.02 -44.75 83.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -1.149 . . . . 0.0 109.565 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.929 HD11 HD13 ' A' ' 19' ' ' LEU . 37.8 mt -60.97 -40.83 94.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 19.4 tttm -63.31 -39.31 94.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -60.86 -36.86 80.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.471 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.02 126.44 81.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.457 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 159' ' ' TYR . 50.1 Cg_endo -70.25 -9.8 26.75 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.71 2.273 . . . . 0.0 111.841 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 86.7 p -59.27 -27.29 65.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 109.485 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 153' ' ' LYS . 96.8 mt-10 -63.28 -35.85 81.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 156' ' ' PRO . 98.3 m-85 -121.87 140.51 52.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.428 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.525 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.3 p -109.55 144.49 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -113.35 152.77 29.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 109.228 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 35.1 m -93.46 142.42 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.18 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -119.21 128.3 54.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.826 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -109.41 138.42 45.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.143 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.45 129.75 45.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.872 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 116' ' ' LYS . 88.7 mt-10 -109.37 123.52 49.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.026 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 11' ' ' THR . 54.6 t80 -135.97 135.54 39.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.846 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 114' ' ' ILE . 14.5 p -94.68 131.31 40.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.124 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.747 ' OG ' HD11 ' A' ' 115' ' ' ILE . 94.4 p -130.55 177.16 7.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.863 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 14' ' ' ILE . 41.3 p-10 -80.78 -175.32 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 152' ' ' LEU . 6.7 mm 68.24 136.12 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.2 Cg_endo -70.84 149.58 60.23 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.452 2.101 . . . . 0.0 111.888 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.83 -52.36 3.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 0.0 111.176 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.72 -50.36 2.45 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.432 2.088 . . . . 0.0 113.228 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 31.2 mttt -61.62 -34.67 76.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.838 -1.164 . . . . 0.0 109.888 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.8 tt -80.59 -28.47 37.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.63 ' HD1' HD23 ' A' ' 105' ' ' LEU . 74.6 t80 -72.35 -34.61 68.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.608 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -68.08 -41.12 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.7 -23.3 27.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.841 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.2 t80 -82.96 -14.45 54.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -119.96 -55.94 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.6 tp -67.77 -38.82 83.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 55.0 m-20 -104.83 18.29 22.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.946 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.87 -37.2 76.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.338 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 42' ' ' ALA . 52.6 t0 -76.78 -20.64 56.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.679 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 93.4 m-20 -104.42 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 HG23 ' A' ' 148' ' ' ILE . 19.0 tp -70.98 -38.83 72.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 27' ' ' ALA . 8.0 mt -55.71 -56.7 27.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -69.63 -11.41 30.94 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.393 2.062 . . . . 0.0 111.67 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 12.0 mttm -83.43 -36.52 24.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 147' ' ' LEU . 80.3 mt -76.88 -30.72 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.48 75.44 7.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.6 Cg_endo -69.63 -28.58 25.71 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.706 2.271 . . . . 0.0 111.694 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.11 -23.88 54.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.278 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.95 65.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 57' ' ' ILE . 5.7 p -116.62 150.75 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 58' ' ' THR . 27.7 tttm -75.46 -51.69 12.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 130.71 0.05 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . . . -94.54 123.0 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -125.82 152.18 45.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 64.7 mt -105.96 119.2 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 25.5 tp -61.99 -43.73 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 53' ' ' THR . 94.4 mt-10 -160.05 154.92 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.54 -42.28 1.94 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.8 m-20 61.39 36.61 17.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.33 34.37 10.64 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.0 -165.17 12.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.96 131.12 20.3 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.733 2.288 . . . . 0.0 111.783 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.53 27.94 72.89 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.7 m -83.23 142.57 31.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -1.162 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.456 HD13 ' HG3' ' A' ' 71' ' ' LYS . 24.0 mm -108.79 131.5 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' CE ' HD11 ' A' ' 72' ' ' ILE . 64.2 mttt -117.17 148.79 41.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 48.4 tttp -132.92 127.24 33.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.346 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.582 HD11 ' CD2' ' A' ' 70' ' ' HIS . 42.5 mt -120.15 131.37 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 40' ' ' LYS . 62.4 m -114.63 127.26 55.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.711 ' HE2' HG23 ' A' ' 68' ' ' VAL . 97.8 m-85 -92.0 136.57 33.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.6 129.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' HG3' ' HE2' ' A' ' 40' ' ' LYS . 82.9 tt0 -64.92 -42.68 94.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.85 -51.11 0.38 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -81.18 174.56 11.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 59' ' ' PHE . 39.7 m170 55.58 58.98 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' GLY . 94.1 m-85 -57.7 -16.75 11.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.504 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' TYR . . . -43.82 144.34 1.83 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.419 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 40.1 p90 -151.89 146.52 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.299 -1.118 . . . . 0.0 109.295 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.892 HG22 ' HA2' ' A' ' 89' ' ' GLY . 41.2 t -124.28 148.21 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.58 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 85.7 mttt -121.51 144.1 48.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 109.359 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 57' ' ' ILE . 90.9 m-70 -122.9 138.48 54.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HG3' HD13 ' A' ' 54' ' ' ILE . 40.0 tttt -117.61 141.85 47.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 44.0 mt -103.03 131.5 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.583 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 97.1 m-70 -92.62 -41.98 9.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.579 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -171.31 146.21 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.4 143.49 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.05 90.92 3.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 96.7 mttt -60.86 -35.33 76.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.79 -41.92 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 80' ' ' HIS . 32.4 m120 -87.86 10.16 19.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 79' ' ' ASN . 65.8 m80 44.42 42.79 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.471 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 m -123.31 132.84 54.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.498 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 70.2 t80 -120.18 124.18 45.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.8 t -118.16 128.84 55.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 30.8 p90 -155.87 171.19 20.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.855 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.7 p -142.45 162.64 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 99' ' ' ILE . 5.0 tt -98.86 129.37 45.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.855 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.9 mm -88.17 -74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.762 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.5 mt-10 -115.24 159.17 21.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.892 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -178.29 159.54 25.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -60.66 -46.6 89.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -1.106 . . . . 0.0 109.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.57 -23.64 67.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.9 mp -82.71 -44.11 16.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 13.9 t 60.18 163.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.317 -0.864 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.68 -11.2 53.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.799 ' HB3' HG11 ' A' ' 127' ' ' VAL . 3.4 m-20 -72.38 -40.26 67.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.613 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 123' ' ' THR . 41.8 pt -151.71 131.34 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 30.5 mt-10 -146.34 106.45 4.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.921 . . . . 0.0 108.967 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 39.5 tptt -179.63 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.872 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.893 HD12 HD13 ' A' ' 86' ' ' LEU . 4.3 mt -124.59 118.16 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.917 -1.114 . . . . 0.0 110.005 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -94.86 121.58 36.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 108.901 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 99' ' ' ILE . 64.9 m-85 -114.14 136.73 52.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.956 . . . . 0.0 109.932 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.1 mt-10 -130.24 126.27 36.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 108.983 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.829 HG21 ' CE2' ' A' ' 23' ' ' PHE . 29.8 m -123.29 131.62 53.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -138.39 122.64 18.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.195 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -94.26 130.81 40.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 78.3 t -131.52 135.53 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.0 p -106.81 142.62 36.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.87 169.36 6.39 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.1 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.717 2.278 . . . . 0.0 111.77 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.23 -15.37 61.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.36 53.06 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.11 168.24 32.34 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.5 m -119.61 126.55 51.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 109.525 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 11' ' ' THR . 65.9 mt -95.73 136.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.747 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.1 mt -119.27 119.93 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 9' ' ' GLU . 10.7 mtpt -105.13 121.17 43.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.11 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 80.1 m -126.73 134.07 50.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 0.0 109.934 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 61.9 m -116.68 138.48 51.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.107 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -131.57 141.58 49.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HE2' ' NE2' ' A' ' 122' ' ' HIS . 22.5 tttt -136.32 149.82 48.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.18 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.977 ' O ' HG21 ' A' ' 3' ' ' VAL . 94.5 m-85 -127.99 142.7 51.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.06 -1.025 . . . . 0.0 109.766 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 64.3 m80 -134.95 165.15 25.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 96' ' ' ILE . 25.7 p -116.3 149.38 39.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.729 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 23.6 mttm -60.7 -53.3 59.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -121.07 -66.48 0.26 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -174.32 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.799 HG11 ' HB3' ' A' ' 95' ' ' ASN . 47.1 t -58.74 -36.05 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 82.8 tt0 65.44 144.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.705 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 tt -127.5 171.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.555 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 78.7 tttt -85.39 125.65 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.39 -41.28 69.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 66.4 m170 -66.49 -42.46 87.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.384 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.517 HG12 ' HE2' ' A' ' 138' ' ' LYS . 42.6 t -69.39 -44.07 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.464 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -55.8 -42.45 75.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.7 -44.5 81.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -37.53 94.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.517 ' HE2' HG12 ' A' ' 134' ' ' VAL . 32.6 mttm -60.12 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -63.7 -43.16 97.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.381 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.93 -45.28 82.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.44 95.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.907 . . . . 0.0 109.43 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.4 99.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.438 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -57.09 -48.77 77.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.424 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.76 -39.51 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.633 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 58.9 t80 -53.96 -41.77 68.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.336 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.4 -41.95 86.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.545 ' HB2' HD13 ' A' ' 34' ' ' ILE . 48.7 mt -57.43 -41.08 79.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.743 HG23 HD21 ' A' ' 30' ' ' LEU . 88.3 mt -54.87 -47.41 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 83.2 mt-10 -54.71 -47.17 74.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.179 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.54 -27.27 71.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.14 -47.26 85.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -1.113 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp -73.66 -49.53 25.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -55.6 -30.85 61.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.257 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 52.8 t0 -85.98 -29.65 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.863 . . . . 0.0 109.309 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 154' ' ' ASP . 42.3 p-80 40.24 66.28 3.39 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.539 -0.726 . . . . 0.0 109.977 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.81 139.3 36.32 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.632 2.222 . . . . 0.0 111.562 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.7 p -117.56 157.83 25.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -113.46 146.29 39.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 71.0 t80 -129.9 137.36 50.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.573 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 159' ' ' TYR . 42.1 p-10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.8 p -114.15 139.73 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.513 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -110.57 156.68 20.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.362 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 17.8 m -93.56 142.78 26.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.403 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -119.41 135.23 54.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -110.45 133.8 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.272 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.02 131.84 54.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.61 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.64 122.88 47.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.319 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 11' ' ' THR . 82.0 t80 -142.82 146.57 34.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.61 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.568 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.0 p -108.29 142.45 38.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.208 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.418 ' OG ' ' CG ' ' A' ' 149' ' ' GLU . 20.8 t -141.12 159.17 42.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.965 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.45 -175.96 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 66.08 141.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.009 . . . . 0.0 109.146 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.2 Cg_endo -70.01 146.52 58.9 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.444 2.096 . . . . 0.0 112.001 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.21 -50.61 6.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.543 -0.723 . . . . 0.0 111.403 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.09 -50.31 3.03 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.29 1.993 . . . . 0.0 113.076 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 33.3 mttp -59.66 -33.59 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.19 . . . . 0.0 109.515 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.9 tt -80.92 -34.39 33.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.808 ' CE1' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -64.81 -32.13 73.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 20.3 tttm -68.89 -46.29 68.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.74 38.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.737 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.874 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 68.1 t80 -86.42 -17.71 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.808 HG21 ' CE1' ' A' ' 20' ' ' PHE . 66.5 t -115.9 -51.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 27.9 tp -68.46 -40.33 81.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 79.2 m-20 -103.38 18.6 21.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.874 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.97 -35.98 74.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.682 ' OD2' HD11 ' A' ' 44' ' ' ILE . 95.2 m-20 -67.76 -32.07 72.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 20.8 t-20 -99.34 -43.63 6.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 148' ' ' ILE . 15.9 tp -55.7 -42.61 75.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.775 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.8 mt -49.78 -62.32 2.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.516 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.51 -16.98 43.59 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.498 2.132 . . . . 0.0 111.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' NZ ' ' CG ' ' A' ' 159' ' ' TYR . 21.3 tptm -67.54 -45.23 76.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.623 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 147' ' ' LEU . 75.7 mt -70.23 -35.17 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.705 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.73 71.76 57.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.61 -30.98 17.53 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 111.715 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -75.06 -30.09 60.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.14 97.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.587 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG23 ' A' ' 57' ' ' ILE . 4.0 p -121.13 150.26 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -74.92 -47.47 29.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 178.48 129.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.28 125.65 36.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.49 155.7 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.682 HD11 ' OD2' ' A' ' 28' ' ' ASP . 54.9 mt -106.03 120.65 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -65.81 -44.0 86.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 53' ' ' THR . 92.9 mt-10 -158.81 154.92 26.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.76 -42.48 1.91 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 59.99 40.17 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.354 -1.086 . . . . 0.0 109.558 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.671 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.17 33.76 22.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.36 -168.46 13.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.59 130.0 18.77 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.705 2.27 . . . . 0.0 111.714 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.01 25.88 72.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.851 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.18 143.12 35.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 68.4 mt -112.51 132.05 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -123.49 150.79 43.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -132.34 122.84 25.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.701 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -113.34 140.58 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.622 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.5 m -120.69 128.3 52.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -103.85 136.43 43.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.0 164.92 37.98 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.79 142.07 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -1.14 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.12 11.86 83.92 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -120.38 143.15 48.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -102.22 -3.97 26.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.545 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.2 154.89 27.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . 95.03 60.22 1.08 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.5 p90 -138.55 144.38 39.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' CA ' ' A' ' 89' ' ' GLY . 40.9 t -124.85 143.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 49.5 mtmt -113.19 147.59 37.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 91.9 m-70 -122.85 136.84 55.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' THR . 66.0 tttt -117.31 138.21 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.382 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 62.8 mt -99.72 132.98 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -90.5 -45.71 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.3 p -169.91 148.84 3.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.08 144.47 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.0 m-20 -131.05 92.16 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -62.8 -34.8 78.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.402 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.54 -39.86 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 31.3 m120 -87.28 4.7 41.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 48.44 43.88 20.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.4 m -126.58 136.99 53.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 61.3 t80 -131.19 127.47 38.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.8 p -121.45 137.18 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -151.37 169.3 22.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 83.0 p -145.55 160.96 40.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 92' ' ' LEU . 4.1 tt -97.59 119.57 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.374 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.847 HG22 ' HG2' ' A' ' 88' ' ' GLU . 93.5 mt -75.58 -56.7 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HG2' HG22 ' A' ' 87' ' ' ILE . 75.4 mm-40 -148.46 162.04 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -0.99 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.33 150.8 11.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 7.9 t0 -60.12 -26.61 66.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -1.131 . . . . 0.0 109.563 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.34 -28.73 47.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 86' ' ' LEU . 2.9 mt -75.19 -33.05 61.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 108.755 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m 52.85 -173.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.606 -0.684 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 124' ' ' LYS . 96.9 mt-10 -80.25 -3.42 49.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.718 ' HB3' HG11 ' A' ' 127' ' ' VAL . 76.4 m-20 -90.68 -36.24 14.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 92' ' ' LEU . 42.6 mt -92.3 130.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 110.041 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 70.4 mm-40 -88.55 -178.35 5.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.6 mttp -56.12 153.62 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.753 HD13 ' CE2' ' A' ' 121' ' ' TYR . 53.8 mt -118.03 137.68 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 87.4 m-20 -93.17 124.95 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.36 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 83.7 m-85 -117.24 140.67 49.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 117' ' ' THR . 93.6 mt-10 -133.76 136.65 44.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -128.4 137.44 51.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -139.76 128.95 23.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -98.31 130.57 44.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.19 145.93 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.7 p -112.68 143.07 44.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.0 109.478 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.46 164.93 13.83 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.8 Cg_endo -69.39 -18.05 38.96 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.634 2.222 . . . . 0.0 111.771 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.01 -15.51 63.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.862 . . . . 0.0 109.43 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.45 26.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.49 -179.84 50.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 66.4 m -124.75 126.87 46.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.159 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 106' ' ' VAL . 66.1 mt -90.38 137.9 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.337 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.753 HD13 ' HZ ' ' A' ' 145' ' ' PHE . 45.6 mt -119.84 129.11 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -118.8 127.0 53.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 0.0 109.205 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 102' ' ' GLU . 52.5 m -126.44 134.46 50.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.729 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.0 m -116.87 142.73 46.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 109.094 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.486 ' OG ' ' CE1' ' A' ' 101' ' ' TYR . 27.1 t -139.33 148.85 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.041 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.737 ' O ' HG23 ' A' ' 99' ' ' ILE . 82.3 tttt -136.5 130.71 32.93 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.901 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.8 m-85 -108.76 126.65 53.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.073 -1.017 . . . . 0.0 109.924 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 34.3 m170 -98.02 146.88 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.16 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 p -129.23 162.02 28.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.097 -1.002 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 94' ' ' GLU . 28.7 mtpp -53.68 -48.97 68.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -169.24 -62.33 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -154.3 51.46 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -1.113 . . . . 0.0 109.634 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 95' ' ' ASN . 85.5 t -65.02 -22.87 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 109.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 68.3 tt0 70.56 127.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.7 tt -128.95 170.91 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -94.13 125.8 38.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.37 -40.55 68.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.4 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.75 -35.29 77.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -66.36 -44.38 83.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.882 . . . . 0.0 109.428 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.72 -43.82 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.909 . . . . 0.0 109.422 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 32.7 ttpt -60.3 -39.55 87.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.354 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -59.84 -43.02 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.6 -43.12 99.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE2' ' OH ' ' A' ' 121' ' ' TYR . 35.5 mmtp -62.02 -41.41 98.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 96.7 mt-10 -62.32 -43.04 99.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 98.8 mttt -57.56 -42.04 82.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.893 . . . . 0.0 109.374 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.09 -42.66 93.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.16 85.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -56.91 -50.94 71.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.92 -47.27 85.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.753 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 49.4 t80 -53.35 -43.26 67.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -55.11 -43.26 73.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.302 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 34' ' ' ILE . 65.2 mt -56.69 -45.02 82.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 30' ' ' LEU . 93.4 mt -53.8 -52.02 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.298 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.418 ' CG ' ' OG ' ' A' ' 12' ' ' SER . 83.7 tt0 -54.27 -41.82 69.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.233 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -77.57 -23.42 67.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 147' ' ' LEU . 70.1 t80 -63.18 -45.68 90.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.341 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.6 mp -75.01 -42.01 58.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.347 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -53.43 -34.12 56.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 0.0 108.863 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 155' ' ' HIS . 89.9 m-20 -76.66 -40.92 47.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.011 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' ASP . 6.8 t-160 43.15 68.22 3.08 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 159' ' ' TYR . 48.7 Cg_endo -69.82 132.49 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.733 2.288 . . . . 0.0 111.824 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.8 m -59.29 -26.26 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 73.1 mm-40 -70.76 -34.34 71.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' A' ' 156' ' ' PRO . 25.2 m-85 -123.2 134.02 54.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.439 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 48.8 t -118.2 134.4 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -1.156 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -123.14 150.52 43.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.617 HG22 ' CG2' ' A' ' 118' ' ' THR . 19.9 m -93.95 138.13 32.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' THR . 77.5 t80 -122.86 134.51 54.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.43 133.77 55.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -121.78 131.66 54.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.8 mt-10 -104.04 118.95 37.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 11' ' ' THR . 62.4 t80 -133.29 132.39 41.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.5 p -93.9 142.96 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 24.4 m -135.3 160.48 38.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.673 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' ILE . 96.5 m-20 -69.26 -175.72 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.739 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mt 61.78 141.72 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.959 . . . . 0.0 109.077 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.0 Cg_endo -69.21 146.23 62.92 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.452 2.102 . . . . 0.0 111.978 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.941 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -41.12 -49.82 8.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.592 -0.692 . . . . 0.0 111.365 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -63.93 -49.32 4.09 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.252 1.968 . . . . 0.0 113.027 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.557 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 96.6 mttt -62.09 -35.48 78.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.523 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' PHE . 20.4 tp -80.57 -27.98 37.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.892 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 64.1 t80 -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -60.4 -43.89 96.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.4 -20.56 40.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.988 ' C ' ' HB2' ' A' ' 27' ' ' ALA . 71.0 t80 -99.09 6.64 46.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.892 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -135.0 -78.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.144 -0.973 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.02 -49.22 74.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 80.0 m-20 -99.07 12.14 36.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' C ' ' A' ' 23' ' ' PHE . . . -69.53 -36.4 76.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 31' ' ' ILE . 52.6 t0 -73.18 -29.87 63.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 87.1 m-20 -91.06 -29.01 17.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.481 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.98 ' O ' HD13 ' A' ' 30' ' ' LEU . 1.8 tm? -73.52 -34.15 65.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.877 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 19.7 mt -51.32 -55.8 25.75 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.605 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.56 -17.89 43.16 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.499 2.132 . . . . 0.0 111.856 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.64 ' HD2' HD22 ' A' ' 30' ' ' LEU . 42.5 mttt -71.09 -40.45 71.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 109.521 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.504 ' CG2' HD13 ' A' ' 147' ' ' LEU . 87.9 mt -68.13 -34.63 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.74 70.39 19.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -70.18 -34.58 12.91 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.656 2.237 . . . . 0.0 111.727 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.75 -19.9 65.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.25 -26.56 21.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 1.9 t -118.01 139.79 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.1 -51.08 23.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.48 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.39 117.67 29.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.22 147.76 45.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.317 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 74.3 mt -106.36 118.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -60.58 -45.19 94.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 53' ' ' THR . 94.7 mt-10 -159.32 157.87 31.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 108.35 -43.03 1.79 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.9 m-20 59.76 38.33 21.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.09 33.01 21.92 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.436 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.78 -168.2 14.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.03 130.75 19.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.692 2.261 . . . . 0.0 111.668 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 71.51 26.73 72.59 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.2 m -80.37 140.3 36.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 64.2 mt -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 2.9 mtpt -119.22 149.17 42.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -131.87 124.43 29.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.641 HD12 ' CE1' ' A' ' 70' ' ' HIS . 20.5 mt -119.96 131.38 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -111.99 121.66 45.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.341 -0.849 . . . . 0.0 109.109 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 60' ' ' GLY . 82.1 m-85 -91.05 133.26 35.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.484 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 59' ' ' PHE . . . -43.36 155.36 0.19 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.3 157.16 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -1.169 . . . . 0.0 109.543 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.91 71.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -106.93 155.35 19.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -56.35 -27.87 57.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.786 ' CD1' ' HB2' ' A' ' 91' ' ' ALA . 16.0 m-85 -122.58 142.63 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . -86.58 -64.83 1.42 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 35.4 p90 -158.25 144.8 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -1.199 . . . . 0.0 109.905 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.812 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.6 m -134.47 150.31 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 109.089 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.644 ' O ' HD12 ' A' ' 86' ' ' LEU . 37.6 mttt -106.45 139.91 40.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.774 ' NE2' HD13 ' A' ' 86' ' ' LEU . 70.3 m80 -114.42 143.82 44.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 109.17 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 17.8 tttp -127.35 138.95 53.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.709 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 59.1 mt -98.69 131.15 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.17 -49.16 6.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m -163.34 152.12 14.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.8 pt -129.21 145.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 69.0 m-20 -122.15 107.09 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.924 . . . . 0.0 109.289 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -82.7 -25.77 32.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 108.553 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -46.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 65.5 m-80 -80.56 -5.37 56.67 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.492 -0.755 . . . . 0.0 109.651 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 m80 60.16 42.74 15.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.497 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 63.5 m -124.36 135.04 53.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 65.9 t80 -124.63 129.5 50.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -122.14 135.28 54.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.649 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.625 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.9 p90 -151.48 168.09 25.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.307 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 95.3 p -149.59 152.16 35.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 70' ' ' HIS . 37.7 tp -91.96 117.42 29.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.292 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.831 HG22 ' HG3' ' A' ' 88' ' ' GLU . 24.1 mm -70.4 -71.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.735 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.831 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -128.06 169.35 14.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.0 109.803 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.812 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . 176.72 137.36 2.63 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 31.3 m-20 -47.55 -40.5 19.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -1.167 . . . . 0.0 109.694 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.786 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . . . -65.23 -15.52 62.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.0 mp -87.89 -43.79 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 m 61.93 178.43 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.408 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.17 -2.05 39.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.632 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 127' ' ' VAL . 16.5 p-10 -91.75 -21.58 20.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 51.5 mt -111.3 141.36 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -0.931 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -95.6 179.84 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 3.8 pttm -57.52 164.61 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 120' ' ' LYS . 68.2 mt -120.72 134.23 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 61.9 t0 -89.7 122.7 33.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 77.9 m-85 -115.51 139.8 49.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.275 -0.891 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 94.1 mt-10 -131.04 136.85 48.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.928 HG21 ' CE2' ' A' ' 23' ' ' PHE . 53.6 m -132.07 133.17 44.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 22.7 tttt -131.61 133.36 44.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 109.477 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 16' ' ' ALA . 1.2 mp -103.84 125.1 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 40.1 t -131.76 140.43 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.7 p -110.57 141.32 43.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -0.933 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -109.75 164.74 14.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.556 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.6 Cg_endo -69.96 -7.12 20.33 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.752 2.301 . . . . 0.0 111.791 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -78.82 -18.5 53.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.91 -29.45 7.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.87 174.53 55.09 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 106' ' ' VAL . 86.9 m -122.14 125.57 46.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 109.539 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.1 mt -90.22 138.34 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.604 HG23 HD12 ' A' ' 105' ' ' LEU . 44.0 mt -125.87 127.8 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.794 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 53.5 mttp -105.05 128.71 53.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -125.88 129.85 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 110.007 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.617 ' CG2' HG22 ' A' ' 5' ' ' THR . 33.1 m -118.49 133.87 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 108.923 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.8 m -123.8 142.46 51.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.09 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 99' ' ' ILE . 75.9 tttt -139.38 129.44 25.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' A' ' 99' ' ' ILE . 25.2 m-85 -111.65 131.57 55.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 109.884 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 71.4 m80 -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.456 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 22.0 p -112.63 163.22 14.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -58.01 -35.93 71.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 169.9 -79.68 0.1 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -98.17 9.57 42.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -1.115 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 95' ' ' ASN . 55.4 t -63.14 130.12 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.7 151.05 29.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.504 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.6 tt -125.08 171.44 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.2 131.77 44.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.513 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.37 -38.31 68.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.97 -38.0 81.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -68.57 -40.44 80.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 -42.42 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -58.89 -41.5 87.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.48 79.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.24 98.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -60.84 -45.15 95.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.36 -40.21 95.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -57.37 -44.12 84.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.335 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.23 -48.65 64.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.72 77.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.331 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.52 -41.58 98.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 144' ' ' LEU . 35.3 mt -61.71 -45.98 91.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -53.28 -42.96 67.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -62.47 -39.67 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.504 HD13 ' CG2' ' A' ' 34' ' ' ILE . 60.5 mt -66.72 -40.73 88.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.401 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.41 HD13 ' HD1' ' A' ' 23' ' ' PHE . 82.2 mt -56.01 -45.73 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 96.6 mt-10 -60.66 -46.64 89.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.76 -39.87 96.96 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -53.4 -55.38 25.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -1.088 . . . . 0.0 109.462 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.739 HD12 HD13 ' A' ' 14' ' ' ILE . 66.1 mt -63.84 -42.22 97.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -56.36 -44.79 80.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.446 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 155' ' ' HIS . 90.7 m-20 -56.96 -53.63 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 154' ' ' ASP . 2.8 t-160 44.49 76.22 0.56 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.526 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 128.97 15.95 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -59.51 -33.32 71.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.72 146.5 25.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -110.6 140.57 44.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.855 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.435 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.991 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.6 p -114.81 138.76 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -1.166 . . . . 0.0 109.511 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.37 156.66 22.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 109.381 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 57.3 m -93.42 143.51 26.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.29 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -109.63 141.97 41.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.278 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -127.83 129.66 47.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 91.2 mt-10 -101.76 124.78 47.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 11' ' ' THR . 46.9 t80 -136.25 127.03 27.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 15.1 p -90.42 154.73 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.563 ' OG ' HD11 ' A' ' 115' ' ' ILE . 88.9 p -149.32 167.9 24.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 87.3 m-20 -77.2 -175.25 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.981 HD12 ' OE1' ' A' ' 149' ' ' GLU . 6.4 mt 63.4 142.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.3 Cg_endo -70.34 147.25 58.75 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.533 2.155 . . . . 0.0 112.106 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.14 -50.4 8.14 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 111.429 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.08 -50.27 3.08 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.303 2.002 . . . . 0.0 113.031 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 60.4 mttt -61.93 -37.02 83.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 149' ' ' GLU . 27.6 tp -81.3 -24.95 36.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.116 -0.99 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' HD1' HD23 ' A' ' 105' ' ' LEU . 66.1 t80 -72.96 -34.56 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 109.859 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 17.5 mttp -67.25 -45.78 75.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.765 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.12 42.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.624 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 59.4 t80 -76.53 -15.69 59.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 44.2 t -119.68 -53.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 46.0 mt -67.85 -40.45 83.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 80.3 m-20 -100.52 11.11 40.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.18 -31.66 69.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.628 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -68.64 -21.83 64.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 27.8 m120 -114.23 -37.81 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.075 -1.016 . . . . 0.0 109.485 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.656 HD11 ' CG ' ' A' ' 151' ' ' TYR . 30.1 tp -58.2 -36.94 73.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 27' ' ' ALA . 11.5 mt -55.78 -60.5 8.47 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.188 -0.945 . . . . 0.0 109.195 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.45 -11.35 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.558 2.172 . . . . 0.0 111.583 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 18.7 mttt -80.84 -35.63 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 109.607 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 147' ' ' LEU . 87.6 mt -73.54 -31.18 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 68.49 54.4 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.4 Cg_endo -70.15 -31.42 18.83 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.7 2.266 . . . . 0.0 111.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.33 -29.29 63.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.02 60.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 ' CG2' ' A' ' 57' ' ' ILE . 5.6 p -128.72 149.23 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.389 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' CD ' ' OE2' ' A' ' 61' ' ' GLU . 21.9 mtpp -71.89 -51.69 20.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.1 144.24 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.67 120.32 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -113.19 156.18 23.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.646 HG21 ' N ' ' A' ' 48' ' ' ASP . 22.1 mm -106.83 133.89 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.5 tp -78.98 -37.91 38.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.813 ' O ' HG23 ' A' ' 53' ' ' THR . 57.8 mm-40 -159.06 133.6 7.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 104.22 -34.74 5.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 44' ' ' ILE . 5.3 m-20 51.49 56.98 7.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -1.109 . . . . 0.0 109.794 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.918 ' H ' HG21 ' A' ' 53' ' ' THR . . . 80.09 36.08 25.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.73 -168.78 14.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.14 133.43 26.69 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.595 2.197 . . . . 0.0 111.47 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.16 20.96 58.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.918 HG21 ' H ' ' A' ' 49' ' ' GLY . 49.5 m -73.38 146.83 44.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 0.0 109.741 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 23.8 mm -106.39 135.8 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' CE ' HD11 ' A' ' 72' ' ' ILE . 45.5 mttt -115.95 143.26 45.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 63.0 tttm -129.68 129.86 44.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 39' ' ' VAL . 44.0 mt -125.59 130.53 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.887 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -112.17 128.1 56.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.132 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HE2' HG23 ' A' ' 68' ' ' VAL . 75.2 m-85 -103.15 132.31 49.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' PHE . . . 50.09 178.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' OE2' ' CD ' ' A' ' 40' ' ' LYS . 65.2 mm-40 -142.08 168.64 19.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 0.0 109.431 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.76 87.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.9 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.174 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -56.13 -46.93 79.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -140.33 175.45 9.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.359 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.12 67.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 45.8 p90 -151.85 143.97 23.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -1.162 . . . . 0.0 109.514 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.86 HG22 ' HA2' ' A' ' 89' ' ' GLY . 61.4 t -118.44 141.77 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.267 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 50.3 mttt -116.56 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.47 ' CD2' ' HG ' ' A' ' 86' ' ' LEU . 75.7 m80 -120.97 144.84 48.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.753 ' HB2' HD11 ' A' ' 87' ' ' ILE . 45.3 tttt -121.36 140.88 51.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.559 HD11 ' CE ' ' A' ' 55' ' ' LYS . 66.0 mt -99.22 134.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.436 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.8 m-70 -88.93 -48.47 7.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.0 p -169.84 150.95 4.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' CE1' ' A' ' 82' ' ' TYR . 21.1 pt -129.08 144.78 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -129.42 92.68 3.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.511 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 95.2 mttt -64.28 -36.29 83.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.73 -42.75 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -87.66 6.68 33.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.0 m80 47.88 44.6 18.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.6 m -124.38 138.5 54.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.38 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 52.6 t80 -134.26 132.46 39.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 m -126.28 140.47 52.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.5 p90 -153.01 171.6 18.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.3 p -149.53 152.67 35.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 92' ' ' LEU . 4.6 tt -87.97 127.59 35.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.817 ' N ' HD23 ' A' ' 86' ' ' LEU . 82.9 mt -86.35 -72.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.441 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.779 ' O ' HG13 ' A' ' 68' ' ' VAL . 95.3 mt-10 -122.74 160.58 25.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -177.91 153.73 13.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -61.83 -25.48 67.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -1.13 . . . . 0.0 109.556 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.69 -30.41 46.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.975 HD11 HD22 ' A' ' 86' ' ' LEU . 3.9 mt -71.71 -31.85 67.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 108.853 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m 50.21 -172.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.626 -0.671 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.26 15.04 9.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.427 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -116.39 -17.87 10.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 91' ' ' ALA . 23.5 mt -109.34 141.47 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 94.0 mt-10 -90.7 -179.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.664 ' HE2' HG23 ' A' ' 87' ' ' ILE . 31.6 mttp -57.62 176.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.687 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 120' ' ' LYS . 59.0 mt -133.18 133.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.414 -0.804 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' SER . 80.5 m-20 -87.28 121.4 29.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 67.0 m-85 -114.39 144.1 43.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 117' ' ' THR . 89.1 mt-10 -132.81 139.24 47.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 23' ' ' PHE . 32.7 m -135.41 128.45 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -134.88 124.66 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.7 mm? -93.7 129.12 40.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 57.5 t -131.99 141.53 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.49 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.5 p -108.43 146.53 32.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.04 164.79 14.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.8 Cg_endo -70.01 -17.61 36.35 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.673 2.249 . . . . 0.0 111.848 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.76 -15.34 61.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -15.45 35.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.22 170.03 46.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.1 m -119.96 126.13 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 67.0 mt -93.16 139.56 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.563 HD11 ' OG ' ' A' ' 12' ' ' SER . 56.2 mt -127.1 121.89 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.728 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 58.0 mttp -106.82 132.37 52.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.046 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 102' ' ' GLU . 74.0 m -131.74 129.79 41.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 30.2 m -113.15 148.63 34.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 0.0 108.922 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 55.3 m -140.23 148.44 41.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.827 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.3 tttt -138.35 127.25 23.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.162 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.991 ' O ' HG21 ' A' ' 3' ' ' VAL . 40.3 m-85 -105.49 121.98 45.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 78.8 m80 -101.74 141.33 34.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 28.8 p -119.2 146.82 44.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.481 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 20.9 tptm -67.26 -44.2 79.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 109.355 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -141.76 38.4 1.5 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 93.0 m-20 61.76 46.83 6.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -1.12 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 9.3 p -49.51 -22.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 81.2 tt0 64.85 134.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.53 171.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.597 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.512 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 46.1 tttp -81.19 125.04 29.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -52.6 -42.59 64.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 65.9 m170 -66.9 -42.35 85.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.53 -46.65 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.421 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -55.86 -43.18 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.69 78.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.41 -40.99 98.36 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -58.71 -48.62 80.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -1.169 . . . . 0.0 109.348 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.28 -41.4 96.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 20.0 tttt -57.69 -45.36 85.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.0 88.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 109.361 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.84 95.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -58.94 -43.94 91.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 47.6 mt -56.94 -49.07 76.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 148' ' ' ILE . 65.7 m-85 -53.13 -43.92 67.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -58.97 -41.05 86.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 151' ' ' TYR . 52.4 mt -64.22 -40.05 95.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.897 . . . . 0.0 109.364 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 145' ' ' PHE . 63.8 mt -55.51 -53.18 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.157 -0.965 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.981 ' OE1' HD12 ' A' ' 14' ' ' ILE . 73.1 mm-40 -54.38 -40.21 67.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.176 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.79 -26.03 59.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.656 ' CG ' HD11 ' A' ' 30' ' ' LEU . 60.0 t80 -60.82 -45.99 92.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -1.126 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp -74.26 -46.86 38.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.3 -0.875 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -53.33 -42.22 66.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -76.38 -33.31 58.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -118.93 88.94 37.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.06 150.23 66.08 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.651 2.234 . . . . 0.0 111.881 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.5 t -88.94 140.41 29.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.379 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -112.73 160.58 17.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.592 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -111.7 138.16 48.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.453 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 122' ' ' HIS . 80.9 t -119.58 134.53 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 109.554 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.21 140.9 48.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.269 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.5 m -105.25 131.73 52.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -0.946 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 97.5 m-85 -124.47 138.82 54.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.378 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.61 136.15 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -117.39 135.58 53.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.41 124.25 51.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 80.6 t80 -146.17 141.7 27.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.528 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.2 p -107.93 151.29 25.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 21.7 t -151.38 154.38 36.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.629 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 10.8 t0 -66.31 -175.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 mm 72.44 141.67 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 109.356 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.55 146.24 60.89 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.481 2.12 . . . . 0.0 112.027 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -42.96 -49.33 14.22 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 111.595 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.5 -50.33 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.145 1.897 . . . . 0.0 113.169 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 67.6 mttt -61.46 -30.35 70.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 109.583 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 148' ' ' ILE . 22.6 tp -80.61 -33.71 35.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.685 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.72 ' HD1' HD23 ' A' ' 105' ' ' LEU . 83.0 t80 -61.7 -41.39 97.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.884 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.5 mttt -65.22 -55.14 20.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.47 -11.0 60.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.761 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.909 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.8 t80 -87.61 -33.43 18.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.1 m -115.75 -40.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.826 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' N ' HG23 ' A' ' 24' ' ' VAL . 20.7 tp -71.39 -34.33 70.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.016 . . . . 0.0 109.435 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 76.7 m-20 -108.04 11.46 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.83 -40.19 76.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -57.5 -32.82 67.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.2 m120 -102.27 -36.36 8.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 148' ' ' ILE . 42.6 tp -72.75 -34.52 67.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.584 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 27' ' ' ALA . 27.3 mt -53.69 -55.61 33.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -68.9 -17.54 41.49 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -72.52 -39.3 67.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.717 HD12 HD11 ' A' ' 144' ' ' LEU . 87.1 mt -72.25 -32.63 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.88 72.53 16.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -69.96 -31.97 18.61 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.69 2.26 . . . . 0.0 111.799 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.17 -26.26 62.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.33 -48.27 76.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.4 m -128.39 157.53 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -73.53 -42.69 61.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.61 135.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -0.87 . . . . 0.0 109.463 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.54 119.0 27.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.27 147.98 40.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.2 mt -106.08 121.12 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.4 tp -65.55 -43.71 89.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' THR . 93.5 mt-10 -159.22 155.81 27.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.33 -40.93 2.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.0 m-20 60.7 40.05 16.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.222 -1.164 . . . . 0.0 109.58 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.24 35.21 15.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.86 -166.56 13.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.73 129.64 17.98 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.758 2.305 . . . . 0.0 111.69 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.96 77.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.0 m -80.02 143.82 33.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -1.129 . . . . 0.0 109.58 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.94 127.98 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' CE ' HD11 ' A' ' 72' ' ' ILE . 56.9 mttt -112.44 152.76 28.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 19.1 tttt -134.62 126.61 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 70' ' ' HIS . 53.1 mt -116.26 139.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -115.86 129.0 56.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.437 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 68' ' ' VAL . 82.9 m-85 -99.08 136.63 38.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.4 57.43 0.49 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -34.07 68.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -1.172 . . . . 0.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.51 119.99 2.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.6 m 45.68 25.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -1.197 . . . . 0.0 109.601 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -132.32 160.98 34.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -117.61 143.36 46.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 174.15 137.87 2.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.426 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 41.1 p90 -157.0 144.53 18.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -1.209 . . . . 0.0 109.752 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.009 ' CG1' HD11 ' A' ' 86' ' ' LEU . 59.2 t -119.43 144.71 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.274 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.9 mttm -121.44 138.29 54.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.562 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.78 ' CE1' HD13 ' A' ' 86' ' ' LEU . 93.5 m-70 -112.12 135.76 52.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.2 139.1 49.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 47.3 mt -104.62 132.03 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -89.13 -47.69 7.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -169.79 153.79 5.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.87 144.1 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -124.91 92.83 3.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -63.13 -35.25 79.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.92 -40.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -87.93 4.63 44.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 m80 47.74 38.36 8.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.482 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -120.74 138.14 54.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 78.0 t80 -125.7 127.77 46.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -118.97 134.01 55.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.676 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 28.2 p90 -157.47 170.07 23.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.205 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 92.9 p -149.0 156.8 42.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 0.0 109.9 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.009 HD11 ' CG1' ' A' ' 68' ' ' VAL . 36.4 tp -91.25 110.86 22.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.201 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 88' ' ' GLU . 4.3 tt -74.93 -47.16 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 68' ' ' VAL . 97.5 mt-10 -142.3 167.16 22.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.891 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.919 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . 172.96 146.55 5.47 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.461 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 55.6 m-20 -58.94 -27.55 65.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.86 51.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.883 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.3 mt -76.31 -33.18 59.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 108.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.4 m 55.12 -179.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.628 -0.67 . . . . 0.0 109.292 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.62 5.29 21.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.721 ' HB3' HG11 ' A' ' 127' ' ' VAL . 73.3 m-20 -97.88 -28.04 14.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 58.8 mt -104.87 137.87 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.4 mm-40 -83.87 -179.47 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 22.7 pttm -57.26 164.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' LYS . 47.7 mt -124.62 133.94 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 82.9 m-20 -90.42 126.18 35.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.875 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 93.4 m-85 -121.09 134.87 55.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.204 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -128.21 138.06 52.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.639 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.654 HG21 ' CE2' ' A' ' 23' ' ' PHE . 61.3 m -128.9 134.43 48.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.535 ' C ' HD22 ' A' ' 105' ' ' LEU . 46.5 tttt -132.61 133.08 43.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -102.83 123.46 46.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 48.2 t -129.02 141.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.3 OUTLIER -113.71 146.49 39.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.565 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.63 174.07 2.56 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.507 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.9 Cg_endo -69.3 -16.58 39.58 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.734 2.289 . . . . 0.0 111.807 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.35 -20.61 63.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.265 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.43 -22.07 25.18 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.26 176.53 54.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.501 HG21 ' HA ' ' A' ' 16' ' ' ALA . 80.1 m -125.21 126.01 44.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -1.158 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.5 mt -91.05 140.64 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 109.172 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 105' ' ' LEU . 55.3 mt -123.94 120.71 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -109.88 132.13 54.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.9 m -127.21 128.74 46.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 143.02 49.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 89.8 p -144.69 147.24 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 110.399 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 99' ' ' ILE . 51.6 mttp -122.03 144.11 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.751 ' O ' HG22 ' A' ' 3' ' ' VAL . 98.1 m-85 -112.11 124.32 52.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 110.065 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.801 ' HA ' HG22 ' A' ' 3' ' ' VAL . 90.8 m-70 -99.91 129.25 45.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.131 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.1 p -122.89 160.67 25.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 109.685 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -71.32 -34.94 71.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . 176.29 47.76 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 95.1 m-20 61.96 48.67 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -1.137 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 95' ' ' ASN . 91.6 t -54.7 -57.14 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -178.95 104.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 tt -138.73 171.79 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.239 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HE2' ' CD ' ' A' ' 132' ' ' GLU . 74.4 tttt -142.1 130.91 22.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.604 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -54.06 -41.48 68.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' CD ' ' HE2' ' A' ' 130' ' ' LYS . 95.2 mt-10 -59.83 -37.21 78.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.898 . . . . 0.0 109.487 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -66.09 -43.84 86.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 121' ' ' TYR . 50.5 t -64.01 -47.8 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -57.68 -42.36 83.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.5 72.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 109.297 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.63 95.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 6' ' ' TYR . 48.2 mmtm -62.77 -41.75 99.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -1.108 . . . . 0.0 109.361 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.89 -40.49 95.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.4 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.56 -42.56 88.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.11 90.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.39 86.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.28 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.42 -46.71 83.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.45 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 78.7 m-85 -53.89 -38.42 64.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.54 -43.43 79.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -66.11 -42.44 89.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 30' ' ' LEU . 85.9 mt -60.95 -38.55 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 13' ' ' ASP . 65.8 tt0 -64.52 -37.3 87.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.26 -41.46 31.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 21.3 m-85 -65.18 -42.54 93.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 14' ' ' ILE . 60.8 mt -67.58 -31.66 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -66.71 -41.45 87.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 42.7 p30 -99.5 7.82 45.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -60.92 131.92 91.83 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD2' ' ND1' ' A' ' 155' ' ' HIS . 49.1 Cg_endo -70.24 147.2 59.23 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.692 2.261 . . . . 0.0 111.774 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.3 m -64.6 156.07 31.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.0 -33.25 75.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -62.06 -33.64 74.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.525 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 122' ' ' HIS . 72.6 t -117.0 136.06 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 109.535 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.44 141.02 47.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.483 HG22 ' CG2' ' A' ' 118' ' ' THR . 23.6 m -93.44 143.78 25.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -124.7 138.99 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.727 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -115.27 131.81 56.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -119.8 133.3 55.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -105.54 125.41 50.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -136.41 133.3 36.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.4 p -100.9 143.32 31.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.254 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 43.7 p -141.11 171.63 13.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.653 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ILE . 67.0 m-20 -76.03 -175.99 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 18' ' ' LYS . 6.6 mm 62.85 138.36 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 49.5 Cg_endo -70.15 150.16 65.46 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.592 2.194 . . . . 0.0 112.059 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.64 -52.25 6.4 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 111.129 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 43.0 Cg_endo -64.89 -49.13 3.15 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.276 1.984 . . . . 0.0 112.907 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 14' ' ' ILE . 13.4 ttmt -57.98 -38.03 75.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.93 -1.106 . . . . 0.0 109.572 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.971 HD11 HG22 ' A' ' 148' ' ' ILE . 20.8 tp -75.28 -39.09 60.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB2' HD12 ' A' ' 105' ' ' LEU . 71.2 t80 -55.45 -47.14 76.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.0 tttt -46.63 -44.15 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.937 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -107.47 14.98 25.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.175 -0.953 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.809 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 92.4 t80 -96.22 -33.0 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 ' HD2' ' A' ' 23' ' ' PHE . 31.3 m -126.09 -39.88 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.811 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 25' ' ' LEU . 15.5 tp -57.32 -66.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.738 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 34.6 p30 -92.27 13.41 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.484 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.78 -35.0 76.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.7 m-20 -59.23 -41.52 88.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -96.62 -29.22 13.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.634 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -72.98 -38.9 66.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 27' ' ' ALA . 32.2 mt -52.25 -55.46 31.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.65 -17.5 42.82 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.41 2.073 . . . . 0.0 111.753 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 28.5 mttm -73.36 -37.06 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' HD13 ' A' ' 147' ' ' LEU . 88.6 mt -71.28 -27.76 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.15 69.23 16.04 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.84 -29.71 23.07 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.58 2.187 . . . . 0.0 111.683 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -71.96 -28.1 63.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -49.28 44.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 57' ' ' ILE . 3.0 p -119.55 150.98 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.68 -51.78 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.72 136.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.81 129.27 38.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.88 148.95 42.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.4 mt -106.25 119.16 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 24.2 tp -64.32 -44.69 90.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.9 mt-10 -159.47 155.35 26.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.72 -39.75 2.69 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.9 m-20 61.74 41.05 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.821 ' H ' HG21 ' A' ' 53' ' ' THR . . . 82.59 36.75 15.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.83 -165.4 12.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.56 130.55 19.78 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.726 2.284 . . . . 0.0 111.797 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 25.28 75.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 99.0 m -80.7 145.91 31.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 53' ' ' THR . 26.2 mm -115.47 132.29 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 mtmp? -128.98 148.39 50.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.03 125.31 44.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.283 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.726 HD11 ' CD2' ' A' ' 70' ' ' HIS . 11.3 mt -115.41 134.91 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.671 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 39' ' ' VAL . 19.5 p -115.55 142.15 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -117.74 140.92 49.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.95 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.21 -165.22 53.11 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.79 171.24 7.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.0 109.4 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.12 -35.24 8.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.3 m -54.74 -37.09 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -99.06 152.94 19.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.35 144.38 41.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.372 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.69 109.69 0.59 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 -144.21 148.05 34.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -1.176 . . . . 0.0 109.384 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.948 HG22 ' CA ' ' A' ' 89' ' ' GLY . 38.2 t -124.98 145.39 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -113.73 142.86 45.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.726 ' CD2' HD11 ' A' ' 57' ' ' ILE . 4.3 m-70 -116.73 133.42 56.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -115.16 137.67 51.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.5 mt -101.89 134.65 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.6 m-70 -91.17 -46.85 7.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 t -173.53 147.66 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.51 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 82' ' ' TYR . 29.0 pt -123.57 144.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 91.6 m-20 -121.58 91.9 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.416 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -63.31 -36.89 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.55 -41.82 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 1.18 56.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.2 m80 54.32 42.34 31.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.994 . . . . 0.0 109.406 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 40.2 m -118.17 142.51 47.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.535 ' CD1' HG22 ' A' ' 75' ' ' ILE . 65.2 t80 -134.73 123.76 24.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.5 m -117.55 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 31.4 p90 -150.87 172.94 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -149.41 155.46 40.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 92' ' ' LEU . 3.0 tt -97.17 118.74 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.966 HG22 ' HG3' ' A' ' 88' ' ' GLU . 87.6 mt -75.46 -56.88 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.627 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.966 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.6 mt-10 -149.09 160.43 43.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.948 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -165.46 152.8 22.44 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -58.17 -24.22 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -1.101 . . . . 0.0 109.324 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.48 -27.43 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 96' ' ' ILE . 2.0 mt -76.63 -32.81 58.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.839 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 92' ' ' LEU . 30.2 t 47.77 -174.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 124' ' ' LYS . 97.5 mt-10 -76.37 -6.49 51.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -0.994 . . . . 0.0 109.461 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.887 ' HB3' HG21 ' A' ' 127' ' ' VAL . 89.0 m-20 -83.1 -38.91 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.85 . . . . 0.0 109.83 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 92' ' ' LEU . 34.6 mt -91.7 135.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.817 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . 38.3 mt-10 -90.14 -179.26 5.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.872 ' HE2' HG23 ' A' ' 87' ' ' ILE . 70.1 mttt -57.04 158.5 4.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.563 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 120' ' ' LYS . 60.4 mt -125.21 131.39 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' LYS . 88.2 m-20 -88.65 124.0 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 75.6 m-85 -115.51 142.24 46.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.671 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -131.93 134.81 46.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.349 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.489 HG21 ' CE2' ' A' ' 23' ' ' PHE . 50.3 m -128.64 138.53 52.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -140.71 127.56 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.274 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 20' ' ' PHE . 37.9 mt -96.49 128.56 43.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.691 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 113' ' ' THR . 46.8 t -132.0 140.86 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.56 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 98.5 p -113.72 144.41 42.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.67 166.21 11.2 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 109.525 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.693 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.0 Cg_endo -70.32 -11.48 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.706 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -76.41 -16.81 59.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.33 -24.4 18.2 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.16 54.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 92.1 m -123.65 122.15 37.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -1.185 . . . . 0.0 109.707 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.0 mt -87.72 144.31 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.061 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.462 HG23 HD23 ' A' ' 105' ' ' LEU . 56.8 mt -131.14 117.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.871 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -97.81 131.98 43.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 108.943 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.8 m -128.91 121.59 28.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 110.007 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.3 m -114.67 141.09 48.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 108.85 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -138.58 156.71 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 110.329 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 99' ' ' ILE . 71.1 tttt -147.57 142.64 27.07 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CB ' HG12 ' A' ' 99' ' ' ILE . 26.6 p90 -135.99 148.55 48.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 109.916 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 97' ' ' GLU . 93.9 m-70 -104.48 172.71 6.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 109.517 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 124' ' ' LYS . 26.7 p -125.7 151.01 47.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.175 -0.953 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 95' ' ' ASN . 14.5 tttt -44.21 -54.68 5.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.268 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.16 -43.19 0.14 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 59.2 p30 -133.23 6.78 3.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.371 -1.076 . . . . 0.0 109.373 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.887 HG21 ' HB3' ' A' ' 95' ' ' ASN . 14.6 p -76.02 122.34 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -104.34 144.93 30.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.4 tt -124.99 171.15 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -98.5 121.35 40.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.14 -39.7 44.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 72.6 mm-40 -57.03 -37.75 72.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.35 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -67.27 -41.75 85.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.35 -42.97 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -55.53 -36.66 66.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.515 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.2 -45.68 83.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.01 -39.14 93.88 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -59.74 -40.65 88.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -1.176 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -62.47 -39.21 92.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -59.48 -43.74 93.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.392 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.29 83.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.77 -31.06 70.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -71.46 -37.62 71.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.448 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 144' ' ' LEU . 49.5 mt -67.59 -44.31 78.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.845 . . . . 0.0 109.363 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 27.3 m-85 -54.38 -44.91 72.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 23.3 mttm -57.48 -36.3 71.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.455 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD13 ' CG2' ' A' ' 34' ' ' ILE . 57.7 mt -66.02 -38.85 89.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.971 HG22 HD11 ' A' ' 19' ' ' LEU . 34.4 mm -56.42 -56.5 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 19.5 mp0 -56.53 -36.52 69.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 109.36 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.77 -27.66 62.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.498 ' CE1' HD21 ' A' ' 30' ' ' LEU . 72.8 t80 -63.7 -41.72 98.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -1.068 . . . . 0.0 109.411 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.1 mp -75.72 -46.81 29.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -53.77 -33.99 57.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.002 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -81.74 -32.14 31.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 109.039 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.89 75.53 57.32 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.64 -16.83 38.27 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.742 2.294 . . . . 0.0 111.706 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.514 ' O ' ' ND2' ' A' ' 160' ' ' ASN . 91.5 p -61.14 -20.37 62.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.0 109.377 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -62.13 -35.0 77.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.5 ' CD1' ' CE ' ' A' ' 18' ' ' LYS . 78.0 t80 -55.68 -38.73 70.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.543 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 157' ' ' SER . 19.1 m120 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.432 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 121' ' ' TYR . 78.1 t -121.76 134.17 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -1.129 . . . . 0.0 109.522 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.5 136.36 52.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 48.3 m -95.51 136.74 35.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CG ' ' HE2' ' A' ' 138' ' ' LYS . 98.4 m-85 -119.49 134.78 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.57 137.29 47.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.443 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 37.1 t-20 -113.54 149.88 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -133.4 134.12 43.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.562 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 11' ' ' THR . 64.6 t80 -161.79 131.71 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.502 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.567 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 15.1 p -98.25 157.39 16.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -157.52 177.01 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.569 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.4 t0 -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.851 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 64.06 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 109.379 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -70.41 147.46 58.7 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.628 2.219 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.21 -51.55 3.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 111.129 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 40.9 Cg_endo -63.63 -50.62 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.339 2.026 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 41.5 mttm -58.6 -37.53 76.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 109.59 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 152' ' ' LEU . 30.5 tp -80.79 -30.03 36.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.771 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -65.2 -32.86 74.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 109.77 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.7 mtpm? -64.16 -50.12 69.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.609 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -79.46 -16.47 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 103' ' ' THR . 49.8 t80 -86.1 -13.44 47.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.783 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 86.4 t -123.8 -58.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp -65.5 -39.92 92.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 42.3 m-20 -98.09 12.56 34.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -40.75 76.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 44' ' ' ILE . 88.6 m-20 -63.33 -35.23 79.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 29.2 t-20 -93.72 -33.91 13.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 31.9 tp -72.86 -44.97 60.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 27' ' ' ALA . 26.0 mt -45.59 -55.91 11.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -69.18 -26.36 30.38 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 111.801 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 31.2 tttm -71.57 -38.94 70.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.655 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 30' ' ' LEU . 63.8 mt -64.26 -24.27 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.578 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -159.08 73.2 3.51 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 50.2 Cg_endo -70.16 -30.61 20.17 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.664 2.243 . . . . 0.0 111.875 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -74.1 -21.13 60.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -73.04 -42.02 63.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.9 m -126.36 152.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.53 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.84 -43.43 62.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.57 129.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.54 125.13 31.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.37 150.91 40.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.4 mt -106.59 118.27 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.9 tp -62.61 -44.9 95.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.517 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.87 155.48 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.78 -41.14 2.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.2 m-20 60.11 37.74 20.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.156 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.739 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.03 34.92 9.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.98 -167.17 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.89 129.22 17.09 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.679 2.253 . . . . 0.0 111.77 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.5 22.44 78.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -77.03 144.47 38.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.54 HG23 ' CD1' ' A' ' 87' ' ' ILE . 65.9 mt -115.39 127.44 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 87.0 mttt -115.92 150.86 36.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 ttpp -132.91 122.44 24.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 39' ' ' VAL . 31.7 mt -113.3 135.06 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.2 m -118.14 131.83 56.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CE2' HG12 ' A' ' 39' ' ' VAL . 13.5 m-85 -99.77 128.93 45.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.62 -177.99 42.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -126.97 130.65 50.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -1.176 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.46 66.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.3 p -123.52 145.46 48.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -1.17 . . . . 0.0 109.423 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -108.35 3.69 23.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.25 157.04 26.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.433 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' OD2' ' A' ' 90' ' ' ASP . . . 76.65 60.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 39.0 p90 -140.35 144.07 36.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG11 HD11 ' A' ' 86' ' ' LEU . 25.5 t -131.26 155.15 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.56 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 45.1 mtmt -124.27 154.3 40.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 6.2 m-70 -123.31 150.14 43.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HB2' HG13 ' A' ' 87' ' ' ILE . 57.9 tttt -132.86 138.15 46.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 31.1 mt -104.32 124.04 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 98.4 m-70 -89.0 -27.39 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 59.7 p 178.9 153.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -136.0 142.53 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.4 m-20 -123.51 94.58 4.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.51 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.26 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 -42.91 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.315 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -87.96 8.14 27.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 48.2 m80 46.28 48.97 13.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.348 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 31.0 m -126.27 136.1 52.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 68.8 t80 -129.98 123.79 31.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -124.52 135.77 53.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.761 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.9 p90 -147.96 -177.14 5.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 88.8 p -151.41 150.83 30.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 87' ' ' ILE . 3.1 tt -87.5 119.52 27.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' A' ' 88' ' ' GLU . 97.4 mt -76.09 -63.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 87' ' ' ILE . 73.6 mm-40 -138.65 154.38 48.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.725 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.544 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -173.15 142.88 6.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 66' ' ' GLY . 6.0 m-20 -53.09 -32.56 47.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -20.17 61.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 86' ' ' LEU . 9.7 mp -85.18 -36.02 21.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 40.5 t 61.79 173.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 98.1 mt-10 -79.73 -7.11 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.403 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 53.1 m-20 -84.82 -39.71 18.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.631 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 29.8 mt -87.52 143.8 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 92.8 mt-10 -91.37 -179.33 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 46.9 mtmt -56.86 160.86 3.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.96 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 120' ' ' LYS . 66.4 mt -120.91 136.65 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 119' ' ' SER . 88.9 m-20 -92.78 126.23 37.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 80.4 m-85 -117.81 137.76 52.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 118' ' ' THR . 94.5 mt-10 -125.01 142.08 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 23' ' ' PHE . 25.9 m -129.86 136.09 49.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 109.334 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.528 ' C ' HD22 ' A' ' 105' ' ' LEU . 25.0 tttt -139.26 128.94 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.847 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -106.33 112.5 25.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.491 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 9.4 t -130.57 128.47 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.9 p -114.78 154.22 28.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.957 . . . . 0.0 110.105 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -96.32 161.54 26.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.634 -0.666 . . . . 0.0 109.248 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.7 Cg_endo -68.5 92.21 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.375 2.05 . . . . 0.0 110.368 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 34.6 t60 78.93 17.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -112.19 12.83 26.35 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 82.95 -151.39 28.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 52.9 m -126.42 134.69 50.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.998 -1.295 . . . . 0.0 109.797 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 49.8 mt -107.05 134.47 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.031 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.503 HG23 HD13 ' A' ' 105' ' ' LEU . 28.4 mt -116.57 116.83 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 29.2 mttp -105.89 130.55 53.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.968 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -124.63 130.66 52.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 109.966 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.3 m -126.02 139.23 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.433 -0.792 . . . . 0.0 108.997 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 94.8 p -143.47 152.16 41.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 99' ' ' ILE . 90.1 mttt -125.86 143.35 51.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.108 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CD1' HD13 ' A' ' 99' ' ' ILE . 82.7 m-85 -111.17 123.48 50.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.752 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -95.16 136.79 35.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.241 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.497 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 21.6 p -129.28 152.65 48.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.587 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' GLU . 76.2 mttt -61.65 -56.42 20.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.15 -69.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -116.46 39.05 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -1.18 . . . . 0.0 109.555 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 95' ' ' ASN . 13.5 m -44.31 -35.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 127' ' ' VAL . 85.1 tt0 60.17 119.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -137.33 171.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -102.91 129.54 49.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -56.14 -34.15 65.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.3 -36.6 80.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.393 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -73.16 -37.14 66.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.66 -44.79 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.6 tttt -59.94 -40.13 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.846 . . . . 0.0 109.441 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.48 93.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.409 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.49 -49.09 76.99 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.572 ' HE2' ' CG ' ' A' ' 6' ' ' TYR . 30.3 mttt -63.96 -42.79 97.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.39 -41.82 88.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 50.1 tttp -53.89 -45.39 71.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.7 -47.71 71.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.569 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.67 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.49 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 86.7 t60 -61.86 -44.66 96.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 81.4 mt -53.64 -46.87 70.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -53.42 -32.75 51.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -68.25 -34.55 76.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.955 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -71.82 -38.86 70.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 76.4 mt -60.02 -46.01 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -69.61 -34.09 73.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.64 -42.24 88.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 27.1 m-85 -63.13 -46.17 88.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.851 HD12 HD13 ' A' ' 14' ' ' ILE . 67.8 mt -57.69 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -55.56 -43.1 75.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -58.65 -39.83 81.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.53 ' NE2' ' ND2' ' A' ' 160' ' ' ASN . 2.0 m170 -109.75 107.36 59.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.33 -19.31 33.59 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.646 2.231 . . . . 0.0 111.763 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 51.1 m -120.18 143.2 48.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.5 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.65 -36.25 78.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.421 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -119.89 143.58 47.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.53 ' ND2' ' NE2' ' A' ' 155' ' ' HIS . 42.7 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.449 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.941 HG11 ' O ' ' A' ' 121' ' ' TYR . 94.0 t -117.53 144.11 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.566 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -100.8 146.1 27.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.566 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 24.8 m -93.55 139.47 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.283 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.45 136.23 53.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.577 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -113.69 135.22 54.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.29 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 27.3 t30 -114.88 131.02 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 90.3 mt-10 -113.99 132.91 55.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.164 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.4 t80 -146.5 144.84 29.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.746 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.756 HG22 HG12 ' A' ' 114' ' ' ILE . 20.4 p -109.64 144.71 37.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -152.23 179.38 8.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.7 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 71.9 m-20 -80.62 -175.71 5.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 13' ' ' ASP . 2.6 mt 69.1 135.13 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 51.0 Cg_endo -71.09 148.14 55.84 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 112.012 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -39.41 -51.46 4.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.557 -0.714 . . . . 0.0 111.311 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.28 -50.32 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.338 2.025 . . . . 0.0 113.072 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 30.9 mttt -59.33 -36.16 75.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.94 -1.1 . . . . 0.0 109.505 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 tp -80.78 -27.08 36.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 24' ' ' VAL . 73.8 t80 -68.93 -38.28 79.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.959 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 60.7 tttt -66.01 -45.07 82.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -29.63 44.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.642 ' HD2' HD13 ' A' ' 148' ' ' ILE . 56.7 t80 -80.88 -10.95 59.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 20' ' ' PHE . 97.8 t -121.9 -55.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.5 tp -69.57 -36.7 76.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.7 m-20 -102.99 15.77 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.783 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -70.2 -40.34 74.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.768 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.656 ' OD2' HD11 ' A' ' 44' ' ' ILE . 87.8 m-20 -66.35 -24.74 66.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.067 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.4 m120 -105.69 -43.22 4.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.967 . . . . 0.0 109.629 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 18.3 tp -59.91 -36.06 76.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 27' ' ' ALA . 22.4 mt -54.16 -60.1 8.35 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -67.99 -14.0 39.85 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.614 2.209 . . . . 0.0 111.801 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 75.8 mttt -75.07 -40.7 59.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.2 mt -73.84 -31.28 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.21 67.12 14.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -70.11 -31.81 18.29 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -70.96 -26.02 62.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -70.78 -43.65 68.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.935 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 57' ' ' ILE . 5.6 p -116.36 146.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -73.74 -46.06 48.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 177.47 136.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.68 130.84 44.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.381 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -125.43 151.63 45.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.656 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.6 mt -105.96 123.41 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.478 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -69.22 -43.11 74.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 109.495 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 53' ' ' THR . 93.1 mt-10 -158.99 158.79 33.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.479 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.68 -41.15 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.4 m-20 59.35 39.71 21.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -1.113 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.848 ' H ' HG21 ' A' ' 53' ' ' THR . . . 81.51 34.2 26.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.9 -165.39 12.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.01 127.65 14.69 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.664 2.242 . . . . 0.0 111.691 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.5 24.85 69.36 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 46' ' ' GLU . 60.3 m -81.19 140.96 34.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -1.145 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.14 133.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.594 ' CE ' HD11 ' A' ' 72' ' ' ILE . 46.7 mttt -121.52 148.06 44.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.688 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 85.8 tttt -130.52 124.49 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.241 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 39' ' ' VAL . 22.3 mt -118.41 133.17 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -118.76 123.2 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.866 . . . . 0.0 109.35 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 41.6 p90 -123.48 138.73 54.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.71 133.34 3.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.39 -34.95 78.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -1.102 . . . . 0.0 109.448 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.29 -39.47 0.71 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -57.38 -40.41 78.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.526 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -111.31 154.99 23.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.81 142.56 48.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.933 . . . . 0.0 109.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -177.84 136.59 3.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 42.3 p90 -155.96 144.19 19.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -1.228 . . . . 0.0 110.031 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 86' ' ' LEU . 43.3 t -121.81 150.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.435 -0.79 . . . . 0.0 109.047 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 34.6 mttt -118.12 140.67 49.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.703 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.478 ' CE1' HD12 ' A' ' 57' ' ' ILE . 80.8 m80 -120.2 131.15 54.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.6 tttp -111.4 141.72 44.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CE ' ' A' ' 55' ' ' LYS . 60.0 mt -100.48 132.18 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.8 m-70 -91.05 -49.25 6.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.535 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.1 t -166.32 147.81 6.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.91 144.78 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -124.34 91.58 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -62.53 -35.31 79.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.49 -40.56 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -88.37 8.74 26.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.8 m80 45.86 44.79 11.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.8 m -125.78 136.59 53.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 72.0 t80 -127.8 127.17 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.459 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -119.45 135.68 54.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 40.5 p90 -151.97 168.77 24.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.467 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -145.52 156.04 43.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.914 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.2 tt -92.57 124.93 36.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.443 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.839 HG22 ' HG3' ' A' ' 88' ' ' GLU . 27.1 mm -79.45 -66.34 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.839 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.7 mt-10 -139.24 160.64 39.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.703 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -176.41 157.54 23.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 62.4 m-20 -61.16 -27.08 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.181 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -32.06 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.914 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.7 mp -75.23 -48.78 21.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.9 m 61.34 170.6 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -72.56 -5.66 38.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.4 ' O ' HG11 ' A' ' 127' ' ' VAL . 86.1 m-20 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.607 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 92' ' ' LEU . 46.6 mt -98.24 151.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 90.2 mt-10 -94.81 -179.98 5.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 87' ' ' ILE . 32.4 mmtm -57.37 159.57 4.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.489 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 120' ' ' LYS . 54.8 mt -120.72 136.5 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 120' ' ' LYS . 59.7 t0 -98.66 125.1 43.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 88.6 m-85 -116.9 142.74 46.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -133.0 138.42 46.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.7 m -130.52 137.71 49.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 105' ' ' LEU . 22.7 tttt -138.98 131.64 28.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.348 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -103.73 115.72 31.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.562 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 114' ' ' ILE . 4.3 t -131.88 131.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 63.1 p -114.69 154.57 28.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.057 -1.027 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -99.62 162.15 22.13 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.565 -0.71 . . . . 0.0 109.316 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.6 Cg_endo -68.92 95.0 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.369 2.046 . . . . 0.0 110.472 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 11.5 m80 78.28 11.48 1.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -105.58 9.09 44.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 83.45 -146.89 23.9 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 90.6 m -126.73 133.95 50.76 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.118 -1.225 . . . . 0.0 109.659 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.756 HG12 HG22 ' A' ' 11' ' ' THR . 61.2 mt -108.65 130.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.2 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 ' CD1' ' A' ' 105' ' ' LEU . 5.2 mt -109.28 117.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.725 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 42.7 mttp -105.15 129.23 53.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.083 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.4 m -128.15 129.6 46.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 109.868 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 5' ' ' THR . 51.4 m -111.3 139.64 46.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.159 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -128.56 135.95 50.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.881 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 99' ' ' ILE . 35.7 tttm -139.13 139.15 37.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.819 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.941 ' O ' HG11 ' A' ' 3' ' ' VAL . 36.5 p90 -134.08 151.26 51.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.08 -1.012 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.9 m80 -109.06 154.79 21.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.498 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 80.5 p -102.99 142.67 33.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.546 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 11.5 tptt -56.42 -45.88 80.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.17 -53.49 0.14 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 83.5 m-20 -116.37 -6.77 11.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.563 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 127' ' ' VAL . 14.5 p -55.84 125.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 94.9 mt-10 -118.31 151.09 38.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.939 . . . . 0.0 109.389 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.94 171.64 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 87.3 mttt -108.28 133.08 53.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.63 -36.18 69.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.16 -35.99 78.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.503 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.548 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 63.1 m170 -70.86 -39.83 72.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -66.76 -41.68 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -58.8 -38.13 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.135 -0.978 . . . . 0.0 109.414 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.81 97.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.24 -36.22 92.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 48.4 mtpt -64.01 -42.63 97.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -1.114 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.56 -41.75 96.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' O ' HD23 ' A' ' 144' ' ' LEU . 54.1 tttp -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.83 84.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.69 -30.76 71.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 65.5 m170 -69.5 -35.27 75.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 140' ' ' LYS . 4.0 mm? -69.91 -42.57 73.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 54.7 m-85 -54.26 -46.19 72.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.484 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 84.7 tttt -60.67 -34.56 74.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 143' ' ' HIS . 41.8 mt -65.26 -38.32 89.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 23' ' ' PHE . 83.4 mt -54.19 -56.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 12' ' ' SER . 30.8 mp0 -55.67 -44.05 76.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.1 -26.23 72.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.48 ' OH ' ' HD3' ' A' ' 33' ' ' LYS . 64.0 t80 -70.37 -41.38 73.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -1.103 . . . . 0.0 109.387 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp -74.15 -44.82 52.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.374 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -53.61 -35.8 61.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 155' ' ' HIS . 19.9 t70 -81.55 -32.49 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 0.0 109.206 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 154' ' ' ASP . 0.7 OUTLIER 43.95 65.09 6.21 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.566 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.26 -19.54 33.62 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.689 2.26 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 95.6 p -67.35 -30.16 69.9 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -56.96 -33.82 67.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.508 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.99 -38.96 80.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 34.9 t30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.406 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 122' ' ' HIS . 27.6 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.317 0.58 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.17 142.03 39.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 109.341 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.649 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.2 m -93.65 143.14 26.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -124.81 137.5 54.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.57 136.3 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.397 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -124.96 134.19 52.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 86.4 mt-10 -109.93 143.42 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 109.366 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 11' ' ' THR . 72.1 t80 -152.16 139.75 19.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 11.3 p -97.73 131.74 43.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.435 ' HG ' ' HE2' ' A' ' 10' ' ' PHE . 7.6 m -132.79 170.85 14.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -80.6 -175.7 5.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' LYS . 7.7 mm 67.4 139.34 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.337 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -70.2 148.89 63.18 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 111.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.47 -52.37 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 111.38 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.86 -50.37 2.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.397 2.064 . . . . 0.0 113.069 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.4 mttp -60.76 -35.02 75.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.823 -1.173 . . . . 0.0 109.498 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 149' ' ' GLU . 23.5 tp -80.59 -36.08 33.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.577 ' HD1' HD23 ' A' ' 105' ' ' LEU . 80.6 t80 -59.17 -48.31 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.836 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -61.32 -54.28 45.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.25 -4.46 21.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.89 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.3 t80 -94.11 -32.84 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' A' ' 82' ' ' TYR . 4.7 m -117.31 -39.19 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 25' ' ' LEU . 22.9 tp -72.87 -38.5 66.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.515 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -104.09 11.33 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.77 -41.1 75.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 44' ' ' ILE . 84.5 m-20 -57.46 -30.6 65.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 25.6 m120 -101.35 -35.78 9.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.442 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 33' ' ' LYS . 17.5 tp -75.2 -39.65 59.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' A' ' 27' ' ' ALA . 33.1 mt -47.98 -55.01 19.66 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.93 . . . . 0.0 109.56 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.4 Cg_endo -69.26 -19.93 37.85 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.383 2.055 . . . . 0.0 111.721 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.7 mttt -74.19 -36.27 64.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.502 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.6 mt -70.15 -29.99 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.975 . . . . 0.0 109.555 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.79 72.18 12.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.7 Cg_endo -69.67 -43.56 2.66 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.658 2.238 . . . . 0.0 111.694 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.9 -20.62 63.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.9 69.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.926 HG12 ' CE1' ' A' ' 59' ' ' PHE . 17.3 m -128.51 154.83 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -73.94 -45.89 47.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.486 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.62 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.37 128.93 35.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.91 144.2 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.525 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 55.4 mt -106.54 119.38 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.458 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -63.31 -44.45 94.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.73 154.6 24.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.11 -41.87 2.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 91.1 m-20 60.52 38.06 19.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.741 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.58 35.29 9.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.503 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.12 -167.56 13.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.15 129.29 16.93 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.733 2.288 . . . . 0.0 111.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.9 24.88 75.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 46' ' ' GLU . 91.9 m -80.05 144.59 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.473 HG22 HD13 ' A' ' 45' ' ' LEU . 24.5 mm -110.65 128.62 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 81.9 mttt -114.94 150.16 36.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HB2' HD11 ' A' ' 45' ' ' LEU . 43.8 tttm -132.55 123.49 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 70' ' ' HIS . 39.8 mt -114.16 136.69 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.3 m -113.73 130.9 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.926 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.0 m-85 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 40.9 p90 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.298 0.57 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.955 HG22 ' CA ' ' A' ' 89' ' ' GLY . 67.7 t -117.27 142.27 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.232 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 88' ' ' GLU . 18.0 mttp -112.03 143.35 43.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.738 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' ILE . 97.0 m-70 -124.45 143.1 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.778 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.0 tttm -125.61 139.55 53.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.672 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.9 mt -96.95 137.98 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.388 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.446 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 87.1 m-70 -90.52 -49.03 6.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -170.02 149.08 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.1 pt -125.81 144.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 83.9 m-20 -127.94 92.4 3.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -63.43 -35.29 79.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.95 -39.38 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.414 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.8 m-20 -88.42 5.09 43.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m80 47.68 46.52 18.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.1 m -129.06 132.22 47.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 64.8 t80 -124.78 125.7 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -118.54 140.61 49.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 32.5 p90 -154.4 170.27 21.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 82.9 p -148.88 157.94 43.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.0 tt -94.99 132.13 40.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.318 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.959 ' N ' HD23 ' A' ' 86' ' ' LEU . 87.8 mt -89.84 -71.68 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 109.592 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.88 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -127.32 159.27 34.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.955 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -175.37 154.35 17.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.22 -35.39 78.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -1.159 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -73.16 -23.84 60.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.989 ' CD2' HD22 ' A' ' 86' ' ' LEU . 9.1 mp -78.85 -49.49 12.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.04 176.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.0 -10.06 59.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.15 -34.25 26.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 92' ' ' LEU . 36.5 mt -96.23 132.72 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 93.4 mt-10 -87.1 -179.16 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.744 ' HE2' HG23 ' A' ' 87' ' ' ILE . 89.9 mttt -56.71 165.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.447 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.776 HG23 ' O ' ' A' ' 120' ' ' LYS . 63.7 mt -125.78 131.79 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.878 . . . . 0.0 109.523 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 50.3 t0 -85.98 119.9 26.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 65.8 m-85 -113.04 142.15 46.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' THR . 92.7 mt-10 -131.47 136.74 48.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 23' ' ' PHE . 27.3 m -125.38 131.58 52.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' C ' HD22 ' A' ' 105' ' ' LEU . 56.2 tttt -133.08 125.03 28.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.845 HD13 HG23 ' A' ' 115' ' ' ILE . 2.9 mm? -99.58 128.65 45.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 114' ' ' ILE . 41.3 t -131.15 140.7 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -109.26 147.92 31.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.69 161.82 23.84 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.7 Cg_endo -70.1 -11.69 30.85 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.727 2.284 . . . . 0.0 111.82 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -77.22 -17.13 58.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.939 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.86 -15.22 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.25 173.43 44.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 99.1 m -127.75 127.61 43.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.565 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 64.5 mt -97.95 143.42 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.282 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.845 HG23 HD13 ' A' ' 105' ' ' LEU . 4.2 mt -124.17 123.61 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 18.6 mttt -105.11 131.32 52.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 102' ' ' GLU . 85.7 m -131.47 132.04 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.2 m -112.28 144.62 41.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.048 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.9 m -130.4 145.55 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 0.0 110.072 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' ILE . 5.1 ttpt -143.75 123.34 13.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 99' ' ' ILE . 14.8 m-85 -106.87 137.94 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.062 -1.023 . . . . 0.0 109.724 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' HG21 ' A' ' 3' ' ' VAL . 67.7 m80 -107.49 148.54 29.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.641 -179.773 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -74.31 -32.2 62.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 144' ' ' LEU . 65.4 mt -68.92 -41.62 77.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.863 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.465 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 60.1 m-85 -53.4 -47.94 69.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -54.69 -40.55 69.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 151' ' ' TYR . 45.8 mt -60.89 -36.95 80.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.379 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 145' ' ' PHE . 92.1 mt -56.04 -55.84 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 19' ' ' LEU . 35.9 mp0 -68.31 -33.99 75.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.15 60.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 147' ' ' LEU . 64.8 m-85 -60.94 -49.21 78.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.173 . . . . 0.0 109.434 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.522 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.732 HG11 ' O ' ' A' ' 121' ' ' TYR . 73.1 t . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.9 148.24 34.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 22.8 m -93.66 140.62 29.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' THR . 73.2 t80 -115.22 131.54 56.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.942 . . . . 0.0 109.643 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.22 138.66 47.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -132.72 129.85 39.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 81.0 mt-10 -105.53 123.96 48.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.282 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -132.99 129.73 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 114' ' ' ILE . 27.6 p -97.39 140.25 32.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -138.88 172.13 13.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.687 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' ILE . 49.7 m-20 -76.18 -175.65 3.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mp 62.48 140.63 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.46 147.95 65.94 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.541 2.161 . . . . 0.0 111.949 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.92 -52.13 2.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 111.289 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.33 -50.05 3.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.076 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 14' ' ' ILE . 36.8 mttt -57.96 -39.62 78.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.881 -1.137 . . . . 0.0 109.585 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 23.7 tp -80.56 -27.71 37.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.76 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.835 ' HB2' HD12 ' A' ' 105' ' ' LEU . 60.4 t80 -61.31 -39.42 90.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 78.3 tttt -66.85 -55.24 15.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.88 0.27 16.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 109.817 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -97.01 -29.17 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.096 -1.003 . . . . 0.0 109.539 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.9 m -122.5 -38.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 23.6 tp -72.24 -38.52 68.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 72.7 m-20 -102.73 4.46 38.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -0.865 . . . . 0.0 109.545 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.85 -32.88 71.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 109.613 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.3 m-20 -57.68 -29.19 64.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.7 m-20 -116.5 -35.86 4.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 63.9 tp -62.79 -34.07 76.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.5 mt -57.63 -58.93 14.83 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.04 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -68.32 -9.86 27.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.627 2.218 . . . . 0.0 111.605 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 65.9 mttt -80.39 -38.06 31.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 147' ' ' LEU . 88.1 mt -77.95 -28.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.18 69.1 41.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.66 -29.56 24.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.752 2.302 . . . . 0.0 111.771 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -73.41 -26.81 61.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.35 -49.59 73.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.7 m -126.54 156.11 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.4 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -71.87 -46.14 58.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.12 134.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.76 129.14 35.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -122.53 144.12 49.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 58.8 mt -106.06 120.28 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -68.59 -44.28 74.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 53' ' ' THR . 91.6 mt-10 -158.16 157.26 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.31 -40.85 2.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 56.95 33.4 23.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.9 26.02 30.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.0 -164.44 15.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.3 126.0 12.48 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.674 2.249 . . . . 0.0 111.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.9 36.43 41.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' GLU . 39.8 m -89.12 142.23 27.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -1.162 . . . . 0.0 109.365 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -112.75 124.81 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' HG12 ' A' ' 44' ' ' ILE . 71.2 mttt -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HB2' HD11 ' A' ' 45' ' ' LEU . 47.7 tttm -133.86 121.85 22.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 70' ' ' HIS . 21.5 mt -116.75 135.47 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.66 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -119.77 139.24 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.773 ' HE1' HG23 ' A' ' 68' ' ' VAL . 93.0 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.1 p90 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG23 ' HE1' ' A' ' 59' ' ' PHE . 44.0 t -121.18 140.32 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.892 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 32.3 mttt -115.49 144.72 43.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.46 ' CE1' HD12 ' A' ' 57' ' ' ILE . 75.9 m80 -124.77 135.66 53.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HB2' HD11 ' A' ' 87' ' ' ILE . 53.8 tttp -118.12 141.11 48.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.9 mt -102.88 138.07 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -93.19 -47.52 6.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 p -172.06 153.72 3.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 82' ' ' TYR . 31.8 pt -127.96 145.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -126.57 92.43 3.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -62.45 -35.0 77.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.397 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -71.84 -41.47 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -86.49 5.29 36.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.2 m80 46.69 40.76 9.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 m -124.16 136.5 54.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 82.5 t80 -123.93 125.48 44.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.306 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -117.08 132.38 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.6 p90 -153.59 168.83 24.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -146.83 152.44 38.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.8 tt -91.89 134.71 34.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.94 ' N ' HD23 ' A' ' 86' ' ' LEU . 93.8 mt -89.8 -70.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.907 . . . . 0.0 109.599 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.775 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.3 mt-10 -125.43 161.23 27.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -179.83 156.29 17.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -58.7 -32.4 69.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -1.164 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.83 -16.43 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.933 HD21 HD22 ' A' ' 86' ' ' LEU . 7.6 mp -86.01 -30.61 22.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 p 59.72 -177.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.95 16.76 13.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -0.892 . . . . 0.0 109.184 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.44 -20.87 7.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 9.8 mt -96.05 142.44 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -87.91 179.97 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 41.6 mtmt -57.55 167.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 120' ' ' LYS . 74.9 mt -119.83 138.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -90.75 122.58 33.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 69.2 m-85 -116.13 138.7 51.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -134.17 137.18 44.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.24 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.559 HG21 ' CE2' ' A' ' 23' ' ' PHE . 44.7 m -131.2 131.47 44.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.622 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -129.24 133.49 47.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 20' ' ' PHE . 17.7 mt -107.31 120.15 41.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.699 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 114' ' ' ILE . 22.6 t -131.94 138.54 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 22.9 m -114.48 151.66 32.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.98 172.01 3.88 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.03 -16.89 40.98 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.802 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.96 -16.49 63.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.345 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.04 -17.42 44.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.31 172.54 45.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 85.7 m -119.27 124.11 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -1.127 . . . . 0.0 109.365 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 11' ' ' THR . 70.8 mt -94.79 143.18 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.137 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.742 HG23 HD23 ' A' ' 105' ' ' LEU . 53.8 mt -132.64 132.35 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.951 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 47.8 mttp -107.09 135.32 48.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.7 m -125.47 130.5 51.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.964 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 29.1 m -123.6 143.42 50.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.948 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.2 t -138.77 140.72 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.997 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 99' ' ' ILE . 72.7 tttt -136.8 133.92 36.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.732 ' O ' HG11 ' A' ' 3' ' ' VAL . 31.8 m-85 -110.02 133.63 52.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.677 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.7 m80 -101.68 136.51 41.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.271 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 146' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.315 0.579 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.482 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.8 t60 -61.37 -47.13 87.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 144' ' ' LEU . 55.1 mt -63.0 -42.13 99.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.384 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 148' ' ' ILE . 57.4 t80 -55.69 -42.04 74.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.361 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 142' ' ' ALA . 98.1 mttt -53.82 -38.09 64.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -67.21 -40.03 86.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 145' ' ' PHE . 87.9 mt -53.9 -51.15 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.43 -48.82 79.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.34 -33.03 86.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.62 -46.38 84.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 14' ' ' ILE . 71.5 mt . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 122' ' ' HIS . 70.6 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.256 0.55 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -111.48 135.62 51.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 33.2 m -101.87 132.91 47.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.14 132.65 56.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.92 141.51 39.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 65.3 t30 -126.58 131.05 51.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.574 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.01 141.91 46.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 83.2 t80 -162.97 143.71 9.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.448 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 8.7 p -102.42 144.63 30.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 115' ' ' ILE . 50.1 m -142.84 167.83 21.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.1 t0 -78.68 -175.97 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 66.49 140.7 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 109.276 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 49.6 Cg_endo -71.12 148.07 55.55 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.605 2.203 . . . . 0.0 112.203 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.79 -51.6 3.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.72 . . . . 0.0 111.388 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.25 -43.72 13.89 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.43 2.087 . . . . 0.0 113.046 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG22 ' A' ' 14' ' ' ILE . 74.9 mttt -64.01 -34.5 78.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.81 -1.181 . . . . 0.0 109.653 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.7 tt -80.64 -31.66 36.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.83 ' CE1' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -65.7 -35.85 81.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.845 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 47.0 mttp -64.52 -42.36 95.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -84.43 -32.18 24.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' A' ' 103' ' ' THR . 53.5 t80 -78.15 -8.02 57.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.83 HG21 ' CE1' ' A' ' 20' ' ' PHE . 63.0 t -123.98 -68.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 12.1 tp -57.23 -43.68 83.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 75.9 m-20 -95.05 12.87 27.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.868 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.67 -32.67 71.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 44' ' ' ILE . 97.3 m-20 -66.32 -34.75 78.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.1 t30 -100.06 -43.09 6.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD21 HG23 ' A' ' 148' ' ' ILE . 30.0 tp -53.79 -43.77 69.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 27' ' ' ALA . 10.8 mt -48.13 -63.35 1.56 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.37 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -68.74 -19.22 41.57 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.502 2.134 . . . . 0.0 111.779 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -66.67 -45.84 77.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.8 mt -72.27 -36.72 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.23 69.98 80.23 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 109.498 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.7 Cg_endo -70.84 -33.88 11.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.588 2.192 . . . . 0.0 111.639 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -75.4 -27.14 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.95 94.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.027 HG12 ' CE1' ' A' ' 59' ' ' PHE . 16.5 m -127.01 160.49 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 29.5 ttpt -72.25 -50.37 27.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.476 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.41 132.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.45 123.39 32.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -121.67 144.87 48.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 28' ' ' ASP . 61.2 mt -105.09 119.49 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 29.0 tp -64.99 -44.29 89.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 53' ' ' THR . 74.1 mm-40 -156.97 151.61 25.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.473 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 109.09 -42.88 1.84 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.2 m-20 61.9 38.85 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.779 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.75 35.11 17.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -118.6 -167.02 13.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.98 130.27 18.79 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.697 2.265 . . . . 0.0 111.813 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.29 24.61 76.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.79 145.16 32.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -1.155 . . . . 0.0 109.525 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.88 133.27 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.326 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 41.6 mttt -121.25 151.53 39.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -134.24 120.59 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.356 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 8.7 mt -117.87 134.25 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 40' ' ' LYS . 29.8 p -112.95 139.23 48.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.027 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.7 m-85 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.279 0.561 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -130.41 147.12 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 109.299 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' O ' HD12 ' A' ' 86' ' ' LEU . 30.8 mttt -109.82 146.36 35.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.647 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 49.8 m80 -117.42 148.29 41.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.616 ' CB ' HD11 ' A' ' 87' ' ' ILE . 39.0 tttm -129.71 141.39 50.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.0 mt -100.09 135.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -88.95 -48.5 7.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 p -166.0 154.45 11.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 pt -128.54 145.2 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -130.63 92.17 3.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.01 -38.58 91.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.43 -42.35 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 71.9 m-20 -86.68 6.6 30.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 37.3 m80 45.63 46.39 11.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.553 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.5 m -125.27 139.05 54.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 71.7 t80 -130.53 125.59 34.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.8 t -119.23 132.95 55.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 35.2 p90 -148.76 164.98 32.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.597 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 84.9 p -148.13 152.37 37.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.058 HD23 HD21 ' A' ' 92' ' ' LEU . 23.2 tp -87.41 137.51 32.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.596 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 71' ' ' LYS . 28.5 mm -94.31 -75.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.0 mt-10 -118.77 151.23 38.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.684 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -169.21 125.52 1.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -48.97 -34.2 12.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 109.378 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.61 -16.5 63.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.058 HD21 HD23 ' A' ' 86' ' ' LEU . 7.0 mp -86.47 -39.45 16.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 69.0 m 62.86 173.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.414 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -74.46 -11.31 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.617 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -80.97 -29.42 35.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 28.8 mt -104.54 120.13 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.7 mm-40 -75.84 -178.92 4.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.358 -0.839 . . . . 0.0 109.242 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.494 ' HE2' HG23 ' A' ' 87' ' ' ILE . 36.2 mttp -56.69 166.33 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.47 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 120' ' ' LYS . 62.0 mt -126.51 133.54 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 109.659 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 120' ' ' LYS . 90.7 m-20 -91.81 126.61 36.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.5 m-85 -116.63 138.16 51.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 117' ' ' THR . 94.3 mt-10 -128.05 135.2 49.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.621 HG21 ' CE1' ' A' ' 23' ' ' PHE . 40.5 m -129.7 131.74 46.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -139.45 124.7 18.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -95.52 132.19 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.3 t -128.96 139.44 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -112.65 145.0 41.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -107.93 167.14 9.73 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.53 -9.23 25.41 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.696 2.264 . . . . 0.0 111.77 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -78.21 -15.21 59.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.18 -21.27 29.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.34 169.12 50.99 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.4 m -124.45 126.21 45.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -1.193 . . . . 0.0 109.611 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 65.7 mt -97.6 142.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.844 HG23 HD13 ' A' ' 105' ' ' LEU . 2.6 mp -125.73 125.55 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.682 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 28.0 mttt -115.03 139.08 50.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.121 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 102' ' ' GLU . 91.4 m -132.06 135.65 46.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.878 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 40.8 m -124.52 138.32 54.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.367 -0.833 . . . . 0.0 108.958 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -131.53 155.75 46.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 110.041 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.0 mttt -138.06 138.49 38.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 3' ' ' VAL . 32.7 m-85 -116.57 128.77 55.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 109.623 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.723 ' HA ' HG22 ' A' ' 3' ' ' VAL . 76.2 m80 -99.68 150.54 22.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -0.894 . . . . 0.0 109.432 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -58.26 -47.21 84.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 144' ' ' LEU . 45.0 mt -62.55 -43.02 99.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 67.0 t80 -54.84 -47.09 74.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.426 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -52.15 -40.4 61.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 147' ' ' LEU . 59.6 mt -63.78 -38.14 90.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.753 HG23 HD21 ' A' ' 30' ' ' LEU . 82.4 mt -55.3 -49.46 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.548 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 13' ' ' ASP . 86.2 tt0 -59.53 -48.44 81.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.91 92.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -57.53 -43.18 84.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 14' ' ' ILE . 72.8 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.986 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.8 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.281 0.563 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 5' ' ' THR . 74.4 t80 -110.16 145.97 36.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.548 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 68.5 m -93.73 143.73 26.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -127.52 141.45 51.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.68 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 84.3 tt0 -112.49 133.01 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -117.92 134.49 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -103.16 109.91 21.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.8 t80 -117.59 131.35 56.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.678 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.564 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 18.7 p -91.81 155.83 17.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.238 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 115' ' ' ILE . 59.7 p -153.61 171.94 17.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.779 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -80.16 -175.43 5.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.807 . . . . 0.0 109.424 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 15' ' ' PRO . 4.2 mm 61.74 141.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.952 . . . . 0.0 109.239 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 14' ' ' ILE . 49.0 Cg_endo -70.65 146.27 54.21 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.492 2.128 . . . . 0.0 112.001 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.82 -51.7 2.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.655 -0.653 . . . . 0.0 111.348 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.18 -50.02 3.2 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.232 1.954 . . . . 0.0 113.123 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 79.3 mttt -61.48 -38.28 86.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.161 . . . . 0.0 109.686 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.81 -25.61 37.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.71 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 63.8 t80 -66.98 -31.69 72.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 77.1 mttt -72.09 -47.53 50.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.0 60.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.795 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.0 t80 -79.36 -16.82 55.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.402 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 67.6 t -114.12 -60.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 35.8 mt -59.41 -44.48 92.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.213 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 69.7 m-20 -100.99 24.4 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.331 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.22 -37.43 78.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -70.4 -33.13 71.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -94.17 -30.44 14.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.493 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.546 HD21 HG23 ' A' ' 148' ' ' ILE . 30.1 tp -64.14 -43.68 94.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 27' ' ' ALA . 3.8 mt -50.2 -59.79 6.44 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 50.2 Cg_endo -68.9 -16.31 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.549 2.166 . . . . 0.0 111.84 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.6 tptp -69.05 -40.29 78.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.612 HG23 HD13 ' A' ' 147' ' ' LEU . 59.1 mt -67.44 -33.44 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.52 71.27 14.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.3 Cg_endo -69.86 -30.92 21.05 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.613 2.208 . . . . 0.0 111.502 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.58 -23.57 64.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.205 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 -24.81 23.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.331 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 59' ' ' PHE . 3.1 t -113.74 133.93 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.345 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -71.92 -50.83 25.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.71 130.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.03 124.81 38.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.27 146.62 46.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.837 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 57.5 mt -104.77 117.81 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.9 mp -63.39 -44.64 94.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.906 ' O ' HG23 ' A' ' 53' ' ' THR . 89.9 mt-10 -159.14 155.28 26.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.5 -41.63 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.8 m-20 61.53 35.27 17.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -1.125 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.822 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.54 34.11 10.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.93 -162.69 11.79 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.17 130.64 19.17 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.699 2.266 . . . . 0.0 111.833 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . 69.31 30.26 71.6 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.906 HG23 ' O ' ' A' ' 46' ' ' GLU . 74.4 m -85.86 143.28 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.4 mm -110.97 132.16 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 72' ' ' ILE . 79.0 mttt -122.83 146.46 47.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -127.71 120.45 28.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.268 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 11.6 mt -117.38 127.49 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -108.6 127.86 54.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.597 ' HE1' HG22 ' A' ' 39' ' ' VAL . 85.1 m-85 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 44.1 p90 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.4 m -121.92 147.98 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.339 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 45.9 mttt -108.01 141.21 40.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 68' ' ' VAL . 73.8 m80 -119.85 133.24 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.85 . . . . 0.0 109.148 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' A' ' 87' ' ' ILE . 21.1 tttt -116.0 139.69 50.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 63.9 mt -98.17 136.26 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 89.0 m-70 -90.09 -47.73 7.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 t -170.3 158.6 6.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.09 145.06 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.5 m-20 -124.94 92.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.473 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -65.34 -38.47 90.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.59 -42.5 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 74.1 m-20 -86.87 8.36 23.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.464 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.7 m80 45.76 41.66 7.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 m -121.74 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 67.4 t80 -130.78 122.99 28.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -117.27 134.02 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 33.9 p90 -151.12 161.79 42.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 93.4 p -139.16 158.32 44.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 87' ' ' ILE . 6.5 tt -98.62 125.1 43.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.802 HG22 ' HG3' ' A' ' 88' ' ' GLU . 31.0 mm -73.7 -68.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.4 mt-10 -140.92 146.44 37.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.657 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -153.24 160.49 29.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 68' ' ' VAL . 67.0 m-20 -60.65 -31.07 70.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.482 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 -27.84 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.36 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' ILE . 5.7 mp -77.28 -39.74 47.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.387 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 30.6 m 59.52 169.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.31 -8.16 54.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -83.93 -27.97 28.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 109.424 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 92' ' ' LEU . 18.7 mt -99.73 146.3 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -90.35 179.9 5.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 109.609 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.68 ' HE2' HG23 ' A' ' 87' ' ' ILE . 37.8 mttt -57.55 162.35 3.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 120' ' ' LYS . 40.5 mt -118.56 141.04 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.704 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 59.0 t0 -97.74 119.86 37.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 95.4 m-85 -113.59 144.87 42.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 91.5 mt-10 -138.67 134.13 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.3 m -126.84 132.86 50.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.563 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 105' ' ' LEU . 34.2 tttt -130.21 132.9 46.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.29 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -106.67 115.22 29.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 23.5 t -131.58 145.33 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 3.2 m -114.43 153.47 29.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.42 167.6 8.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.353 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.27 -7.8 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.626 2.217 . . . . 0.0 111.811 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -76.74 -13.98 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.57 -16.34 44.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.32 172.16 41.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 94.8 m -116.05 124.97 51.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.444 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 59.8 mt -96.42 127.54 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.252 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 105' ' ' LEU . 51.3 mt -113.35 126.77 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 109.768 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 18.1 mttp -103.49 129.35 50.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 108.97 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -129.23 124.78 35.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.155 -0.966 . . . . 0.0 110.096 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 23.4 m -106.6 142.96 35.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 108.964 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -129.12 143.06 50.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 109.913 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 99' ' ' ILE . 24.4 tttt -149.31 119.73 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 109.082 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.986 ' O ' HG21 ' A' ' 3' ' ' VAL . 22.0 m-85 -107.99 133.11 52.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 75.3 m80 -96.47 143.57 27.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 109.273 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.763 -179.829 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -74.21 -31.69 62.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.39 -43.73 80.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 148' ' ' ILE . 77.4 m-85 -54.66 -39.47 68.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.56 -41.71 86.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 109.422 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG23 ' A' ' 34' ' ' ILE . 43.5 mt -67.3 -39.24 85.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.546 HG23 HD21 ' A' ' 30' ' ' LEU . 65.5 mt -54.18 -46.32 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 12' ' ' SER . 42.3 mm-40 -68.89 -40.38 79.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.93 -55.18 27.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -54.85 -56.18 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 109.507 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 44.0 mt . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 121' ' ' TYR . 70.2 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.24 136.75 52.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 30.3 m -101.43 135.95 42.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.421 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' THR . 91.5 m-85 -118.82 139.16 52.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.75 135.48 53.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.78 134.18 55.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 94.8 mt-10 -113.96 126.91 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 65.6 t80 -143.08 136.62 28.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 109.471 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.7 p -103.44 152.23 21.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 109.421 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -154.23 171.1 19.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' HD12 ' A' ' 14' ' ' ILE . 31.9 t0 -71.79 177.52 4.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.2 mt 69.6 135.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.404 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.2 Cg_endo -69.7 150.11 68.15 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.535 2.156 . . . . 0.0 111.96 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.926 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -38.64 -52.27 3.55 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -64.5 -50.5 2.53 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.425 2.083 . . . . 0.0 113.041 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 94.8 mttt -59.62 -35.56 74.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.801 -1.187 . . . . 0.0 109.485 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 18.7 tp -80.37 -33.39 37.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.937 . . . . 0.0 109.372 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' VAL . 72.8 t80 -56.52 -43.43 79.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 98.5 mttt -58.68 -61.09 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 109.646 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -68.59 -7.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.905 . . . . 0.0 109.611 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 103' ' ' THR . 83.1 t80 -84.02 -32.97 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.667 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 82' ' ' TYR . 24.9 m -127.73 -33.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.757 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.8 tp -60.95 -65.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.66 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' CG ' ' HA ' ' A' ' 22' ' ' ALA . 33.5 p30 -93.98 18.95 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.09 -35.27 76.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.126 -0.984 . . . . 0.0 109.503 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.5 -42.39 67.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.5 t-20 -97.61 -34.2 11.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.923 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.6 tm? -69.38 -39.3 78.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.539 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 30.7 mt -51.1 -56.32 20.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -69.02 -21.66 36.61 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.524 2.15 . . . . 0.0 111.764 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -66.1 -37.28 85.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.526 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' CE2' ' A' ' 151' ' ' TYR . 73.3 mt -68.53 -27.16 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.22 69.99 10.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -70.48 -31.61 17.03 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.04 -28.36 60.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.15 -44.11 76.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 57' ' ' ILE . 4.7 p -125.02 154.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -77.33 -47.77 19.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.962 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.15 141.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.529 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.58 119.52 30.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.22 140.67 37.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.441 HG12 ' HG2' ' A' ' 55' ' ' LYS . 60.2 mt -106.49 117.55 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -64.28 -45.76 86.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 53' ' ' THR . 67.3 mm-40 -157.72 155.22 29.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.4 -42.4 1.93 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 85.4 m-20 60.3 36.06 20.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.778 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.08 32.88 11.53 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.467 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.27 -166.34 13.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.85 132.65 23.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.693 2.262 . . . . 0.0 111.656 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.13 29.39 73.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.8 m -84.72 144.52 28.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.136 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 45' ' ' LEU . 60.1 mt -110.51 128.52 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' HG12 ' A' ' 44' ' ' ILE . 31.5 mttt -116.57 149.33 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.2 tttt -129.88 121.21 26.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.879 HG23 HG21 ' A' ' 39' ' ' VAL . 44.9 mt -110.81 134.49 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -119.24 123.13 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HE2' HG23 ' A' ' 68' ' ' VAL . 95.7 m-85 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.9 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 37.1 p90 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 89' ' ' GLY . 48.8 t -123.51 149.88 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 51.4 mtpt -123.6 143.57 50.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.519 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 66.6 m-70 -122.58 141.67 51.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.613 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HB2' HD11 ' A' ' 87' ' ' ILE . 82.8 tttt -123.25 139.13 54.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 54.1 mt -97.76 134.18 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 88.9 m-70 -89.48 -47.6 7.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -170.65 153.79 4.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.15 143.79 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.399 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.48 93.03 3.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -63.15 -35.6 80.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.91 -40.61 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -87.44 1.83 52.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 43.4 m80 50.66 40.51 24.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.5 m -123.02 138.49 54.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.644 ' CD1' HG11 ' A' ' 24' ' ' VAL . 80.3 t80 -127.22 125.94 41.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -117.57 134.37 54.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 109.694 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 29.9 p90 -148.46 167.74 24.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.326 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 97.1 p -144.23 159.01 43.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.948 ' CD2' HD11 ' A' ' 92' ' ' LEU . 4.5 tt -98.99 133.37 43.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.93 ' N ' HD23 ' A' ' 86' ' ' LEU . 75.8 mt -94.69 -74.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.7 mt-10 -116.08 157.96 23.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 174.82 155.65 12.77 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.37 -29.6 70.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -1.151 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -69.5 -32.1 70.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.948 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.7 mt -74.27 -32.94 63.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.037 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.65 -177.56 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.537 -0.727 . . . . 0.0 109.287 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -88.47 18.56 4.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.568 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -125.64 -9.59 6.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.869 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 91' ' ' ALA . 14.2 mt -108.55 145.43 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.055 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 88.3 mt-10 -90.04 -179.83 5.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.656 ' HE2' HG23 ' A' ' 87' ' ' ILE . 49.1 mttt -57.53 166.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.606 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 120' ' ' LYS . 81.7 mt -125.49 134.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 25.1 t70 -92.25 126.26 37.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.0 m-85 -118.72 140.45 49.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.496 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.36 137.52 47.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 23' ' ' PHE . 45.3 m -127.45 133.54 49.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -131.11 132.14 44.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -107.72 124.07 49.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.5 143.48 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.0 p -108.44 148.04 30.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.79 166.74 10.28 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.5 Cg_endo -69.38 -19.35 38.07 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.741 2.294 . . . . 0.0 111.822 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.57 -17.65 64.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.386 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.75 -23.89 18.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.7 179.75 52.14 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 63.8 m -126.62 126.37 43.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -1.185 . . . . 0.0 109.648 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -92.91 140.67 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 105' ' ' LEU . 62.7 mt -127.83 124.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 49.7 mttt -105.62 136.31 45.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.3 m -128.58 126.43 40.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 18.4 m -120.04 138.27 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 108.812 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -137.22 147.02 45.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.231 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 99' ' ' ILE . 91.2 mttt -129.81 144.08 51.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' VAL . 55.2 m-85 -119.42 129.02 54.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.671 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -96.66 141.96 29.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.384 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.318 0.58 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.41 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.1 t60 -60.63 -43.65 97.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 144' ' ' LEU . 73.6 mt -56.08 -46.13 79.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -54.81 -33.15 61.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -66.53 -39.77 88.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -64.31 -45.06 89.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.381 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.04 -55.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -54.67 -35.95 64.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.95 -29.8 66.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CE2' HG12 ' A' ' 34' ' ' ILE . 8.7 m-30 -69.45 -45.4 69.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 122' ' ' HIS . 32.6 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.423 0.63 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -117.93 155.9 29.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.667 HG22 ' CG2' ' A' ' 118' ' ' THR . 10.6 m -93.84 138.83 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 118' ' ' THR . 94.2 m-85 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -114.98 135.84 53.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -120.83 132.51 55.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -107.63 129.14 55.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.538 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.9 t80 -143.19 141.71 31.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.4 p -107.93 148.58 29.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.6 p -149.29 170.8 17.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.979 . . . . 0.0 109.527 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.0 t0 -80.28 -175.86 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.459 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 67.79 140.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -70.21 149.6 64.27 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.213 . . . . 0.0 111.911 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.73 -52.19 3.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.2 -50.34 2.91 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.461 2.107 . . . . 0.0 112.915 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB2' HG22 ' A' ' 14' ' ' ILE . 67.5 mttm -58.91 -34.87 72.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.875 -1.14 . . . . 0.0 109.546 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD12 HD11 ' A' ' 152' ' ' LEU . 8.5 tp -81.06 -28.9 35.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.728 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 56.9 t80 -68.76 -33.3 73.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 17.8 tttp -67.14 -45.35 77.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.12 -25.58 36.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.745 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 52.0 t80 -83.79 -15.6 47.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.935 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.6 t -117.81 -67.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 28.5 tp -55.82 -41.71 74.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.432 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.4 m-20 -97.78 14.72 25.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.864 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -68.64 -37.11 79.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.84 -40.75 89.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.7 m120 -94.4 -31.56 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.84 HD21 HD12 ' A' ' 148' ' ' ILE . 38.9 tp -66.44 -42.25 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 27' ' ' ALA . 6.6 mt -49.99 -57.97 10.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.442 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.68 -22.39 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.485 2.123 . . . . 0.0 111.742 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 11.3 tptt -68.5 -42.01 79.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 147' ' ' LEU . 23.8 mm -61.36 -24.99 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.86 75.06 3.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.7 -32.99 17.74 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.635 2.223 . . . . 0.0 111.645 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -21.77 61.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.62 -41.92 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.419 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' A' ' 59' ' ' PHE . 21.7 m -126.84 148.24 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.402 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HE2' ' CG2' ' A' ' 58' ' ' THR . 11.1 mtmt -72.4 -51.62 19.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.94 129.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.61 124.49 29.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -117.59 146.41 43.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -104.19 126.83 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.0 mm? -71.1 -41.47 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.38 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.96 ' O ' HG23 ' A' ' 53' ' ' THR . 90.7 mt-10 -159.26 151.16 20.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 107.68 -42.92 1.81 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 t0 64.17 39.63 7.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 0.0 109.569 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.776 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.25 37.02 13.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.86 -165.99 13.13 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.09 132.69 23.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.702 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 65.43 28.46 73.6 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.6 m -82.84 144.13 30.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -1.102 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 59.5 mt -105.12 126.09 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 mtpt -115.09 152.98 31.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -135.71 124.77 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' CD2' ' A' ' 70' ' ' HIS . 13.6 mt -113.03 131.75 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.529 ' CG2' ' HE2' ' A' ' 40' ' ' LYS . 75.0 m -109.47 120.62 43.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' A' ' 39' ' ' VAL . 90.1 m-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 46.0 p90 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.857 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.3 m -126.6 147.09 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 88' ' ' GLU . 70.2 mttt -109.54 147.23 33.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 57' ' ' ILE . 48.1 m-70 -125.21 140.1 53.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 87' ' ' ILE . 23.9 tttt -114.96 140.87 48.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.945 HD12 ' HB ' ' A' ' 53' ' ' THR . 65.3 mt -98.18 135.27 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.6 m-70 -89.35 -47.21 8.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -175.09 155.49 1.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.402 HG22 ' CE1' ' A' ' 82' ' ' TYR . 35.0 pt -131.05 144.69 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -127.26 93.11 3.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -62.99 -35.94 81.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -72.32 -39.91 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 80' ' ' HIS . 74.7 m-20 -89.3 7.4 35.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.478 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASN . 37.4 m80 44.28 48.83 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -129.91 129.7 44.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.543 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 75' ' ' ILE . 52.6 t80 -122.19 129.93 52.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.255 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p -124.61 134.62 52.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 35.2 p90 -151.39 164.86 35.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.275 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 77.4 p -142.44 162.44 35.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 87' ' ' ILE . 4.6 tt -101.98 131.49 48.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.507 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.937 ' N ' HD23 ' A' ' 86' ' ' LEU . 80.3 mt -91.98 -76.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.434 -0.791 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.785 ' HG3' HG22 ' A' ' 87' ' ' ILE . 89.0 mt-10 -118.96 147.08 44.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.425 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.857 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -166.33 146.44 10.96 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' H ' HG12 ' A' ' 68' ' ' VAL . 4.1 t0 -49.2 -46.54 45.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -1.153 . . . . 0.0 109.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.94 -22.83 65.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.8 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.0 mp -86.77 -37.87 17.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 4.3 m 58.03 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 95.2 mt-10 -64.96 -9.17 19.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.76 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -77.41 -35.05 54.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 110.098 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 96' ' ' ILE . 9.0 pt -152.1 106.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 110.189 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 93' ' ' SER . 15.7 mt-10 -135.13 107.49 7.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 109.184 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 122' ' ' HIS . 15.8 tttt -179.11 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.663 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 14.1 mt -125.99 123.64 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 54.2 t0 -104.48 113.15 26.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.434 -0.791 . . . . 0.0 108.905 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 73.5 m-85 -103.47 143.07 33.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.98 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -134.7 132.26 38.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.087 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.579 HG21 ' CE1' ' A' ' 23' ' ' PHE . 41.3 m -123.26 135.26 54.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -141.23 125.61 17.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 20' ' ' PHE . 22.1 mt -98.51 130.46 45.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.3 t -131.9 145.2 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 109.422 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -113.95 142.56 45.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.36 167.55 9.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.81 -14.64 36.2 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.698 2.265 . . . . 0.0 111.843 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -71.2 -16.75 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.02 -16.81 38.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.31 173.21 47.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.4 m -119.32 122.28 41.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -1.131 . . . . 0.0 109.53 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.1 mt -92.57 134.04 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 105' ' ' LEU . 25.3 mt -117.9 130.92 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -111.42 129.44 56.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.321 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.3 m -125.26 128.83 48.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.67 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.667 ' CG2' HG22 ' A' ' 5' ' ' THR . 38.9 m -115.25 135.85 53.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.35 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -123.26 140.13 53.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.696 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 10.9 ttpt -125.95 139.33 53.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 69.8 m-85 -122.44 135.6 54.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.4 m80 -125.45 -167.11 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.292 0.567 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.514 ' CE1' HD21 ' A' ' 147' ' ' LEU . 58.4 t-80 -60.03 -44.16 94.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.1 mt -59.13 -43.08 91.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.2 -38.26 65.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -61.3 -38.55 87.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' A' ' 34' ' ' ILE . 3.2 mm? -69.83 -29.75 67.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.84 HD12 HD21 ' A' ' 30' ' ' LEU . 34.0 mm -60.93 -44.19 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.36 -47.28 67.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.16 -30.96 71.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.594 ' CE1' ' HG2' ' A' ' 33' ' ' LYS . 61.4 t80 -63.46 -49.04 75.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.829 HD12 HD13 ' A' ' 14' ' ' ILE . 59.6 mt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 ' O ' ' A' ' 121' ' ' TYR . 11.7 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -112.13 144.68 41.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 40.5 m -93.76 141.25 28.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -117.51 132.09 56.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.59 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.79 137.28 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -118.56 154.16 33.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 114' ' ' ILE . 70.4 tt0 -133.96 109.87 9.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 43.0 t80 -122.66 128.78 51.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 21.1 p -92.32 149.47 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.296 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.3 p -146.18 166.73 25.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -0.949 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 14' ' ' ILE . 99.3 m-20 -73.17 -175.7 1.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 65.41 142.48 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.107 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.7 Cg_endo -69.0 146.37 64.62 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.414 2.076 . . . . 0.0 112.041 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -45.13 -48.12 32.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 111.401 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.72 -40.11 30.99 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.231 1.954 . . . . 0.0 113.094 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.556 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 29.7 mttm -67.97 -37.44 81.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -80.57 -28.0 37.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.721 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.549 ' HD1' HD23 ' A' ' 105' ' ' LEU . 68.7 t80 -65.91 -33.83 76.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.132 -0.98 . . . . 0.0 109.821 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.891 ' HG3' HD12 ' A' ' 25' ' ' LEU . 73.5 tttt -66.75 -46.25 75.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.614 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.06 40.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.698 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.798 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 65.4 t80 -80.52 -19.98 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.549 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 77.2 t -117.15 -63.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.891 HD12 ' HG3' ' A' ' 21' ' ' LYS . 32.4 mt -56.88 -40.74 76.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.302 -0.874 . . . . 0.0 109.581 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.9 m-20 -100.34 15.29 28.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.78 -41.57 74.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.685 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.708 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.4 m-20 -66.07 -30.36 70.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.714 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 94.1 m-20 -97.33 -32.18 12.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 109.589 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 28.4 tp -69.9 -46.5 65.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 27' ' ' ALA . 5.7 mt -47.0 -57.36 9.37 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.2 Cg_endo -68.73 -25.77 33.43 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.52 2.146 . . . . 0.0 111.867 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 60.7 tttt -75.51 -44.25 44.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.561 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' A' ' 147' ' ' LEU . 62.6 mt -67.78 -34.18 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.677 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.21 72.66 32.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.504 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.1 Cg_endo -70.53 -34.4 12.09 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.713 2.275 . . . . 0.0 111.782 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.22 78.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.733 HG12 ' CE1' ' A' ' 59' ' ' PHE . 23.7 m -125.37 155.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -73.22 -44.64 59.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.79 129.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.13 126.19 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -122.47 150.19 42.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.708 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.7 mt -106.35 121.47 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -65.74 -43.99 87.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.412 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.24 155.06 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.64 -41.0 2.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 89.2 m-20 60.54 40.47 16.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -1.102 . . . . 0.0 109.481 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.833 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.74 35.98 12.48 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.69 13.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.7 128.26 15.83 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.698 2.266 . . . . 0.0 111.715 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.65 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 90.0 m -81.07 143.32 32.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 109.587 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 45' ' ' LEU . 62.5 mt -110.14 131.67 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.313 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 50.3 mttt -116.42 150.42 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.589 ' HB2' HD11 ' A' ' 45' ' ' LEU . 25.1 tttm -129.63 125.87 37.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.188 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 68' ' ' VAL . 32.6 mt -117.39 137.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 50.4 m -114.51 133.2 55.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.733 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.2 m-85 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.474 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 44.1 p90 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 10.8 m -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 86' ' ' LEU . 81.5 mttt -119.46 147.58 44.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.582 ' NE2' HD13 ' A' ' 86' ' ' LEU . 62.6 m80 -115.95 166.57 11.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.231 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' SER . 42.5 tttp -143.78 140.72 30.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.473 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.4 mt -104.95 127.51 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 74' ' ' SER . 98.6 m-70 -88.8 -29.98 19.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 91.9 p 178.1 154.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.784 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' ILE . 38.3 pt -135.04 139.56 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -122.7 93.29 3.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -63.27 -37.89 89.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.267 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.06 -41.18 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -88.59 6.18 39.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.561 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m80 46.54 50.57 12.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.2 m -129.76 132.64 46.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.522 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 69.2 t80 -125.19 128.89 49.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.29 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -127.49 139.35 52.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.4 p90 -158.41 177.49 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.437 -0.789 . . . . 0.0 109.091 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' LYS . 89.1 p -151.7 154.77 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.898 ' CD2' HD11 ' A' ' 92' ' ' LEU . 25.5 tp -87.91 124.01 33.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.098 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.856 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.5 mt -80.69 -75.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.852 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.856 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.6 mt-10 -126.46 158.24 36.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 0.0 109.836 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -178.0 134.72 2.49 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -50.67 -37.69 42.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -1.16 . . . . 0.0 109.367 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.36 -17.37 63.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.152 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.898 HD11 ' CD2' ' A' ' 86' ' ' LEU . 6.8 mp -82.6 -42.11 18.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 3.3 t 60.13 177.18 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 97.9 mt-10 -78.89 -3.09 42.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 93' ' ' SER . 34.0 p-10 -90.76 -21.37 21.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 41.6 mt -112.39 132.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.069 -1.02 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 94.4 mt-10 -90.62 -178.56 5.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.148 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.676 ' NZ ' HG23 ' A' ' 87' ' ' ILE . 75.6 mttt -56.14 156.63 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.361 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 120' ' ' LYS . 55.4 mt -118.4 136.2 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.668 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 120' ' ' LYS . 91.7 m-20 -92.15 123.84 35.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.395 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 76.2 m-85 -113.79 139.17 49.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.9 mt-10 -134.33 138.85 45.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.403 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.707 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.3 m -127.96 137.45 52.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 105' ' ' LEU . 54.8 tttt -139.14 125.32 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -101.5 129.56 47.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' ILE . 50.8 t -131.78 144.33 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -109.64 151.99 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.1 160.68 28.09 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.2 Cg_endo -69.95 -17.0 36.97 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.639 2.226 . . . . 0.0 111.855 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -77.58 -12.3 59.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.53 30.46 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.46 172.3 55.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 99.7 m -124.61 128.23 48.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -1.123 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.628 HG21 ' OE2' ' A' ' 9' ' ' GLU . 64.5 mt -99.06 136.24 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 105' ' ' LEU . 62.7 mt -119.75 131.19 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 51.8 mttp -116.84 125.85 52.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -126.07 137.86 53.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 56.3 m -119.86 135.52 54.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -123.33 137.59 54.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.705 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 99' ' ' ILE . 67.5 tttt -143.76 134.45 25.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.235 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.015 ' O ' HG21 ' A' ' 3' ' ' VAL . 39.4 p90 -132.53 146.56 52.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 94.9 m-70 -108.78 159.17 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.495 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -59.26 -47.4 85.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.297 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 53.6 mt -53.45 -48.82 68.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HA ' HD12 ' A' ' 148' ' ' ILE . 72.8 m-85 -54.01 -37.86 64.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -58.75 -41.44 86.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.689 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -68.33 -37.7 80.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.299 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 23' ' ' PHE . 81.7 mt -59.34 -48.6 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.283 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.5 -47.61 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.02 -33.55 84.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.42 -46.9 80.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 14' ' ' ILE . 64.3 mt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.845 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -92.17 141.45 28.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.563 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 38.7 m -93.66 142.66 27.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -119.67 144.35 47.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.533 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' HD3' ' A' ' 116' ' ' LYS . 85.5 tt0 -112.81 141.55 46.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -116.04 142.82 46.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -121.23 138.79 54.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.5 t80 -156.3 145.27 20.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.6 p -112.46 147.64 36.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -150.46 171.62 16.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' ILE . 6.8 t70 -78.66 179.54 7.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.34 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 70.2 142.11 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 109.155 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.6 Cg_endo -68.75 145.9 64.68 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.566 2.177 . . . . 0.0 112.148 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 105' ' ' LEU . . . -46.09 -47.62 43.36 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 111.543 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.1 Cg_endo -64.32 -37.17 41.54 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.081 1.854 . . . . 0.0 113.003 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 78.6 mttt -71.42 -32.43 68.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.884 -1.135 . . . . 0.0 109.556 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.8 tp -80.8 -30.38 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CE1' ' HB2' ' A' ' 82' ' ' TYR . 75.0 t80 -61.09 -41.47 96.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.594 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.583 ' NZ ' HD23 ' A' ' 25' ' ' LEU . 34.1 tttm -65.16 -52.81 52.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.632 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -8.11 52.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.988 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.6 t80 -85.45 -34.67 21.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.575 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.841 HG11 ' CD1' ' A' ' 82' ' ' TYR . 33.1 m -114.48 -37.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.583 HD23 ' NZ ' ' A' ' 21' ' ' LYS . 17.5 tp -71.18 -38.55 72.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.662 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.2 m-20 -108.09 14.38 25.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.9 -39.69 76.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.533 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.655 ' OD2' HD11 ' A' ' 44' ' ' ILE . 89.3 m-20 -58.62 -33.03 69.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.624 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.0 t30 -101.38 -35.91 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.968 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.1 tm? -72.49 -37.47 68.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 27' ' ' ALA . 28.7 mt -50.79 -55.8 24.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.2 Cg_endo -68.47 -18.91 43.51 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.43 2.087 . . . . 0.0 111.821 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 40.2 mttt -71.03 -36.71 72.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 HG23 ' HG ' ' A' ' 147' ' ' LEU . 79.7 mt -66.63 -29.27 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.87 72.2 5.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.6 Cg_endo -69.89 -32.27 18.35 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.665 2.244 . . . . 0.0 111.771 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -75.23 -25.83 58.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.63 -39.49 64.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 57' ' ' ILE . 3.5 p -118.06 151.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -77.56 -47.94 18.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 129.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.22 128.02 34.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -122.52 148.59 44.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.655 HD11 ' OD2' ' A' ' 28' ' ' ASP . 65.6 mt -106.45 118.14 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.428 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.8 mp -61.67 -45.41 94.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' HG23 ' A' ' 53' ' ' THR . 67.5 mm-40 -157.83 156.04 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.23 -41.01 2.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 59.1 36.73 24.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.837 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.17 33.31 10.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.83 -164.99 12.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.72 130.77 19.96 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 30.93 70.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 46' ' ' GLU . 89.3 m -86.36 141.9 28.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.506 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.3 mt -109.57 129.95 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.335 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.491 ' HE3' HD11 ' A' ' 72' ' ' ILE . 48.0 mttt -116.2 146.56 42.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.613 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 tttm -131.06 122.33 26.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 39' ' ' VAL . 28.5 mt -114.98 137.95 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -118.57 131.04 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.562 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.5 p90 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.262 0.553 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 86' ' ' LEU . 48.4 t -122.28 146.46 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 87' ' ' ILE . 26.8 mttt -119.83 139.52 52.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 77.2 m80 -119.64 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.2 tttt -112.61 141.17 46.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 109.553 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' A' ' 53' ' ' THR . 66.6 mt -99.51 134.54 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -91.73 -49.16 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.9 p -167.61 154.7 8.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.53 144.39 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 74.8 m-20 -128.73 91.19 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -63.75 -34.63 78.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.43 -39.24 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.5 m-20 -87.82 4.8 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.5 m80 48.12 46.04 19.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.2 m -130.96 132.14 44.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.841 ' CD1' HG11 ' A' ' 24' ' ' VAL . 78.5 t80 -124.88 121.27 34.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.353 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.1 p -111.81 139.91 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 33.0 p90 -155.59 167.95 28.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 90.4 p -146.31 158.28 43.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.995 HD22 ' CD1' ' A' ' 92' ' ' LEU . 5.4 tt -96.5 121.96 38.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.822 HG22 ' HG3' ' A' ' 88' ' ' GLU . 94.8 mt -76.75 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.871 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.8 mt-10 -133.44 159.92 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.93 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.36 162.2 32.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -65.05 -29.62 70.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 109.631 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.59 -21.75 48.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.995 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 mt -78.68 -30.17 45.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 108.999 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 92' ' ' LEU . 66.6 m 46.37 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.88 9.88 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -110.14 -15.55 13.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 91' ' ' ALA . 18.7 mt -109.36 137.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 122' ' ' HIS . 99.6 mt-10 -84.55 -179.4 7.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.299 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 35.4 mtmm -57.21 164.43 1.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 120' ' ' LYS . 53.4 mt -121.79 131.85 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.525 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 120' ' ' LYS . 90.2 m-20 -90.74 126.33 35.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 66.6 m-85 -116.93 142.06 47.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.2 mt-10 -129.19 136.08 49.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.8 m -125.95 129.25 48.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.492 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.0 tttt -130.36 128.1 40.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.169 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.0 mm? -99.47 123.3 43.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.2 t -130.83 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 72.2 m -113.78 153.43 29.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.56 162.44 20.59 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.1 Cg_endo -69.79 -18.83 36.66 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.613 2.209 . . . . 0.0 111.713 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -67.3 -15.43 63.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.877 . . . . 0.0 109.375 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.92 35.6 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.54 176.37 44.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 16' ' ' ALA . 98.1 m -117.76 129.26 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.2 mt -98.92 131.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.62 HG23 HD13 ' A' ' 105' ' ' LEU . 39.8 mt -117.38 132.72 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.621 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HD3' ' OE2' ' A' ' 7' ' ' GLU . 84.5 mttt -117.68 132.27 56.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.31 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.4 m -130.77 126.92 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.542 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.8 m -108.71 145.76 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -130.85 137.23 49.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.831 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 3' ' ' VAL . 22.1 tttt -141.67 131.78 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.155 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.845 ' O ' HG21 ' A' ' 3' ' ' VAL . 42.5 p90 -129.02 148.09 50.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.426 ' HB3' ' OE1' ' A' ' 97' ' ' GLU . 77.5 m80 -116.58 166.72 11.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 35.1 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 147' ' ' LEU . 52.5 m170 -58.98 -46.81 87.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.8 mt -55.57 -50.97 68.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.385 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.405 ' HE1' ' CE1' ' A' ' 23' ' ' PHE . 73.5 m-85 -53.46 -38.04 63.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -61.97 -42.35 99.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HG ' HG23 ' A' ' 34' ' ' ILE . 4.1 mm? -63.93 -45.02 91.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 19' ' ' LEU . 72.1 mt -55.63 -54.54 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.64 -29.95 53.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.93 -32.07 59.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -73.03 -43.25 62.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.89 136.63 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 29.1 m -93.61 137.19 33.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 109.367 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 118' ' ' THR . 68.4 t80 -119.64 132.79 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -113.94 135.53 53.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.85 . . . . 0.0 109.357 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 42.4 t-20 -119.64 141.12 49.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -115.1 138.14 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 78.1 t80 -154.9 146.53 23.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.8 p -113.22 147.17 38.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.422 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 59.8 p -149.61 171.67 16.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.651 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' O ' HD12 ' A' ' 14' ' ' ILE . 13.4 t0 -77.85 -175.45 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.71 141.06 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.9 Cg_endo -69.66 147.16 62.87 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.618 2.212 . . . . 0.0 112.115 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.695 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -40.86 -50.32 7.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.08 -45.75 9.53 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.297 1.998 . . . . 0.0 113.003 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 20.9 mttm -61.42 -33.04 73.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.782 -1.199 . . . . 0.0 109.542 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD12 HD22 ' A' ' 152' ' ' LEU . 12.4 tp -80.55 -31.75 36.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.725 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.878 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 73.7 t80 -69.0 -32.05 71.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 109.848 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.749 ' HG3' HD12 ' A' ' 25' ' ' LEU . 23.2 tttt -65.98 -44.57 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.609 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.55 -19.73 32.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 103' ' ' THR . 55.9 t80 -83.29 -15.92 48.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.3 t -118.53 -63.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.363 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.749 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.1 mt -57.97 -43.63 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.8 m-20 -96.24 15.42 21.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.391 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.735 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -69.49 -22.23 63.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.664 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.2 m-20 -77.36 -35.54 54.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.401 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 m120 -98.01 -31.5 12.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 148' ' ' ILE . 18.4 tp -63.3 -39.06 93.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -55.53 -59.42 11.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 50.5 Cg_endo -70.67 -11.27 29.39 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.674 2.249 . . . . 0.0 111.605 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -73.33 -43.94 59.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.857 . . . . 0.0 109.395 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.128 HG23 ' CD2' ' A' ' 147' ' ' LEU . 86.5 mt -66.6 -38.81 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.71 76.44 23.91 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.47 -31.64 17.01 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.714 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -74.49 -22.6 58.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -71.81 -37.53 70.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.87 . . . . 0.0 109.362 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG21 ' CG2' ' A' ' 57' ' ' ILE . 2.6 p -120.45 146.35 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -73.64 -45.99 49.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.1 142.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.563 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.97 130.32 53.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -127.63 154.12 45.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.664 HD11 ' OD2' ' A' ' 28' ' ' ASP . 25.9 mt -105.85 122.04 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -68.15 -43.76 77.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.361 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.3 157.7 31.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.47 -40.46 2.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 58.95 37.44 24.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.697 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.91 26.32 29.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -111.63 -166.3 18.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.93 130.07 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.682 2.255 . . . . 0.0 111.757 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.27 69.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.922 HG23 ' O ' ' A' ' 46' ' ' GLU . 97.9 m -80.77 142.53 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -1.181 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HD13 ' A' ' 45' ' ' LEU . 64.3 mt -112.86 130.1 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HG2' HG23 ' A' ' 44' ' ' ILE . 71.7 mttt -124.75 146.38 49.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.647 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 44.4 tttt -122.83 121.72 36.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.668 HD12 ' CD2' ' A' ' 70' ' ' HIS . 17.4 mt -114.75 132.51 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.2 m -113.12 116.82 30.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 53.9 p90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 36.7 p90 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.333 0.587 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.1 m -125.55 147.83 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' HD12 ' A' ' 86' ' ' LEU . 51.1 mttt -103.29 144.69 31.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.987 ' CE1' HD13 ' A' ' 86' ' ' LEU . 64.3 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.9 tttm -125.02 139.09 54.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.56 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.82 HD12 ' HB ' ' A' ' 53' ' ' THR . 70.6 mt -100.95 129.63 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.07 -45.76 9.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -170.3 141.42 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.621 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 pt -123.42 143.83 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -127.77 91.27 3.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -63.59 -37.34 86.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.76 -42.72 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -86.15 3.09 44.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 56.0 m80 52.97 45.12 29.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.109 -0.995 . . . . 0.0 109.491 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -126.76 139.83 52.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.6 t80 -132.98 125.77 30.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -120.76 127.36 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 36.1 p90 -146.64 171.14 15.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 69.1 p -151.5 151.36 31.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.0 109.704 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.987 HD13 ' CE1' ' A' ' 70' ' ' HIS . 32.1 tp -88.71 108.02 19.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.853 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' A' ' 88' ' ' GLU . 95.9 mt -59.11 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.853 ' HG2' HG22 ' A' ' 87' ' ' ILE . 78.2 mm-40 -138.96 169.74 17.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.724 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.86 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -179.55 135.79 2.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -50.37 -41.27 51.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.485 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.74 68.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.624 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.5 mp -78.64 -33.4 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 4.0 m 61.47 178.19 0.12 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.299 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -78.86 -13.95 59.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.555 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -78.11 -28.69 48.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 34.4 mt -105.84 125.83 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.101 -0.999 . . . . 0.0 109.746 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 91.3 mt-10 -80.89 -179.41 7.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.16 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 17.5 ptpt -57.02 159.4 4.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 120' ' ' LYS . 69.5 mt -117.79 138.65 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.596 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 61.1 t0 -95.13 125.72 39.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 90.9 m-85 -117.3 134.08 55.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -123.71 137.64 54.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.807 HG21 ' CE1' ' A' ' 23' ' ' PHE . 30.9 m -127.99 136.72 51.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.573 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.5 tttt -139.77 125.62 19.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.906 HD13 HG23 ' A' ' 115' ' ' ILE . 2.7 mm? -100.16 130.01 46.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.4 t -131.79 140.66 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.6 p -113.27 148.38 35.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.86 164.59 14.38 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.2 Cg_endo -70.34 -10.73 28.73 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 111.74 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -76.02 -15.52 60.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.06 -19.02 28.05 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.88 170.68 45.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.695 HG21 ' HA ' ' A' ' 16' ' ' ALA . 88.4 m -123.8 127.04 47.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.149 . . . . 0.0 109.605 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.3 mt -96.95 139.2 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 109.235 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.906 HG23 HD13 ' A' ' 105' ' ' LEU . 4.7 mt -124.62 121.96 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 45.0 mttt -107.67 139.11 42.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.075 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 m -127.98 130.06 47.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 110.076 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -125.97 140.28 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.875 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -145.21 155.54 43.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 110.196 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 99' ' ' ILE . 25.5 mttp -129.97 148.53 51.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.528 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 80.4 m-85 -118.13 121.81 41.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 0.0 109.834 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 61.2 m170 -89.86 143.5 26.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.577 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.266 0.555 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -59.86 -50.64 73.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.411 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 6.6 mp -68.23 -48.0 66.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.803 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 62.3 t80 -52.96 -45.44 67.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -58.0 -40.65 81.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.128 ' CD2' HG23 ' A' ' 34' ' ' ILE . 17.1 tp -60.08 -39.47 86.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 30' ' ' LEU . 76.0 mt -53.76 -52.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.278 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 81.5 tt0 -54.73 -38.84 67.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.194 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.69 91.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 147' ' ' LEU . 15.4 m-85 -71.38 -42.45 68.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.09 . . . . 0.0 109.337 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 19' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -110.81 154.07 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.417 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 120' ' ' LYS . 23.5 m -94.1 140.36 29.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -111.81 139.77 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -113.25 140.35 48.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -130.1 160.07 34.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.56 ' OE2' HG21 ' A' ' 114' ' ' ILE . 74.6 tt0 -142.72 130.8 21.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 75.7 t80 -141.78 140.32 33.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.565 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.0 p -90.68 143.56 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.956 ' OG ' HD11 ' A' ' 115' ' ' ILE . 83.3 p -141.06 161.29 38.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.588 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 14' ' ' ILE . 29.4 t0 -78.35 179.7 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.29 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.6 141.88 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.232 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.3 Cg_endo -69.32 146.98 64.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.507 2.138 . . . . 0.0 112.158 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.62 -50.57 7.02 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 111.39 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.77 -49.98 3.63 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.23 1.953 . . . . 0.0 112.923 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.8 mttm -60.75 -35.98 77.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.866 -1.146 . . . . 0.0 109.672 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 19' ' ' LEU . 25.4 tp -81.01 -28.4 35.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.973 ' HB2' HD12 ' A' ' 105' ' ' LEU . 69.4 t80 -69.54 -35.01 75.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.82 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HG3' HD12 ' A' ' 25' ' ' LEU . 29.8 tttp -67.34 -37.87 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -88.54 -30.77 19.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.64 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.83 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.6 t80 -77.3 -12.15 59.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -117.76 -63.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' HG3' ' A' ' 21' ' ' LYS . 47.8 mt -65.3 -41.43 94.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.8 m-20 -94.82 9.65 38.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.529 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.19 -45.54 66.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.954 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.563 ' OD2' HD11 ' A' ' 44' ' ' ILE . 94.6 m-20 -65.1 -25.31 67.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 58.8 t30 -101.27 -33.88 9.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.597 HD11 ' CD2' ' A' ' 151' ' ' TYR . 22.0 tp -75.27 -34.56 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 27' ' ' ALA . 34.9 mt -51.34 -54.94 33.2 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.707 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -69.07 -20.32 38.23 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.425 2.084 . . . . 0.0 111.988 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 30' ' ' LEU . 30.2 mmtt -71.32 -34.99 71.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.44 -27.99 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.97 64.62 42.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.5 -46.14 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.671 2.247 . . . . 0.0 111.705 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -65.63 -22.87 66.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -73.29 -50.52 21.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 57' ' ' ILE . 7.4 p -111.61 149.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.476 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -73.25 -46.2 51.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.51 131.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.35 128.03 34.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.439 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -123.93 142.88 50.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.563 HD11 ' OD2' ' A' ' 28' ' ' ASP . 56.1 mt -106.46 118.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 27.2 tp -60.2 -44.94 94.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 53' ' ' THR . 94.9 mt-10 -159.68 157.02 28.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 105.6 -42.06 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 58.26 37.41 26.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.871 ' H ' HG21 ' A' ' 53' ' ' THR . . . 86.11 31.35 20.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -115.56 -166.28 14.81 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.7 130.9 20.23 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.737 2.291 . . . . 0.0 111.598 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.74 29.62 73.94 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' H ' ' A' ' 49' ' ' GLY . 94.3 m -82.76 140.64 32.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 44' ' ' ILE . 22.3 mm -105.81 129.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.276 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 91.3 mttt -114.74 147.3 39.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.655 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 57.3 tttm -131.02 121.52 25.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 0.0 109.297 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 39' ' ' VAL . 60.8 mt -114.04 135.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.6 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 m -123.96 119.46 29.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 33.6 p90 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.567 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 38.9 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.308 0.575 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.046 HG12 HD11 ' A' ' 86' ' ' LEU . 43.0 t -124.08 144.48 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 35.2 mttt -116.9 139.66 50.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.8 ' CE1' HD13 ' A' ' 86' ' ' LEU . 81.0 m-70 -116.98 144.87 44.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' CB ' HD11 ' A' ' 87' ' ' ILE . 25.0 tttt -124.01 142.39 51.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.703 HD12 ' HB ' ' A' ' 53' ' ' THR . 58.3 mt -102.96 131.07 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.411 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 97.2 m-70 -90.5 -48.64 6.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.2 m -163.81 149.49 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -129.89 145.47 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 82.0 m-20 -128.3 91.16 3.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -62.31 -37.66 86.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.96 -40.67 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.4 m-20 -87.8 7.88 28.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 46.5 m80 45.72 40.34 6.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -119.46 136.43 54.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.4 t80 -127.52 126.28 41.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 t -121.06 128.16 52.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 34.1 p90 -145.72 170.26 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -148.1 157.96 43.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.046 HD11 HG12 ' A' ' 68' ' ' VAL . 22.6 tp -93.27 136.75 33.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.58 HG23 ' HE3' ' A' ' 98' ' ' LYS . 26.9 mm -99.13 -71.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.0 mt-10 -118.98 160.78 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 172.44 128.59 1.06 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -46.21 -31.82 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 109.604 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.56 68.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD21 HD23 ' A' ' 86' ' ' LEU . 3.6 mt -74.69 -33.03 62.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 3.5 m 53.14 -177.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.66 -0.65 . . . . 0.0 109.567 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.0 12.53 7.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 26.7 p-10 -111.72 -10.75 14.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mt -114.5 140.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 93.7 mt-10 -91.96 -179.52 5.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.312 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HE3' HG23 ' A' ' 87' ' ' ILE . 52.2 mttp -57.08 161.91 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.492 HG12 ' HB2' ' A' ' 121' ' ' TYR . 49.0 mt -120.47 135.62 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.608 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 120' ' ' LYS . 60.6 t0 -93.04 120.13 33.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 73.1 m-85 -113.8 139.13 49.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.48 135.34 44.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.318 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 m -131.11 135.64 47.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -139.18 129.13 25.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.888 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 20' ' ' PHE . 31.6 mt -98.69 129.61 45.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.7 t -132.05 136.17 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.9 OUTLIER -111.2 146.6 36.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.861 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -106.54 171.38 4.8 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.861 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.4 Cg_endo -69.52 -15.06 37.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.666 2.244 . . . . 0.0 111.791 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.79 -20.81 61.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.9 -25.61 11.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.44 171.55 51.37 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 93.8 m -125.87 124.62 41.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.56 HG21 ' OE2' ' A' ' 9' ' ' GLU . 68.0 mt -97.5 139.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.263 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.956 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.2 mt -121.57 127.96 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.741 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 50.5 mttp -105.87 127.98 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 m -123.43 133.65 54.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.462 ' CG2' HG22 ' A' ' 5' ' ' THR . 60.8 m -119.79 133.54 55.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 0.0 109.016 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -120.32 131.33 54.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 110.006 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HB2' HG23 ' A' ' 5' ' ' THR . 78.5 tttt -140.66 130.35 24.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 3' ' ' VAL . 32.9 p90 -132.11 149.17 52.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.805 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.5 ' ND1' HG11 ' A' ' 3' ' ' VAL . 98.8 m-70 -114.15 158.67 21.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.183 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.428 ' CA ' ' HG3' ' A' ' 97' ' ' GLU . 82.2 p . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.633 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.19 -53.21 60.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HA ' HD23 ' A' ' 147' ' ' LEU . 25.4 mt -62.0 -36.07 80.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 109.39 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.915 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 46.6 t80 -53.44 -43.06 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.197 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 59.4 tttm -59.29 -38.63 80.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -62.58 -36.13 81.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.231 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.538 HD13 ' HD1' ' A' ' 23' ' ' PHE . 98.8 mt -53.68 -55.74 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.163 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.533 ' OE2' ' CE2' ' A' ' 145' ' ' PHE . 40.5 mp0 -54.33 -43.74 71.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.943 . . . . 0.0 109.043 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.48 -29.45 71.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.597 ' CD2' HD11 ' A' ' 30' ' ' LEU . 54.5 t80 -61.16 -43.58 98.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.3 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.713 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.226 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.988 HG21 ' O ' ' A' ' 121' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.333 0.587 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.31 149.57 39.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 118' ' ' THR . 27.6 m -93.56 140.99 28.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.46 137.98 53.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.616 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -108.02 132.76 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.27 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.06 133.41 53.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.52 131.86 54.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.435 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 86.0 t80 -146.56 149.48 33.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 22.0 p -117.96 149.9 40.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 23.2 t -148.51 164.57 33.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.636 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.796 ' O ' HD12 ' A' ' 14' ' ' ILE . 21.1 t0 -72.71 -178.44 2.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 HD12 ' A' ' 152' ' ' LEU . 1.0 OUTLIER 69.05 142.06 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.273 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.8 Cg_endo -69.65 147.21 63.09 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 111.964 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -38.71 -51.44 3.76 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.507 -0.745 . . . . 0.0 111.267 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.19 -50.66 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.318 2.012 . . . . 0.0 113.068 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 95.6 mttt -59.1 -34.98 72.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.808 -1.182 . . . . 0.0 109.55 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 152' ' ' LEU . 22.4 tp -80.77 -36.86 31.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 24' ' ' VAL . 60.0 t80 -57.87 -32.6 67.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HA ' HD13 ' A' ' 25' ' ' LEU . 19.8 tttt -71.57 -52.39 18.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 109.623 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.44 3.06 14.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.0 t80 -99.86 -33.37 10.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.793 ' CG2' HD12 ' A' ' 25' ' ' LEU . 9.8 m -114.19 -46.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.888 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.793 HD12 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -68.7 -33.93 74.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.97 . . . . 0.0 109.478 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 59.0 m-20 -106.33 8.93 32.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.81 -37.05 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 44' ' ' ILE . 92.7 m-20 -57.35 -37.28 72.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.647 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 86.7 m-20 -100.86 -37.65 8.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 26.0 tp -63.96 -43.05 96.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 9.3 mt -47.8 -60.0 4.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.68 -22.74 37.12 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.55 2.166 . . . . 0.0 111.63 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.9 tptm -66.26 -47.06 74.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.534 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG21 ' CB ' ' A' ' 147' ' ' LEU . 67.8 mt -67.91 -36.13 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.534 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.97 71.58 62.52 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.6 Cg_endo -70.4 -37.37 7.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.681 2.254 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.53 -23.06 60.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.34 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' CE1' ' A' ' 59' ' ' PHE . 21.4 m -125.54 149.16 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -72.13 -47.53 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.386 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.98 131.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.59 119.31 27.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -115.53 144.37 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.579 HG23 ' HG2' ' A' ' 55' ' ' LYS . 50.9 mt -106.6 119.67 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 26.4 tp -64.86 -44.12 90.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.938 ' O ' HG23 ' A' ' 53' ' ' THR . 94.3 mt-10 -159.32 154.48 25.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.95 -42.71 1.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 61.84 39.06 14.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.537 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.46 34.92 15.23 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.479 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.33 -166.84 13.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.02 131.85 21.7 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.726 2.284 . . . . 0.0 111.709 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.49 28.82 72.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.938 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.3 m -83.88 144.78 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 53' ' ' THR . 22.1 mm -112.15 131.94 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.95 . . . . 0.0 109.28 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 44' ' ' ILE . 4.4 mtmt -130.09 148.39 51.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.542 ' HE3' ' CD2' ' A' ' 67' ' ' TYR . 67.8 tttt -125.76 126.71 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 14.7 mt -115.92 130.93 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.4 m -107.74 132.02 53.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.341 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.866 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.9 m-85 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 37.3 p90 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.306 0.574 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.868 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -126.65 145.58 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 88' ' ' GLU . 34.7 mttt -102.33 140.52 36.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.624 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 42.3 m170 -115.91 140.92 48.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.297 -0.877 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -124.02 139.22 54.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 49' ' ' GLY . 63.3 mt -101.7 135.74 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 93.9 m-70 -89.17 -48.97 7.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.2 t -174.24 151.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.569 HG22 ' CD1' ' A' ' 82' ' ' TYR . 41.2 pt -127.05 144.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -123.45 90.5 3.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -61.57 -36.8 81.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.466 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.84 -37.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.63 2.85 56.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.5 m80 51.34 46.98 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.8 m -128.8 135.18 48.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.87 . . . . 0.0 109.541 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' HG22 ' A' ' 75' ' ' ILE . 61.5 t80 -128.8 121.55 28.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -116.46 137.8 51.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -152.2 166.37 31.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.301 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 89.4 p -145.43 160.11 42.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.3 tt -100.77 131.81 46.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.1 mm -89.13 -73.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.583 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 87' ' ' ILE . 88.3 mt-10 -121.15 151.79 39.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.513 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.868 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -171.4 154.73 22.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 68' ' ' VAL . 6.0 t0 -56.35 -49.19 75.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 0.0 109.403 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.85 -27.01 59.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.7 mp -80.7 -30.24 36.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' LEU . 3.7 m 56.43 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -68.48 -7.67 34.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 109.236 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 96' ' ' ILE . 26.1 m120 -72.73 -42.29 64.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.285 -0.884 . . . . 0.0 109.668 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -156.25 121.82 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 110.477 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 92' ' ' LEU . 22.1 mt-10 -136.59 107.03 6.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.818 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 122' ' ' HIS . 78.6 tttt -179.01 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.392 -0.817 . . . . 0.0 108.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.658 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 18.8 mt -123.92 117.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -93.78 118.78 31.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.87 . . . . 0.0 109.011 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.658 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 68.1 m-85 -109.23 137.73 46.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.8 mt-10 -130.34 129.79 43.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.5 m -120.8 134.92 55.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HD22 ' A' ' 105' ' ' LEU . 32.5 tttt -133.73 121.65 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.099 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.802 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.1 mm? -95.12 118.85 32.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.759 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 60.5 t -131.88 140.2 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 109.313 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.1 t -107.61 148.05 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.905 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -105.71 173.11 3.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.905 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.97 -16.22 36.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.671 2.248 . . . . 0.0 111.8 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.48 27.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.62 176.63 53.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.714 HG21 ' HA ' ' A' ' 16' ' ' ALA . 65.3 m -122.88 125.05 44.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.3 mt -96.2 139.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.36 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 105' ' ' LEU . 28.7 mt -123.65 123.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.737 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -105.27 133.83 49.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.102 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 86.2 m -131.44 128.93 40.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.0 109.902 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.596 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.1 m -111.7 142.97 43.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.067 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.1 m -135.09 140.62 45.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.987 . . . . 0.0 109.845 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 72.0 tttt -132.29 147.14 52.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.988 ' O ' HG21 ' A' ' 3' ' ' VAL . 96.2 m-85 -126.6 140.31 52.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.81 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 75.8 m-70 -130.55 -177.83 4.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.196 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 96' ' ' ILE . 36.2 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.68 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.473 ' CE1' HD21 ' A' ' 147' ' ' LEU . 58.2 t-80 -61.35 -35.58 77.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.519 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 144' ' ' LEU . 38.6 mt -64.07 -44.37 92.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.672 ' HA ' HD12 ' A' ' 148' ' ' ILE . 66.3 m-85 -53.33 -39.18 63.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -57.33 -41.39 79.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -67.97 -37.92 82.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 145' ' ' PHE . 81.2 mt -54.16 -44.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 86.8 tt0 -65.64 -45.74 81.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.11 -39.79 96.49 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.35 -50.21 73.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -1.12 . . . . 0.0 109.407 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 14' ' ' ILE . 49.2 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.798 HG21 ' O ' ' A' ' 121' ' ' TYR . 59.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.9 t80 -87.43 147.51 25.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.578 HG22 ' CG2' ' A' ' 118' ' ' THR . 22.0 m -93.51 141.89 27.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.6 140.72 51.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.582 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -110.19 136.19 49.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -118.64 131.07 56.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.644 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 92.4 mt-10 -111.48 111.68 22.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.245 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 47.7 t80 -126.95 130.59 50.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 16.2 p -94.0 151.74 19.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 85.8 p -147.15 163.53 36.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 14' ' ' ILE . 90.6 m-20 -71.45 -175.77 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.692 HD12 ' C ' ' A' ' 13' ' ' ASP . 5.0 mp 63.12 142.43 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.6 Cg_endo -69.24 146.56 63.81 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.534 2.156 . . . . 0.0 112.173 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.632 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.46 -47.43 47.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.614 -0.679 . . . . 0.0 111.474 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.2 Cg_endo -63.93 -45.67 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.999 1.799 . . . . 0.0 112.899 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.562 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 61.0 mttm -64.45 -35.0 79.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 152' ' ' LEU . 25.9 tp -80.9 -29.66 35.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HD2' HD23 ' A' ' 105' ' ' LEU . 60.6 t80 -63.02 -37.01 85.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 34.7 tttp -65.51 -42.52 91.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.971 . . . . 0.0 109.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -83.33 -29.96 27.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE1' HG21 ' A' ' 103' ' ' THR . 63.2 t80 -76.63 -18.73 58.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 58.2 t -113.87 -67.0 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 25' ' ' LEU . 18.1 tp -57.99 -42.08 84.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 75.2 m-20 -96.35 12.92 29.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.574 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.973 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -64.4 -35.67 81.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 109.598 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.5 m-20 -65.04 -33.89 77.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.9 t30 -94.34 -33.78 13.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -65.06 -46.14 82.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 27' ' ' ALA . 4.6 mt -48.2 -58.71 7.35 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.72 -21.34 38.89 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.487 2.124 . . . . 0.0 111.558 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 39.1 tptt -65.15 -40.35 94.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.62 HD12 ' HB3' ' A' ' 147' ' ' LEU . 37.7 mm -61.78 -29.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.12 73.15 5.1 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.463 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -69.97 -31.8 18.93 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.675 2.25 . . . . 0.0 111.833 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -70.71 -24.85 62.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.62 -40.23 61.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.708 HG21 HG23 ' A' ' 57' ' ' ILE . 4.9 p -112.74 147.24 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -75.37 -45.14 41.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.42 131.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.49 126.5 35.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.307 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.13 150.44 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.655 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.714 HD11 ' OD2' ' A' ' 28' ' ' ASP . 60.9 mt -106.17 121.34 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 0.0 109.37 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -66.47 -44.0 83.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 53' ' ' THR . 93.8 mt-10 -159.34 157.53 30.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.67 -40.42 2.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 58.32 40.34 24.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.459 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.737 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.88 33.72 20.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.09 -167.19 13.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.72 129.12 17.08 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.595 2.197 . . . . 0.0 111.695 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 72.47 26.35 72.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.4 m -78.99 144.51 34.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 45' ' ' LEU . 63.3 mt -114.33 129.66 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 3.3 mtmt -124.54 149.63 46.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.0 ttpp -130.72 126.1 35.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.708 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -114.94 133.76 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.3 m -115.1 130.92 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.339 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CE1' ' HB ' ' A' ' 39' ' ' VAL . 91.6 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.3 p90 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.732 HG22 ' CA ' ' A' ' 89' ' ' GLY . 46.8 t -125.49 144.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -116.21 143.24 45.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 55' ' ' LYS . 89.9 m-70 -123.28 142.76 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 87' ' ' ILE . 17.8 tttp -123.91 140.66 52.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 64.4 mt -100.75 133.16 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 89.7 m-70 -90.68 -48.49 7.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.5 m -165.03 154.13 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.75 144.89 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.6 m-20 -127.83 93.39 3.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -65.92 -38.12 87.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.319 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.22 -42.06 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 72.3 m-20 -87.3 4.98 40.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.574 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 105' ' ' LEU . 66.7 m80 48.46 41.9 17.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.962 . . . . 0.0 109.472 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.8 m -122.05 136.66 54.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 62.6 t80 -129.12 127.07 40.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.369 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 t -121.77 133.43 54.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.652 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 38.5 p90 -149.51 162.96 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 73' ' ' HIS . 55.4 m -138.87 149.26 44.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.4 tt -88.26 133.81 33.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.974 HG23 ' HE2' ' A' ' 98' ' ' LYS . 71.4 mt -91.45 -77.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.608 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.79 ' HG2' HG22 ' A' ' 87' ' ' ILE . 74.4 mm-40 -115.37 161.81 18.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.651 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.732 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 171.56 160.31 19.81 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.87 -34.06 74.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.665 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.73 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -67.82 -31.47 71.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.724 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.951 HD11 ' CD2' ' A' ' 86' ' ' LEU . 5.8 mt -70.71 -27.77 64.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 109.152 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 92' ' ' LEU . 0.6 OUTLIER 43.73 -166.01 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.645 -0.66 . . . . 0.0 109.457 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.24 14.71 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.579 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -124.39 -11.73 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.73 HD12 ' O ' ' A' ' 91' ' ' ALA . 50.7 mt -111.97 126.26 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.701 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 96.6 mt-10 -77.05 -179.57 5.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.974 ' HE2' HG23 ' A' ' 87' ' ' ILE . 16.3 mttp -57.29 167.06 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 120' ' ' LYS . 83.2 mt -123.29 137.99 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.04 122.75 34.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.427 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 89.9 m-85 -114.62 138.6 50.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.509 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 117' ' ' THR . 93.7 mt-10 -131.68 131.48 43.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.382 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.835 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.6 m -125.85 137.26 53.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' C ' HD22 ' A' ' 105' ' ' LEU . 18.4 tttp -139.03 128.14 23.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -98.5 117.6 33.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.8 t -131.72 143.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.275 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 44.2 m -114.36 151.77 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.11 167.83 8.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.524 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.9 Cg_endo -69.05 -17.22 40.9 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.773 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -64.54 -14.7 58.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.42 -14.8 50.67 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.86 178.37 40.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 99.1 m -117.99 131.36 56.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -1.171 . . . . 0.0 109.727 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.9 mt -101.75 131.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.14 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.13 128.24 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 61.9 mttp -113.21 124.97 53.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 102' ' ' GLU . 62.0 m -129.84 132.72 46.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.007 . . . . 0.0 109.981 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.578 ' CG2' HG22 ' A' ' 5' ' ' THR . 44.0 m -112.48 135.17 53.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 0.0 109.057 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.3 m -125.97 143.12 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.7 tttm -139.26 133.61 31.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 108.969 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.798 ' O ' HG21 ' A' ' 3' ' ' VAL . 61.5 m-85 -111.36 131.83 54.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.816 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.5 m80 -100.74 138.84 37.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.273 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.37 -44.5 88.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.393 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 34' ' ' ILE . 55.8 mt -56.88 -47.66 79.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -54.11 -37.98 64.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.302 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.26 -43.25 87.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -62.93 -36.92 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.446 ' CD1' HD11 ' A' ' 30' ' ' LEU . 29.3 mm -55.74 -44.45 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.506 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 94.1 mt-10 -66.86 -36.64 82.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.92 95.65 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.02 -44.75 83.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -1.149 . . . . 0.0 109.565 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.929 HD11 HD13 ' A' ' 19' ' ' LEU . 37.8 mt . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.3 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.239 0.542 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -113.35 152.77 29.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 109.228 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 35.1 m -93.46 142.42 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.18 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -119.21 128.3 54.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.826 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -109.41 138.42 45.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.143 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.45 129.75 45.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.872 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 116' ' ' LYS . 88.7 mt-10 -109.37 123.52 49.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.026 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 11' ' ' THR . 54.6 t80 -135.97 135.54 39.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.846 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 114' ' ' ILE . 14.5 p -94.68 131.31 40.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.124 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.747 ' OG ' HD11 ' A' ' 115' ' ' ILE . 94.4 p -130.55 177.16 7.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.863 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 14' ' ' ILE . 41.3 p-10 -80.78 -175.32 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 152' ' ' LEU . 6.7 mm 68.24 136.12 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.2 Cg_endo -70.84 149.58 60.23 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.452 2.101 . . . . 0.0 111.888 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.83 -52.36 3.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 0.0 111.176 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.72 -50.36 2.45 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.432 2.088 . . . . 0.0 113.228 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 31.2 mttt -61.62 -34.67 76.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.838 -1.164 . . . . 0.0 109.888 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.8 tt -80.59 -28.47 37.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.63 ' HD1' HD23 ' A' ' 105' ' ' LEU . 74.6 t80 -72.35 -34.61 68.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.608 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -68.08 -41.12 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.7 -23.3 27.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.841 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.2 t80 -82.96 -14.45 54.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -119.96 -55.94 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.6 tp -67.77 -38.82 83.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 55.0 m-20 -104.83 18.29 22.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.946 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.87 -37.2 76.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.338 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 42' ' ' ALA . 52.6 t0 -76.78 -20.64 56.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.679 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 93.4 m-20 -104.42 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 HG23 ' A' ' 148' ' ' ILE . 19.0 tp -70.98 -38.83 72.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 27' ' ' ALA . 8.0 mt -55.71 -56.7 27.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -69.63 -11.41 30.94 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.393 2.062 . . . . 0.0 111.67 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 12.0 mttm -83.43 -36.52 24.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 147' ' ' LEU . 80.3 mt -76.88 -30.72 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.48 75.44 7.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.6 Cg_endo -69.63 -28.58 25.71 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.706 2.271 . . . . 0.0 111.694 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.11 -23.88 54.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.278 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.95 65.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 57' ' ' ILE . 5.7 p -116.62 150.75 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 58' ' ' THR . 27.7 tttm -75.46 -51.69 12.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 130.71 0.05 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . . . -94.54 123.0 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -125.82 152.18 45.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 64.7 mt -105.96 119.2 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 25.5 tp -61.99 -43.73 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 53' ' ' THR . 94.4 mt-10 -160.05 154.92 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.54 -42.28 1.94 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.8 m-20 61.39 36.61 17.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.33 34.37 10.64 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.0 -165.17 12.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.96 131.12 20.3 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.733 2.288 . . . . 0.0 111.783 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.53 27.94 72.89 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.7 m -83.23 142.57 31.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -1.162 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.456 HD13 ' HG3' ' A' ' 71' ' ' LYS . 24.0 mm -108.79 131.5 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' CE ' HD11 ' A' ' 72' ' ' ILE . 64.2 mttt -117.17 148.79 41.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 48.4 tttp -132.92 127.24 33.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.346 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.582 HD11 ' CD2' ' A' ' 70' ' ' HIS . 42.5 mt -120.15 131.37 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 40' ' ' LYS . 62.4 m -114.63 127.26 55.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.711 ' HE2' HG23 ' A' ' 68' ' ' VAL . 97.8 m-85 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.419 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 40.1 p90 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.892 HG22 ' HA2' ' A' ' 89' ' ' GLY . 41.2 t -124.28 148.21 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.58 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 85.7 mttt -121.51 144.1 48.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 109.359 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 57' ' ' ILE . 90.9 m-70 -122.9 138.48 54.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HG3' HD13 ' A' ' 54' ' ' ILE . 40.0 tttt -117.61 141.85 47.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 44.0 mt -103.03 131.5 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.583 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 97.1 m-70 -92.62 -41.98 9.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.579 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -171.31 146.21 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.4 143.49 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.05 90.92 3.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 96.7 mttt -60.86 -35.33 76.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.79 -41.92 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 80' ' ' HIS . 76.1 m-20 -87.86 10.16 19.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 79' ' ' ASN . 65.8 m80 44.42 42.79 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.471 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 m -123.31 132.84 54.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.498 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 70.2 t80 -120.18 124.18 45.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.8 t -118.16 128.84 55.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 30.8 p90 -155.87 171.19 20.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.855 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.7 p -142.45 162.64 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 99' ' ' ILE . 5.0 tt -98.86 129.37 45.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.855 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.9 mm -88.17 -74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.762 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.5 mt-10 -115.24 159.17 21.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.892 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -178.29 159.54 25.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -60.66 -46.6 89.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -1.106 . . . . 0.0 109.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.57 -23.64 67.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.9 mp -82.71 -44.11 16.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 13.9 t 60.18 163.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.317 -0.864 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.68 -11.2 53.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASN . 3.4 m-20 -72.38 -40.26 67.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.613 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 123' ' ' THR . 41.8 pt -151.71 131.34 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 30.5 mt-10 -146.34 106.45 4.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.921 . . . . 0.0 108.967 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 39.5 tptt -179.63 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.872 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.893 HD12 HD13 ' A' ' 86' ' ' LEU . 4.3 mt -124.59 118.16 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.917 -1.114 . . . . 0.0 110.005 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -94.86 121.58 36.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 108.901 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 99' ' ' ILE . 64.9 m-85 -114.14 136.73 52.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.956 . . . . 0.0 109.932 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.1 mt-10 -130.24 126.27 36.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 108.983 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.829 HG21 ' CE2' ' A' ' 23' ' ' PHE . 29.8 m -123.29 131.62 53.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -138.39 122.64 18.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.195 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -94.26 130.81 40.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 78.3 t -131.52 135.53 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.0 p -106.81 142.62 36.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.87 169.36 6.39 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.1 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.717 2.278 . . . . 0.0 111.77 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.23 -15.37 61.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.36 53.06 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.11 168.24 32.34 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.5 m -119.61 126.55 51.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 109.525 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 11' ' ' THR . 65.9 mt -95.73 136.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.747 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.1 mt -119.27 119.93 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 9' ' ' GLU . 10.7 mtpt -105.13 121.17 43.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.11 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 80.1 m -126.73 134.07 50.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 0.0 109.934 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 61.9 m -116.68 138.48 51.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.107 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -131.57 141.58 49.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HE2' ' NE2' ' A' ' 122' ' ' HIS . 22.5 tttt -136.32 149.82 48.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.18 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.977 ' O ' HG21 ' A' ' 3' ' ' VAL . 94.5 m-85 -127.99 142.7 51.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.06 -1.025 . . . . 0.0 109.766 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 64.3 m80 -134.95 165.15 25.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 96' ' ' ILE . 25.7 p . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.729 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -57.09 -48.77 77.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.424 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.76 -39.51 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.633 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 58.9 t80 -53.96 -41.77 68.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.336 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.4 -41.95 86.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.545 ' HB2' HD13 ' A' ' 34' ' ' ILE . 48.7 mt -57.43 -41.08 79.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.743 HG23 HD21 ' A' ' 30' ' ' LEU . 88.3 mt -54.87 -47.41 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 83.2 mt-10 -54.71 -47.17 74.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.179 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.54 -27.27 71.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.14 -47.26 85.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -1.113 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.284 0.564 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -110.57 156.68 20.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.362 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 17.8 m -93.56 142.78 26.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.403 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -119.41 135.23 54.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -110.45 133.8 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.272 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.02 131.84 54.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.61 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.64 122.88 47.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.319 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 11' ' ' THR . 82.0 t80 -142.82 146.57 34.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.61 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.568 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.0 p -108.29 142.45 38.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.208 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.418 ' OG ' ' CG ' ' A' ' 149' ' ' GLU . 20.8 t -141.12 159.17 42.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.965 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.45 -175.96 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 66.08 141.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.009 . . . . 0.0 109.146 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.2 Cg_endo -70.01 146.52 58.9 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.444 2.096 . . . . 0.0 112.001 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.21 -50.61 6.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.543 -0.723 . . . . 0.0 111.403 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.09 -50.31 3.03 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.29 1.993 . . . . 0.0 113.076 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 33.3 mttp -59.66 -33.59 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.19 . . . . 0.0 109.515 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.9 tt -80.92 -34.39 33.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.808 ' CE1' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -64.81 -32.13 73.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 20.3 tttm -68.89 -46.29 68.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.74 38.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.737 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.874 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 68.1 t80 -86.42 -17.71 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.808 HG21 ' CE1' ' A' ' 20' ' ' PHE . 66.5 t -115.9 -51.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 27.9 tp -68.46 -40.33 81.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 79.2 m-20 -103.38 18.6 21.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.874 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.97 -35.98 74.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.682 ' OD2' HD11 ' A' ' 44' ' ' ILE . 95.2 m-20 -67.76 -32.07 72.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 20.8 t-20 -99.34 -43.63 6.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 148' ' ' ILE . 15.9 tp -55.7 -42.61 75.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.775 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.8 mt -49.78 -62.32 2.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.516 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.51 -16.98 43.59 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.498 2.132 . . . . 0.0 111.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -67.54 -45.23 76.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 147' ' ' LEU . 75.7 mt -70.23 -35.17 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.705 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.73 71.76 57.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.61 -30.98 17.53 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 111.715 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -75.06 -30.09 60.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.14 97.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.587 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG23 ' A' ' 57' ' ' ILE . 4.0 p -121.13 150.26 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -74.92 -47.47 29.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 178.48 129.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.28 125.65 36.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.49 155.7 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.682 HD11 ' OD2' ' A' ' 28' ' ' ASP . 54.9 mt -106.03 120.65 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -65.81 -44.0 86.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 53' ' ' THR . 92.9 mt-10 -158.81 154.92 26.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.76 -42.48 1.91 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 59.99 40.17 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.354 -1.086 . . . . 0.0 109.558 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.671 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.17 33.76 22.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.36 -168.46 13.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.59 130.0 18.77 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.705 2.27 . . . . 0.0 111.714 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.01 25.88 72.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.851 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.18 143.12 35.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 68.4 mt -112.51 132.05 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -123.49 150.79 43.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -132.34 122.84 25.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.701 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -113.34 140.58 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.622 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.5 m -120.69 128.3 52.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.577 -179.922 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.5 p90 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' CA ' ' A' ' 89' ' ' GLY . 40.9 t -124.85 143.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 49.5 mtmt -113.19 147.59 37.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 91.9 m-70 -122.85 136.84 55.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' THR . 66.0 tttt -117.31 138.21 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.382 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 62.8 mt -99.72 132.98 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -90.5 -45.71 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.3 p -169.91 148.84 3.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.08 144.47 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.0 m-20 -131.05 92.16 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -62.8 -34.8 78.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.402 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.54 -39.86 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.1 m-20 -87.28 4.7 41.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 48.44 43.88 20.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.4 m -126.58 136.99 53.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 61.3 t80 -131.19 127.47 38.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.8 p -121.45 137.18 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -151.37 169.3 22.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 83.0 p -145.55 160.96 40.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 92' ' ' LEU . 4.1 tt -97.59 119.57 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.374 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.847 HG22 ' HG2' ' A' ' 88' ' ' GLU . 93.5 mt -75.58 -56.7 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HG2' HG22 ' A' ' 87' ' ' ILE . 75.4 mm-40 -148.46 162.04 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -0.99 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.33 150.8 11.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.12 -26.61 66.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -1.131 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.34 -28.73 47.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 86' ' ' LEU . 2.9 mt -75.19 -33.05 61.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 108.755 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m 52.85 -173.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.606 -0.684 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.25 -3.42 49.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.68 -36.24 14.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 92' ' ' LEU . 42.6 mt -92.3 130.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 110.041 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 70.4 mm-40 -88.55 -178.35 5.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.6 mttp -56.12 153.62 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.753 HD13 ' CE2' ' A' ' 121' ' ' TYR . 53.8 mt -118.03 137.68 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 87.4 m-20 -93.17 124.95 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.36 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 83.7 m-85 -117.24 140.67 49.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 117' ' ' THR . 93.6 mt-10 -133.76 136.65 44.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -128.4 137.44 51.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -139.76 128.95 23.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -98.31 130.57 44.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.19 145.93 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.7 p -112.68 143.07 44.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.0 109.478 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.46 164.93 13.83 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.8 Cg_endo -69.39 -18.05 38.96 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.634 2.222 . . . . 0.0 111.771 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.01 -15.51 63.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.862 . . . . 0.0 109.43 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.45 26.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.49 -179.84 50.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 66.4 m -124.75 126.87 46.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.159 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 106' ' ' VAL . 66.1 mt -90.38 137.9 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.337 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.753 HD13 ' HZ ' ' A' ' 145' ' ' PHE . 45.6 mt -119.84 129.11 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -118.8 127.0 53.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 0.0 109.205 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 102' ' ' GLU . 52.5 m -126.44 134.46 50.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.729 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.0 m -116.87 142.73 46.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 109.094 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.486 ' OG ' ' CE1' ' A' ' 101' ' ' TYR . 27.1 t -139.33 148.85 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.041 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.737 ' O ' HG23 ' A' ' 99' ' ' ILE . 82.3 tttt -136.5 130.71 32.93 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.901 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.8 m-85 -108.76 126.65 53.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.073 -1.017 . . . . 0.0 109.924 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 34.3 m170 -98.02 146.88 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.16 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.097 -1.002 . . . . 0.0 109.57 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -56.91 -50.94 71.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.92 -47.27 85.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.753 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 49.4 t80 -53.35 -43.26 67.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -55.11 -43.26 73.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.302 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 34' ' ' ILE . 65.2 mt -56.69 -45.02 82.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 30' ' ' LEU . 93.4 mt -53.8 -52.02 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.298 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.418 ' CG ' ' OG ' ' A' ' 12' ' ' SER . 83.7 tt0 -54.27 -41.82 69.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.233 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -77.57 -23.42 67.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 147' ' ' LEU . 70.1 t80 -63.18 -45.68 90.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.341 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.347 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 48.8 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -123.14 150.52 43.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.617 HG22 ' CG2' ' A' ' 118' ' ' THR . 19.9 m -93.95 138.13 32.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' THR . 77.5 t80 -122.86 134.51 54.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.43 133.77 55.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -121.78 131.66 54.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.8 mt-10 -104.04 118.95 37.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 11' ' ' THR . 62.4 t80 -133.29 132.39 41.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.5 p -93.9 142.96 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 24.4 m -135.3 160.48 38.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.673 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' ILE . 96.5 m-20 -69.26 -175.72 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.739 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mt 61.78 141.72 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.959 . . . . 0.0 109.077 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.0 Cg_endo -69.21 146.23 62.92 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.452 2.102 . . . . 0.0 111.978 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.941 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -41.12 -49.82 8.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.592 -0.692 . . . . 0.0 111.365 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -63.93 -49.32 4.09 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.252 1.968 . . . . 0.0 113.027 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.557 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 96.6 mttt -62.09 -35.48 78.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.523 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' PHE . 20.4 tp -80.57 -27.98 37.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.892 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 64.1 t80 -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -60.4 -43.89 96.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.4 -20.56 40.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.988 ' C ' ' HB2' ' A' ' 27' ' ' ALA . 71.0 t80 -99.09 6.64 46.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.892 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -135.0 -78.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.144 -0.973 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.02 -49.22 74.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 80.0 m-20 -99.07 12.14 36.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' C ' ' A' ' 23' ' ' PHE . . . -69.53 -36.4 76.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 31' ' ' ILE . 52.6 t0 -73.18 -29.87 63.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.8 m120 -91.06 -29.01 17.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.481 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.98 ' O ' HD13 ' A' ' 30' ' ' LEU . 1.8 tm? -73.52 -34.15 65.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.877 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 19.7 mt -51.32 -55.8 25.75 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.605 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.56 -17.89 43.16 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.499 2.132 . . . . 0.0 111.856 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.64 ' HD2' HD22 ' A' ' 30' ' ' LEU . 42.5 mttt -71.09 -40.45 71.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 109.521 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.504 ' CG2' HD13 ' A' ' 147' ' ' LEU . 87.9 mt -68.13 -34.63 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.74 70.39 19.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -70.18 -34.58 12.91 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.656 2.237 . . . . 0.0 111.727 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.75 -19.9 65.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.25 -26.56 21.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 1.9 t -118.01 139.79 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.1 -51.08 23.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.48 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.39 117.67 29.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.22 147.76 45.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.317 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 74.3 mt -106.36 118.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -60.58 -45.19 94.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 53' ' ' THR . 94.7 mt-10 -159.32 157.87 31.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 108.35 -43.03 1.79 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.9 m-20 59.76 38.33 21.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.09 33.01 21.92 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.436 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.78 -168.2 14.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.03 130.75 19.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.692 2.261 . . . . 0.0 111.668 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 71.51 26.73 72.59 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.2 m -80.37 140.3 36.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 64.2 mt -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 2.9 mtpt -119.22 149.17 42.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -131.87 124.43 29.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.641 HD12 ' CE1' ' A' ' 70' ' ' HIS . 20.5 mt -119.96 131.38 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -111.99 121.66 45.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.341 -0.849 . . . . 0.0 109.109 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.484 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 35.4 p90 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.326 0.584 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.812 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.6 m -134.47 150.31 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 109.089 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.644 ' O ' HD12 ' A' ' 86' ' ' LEU . 37.6 mttt -106.45 139.91 40.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.774 ' NE2' HD13 ' A' ' 86' ' ' LEU . 70.3 m80 -114.42 143.82 44.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 109.17 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 17.8 tttp -127.35 138.95 53.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.709 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 59.1 mt -98.69 131.15 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.17 -49.16 6.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m -163.34 152.12 14.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.8 pt -129.21 145.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 69.0 m-20 -122.15 107.09 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.924 . . . . 0.0 109.289 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -82.7 -25.77 32.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 108.553 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -46.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 65.5 m-80 -80.56 -5.37 56.67 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.492 -0.755 . . . . 0.0 109.651 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 m80 60.16 42.74 15.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.497 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 63.5 m -124.36 135.04 53.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 65.9 t80 -124.63 129.5 50.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -122.14 135.28 54.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.649 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.625 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.9 p90 -151.48 168.09 25.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.307 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 95.3 p -149.59 152.16 35.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 70' ' ' HIS . 37.7 tp -91.96 117.42 29.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.292 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.831 HG22 ' HG3' ' A' ' 88' ' ' GLU . 24.1 mm -70.4 -71.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.735 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.831 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -128.06 169.35 14.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.0 109.803 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.812 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . 176.72 137.36 2.63 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -47.55 -40.5 19.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -1.167 . . . . 0.0 109.694 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.23 -15.52 62.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.0 mp -87.89 -43.79 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 m 61.93 178.43 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.408 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.17 -2.05 39.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.632 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 16.5 p-10 -91.75 -21.58 20.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 51.5 mt -111.3 141.36 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -0.931 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -95.6 179.84 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 3.8 pttm -57.52 164.61 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 120' ' ' LYS . 68.2 mt -120.72 134.23 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 61.9 t0 -89.7 122.7 33.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 77.9 m-85 -115.51 139.8 49.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.275 -0.891 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 94.1 mt-10 -131.04 136.85 48.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.928 HG21 ' CE2' ' A' ' 23' ' ' PHE . 53.6 m -132.07 133.17 44.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 22.7 tttt -131.61 133.36 44.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 109.477 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 16' ' ' ALA . 1.2 mp -103.84 125.1 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 40.1 t -131.76 140.43 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.7 p -110.57 141.32 43.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -0.933 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -109.75 164.74 14.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.556 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.6 Cg_endo -69.96 -7.12 20.33 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.752 2.301 . . . . 0.0 111.791 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -78.82 -18.5 53.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.91 -29.45 7.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.87 174.53 55.09 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 106' ' ' VAL . 86.9 m -122.14 125.57 46.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 109.539 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.1 mt -90.22 138.34 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.604 HG23 HD12 ' A' ' 105' ' ' LEU . 44.0 mt -125.87 127.8 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.794 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 53.5 mttp -105.05 128.71 53.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -125.88 129.85 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 110.007 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.617 ' CG2' HG22 ' A' ' 5' ' ' THR . 33.1 m -118.49 133.87 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 108.923 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.8 m -123.8 142.46 51.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.09 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 99' ' ' ILE . 75.9 tttt -139.38 129.44 25.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' A' ' 99' ' ' ILE . 25.2 m-85 -111.65 131.57 55.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 109.884 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 71.4 m80 -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.42 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 22.0 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.52 -41.58 98.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 144' ' ' LEU . 35.3 mt -61.71 -45.98 91.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -53.28 -42.96 67.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -62.47 -39.67 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.504 HD13 ' CG2' ' A' ' 34' ' ' ILE . 60.5 mt -66.72 -40.73 88.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.401 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.41 HD13 ' HD1' ' A' ' 23' ' ' PHE . 82.2 mt -56.01 -45.73 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 96.6 mt-10 -60.66 -46.64 89.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.76 -39.87 96.96 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -53.4 -55.38 25.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -1.088 . . . . 0.0 109.462 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.739 HD12 HD13 ' A' ' 14' ' ' ILE . 66.1 mt . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.991 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.6 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.37 156.66 22.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 109.381 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 57.3 m -93.42 143.51 26.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.29 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -109.63 141.97 41.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.278 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -127.83 129.66 47.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 91.2 mt-10 -101.76 124.78 47.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 11' ' ' THR . 46.9 t80 -136.25 127.03 27.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 15.1 p -90.42 154.73 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.563 ' OG ' HD11 ' A' ' 115' ' ' ILE . 88.9 p -149.32 167.9 24.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 87.3 m-20 -77.2 -175.25 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.981 HD12 ' OE1' ' A' ' 149' ' ' GLU . 6.4 mt 63.4 142.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.3 Cg_endo -70.34 147.25 58.75 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.533 2.155 . . . . 0.0 112.106 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.14 -50.4 8.14 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 111.429 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.08 -50.27 3.08 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.303 2.002 . . . . 0.0 113.031 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 60.4 mttt -61.93 -37.02 83.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 149' ' ' GLU . 27.6 tp -81.3 -24.95 36.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.116 -0.99 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' HD1' HD23 ' A' ' 105' ' ' LEU . 66.1 t80 -72.96 -34.56 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 109.859 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 17.5 mttp -67.25 -45.78 75.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.765 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.12 42.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.624 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 59.4 t80 -76.53 -15.69 59.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 44.2 t -119.68 -53.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 46.0 mt -67.85 -40.45 83.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 80.3 m-20 -100.52 11.11 40.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.18 -31.66 69.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.628 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -68.64 -21.83 64.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 27.8 m120 -114.23 -37.81 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.075 -1.016 . . . . 0.0 109.485 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.656 HD11 ' CG ' ' A' ' 151' ' ' TYR . 30.1 tp -58.2 -36.94 73.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 27' ' ' ALA . 11.5 mt -55.78 -60.5 8.47 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.188 -0.945 . . . . 0.0 109.195 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.45 -11.35 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.558 2.172 . . . . 0.0 111.583 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 18.7 mttt -80.84 -35.63 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 109.607 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 147' ' ' LEU . 87.6 mt -73.54 -31.18 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 68.49 54.4 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.4 Cg_endo -70.15 -31.42 18.83 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.7 2.266 . . . . 0.0 111.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.33 -29.29 63.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.02 60.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 ' CG2' ' A' ' 57' ' ' ILE . 5.6 p -128.72 149.23 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.389 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -71.89 -51.69 20.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.608 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.1 144.24 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.67 120.32 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -113.19 156.18 23.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.646 HG21 ' N ' ' A' ' 48' ' ' ASP . 22.1 mm -106.83 133.89 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.5 tp -78.98 -37.91 38.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.813 ' O ' HG23 ' A' ' 53' ' ' THR . 57.8 mm-40 -159.06 133.6 7.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 104.22 -34.74 5.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 44' ' ' ILE . 5.3 m-20 51.49 56.98 7.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -1.109 . . . . 0.0 109.794 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.918 ' H ' HG21 ' A' ' 53' ' ' THR . . . 80.09 36.08 25.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.73 -168.78 14.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.14 133.43 26.69 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.595 2.197 . . . . 0.0 111.47 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.16 20.96 58.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.918 HG21 ' H ' ' A' ' 49' ' ' GLY . 49.5 m -73.38 146.83 44.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 0.0 109.741 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 23.8 mm -106.39 135.8 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' CE ' HD11 ' A' ' 72' ' ' ILE . 45.5 mttt -115.95 143.26 45.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 63.0 tttm -129.68 129.86 44.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 39' ' ' VAL . 44.0 mt -125.59 130.53 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.887 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -112.17 128.1 56.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.132 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HE2' HG23 ' A' ' 68' ' ' VAL . 75.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 45.8 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.343 0.592 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.86 HG22 ' HA2' ' A' ' 89' ' ' GLY . 61.4 t -118.44 141.77 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.267 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 50.3 mttt -116.56 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CE1' ' HG ' ' A' ' 86' ' ' LEU . 94.0 m-70 -120.97 144.84 48.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.753 ' HB2' HD11 ' A' ' 87' ' ' ILE . 45.3 tttt -121.36 140.88 51.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.559 HD11 ' CE ' ' A' ' 55' ' ' LYS . 66.0 mt -99.22 134.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.436 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.8 m-70 -88.93 -48.47 7.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.0 p -169.84 150.95 4.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' CE1' ' A' ' 82' ' ' TYR . 21.1 pt -129.08 144.78 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -129.42 92.68 3.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.511 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 95.2 mttt -64.28 -36.29 83.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.73 -42.75 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -87.66 6.68 33.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.0 m80 47.88 44.6 18.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.6 m -124.38 138.5 54.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.38 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 52.6 t80 -134.26 132.46 39.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 m -126.28 140.47 52.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.5 p90 -153.01 171.6 18.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.3 p -149.53 152.67 35.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 92' ' ' LEU . 4.6 tt -87.97 127.59 35.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.817 ' N ' HD23 ' A' ' 86' ' ' LEU . 82.9 mt -86.35 -72.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.441 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.779 ' O ' HG13 ' A' ' 68' ' ' VAL . 95.3 mt-10 -122.74 160.58 25.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -177.91 153.73 13.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -61.83 -25.48 67.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -1.13 . . . . 0.0 109.556 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.69 -30.41 46.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.975 HD11 HD22 ' A' ' 86' ' ' LEU . 3.9 mt -71.71 -31.85 67.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 108.853 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m 50.21 -172.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.626 -0.671 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.26 15.04 9.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.427 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -116.39 -17.87 10.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 91' ' ' ALA . 23.5 mt -109.34 141.47 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 94.0 mt-10 -90.7 -179.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.664 ' HE2' HG23 ' A' ' 87' ' ' ILE . 31.6 mttp -57.62 176.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.687 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 120' ' ' LYS . 59.0 mt -133.18 133.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.414 -0.804 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' SER . 80.5 m-20 -87.28 121.4 29.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 67.0 m-85 -114.39 144.1 43.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 117' ' ' THR . 89.1 mt-10 -132.81 139.24 47.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 23' ' ' PHE . 32.7 m -135.41 128.45 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -134.88 124.66 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.7 mm? -93.7 129.12 40.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 57.5 t -131.99 141.53 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.49 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.5 p -108.43 146.53 32.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.04 164.79 14.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.8 Cg_endo -70.01 -17.61 36.35 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.673 2.249 . . . . 0.0 111.848 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.76 -15.34 61.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -15.45 35.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.22 170.03 46.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.1 m -119.96 126.13 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 67.0 mt -93.16 139.56 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.563 HD11 ' OG ' ' A' ' 12' ' ' SER . 56.2 mt -127.1 121.89 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.728 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 58.0 mttp -106.82 132.37 52.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.046 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 102' ' ' GLU . 74.0 m -131.74 129.79 41.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 30.2 m -113.15 148.63 34.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 0.0 108.922 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 55.3 m -140.23 148.44 41.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.827 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.3 tttt -138.35 127.25 23.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.162 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.991 ' O ' HG21 ' A' ' 3' ' ' VAL . 40.3 m-85 -105.49 121.98 45.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 78.8 m80 -101.74 141.33 34.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 28.8 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -58.94 -43.94 91.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 47.6 mt -56.94 -49.07 76.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 148' ' ' ILE . 65.7 m-85 -53.13 -43.92 67.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -58.97 -41.05 86.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 151' ' ' TYR . 52.4 mt -64.22 -40.05 95.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.897 . . . . 0.0 109.364 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 145' ' ' PHE . 63.8 mt -55.51 -53.18 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.157 -0.965 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.981 ' OE1' HD12 ' A' ' 14' ' ' ILE . 73.1 mm-40 -54.38 -40.21 67.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.176 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.79 -26.03 59.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.656 ' CG ' HD11 ' A' ' 30' ' ' LEU . 60.0 t80 -60.82 -45.99 92.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -1.126 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.3 -0.875 . . . . 0.0 109.398 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 122' ' ' HIS . 80.9 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.21 140.9 48.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.269 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.5 m -105.25 131.73 52.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -0.946 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.47 138.82 54.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.378 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.61 136.15 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -117.39 135.58 53.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.41 124.25 51.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 80.6 t80 -146.17 141.7 27.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.528 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.2 p -107.93 151.29 25.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 21.7 t -151.38 154.38 36.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.629 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 10.8 t0 -66.31 -175.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 mm 72.44 141.67 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 109.356 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.55 146.24 60.89 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.481 2.12 . . . . 0.0 112.027 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -42.96 -49.33 14.22 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 111.595 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.5 -50.33 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.145 1.897 . . . . 0.0 113.169 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.56 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 67.6 mttt -61.46 -30.35 70.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 109.583 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 148' ' ' ILE . 22.6 tp -80.61 -33.71 35.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.685 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.72 ' HD1' HD23 ' A' ' 105' ' ' LEU . 83.0 t80 -61.7 -41.39 97.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.884 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.5 mttt -65.22 -55.14 20.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.47 -11.0 60.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.761 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.909 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.8 t80 -87.61 -33.43 18.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.1 m -115.75 -40.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.826 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' N ' HG23 ' A' ' 24' ' ' VAL . 20.7 tp -71.39 -34.33 70.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.016 . . . . 0.0 109.435 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 76.7 m-20 -108.04 11.46 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.83 -40.19 76.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -57.5 -32.82 67.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.2 m120 -102.27 -36.36 8.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 148' ' ' ILE . 42.6 tp -72.75 -34.52 67.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.584 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 27' ' ' ALA . 27.3 mt -53.69 -55.61 33.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -68.9 -17.54 41.49 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -72.52 -39.3 67.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.717 HD12 HD11 ' A' ' 144' ' ' LEU . 87.1 mt -72.25 -32.63 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.88 72.53 16.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -69.96 -31.97 18.61 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.69 2.26 . . . . 0.0 111.799 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.17 -26.26 62.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.33 -48.27 76.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.4 m -128.39 157.53 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -73.53 -42.69 61.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.61 135.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -0.87 . . . . 0.0 109.463 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.54 119.0 27.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.27 147.98 40.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.2 mt -106.08 121.12 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.4 tp -65.55 -43.71 89.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' THR . 93.5 mt-10 -159.22 155.81 27.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.33 -40.93 2.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.0 m-20 60.7 40.05 16.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.222 -1.164 . . . . 0.0 109.58 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.24 35.21 15.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.86 -166.56 13.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.73 129.64 17.98 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.758 2.305 . . . . 0.0 111.69 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.96 77.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.0 m -80.02 143.82 33.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -1.129 . . . . 0.0 109.58 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.94 127.98 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' CE ' HD11 ' A' ' 72' ' ' ILE . 56.9 mttt -112.44 152.76 28.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 19.1 tttt -134.62 126.61 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 70' ' ' HIS . 53.1 mt -116.26 139.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -115.86 129.0 56.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.437 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 68' ' ' VAL . 82.9 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.544 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.426 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 41.1 p90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.351 0.596 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.009 ' CG1' HD11 ' A' ' 86' ' ' LEU . 59.2 t -119.43 144.71 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.274 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.9 mttm -121.44 138.29 54.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.562 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.78 ' CE1' HD13 ' A' ' 86' ' ' LEU . 93.5 m-70 -112.12 135.76 52.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.2 139.1 49.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 47.3 mt -104.62 132.03 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -89.13 -47.69 7.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -169.79 153.79 5.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.87 144.1 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -124.91 92.83 3.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -63.13 -35.25 79.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.92 -40.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -87.93 4.63 44.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 m80 47.74 38.36 8.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.482 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -120.74 138.14 54.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 78.0 t80 -125.7 127.77 46.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -118.97 134.01 55.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.676 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 28.2 p90 -157.47 170.07 23.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.205 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 92.9 p -149.0 156.8 42.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 0.0 109.9 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.009 HD11 ' CG1' ' A' ' 68' ' ' VAL . 36.4 tp -91.25 110.86 22.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.201 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 88' ' ' GLU . 4.3 tt -74.93 -47.16 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 68' ' ' VAL . 97.5 mt-10 -142.3 167.16 22.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.891 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.919 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . 172.96 146.55 5.47 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.94 -27.55 65.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.61 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.86 51.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.883 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.3 mt -76.31 -33.18 59.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 108.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.4 m 55.12 -179.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.628 -0.67 . . . . 0.0 109.292 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.62 5.29 21.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -97.88 -28.04 14.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 58.8 mt -104.87 137.87 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.4 mm-40 -83.87 -179.47 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 22.7 pttm -57.26 164.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' LYS . 47.7 mt -124.62 133.94 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 82.9 m-20 -90.42 126.18 35.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.875 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 93.4 m-85 -121.09 134.87 55.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.204 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -128.21 138.06 52.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.639 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.654 HG21 ' CE2' ' A' ' 23' ' ' PHE . 61.3 m -128.9 134.43 48.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.535 ' C ' HD22 ' A' ' 105' ' ' LEU . 46.5 tttt -132.61 133.08 43.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -102.83 123.46 46.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 48.2 t -129.02 141.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.3 OUTLIER -113.71 146.49 39.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.565 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.63 174.07 2.56 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.507 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.9 Cg_endo -69.3 -16.58 39.58 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.734 2.289 . . . . 0.0 111.807 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.35 -20.61 63.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.265 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.43 -22.07 25.18 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.26 176.53 54.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.501 HG21 ' HA ' ' A' ' 16' ' ' ALA . 80.1 m -125.21 126.01 44.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -1.158 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.5 mt -91.05 140.64 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 109.172 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 105' ' ' LEU . 55.3 mt -123.94 120.71 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -109.88 132.13 54.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.9 m -127.21 128.74 46.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 143.02 49.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 89.8 p -144.69 147.24 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 110.399 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 99' ' ' ILE . 51.6 mttp -122.03 144.11 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.751 ' O ' HG22 ' A' ' 3' ' ' VAL . 98.1 m-85 -112.11 124.32 52.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 110.065 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.801 ' HA ' HG22 ' A' ' 3' ' ' VAL . 78.9 m80 -99.91 129.25 45.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.131 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 109.685 -179.703 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.28 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.42 -46.71 83.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.45 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 78.7 m-85 -53.89 -38.42 64.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.54 -43.43 79.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -66.11 -42.44 89.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 30' ' ' LEU . 85.9 mt -60.95 -38.55 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 13' ' ' ASP . 65.8 tt0 -64.52 -37.3 87.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.26 -41.46 31.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 21.3 m-85 -65.18 -42.54 93.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 14' ' ' ILE . 60.8 mt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 122' ' ' HIS . 72.6 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.26 0.552 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.44 141.02 47.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.483 HG22 ' CG2' ' A' ' 118' ' ' THR . 23.6 m -93.44 143.78 25.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -124.7 138.99 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.727 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -115.27 131.81 56.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -119.8 133.3 55.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -105.54 125.41 50.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -136.41 133.3 36.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.4 p -100.9 143.32 31.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.254 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 43.7 p -141.11 171.63 13.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.653 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ILE . 67.0 m-20 -76.03 -175.99 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 18' ' ' LYS . 6.6 mm 62.85 138.36 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 49.5 Cg_endo -70.15 150.16 65.46 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.592 2.194 . . . . 0.0 112.059 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.64 -52.25 6.4 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 111.129 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 43.0 Cg_endo -64.89 -49.13 3.15 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.276 1.984 . . . . 0.0 112.907 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 14' ' ' ILE . 13.4 ttmt -57.98 -38.03 75.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.93 -1.106 . . . . 0.0 109.572 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.971 HD11 HG22 ' A' ' 148' ' ' ILE . 20.8 tp -75.28 -39.09 60.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB2' HD12 ' A' ' 105' ' ' LEU . 71.2 t80 -55.45 -47.14 76.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.0 tttt -46.63 -44.15 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.937 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -107.47 14.98 25.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.175 -0.953 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.809 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 92.4 t80 -96.22 -33.0 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 ' HD2' ' A' ' 23' ' ' PHE . 31.3 m -126.09 -39.88 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.811 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 25' ' ' LEU . 15.5 tp -57.32 -66.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.738 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 34.6 p30 -92.27 13.41 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.484 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.78 -35.0 76.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.7 m-20 -59.23 -41.52 88.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -96.62 -29.22 13.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.634 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -72.98 -38.9 66.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 27' ' ' ALA . 32.2 mt -52.25 -55.46 31.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.65 -17.5 42.82 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.41 2.073 . . . . 0.0 111.753 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 28.5 mttm -73.36 -37.06 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' HD13 ' A' ' 147' ' ' LEU . 88.6 mt -71.28 -27.76 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.15 69.23 16.04 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.84 -29.71 23.07 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.58 2.187 . . . . 0.0 111.683 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -71.96 -28.1 63.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -49.28 44.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 57' ' ' ILE . 3.0 p -119.55 150.98 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.68 -51.78 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.72 136.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.81 129.27 38.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.88 148.95 42.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.4 mt -106.25 119.16 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 24.2 tp -64.32 -44.69 90.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.9 mt-10 -159.47 155.35 26.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.72 -39.75 2.69 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.9 m-20 61.74 41.05 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.821 ' H ' HG21 ' A' ' 53' ' ' THR . . . 82.59 36.75 15.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.83 -165.4 12.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.56 130.55 19.78 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.726 2.284 . . . . 0.0 111.797 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 25.28 75.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 99.0 m -80.7 145.91 31.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 53' ' ' THR . 26.2 mm -115.47 132.29 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 mtmp? -128.98 148.39 50.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.03 125.31 44.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.283 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.634 ' CG2' HG21 ' A' ' 39' ' ' VAL . 11.3 mt -115.41 134.91 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.671 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 39' ' ' VAL . 19.5 p -115.55 142.15 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.95 . . . . 0.0 109.591 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.948 HG22 ' CA ' ' A' ' 89' ' ' GLY . 38.2 t -124.98 145.39 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -113.73 142.86 45.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.581 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 67.8 m170 -116.73 133.42 56.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -115.16 137.67 51.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.5 mt -101.89 134.65 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.6 m-70 -91.17 -46.85 7.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 t -173.53 147.66 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.51 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 82' ' ' TYR . 29.0 pt -123.57 144.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 91.6 m-20 -121.58 91.9 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.416 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -63.31 -36.89 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.55 -41.82 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 1.18 56.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.2 m80 54.32 42.34 31.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.994 . . . . 0.0 109.406 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 40.2 m -118.17 142.51 47.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.535 ' CD1' HG22 ' A' ' 75' ' ' ILE . 65.2 t80 -134.73 123.76 24.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.5 m -117.55 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 31.4 p90 -150.87 172.94 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -149.41 155.46 40.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 92' ' ' LEU . 3.0 tt -97.17 118.74 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.966 HG22 ' HG3' ' A' ' 88' ' ' GLU . 87.6 mt -75.46 -56.88 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.627 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.966 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.6 mt-10 -149.09 160.43 43.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.948 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -165.46 152.8 22.44 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -58.17 -24.22 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -1.101 . . . . 0.0 109.324 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.48 -27.43 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 96' ' ' ILE . 2.0 mt -76.63 -32.81 58.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.839 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 92' ' ' LEU . 30.2 t 47.77 -174.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' N ' ' OG ' ' A' ' 93' ' ' SER . 97.5 mt-10 -76.37 -6.49 51.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -0.994 . . . . 0.0 109.461 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -83.1 -38.91 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.85 . . . . 0.0 109.83 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 92' ' ' LEU . 34.6 mt -91.7 135.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.817 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . 38.3 mt-10 -90.14 -179.26 5.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.872 ' HE2' HG23 ' A' ' 87' ' ' ILE . 70.1 mttt -57.04 158.5 4.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.563 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 120' ' ' LYS . 60.4 mt -125.21 131.39 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' LYS . 88.2 m-20 -88.65 124.0 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 75.6 m-85 -115.51 142.24 46.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.671 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -131.93 134.81 46.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.349 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.489 HG21 ' CE2' ' A' ' 23' ' ' PHE . 50.3 m -128.64 138.53 52.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -140.71 127.56 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.274 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 20' ' ' PHE . 37.9 mt -96.49 128.56 43.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.691 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 113' ' ' THR . 46.8 t -132.0 140.86 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.56 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 98.5 p -113.72 144.41 42.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.67 166.21 11.2 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 109.525 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.693 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.0 Cg_endo -70.32 -11.48 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.706 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -76.41 -16.81 59.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.33 -24.4 18.2 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.16 54.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 92.1 m -123.65 122.15 37.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -1.185 . . . . 0.0 109.707 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.0 mt -87.72 144.31 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.061 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.462 HG23 HD23 ' A' ' 105' ' ' LEU . 56.8 mt -131.14 117.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.871 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -97.81 131.98 43.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 108.943 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.8 m -128.91 121.59 28.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 110.007 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.3 m -114.67 141.09 48.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 108.85 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -138.58 156.71 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 110.329 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 99' ' ' ILE . 71.1 tttt -147.57 142.64 27.07 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CB ' HG12 ' A' ' 99' ' ' ILE . 26.6 p90 -135.99 148.55 48.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 109.916 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 97' ' ' GLU . 93.9 m-70 -104.48 172.71 6.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 109.517 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.175 -0.953 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -71.46 -37.62 71.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.448 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 144' ' ' LEU . 49.5 mt -67.59 -44.31 78.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.845 . . . . 0.0 109.363 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 27.3 m-85 -54.38 -44.91 72.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 23.3 mttm -57.48 -36.3 71.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.455 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD13 ' CG2' ' A' ' 34' ' ' ILE . 57.7 mt -66.02 -38.85 89.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.971 HG22 HD11 ' A' ' 19' ' ' LEU . 34.4 mm -56.42 -56.5 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 19.5 mp0 -56.53 -36.52 69.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 109.36 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.77 -27.66 62.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.498 ' CE1' HD21 ' A' ' 30' ' ' LEU . 72.8 t80 -63.7 -41.72 98.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -1.068 . . . . 0.0 109.411 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 121' ' ' TYR . 78.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.5 136.36 52.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 48.3 m -95.51 136.74 35.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 118' ' ' THR . 98.4 m-85 -119.49 134.78 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.57 137.29 47.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.443 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 37.1 t-20 -113.54 149.88 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -133.4 134.12 43.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.562 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 11' ' ' THR . 64.6 t80 -161.79 131.71 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.502 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.567 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 15.1 p -98.25 157.39 16.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -157.52 177.01 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.569 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.4 t0 -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.851 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 64.06 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 109.379 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -70.41 147.46 58.7 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.628 2.219 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.21 -51.55 3.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 111.129 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 40.9 Cg_endo -63.63 -50.62 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.339 2.026 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 41.5 mttm -58.6 -37.53 76.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 109.59 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 152' ' ' LEU . 30.5 tp -80.79 -30.03 36.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.771 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -65.2 -32.86 74.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 109.77 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.7 mtpm? -64.16 -50.12 69.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.609 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -79.46 -16.47 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 103' ' ' THR . 49.8 t80 -86.1 -13.44 47.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.783 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 86.4 t -123.8 -58.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp -65.5 -39.92 92.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 42.3 m-20 -98.09 12.56 34.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -40.75 76.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 44' ' ' ILE . 88.6 m-20 -63.33 -35.23 79.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 29.2 t-20 -93.72 -33.91 13.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 31.9 tp -72.86 -44.97 60.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 27' ' ' ALA . 26.0 mt -45.59 -55.91 11.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -69.18 -26.36 30.38 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 111.801 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 31.2 tttm -71.57 -38.94 70.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.655 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 30' ' ' LEU . 63.8 mt -64.26 -24.27 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.578 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -159.08 73.2 3.51 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 50.2 Cg_endo -70.16 -30.61 20.17 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.664 2.243 . . . . 0.0 111.875 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -74.1 -21.13 60.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -73.04 -42.02 63.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.9 m -126.36 152.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.53 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.84 -43.43 62.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.57 129.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.54 125.13 31.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.37 150.91 40.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.4 mt -106.59 118.27 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.9 tp -62.61 -44.9 95.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.517 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.87 155.48 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.78 -41.14 2.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.2 m-20 60.11 37.74 20.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.156 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.739 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.03 34.92 9.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.98 -167.17 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.89 129.22 17.09 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.679 2.253 . . . . 0.0 111.77 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.5 22.44 78.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -77.03 144.47 38.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.54 HG23 ' CD1' ' A' ' 87' ' ' ILE . 65.9 mt -115.39 127.44 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 87.0 mttt -115.92 150.86 36.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 ttpp -132.91 122.44 24.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.445 HD11 ' CE1' ' A' ' 70' ' ' HIS . 31.7 mt -113.3 135.06 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.2 m -118.14 131.83 56.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CE2' HG12 ' A' ' 39' ' ' VAL . 13.5 m-85 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 39.0 p90 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.281 0.563 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG11 HD11 ' A' ' 86' ' ' LEU . 25.5 t -131.26 155.15 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.56 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 45.1 mtmt -124.27 154.3 40.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.445 ' CE1' HD11 ' A' ' 57' ' ' ILE . 61.2 m170 -123.31 150.14 43.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HB2' HG13 ' A' ' 87' ' ' ILE . 57.9 tttt -132.86 138.15 46.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 31.1 mt -104.32 124.04 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 98.4 m-70 -89.0 -27.39 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 59.7 p 178.9 153.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -136.0 142.53 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.4 m-20 -123.51 94.58 4.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.51 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.26 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 -42.91 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.315 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -87.96 8.14 27.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 48.2 m80 46.28 48.97 13.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.348 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 31.0 m -126.27 136.1 52.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 68.8 t80 -129.98 123.79 31.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -124.52 135.77 53.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.761 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.9 p90 -147.96 -177.14 5.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 88.8 p -151.41 150.83 30.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 87' ' ' ILE . 3.1 tt -87.5 119.52 27.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' A' ' 88' ' ' GLU . 97.4 mt -76.09 -63.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 87' ' ' ILE . 73.6 mm-40 -138.65 154.38 48.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.725 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.544 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -173.15 142.88 6.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.09 -32.56 47.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 109.645 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -20.17 61.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 86' ' ' LEU . 9.7 mp -85.18 -36.02 21.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 40.5 t 61.79 173.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.73 -7.11 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -84.82 -39.71 18.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.631 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 29.8 mt -87.52 143.8 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 92.8 mt-10 -91.37 -179.33 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 46.9 mtmt -56.86 160.86 3.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.96 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 120' ' ' LYS . 66.4 mt -120.91 136.65 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 119' ' ' SER . 88.9 m-20 -92.78 126.23 37.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 80.4 m-85 -117.81 137.76 52.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 118' ' ' THR . 94.5 mt-10 -125.01 142.08 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 23' ' ' PHE . 25.9 m -129.86 136.09 49.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 109.334 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.528 ' C ' HD22 ' A' ' 105' ' ' LEU . 25.0 tttt -139.26 128.94 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.847 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -106.33 112.5 25.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.491 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 9.4 t -130.57 128.47 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.9 p -114.78 154.22 28.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.957 . . . . 0.0 110.105 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -96.32 161.54 26.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.634 -0.666 . . . . 0.0 109.248 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.7 Cg_endo -68.5 92.21 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.375 2.05 . . . . 0.0 110.368 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 34.6 t60 78.93 17.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -112.19 12.83 26.35 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 82.95 -151.39 28.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 52.9 m -126.42 134.69 50.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.998 -1.295 . . . . 0.0 109.797 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 49.8 mt -107.05 134.47 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.031 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.503 HG23 HD13 ' A' ' 105' ' ' LEU . 28.4 mt -116.57 116.83 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 29.2 mttp -105.89 130.55 53.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.968 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -124.63 130.66 52.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 109.966 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.3 m -126.02 139.23 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.433 -0.792 . . . . 0.0 108.997 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 94.8 p -143.47 152.16 41.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 99' ' ' ILE . 90.1 mttt -125.86 143.35 51.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.108 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CD1' HD13 ' A' ' 99' ' ' ILE . 82.7 m-85 -111.17 123.48 50.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.752 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -95.16 136.79 35.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.241 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.587 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.49 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 86.7 t60 -61.86 -44.66 96.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 147' ' ' LEU . 81.4 mt -53.64 -46.87 70.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -53.42 -32.75 51.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -68.25 -34.55 76.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.955 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -71.82 -38.86 70.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 76.4 mt -60.02 -46.01 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -69.61 -34.09 73.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.64 -42.24 88.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 27.1 m-85 -63.13 -46.17 88.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.851 HD12 HD13 ' A' ' 14' ' ' ILE . 67.8 mt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.941 HG11 ' O ' ' A' ' 121' ' ' TYR . 94.0 t . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.566 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -100.8 146.1 27.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.566 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 24.8 m -93.55 139.47 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.283 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.45 136.23 53.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.577 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -113.69 135.22 54.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.29 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 27.3 t30 -114.88 131.02 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 90.3 mt-10 -113.99 132.91 55.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.164 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.4 t80 -146.5 144.84 29.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.746 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.756 HG22 HG12 ' A' ' 114' ' ' ILE . 20.4 p -109.64 144.71 37.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -152.23 179.38 8.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.7 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 71.9 m-20 -80.62 -175.71 5.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 13' ' ' ASP . 2.6 mt 69.1 135.13 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 51.0 Cg_endo -71.09 148.14 55.84 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 112.012 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -39.41 -51.46 4.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.557 -0.714 . . . . 0.0 111.311 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.28 -50.32 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.338 2.025 . . . . 0.0 113.072 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 30.9 mttt -59.33 -36.16 75.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.94 -1.1 . . . . 0.0 109.505 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 tp -80.78 -27.08 36.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 24' ' ' VAL . 73.8 t80 -68.93 -38.28 79.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.959 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 60.7 tttt -66.01 -45.07 82.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -29.63 44.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.642 ' HD2' HD13 ' A' ' 148' ' ' ILE . 56.7 t80 -80.88 -10.95 59.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 20' ' ' PHE . 97.8 t -121.9 -55.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.5 tp -69.57 -36.7 76.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.7 m-20 -102.99 15.77 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.783 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -70.2 -40.34 74.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.768 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.656 ' OD2' HD11 ' A' ' 44' ' ' ILE . 87.8 m-20 -66.35 -24.74 66.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.067 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.4 m120 -105.69 -43.22 4.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.967 . . . . 0.0 109.629 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 18.3 tp -59.91 -36.06 76.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 27' ' ' ALA . 22.4 mt -54.16 -60.1 8.35 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -67.99 -14.0 39.85 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.614 2.209 . . . . 0.0 111.801 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 75.8 mttt -75.07 -40.7 59.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.2 mt -73.84 -31.28 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.21 67.12 14.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -70.11 -31.81 18.29 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -70.96 -26.02 62.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -70.78 -43.65 68.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.935 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 57' ' ' ILE . 5.6 p -116.36 146.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -73.74 -46.06 48.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 177.47 136.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.68 130.84 44.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.381 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -125.43 151.63 45.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.656 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.6 mt -105.96 123.41 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.478 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -69.22 -43.11 74.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 109.495 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 53' ' ' THR . 93.1 mt-10 -158.99 158.79 33.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.479 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.68 -41.15 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.4 m-20 59.35 39.71 21.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -1.113 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.848 ' H ' HG21 ' A' ' 53' ' ' THR . . . 81.51 34.2 26.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.9 -165.39 12.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.01 127.65 14.69 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.664 2.242 . . . . 0.0 111.691 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.5 24.85 69.36 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 46' ' ' GLU . 60.3 m -81.19 140.96 34.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -1.145 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.14 133.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.594 ' CE ' HD11 ' A' ' 72' ' ' ILE . 46.7 mttt -121.52 148.06 44.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.688 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 85.8 tttt -130.52 124.49 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.241 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 39' ' ' VAL . 22.3 mt -118.41 133.17 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -118.76 123.2 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.866 . . . . 0.0 109.35 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 41.6 p90 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 42.3 p90 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.375 0.607 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 86' ' ' LEU . 43.3 t -121.81 150.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.435 -0.79 . . . . 0.0 109.047 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 34.6 mttt -118.12 140.67 49.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.703 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.478 ' CE1' HD12 ' A' ' 57' ' ' ILE . 80.8 m80 -120.2 131.15 54.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.6 tttp -111.4 141.72 44.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CE ' ' A' ' 55' ' ' LYS . 60.0 mt -100.48 132.18 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.8 m-70 -91.05 -49.25 6.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.535 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.1 t -166.32 147.81 6.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.91 144.78 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -124.34 91.58 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -62.53 -35.31 79.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.49 -40.56 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.37 8.74 26.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.8 m80 45.86 44.79 11.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.8 m -125.78 136.59 53.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 72.0 t80 -127.8 127.17 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.459 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -119.45 135.68 54.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 40.5 p90 -151.97 168.77 24.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.467 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -145.52 156.04 43.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.914 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.2 tt -92.57 124.93 36.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.443 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.839 HG22 ' HG3' ' A' ' 88' ' ' GLU . 27.1 mm -79.45 -66.34 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.839 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.7 mt-10 -139.24 160.64 39.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.703 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -176.41 157.54 23.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -61.16 -27.08 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.181 . . . . 0.0 109.559 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -32.06 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.914 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.7 mp -75.23 -48.78 21.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.9 m 61.34 170.6 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -72.56 -5.66 38.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.607 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 92' ' ' LEU . 46.6 mt -98.24 151.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 90.2 mt-10 -94.81 -179.98 5.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 87' ' ' ILE . 32.4 mmtm -57.37 159.57 4.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.489 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 120' ' ' LYS . 54.8 mt -120.72 136.5 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 120' ' ' LYS . 59.7 t0 -98.66 125.1 43.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 88.6 m-85 -116.9 142.74 46.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -133.0 138.42 46.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.7 m -130.52 137.71 49.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 105' ' ' LEU . 22.7 tttt -138.98 131.64 28.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.348 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -103.73 115.72 31.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.562 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 114' ' ' ILE . 4.3 t -131.88 131.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 63.1 p -114.69 154.57 28.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.057 -1.027 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -99.62 162.15 22.13 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.565 -0.71 . . . . 0.0 109.316 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.6 Cg_endo -68.92 95.0 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.369 2.046 . . . . 0.0 110.472 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 26.3 m-70 78.28 11.48 1.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -105.58 9.09 44.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 83.45 -146.89 23.9 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 90.6 m -126.73 133.95 50.76 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.118 -1.225 . . . . 0.0 109.659 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.756 HG12 HG22 ' A' ' 11' ' ' THR . 61.2 mt -108.65 130.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.2 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 ' CD1' ' A' ' 105' ' ' LEU . 5.2 mt -109.28 117.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.725 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 42.7 mttp -105.15 129.23 53.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.083 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.4 m -128.15 129.6 46.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 109.868 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 5' ' ' THR . 51.4 m -111.3 139.64 46.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.159 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -128.56 135.95 50.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.881 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 99' ' ' ILE . 35.7 tttm -139.13 139.15 37.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.819 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.941 ' O ' HG11 ' A' ' 3' ' ' VAL . 36.5 p90 -134.08 151.26 51.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.08 -1.012 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.9 m80 -109.06 154.79 21.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.546 -179.934 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 65.5 m170 -69.5 -35.27 75.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.91 -42.57 73.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 54.7 m-85 -54.26 -46.19 72.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.484 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 84.7 tttt -60.67 -34.56 74.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 143' ' ' HIS . 41.8 mt -65.26 -38.32 89.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 23' ' ' PHE . 83.4 mt -54.19 -56.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 12' ' ' SER . 30.8 mp0 -55.67 -44.05 76.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.1 -26.23 72.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.48 ' OH ' ' HD3' ' A' ' 33' ' ' LYS . 64.0 t80 -70.37 -41.38 73.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -1.103 . . . . 0.0 109.387 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.374 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 122' ' ' HIS . 27.6 t -118.64 133.14 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 109.473 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.17 142.03 39.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 109.341 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.649 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.2 m -93.65 143.14 26.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -124.81 137.5 54.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.57 136.3 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.397 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -124.96 134.19 52.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 86.4 mt-10 -109.93 143.42 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 109.366 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 11' ' ' THR . 72.1 t80 -152.16 139.75 19.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.576 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 11.3 p -97.73 131.74 43.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.435 ' HG ' ' HE2' ' A' ' 10' ' ' PHE . 7.6 m -132.79 170.85 14.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -80.6 -175.7 5.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.42 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 18' ' ' LYS . 7.7 mm 67.4 139.34 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.337 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.6 Cg_endo -70.2 148.89 63.18 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 111.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.47 -52.37 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.671 . . . . 0.0 111.38 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.86 -50.37 2.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.397 2.064 . . . . 0.0 113.069 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.4 mttp -60.76 -35.02 75.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.823 -1.173 . . . . 0.0 109.498 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 149' ' ' GLU . 23.5 tp -80.59 -36.08 33.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.486 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.577 ' HD1' HD23 ' A' ' 105' ' ' LEU . 80.6 t80 -59.17 -48.31 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.836 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -61.32 -54.28 45.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 109.816 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.25 -4.46 21.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.89 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.3 t80 -94.11 -32.84 13.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.096 -1.002 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' A' ' 82' ' ' TYR . 4.7 m -117.31 -39.19 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 25' ' ' LEU . 22.9 tp -72.87 -38.5 66.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.515 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -104.09 11.33 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.77 -41.1 75.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 44' ' ' ILE . 84.5 m-20 -57.46 -30.6 65.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.505 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 25.6 m120 -101.35 -35.78 9.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.442 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 33' ' ' LYS . 17.5 tp -75.2 -39.65 59.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' A' ' 27' ' ' ALA . 33.1 mt -47.98 -55.01 19.66 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.93 . . . . 0.0 109.56 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.4 Cg_endo -69.26 -19.93 37.85 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.383 2.055 . . . . 0.0 111.721 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB2' HD12 ' A' ' 30' ' ' LEU . 15.7 mttt -74.19 -36.27 64.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.502 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.6 mt -70.15 -29.99 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.975 . . . . 0.0 109.555 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.79 72.18 12.52 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.7 Cg_endo -69.67 -43.56 2.66 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.658 2.238 . . . . 0.0 111.694 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.9 -20.62 63.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.9 69.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.926 HG12 ' CE1' ' A' ' 59' ' ' PHE . 17.3 m -128.51 154.83 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -73.94 -45.89 47.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.486 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.62 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.37 128.93 35.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.91 144.2 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.525 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 55.4 mt -106.54 119.38 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.458 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -63.31 -44.45 94.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.73 154.6 24.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.11 -41.87 2.06 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 91.1 m-20 60.52 38.06 19.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.741 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.58 35.29 9.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.503 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.12 -167.56 13.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.15 129.29 16.93 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.733 2.288 . . . . 0.0 111.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.9 24.88 75.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.956 HG23 ' O ' ' A' ' 46' ' ' GLU . 91.9 m -80.05 144.59 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.473 HG22 HD13 ' A' ' 45' ' ' LEU . 24.5 mm -110.65 128.62 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 81.9 mttt -114.94 150.16 36.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HB2' HD11 ' A' ' 45' ' ' LEU . 43.8 tttm -132.55 123.49 26.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 70' ' ' HIS . 39.8 mt -114.16 136.69 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.3 m -113.73 130.9 56.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.926 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.0 m-85 -102.48 131.28 49.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.523 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.91 6.17 47.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -116.04 167.88 10.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -1.2 . . . . 0.0 109.404 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.24 -126.4 8.22 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 65' ' ' TYR . 99.8 p -60.98 174.8 0.58 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -1.148 . . . . 0.0 109.496 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -71.46 -35.2 70.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' O ' ' OG ' ' A' ' 63' ' ' SER . 41.6 p90 -133.5 170.69 15.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 154.35 143.4 3.67 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 40.9 p90 -160.97 144.04 12.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -1.16 . . . . 0.0 109.749 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.955 HG22 ' CA ' ' A' ' 89' ' ' GLY . 67.7 t -117.27 142.27 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -0.849 . . . . 0.0 109.232 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 88' ' ' GLU . 18.0 mttp -112.03 143.35 43.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.738 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' ILE . 97.0 m-70 -124.45 143.1 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.265 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.778 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.0 tttm -125.61 139.55 53.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.672 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 60.9 mt -96.95 137.98 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.388 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.446 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 87.1 m-70 -90.52 -49.03 6.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -170.02 149.08 3.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.1 pt -125.81 144.16 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 83.9 m-20 -127.94 92.4 3.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -63.43 -35.29 79.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.95 -39.38 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.414 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.8 m-20 -88.42 5.09 43.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m80 47.68 46.52 18.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.1 m -129.06 132.22 47.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 64.8 t80 -124.78 125.7 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -118.54 140.61 49.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.597 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 32.5 p90 -154.4 170.27 21.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 82.9 p -148.88 157.94 43.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.0 tt -94.99 132.13 40.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.318 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.959 ' N ' HD23 ' A' ' 86' ' ' LEU . 87.8 mt -89.84 -71.68 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 109.592 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.88 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -127.32 159.27 34.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.955 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -175.37 154.35 17.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 82.6 m-20 -62.22 -35.39 78.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -1.159 . . . . 0.0 109.434 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -73.16 -23.84 60.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.989 ' CD2' HD22 ' A' ' 86' ' ' LEU . 9.1 mp -78.85 -49.49 12.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.04 176.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 97.4 mt-10 -76.0 -10.06 59.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.654 ' O ' HG21 ' A' ' 127' ' ' VAL . 27.6 m120 -83.15 -34.25 26.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 92' ' ' LEU . 36.5 mt -96.23 132.72 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 93.4 mt-10 -87.1 -179.16 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.744 ' HE2' HG23 ' A' ' 87' ' ' ILE . 89.9 mttt -56.71 165.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.447 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.776 HG23 ' O ' ' A' ' 120' ' ' LYS . 63.7 mt -125.78 131.79 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.878 . . . . 0.0 109.523 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 50.3 t0 -85.98 119.9 26.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 65.8 m-85 -113.04 142.15 46.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' THR . 92.7 mt-10 -131.47 136.74 48.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 23' ' ' PHE . 27.3 m -125.38 131.58 52.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.515 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' C ' HD22 ' A' ' 105' ' ' LEU . 56.2 tttt -133.08 125.03 28.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.845 HD13 HG23 ' A' ' 115' ' ' ILE . 2.9 mm? -99.58 128.65 45.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 114' ' ' ILE . 41.3 t -131.15 140.7 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -109.26 147.92 31.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.69 161.82 23.84 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.7 Cg_endo -70.1 -11.69 30.85 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.727 2.284 . . . . 0.0 111.82 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -77.22 -17.13 58.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.939 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.86 -15.22 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.25 173.43 44.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 99.1 m -127.75 127.61 43.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.565 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 64.5 mt -97.95 143.42 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.282 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.845 HG23 HD13 ' A' ' 105' ' ' LEU . 4.2 mt -124.17 123.61 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 18.6 mttt -105.11 131.32 52.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 102' ' ' GLU . 85.7 m -131.47 132.04 43.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.861 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.2 m -112.28 144.62 41.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.048 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.9 m -130.4 145.55 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 0.0 110.072 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' ILE . 5.1 ttpt -143.75 123.34 13.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 99' ' ' ILE . 14.8 m-85 -106.87 137.94 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.062 -1.023 . . . . 0.0 109.724 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' HG21 ' A' ' 3' ' ' VAL . 67.7 m80 -107.49 148.54 29.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.011 ' HB ' HG23 ' A' ' 127' ' ' VAL . 15.4 p -126.55 159.62 32.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 95' ' ' ASN . 4.2 mtmp? -58.27 -44.06 88.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.281 -0.887 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.51 -60.57 0.09 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 93.9 m-20 -98.19 -32.45 11.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.491 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.011 HG23 ' HB ' ' A' ' 123' ' ' THR . 3.5 m -52.24 117.78 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 94.9 mt-10 -131.65 165.41 23.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.516 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.639 HD11 ' HD2' ' A' ' 133' ' ' HIS . 15.7 tt -117.87 171.54 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.289 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -99.13 131.9 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -54.25 -37.84 65.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.467 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 71.4 mm-40 -59.29 -39.74 83.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.639 ' HD2' HD11 ' A' ' 129' ' ' ILE . 84.0 t60 -65.91 -42.72 89.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.411 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' A' ' 138' ' ' LYS . 47.6 t -65.38 -41.37 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.365 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -55.66 -41.82 74.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.406 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.25 94.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.862 . . . . 0.0 109.391 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.39 -40.49 96.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.512 ' NZ ' ' OH ' ' A' ' 121' ' ' TYR . 22.1 mmtm -56.31 -43.09 78.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -50.68 73.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.397 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 90.0 mttt -57.69 -42.03 82.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.354 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.25 -46.68 82.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.364 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.71 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -74.31 -32.2 62.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 65.4 mt -68.92 -41.62 77.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.863 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.465 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 60.1 m-85 -53.4 -47.94 69.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -54.69 -40.55 69.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 151' ' ' TYR . 45.8 mt -60.89 -36.95 80.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.379 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 145' ' ' PHE . 92.1 mt -56.04 -55.84 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 19' ' ' LEU . 35.9 mp0 -68.31 -33.99 75.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.15 60.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 147' ' ' LEU . 64.8 m-85 -60.94 -49.21 78.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.173 . . . . 0.0 109.434 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.31 -39.74 73.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -62.96 -40.21 97.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.02 -41.19 87.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.46 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.82 79.23 0.35 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 109.552 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.8 142.85 44.32 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.678 2.252 . . . . 0.0 111.672 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -113.64 147.42 38.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.73 -31.41 70.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.08 -40.54 77.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.443 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.732 HG11 ' O ' ' A' ' 121' ' ' TYR . 73.1 t -117.9 136.36 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.158 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.9 148.24 34.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 22.8 m -93.66 140.62 29.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' THR . 73.2 t80 -115.22 131.54 56.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.942 . . . . 0.0 109.643 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.22 138.66 47.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -132.72 129.85 39.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 81.0 mt-10 -105.53 123.96 48.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.282 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -132.99 129.73 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 114' ' ' ILE . 27.6 p -97.39 140.25 32.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.5 p -138.88 172.13 13.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.687 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' ILE . 49.7 m-20 -76.18 -175.65 3.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mp 62.48 140.63 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.46 147.95 65.94 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.541 2.161 . . . . 0.0 111.949 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.92 -52.13 2.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 111.289 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.33 -50.05 3.04 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.076 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 14' ' ' ILE . 36.8 mttt -57.96 -39.62 78.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.881 -1.137 . . . . 0.0 109.585 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 23.7 tp -80.56 -27.71 37.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.76 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.835 ' HB2' HD12 ' A' ' 105' ' ' LEU . 60.4 t80 -61.31 -39.42 90.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 78.3 tttt -66.85 -55.24 15.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.88 0.27 16.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 109.817 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -97.01 -29.17 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.096 -1.003 . . . . 0.0 109.539 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.9 m -122.5 -38.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 23.6 tp -72.24 -38.52 68.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 72.7 m-20 -102.73 4.46 38.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -0.865 . . . . 0.0 109.545 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.891 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.85 -32.88 71.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 109.613 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.3 m-20 -57.68 -29.19 64.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.7 m-20 -116.5 -35.86 4.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 63.9 tp -62.79 -34.07 76.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.891 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.5 mt -57.63 -58.93 14.83 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.04 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -68.32 -9.86 27.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.627 2.218 . . . . 0.0 111.605 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 65.9 mttt -80.39 -38.06 31.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 147' ' ' LEU . 88.1 mt -77.95 -28.44 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.18 69.1 41.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.66 -29.56 24.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.752 2.302 . . . . 0.0 111.771 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -73.41 -26.81 61.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.35 -49.59 73.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.7 m -126.54 156.11 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 109.4 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -71.87 -46.14 58.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.12 134.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.76 129.14 35.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -122.53 144.12 49.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 58.8 mt -106.06 120.28 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -68.59 -44.28 74.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.823 ' O ' HG23 ' A' ' 53' ' ' THR . 91.6 mt-10 -158.16 157.26 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.31 -40.85 2.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 56.95 33.4 23.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.9 26.02 30.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.0 -164.44 15.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.3 126.0 12.48 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.674 2.249 . . . . 0.0 111.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.9 36.43 41.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 46' ' ' GLU . 39.8 m -89.12 142.23 27.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -1.162 . . . . 0.0 109.365 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -112.75 124.81 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' HG12 ' A' ' 44' ' ' ILE . 71.2 mttt -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HB2' HD11 ' A' ' 45' ' ' LEU . 47.7 tttm -133.86 121.85 22.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 70' ' ' HIS . 21.5 mt -116.75 135.47 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.66 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -119.77 139.24 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.376 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.773 ' HE1' HG23 ' A' ' 68' ' ' VAL . 93.0 m-85 -95.84 133.23 40.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.53 27.19 7.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -58.83 -31.47 68.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -1.181 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.22 -52.44 2.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.2 p -61.13 -32.12 71.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -133.92 146.23 50.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -118.0 136.34 53.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . 175.13 -179.25 46.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.1 p90 -160.31 146.08 15.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -1.154 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG23 ' HE1' ' A' ' 59' ' ' PHE . 44.0 t -121.18 140.32 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.892 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 32.3 mttt -115.49 144.72 43.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.46 ' CE1' HD12 ' A' ' 57' ' ' ILE . 75.9 m80 -124.77 135.66 53.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HB2' HD11 ' A' ' 87' ' ' ILE . 53.8 tttp -118.12 141.11 48.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.9 mt -102.88 138.07 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -93.19 -47.52 6.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.434 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 p -172.06 153.72 3.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 82' ' ' TYR . 31.8 pt -127.96 145.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.407 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -126.57 92.43 3.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -62.45 -35.0 77.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.397 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -71.84 -41.47 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -86.49 5.29 36.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.2 m80 46.69 40.76 9.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 m -124.16 136.5 54.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 82.5 t80 -123.93 125.48 44.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.306 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -117.08 132.38 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.619 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.6 p90 -153.59 168.83 24.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -146.83 152.44 38.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.8 tt -91.89 134.71 34.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.94 ' N ' HD23 ' A' ' 86' ' ' LEU . 93.8 mt -89.8 -70.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.907 . . . . 0.0 109.599 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.775 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.3 mt-10 -125.43 161.23 27.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -179.83 156.29 17.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' OD1' ' HA3' ' A' ' 66' ' ' GLY . 85.0 m-20 -58.7 -32.4 69.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -1.164 . . . . 0.0 109.432 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.83 -16.43 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.933 HD21 HD22 ' A' ' 86' ' ' LEU . 7.6 mp -86.01 -30.61 22.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 p 59.72 -177.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.95 16.76 13.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.272 -0.892 . . . . 0.0 109.184 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.855 ' O ' HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -119.44 -20.87 7.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 109.368 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.469 ' CD1' HD12 ' A' ' 129' ' ' ILE . 9.8 mt -96.05 142.44 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -87.91 179.97 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 41.6 mtmt -57.55 167.06 1.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 120' ' ' LYS . 74.9 mt -119.83 138.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -90.75 122.58 33.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 69.2 m-85 -116.13 138.7 51.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -134.17 137.18 44.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.24 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.559 HG21 ' CE2' ' A' ' 23' ' ' PHE . 44.7 m -131.2 131.47 44.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.622 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -129.24 133.49 47.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD12 ' HB2' ' A' ' 20' ' ' PHE . 17.7 mt -107.31 120.15 41.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.699 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 114' ' ' ILE . 22.6 t -131.94 138.54 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 22.9 m -114.48 151.66 32.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.98 172.01 3.88 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.03 -16.89 40.98 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.802 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.96 -16.49 63.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.345 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.04 -17.42 44.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.31 172.54 45.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 85.7 m -119.27 124.11 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -1.127 . . . . 0.0 109.365 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 11' ' ' THR . 70.8 mt -94.79 143.18 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.137 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.742 HG23 HD23 ' A' ' 105' ' ' LEU . 53.8 mt -132.64 132.35 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.951 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 47.8 mttp -107.09 135.32 48.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.7 m -125.47 130.5 51.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.964 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.558 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 29.1 m -123.6 143.42 50.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.948 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.2 t -138.77 140.72 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.0 109.997 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 99' ' ' ILE . 72.7 tttt -136.8 133.92 36.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.732 ' O ' HG11 ' A' ' 3' ' ' VAL . 31.8 m-85 -110.02 133.63 52.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.677 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.7 m80 -101.68 136.51 41.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.271 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 11.1 p -109.82 149.84 29.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 95' ' ' ASN . 3.7 mtpm? -54.09 -52.73 60.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -170.33 -73.03 0.04 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.6 p30 -107.93 -1.38 20.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -1.176 . . . . 0.0 109.801 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.855 HG21 ' O ' ' A' ' 95' ' ' ASN . 19.8 m -60.44 134.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.408 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.57 162.09 18.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.492 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 96' ' ' ILE . 16.7 tt -128.42 171.64 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.592 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 21.7 mttm -94.26 127.39 40.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -55.06 -39.54 69.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.58 -36.8 76.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.592 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 36.0 m80 -70.69 -41.37 72.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.481 HG12 ' HE3' ' A' ' 138' ' ' LYS . 57.8 t -66.57 -41.47 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -61.05 -39.27 89.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -62.75 -42.96 99.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.424 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.4 -44.09 98.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE3' HG12 ' A' ' 134' ' ' VAL . 92.8 mttt -63.34 -42.36 98.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.455 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.04 -42.13 97.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.375 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 31.3 mttt -61.05 -41.32 96.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -44.35 85.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 146' ' ' LYS . . . -71.02 -35.33 71.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.482 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.8 t60 -61.37 -47.13 87.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.1 mt -63.0 -42.13 99.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.384 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 148' ' ' ILE . 57.4 t80 -55.69 -42.04 74.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.361 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 142' ' ' ALA . 98.1 mttt -53.82 -38.09 64.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -67.21 -40.03 86.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 145' ' ' PHE . 87.9 mt -53.9 -51.15 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.43 -48.82 79.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.34 -33.03 86.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.62 -46.38 84.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -1.185 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 14' ' ' ILE . 71.5 mt -64.87 -42.21 95.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 109.365 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.46 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.67 -38.02 77.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -127.11 84.01 64.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 138.77 35.18 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.649 2.233 . . . . 0.0 111.859 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.4 p -75.13 158.0 33.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.273 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.64 155.12 26.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.605 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -56.22 -40.52 74.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.516 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 122' ' ' HIS . 70.6 t -121.37 136.09 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.588 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -111.48 135.62 51.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.916 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 33.2 m -101.87 132.91 47.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.14 132.65 56.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.92 141.51 39.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 65.3 t30 -126.58 131.05 51.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.574 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.01 141.91 46.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 83.2 t80 -162.97 143.71 9.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.448 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 8.7 p -102.42 144.63 30.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 115' ' ' ILE . 50.1 m -142.84 167.83 21.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.687 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.1 t0 -78.68 -175.97 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 66.49 140.7 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.345 -0.847 . . . . 0.0 109.276 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 49.6 Cg_endo -71.12 148.07 55.55 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.605 2.203 . . . . 0.0 112.203 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.79 -51.6 3.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.72 . . . . 0.0 111.388 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.25 -43.72 13.89 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.43 2.087 . . . . 0.0 113.046 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG22 ' A' ' 14' ' ' ILE . 74.9 mttt -64.01 -34.5 78.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.81 -1.181 . . . . 0.0 109.653 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.7 tt -80.64 -31.66 36.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.83 ' CE1' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -65.7 -35.85 81.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.845 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 47.0 mttp -64.52 -42.36 95.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -84.43 -32.18 24.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' A' ' 103' ' ' THR . 53.5 t80 -78.15 -8.02 57.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.83 HG21 ' CE1' ' A' ' 20' ' ' PHE . 63.0 t -123.98 -68.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 12.1 tp -57.23 -43.68 83.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 75.9 m-20 -95.05 12.87 27.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.868 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.67 -32.67 71.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 44' ' ' ILE . 97.3 m-20 -66.32 -34.75 78.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.1 t30 -100.06 -43.09 6.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD21 HG23 ' A' ' 148' ' ' ILE . 30.0 tp -53.79 -43.77 69.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.525 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 27' ' ' ALA . 10.8 mt -48.13 -63.35 1.56 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.37 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -68.74 -19.22 41.57 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.502 2.134 . . . . 0.0 111.779 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -66.67 -45.84 77.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.602 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.8 mt -72.27 -36.72 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.23 69.98 80.23 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 109.498 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.7 Cg_endo -70.84 -33.88 11.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.588 2.192 . . . . 0.0 111.639 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -75.4 -27.14 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.95 94.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.027 HG12 ' CE1' ' A' ' 59' ' ' PHE . 16.5 m -127.01 160.49 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 29.5 ttpt -72.25 -50.37 27.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.476 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.41 132.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.45 123.39 32.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -121.67 144.87 48.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 28' ' ' ASP . 61.2 mt -105.09 119.49 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 29.0 tp -64.99 -44.29 89.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 53' ' ' THR . 74.1 mm-40 -156.97 151.61 25.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.473 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 109.09 -42.88 1.84 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.2 m-20 61.9 38.85 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -1.146 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.779 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.75 35.11 17.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -118.6 -167.02 13.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.98 130.27 18.79 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.697 2.265 . . . . 0.0 111.813 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.29 24.61 76.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.79 145.16 32.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -1.155 . . . . 0.0 109.525 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.88 133.27 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.326 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 41.6 mttt -121.25 151.53 39.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -134.24 120.59 20.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.356 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 8.7 mt -117.87 134.25 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.587 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 40' ' ' LYS . 29.8 p -112.95 139.23 48.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.44 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.027 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.7 m-85 -107.73 143.18 36.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.35 36.98 0.93 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.55 -30.13 53.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 0.0 109.568 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.83 -80.09 0.35 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -59.61 -27.25 66.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -1.155 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -125.21 129.49 50.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -126.78 135.75 51.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 176.92 179.27 47.24 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 -154.09 144.05 21.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -1.176 . . . . 0.0 109.585 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -130.41 147.12 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 109.299 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' O ' HD12 ' A' ' 86' ' ' LEU . 30.8 mttt -109.82 146.36 35.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.647 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 86' ' ' LEU . 49.8 m80 -117.42 148.29 41.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.616 ' CB ' HD11 ' A' ' 87' ' ' ILE . 39.0 tttm -129.71 141.39 50.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.0 mt -100.09 135.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -88.95 -48.5 7.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 p -166.0 154.45 11.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 pt -128.54 145.2 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -130.63 92.17 3.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.01 -38.58 91.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.43 -42.35 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 71.9 m-20 -86.68 6.6 30.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 37.3 m80 45.63 46.39 11.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.933 . . . . 0.0 109.553 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.5 m -125.27 139.05 54.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 71.7 t80 -130.53 125.59 34.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.8 t -119.23 132.95 55.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 35.2 p90 -148.76 164.98 32.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.597 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 84.9 p -148.13 152.37 37.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.058 HD23 HD21 ' A' ' 92' ' ' LEU . 23.2 tp -87.41 137.51 32.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.596 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 71' ' ' LYS . 28.5 mm -94.31 -75.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.0 mt-10 -118.77 151.23 38.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.579 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.684 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -169.21 125.52 1.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 67.3 m-20 -48.97 -34.2 12.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 109.378 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.61 -16.5 63.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.333 -0.854 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.058 HD21 HD23 ' A' ' 86' ' ' LEU . 7.0 mp -86.47 -39.45 16.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 69.0 m 62.86 173.35 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.414 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 72.8 mm-40 -74.46 -11.31 60.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.617 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.47 ' O ' HG21 ' A' ' 127' ' ' VAL . 31.1 m-20 -80.97 -29.42 35.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 28.8 mt -104.54 120.13 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.7 mm-40 -75.84 -178.92 4.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.358 -0.839 . . . . 0.0 109.242 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.494 ' HE2' HG23 ' A' ' 87' ' ' ILE . 36.2 mttp -56.69 166.33 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.47 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 120' ' ' LYS . 62.0 mt -126.51 133.54 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 109.659 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 120' ' ' LYS . 90.7 m-20 -91.81 126.61 36.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.5 m-85 -116.63 138.16 51.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.331 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 117' ' ' THR . 94.3 mt-10 -128.05 135.2 49.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.621 HG21 ' CE1' ' A' ' 23' ' ' PHE . 40.5 m -129.7 131.74 46.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.367 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -139.45 124.7 18.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -95.52 132.19 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.3 t -128.96 139.44 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -112.65 145.0 41.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -107.93 167.14 9.73 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.53 -9.23 25.41 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.696 2.264 . . . . 0.0 111.77 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -78.21 -15.21 59.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.18 -21.27 29.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.34 169.12 50.99 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.4 m -124.45 126.21 45.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -1.193 . . . . 0.0 109.611 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 65.7 mt -97.6 142.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.266 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.844 HG23 HD13 ' A' ' 105' ' ' LEU . 2.6 mp -125.73 125.55 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.682 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 28.0 mttt -115.03 139.08 50.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.121 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 102' ' ' GLU . 91.4 m -132.06 135.65 46.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.878 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.576 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 40.8 m -124.52 138.32 54.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.367 -0.833 . . . . 0.0 108.958 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -131.53 155.75 46.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.024 . . . . 0.0 110.041 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.0 mttt -138.06 138.49 38.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 3' ' ' VAL . 32.7 m-85 -116.57 128.77 55.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 109.623 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.723 ' HA ' HG22 ' A' ' 3' ' ' VAL . 76.2 m80 -99.68 150.54 22.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.269 -0.894 . . . . 0.0 109.432 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.018 ' HB ' HG23 ' A' ' 127' ' ' VAL . 5.8 p -126.01 161.06 28.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.456 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 13.3 mtmt -56.83 -35.91 69.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 165.42 -64.69 0.22 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 57.9 t0 -97.92 -22.31 16.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -1.151 . . . . 0.0 109.715 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.018 HG23 ' HB ' ' A' ' 123' ' ' THR . 6.1 m -59.43 112.48 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 109.505 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 98.6 mt-10 -114.65 174.85 5.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.394 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.793 HD11 ' HD2' ' A' ' 133' ' ' HIS . 16.7 tt -127.88 171.4 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -98.51 133.16 43.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.78 -39.97 65.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.895 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.33 -38.33 76.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.549 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.793 ' HD2' HD11 ' A' ' 129' ' ' ILE . 84.0 t60 -68.68 -42.24 78.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.44 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.78 -43.0 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 109.41 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 23.8 tptm -56.12 -41.6 75.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.64 -46.94 77.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.35 96.46 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.1 tttp -59.84 -43.16 94.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -1.135 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 135' ' ' LYS . 76.3 mm-40 -60.46 -43.22 97.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -55.66 -46.1 77.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.28 -45.28 81.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.346 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.92 85.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.389 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -58.26 -47.21 84.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 144' ' ' LEU . 45.0 mt -62.55 -43.02 99.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 67.0 t80 -54.84 -47.09 74.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.426 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -52.15 -40.4 61.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 147' ' ' LEU . 59.6 mt -63.78 -38.14 90.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.753 HG23 HD21 ' A' ' 30' ' ' LEU . 82.4 mt -55.3 -49.46 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.548 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 13' ' ' ASP . 86.2 tt0 -59.53 -48.44 81.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.91 92.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 59.1 t80 -57.53 -43.18 84.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 14' ' ' ILE . 72.8 mt -68.8 -32.17 71.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -70.05 -37.68 75.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 39.8 p30 -100.21 7.6 44.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.507 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 3.3 p-80 -51.13 121.76 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.537 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.09 -25.53 26.96 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.661 2.241 . . . . 0.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.6 t -129.36 141.81 50.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.8 -33.27 70.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.415 ' O ' ' OD1' ' A' ' 160' ' ' ASN . 93.4 m-85 -114.79 136.65 52.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 159' ' ' TYR . 88.2 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.986 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.8 p -113.26 139.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -1.228 . . . . 0.0 109.527 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 5' ' ' THR . 74.4 t80 -110.16 145.97 36.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.548 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 68.5 m -93.73 143.73 26.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -127.52 141.45 51.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.0 109.68 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 84.3 tt0 -112.49 133.01 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -117.92 134.49 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -103.16 109.91 21.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.8 t80 -117.59 131.35 56.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.678 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.564 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 18.7 p -91.81 155.83 17.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.238 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 115' ' ' ILE . 59.7 p -153.61 171.94 17.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.108 -0.995 . . . . 0.0 109.779 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -80.16 -175.43 5.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.41 -0.807 . . . . 0.0 109.424 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 15' ' ' PRO . 4.2 mm 61.74 141.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.952 . . . . 0.0 109.239 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 14' ' ' ILE . 49.0 Cg_endo -70.65 146.27 54.21 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.492 2.128 . . . . 0.0 112.001 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -37.82 -51.7 2.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.655 -0.653 . . . . 0.0 111.348 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.18 -50.02 3.2 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.232 1.954 . . . . 0.0 113.123 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 79.3 mttt -61.48 -38.28 86.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.161 . . . . 0.0 109.686 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.81 -25.61 37.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.71 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 63.8 t80 -66.98 -31.69 72.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 77.1 mttt -72.09 -47.53 50.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.0 60.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.795 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.0 t80 -79.36 -16.82 55.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.402 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 67.6 t -114.12 -60.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 35.8 mt -59.41 -44.48 92.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 109.213 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 69.7 m-20 -100.99 24.4 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.331 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.003 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.22 -37.43 78.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -70.4 -33.13 71.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -94.17 -30.44 14.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.493 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.546 HD21 HG23 ' A' ' 148' ' ' ILE . 30.1 tp -64.14 -43.68 94.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' O ' ' A' ' 27' ' ' ALA . 3.8 mt -50.2 -59.79 6.44 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 50.2 Cg_endo -68.9 -16.31 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.549 2.166 . . . . 0.0 111.84 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.6 tptp -69.05 -40.29 78.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.512 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.612 HG23 HD13 ' A' ' 147' ' ' LEU . 59.1 mt -67.44 -33.44 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.52 71.27 14.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.3 Cg_endo -69.86 -30.92 21.05 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.613 2.208 . . . . 0.0 111.502 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.58 -23.57 64.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.205 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 -24.81 23.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.331 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 59' ' ' PHE . 3.1 t -113.74 133.93 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.345 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -71.92 -50.83 25.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.71 130.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.03 124.81 38.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.27 146.62 46.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.36 -0.837 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 57.5 mt -104.77 117.81 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.9 mp -63.39 -44.64 94.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.388 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.906 ' O ' HG23 ' A' ' 53' ' ' THR . 89.9 mt-10 -159.14 155.28 26.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.5 -41.63 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.8 m-20 61.53 35.27 17.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -1.125 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.822 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.54 34.11 10.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.93 -162.69 11.79 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.17 130.64 19.17 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.699 2.266 . . . . 0.0 111.833 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . 69.31 30.26 71.6 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.906 HG23 ' O ' ' A' ' 46' ' ' GLU . 74.4 m -85.86 143.28 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.436 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.4 mm -110.97 132.16 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 72' ' ' ILE . 79.0 mttt -122.83 146.46 47.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -127.71 120.45 28.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.268 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 11.6 mt -117.38 127.49 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -108.6 127.86 54.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.597 ' HE1' HG22 ' A' ' 39' ' ' VAL . 85.1 m-85 -107.06 141.25 38.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.554 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.81 131.5 5.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.09 -38.36 62.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -1.118 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.99 -163.04 20.6 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 89.0 p -125.41 154.8 41.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -1.135 . . . . 0.0 109.495 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' A' ' 63' ' ' SER . 0.2 OUTLIER 69.36 9.43 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 65' ' ' TYR . 44.7 t80 -80.84 -17.71 49.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.541 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . 155.5 131.19 1.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 44.1 p90 -154.63 144.17 21.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.4 m -121.92 147.98 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.339 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 45.9 mttt -108.01 141.21 40.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 68' ' ' VAL . 73.8 m80 -119.85 133.24 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.85 . . . . 0.0 109.148 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' A' ' 87' ' ' ILE . 21.1 tttt -116.0 139.69 50.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 63.9 mt -98.17 136.26 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 89.0 m-70 -90.09 -47.73 7.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.7 t -170.3 158.6 6.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.09 145.06 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.59 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.5 m-20 -124.94 92.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.473 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -65.34 -38.47 90.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.369 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -68.59 -42.5 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 74.1 m-20 -86.87 8.36 23.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.464 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.7 m80 45.76 41.66 7.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.3 m -121.74 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 67.4 t80 -130.78 122.99 28.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.444 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -117.27 134.02 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.9 . . . . 0.0 109.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 33.9 p90 -151.12 161.79 42.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 93.4 p -139.16 158.32 44.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 87' ' ' ILE . 6.5 tt -98.62 125.1 43.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.802 HG22 ' HG3' ' A' ' 88' ' ' GLU . 31.0 mm -73.7 -68.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.4 mt-10 -140.92 146.44 37.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.657 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -153.24 160.49 29.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 68' ' ' VAL . 67.0 m-20 -60.65 -31.07 70.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.482 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 -27.84 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.36 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' ILE . 5.7 mp -77.28 -39.74 47.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.88 . . . . 0.0 109.387 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 30.6 m 59.52 169.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.31 -8.16 54.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.537 ' HB3' HG23 ' A' ' 127' ' ' VAL . 61.2 m-20 -83.93 -27.97 28.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 92' ' ' LEU . 18.7 mt -99.73 146.3 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -90.35 179.9 5.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 109.609 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.68 ' HE2' HG23 ' A' ' 87' ' ' ILE . 37.8 mttt -57.55 162.35 3.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 120' ' ' LYS . 40.5 mt -118.56 141.04 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.704 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 59.0 t0 -97.74 119.86 37.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 95.4 m-85 -113.59 144.87 42.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 91.5 mt-10 -138.67 134.13 33.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.308 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.3 m -126.84 132.86 50.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.563 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 105' ' ' LEU . 34.2 tttt -130.21 132.9 46.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.29 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -106.67 115.22 29.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 23.5 t -131.58 145.33 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 3.2 m -114.43 153.47 29.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.42 167.6 8.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.353 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.27 -7.8 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.626 2.217 . . . . 0.0 111.811 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -76.74 -13.98 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.57 -16.34 44.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.32 172.16 41.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 94.8 m -116.05 124.97 51.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.444 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 59.8 mt -96.42 127.54 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.252 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 HD13 ' A' ' 105' ' ' LEU . 51.3 mt -113.35 126.77 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 109.768 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 18.1 mttp -103.49 129.35 50.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 108.97 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -129.23 124.78 35.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.155 -0.966 . . . . 0.0 110.096 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 23.4 m -106.6 142.96 35.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 108.964 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -129.12 143.06 50.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 109.913 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 99' ' ' ILE . 24.4 tttt -149.31 119.73 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 109.082 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.986 ' O ' HG21 ' A' ' 3' ' ' VAL . 22.0 m-85 -107.99 133.11 52.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 75.3 m80 -96.47 143.57 27.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 109.273 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.415 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 27.7 p -109.91 152.48 25.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.763 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 2.8 tttt -62.49 -66.14 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 109.339 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -168.08 -42.51 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 55.0 p30 -133.41 2.13 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 0.0 109.363 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 128' ' ' GLU . 5.5 p -43.36 -45.82 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.358 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.555 ' N ' HG13 ' A' ' 127' ' ' VAL . 95.9 mt-10 61.29 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.52 172.4 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.326 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 52.1 tttp -104.06 125.99 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.55 -38.08 63.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.8 -35.23 79.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 61.9 m170 -69.51 -40.27 77.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.498 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.8 t -68.06 -43.24 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -62.15 -38.51 89.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.24 98.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.57 -39.82 98.35 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -63.21 -46.21 88.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -1.109 . . . . 0.0 109.439 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -62.72 -44.69 95.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 109.45 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -52.93 -45.92 67.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -46.23 90.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.3 -30.54 64.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.336 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -74.21 -31.69 62.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.39 -43.73 80.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.404 ' HA ' HD12 ' A' ' 148' ' ' ILE . 77.4 m-85 -54.66 -39.47 68.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.56 -41.71 86.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 109.422 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.612 HD13 HG23 ' A' ' 34' ' ' ILE . 43.5 mt -67.3 -39.24 85.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.546 HG23 HD21 ' A' ' 30' ' ' LEU . 65.5 mt -54.18 -46.32 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 12' ' ' SER . 42.3 mm-40 -68.89 -40.38 79.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.93 -55.18 27.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -54.85 -56.18 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 109.507 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 44.0 mt -58.7 -40.54 83.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.87 -48.14 70.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.418 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -57.36 -58.86 6.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.403 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 50.1 68.71 3.18 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.36 128.62 15.73 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.803 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.4 t -49.94 -37.33 31.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.52 161.49 24.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 109.402 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -60.38 -32.26 71.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.478 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 121' ' ' TYR . 70.2 t -116.1 136.13 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.479 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.24 136.75 52.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.945 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 30.3 m -101.43 135.95 42.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.421 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' THR . 91.5 m-85 -118.82 139.16 52.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.75 135.48 53.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.78 134.18 55.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 94.8 mt-10 -113.96 126.91 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 11' ' ' THR . 65.6 t80 -143.08 136.62 28.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 109.471 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 11.7 p -103.44 152.23 21.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 109.421 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -154.23 171.1 19.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' HD12 ' A' ' 14' ' ' ILE . 31.9 t0 -71.79 177.52 4.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.2 mt 69.6 135.77 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.404 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.2 Cg_endo -69.7 150.11 68.15 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.535 2.156 . . . . 0.0 111.96 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.926 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -38.64 -52.27 3.55 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -64.5 -50.5 2.53 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.425 2.083 . . . . 0.0 113.041 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 94.8 mttt -59.62 -35.56 74.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.801 -1.187 . . . . 0.0 109.485 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 18.7 tp -80.37 -33.39 37.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.937 . . . . 0.0 109.372 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 24' ' ' VAL . 72.8 t80 -56.52 -43.43 79.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 98.5 mttt -58.68 -61.09 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 109.646 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -68.59 -7.11 29.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.905 . . . . 0.0 109.611 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 103' ' ' THR . 83.1 t80 -84.02 -32.97 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.667 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 82' ' ' TYR . 24.9 m -127.73 -33.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.757 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.8 tp -60.95 -65.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.66 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' CG ' ' HA ' ' A' ' 22' ' ' ALA . 33.5 p30 -93.98 18.95 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.09 -35.27 76.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.126 -0.984 . . . . 0.0 109.503 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.5 -42.39 67.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.5 t-20 -97.61 -34.2 11.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.586 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.923 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.6 tm? -69.38 -39.3 78.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.539 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 30.7 mt -51.1 -56.32 20.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.9 Cg_endo -69.02 -21.66 36.61 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.524 2.15 . . . . 0.0 111.764 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -66.1 -37.28 85.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.526 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' CE2' ' A' ' 151' ' ' TYR . 73.3 mt -68.53 -27.16 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.22 69.99 10.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -70.48 -31.61 17.03 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.04 -28.36 60.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.15 -44.11 76.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 57' ' ' ILE . 4.7 p -125.02 154.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -77.33 -47.77 19.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.962 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.15 141.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.529 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.58 119.52 30.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.22 140.67 37.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.441 HG12 ' HG2' ' A' ' 55' ' ' LYS . 60.2 mt -106.49 117.55 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -64.28 -45.76 86.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 53' ' ' THR . 67.3 mm-40 -157.72 155.22 29.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.4 -42.4 1.93 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 85.4 m-20 60.3 36.06 20.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.778 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.08 32.88 11.53 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.27 -166.34 13.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.85 132.65 23.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.693 2.262 . . . . 0.0 111.656 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.13 29.39 73.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.8 m -84.72 144.52 28.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.136 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 45' ' ' LEU . 60.1 mt -110.51 128.52 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG2' HG12 ' A' ' 44' ' ' ILE . 31.5 mttt -116.57 149.33 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.2 tttt -129.88 121.21 26.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.879 HG23 HG21 ' A' ' 39' ' ' VAL . 44.9 mt -110.81 134.49 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -119.24 123.13 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HE2' HG23 ' A' ' 68' ' ' VAL . 95.7 m-85 -92.55 138.02 31.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.9 . . . . 0.0 109.558 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.98 -165.91 41.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.93 135.95 57.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 65' ' ' TYR . . . -179.31 -164.05 31.23 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.7 m -66.02 -24.58 66.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -128.22 139.13 52.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.38 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 62' ' ' GLY . 58.3 m-85 -119.29 135.79 54.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 151.39 -166.93 30.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 37.1 p90 -147.32 147.92 30.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 109.445 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 89' ' ' GLY . 48.8 t -123.51 149.88 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 51.4 mtpt -123.6 143.57 50.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.519 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 66.6 m-70 -122.58 141.67 51.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.613 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HB2' HD11 ' A' ' 87' ' ' ILE . 82.8 tttt -123.25 139.13 54.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 54.1 mt -97.76 134.18 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 88.9 m-70 -89.48 -47.6 7.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 p -170.65 153.79 4.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.15 143.79 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.399 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.48 93.03 3.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -63.15 -35.6 80.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.38 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.91 -40.61 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.434 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -87.44 1.83 52.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 43.4 m80 50.66 40.51 24.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.5 m -123.02 138.49 54.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.644 ' CD1' HG11 ' A' ' 24' ' ' VAL . 80.3 t80 -127.22 125.94 41.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -117.57 134.37 54.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 109.694 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 29.9 p90 -148.46 167.74 24.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.326 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 97.1 p -144.23 159.01 43.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.948 ' CD2' HD11 ' A' ' 92' ' ' LEU . 4.5 tt -98.99 133.37 43.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.93 ' N ' HD23 ' A' ' 86' ' ' LEU . 75.8 mt -94.69 -74.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.7 mt-10 -116.08 157.96 23.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 174.82 155.65 12.77 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.432 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 64.3 m-20 -62.37 -29.6 70.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -1.151 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.732 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -69.5 -32.1 70.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.948 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.7 mt -74.27 -32.94 63.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.037 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.65 -177.56 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.537 -0.727 . . . . 0.0 109.287 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -88.47 18.56 4.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.568 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.523 ' O ' HG21 ' A' ' 127' ' ' VAL . 14.1 m120 -125.64 -9.59 6.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.869 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 91' ' ' ALA . 14.2 mt -108.55 145.43 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.055 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 88.3 mt-10 -90.04 -179.83 5.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.656 ' HE2' HG23 ' A' ' 87' ' ' ILE . 49.1 mttt -57.53 166.28 1.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.606 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 120' ' ' LYS . 81.7 mt -125.49 134.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 25.1 t70 -92.25 126.26 37.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 76.0 m-85 -118.72 140.45 49.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.496 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.36 137.52 47.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 23' ' ' PHE . 45.3 m -127.45 133.54 49.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -131.11 132.14 44.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -107.72 124.07 49.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.5 143.48 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.0 p -108.44 148.04 30.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.79 166.74 10.28 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.5 Cg_endo -69.38 -19.35 38.07 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.741 2.294 . . . . 0.0 111.822 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.57 -17.65 64.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.386 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.75 -23.89 18.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.7 179.75 52.14 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 63.8 m -126.62 126.37 43.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -1.185 . . . . 0.0 109.648 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.2 mt -92.91 140.67 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 105' ' ' LEU . 62.7 mt -127.83 124.15 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 49.7 mttt -105.62 136.31 45.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.3 m -128.58 126.43 40.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 18.4 m -120.04 138.27 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 108.812 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -137.22 147.02 45.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.231 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.69 ' O ' HG23 ' A' ' 99' ' ' ILE . 91.2 mttt -129.81 144.08 51.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' VAL . 55.2 m-85 -119.42 129.02 54.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.671 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 77.5 m80 -96.66 141.96 29.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 109.384 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.496 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 80.7 p -106.08 145.05 31.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 40.5 mttt -67.8 -42.89 80.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.03 -75.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -104.23 7.16 35.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.133 . . . . 0.0 109.532 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 95' ' ' ASN . 14.0 p -64.7 132.28 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -129.02 151.08 50.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 0.0 109.499 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.855 HD11 ' HD2' ' A' ' 133' ' ' HIS . 14.6 tt -129.41 171.56 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -102.26 133.9 46.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -53.28 -39.8 64.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 73.6 mm-40 -60.43 -38.01 82.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.855 ' HD2' HD11 ' A' ' 129' ' ' ILE . 85.6 t60 -67.53 -42.18 83.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 109.43 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.0 -45.11 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.418 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -56.58 -40.38 75.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.1 -41.67 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.76 -41.41 95.91 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -62.54 -42.24 99.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -1.145 . . . . 0.0 109.392 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.78 -42.83 94.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 32.7 tttm -56.4 -46.11 80.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.42 68.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.71 75.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.41 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 85.1 t60 -60.63 -43.65 97.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 73.6 mt -56.08 -46.13 79.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -54.81 -33.15 61.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -66.53 -39.77 88.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -64.31 -45.06 89.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.381 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.04 -55.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -54.67 -35.95 64.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.95 -29.8 66.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CE2' HG12 ' A' ' 34' ' ' ILE . 8.7 m-30 -69.45 -45.4 69.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -1.108 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp -75.05 -50.42 16.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -53.39 -35.84 60.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.096 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -79.86 -33.37 40.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.318 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.79 66.4 4.52 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.98 -12.37 32.35 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.726 2.284 . . . . 0.0 111.671 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 99.8 p -118.28 151.66 37.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -57.69 144.28 38.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 160' ' ' ASN . 36.4 p90 -65.03 -32.73 74.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.464 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' TYR . 77.3 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 122' ' ' HIS . 32.6 t -118.17 139.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -1.172 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -117.93 155.9 29.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.667 HG22 ' CG2' ' A' ' 118' ' ' THR . 10.6 m -93.84 138.83 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 118' ' ' THR . 94.2 m-85 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -114.98 135.84 53.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -120.83 132.51 55.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.582 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -107.63 129.14 55.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.538 ' CE2' ' O ' ' A' ' 11' ' ' THR . 74.9 t80 -143.19 141.71 31.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.4 p -107.93 148.58 29.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.467 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.6 p -149.29 170.8 17.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.979 . . . . 0.0 109.527 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.727 ' O ' HD12 ' A' ' 14' ' ' ILE . 14.0 t0 -80.28 -175.86 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.459 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 67.79 140.24 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -70.21 149.6 64.27 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.213 . . . . 0.0 111.911 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.73 -52.19 3.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.4 Cg_endo -64.2 -50.34 2.91 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.461 2.107 . . . . 0.0 112.915 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB2' HG22 ' A' ' 14' ' ' ILE . 67.5 mttm -58.91 -34.87 72.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.875 -1.14 . . . . 0.0 109.546 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD12 HD11 ' A' ' 152' ' ' LEU . 8.5 tp -81.06 -28.9 35.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.728 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 56.9 t80 -68.76 -33.3 73.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 17.8 tttp -67.14 -45.35 77.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.12 -25.58 36.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.745 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 52.0 t80 -83.79 -15.6 47.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.935 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.6 t -117.81 -67.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 28.5 tp -55.82 -41.71 74.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.432 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.4 m-20 -97.78 14.72 25.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.864 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -68.64 -37.11 79.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.84 -40.75 89.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.7 m120 -94.4 -31.56 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.84 HD21 HD12 ' A' ' 148' ' ' ILE . 38.9 tp -66.44 -42.25 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 27' ' ' ALA . 6.6 mt -49.99 -57.97 10.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.442 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.68 -22.39 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.485 2.123 . . . . 0.0 111.742 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 11.3 tptt -68.5 -42.01 79.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.79 HD12 ' CB ' ' A' ' 147' ' ' LEU . 23.8 mm -61.36 -24.99 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.86 75.06 3.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.7 -32.99 17.74 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.635 2.223 . . . . 0.0 111.645 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -21.77 61.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.62 -41.92 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.937 . . . . 0.0 109.419 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.765 HG12 ' CE2' ' A' ' 59' ' ' PHE . 21.7 m -126.84 148.24 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.402 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.529 ' HE2' ' CG2' ' A' ' 58' ' ' THR . 11.1 mtmt -72.4 -51.62 19.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.94 129.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.61 124.49 29.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -117.59 146.41 43.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 62.6 mt -104.19 126.83 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 45' ' ' LEU . 4.0 mm? -71.1 -41.47 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.38 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.96 ' O ' HG23 ' A' ' 53' ' ' THR . 90.7 mt-10 -159.26 151.16 20.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 107.68 -42.92 1.81 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 t0 64.17 39.63 7.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 0.0 109.569 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.776 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.25 37.02 13.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.86 -165.99 13.13 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.09 132.69 23.31 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.702 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 65.43 28.46 73.6 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 46' ' ' GLU . 84.6 m -82.84 144.13 30.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -1.102 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 59.5 mt -105.12 126.09 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 mtpt -115.09 152.98 31.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -135.71 124.77 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' CD2' ' A' ' 70' ' ' HIS . 13.6 mt -113.03 131.75 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.529 ' CG2' ' HE2' ' A' ' 40' ' ' LYS . 75.0 m -109.47 120.62 43.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.765 ' CE2' HG12 ' A' ' 39' ' ' VAL . 90.1 m-85 -92.53 135.74 33.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.67 -176.42 36.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 22.0 pt-20 -52.02 125.02 14.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -1.188 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.565 ' O ' ' CZ ' ' A' ' 65' ' ' TYR . . . 167.58 -156.98 29.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -70.71 -12.54 61.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -1.187 . . . . 0.0 109.442 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -114.3 138.64 50.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.44 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 62' ' ' GLY . 91.6 m-85 -130.69 150.27 51.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.92 -166.5 41.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 46.0 p90 -139.07 150.15 45.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 109.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.857 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.3 m -126.6 147.09 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 88' ' ' GLU . 70.2 mttt -109.54 147.23 33.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.559 ' CD2' HD12 ' A' ' 57' ' ' ILE . 48.1 m-70 -125.21 140.1 53.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 87' ' ' ILE . 23.9 tttt -114.96 140.87 48.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.945 HD12 ' HB ' ' A' ' 53' ' ' THR . 65.3 mt -98.18 135.27 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.6 m-70 -89.35 -47.21 8.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -175.09 155.49 1.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.402 HG22 ' CE1' ' A' ' 82' ' ' TYR . 35.0 pt -131.05 144.69 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.423 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -127.26 93.11 3.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -62.99 -35.94 81.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -72.32 -39.91 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.337 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 80' ' ' HIS . 74.7 m-20 -89.3 7.4 35.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.478 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 79' ' ' ASN . 37.4 m80 44.28 48.83 7.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -129.91 129.7 44.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.543 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 75' ' ' ILE . 52.6 t80 -122.19 129.93 52.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -0.843 . . . . 0.0 109.255 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p -124.61 134.62 52.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 35.2 p90 -151.39 164.86 35.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.275 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 77.4 p -142.44 162.44 35.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.686 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 87' ' ' ILE . 4.6 tt -101.98 131.49 48.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.507 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.937 ' N ' HD23 ' A' ' 86' ' ' LEU . 80.3 mt -91.98 -76.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.434 -0.791 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.785 ' HG3' HG22 ' A' ' 87' ' ' ILE . 89.0 mt-10 -118.96 147.08 44.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.425 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.857 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -166.33 146.44 10.96 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 65' ' ' TYR . 4.1 t0 -49.2 -46.54 45.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -1.153 . . . . 0.0 109.438 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.94 -22.83 65.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.8 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.0 mp -86.77 -37.87 17.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 4.3 m 58.03 157.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 95.2 mt-10 -64.96 -9.17 19.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 109.76 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.978 ' HB3' HG11 ' A' ' 127' ' ' VAL . 23.1 m120 -77.41 -35.05 54.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 110.098 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.666 ' CD1' HD12 ' A' ' 129' ' ' ILE . 9.0 pt -152.1 106.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 110.189 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 93' ' ' SER . 15.7 mt-10 -135.13 107.49 7.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.137 -0.977 . . . . 0.0 109.184 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 122' ' ' HIS . 15.8 tttt -179.11 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.663 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 14.1 mt -125.99 123.64 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.081 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 54.2 t0 -104.48 113.15 26.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.434 -0.791 . . . . 0.0 108.905 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 73.5 m-85 -103.47 143.07 33.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.98 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -134.7 132.26 38.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.087 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.579 HG21 ' CE1' ' A' ' 23' ' ' PHE . 41.3 m -123.26 135.26 54.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -141.23 125.61 17.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 20' ' ' PHE . 22.1 mt -98.51 130.46 45.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.637 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.3 t -131.9 145.2 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 109.422 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.3 p -113.95 142.56 45.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.36 167.55 9.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.81 -14.64 36.2 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.698 2.265 . . . . 0.0 111.843 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -71.2 -16.75 62.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.02 -16.81 38.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.31 173.21 47.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.4 m -119.32 122.28 41.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -1.131 . . . . 0.0 109.53 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.1 mt -92.57 134.04 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.699 HG23 HD23 ' A' ' 105' ' ' LEU . 25.3 mt -117.9 130.92 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -111.42 129.44 56.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.321 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.3 m -125.26 128.83 48.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.67 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.667 ' CG2' HG22 ' A' ' 5' ' ' THR . 38.9 m -115.25 135.85 53.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.35 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -123.26 140.13 53.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.696 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 10.9 ttpt -125.95 139.33 53.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.759 ' CD2' HG13 ' A' ' 134' ' ' VAL . 69.8 m-85 -122.44 135.6 54.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.927 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 3' ' ' VAL . 1.4 m80 -125.45 -167.11 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.3 p -135.33 152.53 51.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' ASN . 19.6 tptm -59.38 -53.61 56.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -168.74 -70.4 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.58 4.47 18.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -1.181 . . . . 0.0 109.967 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.978 HG11 ' HB3' ' A' ' 95' ' ' ASN . 43.1 t -95.34 115.76 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -96.11 170.58 9.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.593 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' A' ' 96' ' ' ILE . 16.2 tt -134.62 171.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 133' ' ' HIS . 23.1 mtpt -97.01 136.79 37.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.56 -33.76 70.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.65 -36.47 82.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CD2' ' HB2' ' A' ' 130' ' ' LYS . 36.3 m-70 -74.29 -39.25 63.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.377 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.759 HG13 ' CD2' ' A' ' 121' ' ' TYR . 58.5 t -67.44 -42.07 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.422 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -58.41 -40.67 83.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.68 -44.01 72.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.42 -42.76 95.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -57.9 -44.05 86.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 109.403 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 48.0 mttp -53.54 -44.59 69.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.06 79.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.05 84.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.513 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.514 ' CE1' HD21 ' A' ' 147' ' ' LEU . 58.4 t-80 -60.03 -44.16 94.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.1 mt -59.13 -43.08 91.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -54.2 -38.26 65.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -61.3 -38.55 87.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' A' ' 34' ' ' ILE . 3.2 mm? -69.83 -29.75 67.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.84 HD12 HD21 ' A' ' 30' ' ' LEU . 34.0 mm -60.93 -44.19 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.36 -47.28 67.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.16 -30.96 71.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.594 ' CE1' ' HG2' ' A' ' 33' ' ' LYS . 61.4 t80 -63.46 -49.04 75.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.829 HD12 HD13 ' A' ' 14' ' ' ILE . 59.6 mt -61.46 -43.6 98.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -60.9 -42.63 98.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -62.11 -39.54 92.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.421 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.97 160.03 41.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.04 161.35 46.28 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.634 2.222 . . . . 0.0 111.844 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.1 m -53.31 -32.94 51.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.408 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -87.09 139.41 30.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -107.03 135.0 49.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.538 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 ' O ' ' A' ' 121' ' ' TYR . 11.7 p -118.32 143.66 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -112.13 144.68 41.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 40.5 m -93.76 141.25 28.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -117.51 132.09 56.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.59 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -108.79 137.28 46.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -118.56 154.16 33.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 114' ' ' ILE . 70.4 tt0 -133.96 109.87 9.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 43.0 t80 -122.66 128.78 51.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 21.1 p -92.32 149.47 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.296 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.3 p -146.18 166.73 25.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -0.949 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 14' ' ' ILE . 99.3 m-20 -73.17 -175.7 1.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.243 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp 65.41 142.48 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.107 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.7 Cg_endo -69.0 146.37 64.62 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.414 2.076 . . . . 0.0 112.041 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -45.13 -48.12 32.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 111.401 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.72 -40.11 30.99 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.231 1.954 . . . . 0.0 113.094 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.556 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 29.7 mttm -67.97 -37.44 81.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -80.57 -28.0 37.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.721 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.549 ' HD1' HD23 ' A' ' 105' ' ' LEU . 68.7 t80 -65.91 -33.83 76.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.132 -0.98 . . . . 0.0 109.821 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.891 ' HG3' HD12 ' A' ' 25' ' ' LEU . 73.5 tttt -66.75 -46.25 75.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.614 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.81 -22.06 40.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.698 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.798 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 65.4 t80 -80.52 -19.98 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.549 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 77.2 t -117.15 -63.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.891 HD12 ' HG3' ' A' ' 21' ' ' LYS . 32.4 mt -56.88 -40.74 76.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.302 -0.874 . . . . 0.0 109.581 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.9 m-20 -100.34 15.29 28.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.78 -41.57 74.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.685 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.708 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.4 m-20 -66.07 -30.36 70.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.714 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 94.1 m-20 -97.33 -32.18 12.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.948 . . . . 0.0 109.589 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 28.4 tp -69.9 -46.5 65.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.941 HD12 ' O ' ' A' ' 27' ' ' ALA . 5.7 mt -47.0 -57.36 9.37 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.2 Cg_endo -68.73 -25.77 33.43 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.52 2.146 . . . . 0.0 111.867 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 60.7 tttt -75.51 -44.25 44.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.561 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' A' ' 147' ' ' LEU . 62.6 mt -67.78 -34.18 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.677 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.21 72.66 32.55 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.504 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.1 Cg_endo -70.53 -34.4 12.09 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.713 2.275 . . . . 0.0 111.782 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.22 78.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.733 HG12 ' CE1' ' A' ' 59' ' ' PHE . 23.7 m -125.37 155.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -73.22 -44.64 59.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.79 129.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.13 126.19 34.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -122.47 150.19 42.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.708 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.7 mt -106.35 121.47 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -65.74 -43.99 87.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.412 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.24 155.06 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.64 -41.0 2.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 89.2 m-20 60.54 40.47 16.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -1.102 . . . . 0.0 109.481 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.833 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.74 35.98 12.48 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.86 -166.69 13.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.7 128.26 15.83 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.698 2.266 . . . . 0.0 111.715 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.65 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 90.0 m -81.07 143.32 32.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 109.587 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 45' ' ' LEU . 62.5 mt -110.14 131.67 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.313 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 50.3 mttt -116.42 150.42 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.589 ' HB2' HD11 ' A' ' 45' ' ' LEU . 25.1 tttm -129.63 125.87 37.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.188 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 68' ' ' VAL . 32.6 mt -117.39 137.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 50.4 m -114.51 133.2 55.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.232 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.733 ' CE1' HG12 ' A' ' 39' ' ' VAL . 91.2 m-85 -103.53 130.33 50.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.609 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . -93.99 -69.29 1.08 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.24 133.47 39.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 0.0 109.377 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 -172.18 49.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.5 m 46.32 25.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -1.121 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' TYR . 56.3 m170 46.2 45.78 12.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 15.3 m-85 44.06 36.09 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -90.49 -179.33 43.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.474 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 44.1 p90 -144.05 146.72 33.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -1.106 . . . . 0.0 109.398 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 ' CA ' ' A' ' 89' ' ' GLY . 10.8 m -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 86' ' ' LEU . 81.5 mttt -119.46 147.58 44.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.582 ' NE2' HD13 ' A' ' 86' ' ' LEU . 62.6 m80 -115.95 166.57 11.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.231 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' SER . 42.5 tttp -143.78 140.72 30.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.473 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 55.4 mt -104.95 127.51 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 74' ' ' SER . 98.6 m-70 -88.8 -29.98 19.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 91.9 p 178.1 154.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.784 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' ILE . 38.3 pt -135.04 139.56 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -122.7 93.29 3.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -63.27 -37.89 89.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.267 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.06 -41.18 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -88.59 6.18 39.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.561 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m80 46.54 50.57 12.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.526 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.2 m -129.76 132.64 46.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.522 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 69.2 t80 -125.19 128.89 49.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.29 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -127.49 139.35 52.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.4 p90 -158.41 177.49 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.437 -0.789 . . . . 0.0 109.091 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 71' ' ' LYS . 89.1 p -151.7 154.77 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.898 ' CD2' HD11 ' A' ' 92' ' ' LEU . 25.5 tp -87.91 124.01 33.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.318 -0.864 . . . . 0.0 109.098 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.856 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.5 mt -80.69 -75.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.852 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.856 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.6 mt-10 -126.46 158.24 36.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 0.0 109.836 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.785 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -178.0 134.72 2.49 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 51.2 m-20 -50.67 -37.69 42.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -1.16 . . . . 0.0 109.367 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.36 -17.37 63.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.903 . . . . 0.0 109.152 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.898 HD11 ' CD2' ' A' ' 86' ' ' LEU . 6.8 mp -82.6 -42.11 18.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 3.3 t 60.13 177.18 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.523 ' O ' ' CD ' ' A' ' 124' ' ' LYS . 97.9 mt-10 -78.89 -3.09 42.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' HA ' ' HE3' ' A' ' 124' ' ' LYS . 34.0 p-10 -90.76 -21.37 21.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 41.6 mt -112.39 132.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.069 -1.02 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 94.4 mt-10 -90.62 -178.56 5.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.148 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.676 ' NZ ' HG23 ' A' ' 87' ' ' ILE . 75.6 mttt -56.14 156.63 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.361 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 120' ' ' LYS . 55.4 mt -118.4 136.2 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.668 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 120' ' ' LYS . 91.7 m-20 -92.15 123.84 35.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.395 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 76.2 m-85 -113.79 139.17 49.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.9 mt-10 -134.33 138.85 45.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.403 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.707 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.3 m -127.96 137.45 52.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 105' ' ' LEU . 54.8 tttt -139.14 125.32 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.459 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -101.5 129.56 47.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' ILE . 50.8 t -131.78 144.33 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -109.64 151.99 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.1 160.68 28.09 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.2 Cg_endo -69.95 -17.0 36.97 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.639 2.226 . . . . 0.0 111.855 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -77.58 -12.3 59.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.53 30.46 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.46 172.3 55.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 99.7 m -124.61 128.23 48.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -1.123 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.628 HG21 ' OE2' ' A' ' 9' ' ' GLU . 64.5 mt -99.06 136.24 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 105' ' ' LEU . 62.7 mt -119.75 131.19 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 51.8 mttp -116.84 125.85 52.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -126.07 137.86 53.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 56.3 m -119.86 135.52 54.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -123.33 137.59 54.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.705 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 99' ' ' ILE . 67.5 tttt -143.76 134.45 25.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.235 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.015 ' O ' HG21 ' A' ' 3' ' ' VAL . 39.4 p90 -132.53 146.56 52.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 94.9 m-70 -108.78 159.17 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.495 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.771 ' HB ' HG22 ' A' ' 127' ' ' VAL . 28.6 p -131.17 161.76 31.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' GLU . 4.2 mtmp? -56.94 -35.0 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.389 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -172.58 64.75 0.13 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 90.6 m-20 60.72 38.61 18.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -1.134 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.771 HG22 ' HB ' ' A' ' 123' ' ' THR . 18.6 m -48.95 135.2 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.74 139.17 39.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.477 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.2 tt -129.5 170.8 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.539 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 43.2 mttt -92.39 129.23 38.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.496 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -55.7 -38.07 69.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.29 -37.56 80.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.373 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.539 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 64.4 m170 -67.61 -43.98 79.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.261 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.44 -45.67 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 109.472 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 24.8 tttt -60.67 -43.83 97.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -59.23 -46.78 87.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA2' ' CE ' ' A' ' 140' ' ' LYS . . . -59.23 -42.58 97.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.63 -45.85 92.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -1.117 . . . . 0.0 109.334 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 94.9 mt-10 -61.94 -42.46 99.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 55.9 mtmt -59.0 -43.97 91.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.7 72.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.933 . . . . 0.0 109.383 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.44 79.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.358 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -59.26 -47.4 85.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.297 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 53.6 mt -53.45 -48.82 68.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.417 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.503 ' HA ' HD12 ' A' ' 148' ' ' ILE . 72.8 m-85 -54.01 -37.86 64.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -58.75 -41.44 86.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.689 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.4 mm? -68.33 -37.7 80.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.299 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 23' ' ' PHE . 81.7 mt -59.34 -48.6 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.283 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.5 -47.61 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.341 -0.849 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.02 -33.55 84.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.42 -46.9 80.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 14' ' ' ILE . 64.3 mt -66.15 -40.03 90.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -64.09 -41.17 97.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.71 -33.94 77.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 109.514 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 132.62 75.23 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.09 152.74 67.73 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.662 2.241 . . . . 0.0 111.856 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' ASN . 21.1 t -70.6 148.91 47.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.444 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.57 -32.97 74.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 160' ' ' ASN . 18.9 m-30 -62.58 -34.82 77.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 157' ' ' SER . 43.4 p-10 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.845 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p -113.53 140.08 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -92.17 141.45 28.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.563 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 38.7 m -93.66 142.66 27.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -119.67 144.35 47.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.533 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' HD3' ' A' ' 116' ' ' LYS . 85.5 tt0 -112.81 141.55 46.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -116.04 142.82 46.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -121.23 138.79 54.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.5 t80 -156.3 145.27 20.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.6 p -112.46 147.64 36.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 p -150.46 171.62 16.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' ILE . 6.8 t70 -78.66 179.54 7.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 0.0 109.34 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER 70.2 142.11 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 109.155 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.6 Cg_endo -68.75 145.9 64.68 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.566 2.177 . . . . 0.0 112.148 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.754 ' HB1' ' HB3' ' A' ' 105' ' ' LEU . . . -46.09 -47.62 43.36 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.601 -0.687 . . . . 0.0 111.543 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.1 Cg_endo -64.32 -37.17 41.54 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.081 1.854 . . . . 0.0 113.003 -178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 78.6 mttt -71.42 -32.43 68.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.884 -1.135 . . . . 0.0 109.556 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.8 tp -80.8 -30.38 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CE1' ' HB2' ' A' ' 82' ' ' TYR . 75.0 t80 -61.09 -41.47 96.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.594 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.583 ' NZ ' HD23 ' A' ' 25' ' ' LEU . 34.1 tttm -65.16 -52.81 52.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.632 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -8.11 52.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.988 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.6 t80 -85.45 -34.67 21.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.575 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.841 HG11 ' CD1' ' A' ' 82' ' ' TYR . 33.1 m -114.48 -37.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.583 HD23 ' NZ ' ' A' ' 21' ' ' LYS . 17.5 tp -71.18 -38.55 72.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.662 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.2 m-20 -108.09 14.38 25.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.9 -39.69 76.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.533 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.655 ' OD2' HD11 ' A' ' 44' ' ' ILE . 89.3 m-20 -58.62 -33.03 69.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.624 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.0 t30 -101.38 -35.91 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.968 ' O ' HD13 ' A' ' 30' ' ' LEU . 2.1 tm? -72.49 -37.47 68.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 27' ' ' ALA . 28.7 mt -50.79 -55.8 24.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.2 Cg_endo -68.47 -18.91 43.51 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.43 2.087 . . . . 0.0 111.821 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 40.2 mttt -71.03 -36.71 72.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 HG23 ' HG ' ' A' ' 147' ' ' LEU . 79.7 mt -66.63 -29.27 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.87 72.2 5.27 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.6 Cg_endo -69.89 -32.27 18.35 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.665 2.244 . . . . 0.0 111.771 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -75.23 -25.83 58.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.63 -39.49 64.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 57' ' ' ILE . 3.5 p -118.06 151.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -77.56 -47.94 18.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 129.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.22 128.02 34.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.375 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -122.52 148.59 44.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.655 HD11 ' OD2' ' A' ' 28' ' ' ASP . 65.6 mt -106.45 118.14 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.428 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' H ' HD12 ' A' ' 45' ' ' LEU . 6.8 mp -61.67 -45.41 94.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.923 ' O ' HG23 ' A' ' 53' ' ' THR . 67.5 mm-40 -157.83 156.04 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.537 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.23 -41.01 2.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 59.1 36.73 24.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.837 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.17 33.31 10.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.83 -164.99 12.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.72 130.77 19.96 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 30.93 70.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 46' ' ' GLU . 89.3 m -86.36 141.9 28.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.506 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.3 mt -109.57 129.95 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.335 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.491 ' HE3' HD11 ' A' ' 72' ' ' ILE . 48.0 mttt -116.2 146.56 42.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.613 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.7 tttm -131.06 122.33 26.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 39' ' ' VAL . 28.5 mt -114.98 137.95 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -118.57 131.04 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -104.07 135.81 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.562 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.7 -170.06 54.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -58.95 -30.2 67.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -1.141 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.06 5.79 62.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.1 p -65.78 -24.42 66.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -125.75 176.08 7.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.898 . . . . 0.0 109.454 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -54.27 168.64 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 126.21 65.39 0.16 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.5 p90 -151.45 144.25 24.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -1.14 . . . . 0.0 109.61 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 86' ' ' LEU . 48.4 t -122.28 146.46 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 87' ' ' ILE . 26.8 mttt -119.83 139.52 52.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 77.2 m80 -119.64 134.52 55.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB2' HD11 ' A' ' 87' ' ' ILE . 19.2 tttt -112.61 141.17 46.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 109.553 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' A' ' 53' ' ' THR . 66.6 mt -99.51 134.54 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -91.73 -49.16 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.9 p -167.61 154.7 8.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.53 144.39 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 74.8 m-20 -128.73 91.19 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -63.75 -34.63 78.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.1 t -73.43 -39.24 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.5 m-20 -87.82 4.8 43.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.5 m80 48.12 46.04 19.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.2 m -130.96 132.14 44.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.841 ' CD1' HG11 ' A' ' 24' ' ' VAL . 78.5 t80 -124.88 121.27 34.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.353 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.1 p -111.81 139.91 46.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 33.0 p90 -155.59 167.95 28.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 90.4 p -146.31 158.28 43.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.635 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.995 HD22 ' CD1' ' A' ' 92' ' ' LEU . 5.4 tt -96.5 121.96 38.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.822 HG22 ' HG3' ' A' ' 88' ' ' GLU . 94.8 mt -76.75 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.578 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.871 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.8 mt-10 -133.44 159.92 38.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.93 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.36 162.2 32.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.465 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 39.2 m-20 -65.05 -29.62 70.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 109.631 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.59 -21.75 48.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.995 ' CD1' HD22 ' A' ' 86' ' ' LEU . 5.6 mt -78.68 -30.17 45.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 108.999 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 92' ' ' LEU . 66.6 m 46.37 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.88 9.88 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.633 ' HB3' HG21 ' A' ' 127' ' ' VAL . 76.3 m-20 -110.14 -15.55 13.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.841 HD12 ' O ' ' A' ' 91' ' ' ALA . 18.7 mt -109.36 137.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 122' ' ' HIS . 99.6 mt-10 -84.55 -179.4 7.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.867 . . . . 0.0 109.299 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 35.4 mtmm -57.21 164.43 1.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 120' ' ' LYS . 53.4 mt -121.79 131.85 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.525 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 120' ' ' LYS . 90.2 m-20 -90.74 126.33 35.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.307 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 66.6 m-85 -116.93 142.06 47.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 93.2 mt-10 -129.19 136.08 49.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.8 m -125.95 129.25 48.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.652 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.492 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.0 tttt -130.36 128.1 40.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 0.0 109.169 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.0 mm? -99.47 123.3 43.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' ILE . 42.2 t -130.83 149.05 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 72.2 m -113.78 153.43 29.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.56 162.44 20.59 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.1 Cg_endo -69.79 -18.83 36.66 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.613 2.209 . . . . 0.0 111.713 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -67.3 -15.43 63.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.877 . . . . 0.0 109.375 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.92 35.6 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.54 176.37 44.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 16' ' ' ALA . 98.1 m -117.76 129.26 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -1.114 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 106' ' ' VAL . 68.2 mt -98.92 131.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.62 HG23 HD13 ' A' ' 105' ' ' LEU . 39.8 mt -117.38 132.72 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 109.621 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HD3' ' OE2' ' A' ' 7' ' ' GLU . 84.5 mttt -117.68 132.27 56.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.31 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.4 m -130.77 126.92 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.542 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.8 m -108.71 145.76 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -130.85 137.23 49.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.831 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HE2' HG13 ' A' ' 3' ' ' VAL . 22.1 tttt -141.67 131.78 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.155 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.845 ' O ' HG21 ' A' ' 3' ' ' VAL . 42.5 p90 -129.02 148.09 50.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.426 ' HB3' ' OE1' ' A' ' 97' ' ' GLU . 77.5 m80 -116.58 166.72 11.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 126' ' ' ASP . 35.1 p -129.94 156.97 43.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.77 -41.75 78.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -141.42 42.66 1.15 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 123' ' ' THR . 91.1 m-20 60.19 46.46 10.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 95' ' ' ASN . 9.6 p -55.0 -21.5 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 83.6 tt0 63.79 143.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 tt -124.25 170.56 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.419 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 30.0 mttp -85.56 122.27 29.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.943 . . . . 0.0 109.293 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -47.52 -37.83 12.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.152 -0.967 . . . . 0.0 109.431 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 70.2 mm-40 -57.29 -38.83 74.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.312 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.419 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 67.2 m170 -66.16 -44.33 84.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.325 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.51 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 109.274 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -56.48 -42.55 78.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.62 97.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.81 93.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -58.89 -44.01 91.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.306 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 143' ' ' HIS . 95.8 mt-10 -66.37 -39.67 89.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 18.7 tttt -58.25 -45.53 87.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 109.36 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.69 -47.9 73.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -39.79 88.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.381 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 147' ' ' LEU . 52.5 m170 -58.98 -46.81 87.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 59.8 mt -55.57 -50.97 68.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.385 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 141' ' ' ALA . 73.5 m-85 -53.46 -38.04 63.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -61.97 -42.35 99.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HG ' HG23 ' A' ' 34' ' ' ILE . 4.1 mm? -63.93 -45.02 91.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 19' ' ' LEU . 72.1 mt -55.63 -54.54 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.64 -29.95 53.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.93 -32.07 59.25 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 57.7 m-85 -73.03 -43.25 62.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.3 mp -75.12 -45.75 38.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -55.74 -34.47 65.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.985 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.17 -32.82 21.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.342 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 60.1 60.09 4.13 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 151' ' ' TYR . 49.7 Cg_endo -70.38 147.93 59.96 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.707 2.272 . . . . 0.0 111.664 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.4 m -116.62 147.3 42.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.518 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -106.74 148.41 28.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -64.21 -32.49 74.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.538 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 121' ' ' TYR . 7.7 p -105.86 142.6 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -1.202 . . . . 0.0 109.452 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.89 136.63 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 29.1 m -93.61 137.19 33.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 109.367 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.554 ' CE2' ' HE3' ' A' ' 138' ' ' LYS . 68.4 t80 -119.64 132.79 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -113.94 135.53 53.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.85 . . . . 0.0 109.357 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 42.4 t-20 -119.64 141.12 49.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -115.1 138.14 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 78.1 t80 -154.9 146.53 23.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.8 p -113.22 147.17 38.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.422 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 59.8 p -149.61 171.67 16.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.651 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' O ' HD12 ' A' ' 14' ' ' ILE . 13.4 t0 -77.85 -175.45 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.71 141.06 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.342 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.9 Cg_endo -69.66 147.16 62.87 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.618 2.212 . . . . 0.0 112.115 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.695 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -40.86 -50.32 7.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.518 -0.739 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.08 -45.75 9.53 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.297 1.998 . . . . 0.0 113.003 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 20.9 mttm -61.42 -33.04 73.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.782 -1.199 . . . . 0.0 109.542 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD12 HD22 ' A' ' 152' ' ' LEU . 12.4 tp -80.55 -31.75 36.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.725 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.878 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 73.7 t80 -69.0 -32.05 71.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 109.848 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.749 ' HG3' HD12 ' A' ' 25' ' ' LEU . 23.2 tttt -65.98 -44.57 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.609 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.55 -19.73 32.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.496 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 103' ' ' THR . 55.9 t80 -83.29 -15.92 48.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 84.3 t -118.53 -63.06 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.363 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.749 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.1 mt -57.97 -43.63 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 48.8 m-20 -96.24 15.42 21.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.391 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.735 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -69.49 -22.23 63.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.664 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.2 m-20 -77.36 -35.54 54.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.374 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.401 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 m120 -98.01 -31.5 12.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.899 HD21 HG23 ' A' ' 148' ' ' ILE . 18.4 tp -63.3 -39.06 93.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -55.53 -59.42 11.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 50.5 Cg_endo -70.67 -11.27 29.39 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.674 2.249 . . . . 0.0 111.605 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -73.33 -43.94 59.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.857 . . . . 0.0 109.395 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.128 HG23 ' CD2' ' A' ' 147' ' ' LEU . 86.5 mt -66.6 -38.81 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.71 76.44 23.91 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.47 -31.64 17.01 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.689 2.259 . . . . 0.0 111.714 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -74.49 -22.6 58.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 109.355 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.845 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -71.81 -37.53 70.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.307 -0.87 . . . . 0.0 109.362 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG21 ' CG2' ' A' ' 57' ' ' ILE . 2.6 p -120.45 146.35 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -73.64 -45.99 49.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.1 142.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.563 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.97 130.32 53.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 109.386 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -127.63 154.12 45.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.664 HD11 ' OD2' ' A' ' 28' ' ' ASP . 25.9 mt -105.85 122.04 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.7 mp -68.15 -43.76 77.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.361 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 53' ' ' THR . 93.3 mt-10 -159.3 157.7 31.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.47 -40.46 2.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 58.95 37.44 24.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.697 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.91 26.32 29.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -111.63 -166.3 18.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.93 130.07 18.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.682 2.255 . . . . 0.0 111.757 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.27 69.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.922 HG23 ' O ' ' A' ' 46' ' ' GLU . 97.9 m -80.77 142.53 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -1.181 . . . . 0.0 109.472 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HD13 ' A' ' 45' ' ' LEU . 64.3 mt -112.86 130.1 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HG2' HG23 ' A' ' 44' ' ' ILE . 71.7 mttt -124.75 146.38 49.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.647 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 44.4 tttt -122.83 121.72 36.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.668 HD12 ' CD2' ' A' ' 70' ' ' HIS . 17.4 mt -114.75 132.51 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.2 m -113.12 116.82 30.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 53.9 p90 -119.99 143.54 47.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' HA3' ' CD1' ' A' ' 65' ' ' TYR . . . -126.53 46.98 1.04 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.845 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 97.6 mt-10 -67.44 -42.76 82.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.52 175.1 54.45 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.6 p -56.33 -24.81 46.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -1.167 . . . . 0.0 109.57 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -105.25 -174.75 2.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.545 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 98.9 m-85 -119.07 131.72 55.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.499 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -126.05 174.88 17.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 36.7 p90 -157.76 144.25 17.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -1.204 . . . . 0.0 109.545 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.1 m -125.55 147.83 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' HD12 ' A' ' 86' ' ' LEU . 51.1 mttt -103.29 144.69 31.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.987 ' CE1' HD13 ' A' ' 86' ' ' LEU . 64.3 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.9 tttm -125.02 139.09 54.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.56 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.82 HD12 ' HB ' ' A' ' 53' ' ' THR . 70.6 mt -100.95 129.63 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -89.07 -45.76 9.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.551 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -170.3 141.42 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.621 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 pt -123.42 143.83 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -127.77 91.27 3.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -63.59 -37.34 86.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.76 -42.72 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -86.15 3.09 44.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.421 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 56.0 m80 52.97 45.12 29.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.109 -0.995 . . . . 0.0 109.491 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -126.76 139.83 52.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.6 t80 -132.98 125.77 30.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -120.76 127.36 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 36.1 p90 -146.64 171.14 15.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 69.1 p -151.5 151.36 31.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.0 109.704 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.987 HD13 ' CE1' ' A' ' 70' ' ' HIS . 32.1 tp -88.71 108.02 19.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.853 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' A' ' 88' ' ' GLU . 95.9 mt -59.11 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.853 ' HG2' HG22 ' A' ' 87' ' ' ILE . 78.2 mm-40 -138.96 169.74 17.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.724 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.86 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -179.55 135.79 2.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 69.3 m-20 -50.37 -41.27 51.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.485 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.74 68.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.624 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.5 mp -78.64 -33.4 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 4.0 m 61.47 178.19 0.12 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.299 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 98.2 mt-10 -78.86 -13.95 59.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.555 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.831 ' O ' HG11 ' A' ' 127' ' ' VAL . 15.2 m120 -78.11 -28.69 48.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 34.4 mt -105.84 125.83 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.101 -0.999 . . . . 0.0 109.746 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 91.3 mt-10 -80.89 -179.41 7.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.16 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 17.5 ptpt -57.02 159.4 4.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 120' ' ' LYS . 69.5 mt -117.79 138.65 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.596 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 61.1 t0 -95.13 125.72 39.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 90.9 m-85 -117.3 134.08 55.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -123.71 137.64 54.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.807 HG21 ' CE1' ' A' ' 23' ' ' PHE . 30.9 m -127.99 136.72 51.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.573 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' C ' HD22 ' A' ' 105' ' ' LEU . 84.5 tttt -139.77 125.62 19.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.906 HD13 HG23 ' A' ' 115' ' ' ILE . 2.7 mm? -100.16 130.01 46.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.4 t -131.79 140.66 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.6 p -113.27 148.38 35.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -108.86 164.59 14.38 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.2 Cg_endo -70.34 -10.73 28.73 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 111.74 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -76.02 -15.52 60.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.06 -19.02 28.05 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.88 170.68 45.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.695 HG21 ' HA ' ' A' ' 16' ' ' ALA . 88.4 m -123.8 127.04 47.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.149 . . . . 0.0 109.605 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.3 mt -96.95 139.2 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.933 . . . . 0.0 109.235 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.906 HG23 HD13 ' A' ' 105' ' ' LEU . 4.7 mt -124.62 121.96 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 45.0 mttt -107.67 139.11 42.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.075 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 m -127.98 130.06 47.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 110.076 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.536 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 27.1 m -125.97 140.28 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.875 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -145.21 155.54 43.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 110.196 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 99' ' ' ILE . 25.5 mttp -129.97 148.53 51.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.528 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 80.4 m-85 -118.13 121.81 41.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 0.0 109.834 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 61.2 m170 -89.86 143.5 26.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.51 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 28.5 p -129.51 157.62 41.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.771 ' HE3' HG12 ' A' ' 127' ' ' VAL . 4.8 mtmt -52.05 -45.81 64.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.36 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 164.02 -43.96 0.31 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 52.9 p30 -135.52 18.89 3.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -1.153 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.831 HG11 ' O ' ' A' ' 95' ' ' ASN . 8.3 m -54.21 -40.6 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 127' ' ' VAL . 95.4 mt-10 61.6 128.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.571 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.27 171.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -99.62 133.31 44.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -56.38 -35.49 67.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.443 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.27 -38.69 84.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.13 -41.71 81.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.27 -41.43 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -61.25 -37.2 82.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -60.87 -44.28 97.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.53 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.55 -41.24 99.81 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HE3' ' CE2' ' A' ' 6' ' ' TYR . 63.6 tttm -59.72 -42.17 92.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -1.147 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.575 ' O ' ' CD2' ' A' ' 143' ' ' HIS . 75.1 mm-40 -64.38 -36.36 83.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.544 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.457 ' O ' HD13 ' A' ' 144' ' ' LEU . 84.6 mttt -61.48 -37.9 85.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.73 69.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 109.478 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.9 -42.23 67.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 139' ' ' GLU . 86.2 m-70 -59.86 -50.64 73.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.411 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 6.6 mp -68.23 -48.0 66.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.742 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.803 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 62.3 t80 -52.96 -45.44 67.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.594 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -58.0 -40.65 81.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.128 ' CD2' HG23 ' A' ' 34' ' ' ILE . 17.1 tp -60.08 -39.47 86.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.899 HG23 HD21 ' A' ' 30' ' ' LEU . 76.0 mt -53.76 -52.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.278 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 81.5 tt0 -54.73 -38.84 67.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.194 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 154' ' ' ASP . . . -61.33 -35.69 91.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.585 ' CE2' ' HG ' ' A' ' 147' ' ' LEU . 15.4 m-85 -71.38 -42.45 68.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -1.09 . . . . 0.0 109.337 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.734 HD22 HD12 ' A' ' 19' ' ' LEU . 6.4 mp -75.51 -37.85 59.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.6 tttp -60.13 -36.58 77.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 26.2 p30 -101.47 -9.8 20.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -44.51 139.79 3.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 160' ' ' ASN . 49.0 Cg_endo -69.53 -24.89 30.21 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.732 2.288 . . . . 0.0 111.808 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 90.8 p -60.93 -29.07 69.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.377 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 160' ' ' ASN . 76.5 mm-40 -112.32 160.57 17.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 158' ' ' GLU . 58.1 t80 66.94 -63.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 158' ' ' GLU . 11.6 m120 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 121' ' ' TYR . 13.6 p -117.42 139.76 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -1.158 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -110.81 154.07 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.417 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 120' ' ' LYS . 23.5 m -94.1 140.36 29.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -111.81 139.77 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -113.25 140.35 48.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -130.1 160.07 34.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.56 ' OE2' HG21 ' A' ' 114' ' ' ILE . 74.6 tt0 -142.72 130.8 21.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 75.7 t80 -141.78 140.32 33.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.565 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 16.0 p -90.68 143.56 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.956 ' OG ' HD11 ' A' ' 115' ' ' ILE . 83.3 p -141.06 161.29 38.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 0.0 109.588 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.62 ' O ' HD12 ' A' ' 14' ' ' ILE . 29.4 t0 -78.35 179.7 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.29 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 13' ' ' ASP . 1.1 mp 68.6 141.88 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.232 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.3 Cg_endo -69.32 146.98 64.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.507 2.138 . . . . 0.0 112.158 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.62 -50.57 7.02 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 111.39 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.4 Cg_endo -63.77 -49.98 3.63 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.23 1.953 . . . . 0.0 112.923 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 28.8 mttm -60.75 -35.98 77.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.866 -1.146 . . . . 0.0 109.672 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 19' ' ' LEU . 25.4 tp -81.01 -28.4 35.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.973 ' HB2' HD12 ' A' ' 105' ' ' LEU . 69.4 t80 -69.54 -35.01 75.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.82 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.658 ' HG3' HD12 ' A' ' 25' ' ' LEU . 29.8 tttp -67.34 -37.87 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.836 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -88.54 -30.77 19.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.64 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.83 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.6 t80 -77.3 -12.15 59.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -117.76 -63.4 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' HG3' ' A' ' 21' ' ' LYS . 47.8 mt -65.3 -41.43 94.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.8 m-20 -94.82 9.65 38.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.529 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.19 -45.54 66.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.954 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.563 ' OD2' HD11 ' A' ' 44' ' ' ILE . 94.6 m-20 -65.1 -25.31 67.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 58.8 t30 -101.27 -33.88 9.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.597 HD11 ' CD2' ' A' ' 151' ' ' TYR . 22.0 tp -75.27 -34.56 61.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.541 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 27' ' ' ALA . 34.9 mt -51.34 -54.94 33.2 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.915 . . . . 0.0 109.707 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -69.07 -20.32 38.23 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.425 2.084 . . . . 0.0 111.988 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 30' ' ' LEU . 30.2 mmtt -71.32 -34.99 71.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.44 -27.99 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.97 64.62 42.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.5 -46.14 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.671 2.247 . . . . 0.0 111.705 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -65.63 -22.87 66.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -73.29 -50.52 21.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 57' ' ' ILE . 7.4 p -111.61 149.68 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.476 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -73.25 -46.2 51.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.51 131.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.35 128.03 34.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.439 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -123.93 142.88 50.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.563 HD11 ' OD2' ' A' ' 28' ' ' ASP . 56.1 mt -106.46 118.85 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 27.2 tp -60.2 -44.94 94.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 53' ' ' THR . 94.9 mt-10 -159.68 157.02 28.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 105.6 -42.06 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 58.26 37.41 26.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.871 ' H ' HG21 ' A' ' 53' ' ' THR . . . 86.11 31.35 20.33 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -115.56 -166.28 14.81 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.7 130.9 20.23 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.737 2.291 . . . . 0.0 111.598 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.74 29.62 73.94 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' H ' ' A' ' 49' ' ' GLY . 94.3 m -82.76 140.64 32.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 44' ' ' ILE . 22.3 mm -105.81 129.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.276 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 91.3 mttt -114.74 147.3 39.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.655 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 57.3 tttm -131.02 121.52 25.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 0.0 109.297 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 39' ' ' VAL . 60.8 mt -114.04 135.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.6 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 m -123.96 119.46 29.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 33.6 p90 -124.48 143.5 50.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.47 86.99 0.62 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -51.13 -38.11 50.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.67 -100.25 0.22 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.1 m -62.0 -28.22 69.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -1.17 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -129.1 155.15 45.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.504 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -116.05 143.57 45.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -138.84 170.96 23.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 38.9 p90 -155.76 144.09 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.139 . . . . 0.0 109.657 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.046 HG12 HD11 ' A' ' 86' ' ' LEU . 43.0 t -124.08 144.48 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 35.2 mttt -116.9 139.66 50.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.8 ' CE1' HD13 ' A' ' 86' ' ' LEU . 81.0 m-70 -116.98 144.87 44.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.382 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' CB ' HD11 ' A' ' 87' ' ' ILE . 25.0 tttt -124.01 142.39 51.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.703 HD12 ' HB ' ' A' ' 53' ' ' THR . 58.3 mt -102.96 131.07 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 0.0 109.476 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.411 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 97.2 m-70 -90.5 -48.64 6.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.2 m -163.81 149.49 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 pt -129.89 145.47 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 82.0 m-20 -128.3 91.16 3.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -62.31 -37.66 86.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -70.96 -40.67 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.4 m-20 -87.8 7.88 28.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 46.5 m80 45.72 40.34 6.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -119.46 136.43 54.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 70.4 t80 -127.52 126.28 41.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 t -121.06 128.16 52.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 34.1 p90 -145.72 170.26 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 81.0 p -148.1 157.96 43.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.046 HD11 HG12 ' A' ' 68' ' ' VAL . 22.6 tp -93.27 136.75 33.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.58 HG23 ' HE3' ' A' ' 98' ' ' LYS . 26.9 mm -99.13 -71.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.562 ' HG3' HG22 ' A' ' 87' ' ' ILE . 95.0 mt-10 -118.98 160.78 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 68' ' ' VAL . . . 172.44 128.59 1.06 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 38.0 m-20 -46.21 -31.82 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 109.604 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.56 68.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 0.0 109.365 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD21 HD23 ' A' ' 86' ' ' LEU . 3.6 mt -74.69 -33.03 62.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.451 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 3.5 m 53.14 -177.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.66 -0.65 . . . . 0.0 109.567 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.0 12.53 7.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 93' ' ' SER . 26.7 p-10 -111.72 -10.75 14.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.658 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 22.1 mt -114.5 140.2 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 93.7 mt-10 -91.96 -179.52 5.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.312 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HE3' HG23 ' A' ' 87' ' ' ILE . 52.2 mttp -57.08 161.91 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.492 HG12 ' HB2' ' A' ' 121' ' ' TYR . 49.0 mt -120.47 135.62 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.608 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 120' ' ' LYS . 60.6 t0 -93.04 120.13 33.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 73.1 m-85 -113.8 139.13 49.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -133.48 135.34 44.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.318 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.4 m -131.11 135.64 47.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.171 -0.956 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -139.18 129.13 25.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.888 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.973 HD12 ' HB2' ' A' ' 20' ' ' PHE . 31.6 mt -98.69 129.61 45.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 114' ' ' ILE . 44.7 t -132.05 136.17 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.9 OUTLIER -111.2 146.6 36.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.861 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -106.54 171.38 4.8 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.861 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.4 Cg_endo -69.52 -15.06 37.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.666 2.244 . . . . 0.0 111.791 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.79 -20.81 61.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.9 -25.61 11.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.44 171.55 51.37 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 93.8 m -125.87 124.62 41.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.56 HG21 ' OE2' ' A' ' 9' ' ' GLU . 68.0 mt -97.5 139.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.263 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.956 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.2 mt -121.57 127.96 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 109.741 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 9' ' ' GLU . 50.5 mttp -105.87 127.98 53.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.2 m -123.43 133.65 54.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.462 ' CG2' HG22 ' A' ' 5' ' ' THR . 60.8 m -119.79 133.54 55.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 0.0 109.016 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -120.32 131.33 54.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 110.006 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HB2' HG23 ' A' ' 5' ' ' THR . 78.5 tttt -140.66 130.35 24.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 3' ' ' VAL . 32.9 p90 -132.11 149.17 52.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.805 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.5 ' ND1' HG11 ' A' ' 3' ' ' VAL . 98.8 m-70 -114.15 158.67 21.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.183 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.428 ' CA ' ' HG3' ' A' ' 97' ' ' GLU . 82.2 p -130.52 157.09 43.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.633 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -55.01 -25.88 33.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.268 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . 160.01 43.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 91.0 m-20 61.92 41.97 10.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 95' ' ' ASN . 60.8 t -53.1 -55.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.432 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -176.44 103.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.22 171.79 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -135.81 133.36 37.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.567 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -54.65 -38.72 67.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.41 -36.69 83.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.373 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -65.13 -46.45 80.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.94 -46.93 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.303 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 54.4 tttt -57.92 -41.21 82.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.32 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.38 77.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.9 . . . . 0.0 109.363 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.93 93.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.8 mtmm -64.28 -39.03 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 109.327 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.77 -38.52 91.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.381 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.07 -43.69 95.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.415 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.24 -40.52 70.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.338 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.47 88.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.336 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -60.19 -53.21 60.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.54 ' HA ' HD23 ' A' ' 147' ' ' LEU . 25.4 mt -62.0 -36.07 80.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 109.39 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.915 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 46.6 t80 -53.44 -43.06 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.197 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 59.4 tttm -59.29 -38.63 80.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.321 -0.862 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.652 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.6 mm? -62.58 -36.13 81.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.231 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.538 HD13 ' HD1' ' A' ' 23' ' ' PHE . 98.8 mt -53.68 -55.74 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.163 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.533 ' OE2' ' CE2' ' A' ' 145' ' ' PHE . 40.5 mp0 -54.33 -43.74 71.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.943 . . . . 0.0 109.043 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.48 -29.45 71.6 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.597 ' CD2' HD11 ' A' ' 30' ' ' LEU . 54.5 t80 -61.16 -43.58 98.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.3 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.713 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.4 mp -75.49 -44.7 42.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -0.897 . . . . 0.0 109.226 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -53.31 -33.89 55.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 108.701 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.89 -34.14 57.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 74.79 1.14 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 158' ' ' GLU . 49.6 Cg_endo -69.29 -40.33 6.21 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.794 2.329 . . . . 0.0 112.01 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 65.4 m 47.61 24.32 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.251 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.455 ' HG3' ' HB2' ' A' ' 156' ' ' PRO . 94.0 mt-10 -55.36 139.61 42.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.76 141.43 46.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.47 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.454 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.988 HG21 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -111.55 145.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -1.137 . . . . 0.0 109.578 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.31 149.57 39.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 118' ' ' THR . 27.6 m -93.56 140.99 28.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.46 137.98 53.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.616 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -108.02 132.76 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.27 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.06 133.41 53.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.614 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.52 131.86 54.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.435 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 11' ' ' THR . 86.0 t80 -146.56 149.48 33.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.565 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 22.0 p -117.96 149.9 40.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 23.2 t -148.51 164.57 33.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.636 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.796 ' O ' HD12 ' A' ' 14' ' ' ILE . 21.1 t0 -72.71 -178.44 2.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.849 HD13 HD12 ' A' ' 152' ' ' LEU . 1.0 OUTLIER 69.05 142.06 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.273 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.8 Cg_endo -69.65 147.21 63.09 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 111.964 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 113' ' ' THR . . . -38.71 -51.44 3.76 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.507 -0.745 . . . . 0.0 111.267 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.0 Cg_endo -64.19 -50.66 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.318 2.012 . . . . 0.0 113.068 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 95.6 mttt -59.1 -34.98 72.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.808 -1.182 . . . . 0.0 109.55 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 152' ' ' LEU . 22.4 tp -80.77 -36.86 31.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 24' ' ' VAL . 60.0 t80 -57.87 -32.6 67.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.577 ' HA ' HD13 ' A' ' 25' ' ' LEU . 19.8 tttt -71.57 -52.39 18.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 109.623 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.44 3.06 14.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.0 t80 -99.86 -33.37 10.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.793 ' CG2' HD12 ' A' ' 25' ' ' LEU . 9.8 m -114.19 -46.53 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.095 -1.003 . . . . 0.0 109.888 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.793 HD12 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -68.7 -33.93 74.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.97 . . . . 0.0 109.478 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 59.0 m-20 -106.33 8.93 32.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.81 -37.05 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 44' ' ' ILE . 92.7 m-20 -57.35 -37.28 72.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.647 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 86.7 m-20 -100.86 -37.65 8.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.515 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 26.0 tp -63.96 -43.05 96.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 9.3 mt -47.8 -60.0 4.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.68 -22.74 37.12 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.55 2.166 . . . . 0.0 111.63 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.9 tptm -66.26 -47.06 74.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.534 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG21 ' CB ' ' A' ' 147' ' ' LEU . 67.8 mt -67.91 -36.13 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.534 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.97 71.58 62.52 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.6 Cg_endo -70.4 -37.37 7.73 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.681 2.254 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.53 -23.06 60.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.34 76.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' CE1' ' A' ' 59' ' ' PHE . 21.4 m -125.54 149.16 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -72.13 -47.53 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.386 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.98 131.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.59 119.31 27.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -115.53 144.37 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.579 HG23 ' HG2' ' A' ' 55' ' ' LYS . 50.9 mt -106.6 119.67 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 26.4 tp -64.86 -44.12 90.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.938 ' O ' HG23 ' A' ' 53' ' ' THR . 94.3 mt-10 -159.32 154.48 25.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.95 -42.71 1.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 61.84 39.06 14.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.537 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.46 34.92 15.23 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -119.33 -166.84 13.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.02 131.85 21.7 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.726 2.284 . . . . 0.0 111.709 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 68.49 28.82 72.99 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.938 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.3 m -83.88 144.78 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 53' ' ' THR . 22.1 mm -112.15 131.94 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.95 . . . . 0.0 109.28 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 44' ' ' ILE . 4.4 mtmt -130.09 148.39 51.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.542 ' HE3' ' CD2' ' A' ' 67' ' ' TYR . 67.8 tttt -125.76 126.71 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.284 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 14.7 mt -115.92 130.93 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.4 m -107.74 132.02 53.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.341 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.866 ' CE1' HG12 ' A' ' 39' ' ' VAL . 97.9 m-85 -104.47 132.46 50.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.5 -178.86 30.76 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -57.93 -24.56 58.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.148 -1.207 . . . . 0.0 109.337 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.25 -8.97 55.9 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.6 p -62.19 -27.67 69.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -1.145 . . . . 0.0 109.532 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 76.3 m80 -92.16 3.19 55.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 75.2 t80 61.13 100.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.02 90.11 0.1 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 37.3 p90 -145.47 146.3 31.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.497 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.868 HG12 ' CA ' ' A' ' 89' ' ' GLY . 3.2 m -126.65 145.58 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 88' ' ' GLU . 34.7 mttt -102.33 140.52 36.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.624 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 42.3 m170 -115.91 140.92 48.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.297 -0.877 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -124.02 139.22 54.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 49' ' ' GLY . 63.3 mt -101.7 135.74 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.376 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 93.9 m-70 -89.17 -48.97 7.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.2 t -174.24 151.88 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.569 HG22 ' CD1' ' A' ' 82' ' ' TYR . 41.2 pt -127.05 144.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -123.45 90.5 3.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -61.57 -36.8 81.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.466 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.84 -37.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.63 2.85 56.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.5 m80 51.34 46.98 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.8 m -128.8 135.18 48.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.87 . . . . 0.0 109.541 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' HG22 ' A' ' 75' ' ' ILE . 61.5 t80 -128.8 121.55 28.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -116.46 137.8 51.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -152.2 166.37 31.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.301 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 89.4 p -145.43 160.11 42.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.3 tt -100.77 131.81 46.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.1 mm -89.13 -73.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 0.0 109.583 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 87' ' ' ILE . 88.3 mt-10 -121.15 151.79 39.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.513 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.868 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -171.4 154.73 22.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 68' ' ' VAL . 6.0 t0 -56.35 -49.19 75.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 0.0 109.403 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.85 -27.01 59.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.7 mp -80.7 -30.24 36.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' LEU . 3.7 m 56.43 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 97.6 mt-10 -68.48 -7.67 34.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 109.236 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.797 ' HB3' HG11 ' A' ' 127' ' ' VAL . 26.1 m120 -72.73 -42.29 64.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.285 -0.884 . . . . 0.0 109.668 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -156.25 121.82 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 110.477 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 92' ' ' LEU . 22.1 mt-10 -136.59 107.03 6.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.818 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 122' ' ' HIS . 78.6 tttt -179.01 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.392 -0.817 . . . . 0.0 108.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.658 HG21 ' CZ ' ' A' ' 101' ' ' TYR . 18.8 mt -123.92 117.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 110.044 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -93.78 118.78 31.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.87 . . . . 0.0 109.011 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.658 ' CZ ' HG21 ' A' ' 99' ' ' ILE . 68.1 m-85 -109.23 137.73 46.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.691 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.8 mt-10 -130.34 129.79 43.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 23' ' ' PHE . 28.5 m -120.8 134.92 55.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HD22 ' A' ' 105' ' ' LEU . 32.5 tttt -133.73 121.65 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.099 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.802 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.1 mm? -95.12 118.85 32.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.759 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 60.5 t -131.88 140.2 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 109.313 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.1 t -107.61 148.05 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.905 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -105.71 173.11 3.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.905 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.97 -16.22 36.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.671 2.248 . . . . 0.0 111.8 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.48 27.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.62 176.63 53.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.714 HG21 ' HA ' ' A' ' 16' ' ' ALA . 65.3 m -122.88 125.05 44.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.3 mt -96.2 139.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.36 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 105' ' ' LEU . 28.7 mt -123.65 123.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.737 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -105.27 133.83 49.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.102 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 86.2 m -131.44 128.93 40.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.005 . . . . 0.0 109.902 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.596 ' CG2' HG22 ' A' ' 5' ' ' THR . 27.1 m -111.7 142.97 43.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 109.067 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.1 m -135.09 140.62 45.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.987 . . . . 0.0 109.845 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 72.0 tttt -132.29 147.14 52.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.988 ' O ' HG21 ' A' ' 3' ' ' VAL . 96.2 m-85 -126.6 140.31 52.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.81 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 98' ' ' LYS . 75.8 m-70 -130.55 -177.83 4.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.196 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 96' ' ' ILE . 36.2 p -128.07 147.35 50.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.68 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 94' ' ' GLU . 31.7 mtpt -52.98 -49.12 66.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.491 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -135.31 -65.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -163.52 39.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -1.186 . . . . 0.0 109.7 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.797 HG11 ' HB3' ' A' ' 95' ' ' ASN . 1.0 OUTLIER -82.56 130.02 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 109.28 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -80.62 149.64 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.608 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.0 tt -134.46 171.78 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -92.8 121.24 33.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -54.43 -42.38 70.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.04 -35.01 74.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.424 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -65.68 -45.05 84.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.932 . . . . 0.0 109.449 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.67 -42.33 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -57.9 -39.44 77.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.33 -44.02 83.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.16 96.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -59.58 -44.95 93.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -1.131 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -60.18 -43.06 96.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mttm -53.64 -43.18 68.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.22 75.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.74 85.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.473 ' CE1' HD21 ' A' ' 147' ' ' LEU . 58.2 t-80 -61.35 -35.58 77.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.519 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 38.6 mt -64.07 -44.37 92.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.672 ' HA ' HD12 ' A' ' 148' ' ' ILE . 66.3 m-85 -53.33 -39.18 63.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -57.33 -41.39 79.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -67.97 -37.92 82.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 145' ' ' PHE . 81.2 mt -54.16 -44.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 86.8 tt0 -65.64 -45.74 81.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.11 -39.79 96.49 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.35 -50.21 73.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -1.12 . . . . 0.0 109.407 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 14' ' ' ILE . 49.2 mt -62.58 -41.93 99.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.467 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 69.9 tttt -56.48 -44.96 81.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.58 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -60.36 -39.59 87.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -127.54 79.25 73.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.421 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 153' ' ' LYS . 49.6 Cg_endo -70.03 -24.6 28.25 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.768 2.312 . . . . 0.0 111.756 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.1 p -149.39 159.08 44.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -102.04 133.15 47.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -62.75 -39.51 94.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.442 179.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.798 HG21 ' O ' ' A' ' 121' ' ' TYR . 59.8 t -115.36 138.45 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -1.169 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.9 t80 -87.43 147.51 25.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.578 HG22 ' CG2' ' A' ' 118' ' ' THR . 22.0 m -93.51 141.89 27.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.6 140.72 51.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.582 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -110.19 136.19 49.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -118.64 131.07 56.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.644 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 92.4 mt-10 -111.48 111.68 22.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.245 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 11' ' ' THR . 47.7 t80 -126.95 130.59 50.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.576 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 16.2 p -94.0 151.74 19.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.324 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.506 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 85.8 p -147.15 163.53 36.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 14' ' ' ILE . 90.6 m-20 -71.45 -175.77 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.692 HD12 ' C ' ' A' ' 13' ' ' ASP . 5.0 mp 63.12 142.43 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.6 Cg_endo -69.24 146.56 63.81 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.534 2.156 . . . . 0.0 112.173 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.632 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -46.46 -47.43 47.86 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.614 -0.679 . . . . 0.0 111.474 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 41.2 Cg_endo -63.93 -45.67 10.03 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.999 1.799 . . . . 0.0 112.899 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.562 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 61.0 mttm -64.45 -35.0 79.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 152' ' ' LEU . 25.9 tp -80.9 -29.66 35.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HD2' HD23 ' A' ' 105' ' ' LEU . 60.6 t80 -63.02 -37.01 85.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 34.7 tttp -65.51 -42.52 91.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.971 . . . . 0.0 109.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -83.33 -29.96 27.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE1' HG21 ' A' ' 103' ' ' THR . 63.2 t80 -76.63 -18.73 58.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 58.2 t -113.87 -67.0 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.571 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 25' ' ' LEU . 18.1 tp -57.99 -42.08 84.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 75.2 m-20 -96.35 12.92 29.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.574 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.973 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -64.4 -35.67 81.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 109.598 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 44' ' ' ILE . 91.5 m-20 -65.04 -33.89 77.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 46.9 t30 -94.34 -33.78 13.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -65.06 -46.14 82.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 27' ' ' ALA . 4.6 mt -48.2 -58.71 7.35 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.72 -21.34 38.89 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.487 2.124 . . . . 0.0 111.558 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 39.1 tptt -65.15 -40.35 94.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.62 HD12 ' HB3' ' A' ' 147' ' ' LEU . 37.7 mm -61.78 -29.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.12 73.15 5.1 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.463 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 49.8 Cg_endo -69.97 -31.8 18.93 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.675 2.25 . . . . 0.0 111.833 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -70.71 -24.85 62.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.62 -40.23 61.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.257 -0.902 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.708 HG21 HG23 ' A' ' 57' ' ' ILE . 4.9 p -112.74 147.24 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -75.37 -45.14 41.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.42 131.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.49 126.5 35.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.307 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -121.13 150.44 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.655 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.714 HD11 ' OD2' ' A' ' 28' ' ' ASP . 60.9 mt -106.17 121.34 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 0.0 109.37 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.6 mp -66.47 -44.0 83.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.905 ' O ' HG23 ' A' ' 53' ' ' THR . 93.8 mt-10 -159.34 157.53 30.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 102.67 -40.42 2.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 58.32 40.34 24.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.459 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.737 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.88 33.72 20.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.09 -167.19 13.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.72 129.12 17.08 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.595 2.197 . . . . 0.0 111.695 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 72.47 26.35 72.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 46' ' ' GLU . 96.4 m -78.99 144.51 34.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 45' ' ' LEU . 63.3 mt -114.33 129.66 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 3.3 mtmt -124.54 149.63 46.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 45' ' ' LEU . 11.0 ttpp -130.72 126.1 35.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.708 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -114.94 133.76 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.484 ' CG2' ' HA2' ' A' ' 62' ' ' GLY . 88.3 m -115.1 130.92 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' CE1' ' HB ' ' A' ' 39' ' ' VAL . 91.6 m-85 -108.39 143.38 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.1 -169.33 41.91 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -58.2 -28.56 64.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' HA2' ' CG2' ' A' ' 58' ' ' THR . . . 131.9 36.51 0.31 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.4 m -61.02 157.77 14.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -1.162 . . . . 0.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -58.4 -34.1 70.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.93 151.82 24.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.474 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 90' ' ' ASP . . . 103.71 51.22 0.97 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.3 p90 -146.9 146.78 30.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.732 HG22 ' CA ' ' A' ' 89' ' ' GLY . 46.8 t -125.49 144.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -116.21 143.24 45.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 55' ' ' LYS . 89.9 m-70 -123.28 142.76 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.438 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HB2' HD11 ' A' ' 87' ' ' ILE . 17.8 tttp -123.91 140.66 52.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 64.4 mt -100.75 133.16 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 85' ' ' SER . 89.7 m-70 -90.68 -48.49 7.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.5 m -165.03 154.13 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.75 144.89 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 91.6 m-20 -127.83 93.39 3.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -65.92 -38.12 87.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.319 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.22 -42.06 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 72.3 m-20 -87.3 4.98 40.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.574 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 105' ' ' LEU . 66.7 m80 48.46 41.9 17.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.962 . . . . 0.0 109.472 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.8 m -122.05 136.66 54.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 62.6 t80 -129.12 127.07 40.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.369 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 t -121.77 133.43 54.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.652 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 38.5 p90 -149.51 162.96 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.487 ' OG ' ' NE2' ' A' ' 73' ' ' HIS . 55.4 m -138.87 149.26 44.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 87' ' ' ILE . 5.4 tt -88.26 133.81 33.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.974 HG23 ' HE2' ' A' ' 98' ' ' LYS . 71.4 mt -91.45 -77.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.608 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.79 ' HG2' HG22 ' A' ' 87' ' ' ILE . 74.4 mm-40 -115.37 161.81 18.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.651 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.732 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . 171.56 160.31 19.81 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 66' ' ' GLY . 72.0 m-20 -60.87 -34.06 74.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.665 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.73 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -67.82 -31.47 71.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.925 . . . . 0.0 109.724 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.951 HD11 ' CD2' ' A' ' 86' ' ' LEU . 5.8 mt -70.71 -27.77 64.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.185 -0.947 . . . . 0.0 109.152 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 92' ' ' LEU . 0.6 OUTLIER 43.73 -166.01 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.645 -0.66 . . . . 0.0 109.457 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.24 14.71 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.579 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.73 ' O ' HG21 ' A' ' 127' ' ' VAL . 25.9 p-10 -124.39 -11.73 7.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.73 HD12 ' O ' ' A' ' 91' ' ' ALA . 50.7 mt -111.97 126.26 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.701 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 96.6 mt-10 -77.05 -179.57 5.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.974 ' HE2' HG23 ' A' ' 87' ' ' ILE . 16.3 mttp -57.29 167.06 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 120' ' ' LYS . 83.2 mt -123.29 137.99 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.04 122.75 34.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.427 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 89.9 m-85 -114.62 138.6 50.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.509 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 117' ' ' THR . 93.7 mt-10 -131.68 131.48 43.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.382 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.835 HG21 ' CE1' ' A' ' 23' ' ' PHE . 28.6 m -125.85 137.26 53.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' C ' HD22 ' A' ' 105' ' ' LEU . 18.4 tttp -139.03 128.14 23.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.8 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -98.5 117.6 33.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 114' ' ' ILE . 43.8 t -131.72 143.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.275 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 44.2 m -114.36 151.77 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.11 167.83 8.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.524 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.9 Cg_endo -69.05 -17.22 40.9 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.754 2.302 . . . . 0.0 111.773 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -64.54 -14.7 58.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.42 -14.8 50.67 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.86 178.37 40.72 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 99.1 m -117.99 131.36 56.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -1.171 . . . . 0.0 109.727 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 106' ' ' VAL . 64.9 mt -101.75 131.1 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.14 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.13 128.24 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 109.809 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 61.9 mttp -113.21 124.97 53.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.371 -0.831 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 102' ' ' GLU . 62.0 m -129.84 132.72 46.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.007 . . . . 0.0 109.981 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.578 ' CG2' HG22 ' A' ' 5' ' ' THR . 44.0 m -112.48 135.17 53.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.843 . . . . 0.0 109.057 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.3 m -125.97 143.12 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.7 tttm -139.26 133.61 31.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 108.969 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.798 ' O ' HG21 ' A' ' 3' ' ' VAL . 61.5 m-85 -111.36 131.83 54.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.816 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 79.5 m80 -100.74 138.84 37.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.273 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.697 ' HB ' HG23 ' A' ' 127' ' ' VAL . 12.7 p -107.82 156.72 18.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 95' ' ' ASN . 14.2 mmtt -56.74 -41.7 78.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.71 -78.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -101.74 -1.25 32.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -1.184 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.73 HG21 ' O ' ' A' ' 95' ' ' ASN . 30.0 m -61.72 130.04 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -113.9 158.2 21.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.515 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.4 tt -128.54 170.61 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.545 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 81.9 tttt -86.41 120.77 28.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.51 -42.51 33.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' OE1' ' HE2' ' A' ' 130' ' ' LYS . 93.7 mt-10 -57.17 -38.8 74.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.421 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 64.3 m170 -65.43 -44.41 87.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.02 -48.3 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.356 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.63 -43.54 80.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.291 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.53 -43.83 80.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.99 -43.17 93.16 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.06 -45.56 90.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -1.14 . . . . 0.0 109.372 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.47 -42.48 96.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.33 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 60.0 mttp -53.99 -44.63 71.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.306 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.76 -46.82 83.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 0.0 109.343 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.87 85.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.37 -44.5 88.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.393 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 55.8 mt -56.88 -47.66 79.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -54.11 -37.98 64.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.302 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -58.26 -43.25 87.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -62.93 -36.92 85.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.446 ' CD1' HD11 ' A' ' 30' ' ' LEU . 29.3 mm -55.74 -44.45 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 94.1 mt-10 -66.86 -36.64 82.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.92 95.65 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.02 -44.75 83.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -1.149 . . . . 0.0 109.565 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.929 HD11 HD13 ' A' ' 19' ' ' LEU . 37.8 mt -60.97 -40.83 94.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 19.4 tttm -63.31 -39.31 94.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -60.86 -36.86 80.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.471 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.02 126.44 81.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.457 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 159' ' ' TYR . 50.1 Cg_endo -70.25 -9.8 26.75 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.71 2.273 . . . . 0.0 111.841 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 86.7 p -59.27 -27.29 65.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 109.485 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 153' ' ' LYS . 96.8 mt-10 -63.28 -35.85 81.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 156' ' ' PRO . 98.3 m-85 -121.87 140.51 52.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.902 . . . . 0.0 109.428 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.525 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.3 p -109.55 144.49 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -113.35 152.77 29.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 109.228 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 35.1 m -93.46 142.42 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.18 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -119.21 128.3 54.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.826 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -109.41 138.42 45.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.143 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.45 129.75 45.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.872 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 116' ' ' LYS . 88.7 mt-10 -109.37 123.52 49.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.026 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 11' ' ' THR . 54.6 t80 -135.97 135.54 39.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.846 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 114' ' ' ILE . 14.5 p -94.68 131.31 40.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.124 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.747 ' OG ' HD11 ' A' ' 115' ' ' ILE . 94.4 p -130.55 177.16 7.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.863 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 14' ' ' ILE . 41.3 p-10 -80.78 -175.32 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 152' ' ' LEU . 6.7 mm 68.24 136.12 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 49.2 Cg_endo -70.84 149.58 60.23 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.452 2.101 . . . . 0.0 111.888 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.83 -52.36 3.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 0.0 111.176 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.6 Cg_endo -64.72 -50.36 2.45 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.432 2.088 . . . . 0.0 113.228 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 31.2 mttt -61.62 -34.67 76.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.838 -1.164 . . . . 0.0 109.888 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.8 tt -80.59 -28.47 37.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.648 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.63 ' HD1' HD23 ' A' ' 105' ' ' LEU . 74.6 t80 -72.35 -34.61 68.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.608 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 97.3 mttt -68.08 -41.12 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.7 -23.3 27.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.841 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.2 t80 -82.96 -14.45 54.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CE1' ' A' ' 20' ' ' PHE . 59.0 t -119.96 -55.94 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.6 tp -67.77 -38.82 83.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 55.0 m-20 -104.83 18.29 22.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.946 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -69.87 -37.2 76.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.338 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 42' ' ' ALA . 52.6 t0 -76.78 -20.64 56.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.679 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 93.4 m-20 -104.42 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.935 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 HG23 ' A' ' 148' ' ' ILE . 19.0 tp -70.98 -38.83 72.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.946 HD12 ' O ' ' A' ' 27' ' ' ALA . 8.0 mt -55.71 -56.7 27.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.8 Cg_endo -69.63 -11.41 30.94 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.393 2.062 . . . . 0.0 111.67 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 12.0 mttm -83.43 -36.52 24.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 147' ' ' LEU . 80.3 mt -76.88 -30.72 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.48 75.44 7.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 39' ' ' VAL . 48.6 Cg_endo -69.63 -28.58 25.71 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.706 2.271 . . . . 0.0 111.694 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.11 -23.88 54.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.278 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.9 -39.95 65.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 57' ' ' ILE . 5.7 p -116.62 150.75 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 58' ' ' THR . 27.7 tttm -75.46 -51.69 12.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 130.71 0.05 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . . . -94.54 123.0 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -125.82 152.18 45.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 64.7 mt -105.96 119.2 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 25.5 tp -61.99 -43.73 98.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.902 ' O ' HG23 ' A' ' 53' ' ' THR . 94.4 mt-10 -160.05 154.92 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 105.54 -42.28 1.94 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.8 m-20 61.39 36.61 17.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 53' ' ' THR . . . 87.33 34.37 10.64 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.0 -165.17 12.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.96 131.12 20.3 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.733 2.288 . . . . 0.0 111.783 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.53 27.94 72.89 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.902 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.7 m -83.23 142.57 31.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -1.162 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.456 HD13 ' HG3' ' A' ' 71' ' ' LYS . 24.0 mm -108.79 131.5 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' CE ' HD11 ' A' ' 72' ' ' ILE . 64.2 mttt -117.17 148.79 41.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 48.4 tttp -132.92 127.24 33.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.346 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.582 HD11 ' CD2' ' A' ' 70' ' ' HIS . 42.5 mt -120.15 131.37 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 40' ' ' LYS . 62.4 m -114.63 127.26 55.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.711 ' HE2' HG23 ' A' ' 68' ' ' VAL . 97.8 m-85 -92.0 136.57 33.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.6 129.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' HG3' ' HE2' ' A' ' 40' ' ' LYS . 82.9 tt0 -64.92 -42.68 94.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.85 -51.11 0.38 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -81.18 174.56 11.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 59' ' ' PHE . 39.7 m170 55.58 58.98 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' GLY . 94.1 m-85 -57.7 -16.75 11.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.504 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' TYR . . . -43.82 144.34 1.83 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.419 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 40.1 p90 -151.89 146.52 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.299 -1.118 . . . . 0.0 109.295 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.892 HG22 ' HA2' ' A' ' 89' ' ' GLY . 41.2 t -124.28 148.21 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.58 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 85.7 mttt -121.51 144.1 48.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.0 109.359 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 57' ' ' ILE . 90.9 m-70 -122.9 138.48 54.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HG3' HD13 ' A' ' 54' ' ' ILE . 40.0 tttt -117.61 141.85 47.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 44.0 mt -103.03 131.5 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.583 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 97.1 m-70 -92.62 -41.98 9.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.579 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -171.31 146.21 2.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.4 143.49 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.05 90.92 3.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 96.7 mttt -60.86 -35.33 76.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.79 -41.92 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 80' ' ' HIS . 76.1 m-20 -87.86 10.16 19.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 79' ' ' ASN . 65.8 m80 44.42 42.79 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.471 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.6 m -123.31 132.84 54.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.498 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 70.2 t80 -120.18 124.18 45.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.388 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.8 t -118.16 128.84 55.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.62 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 30.8 p90 -155.87 171.19 20.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.855 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.7 p -142.45 162.64 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 99' ' ' ILE . 5.0 tt -98.86 129.37 45.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.855 ' N ' HD23 ' A' ' 86' ' ' LEU . 23.9 mm -88.17 -74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.762 ' O ' HD21 ' A' ' 86' ' ' LEU . 95.5 mt-10 -115.24 159.17 21.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.892 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -178.29 159.54 25.05 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -60.66 -46.6 89.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -1.106 . . . . 0.0 109.39 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.57 -23.64 67.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.951 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 92' ' ' LEU . 5.9 mp -82.71 -44.11 16.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 13.9 t 60.18 163.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.317 -0.864 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.68 -11.2 53.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.799 ' HB3' HG11 ' A' ' 127' ' ' VAL . 3.4 m-20 -72.38 -40.26 67.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.613 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 123' ' ' THR . 41.8 pt -151.71 131.34 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 30.5 mt-10 -146.34 106.45 4.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.921 . . . . 0.0 108.967 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . 39.5 tptt -179.63 93.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.872 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.893 HD12 HD13 ' A' ' 86' ' ' LEU . 4.3 mt -124.59 118.16 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.917 -1.114 . . . . 0.0 110.005 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -94.86 121.58 36.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.0 108.901 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 99' ' ' ILE . 64.9 m-85 -114.14 136.73 52.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.956 . . . . 0.0 109.932 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.1 mt-10 -130.24 126.27 36.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 108.983 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.829 HG21 ' CE2' ' A' ' 23' ' ' PHE . 29.8 m -123.29 131.62 53.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -138.39 122.64 18.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.195 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -94.26 130.81 40.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' ILE . 78.3 t -131.52 135.53 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.0 p -106.81 142.62 36.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 109.476 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.787 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.87 169.36 6.39 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.787 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.1 Cg_endo -70.26 -14.9 35.01 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 122.717 2.278 . . . . 0.0 111.77 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.23 -15.37 61.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.36 53.06 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.11 168.24 32.34 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.5 m -119.61 126.55 51.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 109.525 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 11' ' ' THR . 65.9 mt -95.73 136.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.747 HD11 ' OG ' ' A' ' 12' ' ' SER . 3.1 mt -119.27 119.93 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 9' ' ' GLU . 10.7 mtpt -105.13 121.17 43.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.11 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 80.1 m -126.73 134.07 50.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 0.0 109.934 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.524 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 61.9 m -116.68 138.48 51.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.107 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -131.57 141.58 49.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 109.811 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HE2' ' NE2' ' A' ' 122' ' ' HIS . 22.5 tttt -136.32 149.82 48.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.444 -0.785 . . . . 0.0 109.18 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.977 ' O ' HG21 ' A' ' 3' ' ' VAL . 94.5 m-85 -127.99 142.7 51.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.06 -1.025 . . . . 0.0 109.766 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 64.3 m80 -134.95 165.15 25.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 96' ' ' ILE . 25.7 p -116.3 149.38 39.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.965 . . . . 0.0 109.729 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 23.6 mttm -60.7 -53.3 59.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -121.07 -66.48 0.26 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -174.32 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.799 HG11 ' HB3' ' A' ' 95' ' ' ASN . 47.1 t -58.74 -36.05 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 82.8 tt0 65.44 144.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.705 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.1 tt -127.5 171.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.555 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 78.7 tttt -85.39 125.65 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -54.39 -41.28 69.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.555 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 66.4 m170 -66.49 -42.46 87.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.384 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.517 HG12 ' HE2' ' A' ' 138' ' ' LYS . 42.6 t -69.39 -44.07 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.464 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -55.8 -42.45 75.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.7 -44.5 81.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -37.53 94.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.517 ' HE2' HG12 ' A' ' 134' ' ' VAL . 32.6 mttm -60.12 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -63.7 -43.16 97.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.381 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.9 tttm -56.93 -45.28 82.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.44 95.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.907 . . . . 0.0 109.43 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.4 99.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.438 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -57.09 -48.77 77.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.424 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -61.76 -39.51 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.366 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.633 ' CZ ' HD13 ' A' ' 115' ' ' ILE . 58.9 t80 -53.96 -41.77 68.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.336 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -58.4 -41.95 86.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.545 ' HB2' HD13 ' A' ' 34' ' ' ILE . 48.7 mt -57.43 -41.08 79.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.743 HG23 HD21 ' A' ' 30' ' ' LEU . 88.3 mt -54.87 -47.41 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 83.2 mt-10 -54.71 -47.17 74.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.179 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.54 -27.27 71.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.14 -47.26 85.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -1.113 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.5 mp -73.66 -49.53 25.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -55.6 -30.85 61.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.25 -0.906 . . . . 0.0 109.257 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 52.8 t0 -85.98 -29.65 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.863 . . . . 0.0 109.309 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 154' ' ' ASP . 42.3 p-80 40.24 66.28 3.39 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.539 -0.726 . . . . 0.0 109.977 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.81 139.3 36.32 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.632 2.222 . . . . 0.0 111.562 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.7 p -117.56 157.83 25.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -113.46 146.29 39.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 71.0 t80 -129.9 137.36 50.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.573 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 159' ' ' TYR . 42.1 p-10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 121' ' ' TYR . 7.8 p -114.15 139.73 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.513 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -110.57 156.68 20.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.362 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 17.8 m -93.56 142.78 26.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.403 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -119.41 135.23 54.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -110.45 133.8 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.272 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.02 131.84 54.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.61 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.64 122.88 47.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.319 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 11' ' ' THR . 82.0 t80 -142.82 146.57 34.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.61 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.568 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 17.0 p -108.29 142.45 38.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.208 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.418 ' OG ' ' CG ' ' A' ' 149' ' ' GLU . 20.8 t -141.12 159.17 42.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.965 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.45 -175.96 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mt 66.08 141.92 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.085 -1.009 . . . . 0.0 109.146 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 47.2 Cg_endo -70.01 146.52 58.9 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.444 2.096 . . . . 0.0 112.001 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.21 -50.61 6.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.543 -0.723 . . . . 0.0 111.403 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.09 -50.31 3.03 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.29 1.993 . . . . 0.0 113.076 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 33.3 mttp -59.66 -33.59 71.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.795 -1.19 . . . . 0.0 109.515 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 19' ' ' LEU . 9.9 tt -80.92 -34.39 33.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.808 ' CE1' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -64.81 -32.13 73.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.835 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 20.3 tttm -68.89 -46.29 68.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.713 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.51 -21.74 38.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.737 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.874 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 68.1 t80 -86.42 -17.71 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.808 HG21 ' CE1' ' A' ' 20' ' ' PHE . 66.5 t -115.9 -51.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 27.9 tp -68.46 -40.33 81.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.484 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 79.2 m-20 -103.38 18.6 21.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.874 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.97 -35.98 74.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.682 ' OD2' HD11 ' A' ' 44' ' ' ILE . 95.2 m-20 -67.76 -32.07 72.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 20.8 t-20 -99.34 -43.63 6.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 148' ' ' ILE . 15.9 tp -55.7 -42.61 75.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.775 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 27' ' ' ALA . 13.8 mt -49.78 -62.32 2.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.516 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.51 -16.98 43.59 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.498 2.132 . . . . 0.0 111.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' NZ ' ' CG ' ' A' ' 159' ' ' TYR . 21.3 tptm -67.54 -45.23 76.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.623 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 147' ' ' LEU . 75.7 mt -70.23 -35.17 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.705 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.73 71.76 57.07 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.7 Cg_endo -70.61 -30.98 17.53 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 111.715 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -75.06 -30.09 60.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.14 97.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.587 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG23 ' A' ' 57' ' ' ILE . 4.0 p -121.13 150.26 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -74.92 -47.47 29.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.515 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 178.48 129.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.28 125.65 36.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.49 155.7 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.682 HD11 ' OD2' ' A' ' 28' ' ' ASP . 54.9 mt -106.03 120.65 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -65.81 -44.0 86.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 53' ' ' THR . 92.9 mt-10 -158.81 154.92 26.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 106.76 -42.48 1.91 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.6 m-20 59.99 40.17 19.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.354 -1.086 . . . . 0.0 109.558 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.671 ' H ' HG21 ' A' ' 53' ' ' THR . . . 83.17 33.76 22.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.36 -168.46 13.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.59 130.0 18.77 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.705 2.27 . . . . 0.0 111.714 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.01 25.88 72.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.851 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -79.18 143.12 35.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 68.4 mt -112.51 132.05 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 28' ' ' ASP . 46.7 mttt -123.49 150.79 43.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.622 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -132.34 122.84 25.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.701 HG23 HG21 ' A' ' 39' ' ' VAL . 36.1 mt -113.34 140.58 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.622 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.5 m -120.69 128.3 52.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -103.85 136.43 43.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.219 -0.925 . . . . 0.0 109.577 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.0 164.92 37.98 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -122.79 142.07 51.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -1.14 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.12 11.86 83.92 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.9 m -120.38 143.15 48.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.564 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -102.22 -3.97 26.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.545 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -114.2 154.89 27.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.378 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 90' ' ' ASP . . . 95.03 60.22 1.08 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 38.5 p90 -138.55 144.38 39.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.647 HG22 ' CA ' ' A' ' 89' ' ' GLY . 40.9 t -124.85 143.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 49.5 mtmt -113.19 147.59 37.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' ' CD1' ' A' ' 57' ' ' ILE . 91.9 m-70 -122.85 136.84 55.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' THR . 66.0 tttt -117.31 138.21 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.382 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 62.8 mt -99.72 132.98 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -90.5 -45.71 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.3 p -169.91 148.84 3.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.08 144.47 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.0 m-20 -131.05 92.16 3.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -62.8 -34.8 78.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.402 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.54 -39.86 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 77.1 m-20 -87.28 4.7 41.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 48.44 43.88 20.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.4 m -126.58 136.99 53.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 61.3 t80 -131.19 127.47 38.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.33 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.8 p -121.45 137.18 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.614 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.0 p90 -151.37 169.3 22.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 83.0 p -145.55 160.96 40.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 92' ' ' LEU . 4.1 tt -97.59 119.57 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.374 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.847 HG22 ' HG2' ' A' ' 88' ' ' GLU . 93.5 mt -75.58 -56.7 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HG2' HG22 ' A' ' 87' ' ' ILE . 75.4 mm-40 -148.46 162.04 40.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -0.99 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -174.33 150.8 11.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 7.9 t0 -60.12 -26.61 66.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -1.131 . . . . 0.0 109.563 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.34 -28.73 47.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 86' ' ' LEU . 2.9 mt -75.19 -33.05 61.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 108.755 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m 52.85 -173.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.606 -0.684 . . . . 0.0 109.451 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 124' ' ' LYS . 96.9 mt-10 -80.25 -3.42 49.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.718 ' HB3' HG11 ' A' ' 127' ' ' VAL . 76.4 m-20 -90.68 -36.24 14.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 92' ' ' LEU . 42.6 mt -92.3 130.41 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 110.041 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 70.4 mm-40 -88.55 -178.35 5.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 36.6 mttp -56.12 153.62 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.753 HD13 ' CE2' ' A' ' 121' ' ' TYR . 53.8 mt -118.03 137.68 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 120' ' ' LYS . 87.4 m-20 -93.17 124.95 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.36 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.614 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 83.7 m-85 -117.24 140.67 49.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 117' ' ' THR . 93.6 mt-10 -133.76 136.65 44.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.304 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -128.4 137.44 51.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -139.76 128.95 23.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.8 mm? -98.31 130.57 44.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.528 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 114' ' ' ILE . 38.7 t -131.19 145.93 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 94.7 p -112.68 143.07 44.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.865 . . . . 0.0 109.478 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -111.46 164.93 13.83 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.8 Cg_endo -69.39 -18.05 38.96 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.634 2.222 . . . . 0.0 111.771 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -66.01 -15.51 63.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.862 . . . . 0.0 109.43 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.45 26.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -85.49 -179.84 50.48 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 66.4 m -124.75 126.87 46.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.159 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 106' ' ' VAL . 66.1 mt -90.38 137.9 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.337 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.753 HD13 ' HZ ' ' A' ' 145' ' ' PHE . 45.6 mt -119.84 129.11 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -118.8 127.0 53.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 0.0 109.205 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 102' ' ' GLU . 52.5 m -126.44 134.46 50.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.729 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.0 m -116.87 142.73 46.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 109.094 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.486 ' OG ' ' CE1' ' A' ' 101' ' ' TYR . 27.1 t -139.33 148.85 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.041 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.737 ' O ' HG23 ' A' ' 99' ' ' ILE . 82.3 tttt -136.5 130.71 32.93 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.901 ' O ' HG21 ' A' ' 3' ' ' VAL . 27.8 m-85 -108.76 126.65 53.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.073 -1.017 . . . . 0.0 109.924 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 34.3 m170 -98.02 146.88 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.16 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 p -129.23 162.02 28.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.097 -1.002 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 94' ' ' GLU . 28.7 mtpp -53.68 -48.97 68.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -169.24 -62.33 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -154.3 51.46 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -1.113 . . . . 0.0 109.634 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 95' ' ' ASN . 85.5 t -65.02 -22.87 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 109.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 68.3 tt0 70.56 127.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.7 tt -128.95 170.91 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -94.13 125.8 38.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.37 -40.55 68.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.4 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.75 -35.29 77.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -66.36 -44.38 83.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.882 . . . . 0.0 109.428 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.72 -43.82 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.909 . . . . 0.0 109.422 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 32.7 ttpt -60.3 -39.55 87.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.354 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -59.84 -43.02 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.6 -43.12 99.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HE2' ' OH ' ' A' ' 121' ' ' TYR . 35.5 mmtp -62.02 -41.41 98.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.35 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' O ' ' CD2' ' A' ' 143' ' ' HIS . 96.7 mt-10 -62.32 -43.04 99.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 98.8 mttt -57.56 -42.04 82.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.893 . . . . 0.0 109.374 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.09 -42.66 93.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.16 85.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 139' ' ' GLU . 86.3 m-70 -56.91 -50.94 71.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.92 -47.27 85.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.753 ' HZ ' HD13 ' A' ' 115' ' ' ILE . 49.4 t80 -53.35 -43.26 67.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -55.11 -43.26 73.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.302 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 34' ' ' ILE . 65.2 mt -56.69 -45.02 82.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 30' ' ' LEU . 93.4 mt -53.8 -52.02 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.298 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.418 ' CG ' ' OG ' ' A' ' 12' ' ' SER . 83.7 tt0 -54.27 -41.82 69.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.233 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -77.57 -23.42 67.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 147' ' ' LEU . 70.1 t80 -63.18 -45.68 90.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.341 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.6 mp -75.01 -42.01 58.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.347 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -53.43 -34.12 56.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.876 . . . . 0.0 108.863 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 155' ' ' HIS . 89.9 m-20 -76.66 -40.92 47.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.011 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' ASP . 6.8 t-160 43.15 68.22 3.08 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 159' ' ' TYR . 48.7 Cg_endo -69.82 132.49 23.35 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.733 2.288 . . . . 0.0 111.824 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.8 m -59.29 -26.26 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.427 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 73.1 mm-40 -70.76 -34.34 71.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' A' ' 156' ' ' PRO . 25.2 m-85 -123.2 134.02 54.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.488 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.439 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 121' ' ' TYR . 48.8 t -118.2 134.4 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -1.156 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -123.14 150.52 43.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.617 HG22 ' CG2' ' A' ' 118' ' ' THR . 19.9 m -93.95 138.13 32.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' THR . 77.5 t80 -122.86 134.51 54.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.579 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -113.43 133.77 55.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -121.78 131.66 54.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 88.8 mt-10 -104.04 118.95 37.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 11' ' ' THR . 62.4 t80 -133.29 132.39 41.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.5 p -93.9 142.96 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 149' ' ' GLU . 24.4 m -135.3 160.48 38.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.673 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' ILE . 96.5 m-20 -69.26 -175.72 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.739 HD13 HD12 ' A' ' 152' ' ' LEU . 1.3 mt 61.78 141.72 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.959 . . . . 0.0 109.077 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 46.0 Cg_endo -69.21 146.23 62.92 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.452 2.102 . . . . 0.0 111.978 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.941 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -41.12 -49.82 8.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.592 -0.692 . . . . 0.0 111.365 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.3 Cg_endo -63.93 -49.32 4.09 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.252 1.968 . . . . 0.0 113.027 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.557 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 96.6 mttt -62.09 -35.48 78.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.523 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' PHE . 20.4 tp -80.57 -27.98 37.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.892 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 64.1 t80 -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.72 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -60.4 -43.89 96.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -81.4 -20.56 40.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.988 ' C ' ' HB2' ' A' ' 27' ' ' ALA . 71.0 t80 -99.09 6.64 46.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.892 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 94.6 t -135.0 -78.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.144 -0.973 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.02 -49.22 74.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 80.0 m-20 -99.07 12.14 36.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.988 ' HB2' ' C ' ' A' ' 23' ' ' PHE . . . -69.53 -36.4 76.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 31' ' ' ILE . 52.6 t0 -73.18 -29.87 63.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 22.8 m120 -91.06 -29.01 17.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.481 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.98 ' O ' HD13 ' A' ' 30' ' ' LEU . 1.8 tm? -73.52 -34.15 65.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.877 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 19.7 mt -51.32 -55.8 25.75 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.605 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.56 -17.89 43.16 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.499 2.132 . . . . 0.0 111.856 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.64 ' HD2' HD22 ' A' ' 30' ' ' LEU . 42.5 mttt -71.09 -40.45 71.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 109.521 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.504 ' CG2' HD13 ' A' ' 147' ' ' LEU . 87.9 mt -68.13 -34.63 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.74 70.39 19.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.3 Cg_endo -70.18 -34.58 12.91 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.656 2.237 . . . . 0.0 111.727 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.75 -19.9 65.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.25 -26.56 21.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 57' ' ' ILE . 1.9 t -118.01 139.79 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.1 -51.08 23.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.48 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.907 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.39 117.67 29.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.22 147.76 45.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.317 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 74.3 mt -106.36 118.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.2 tp -60.58 -45.19 94.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 53' ' ' THR . 94.7 mt-10 -159.32 157.87 31.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 108.35 -43.03 1.79 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 87.9 m-20 59.76 38.33 21.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.09 33.01 21.92 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.436 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -118.78 -168.2 14.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.03 130.75 19.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.692 2.261 . . . . 0.0 111.668 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 71.51 26.73 72.59 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 46' ' ' GLU . 88.2 m -80.37 140.3 36.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 64.2 mt -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 2.9 mtpt -119.22 149.17 42.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -131.87 124.43 29.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.641 HD12 ' CE1' ' A' ' 70' ' ' HIS . 20.5 mt -119.96 131.38 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -111.99 121.66 45.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.341 -0.849 . . . . 0.0 109.109 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 60' ' ' GLY . 82.1 m-85 -91.05 133.26 35.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.484 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 59' ' ' PHE . . . -43.36 155.36 0.19 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.3 157.16 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -1.169 . . . . 0.0 109.543 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.91 71.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -106.93 155.35 19.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -56.35 -27.87 57.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.786 ' CD1' ' HB2' ' A' ' 91' ' ' ALA . 16.0 m-85 -122.58 142.63 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . -86.58 -64.83 1.42 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 35.4 p90 -158.25 144.8 17.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -1.199 . . . . 0.0 109.905 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.812 HG12 ' CA ' ' A' ' 89' ' ' GLY . 4.6 m -134.47 150.31 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 109.089 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.644 ' O ' HD12 ' A' ' 86' ' ' LEU . 37.6 mttt -106.45 139.91 40.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.774 ' NE2' HD13 ' A' ' 86' ' ' LEU . 70.3 m80 -114.42 143.82 44.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 109.17 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 87' ' ' ILE . 17.8 tttp -127.35 138.95 53.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.709 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 59.1 mt -98.69 131.15 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.17 -49.16 6.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m -163.34 152.12 14.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.8 pt -129.21 145.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 69.0 m-20 -122.15 107.09 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.221 -0.924 . . . . 0.0 109.289 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -82.7 -25.77 32.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 108.553 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -46.99 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 65.5 m-80 -80.56 -5.37 56.67 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.492 -0.755 . . . . 0.0 109.651 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 57.2 m80 60.16 42.74 15.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.497 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 63.5 m -124.36 135.04 53.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 65.9 t80 -124.63 129.5 50.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.0 m -122.14 135.28 54.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.649 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.625 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 34.9 p90 -151.48 168.09 25.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.307 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 95.3 p -149.59 152.16 35.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.937 . . . . 0.0 109.588 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 70' ' ' HIS . 37.7 tp -91.96 117.42 29.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.292 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.831 HG22 ' HG3' ' A' ' 88' ' ' GLU . 24.1 mm -70.4 -71.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.735 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.831 ' HG3' HG22 ' A' ' 87' ' ' ILE . 96.2 mt-10 -128.06 169.35 14.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.0 109.803 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.812 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . 176.72 137.36 2.63 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 31.3 m-20 -47.55 -40.5 19.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -1.167 . . . . 0.0 109.694 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.786 ' HB2' ' CD1' ' A' ' 65' ' ' TYR . . . -65.23 -15.52 62.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 92' ' ' LEU . 7.0 mp -87.89 -43.79 11.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 m 61.93 178.43 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.408 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.17 -2.05 39.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.632 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 127' ' ' VAL . 16.5 p-10 -91.75 -21.58 20.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.176 -0.953 . . . . 0.0 109.716 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 51.5 mt -111.3 141.36 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.211 -0.931 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 97.0 mt-10 -95.6 179.84 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 3.8 pttm -57.52 164.61 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 120' ' ' LYS . 68.2 mt -120.72 134.23 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 120' ' ' LYS . 61.9 t0 -89.7 122.7 33.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 77.9 m-85 -115.51 139.8 49.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.275 -0.891 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 94.1 mt-10 -131.04 136.85 48.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.928 HG21 ' CE2' ' A' ' 23' ' ' PHE . 53.6 m -132.07 133.17 44.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 22.7 tttt -131.61 133.36 44.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 109.477 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 16' ' ' ALA . 1.2 mp -103.84 125.1 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 40.1 t -131.76 140.43 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 92.7 p -110.57 141.32 43.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -0.933 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -109.75 164.74 14.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.556 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.645 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.6 Cg_endo -69.96 -7.12 20.33 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.752 2.301 . . . . 0.0 111.791 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -78.82 -18.5 53.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.448 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.91 -29.45 7.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.87 174.53 55.09 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 106' ' ' VAL . 86.9 m -122.14 125.57 46.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 109.539 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 62.1 mt -90.22 138.34 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.604 HG23 HD12 ' A' ' 105' ' ' LEU . 44.0 mt -125.87 127.8 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.794 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 53.5 mttp -105.05 128.71 53.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -125.88 129.85 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 110.007 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.617 ' CG2' HG22 ' A' ' 5' ' ' THR . 33.1 m -118.49 133.87 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 108.923 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.8 m -123.8 142.46 51.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 110.09 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.703 ' O ' HG23 ' A' ' 99' ' ' ILE . 75.9 tttt -139.38 129.44 25.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' A' ' 99' ' ' ILE . 25.2 m-85 -111.65 131.57 55.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 109.884 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 71.4 m80 -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.456 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 22.0 p -112.63 163.22 14.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.541 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -58.01 -35.93 71.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 169.9 -79.68 0.1 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -98.17 9.57 42.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -1.115 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 95' ' ' ASN . 55.4 t -63.14 130.12 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.7 151.05 29.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.504 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.65 HD11 ' HD2' ' A' ' 133' ' ' HIS . 16.6 tt -125.08 171.44 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.2 131.77 44.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.513 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.37 -38.31 68.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.97 -38.0 81.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.65 ' HD2' HD11 ' A' ' 129' ' ' ILE . 85.9 t60 -68.57 -40.44 80.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.36 -42.42 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -58.89 -41.5 87.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.412 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.48 79.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.24 98.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -60.84 -45.15 95.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.36 -40.21 95.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -57.37 -44.12 84.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.335 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.23 -48.65 64.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.72 77.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.331 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -63.52 -41.58 98.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.863 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 144' ' ' LEU . 35.3 mt -61.71 -45.98 91.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -53.28 -42.96 67.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.399 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -62.47 -39.67 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.504 HD13 ' CG2' ' A' ' 34' ' ' ILE . 60.5 mt -66.72 -40.73 88.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.401 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.41 HD13 ' HD1' ' A' ' 23' ' ' PHE . 82.2 mt -56.01 -45.73 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.34 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 96.6 mt-10 -60.66 -46.64 89.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.76 -39.87 96.96 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -53.4 -55.38 25.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -1.088 . . . . 0.0 109.462 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.739 HD12 HD13 ' A' ' 14' ' ' ILE . 66.1 mt -63.84 -42.22 97.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -56.36 -44.79 80.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.446 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 155' ' ' HIS . 90.7 m-20 -56.96 -53.63 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.482 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 154' ' ' ASP . 2.8 t-160 44.49 76.22 0.56 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.526 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.62 128.97 15.95 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -59.51 -33.32 71.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.72 146.5 25.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.479 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -110.6 140.57 44.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.855 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.435 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.991 HG21 ' O ' ' A' ' 121' ' ' TYR . 9.6 p -114.81 138.76 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -1.166 . . . . 0.0 109.511 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.37 156.66 22.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 109.381 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 57.3 m -93.42 143.51 26.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.29 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -109.63 141.97 41.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.278 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -127.83 129.66 47.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 91.2 mt-10 -101.76 124.78 47.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 11' ' ' THR . 46.9 t80 -136.25 127.03 27.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.233 -0.917 . . . . 0.0 109.526 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 15.1 p -90.42 154.73 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.563 ' OG ' HD11 ' A' ' 115' ' ' ILE . 88.9 p -149.32 167.9 24.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 87.3 m-20 -77.2 -175.25 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.446 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.981 HD12 ' OE1' ' A' ' 149' ' ' GLU . 6.4 mt 63.4 142.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 14' ' ' ILE . 48.3 Cg_endo -70.34 147.25 58.75 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.533 2.155 . . . . 0.0 112.106 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -41.14 -50.4 8.14 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.514 -0.741 . . . . 0.0 111.429 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.2 Cg_endo -64.08 -50.27 3.08 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.303 2.002 . . . . 0.0 113.031 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 60.4 mttt -61.93 -37.02 83.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 149' ' ' GLU . 27.6 tp -81.3 -24.95 36.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.116 -0.99 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' HD1' HD23 ' A' ' 105' ' ' LEU . 66.1 t80 -72.96 -34.56 66.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 109.859 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 17.5 mttp -67.25 -45.78 75.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.765 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.29 -28.12 42.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.624 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 59.4 t80 -76.53 -15.69 59.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 44.2 t -119.68 -53.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 46.0 mt -67.85 -40.45 83.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 80.3 m-20 -100.52 11.11 40.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -70.18 -31.66 69.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.89 . . . . 0.0 109.628 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -68.64 -21.83 64.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 27.8 m120 -114.23 -37.81 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.075 -1.016 . . . . 0.0 109.485 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.656 HD11 ' CG ' ' A' ' 151' ' ' TYR . 30.1 tp -58.2 -36.94 73.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 27' ' ' ALA . 11.5 mt -55.78 -60.5 8.47 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.188 -0.945 . . . . 0.0 109.195 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.45 -11.35 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.558 2.172 . . . . 0.0 111.583 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 18.7 mttt -80.84 -35.63 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 109.607 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 147' ' ' LEU . 87.6 mt -73.54 -31.18 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.36 68.49 54.4 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 39' ' ' VAL . 49.4 Cg_endo -70.15 -31.42 18.83 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.7 2.266 . . . . 0.0 111.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.33 -29.29 63.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.363 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.02 60.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 ' CG2' ' A' ' 57' ' ' ILE . 5.6 p -128.72 149.23 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.389 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' CD ' ' OE2' ' A' ' 61' ' ' GLU . 21.9 mtpp -71.89 -51.69 20.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 109.608 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.1 144.24 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.67 120.32 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -113.19 156.18 23.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.646 HG21 ' N ' ' A' ' 48' ' ' ASP . 22.1 mm -106.83 133.89 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.5 tp -78.98 -37.91 38.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.518 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.813 ' O ' HG23 ' A' ' 53' ' ' THR . 57.8 mm-40 -159.06 133.6 7.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 104.22 -34.74 5.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 44' ' ' ILE . 5.3 m-20 51.49 56.98 7.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -1.109 . . . . 0.0 109.794 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.918 ' H ' HG21 ' A' ' 53' ' ' THR . . . 80.09 36.08 25.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.73 -168.78 14.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.14 133.43 26.69 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.595 2.197 . . . . 0.0 111.47 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.16 20.96 58.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.918 HG21 ' H ' ' A' ' 49' ' ' GLY . 49.5 m -73.38 146.83 44.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 0.0 109.741 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 23.8 mm -106.39 135.8 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' CE ' HD11 ' A' ' 72' ' ' ILE . 45.5 mttt -115.95 143.26 45.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.672 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 63.0 tttm -129.68 129.86 44.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 39' ' ' VAL . 44.0 mt -125.59 130.53 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.887 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -112.17 128.1 56.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.132 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.479 ' HE2' HG23 ' A' ' 68' ' ' VAL . 75.2 m-85 -103.15 132.31 49.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' PHE . . . 50.09 178.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' OE2' ' CD ' ' A' ' 40' ' ' LYS . 65.2 mm-40 -142.08 168.64 19.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 0.0 109.431 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.76 87.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.9 p -106.25 145.64 31.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.174 . . . . 0.0 109.421 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -56.13 -46.93 79.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -140.33 175.45 9.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.359 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.12 67.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE1' ' HE3' ' A' ' 69' ' ' LYS . 45.8 p90 -151.85 143.97 23.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -1.162 . . . . 0.0 109.514 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.86 HG22 ' HA2' ' A' ' 89' ' ' GLY . 61.4 t -118.44 141.77 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.267 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 50.3 mttt -116.56 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CE1' ' HG ' ' A' ' 86' ' ' LEU . 94.0 m-70 -120.97 144.84 48.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.753 ' HB2' HD11 ' A' ' 87' ' ' ILE . 45.3 tttt -121.36 140.88 51.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.559 HD11 ' CE ' ' A' ' 55' ' ' LYS . 66.0 mt -99.22 134.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.436 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.469 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.8 m-70 -88.93 -48.47 7.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.0 p -169.84 150.95 4.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' CE1' ' A' ' 82' ' ' TYR . 21.1 pt -129.08 144.78 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -129.42 92.68 3.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.511 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 95.2 mttt -64.28 -36.29 83.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.73 -42.75 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -87.66 6.68 33.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.0 m80 47.88 44.6 18.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.6 m -124.38 138.5 54.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.38 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 52.6 t80 -134.26 132.46 39.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 m -126.28 140.47 52.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 36.5 p90 -153.01 171.6 18.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.3 p -149.53 152.67 35.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 92' ' ' LEU . 4.6 tt -87.97 127.59 35.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.817 ' N ' HD23 ' A' ' 86' ' ' LEU . 82.9 mt -86.35 -72.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.15 -0.969 . . . . 0.0 109.441 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.779 ' O ' HG13 ' A' ' 68' ' ' VAL . 95.3 mt-10 -122.74 160.58 25.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.86 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . -177.91 153.73 13.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -61.83 -25.48 67.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -1.13 . . . . 0.0 109.556 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' HD12 ' A' ' 96' ' ' ILE . . . -78.69 -30.41 46.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.975 HD11 HD22 ' A' ' 86' ' ' LEU . 3.9 mt -71.71 -31.85 67.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 108.853 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m 50.21 -172.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.626 -0.671 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.26 15.04 9.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.427 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -116.39 -17.87 10.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 91' ' ' ALA . 23.5 mt -109.34 141.47 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 94.0 mt-10 -90.7 -179.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.664 ' HE2' HG23 ' A' ' 87' ' ' ILE . 31.6 mttp -57.62 176.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.687 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 120' ' ' LYS . 59.0 mt -133.18 133.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.414 -0.804 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' SER . 80.5 m-20 -87.28 121.4 29.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 67.0 m-85 -114.39 144.1 43.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 117' ' ' THR . 89.1 mt-10 -132.81 139.24 47.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 23' ' ' PHE . 32.7 m -135.41 128.45 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -134.88 124.66 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.827 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.7 mm? -93.7 129.12 40.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 114' ' ' ILE . 57.5 t -131.99 141.53 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.49 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.5 p -108.43 146.53 32.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -112.04 164.79 14.32 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.8 Cg_endo -70.01 -17.61 36.35 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.673 2.249 . . . . 0.0 111.848 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.76 -15.34 61.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -15.45 35.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.22 170.03 46.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.1 m -119.96 126.13 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 106' ' ' VAL . 67.0 mt -93.16 139.56 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.563 HD11 ' OG ' ' A' ' 12' ' ' SER . 56.2 mt -127.1 121.89 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 109.728 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 58.0 mttp -106.82 132.37 52.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.046 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 102' ' ' GLU . 74.0 m -131.74 129.79 41.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.584 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 30.2 m -113.15 148.63 34.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.797 . . . . 0.0 108.922 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 55.3 m -140.23 148.44 41.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.827 ' O ' HG23 ' A' ' 99' ' ' ILE . 77.3 tttt -138.35 127.25 23.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.162 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.991 ' O ' HG21 ' A' ' 3' ' ' VAL . 40.3 m-85 -105.49 121.98 45.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 78.8 m80 -101.74 141.33 34.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 97' ' ' GLU . 28.8 p -119.2 146.82 44.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.481 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 20.9 tptm -67.26 -44.2 79.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 109.355 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . -141.76 38.4 1.5 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 93.0 m-20 61.76 46.83 6.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -1.12 . . . . 0.0 109.474 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 9.3 p -49.51 -22.61 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 81.2 tt0 64.85 134.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.53 171.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.597 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.512 ' HB3' ' CG ' ' A' ' 133' ' ' HIS . 46.1 tttp -81.19 125.04 29.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -52.6 -42.59 64.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 130' ' ' LYS . 65.9 m170 -66.9 -42.35 85.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.452 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.53 -46.65 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.421 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -55.86 -43.18 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.445 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.42 -42.69 78.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.41 -40.99 98.36 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -58.71 -48.62 80.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -1.169 . . . . 0.0 109.348 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' O ' ' CD2' ' A' ' 143' ' ' HIS . 94.4 mt-10 -61.28 -41.4 96.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 20.0 tttt -57.69 -45.36 85.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.73 -47.0 88.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 109.361 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.84 95.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.895 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 139' ' ' GLU . 76.3 m-70 -58.94 -43.94 91.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 47.6 mt -56.94 -49.07 76.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 148' ' ' ILE . 65.7 m-85 -53.13 -43.92 67.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -58.97 -41.05 86.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.353 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 151' ' ' TYR . 52.4 mt -64.22 -40.05 95.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.897 . . . . 0.0 109.364 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 145' ' ' PHE . 63.8 mt -55.51 -53.18 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.157 -0.965 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.981 ' OE1' HD12 ' A' ' 14' ' ' ILE . 73.1 mm-40 -54.38 -40.21 67.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.176 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.79 -26.03 59.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.656 ' CG ' HD11 ' A' ' 30' ' ' LEU . 60.0 t80 -60.82 -45.99 92.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -1.126 . . . . 0.0 109.307 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp -74.26 -46.86 38.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.3 -0.875 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -53.33 -42.22 66.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -76.38 -33.31 58.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.238 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -118.93 88.94 37.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.249 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.06 150.23 66.08 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.651 2.234 . . . . 0.0 111.881 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.5 t -88.94 140.41 29.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.379 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -112.73 160.58 17.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 109.592 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -111.7 138.16 48.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.351 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.453 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 122' ' ' HIS . 80.9 t -119.58 134.53 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 109.554 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.21 140.9 48.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.269 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.5 m -105.25 131.73 52.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -0.946 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 97.5 m-85 -124.47 138.82 54.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.378 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.61 136.15 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -117.39 135.58 53.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.41 124.25 51.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.503 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 11' ' ' THR . 80.6 t80 -146.17 141.7 27.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.528 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.57 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 19.2 p -107.93 151.29 25.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 149' ' ' GLU . 21.7 t -151.38 154.38 36.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.629 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 10.8 t0 -66.31 -175.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 mm 72.44 141.67 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 109.356 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 48.1 Cg_endo -69.55 146.24 60.89 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.481 2.12 . . . . 0.0 112.027 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -42.96 -49.33 14.22 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 111.595 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.7 Cg_endo -64.5 -50.33 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.145 1.897 . . . . 0.0 113.169 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 67.6 mttt -61.46 -30.35 70.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 109.583 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 148' ' ' ILE . 22.6 tp -80.61 -33.71 35.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.685 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.72 ' HD1' HD23 ' A' ' 105' ' ' LEU . 83.0 t80 -61.7 -41.39 97.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.884 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.5 mttt -65.22 -55.14 20.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.47 -11.0 60.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.761 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.909 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 72.8 t80 -87.61 -33.43 18.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.1 m -115.75 -40.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.826 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' N ' HG23 ' A' ' 24' ' ' VAL . 20.7 tp -71.39 -34.33 70.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.016 . . . . 0.0 109.435 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 76.7 m-20 -108.04 11.46 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.83 -40.19 76.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.633 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -57.5 -32.82 67.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.2 m120 -102.27 -36.36 8.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 148' ' ' ILE . 42.6 tp -72.75 -34.52 67.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.584 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 27' ' ' ALA . 27.3 mt -53.69 -55.61 33.61 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -68.9 -17.54 41.49 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -72.52 -39.3 67.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.717 HD12 HD11 ' A' ' 144' ' ' LEU . 87.1 mt -72.25 -32.63 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.88 72.53 16.87 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -69.96 -31.97 18.61 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.69 2.26 . . . . 0.0 111.799 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -71.17 -26.26 62.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.33 -48.27 76.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.4 m -128.39 157.53 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -73.53 -42.69 61.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p 177.61 135.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -0.87 . . . . 0.0 109.463 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.54 119.0 27.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.27 147.98 40.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 50.2 mt -106.08 121.12 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 23.4 tp -65.55 -43.71 89.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 53' ' ' THR . 93.5 mt-10 -159.22 155.81 27.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.33 -40.93 2.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.0 m-20 60.7 40.05 16.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.222 -1.164 . . . . 0.0 109.58 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 53' ' ' THR . . . 84.24 35.21 15.32 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.86 -166.56 13.07 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.73 129.64 17.98 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.758 2.305 . . . . 0.0 111.69 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.96 77.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.0 m -80.02 143.82 33.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -1.129 . . . . 0.0 109.58 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.94 127.98 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' CE ' HD11 ' A' ' 72' ' ' ILE . 56.9 mttt -112.44 152.76 28.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 19.1 tttt -134.62 126.61 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 70' ' ' HIS . 53.1 mt -116.26 139.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -115.86 129.0 56.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.437 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 68' ' ' VAL . 82.9 m-85 -99.08 136.63 38.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.4 57.43 0.49 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.21 -34.07 68.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -1.172 . . . . 0.0 109.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 64' ' ' HIS . . . 118.51 119.99 2.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.6 m 45.68 25.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -1.197 . . . . 0.0 109.601 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 62' ' ' GLY . 73.7 m-70 -132.32 160.98 34.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -117.61 143.36 46.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 174.15 137.87 2.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.426 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 41.1 p90 -157.0 144.53 18.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -1.209 . . . . 0.0 109.752 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.009 ' CG1' HD11 ' A' ' 86' ' ' LEU . 59.2 t -119.43 144.71 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.274 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.9 mttm -121.44 138.29 54.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.562 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.78 ' CE1' HD13 ' A' ' 86' ' ' LEU . 93.5 m-70 -112.12 135.76 52.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.2 139.1 49.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 47.3 mt -104.62 132.03 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -89.13 -47.69 7.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.2 t -169.79 153.79 5.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.6 pt -128.87 144.1 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -124.91 92.83 3.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -63.13 -35.25 79.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.92 -40.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -87.93 4.63 44.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 m80 47.74 38.36 8.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.482 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -120.74 138.14 54.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 78.0 t80 -125.7 127.77 46.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -118.97 134.01 55.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.676 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 28.2 p90 -157.47 170.07 23.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.205 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 100' ' ' ASP . 92.9 p -149.0 156.8 42.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 0.0 109.9 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.009 HD11 ' CG1' ' A' ' 68' ' ' VAL . 36.4 tp -91.25 110.86 22.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.201 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 88' ' ' GLU . 4.3 tt -74.93 -47.16 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 68' ' ' VAL . 97.5 mt-10 -142.3 167.16 22.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.891 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.919 ' HA2' HG22 ' A' ' 68' ' ' VAL . . . 172.96 146.55 5.47 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.461 ' OD2' ' HA3' ' A' ' 66' ' ' GLY . 55.6 m-20 -58.94 -27.55 65.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.86 51.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.883 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.3 mt -76.31 -33.18 59.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 108.867 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.4 m 55.12 -179.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.628 -0.67 . . . . 0.0 109.292 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.62 5.29 21.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.721 ' HB3' HG11 ' A' ' 127' ' ' VAL . 73.3 m-20 -97.88 -28.04 14.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.552 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 58.8 mt -104.87 137.87 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 75.4 mm-40 -83.87 -179.47 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.296 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 86' ' ' LEU . 22.7 pttm -57.26 164.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' LYS . 47.7 mt -124.62 133.94 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.778 . . . . 0.0 109.118 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 82.9 m-20 -90.42 126.18 35.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.875 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 93.4 m-85 -121.09 134.87 55.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.204 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -128.21 138.06 52.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.639 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.654 HG21 ' CE2' ' A' ' 23' ' ' PHE . 61.3 m -128.9 134.43 48.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.535 ' C ' HD22 ' A' ' 105' ' ' LEU . 46.5 tttt -132.61 133.08 43.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -102.83 123.46 46.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 48.2 t -129.02 141.86 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 0.3 OUTLIER -113.71 146.49 39.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.565 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.63 174.07 2.56 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 109.507 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.9 Cg_endo -69.3 -16.58 39.58 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.734 2.289 . . . . 0.0 111.807 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.35 -20.61 63.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.265 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.43 -22.07 25.18 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.26 176.53 54.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.501 HG21 ' HA ' ' A' ' 16' ' ' ALA . 80.1 m -125.21 126.01 44.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -1.158 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 65.5 mt -91.05 140.64 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 109.172 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 105' ' ' LEU . 55.3 mt -123.94 120.71 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -109.88 132.13 54.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 108.963 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.9 m -127.21 128.74 46.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -121.47 143.02 49.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 89.8 p -144.69 147.24 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 110.399 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 99' ' ' ILE . 51.6 mttp -122.03 144.11 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.751 ' O ' HG22 ' A' ' 3' ' ' VAL . 98.1 m-85 -112.11 124.32 52.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 110.065 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.801 ' HA ' HG22 ' A' ' 3' ' ' VAL . 78.9 m80 -99.91 129.25 45.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.131 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.1 p -122.89 160.67 25.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 109.685 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -71.32 -34.94 71.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASP . . . 176.29 47.76 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLY . 95.1 m-20 61.96 48.67 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -1.137 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 95' ' ' ASN . 91.6 t -54.7 -57.14 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -178.95 104.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 tt -138.73 171.79 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.239 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HE2' ' CD ' ' A' ' 132' ' ' GLU . 74.4 tttt -142.1 130.91 22.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.604 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -54.06 -41.48 68.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.399 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' CD ' ' HE2' ' A' ' 130' ' ' LYS . 95.2 mt-10 -59.83 -37.21 78.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.898 . . . . 0.0 109.487 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -66.09 -43.84 86.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 121' ' ' TYR . 50.5 t -64.01 -47.8 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -57.68 -42.36 83.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.5 72.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 109.297 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.08 -40.63 95.85 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 6' ' ' TYR . 48.2 mmtm -62.77 -41.75 99.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -1.108 . . . . 0.0 109.361 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.89 -40.49 95.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.4 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.56 -42.56 88.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 109.404 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.11 90.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.39 86.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.28 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.42 -46.71 83.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.45 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 78.7 m-85 -53.89 -38.42 64.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.54 -43.43 79.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.7 mm? -66.11 -42.44 89.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 30' ' ' LEU . 85.9 mt -60.95 -38.55 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 13' ' ' ASP . 65.8 tt0 -64.52 -37.3 87.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.26 -41.46 31.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 21.3 m-85 -65.18 -42.54 93.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 14' ' ' ILE . 60.8 mt -67.58 -31.66 71.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -66.71 -41.45 87.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 151' ' ' TYR . 42.7 p30 -99.5 7.82 45.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -60.92 131.92 91.83 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD2' ' ND1' ' A' ' 155' ' ' HIS . 49.1 Cg_endo -70.24 147.2 59.23 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.692 2.261 . . . . 0.0 111.774 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.3 m -64.6 156.07 31.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.0 -33.25 75.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -62.06 -33.64 74.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.525 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 122' ' ' HIS . 72.6 t -117.0 136.06 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 109.535 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.44 141.02 47.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.483 HG22 ' CG2' ' A' ' 118' ' ' THR . 23.6 m -93.44 143.78 25.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.226 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -124.7 138.99 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.727 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -115.27 131.81 56.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -119.8 133.3 55.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -105.54 125.41 50.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -136.41 133.3 36.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.4 p -100.9 143.32 31.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.254 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 43.7 p -141.11 171.63 13.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.653 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ILE . 67.0 m-20 -76.03 -175.99 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 18' ' ' LYS . 6.6 mm 62.85 138.36 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HG2' ' CB ' ' A' ' 18' ' ' LYS . 49.5 Cg_endo -70.15 150.16 65.46 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.592 2.194 . . . . 0.0 112.059 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -40.64 -52.25 6.4 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 111.129 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 43.0 Cg_endo -64.89 -49.13 3.15 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.276 1.984 . . . . 0.0 112.907 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HB3' HG22 ' A' ' 14' ' ' ILE . 13.4 ttmt -57.98 -38.03 75.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.93 -1.106 . . . . 0.0 109.572 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.971 HD11 HG22 ' A' ' 148' ' ' ILE . 20.8 tp -75.28 -39.09 60.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB2' HD12 ' A' ' 105' ' ' LEU . 71.2 t80 -55.45 -47.14 76.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.0 tttt -46.63 -44.15 18.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.937 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' ASP . . . -107.47 14.98 25.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.175 -0.953 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.809 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 92.4 t80 -96.22 -33.0 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 ' HD2' ' A' ' 23' ' ' PHE . 31.3 m -126.09 -39.88 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.811 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 25' ' ' LEU . 15.5 tp -57.32 -66.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.738 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 34.6 p30 -92.27 13.41 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.484 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.78 -35.0 76.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 44' ' ' ILE . 90.7 m-20 -59.23 -41.52 88.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -96.62 -29.22 13.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.634 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 30' ' ' LEU . 3.4 tm? -72.98 -38.9 66.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 27' ' ' ALA . 32.2 mt -52.25 -55.46 31.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.65 -17.5 42.82 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.41 2.073 . . . . 0.0 111.753 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 28.5 mttm -73.36 -37.06 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' HD13 ' A' ' 147' ' ' LEU . 88.6 mt -71.28 -27.76 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.15 69.23 16.04 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 48.3 Cg_endo -69.84 -29.71 23.07 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.58 2.187 . . . . 0.0 111.683 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -71.96 -28.1 63.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -49.28 44.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 57' ' ' ILE . 3.0 p -119.55 150.98 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.68 -51.78 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.584 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.72 136.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 0.0 109.436 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.81 129.27 38.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.88 148.95 42.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.573 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 54.4 mt -106.25 119.16 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 24.2 tp -64.32 -44.69 90.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.943 ' O ' HG23 ' A' ' 53' ' ' THR . 93.9 mt-10 -159.47 155.35 26.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.72 -39.75 2.69 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 88.9 m-20 61.74 41.05 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.821 ' H ' HG21 ' A' ' 53' ' ' THR . . . 82.59 36.75 15.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.83 -165.4 12.71 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.56 130.55 19.78 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.726 2.284 . . . . 0.0 111.797 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.46 25.28 75.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 46' ' ' GLU . 99.0 m -80.7 145.91 31.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 53' ' ' THR . 26.2 mm -115.47 132.29 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 mtmp? -128.98 148.39 50.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.493 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.03 125.31 44.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.283 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.634 ' CG2' HG21 ' A' ' 39' ' ' VAL . 11.3 mt -115.41 134.91 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.671 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 39' ' ' VAL . 19.5 p -115.55 142.15 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -117.74 140.92 49.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.95 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.21 -165.22 53.11 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.79 171.24 7.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.0 109.4 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.12 -35.24 8.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.3 m -54.74 -37.09 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.527 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -99.06 152.94 19.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.35 144.38 41.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.372 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 146.69 109.69 0.59 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 39.4 p90 -144.21 148.05 34.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -1.176 . . . . 0.0 109.384 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.948 HG22 ' CA ' ' A' ' 89' ' ' GLY . 38.2 t -124.98 145.39 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -113.73 142.86 45.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.581 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 67.8 m170 -116.73 133.42 56.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -115.16 137.67 51.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 56.5 mt -101.89 134.65 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 92.6 m-70 -91.17 -46.85 7.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.4 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 t -173.53 147.66 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.51 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 82' ' ' TYR . 29.0 pt -123.57 144.86 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 91.6 m-20 -121.58 91.9 3.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.416 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -63.31 -36.89 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.55 -41.82 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 1.18 56.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.2 m80 54.32 42.34 31.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.994 . . . . 0.0 109.406 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 40.2 m -118.17 142.51 47.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.535 ' CD1' HG22 ' A' ' 75' ' ' ILE . 65.2 t80 -134.73 123.76 24.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.5 m -117.55 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.596 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 31.4 p90 -150.87 172.94 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -149.41 155.46 40.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 92' ' ' LEU . 3.0 tt -97.17 118.74 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.966 HG22 ' HG3' ' A' ' 88' ' ' GLU . 87.6 mt -75.46 -56.88 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 109.627 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.966 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.6 mt-10 -149.09 160.43 43.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.948 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -165.46 152.8 22.44 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -58.17 -24.22 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -1.101 . . . . 0.0 109.324 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.48 -27.43 25.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 96' ' ' ILE . 2.0 mt -76.63 -32.81 58.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.839 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 92' ' ' LEU . 30.2 t 47.77 -174.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 124' ' ' LYS . 97.5 mt-10 -76.37 -6.49 51.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -0.994 . . . . 0.0 109.461 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.887 ' HB3' HG21 ' A' ' 127' ' ' VAL . 89.0 m-20 -83.1 -38.91 21.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.85 . . . . 0.0 109.83 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 92' ' ' LEU . 34.6 mt -91.7 135.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.817 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . 38.3 mt-10 -90.14 -179.26 5.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.872 ' HE2' HG23 ' A' ' 87' ' ' ILE . 70.1 mttt -57.04 158.5 4.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.563 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 120' ' ' LYS . 60.4 mt -125.21 131.39 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' LYS . 88.2 m-20 -88.65 124.0 33.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.596 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 75.6 m-85 -115.51 142.24 46.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.671 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -131.93 134.81 46.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.349 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.489 HG21 ' CE2' ' A' ' 23' ' ' PHE . 50.3 m -128.64 138.53 52.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -140.71 127.56 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.274 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 20' ' ' PHE . 37.9 mt -96.49 128.56 43.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.691 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 113' ' ' THR . 46.8 t -132.0 140.86 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.56 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 98.5 p -113.72 144.41 42.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -110.67 166.21 11.2 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 109.525 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.693 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 50.0 Cg_endo -70.32 -11.48 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.686 2.257 . . . . 0.0 111.706 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -76.41 -16.81 59.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.33 -24.4 18.2 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.16 54.53 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 15' ' ' PRO . 92.1 m -123.65 122.15 37.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -1.185 . . . . 0.0 109.707 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 106' ' ' VAL . 61.0 mt -87.72 144.31 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.061 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.462 HG23 HD23 ' A' ' 105' ' ' LEU . 56.8 mt -131.14 117.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.871 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -97.81 131.98 43.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 108.943 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.8 m -128.91 121.59 28.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 110.007 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' HG22 ' A' ' 5' ' ' THR . 32.3 m -114.67 141.09 48.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 108.85 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -138.58 156.71 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 110.329 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.66 ' O ' HG23 ' A' ' 99' ' ' ILE . 71.1 tttt -147.57 142.64 27.07 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CB ' HG12 ' A' ' 99' ' ' ILE . 26.6 p90 -135.99 148.55 48.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 109.916 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 97' ' ' GLU . 93.9 m-70 -104.48 172.71 6.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 109.517 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 124' ' ' LYS . 26.7 p -125.7 151.01 47.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.175 -0.953 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 95' ' ' ASN . 14.5 tttt -44.21 -54.68 5.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.268 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.16 -43.19 0.14 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 59.2 p30 -133.23 6.78 3.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.371 -1.076 . . . . 0.0 109.373 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.887 HG21 ' HB3' ' A' ' 95' ' ' ASN . 14.6 p -76.02 122.34 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -104.34 144.93 30.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.4 tt -124.99 171.15 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -98.5 121.35 40.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.14 -39.7 44.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 72.6 mm-40 -57.03 -37.75 72.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.35 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -67.27 -41.75 85.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.35 -42.97 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.513 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -55.53 -36.66 66.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.515 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.2 -45.68 83.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.01 -39.14 93.88 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -59.74 -40.65 88.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -1.176 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -62.47 -39.21 92.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -59.48 -43.74 93.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.392 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.29 83.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.77 -31.06 70.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -71.46 -37.62 71.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.448 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 144' ' ' LEU . 49.5 mt -67.59 -44.31 78.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.845 . . . . 0.0 109.363 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 27.3 m-85 -54.38 -44.91 72.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 23.3 mttm -57.48 -36.3 71.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.455 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD13 ' CG2' ' A' ' 34' ' ' ILE . 57.7 mt -66.02 -38.85 89.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.971 HG22 HD11 ' A' ' 19' ' ' LEU . 34.4 mm -56.42 -56.5 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.226 -0.921 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 145' ' ' PHE . 19.5 mp0 -56.53 -36.52 69.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 109.36 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.77 -27.66 62.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.498 ' CE1' HD21 ' A' ' 30' ' ' LEU . 72.8 t80 -63.7 -41.72 98.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -1.068 . . . . 0.0 109.411 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.1 mp -75.72 -46.81 29.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -53.77 -33.99 57.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.002 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -81.74 -32.14 31.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 109.039 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.89 75.53 57.32 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.64 -16.83 38.27 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.742 2.294 . . . . 0.0 111.706 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.514 ' O ' ' ND2' ' A' ' 160' ' ' ASN . 91.5 p -61.14 -20.37 62.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.0 109.377 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -62.13 -35.0 77.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.5 ' CD1' ' CE ' ' A' ' 18' ' ' LYS . 78.0 t80 -55.68 -38.73 70.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.543 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 157' ' ' SER . 19.1 m120 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.432 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 121' ' ' TYR . 78.1 t -121.76 134.17 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -1.129 . . . . 0.0 109.522 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.5 136.36 52.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 118' ' ' THR . 48.3 m -95.51 136.74 35.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CG ' ' HE2' ' A' ' 138' ' ' LYS . 98.4 m-85 -119.49 134.78 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.57 137.29 47.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.443 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 37.1 t-20 -113.54 149.88 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -133.4 134.12 43.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.562 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 11' ' ' THR . 64.6 t80 -161.79 131.71 4.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.502 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.567 ' O ' ' CE2' ' A' ' 10' ' ' PHE . 15.1 p -98.25 157.39 16.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -157.52 177.01 11.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.569 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.4 t0 -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.851 HD13 HD12 ' A' ' 152' ' ' LEU . 1.1 mp 64.06 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 109.379 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HD2' ' A' ' 18' ' ' LYS . 48.8 Cg_endo -70.41 147.46 58.7 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.628 2.219 . . . . 0.0 112.116 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -38.21 -51.55 3.27 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 111.129 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 40.9 Cg_endo -63.63 -50.62 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.339 2.026 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 41.5 mttm -58.6 -37.53 76.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 109.59 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 152' ' ' LEU . 30.5 tp -80.79 -30.03 36.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.771 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.783 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 65.6 t80 -65.2 -32.86 74.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 109.77 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 9.7 mtpm? -64.16 -50.12 69.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.864 . . . . 0.0 109.609 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . . . -79.46 -16.47 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 103' ' ' THR . 49.8 t80 -86.1 -13.44 47.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.783 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 86.4 t -123.8 -58.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.1 mp -65.5 -39.92 92.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 42.3 m-20 -98.09 12.56 34.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -40.75 76.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' OD2' HD11 ' A' ' 44' ' ' ILE . 88.6 m-20 -63.33 -35.23 79.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 29.2 t-20 -93.72 -33.91 13.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 31.9 tp -72.86 -44.97 60.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 27' ' ' ALA . 26.0 mt -45.59 -55.91 11.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.5 Cg_endo -69.18 -26.36 30.38 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 111.801 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 31.2 tttm -71.57 -38.94 70.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.655 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 30' ' ' LEU . 63.8 mt -64.26 -24.27 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.0 109.578 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -159.08 73.2 3.51 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 50.2 Cg_endo -70.16 -30.61 20.17 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.664 2.243 . . . . 0.0 111.875 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -74.1 -21.13 60.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -73.04 -42.02 63.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG12 ' CE2' ' A' ' 59' ' ' PHE . 17.9 m -126.36 152.49 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.53 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.84 -43.43 62.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 177.57 129.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.54 125.13 31.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.37 150.91 40.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG2' ' CG2' ' A' ' 53' ' ' THR . 56.4 mt -106.59 118.27 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 20.9 tp -62.61 -44.9 95.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.517 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 53' ' ' THR . 94.2 mt-10 -159.87 155.48 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.78 -41.14 2.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.2 m-20 60.11 37.74 20.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.156 . . . . 0.0 109.471 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.739 ' H ' HG21 ' A' ' 53' ' ' THR . . . 88.03 34.92 9.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -120.98 -167.17 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.89 129.22 17.09 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.679 2.253 . . . . 0.0 111.77 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.5 22.44 78.54 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -77.03 144.47 38.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.485 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.54 HG23 ' CD1' ' A' ' 87' ' ' ILE . 65.9 mt -115.39 127.44 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 87.0 mttt -115.92 150.86 36.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 ttpp -132.91 122.44 24.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.445 HD11 ' CE1' ' A' ' 70' ' ' HIS . 31.7 mt -113.3 135.06 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.2 m -118.14 131.83 56.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CE2' HG12 ' A' ' 39' ' ' VAL . 13.5 m-85 -99.77 128.93 45.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.62 -177.99 42.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -126.97 130.65 50.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -1.176 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.46 66.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.3 p -123.52 145.46 48.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -1.17 . . . . 0.0 109.423 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -108.35 3.69 23.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -117.25 157.04 26.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.433 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' OD2' ' A' ' 90' ' ' ASP . . . 76.65 60.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 39.0 p90 -140.35 144.07 36.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG11 HD11 ' A' ' 86' ' ' LEU . 25.5 t -131.26 155.15 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.56 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 56' ' ' LYS . 45.1 mtmt -124.27 154.3 40.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.445 ' CE1' HD11 ' A' ' 57' ' ' ILE . 61.2 m170 -123.31 150.14 43.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HB2' HG13 ' A' ' 87' ' ' ILE . 57.9 tttt -132.86 138.15 46.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 82' ' ' TYR . 31.1 mt -104.32 124.04 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.519 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 98.4 m-70 -89.0 -27.39 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 59.7 p 178.9 153.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.69 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -136.0 142.53 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.343 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.4 m-20 -123.51 94.58 4.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.51 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.26 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 -42.91 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.315 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -87.96 8.14 27.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 17' ' ' PRO . 48.2 m80 46.28 48.97 13.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.348 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 76' ' ' ASP . 31.0 m -126.27 136.1 52.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 68.8 t80 -129.98 123.79 31.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -124.52 135.77 53.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.761 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 101' ' ' TYR . 39.9 p90 -147.96 -177.14 5.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 88.8 p -151.41 150.83 30.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 87' ' ' ILE . 3.1 tt -87.5 119.52 27.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' A' ' 88' ' ' GLU . 97.4 mt -76.09 -63.23 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 87' ' ' ILE . 73.6 mm-40 -138.65 154.38 48.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.725 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.544 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -173.15 142.88 6.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 66' ' ' GLY . 6.0 m-20 -53.09 -32.56 47.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -20.17 61.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 86' ' ' LEU . 9.7 mp -85.18 -36.02 21.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 40.5 t 61.79 173.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 98.1 mt-10 -79.73 -7.11 58.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.403 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 53.1 m-20 -84.82 -39.71 18.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.631 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 29.8 mt -87.52 143.8 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 122' ' ' HIS . 92.8 mt-10 -91.37 -179.33 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 46.9 mtmt -56.86 160.86 3.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.96 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 120' ' ' LYS . 66.4 mt -120.91 136.65 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 119' ' ' SER . 88.9 m-20 -92.78 126.23 37.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 84' ' ' TYR . 80.4 m-85 -117.81 137.76 52.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 118' ' ' THR . 94.5 mt-10 -125.01 142.08 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 23' ' ' PHE . 25.9 m -129.86 136.09 49.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 109.334 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.528 ' C ' HD22 ' A' ' 105' ' ' LEU . 25.0 tttt -139.26 128.94 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.847 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.6 mm? -106.33 112.5 25.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.491 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 114' ' ' ILE . 9.4 t -130.57 128.47 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.9 p -114.78 154.22 28.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.957 . . . . 0.0 110.105 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -96.32 161.54 26.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.634 -0.666 . . . . 0.0 109.248 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.7 Cg_endo -68.5 92.21 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.375 2.05 . . . . 0.0 110.368 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 34.6 t60 78.93 17.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -112.19 12.83 26.35 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 82.95 -151.39 28.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 52.9 m -126.42 134.69 50.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.998 -1.295 . . . . 0.0 109.797 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 106' ' ' VAL . 49.8 mt -107.05 134.47 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.031 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.503 HG23 HD13 ' A' ' 105' ' ' LEU . 28.4 mt -116.57 116.83 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 29.2 mttp -105.89 130.55 53.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.968 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.3 m -124.63 130.66 52.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 109.966 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 36.3 m -126.02 139.23 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.433 -0.792 . . . . 0.0 108.997 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 94.8 p -143.47 152.16 41.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 99' ' ' ILE . 90.1 mttt -125.86 143.35 51.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.375 -0.828 . . . . 0.0 109.108 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CD1' HD13 ' A' ' 99' ' ' ILE . 82.7 m-85 -111.17 123.48 50.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.752 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 98.8 m-70 -95.16 136.79 35.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.241 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.497 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 21.6 p -129.28 152.65 48.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.938 . . . . 0.0 109.587 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' GLU . 76.2 mttt -61.65 -56.42 20.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -167.15 -69.98 0.03 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -116.46 39.05 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -1.18 . . . . 0.0 109.555 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 95' ' ' ASN . 13.5 m -44.31 -35.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 127' ' ' VAL . 85.1 tt0 60.17 119.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -137.33 171.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 133' ' ' HIS . 55.6 mttm -102.91 129.54 49.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -56.14 -34.15 65.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.3 -36.6 80.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.393 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 130' ' ' LYS . 35.9 m-70 -73.16 -37.14 66.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.66 -44.79 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.6 tttt -59.94 -40.13 87.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.846 . . . . 0.0 109.441 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.48 93.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.409 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.49 -49.09 76.99 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.572 ' HE2' ' CG ' ' A' ' 6' ' ' TYR . 30.3 mttt -63.96 -42.79 97.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.474 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.39 -41.82 88.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 50.1 tttp -53.89 -45.39 71.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.7 -47.71 71.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.569 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.67 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.49 ' O ' ' CD2' ' A' ' 147' ' ' LEU . 86.7 t60 -61.86 -44.66 96.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 81.4 mt -53.64 -46.87 70.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -53.42 -32.75 51.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -68.25 -34.55 76.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.955 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.2 mm? -71.82 -38.86 70.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 76.4 mt -60.02 -46.01 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -69.61 -34.09 73.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -67.64 -42.24 88.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 147' ' ' LEU . 27.1 m-85 -63.13 -46.17 88.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.851 HD12 HD13 ' A' ' 14' ' ' ILE . 67.8 mt -57.69 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -55.56 -43.1 75.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -58.65 -39.83 81.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.53 ' NE2' ' ND2' ' A' ' 160' ' ' ASN . 2.0 m170 -109.75 107.36 59.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.33 -19.31 33.59 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.646 2.231 . . . . 0.0 111.763 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 51.1 m -120.18 143.2 48.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.5 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.65 -36.25 78.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.421 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -119.89 143.58 47.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.475 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.53 ' ND2' ' NE2' ' A' ' 155' ' ' HIS . 42.7 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.449 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.941 HG11 ' O ' ' A' ' 121' ' ' TYR . 94.0 t -117.53 144.11 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.566 ' CE2' ' O ' ' A' ' 5' ' ' THR . 69.2 t80 -100.8 146.1 27.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.442 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.566 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 24.8 m -93.55 139.47 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.283 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.45 136.23 53.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.577 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -113.69 135.22 54.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.29 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 27.3 t30 -114.88 131.02 56.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 116' ' ' LYS . 90.3 mt-10 -113.99 132.91 55.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.164 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' A' ' 11' ' ' THR . 73.4 t80 -146.5 144.84 29.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.746 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.756 HG22 HG12 ' A' ' 114' ' ' ILE . 20.4 p -109.64 144.71 37.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -152.23 179.38 8.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.7 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 71.9 m-20 -80.62 -175.71 5.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 13' ' ' ASP . 2.6 mt 69.1 135.13 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 18' ' ' LYS . 51.0 Cg_endo -71.09 148.14 55.84 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 112.012 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 17' ' ' PRO . . . -39.41 -51.46 4.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.557 -0.714 . . . . 0.0 111.311 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 16' ' ' ALA . 42.5 Cg_endo -64.28 -50.32 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.338 2.025 . . . . 0.0 113.072 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CG ' ' HG2' ' A' ' 15' ' ' PRO . 30.9 mttt -59.33 -36.16 75.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.94 -1.1 . . . . 0.0 109.505 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.6 tp -80.78 -27.08 36.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 24' ' ' VAL . 73.8 t80 -68.93 -38.28 79.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.959 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 60.7 tttt -66.01 -45.07 82.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -29.63 44.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.642 ' HD2' HD13 ' A' ' 148' ' ' ILE . 56.7 t80 -80.88 -10.95 59.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 20' ' ' PHE . 97.8 t -121.9 -55.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.531 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 16.5 tp -69.57 -36.7 76.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 73.7 m-20 -102.99 15.77 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.783 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -70.2 -40.34 74.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.768 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.656 ' OD2' HD11 ' A' ' 44' ' ' ILE . 87.8 m-20 -66.35 -24.74 66.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.067 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.4 m120 -105.69 -43.22 4.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.967 . . . . 0.0 109.629 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 18.3 tp -59.91 -36.06 76.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 27' ' ' ALA . 22.4 mt -54.16 -60.1 8.35 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -67.99 -14.0 39.85 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.614 2.209 . . . . 0.0 111.801 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD3' ' OH ' ' A' ' 151' ' ' TYR . 75.8 mttt -75.07 -40.7 59.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.2 mt -73.84 -31.28 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.21 67.12 14.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.498 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' VAL . 50.0 Cg_endo -70.11 -31.81 18.29 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.664 2.242 . . . . 0.0 111.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -70.96 -26.02 62.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 59' ' ' PHE . . . -70.78 -43.65 68.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.935 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 57' ' ' ILE . 5.6 p -116.36 146.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -73.74 -46.06 48.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 177.47 136.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.68 130.84 44.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.856 . . . . 0.0 109.381 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -125.43 151.63 45.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.656 HD11 ' OD2' ' A' ' 28' ' ' ASP . 62.6 mt -105.96 123.41 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.478 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.5 mp -69.22 -43.11 74.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 109.495 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 53' ' ' THR . 93.1 mt-10 -158.99 158.79 33.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.479 ' HA3' ' OG1' ' A' ' 53' ' ' THR . . . 103.68 -41.15 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 90.4 m-20 59.35 39.71 21.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -1.113 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.848 ' H ' HG21 ' A' ' 53' ' ' THR . . . 81.51 34.2 26.11 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' C ' ' HG1' ' A' ' 53' ' ' THR . . . -121.9 -165.39 12.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.01 127.65 14.69 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.664 2.242 . . . . 0.0 111.691 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.5 24.85 69.36 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 46' ' ' GLU . 60.3 m -81.19 140.96 34.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -1.145 . . . . 0.0 109.523 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.14 133.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.265 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.594 ' CE ' HD11 ' A' ' 72' ' ' ILE . 46.7 mttt -121.52 148.06 44.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.688 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 85.8 tttt -130.52 124.49 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.241 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 39' ' ' VAL . 22.3 mt -118.41 133.17 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -118.76 123.2 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.866 . . . . 0.0 109.35 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 41.6 p90 -123.48 138.73 54.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.71 133.34 3.0 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.39 -34.95 78.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -1.102 . . . . 0.0 109.448 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.29 -39.47 0.71 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -57.38 -40.41 78.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.526 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -111.31 154.99 23.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.81 142.56 48.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.933 . . . . 0.0 109.57 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' ' OD2' ' A' ' 90' ' ' ASP . . . -177.84 136.59 3.08 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 42.3 p90 -155.96 144.19 19.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -1.228 . . . . 0.0 110.031 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 86' ' ' LEU . 43.3 t -121.81 150.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.435 -0.79 . . . . 0.0 109.047 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 34.6 mttt -118.12 140.67 49.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.703 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.478 ' CE1' HD12 ' A' ' 57' ' ' ILE . 80.8 m80 -120.2 131.15 54.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 87' ' ' ILE . 20.6 tttp -111.4 141.72 44.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CE ' ' A' ' 55' ' ' LYS . 60.0 mt -100.48 132.18 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.44 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 85' ' ' SER . 94.8 m-70 -91.05 -49.25 6.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.535 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.1 t -166.32 147.81 6.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.55 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.91 144.78 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -124.34 91.58 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -62.53 -35.31 79.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.49 -40.56 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.37 8.74 26.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.8 m80 45.86 44.79 11.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.8 m -125.78 136.59 53.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 109.432 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 72' ' ' ILE . 72.0 t80 -127.8 127.17 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.459 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -119.45 135.68 54.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 101' ' ' TYR . 40.5 p90 -151.97 168.77 24.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.401 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.467 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 84.4 p -145.52 156.04 43.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.914 HD22 ' CD2' ' A' ' 92' ' ' LEU . 5.2 tt -92.57 124.93 36.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.443 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.839 HG22 ' HG3' ' A' ' 88' ' ' GLU . 27.1 mm -79.45 -66.34 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.839 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.7 mt-10 -139.24 160.64 39.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.703 ' CA ' HG22 ' A' ' 68' ' ' VAL . . . -176.41 157.54 23.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' OD2' ' CA ' ' A' ' 66' ' ' GLY . 62.4 m-20 -61.16 -27.08 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.181 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -32.06 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.914 ' CD2' HD22 ' A' ' 86' ' ' LEU . 6.7 mp -75.23 -48.78 21.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.9 m 61.34 170.6 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.267 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -72.56 -5.66 38.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.4 ' O ' HG11 ' A' ' 127' ' ' VAL . 86.1 m-20 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.607 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 92' ' ' LEU . 46.6 mt -98.24 151.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' HIS . 90.2 mt-10 -94.81 -179.98 5.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.455 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 87' ' ' ILE . 32.4 mmtm -57.37 159.57 4.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.489 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 120' ' ' LYS . 54.8 mt -120.72 136.5 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 120' ' ' LYS . 59.7 t0 -98.66 125.1 43.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 84' ' ' TYR . 88.6 m-85 -116.9 142.74 46.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -133.0 138.42 46.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.7 m -130.52 137.71 49.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 105' ' ' LEU . 22.7 tttt -138.98 131.64 28.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.348 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.9 mm? -103.73 115.72 31.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 109.562 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 114' ' ' ILE . 4.3 t -131.88 131.97 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 63.1 p -114.69 154.57 28.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.057 -1.027 . . . . 0.0 110.194 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -99.62 162.15 22.13 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.565 -0.71 . . . . 0.0 109.316 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 45.6 Cg_endo -68.92 95.0 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.369 2.046 . . . . 0.0 110.472 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 26.3 m-70 78.28 11.48 1.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 108' ' ' ALA . . . -105.58 9.09 44.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 107' ' ' SER . . . 83.45 -146.89 23.9 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 107' ' ' SER . 90.6 m -126.73 133.95 50.76 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.118 -1.225 . . . . 0.0 109.659 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.756 HG12 HG22 ' A' ' 11' ' ' THR . 61.2 mt -108.65 130.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.2 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 ' CD1' ' A' ' 105' ' ' LEU . 5.2 mt -109.28 117.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.725 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 9' ' ' GLU . 42.7 mttp -105.15 129.23 53.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.083 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.4 m -128.15 129.6 46.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 109.868 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 5' ' ' THR . 51.4 m -111.3 139.64 46.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.159 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -128.56 135.95 50.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.116 -0.99 . . . . 0.0 109.881 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 99' ' ' ILE . 35.7 tttm -139.13 139.15 37.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -0.819 . . . . 0.0 109.109 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.941 ' O ' HG11 ' A' ' 3' ' ' VAL . 36.5 p90 -134.08 151.26 51.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.08 -1.012 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.9 m80 -109.06 154.79 21.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.498 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 80.5 p -102.99 142.67 33.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.546 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 11.5 tptt -56.42 -45.88 80.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 109.558 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.17 -53.49 0.14 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 83.5 m-20 -116.37 -6.77 11.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -1.181 . . . . 0.0 109.563 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 127' ' ' VAL . 14.5 p -55.84 125.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 94.9 mt-10 -118.31 151.09 38.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.939 . . . . 0.0 109.389 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.94 171.64 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' HD2' ' CE1' ' A' ' 133' ' ' HIS . 87.3 mttt -108.28 133.08 53.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.63 -36.18 69.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.16 -35.99 78.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.503 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.548 ' CE1' ' HD2' ' A' ' 130' ' ' LYS . 63.1 m170 -70.86 -39.83 72.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -66.76 -41.68 88.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -58.8 -38.13 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.135 -0.978 . . . . 0.0 109.414 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.81 97.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.24 -36.22 92.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 48.4 mtpt -64.01 -42.63 97.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -1.114 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.56 -41.75 96.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.536 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' O ' HD23 ' A' ' 144' ' ' LEU . 54.1 tttp -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.04 -46.83 84.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.501 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.69 -30.76 71.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 65.5 m170 -69.5 -35.27 75.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 140' ' ' LYS . 4.0 mm? -69.91 -42.57 73.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLU . 54.7 m-85 -54.26 -46.19 72.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.484 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.405 ' HA ' ' OE1' ' A' ' 149' ' ' GLU . 84.7 tttt -60.67 -34.56 74.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 143' ' ' HIS . 41.8 mt -65.26 -38.32 89.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 23' ' ' PHE . 83.4 mt -54.19 -56.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 109.425 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 12' ' ' SER . 30.8 mp0 -55.67 -44.05 76.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.1 -26.23 72.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.48 ' OH ' ' HD3' ' A' ' 33' ' ' LYS . 64.0 t80 -70.37 -41.38 73.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -1.103 . . . . 0.0 109.387 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.7 mp -74.15 -44.82 52.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.374 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -53.61 -35.8 61.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 155' ' ' HIS . 19.9 t70 -81.55 -32.49 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 0.0 109.206 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 154' ' ' ASP . 0.7 OUTLIER 43.95 65.09 6.21 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.566 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.26 -19.54 33.62 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.689 2.26 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 95.6 p -67.35 -30.16 69.9 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -56.96 -33.82 67.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.508 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -58.99 -38.96 80.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 34.9 t30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.406 179.997 . . . . . . . . 0 0 . 1 stop_ save_